data_2kno_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kno _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.0 p . . . . . 0 N--CA 1.446 -0.666 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.1 p -58.2 -45.0 88.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -174.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -13.25 62.11 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -74.48 -35.74 63.28 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.154 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.474 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 41.3 p-90 -110.36 -26.7 9.42 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 114.058 1.132 . . . . 0.0 114.058 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -90.81 113.32 25.44 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.316 0.579 . . . . 0.0 111.656 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.66 93.89 4.21 Favored Pre-proline 0 C--N 1.299 -1.627 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.846 174.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.43 -0.09 10.04 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 123.58 2.853 . . . . 0.0 114.334 -172.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -94.93 -1.54 52.35 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.088 0.471 . . . . 0.0 111.752 -173.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.524 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 73.3 mt -94.86 145.88 24.6 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.309 0.576 . . . . 0.0 111.746 -178.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.478 ' HA ' ' NH1' ' A' ' 47' ' ' ARG . 23.1 t -100.74 177.23 5.05 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.1 ttt180 -52.99 -53.4 50.57 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.654 0.782 . . . . 0.0 112.585 -173.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -64.0 -32.47 74.02 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.981 0.419 . . . . 0.0 111.411 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.414 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 15.7 mm-40 -73.03 -34.57 66.42 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.822 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.05 -44.94 83.13 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.414 0.626 . . . . 0.0 109.619 178.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.8 mt -63.93 -36.39 76.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.425 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.19 -36.04 72.49 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.481 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.458 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 4.4 mm? -75.78 -47.84 24.19 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.278 174.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.3 mt -66.42 -21.54 66.22 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -174.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -74.25 -5.24 40.89 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.417 0.627 . . . . 0.0 111.47 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -112.57 5.46 17.89 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.458 ' HG2' ' O ' ' A' ' 35' ' ' LEU . 31.3 mmmt -110.98 145.17 38.88 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.385 0.612 . . . . 0.0 110.992 -177.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -76.74 141.57 68.82 Favored Pre-proline 0 C--N 1.301 -1.531 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.221 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -47.64 118.9 3.28 Favored 'Trans proline' 0 C--N 1.364 1.375 0 C-N-CA 123.938 3.092 . . . . 0.0 113.467 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.24 -30.51 3.47 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.39 151.89 39.62 Favored 'General case' 0 C--O 1.253 1.239 0 CA-C-O 120.717 0.294 . . . . 0.0 110.54 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -147.32 175.9 10.42 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.671 -176.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -149.59 147.37 28.06 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 170.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.474 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 62.4 mt -112.19 122.21 66.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.524 ' HD2' ' O ' ' A' ' 27' ' ' LEU . 28.5 ptt85 -121.09 -173.94 2.72 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -95.22 153.51 17.63 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.5 t -97.39 132.35 43.19 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.95 0.881 . . . . 0.0 111.131 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -85.3 -14.79 45.45 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.803 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.7 m -78.53 -51.74 9.51 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.195 -175.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -128.98 144.22 51.12 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -73.76 132.93 43.14 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.01 31.65 25.55 Favored Glycine 0 N--CA 1.436 -1.367 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.146 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.0 145.97 49.98 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -113.72 134.47 54.73 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.83 118.02 5.15 Favored Glycine 0 N--CA 1.421 -2.356 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.042 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -96.69 118.29 32.84 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.98 119.75 40.3 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.0 tp -121.37 131.56 54.26 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.473 -176.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -88.81 113.99 24.96 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 175.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.468 HG21 ' O ' ' A' ' 80' ' ' LEU . 26.1 m -102.26 169.52 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.999 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.64 -57.6 4.0 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.87 118.81 2.15 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.134 0.974 . . . . 0.0 110.697 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.615 ' N ' ' HD3' ' A' ' 66' ' ' PRO . 21.5 Cg_endo -99.42 12.31 0.64 Allowed 'Trans proline' 0 CA--C 1.601 3.847 0 C-N-CA 122.84 2.36 . . . . 0.0 118.037 178.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.615 ' HD3' ' N ' ' A' ' 65' ' ' PRO . 2.0 Cg_endo -93.58 164.92 2.31 Favored 'Trans proline' 0 C--N 1.384 2.407 0 CA-C-N 123.051 2.125 . . . . 0.0 111.218 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -74.03 -22.16 17.43 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 121.861 1.707 . . . . 0.0 111.782 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.1 p -134.45 -43.2 0.77 Allowed 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.392 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 75.84 3.76 3.83 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.026 1.33 . . . . 0.0 112.982 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.42 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 34.9 tt0 -86.68 -52.44 0.43 Allowed Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 172.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.42 ' HD3' ' HB3' ' A' ' 70' ' ' GLN . 7.3 Cg_exo -76.02 107.09 2.39 Favored 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 121.317 1.344 . . . . 0.0 108.708 171.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 59.6 t-105 -117.56 135.42 53.97 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.934 -177.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -158.15 81.7 0.85 Allowed 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 114.616 -1.174 . . . . 0.0 108.609 174.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -169.94 -178.55 41.02 Favored Glycine 0 C--N 1.268 -3.208 0 CA-C-N 113.734 -1.575 . . . . 0.0 110.28 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -89.8 115.87 64.95 Favored Pre-proline 0 C--N 1.294 -1.829 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.545 ' O ' ' HG ' ' A' ' 80' ' ' LEU . 47.5 Cg_exo -32.47 -78.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 125.098 3.865 . . . . 0.0 117.048 -172.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -73.31 -30.08 29.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -174.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -71.23 -26.77 63.07 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.83 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.439 ' O ' ' HG3' ' A' ' 65' ' ' PRO . 4.9 tp60 -88.01 -18.06 29.82 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 121.139 0.495 . . . . 0.0 110.225 177.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 76' ' ' PRO . 91.1 mt -80.99 -12.01 59.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.482 0.658 . . . . 0.0 109.26 174.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.8 t -96.13 118.99 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -103.17 142.32 34.36 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.768 -177.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -123.36 122.08 37.41 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.387 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -126.72 170.09 12.49 Favored 'General case' 0 C--N 1.273 -2.728 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -135.86 135.38 39.73 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 118.767 -1.173 . . . . 0.0 112.119 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.591 ' CG2' ' HB ' ' A' ' 93' ' ' VAL . 59.5 mt -94.24 110.78 24.14 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 CA-C-N 114.014 -1.448 . . . . 0.0 107.408 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -105.57 121.22 43.52 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.831 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.498 ' HB ' ' CG1' ' A' ' 93' ' ' VAL . 1.4 t -94.95 118.68 32.21 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.691 0.758 . . . . 0.0 110.36 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -106.43 -157.99 21.74 Favored Glycine 0 N--CA 1.427 -1.946 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -66.4 -26.7 47.78 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.964 1.776 . . . . 0.0 110.528 176.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -73.74 -73.34 0.22 Allowed 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.167 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 179.02 -151.22 10.07 Favored Glycine 0 N--CA 1.423 -2.191 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.591 ' HB ' ' CG2' ' A' ' 86' ' ' ILE . 35.7 m -103.71 145.9 12.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 O-C-N 123.739 0.317 . . . . 0.0 110.865 -176.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.75 155.8 30.49 Favored 'General case' 0 C--O 1.259 1.565 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 176.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.503 HG12 HG12 ' A' ' 86' ' ' ILE . 59.4 mt -94.39 114.12 30.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.429 0.633 . . . . 0.0 111.765 -176.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -62.15 120.75 11.5 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.392 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.39 -28.61 2.44 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.573 ' SG ' HG21 ' A' ' 119' ' ' ILE . 49.6 t -112.98 132.1 22.5 Favored Pre-proline 0 N--CA 1.426 -1.656 0 CA-C-N 114.817 -0.691 . . . . 0.0 110.201 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -99.51 11.38 0.67 Allowed 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 122.628 2.219 . . . . 0.0 112.525 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.0 m -122.81 18.64 10.23 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.82 0.343 . . . . 0.0 111.087 -174.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -113.39 136.73 21.9 Favored Pre-proline 0 C--N 1.31 -1.111 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -174.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -82.33 -179.68 4.83 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.135 2.557 . . . . 0.0 113.292 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -98.93 108.55 21.26 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -76.44 -60.36 2.37 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.291 0.567 . . . . 0.0 110.21 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.456 ' H ' HG22 ' A' ' 93' ' ' VAL . . . 124.37 -66.53 0.52 Allowed Glycine 0 C--N 1.306 -1.131 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 177.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.7 m -93.61 150.62 20.28 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.13 -41.28 94.96 Favored 'General case' 0 C--O 1.216 -0.661 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.354 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 38.6 t -54.94 -31.37 60.39 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.229 0.612 . . . . 0.0 111.028 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.28 -49.28 74.67 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.378 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 111' ' ' VAL . 4.1 pp -75.01 -32.44 61.62 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 120.838 0.351 . . . . 0.0 110.936 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.453 ' N ' HD12 ' A' ' 110' ' ' LEU . 69.7 t -63.09 -44.66 99.63 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.821 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.569 178.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.3 t -73.28 -21.83 60.51 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.006 0.432 . . . . 0.0 111.819 177.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -83.42 -4.64 58.68 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 121.388 0.613 . . . . 0.0 110.085 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 125' ' ' LEU . 6.0 p80 -42.62 -50.4 5.42 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 126.694 1.997 . . . . 0.0 115.893 -173.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.4 t -103.7 4.78 35.74 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 121.438 0.637 . . . . 0.0 109.286 -172.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.5 mt -99.47 -48.54 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.8 m -141.27 86.21 11.38 Favored Pre-proline 0 N--CA 1.437 -1.103 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.459 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.88 89.49 1.13 Allowed 'Trans proline' 0 N--CA 1.44 -1.649 0 C-N-CA 121.681 1.587 . . . . 0.0 108.054 173.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.573 HG21 ' SG ' ' A' ' 98' ' ' CYS . 36.3 mt -90.28 -64.02 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.79 -174.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.8 t -73.4 -30.25 63.13 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 120.851 0.358 . . . . 0.0 111.073 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.66 127.21 73.65 Favored Pre-proline 0 N--CA 1.435 -1.203 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.417 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -69.23 -24.45 32.1 Favored 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 122.327 2.018 . . . . 0.0 111.457 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.421 ' SG ' ' HB ' ' A' ' 62' ' ' VAL . 83.4 m -114.74 145.73 41.76 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 53.4 m -64.16 111.88 2.77 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.124 0.488 . . . . 0.0 109.937 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 114' ' ' HIS . 27.9 tp -58.21 135.79 57.16 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 125.0 1.32 . . . . 0.0 110.041 -176.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -130.92 134.99 47.26 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.1 mp -80.96 136.15 50.93 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo . . . . . 0 CA--C 1.543 0.928 0 C-N-CA 122.131 1.887 . . . . 0.0 112.129 177.367 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.3 p . . . . . 0 N--CA 1.435 -1.18 0 CA-C-O 120.774 0.321 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.5 m -45.46 -60.86 1.93 Allowed 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 125.853 1.661 . . . . 0.0 112.805 -173.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.417 ' HE2' ' CE2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -67.48 -12.69 60.9 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -176.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.417 ' CE2' ' HE2' ' A' ' 20' ' ' LYS . 74.6 m-85 -76.99 -23.24 52.29 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.419 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.417 ' CZ3' HD11 ' A' ' 46' ' ' ILE . 31.3 p-90 -121.0 -24.75 5.51 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 35.8 t80 -95.31 116.79 29.24 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.992 -0.442 . . . . 0.0 110.045 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.431 ' CB ' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -138.04 97.9 9.65 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.097 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.88 21.55 0.37 Allowed 'Trans proline' 0 CA--C 1.552 1.418 0 C-N-CA 123.326 2.684 . . . . 0.0 113.977 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -114.78 -20.44 10.62 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.241 0.543 . . . . 0.0 110.088 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.431 HD23 ' CB ' ' A' ' 24' ' ' LYS . 3.5 mm? -76.75 120.51 22.01 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.668 0.747 . . . . 0.0 111.355 -175.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.0 p -85.27 177.69 7.75 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.57 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -49.7 -55.85 12.34 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.079 0.952 . . . . 0.0 111.622 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -72.78 -32.45 65.6 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.98 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -70.77 -33.53 70.88 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.871 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.98 -42.51 99.86 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.576 0.703 . . . . 0.0 109.13 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 85.0 mt -65.27 -44.01 95.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.465 178.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.48 -28.64 68.5 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.375 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.03 -51.99 10.12 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.517 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 57.2 mt -72.84 -25.56 61.16 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -174.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -56.91 -33.8 67.31 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -89.51 -21.29 23.01 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.543 0.687 . . . . 0.0 110.77 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -78.62 164.77 24.36 Favored 'General case' 0 C--O 1.255 1.389 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -172.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.54 137.38 76.79 Favored Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 111.917 -2.401 . . . . 0.0 111.329 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -63.0 107.56 0.65 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.922 1.748 . . . . 0.0 109.342 170.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.46 -17.93 5.52 Favored Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 -175.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.37 154.96 27.4 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 120.644 0.259 . . . . 0.0 110.66 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.475 ' CG ' HD11 ' A' ' 125' ' ' LEU . 5.4 p90 -149.45 177.68 9.49 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.279 -174.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -155.31 147.09 23.26 Favored 'General case' 0 C--O 1.253 1.237 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 169.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 23' ' ' TYR . 63.2 mt -117.81 135.33 58.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.42 HH12 ' HB1' ' A' ' 59' ' ' ALA . 0.1 OUTLIER -144.73 162.45 36.7 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 174.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.07 131.88 48.69 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 173.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.433 ' HB3' ' O ' ' A' ' 52' ' ' PHE . 30.4 t -75.67 118.81 18.9 Favored 'General case' 0 N--CA 1.413 -2.312 0 C-N-CA 119.024 -1.071 . . . . 0.0 109.087 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 27.6 m-70 -77.24 -16.11 59.17 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.87 175.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.0 m -84.11 -46.79 11.58 Favored 'General case' 0 N--CA 1.408 -2.568 0 CA-C-N 114.229 -1.35 . . . . 0.0 109.535 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.433 ' O ' ' HB3' ' A' ' 49' ' ' SER . 89.9 m-85 -127.15 127.97 45.41 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-O 121.35 0.595 . . . . 0.0 111.095 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -83.61 128.03 34.2 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.658 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.22 15.75 52.63 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -177.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.74 160.81 36.99 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -122.4 129.88 52.53 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.95 115.58 4.14 Favored Glycine 0 C--N 1.293 -1.832 0 C-N-CA 119.968 -1.11 . . . . 0.0 111.302 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -93.29 119.56 32.58 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.42 ' HB1' HH12 ' A' ' 47' ' ' ARG . . . -114.53 129.76 56.69 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.431 HD22 ' SG ' ' A' ' 123' ' ' CYS . 58.9 tp -126.85 128.62 46.81 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 123.488 0.493 . . . . 0.0 110.801 -177.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.517 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 22.3 tptm -88.36 115.14 25.66 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 176.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.482 HG12 ' SG ' ' A' ' 123' ' ' CYS . 34.1 m -105.82 170.69 2.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.87 -48.48 12.33 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 p -167.29 120.97 0.79 Allowed Pre-proline 0 C--N 1.32 -0.681 0 C-N-CA 125.291 1.436 . . . . 0.0 109.025 178.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.561 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 28.2 Cg_exo -60.57 -46.84 15.65 Favored 'Trans proline' 0 CA--C 1.575 2.567 0 C-N-CA 121.149 1.232 . . . . 0.0 110.993 170.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.561 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 85.1 Cg_endo -77.73 158.66 31.72 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.86 2.374 . . . . 0.0 109.917 173.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -70.03 -54.16 0.22 Allowed 'Trans proline' 0 CA--C 1.551 1.357 0 C-N-CA 121.715 1.61 . . . . 0.0 112.189 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.1 m -104.86 -19.84 13.76 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.837 0.351 . . . . 0.0 110.906 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 66.98 34.7 5.07 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 124.169 0.987 . . . . 0.0 111.274 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -60.68 -44.29 94.78 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.857 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.62 82.39 0.73 Allowed 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 121.11 1.206 . . . . 0.0 111.285 173.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 36.4 t-105 -85.87 136.73 33.18 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.0 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.9 mtmm -127.06 6.66 6.53 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -173.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.03 24.58 44.11 Favored Glycine 0 CA--C 1.489 -1.543 0 N-CA-C 108.554 -1.819 . . . . 0.0 108.554 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -86.21 127.05 63.06 Favored Pre-proline 0 N--CA 1.423 -1.799 0 CA-C-N 113.744 -1.228 . . . . 0.0 111.308 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -96.26 -165.12 0.1 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.7 0 C-N-CA 122.938 2.425 . . . . 0.0 110.867 176.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.435 ' HA ' HD22 ' A' ' 80' ' ' LEU . 9.8 p -56.46 -21.3 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 123.633 0.773 . . . . 0.0 112.405 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -62.56 -33.63 75.33 Favored 'General case' 0 C--O 1.213 -0.819 0 C-N-CA 122.853 0.461 . . . . 0.0 110.909 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.62 -20.34 56.84 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 121.461 0.648 . . . . 0.0 109.819 -178.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 77' ' ' VAL . 3.5 mm? -81.03 -3.08 50.56 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.097 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.9 t -101.66 104.83 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.875 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 174.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -78.85 139.76 38.28 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -120.65 122.44 40.49 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-O 121.872 0.844 . . . . 0.0 111.688 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -131.41 170.74 14.25 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.48 136.82 41.58 Favored 'General case' 0 C--N 1.283 -2.325 0 C-N-CA 119.944 -0.703 . . . . 0.0 111.088 175.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 74.9 mt -91.43 114.72 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.632 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 30.7 mt-10 -99.75 140.08 34.47 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.503 ' HB ' HG12 ' A' ' 93' ' ' VAL . 1.3 t -116.17 127.46 54.81 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.439 0.638 . . . . 0.0 110.626 175.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.4 -169.97 14.01 Favored Glycine 0 N--CA 1.424 -2.163 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.2 -27.81 31.4 Favored 'Trans proline' 0 CA--C 1.553 1.43 0 C-N-CA 123.425 2.75 . . . . 0.0 114.858 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.472 ' HD2' ' N ' ' A' ' 91' ' ' LYS . 10.7 mptt -80.28 -21.32 42.8 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.073 0.463 . . . . 0.0 111.121 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.28 -149.07 16.88 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 87' ' ' GLU . 31.3 m -104.64 149.08 8.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.41 155.02 19.49 Favored 'General case' 0 C--O 1.251 1.147 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 71.6 mt -86.94 114.34 25.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.423 0.63 . . . . 0.0 111.311 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.537 ' HE2' ' CD ' ' A' ' 87' ' ' GLU . 19.4 ttmm -64.83 126.93 29.52 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.438 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 110.13 40.05 1.45 Allowed Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.4 ' HG ' ' HB2' ' A' ' 101' ' ' GLU . 35.5 t -142.33 132.4 12.44 Favored Pre-proline 0 N--CA 1.432 -1.33 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -178.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -86.8 8.11 4.57 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.602 2.202 . . . . 0.0 112.648 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.6 m -148.4 -148.0 0.24 Allowed 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.4 ' HB2' ' HG ' ' A' ' 98' ' ' CYS . 35.7 tt0 80.75 123.93 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.135 0 C-N-CA 124.963 1.305 . . . . 0.0 113.161 174.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.16 171.28 18.6 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.681 2.254 . . . . 0.0 111.74 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -95.59 132.38 40.79 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -108.25 154.68 21.42 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -178.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -95.4 -25.27 14.21 Favored Glycine 0 C--N 1.3 -1.42 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.772 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 11.1 m -122.65 144.62 49.01 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 90.2 mt -62.56 -37.83 87.69 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.196 0.522 . . . . 0.0 109.661 175.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.3 m -54.17 -34.44 60.49 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.593 1.157 . . . . 0.0 111.163 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.9 -39.32 83.62 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.7 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.474 HD13 ' N ' ' A' ' 111' ' ' VAL . 4.0 pp -76.2 -36.98 58.36 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.144 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.474 ' N ' HD13 ' A' ' 110' ' ' LEU . 43.0 t -55.9 -51.79 56.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.727 177.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.4 m -71.94 -26.71 62.39 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.967 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -83.46 -37.85 22.62 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -176.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -72.3 -6.17 41.31 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -174.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.8 m -75.26 -24.35 57.59 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 171.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 65.5 mt -101.61 -50.02 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.426 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.8 m -120.4 97.84 48.75 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.241 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.78 92.11 1.1 Allowed 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.473 2.115 . . . . 0.0 109.565 174.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 23.6 mt -84.97 -67.62 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.28 -174.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.8 p -77.67 -33.54 53.33 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.88 0.848 . . . . 0.0 110.338 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.6 mt -84.73 140.83 38.06 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.137 -177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.56 -11.3 15.69 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.863 2.375 . . . . 0.0 113.454 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.482 ' SG ' HG12 ' A' ' 62' ' ' VAL . 22.6 p -136.05 162.21 33.54 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 59.6 m -69.33 138.38 53.71 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 123.485 0.49 . . . . 0.0 110.021 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.475 HD11 ' CG ' ' A' ' 44' ' ' PHE . 19.6 tp -77.72 121.34 23.89 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.744 -175.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -95.76 114.47 26.21 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 123.51 0.724 . . . . 0.0 110.577 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 66.8 mt -81.15 121.97 81.05 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 175.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 CA--C 1.535 0.528 0 C-N-CA 122.646 2.231 . . . . 0.0 113.681 -176.319 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.0 p . . . . . 0 N--CA 1.425 -1.69 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.8 m -73.59 -33.06 64.44 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.609 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -61.46 -18.26 58.17 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -79.21 -26.91 42.53 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.522 ' CZ3' HD11 ' A' ' 46' ' ' ILE . 21.9 p-90 -131.91 -9.49 3.48 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -175.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -98.92 113.38 25.5 Favored 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.655 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.07 91.1 9.03 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.983 175.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.94 -17.08 46.4 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.904 2.403 . . . . 0.0 113.891 -175.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -71.86 -18.89 62.03 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.037 0.446 . . . . 0.0 111.294 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.9 tp -80.54 139.17 36.47 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.116 0.484 . . . . 0.0 110.61 -176.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.555 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 15.5 m -91.95 168.2 11.58 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.046 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -57.12 -51.68 68.31 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.067 0.947 . . . . 0.0 113.39 -175.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.87 -39.8 95.56 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 121.561 0.696 . . . . 0.0 110.985 -176.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.555 ' OE1' ' HB2' ' A' ' 28' ' ' SER . 21.1 mp0 -67.03 -40.12 87.13 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.862 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.93 -41.77 75.1 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 123.197 0.599 . . . . 0.0 111.627 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 60.1 mt -65.2 -35.67 75.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.867 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.1 -33.04 72.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.778 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.91 -40.52 65.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.043 0.449 . . . . 0.0 110.647 177.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 75.6 mt -76.16 -27.1 56.85 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -175.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -77.22 -3.37 39.32 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.551 0.691 . . . . 0.0 109.934 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -106.19 -5.29 19.38 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.747 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.509 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -119.74 170.2 9.43 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.111 0.482 . . . . 0.0 112.177 -175.244 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -85.85 160.31 53.0 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.294 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 61' ' ' LYS . 10.8 Cg_endo -56.11 127.47 26.17 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.775 2.316 . . . . 0.0 111.265 173.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.41 -24.01 8.28 Favored Glycine 0 N--CA 1.434 -1.446 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.56 146.61 40.32 Favored 'General case' 0 C--O 1.253 1.239 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -151.87 177.52 10.34 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 121.019 0.438 . . . . 0.0 110.119 -176.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -162.05 150.04 14.68 Favored 'General case' 0 C--O 1.251 1.152 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 173.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.522 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 68.6 mt -123.93 134.16 67.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.435 HH22 ' CD2' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -133.59 173.62 11.31 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.241 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -80.06 146.5 31.9 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.1 t -99.56 139.94 34.47 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.528 0.68 . . . . 0.0 111.682 -176.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -99.59 -8.5 24.41 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.476 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.5 t -76.38 -40.87 49.86 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -129.9 140.92 50.88 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -83.57 124.63 30.97 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.989 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.42 31.66 18.56 Favored Glycine 0 N--CA 1.435 -1.385 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -177.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.75 157.98 45.31 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.971 -0.615 . . . . 0.0 109.602 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -124.65 161.06 27.1 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.34 123.56 5.55 Favored Glycine 0 C--N 1.288 -2.091 0 C-N-CA 119.908 -1.139 . . . . 0.0 111.036 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 84' ' ' PHE . 2.2 tm? -101.68 130.51 48.06 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 123.947 0.899 . . . . 0.0 108.74 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -119.28 125.34 48.87 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.5 tp -119.88 131.3 55.21 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 123.686 0.616 . . . . 0.0 110.535 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 41' ' ' PRO . 22.3 tptm -88.5 116.05 26.45 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 80' ' ' LEU . 18.7 m -109.94 171.77 2.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.79 -60.07 2.54 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.4 p -150.81 138.38 12.1 Favored Pre-proline 0 C--N 1.308 -1.207 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.247 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.591 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 24.4 Cg_exo -61.46 -43.55 27.15 Favored 'Trans proline' 0 CA--C 1.577 2.67 0 C-N-CA 121.969 1.779 . . . . 0.0 111.854 171.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.591 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 56.4 Cg_endo -68.25 143.16 57.71 Favored 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 122.547 2.164 . . . . 0.0 110.105 170.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.88 -32.81 35.26 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.547 2.165 . . . . 0.0 112.644 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.9 t -114.27 -42.74 3.29 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.079 0.466 . . . . 0.0 110.096 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.444 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 74.56 -3.04 2.66 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.972 1.309 . . . . 0.0 112.134 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.412 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 8.6 tt0 -59.72 -50.09 88.57 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 171.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 70' ' ' GLN . 16.9 Cg_exo -70.56 101.23 1.0 Allowed 'Trans proline' 0 C--N 1.374 1.88 0 N-CA-C 106.615 -2.11 . . . . 0.0 106.615 164.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 46.3 t-105 -109.87 150.11 28.89 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.376 -172.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.466 ' HB3' ' HZ2' ' A' ' 73' ' ' LYS . 7.1 ttpm? -114.29 -63.0 1.51 Allowed 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.98 178.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 158.3 67.0 0.01 OUTLIER Glycine 0 CA--C 1.471 -2.718 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -118.94 121.51 30.44 Favored Pre-proline 0 C--N 1.285 -2.238 0 CA-C-N 114.695 -0.753 . . . . 0.0 109.971 -169.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -85.16 178.56 4.59 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.304 2.003 . . . . 0.0 112.129 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.0 p -57.31 -30.12 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 123.353 0.661 . . . . 0.0 112.681 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.3 mp0 -68.84 -19.74 64.27 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.975 -0.453 . . . . 0.0 111.46 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.588 HE21 ' HA ' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -84.69 -19.74 32.31 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.48 ' O ' HG23 ' A' ' 62' ' ' VAL . 46.7 mt -74.26 -17.47 60.87 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.8 t -87.74 112.58 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 173.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -98.55 131.5 44.72 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -176.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.435 ' CD2' HH22 ' A' ' 47' ' ' ARG . 36.0 m80 -105.07 124.5 49.64 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 121.402 0.62 . . . . 0.0 112.02 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.417 ' O ' ' HB3' ' A' ' 58' ' ' LEU . 93.9 m-85 -131.3 126.73 36.11 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 177.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.9 pp -99.1 144.49 28.18 Favored 'General case' 0 C--N 1.285 -2.228 0 C-N-CA 118.443 -1.303 . . . . 0.0 111.132 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 62.5 mt -105.82 135.23 44.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.367 -174.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.457 ' OE1' ' HA ' ' A' ' 96' ' ' LYS . 30.6 mt-10 -116.55 142.75 46.47 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -176.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.7 t -131.39 139.51 49.47 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 175.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.22 -161.04 11.56 Favored Glycine 0 N--CA 1.433 -1.502 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.29 -17.66 61.14 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.038 2.492 . . . . 0.0 113.88 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -79.72 -42.04 25.48 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 122.076 0.941 . . . . 0.0 109.217 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 146.71 -154.42 25.96 Favored Glycine 0 N--CA 1.422 -2.296 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.4 p -114.02 137.82 45.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.98 171.93 19.13 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.47 ' HB ' ' HB3' ' A' ' 98' ' ' CYS . 58.7 mt -90.54 143.85 10.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.457 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 17.0 tppt? -48.02 -45.63 32.11 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.576 1.151 . . . . 0.0 112.482 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -120.44 62.15 0.5 Allowed Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.812 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.47 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 19.7 p -98.7 127.8 34.53 Favored Pre-proline 0 C--N 1.299 -1.588 0 CA-C-O 120.931 0.396 . . . . 0.0 111.429 178.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -90.04 32.93 0.34 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.242 2.628 . . . . 0.0 110.13 174.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.1 t -92.69 -147.65 0.23 Allowed 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.418 ' H ' ' HD2' ' A' ' 102' ' ' PRO . 17.9 tp10 -152.62 -55.52 0.02 OUTLIER Pre-proline 0 C--N 1.289 -2.05 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.733 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.418 ' HD2' ' H ' ' A' ' 101' ' ' GLU . 88.5 Cg_endo -77.81 158.72 31.41 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 121.384 1.39 . . . . 0.0 113.155 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -100.21 157.13 16.81 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -114.02 165.28 12.78 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.7 -47.04 3.54 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.304 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.7 m -121.87 159.25 27.19 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.425 ' O ' HG23 ' A' ' 111' ' ' VAL . 95.2 mt -57.22 -45.73 83.57 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 122.815 0.446 . . . . 0.0 111.757 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 72.4 m -54.26 -29.36 46.61 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.73 -48.83 67.93 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.494 0.187 . . . . 0.0 110.601 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.88 -26.15 63.11 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.158 0.504 . . . . 0.0 110.642 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 107' ' ' LEU . 73.5 t -67.5 -51.69 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.299 176.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 28.6 t -68.25 -27.84 66.69 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.221 0.534 . . . . 0.0 110.467 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.495 ' NE2' ' HB2' ' A' ' 117' ' ' SER . 0.6 OUTLIER -63.28 -50.48 69.96 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.427 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -77.19 -0.37 24.84 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -176.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 7.1 m -75.55 -37.22 60.15 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.484 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 73.3 mt -101.31 -53.94 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.083 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.495 ' HB2' ' NE2' ' A' ' 113' ' ' GLN . 19.9 m -107.94 97.6 21.84 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 116' ' ' ILE . 5.8 Cg_exo -78.64 84.53 2.01 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 122.412 2.075 . . . . 0.0 110.388 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 68.8 mt -80.96 -54.67 9.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.556 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.7 m -92.39 -15.6 27.03 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.453 0.644 . . . . 0.0 110.524 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 71.7 mt -112.6 136.88 21.53 Favored Pre-proline 0 N--CA 1.428 -1.541 0 CA-C-N 115.435 -0.802 . . . . 0.0 108.907 -175.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.64 -5.84 16.41 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.537 2.158 . . . . 0.0 112.677 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 50.8 t -128.86 149.59 50.69 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 21.2 m -71.33 133.25 45.87 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 16.6 tp -77.77 138.02 38.77 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.247 -175.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -122.41 118.2 27.82 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.533 0.683 . . . . 0.0 111.95 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.443 HD11 ' H ' ' A' ' 127' ' ' ILE . 2.7 mp -91.46 135.31 28.13 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -176.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo . . . . . 0 N--CA 1.48 0.731 0 C-N-CA 122.053 1.835 . . . . 0.0 110.926 175.719 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.9 p . . . . . 0 N--CA 1.428 -1.573 0 CA-C-O 121.881 0.848 . . . . 0.0 110.788 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.422 ' HA ' ' CE2' ' A' ' 22' ' ' TRP . 14.8 m -68.31 -30.15 69.07 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 114.22 -1.354 . . . . 0.0 111.785 -177.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -61.03 -22.29 64.41 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -176.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -76.71 -28.56 55.89 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.392 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.422 ' CE2' ' HA ' ' A' ' 19' ' ' SER . 26.0 p-90 -116.54 -18.07 10.46 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -93.55 119.76 33.0 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.909 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.57 100.14 3.14 Favored Pre-proline 0 C--N 1.308 -1.234 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.246 173.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.72 -4.23 13.35 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.952 2.435 . . . . 0.0 113.471 -173.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -92.63 -12.11 32.47 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.014 -177.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.508 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 17.5 tp -86.47 124.02 32.33 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.0 m -75.9 173.24 11.44 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -173.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.4 tpp180 -57.84 -53.67 55.62 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.726 0.811 . . . . 0.0 110.935 -175.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -67.31 -30.55 70.43 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.278 -177.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -76.32 -35.9 58.55 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.276 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.93 97.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.595 0.712 . . . . 0.0 109.712 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 82.8 mt -66.71 -43.31 90.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.465 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.5 -30.9 70.0 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.501 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.33 -44.77 43.46 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.794 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 65.0 mt -74.3 -25.14 59.4 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -177.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -71.78 -19.02 62.07 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 121.665 -0.647 . . . . 0.0 110.285 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -89.21 -10.16 48.1 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.601 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.595 ' HE2' ' HA ' ' A' ' 39' ' ' LYS . 3.8 mmpt? -108.68 164.78 12.07 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -176.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.0 151.71 86.34 Favored Pre-proline 0 C--N 1.309 -1.171 0 CA-C-N 112.667 -2.06 . . . . 0.0 108.863 -175.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -61.04 131.37 36.58 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.636 1.557 . . . . 0.0 109.529 173.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.91 -13.2 31.98 Favored Glycine 0 C--N 1.302 -1.351 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.3 151.21 31.22 Favored 'General case' 0 C--O 1.246 0.898 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 31.9 p90 -154.73 164.72 38.37 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -175.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -152.31 157.12 40.9 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 172.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.6 mt -127.11 132.1 70.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.508 ' HD2' ' O ' ' A' ' 27' ' ' LEU . 7.2 ptm180 -127.87 153.77 46.25 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 175.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -60.07 127.41 31.74 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.3 t -77.51 119.18 20.74 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -86.87 -20.9 26.77 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 m -61.24 -49.93 75.13 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 112.883 -1.962 . . . . 0.0 110.237 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -125.55 133.27 52.37 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -82.73 121.93 27.52 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.785 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.86 23.67 14.89 Favored Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.23 152.1 51.64 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 121.147 0.499 . . . . 0.0 110.035 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -120.58 136.17 54.88 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.73 112.13 4.34 Favored Glycine 0 C--N 1.284 -2.309 0 C-N-CA 120.039 -1.077 . . . . 0.0 111.005 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 44.7 tp -87.05 130.42 34.49 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 44' ' ' PHE . . . -113.31 119.49 37.86 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 176.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.4 tp -115.68 130.17 56.75 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 123.65 0.594 . . . . 0.0 110.603 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 22.6 tptm -88.71 115.07 25.98 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.6 m -105.4 171.33 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 175.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.86 -54.39 10.24 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.6 p -160.22 142.98 9.91 Favored Pre-proline 0 C--N 1.319 -0.722 0 C-N-CA 124.753 1.221 . . . . 0.0 108.112 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.604 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 24.1 Cg_exo -62.57 -49.48 5.63 Favored 'Trans proline' 0 CA--C 1.576 2.579 0 C-N-CA 121.613 1.542 . . . . 0.0 111.386 169.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.604 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 69.3 Cg_endo -68.2 151.67 76.68 Favored 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 122.813 2.342 . . . . 0.0 109.866 173.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -59.09 -48.75 13.01 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.396 2.064 . . . . 0.0 112.617 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.6 p -118.57 -22.34 7.56 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.663 -177.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 67.42 34.77 4.56 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 124.056 0.943 . . . . 0.0 109.813 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -59.67 -51.18 82.8 Favored Pre-proline 0 CA--C 1.553 1.084 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.496 177.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -83.24 114.4 2.17 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 121.156 1.238 . . . . 0.0 110.025 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 38.7 t-105 -125.68 143.08 51.19 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 120.983 0.42 . . . . 0.0 110.215 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -127.54 -61.25 1.14 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 175.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -178.49 65.88 0.08 OUTLIER Glycine 0 CA--C 1.486 -1.758 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 177.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -82.32 130.36 59.78 Favored Pre-proline 0 C--N 1.297 -1.685 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -175.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.57 159.54 32.05 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.256 1.97 . . . . 0.0 113.096 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.6 p -66.22 -14.8 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 121.828 0.823 . . . . 0.0 110.392 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -68.73 -13.49 62.41 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.89 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -89.44 -25.27 21.58 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 121.04 0.447 . . . . 0.0 110.305 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 69.3 mt -74.92 -22.66 58.48 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.793 0.806 . . . . 0.0 109.156 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 98.1 t -100.4 127.36 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 174.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.501 ' HA ' ' NE ' ' A' ' 82' ' ' ARG . 3.5 mmp_? -107.32 139.88 41.11 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.941 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -116.1 122.71 45.94 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.248 0.547 . . . . 0.0 110.522 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -129.3 128.27 42.84 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.37 138.28 34.2 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 118.901 -1.12 . . . . 0.0 111.017 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.7 mt -102.56 119.12 50.47 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.079 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -101.64 143.88 31.05 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -176.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 92' ' ' GLY . 4.2 t -127.69 120.28 27.67 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-O 121.569 0.7 . . . . 0.0 110.229 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -140.67 -154.84 6.33 Favored Glycine 0 N--CA 1.435 -1.433 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.25 -15.82 28.34 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.118 1.878 . . . . 0.0 111.029 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -72.71 -27.89 62.33 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.415 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 122.83 -153.89 16.99 Favored Glycine 0 N--CA 1.426 -2.025 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -175.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.2 p -118.27 132.56 67.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.32 157.72 36.19 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.109 -178.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 98' ' ' CYS . 85.6 mt -72.42 140.55 17.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -78.85 128.72 33.72 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 108.69 -54.4 0.55 Allowed Glycine 0 N--CA 1.437 -1.237 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.458 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 49.7 t -139.88 121.92 9.89 Favored Pre-proline 0 N--CA 1.414 -2.273 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 176.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 98' ' ' CYS . 10.1 Cg_exo -73.09 -53.7 0.13 Allowed 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 121.741 1.628 . . . . 0.0 110.535 -177.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.2 t 156.21 -83.99 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 129.004 2.922 . . . . 0.0 103.263 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.541 ' HB2' ' HD3' ' A' ' 102' ' ' PRO . 45.7 mt-10 -144.5 -59.55 0.02 OUTLIER Pre-proline 0 N--CA 1.435 -1.202 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 173.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.541 ' HD3' ' HB2' ' A' ' 101' ' ' GLU . 16.6 Cg_endo -101.29 -172.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 121.345 1.363 . . . . 0.0 110.457 171.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -105.97 125.65 51.25 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 173.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.483 ' CD1' ' HB3' ' A' ' 110' ' ' LEU . 97.2 m-85 -84.59 172.64 11.43 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -172.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -101.4 -23.98 9.18 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.218 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.2 m -145.98 160.27 42.09 Favored 'General case' 0 C--O 1.247 0.954 0 O-C-N 122.289 -0.536 . . . . 0.0 110.658 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.92 -48.03 82.26 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 123.356 0.662 . . . . 0.0 112.589 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 m -54.61 -31.95 57.99 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.005 0.522 . . . . 0.0 112.02 -175.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.602 ' O ' ' HG2' ' A' ' 113' ' ' GLN . . . -63.8 -51.71 63.55 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.426 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.483 ' HB3' ' CD1' ' A' ' 104' ' ' PHE . 4.3 pp -70.2 -27.67 64.68 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.711 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.77 -53.22 44.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.742 178.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.1 t -64.35 -29.59 70.65 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.566 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.602 ' HG2' ' O ' ' A' ' 109' ' ' ALA . 81.3 mm-40 -68.01 -33.89 75.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.778 0.323 . . . . 0.0 110.905 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -82.1 -0.02 42.73 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 26.0 m -85.45 -21.73 28.6 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 172.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 67.6 mt -106.14 -49.1 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.653 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.2 m -120.43 102.12 45.73 Favored Pre-proline 0 C--N 1.302 -1.486 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.429 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.33 84.82 1.64 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.351 2.034 . . . . 0.0 109.942 175.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 72.5 mt -87.79 -67.53 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.935 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.2 m -85.03 -11.25 55.8 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.435 0.636 . . . . 0.0 110.936 -176.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 76.2 mt -120.16 137.89 26.48 Favored Pre-proline 0 N--CA 1.429 -1.479 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.493 -175.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -64.48 -34.03 54.98 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.621 2.214 . . . . 0.0 112.341 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 66.2 m -111.61 157.16 20.73 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 9.9 p -81.53 143.59 31.92 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 72.0 mt -78.01 119.12 21.0 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 123.109 0.256 . . . . 0.0 111.612 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -94.97 105.78 17.72 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 175.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.9 mt -78.0 121.87 84.65 Favored Pre-proline 0 C--N 1.301 -1.533 0 CA-C-N 115.305 -0.862 . . . . 0.0 112.063 -171.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 C--N 1.357 1.001 0 C-N-CA 123.471 2.781 . . . . 0.0 112.513 -179.195 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.409 ' HA ' ' CE1' ' A' ' 21' ' ' PHE . 26.8 p . . . . . 0 N--CA 1.451 -0.406 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.2 m -101.11 -37.81 8.42 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.279 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -13.09 58.05 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.409 ' CE1' ' HA ' ' A' ' 18' ' ' THR . 96.9 m-85 -64.0 -50.79 67.14 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.232 0.539 . . . . 0.0 110.18 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 46.5 p-90 -109.89 -19.03 13.26 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -175.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -95.94 113.79 25.45 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.436 0.636 . . . . 0.0 111.61 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.81 94.55 5.43 Favored Pre-proline 0 C--N 1.303 -1.427 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.437 173.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -78.16 2.95 7.5 Favored 'Trans proline' 0 C--O 1.223 -0.24 0 C-N-CA 123.447 2.765 . . . . 0.0 115.23 -171.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -97.21 -3.22 41.25 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.066 -0.653 . . . . 0.0 111.885 -177.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.403 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 76.2 mt -91.42 134.03 34.97 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 120.946 0.403 . . . . 0.0 110.168 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.0 t -90.66 177.83 6.24 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.272 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -48.31 -57.48 5.94 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.863 1.265 . . . . 0.0 111.162 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.63 -32.03 73.38 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.829 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -75.55 -37.3 60.09 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.085 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.13 -42.63 95.21 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.603 0.716 . . . . 0.0 109.751 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 78.7 mt -66.57 -40.85 87.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.365 177.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.76 -27.32 67.88 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.522 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.29 -53.1 6.63 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 172.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 52.7 mt -61.89 -24.5 66.98 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -174.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -57.23 -35.53 69.81 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -102.22 6.66 40.76 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.637 0.732 . . . . 0.0 110.546 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -94.4 156.63 16.4 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.988 177.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.72 149.16 56.41 Favored Pre-proline 0 C--N 1.296 -1.757 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.6 -176.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 61' ' ' LYS . 78.3 Cg_exo -53.34 118.94 5.39 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.634 2.223 . . . . 0.0 111.098 175.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.94 -22.18 6.85 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -176.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.51 147.05 36.01 Favored 'General case' 0 C--O 1.247 0.926 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.473 ' CD1' HD23 ' A' ' 125' ' ' LEU . 33.0 p90 -150.6 165.59 32.88 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -175.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -151.72 150.9 30.72 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.7 mt -116.26 127.14 73.95 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.403 ' HD2' ' O ' ' A' ' 27' ' ' LEU . 50.1 ptt85 -125.44 170.98 10.86 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.92 -176.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -88.63 136.78 32.82 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 176.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.3 m -116.8 123.52 47.32 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 121.411 0.624 . . . . 0.0 112.345 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -84.88 80.51 9.25 Favored 'General case' 0 CA--C 1.487 -1.454 0 CA-C-O 122.304 1.05 . . . . 0.0 108.316 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.3 t -142.28 -62.24 0.44 Allowed 'General case' 0 C--N 1.268 -2.966 0 CA-C-N 113.128 -1.851 . . . . 0.0 107.271 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -126.83 161.77 27.43 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -78.51 121.12 24.17 Favored 'General case' 0 C--O 1.254 1.339 0 CA-C-O 121.182 0.515 . . . . 0.0 110.827 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.7 46.59 9.53 Favored Glycine 0 N--CA 1.437 -1.297 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.68 116.31 22.17 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 121.222 0.534 . . . . 0.0 109.738 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -103.12 118.29 36.47 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.39 122.47 6.48 Favored Glycine 0 C--N 1.277 -2.733 0 C-N-CA 119.839 -1.172 . . . . 0.0 111.239 -177.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 31.7 tp -93.94 124.55 38.02 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.64 121.32 44.76 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 60.3 tp -116.88 126.46 53.04 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 123.039 0.536 . . . . 0.0 110.501 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 21.9 tptm -89.0 115.68 26.74 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.7 m -110.11 170.36 3.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.58 -59.56 3.26 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.6 p -157.66 140.36 10.66 Favored Pre-proline 0 C--N 1.311 -1.071 0 C-N-CA 124.396 1.078 . . . . 0.0 108.204 177.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.569 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 31.3 Cg_exo -59.75 -44.14 33.27 Favored 'Trans proline' 0 CA--C 1.573 2.448 0 C-N-CA 121.999 1.799 . . . . 0.0 111.937 173.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.569 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 78.3 Cg_endo -70.89 154.17 63.4 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.402 2.068 . . . . 0.0 109.02 169.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.42 -47.56 1.0 Allowed 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 121.98 1.787 . . . . 0.0 112.11 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.4 p -103.06 -43.92 5.36 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.004 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.439 ' HB1' ' HG2' ' A' ' 66' ' ' PRO . . . 67.89 23.12 8.46 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.524 1.13 . . . . 0.0 110.602 -177.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -65.25 -47.16 71.73 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.42 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -57.99 120.82 8.97 Favored 'Trans proline' 0 C--N 1.376 1.992 0 N-CA-C 106.436 -2.179 . . . . 0.0 106.436 165.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -34.71 127.74 0.48 Allowed 'General case' 0 C--O 1.243 0.742 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -166.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -139.31 73.49 1.43 Allowed 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 113.899 -1.5 . . . . 0.0 108.88 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.96 48.06 1.0 Allowed Glycine 0 C--N 1.289 -2.047 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 175.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -98.8 146.62 31.96 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -176.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -50.24 157.43 3.07 Favored 'Trans proline' 0 C--O 1.246 0.919 0 C-N-CA 123.527 2.818 . . . . 0.0 114.011 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.5 p -61.94 -11.65 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.851 -178.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -62.03 -27.64 69.02 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 122.833 0.453 . . . . 0.0 110.687 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.402 ' HG2' ' HG2' ' A' ' 65' ' ' PRO . 7.7 tt0 -79.1 -33.59 44.27 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.019 0.438 . . . . 0.0 109.904 177.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.8 mt -72.15 -20.11 61.66 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.468 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 81.7 t -94.12 118.96 41.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 173.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -99.3 129.06 45.49 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 -178.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -106.43 122.92 47.25 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-O 121.28 0.562 . . . . 0.0 111.089 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -130.08 131.11 45.63 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 176.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.2 pp -102.99 140.6 37.05 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 118.32 -1.352 . . . . 0.0 111.584 -175.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.497 HG12 HG12 ' A' ' 95' ' ' ILE . 63.8 mt -102.18 126.1 56.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.587 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.519 ' OE2' ' HE2' ' A' ' 96' ' ' LYS . 38.5 mt-10 -103.53 146.02 29.15 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 92' ' ' GLY . 4.6 t -130.27 128.73 42.17 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 170.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.77 -137.22 2.22 Favored Glycine 0 N--CA 1.427 -1.95 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.829 -177.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.44 1.93 7.4 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.302 2.668 . . . . 0.0 113.721 -175.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -112.34 -20.6 11.76 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.722 0.772 . . . . 0.0 111.714 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 121.98 -154.26 16.76 Favored Glycine 0 CA--C 1.485 -1.819 0 N-CA-C 108.021 -2.032 . . . . 0.0 108.021 -177.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.5 p -107.92 127.1 64.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.55 ' HG2' ' CD2' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -158.02 151.54 23.52 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -172.713 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.497 HG12 HG12 ' A' ' 86' ' ' ILE . 60.3 mt -83.35 133.39 29.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.85 -177.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.519 ' HE2' ' OE2' ' A' ' 87' ' ' GLU . 18.2 ttmm -90.38 140.79 29.37 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.039 176.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.99 3.29 24.83 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -177.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 52.7 t -143.04 140.93 18.5 Favored Pre-proline 0 N--CA 1.422 -1.836 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -99.5 -2.49 0.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.539 2.159 . . . . 0.0 111.526 174.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.2 m -100.37 -10.28 21.38 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.396 -174.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -74.41 127.16 88.04 Favored Pre-proline 0 N--CA 1.426 -1.651 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -174.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.75 -177.4 3.11 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.376 2.051 . . . . 0.0 112.051 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.55 ' CD2' ' HG2' ' A' ' 94' ' ' LYS . 83.6 m-85 -110.88 119.1 37.96 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -106.14 174.49 5.86 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.645 -176.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -97.91 -39.87 3.71 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.913 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 51.1 m -128.45 162.17 27.8 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.73 -37.35 87.3 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 120.9 0.381 . . . . 0.0 110.271 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.0 m -51.59 -35.22 40.57 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.494 1.117 . . . . 0.0 112.04 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.67 -43.43 76.2 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.606 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 pp -74.55 -29.09 61.23 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.976 0.417 . . . . 0.0 111.175 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 75.6 t -64.77 -51.54 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.964 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.3 t -69.04 -31.97 71.14 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.427 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -63.98 -40.8 97.22 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.662 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.527 ' CD2' ' HA ' ' A' ' 118' ' ' PRO . 30.9 m80 -73.7 -3.88 30.96 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.9 m -82.8 -29.85 29.27 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 171.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.7 mt -90.83 -53.01 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.901 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.6 m -135.33 106.3 10.17 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.527 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 48.0 Cg_endo -78.73 100.9 1.4 Allowed 'Trans proline' 0 N--CA 1.437 -1.823 0 C-N-CA 121.413 1.409 . . . . 0.0 111.171 176.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 68.6 mt -84.07 -65.08 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.798 -176.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.7 m -85.98 -28.54 24.16 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.315 0.578 . . . . 0.0 111.415 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 63.6 mt -93.47 133.37 28.39 Favored Pre-proline 0 C--N 1.293 -1.868 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.146 -176.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.0 -13.47 31.57 Favored 'Trans proline' 0 N--CA 1.482 0.798 0 C-N-CA 123.092 2.528 . . . . 0.0 112.497 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 43.9 t -123.92 148.52 46.8 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . 0.5 ' SG ' ' HG3' ' A' ' 118' ' ' PRO . 45.6 m -73.29 147.16 44.78 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.473 HD23 ' CD1' ' A' ' 44' ' ' PHE . 44.5 mt -78.5 114.14 17.15 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.294 0.569 . . . . 0.0 111.452 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -97.17 96.64 8.57 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.1 mp -62.64 129.86 93.15 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo . . . . . 0 C--N 1.36 1.172 0 C-N-CA 123.176 2.584 . . . . 0.0 112.67 179.68 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.3 p . . . . . 0 N--CA 1.429 -1.508 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.9 m -68.97 -35.49 76.81 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.587 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.04 -11.09 45.89 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -177.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -76.22 -25.65 55.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.961 0.41 . . . . 0.0 110.264 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.51 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 37.0 p-90 -125.83 -26.1 3.53 Favored 'General case' 0 C--O 1.208 -1.082 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -176.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -84.43 111.29 19.33 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.599 -0.688 . . . . 0.0 111.022 -176.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -134.71 85.09 37.16 Favored Pre-proline 0 C--N 1.313 -0.978 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.48 -8.14 17.09 Favored 'Trans proline' 0 C--N 1.333 -0.264 0 C-N-CA 122.327 2.018 . . . . 0.0 113.538 -173.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -93.69 -5.36 48.71 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.318 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.8 tp -94.51 126.96 40.13 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -173.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.5 m -83.85 173.9 10.86 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.068 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -52.21 -55.28 22.13 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.23 1.012 . . . . 0.0 112.506 -175.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -55.7 -44.73 77.68 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.835 0.826 . . . . 0.0 110.684 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -73.39 -31.49 63.93 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 113.828 -1.533 . . . . 0.0 111.17 -174.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.39 74.76 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.447 0.641 . . . . 0.0 110.083 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 76.7 mt -68.13 -37.64 78.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.824 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.61 -32.48 70.45 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.645 175.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.424 ' O ' ' HB3' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -76.47 -47.86 21.52 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.28 -178.112 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.418 ' CD1' HD21 ' A' ' 45' ' ' LEU . 5.7 mp -75.2 -16.54 60.48 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -177.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -80.17 -8.82 59.61 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.326 174.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.424 ' HB3' ' O ' ' A' ' 35' ' ' LEU . 5.1 t70 -91.14 -41.2 11.15 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.017 177.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -91.59 179.56 5.62 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -176.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -86.86 153.45 54.89 Favored Pre-proline 0 C--N 1.31 -1.118 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 -172.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.09 122.78 12.15 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 122.24 1.96 . . . . 0.0 109.946 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.93 -24.89 5.36 Favored Glycine 0 N--CA 1.42 -2.378 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -175.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.8 148.93 39.88 Favored 'General case' 0 C--O 1.248 0.991 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.402 ' CE1' ' HB3' ' A' ' 125' ' ' LEU . 34.1 p90 -149.12 167.05 26.96 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -178.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.418 HD21 ' CD1' ' A' ' 36' ' ' LEU . 1.8 pt? -152.58 151.98 31.29 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 174.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.51 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 55.4 mt -113.12 113.34 43.77 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.404 HH12 ' CD2' ' A' ' 83' ' ' HIS . 15.1 ptt-85 -109.3 -173.82 2.36 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -90.48 129.46 36.65 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 172.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.1 t -82.65 107.45 15.29 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -78.29 75.04 4.82 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 122.459 1.123 . . . . 0.0 110.77 -175.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.3 m -150.61 -45.71 0.12 Allowed 'General case' 0 C--N 1.267 -2.989 0 CA-C-N 113.613 -1.63 . . . . 0.0 108.901 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -131.01 154.38 48.25 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -84.3 121.63 27.78 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.91 37.46 7.28 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.08 119.89 21.61 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -97.97 136.58 38.05 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -101.88 106.76 3.06 Favored Glycine 0 C--N 1.286 -2.218 0 C-N-CA 120.324 -0.941 . . . . 0.0 110.984 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -85.14 117.87 24.36 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 82' ' ' ARG . . . -115.03 125.67 53.84 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.9 tp -120.7 127.1 51.72 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 123.958 0.786 . . . . 0.0 109.446 -177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -88.96 114.74 25.91 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.455 HG12 ' SG ' ' A' ' 123' ' ' CYS . 33.3 m -104.25 169.37 2.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.219 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.88 -43.38 25.1 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 p -160.89 123.01 1.74 Allowed Pre-proline 0 C--N 1.32 -0.707 0 C-N-CA 124.93 1.292 . . . . 0.0 109.534 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.566 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 23.9 Cg_exo -64.85 -47.49 5.0 Favored 'Trans proline' 0 CA--C 1.566 2.101 0 C-N-CA 121.916 1.744 . . . . 0.0 112.232 172.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.566 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 58.1 Cg_endo -71.79 134.17 23.32 Favored 'Trans proline' 0 C--N 1.384 2.425 0 C-N-CA 121.626 1.551 . . . . 0.0 109.959 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.88 -24.47 33.86 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.806 2.337 . . . . 0.0 113.01 -176.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.4 t -115.38 -37.8 3.95 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.465 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 64.34 32.06 12.41 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.957 0.903 . . . . 0.0 112.965 174.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -63.03 -46.17 86.79 Favored Pre-proline 0 CA--C 1.557 1.234 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -56.4 123.04 12.87 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 121.804 1.669 . . . . 0.0 112.089 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -108.88 132.43 54.05 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.051 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -147.26 7.87 0.91 Allowed 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 124.413 1.085 . . . . 0.0 109.536 177.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.54 117.63 0.76 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -172.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -108.74 107.23 59.91 Favored Pre-proline 0 C--N 1.296 -1.742 0 CA-C-O 121.333 0.587 . . . . 0.0 111.256 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -85.42 148.15 10.05 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.12 1.88 . . . . 0.0 109.972 174.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.2 p -53.37 -25.54 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 123.612 0.765 . . . . 0.0 112.722 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -70.71 -27.02 63.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.237 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.2 -31.55 62.69 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.35 -4.48 33.63 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.493 -177.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 73.6 t -91.89 119.13 38.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 6.2 mmp_? -93.26 149.57 21.13 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.404 ' CD2' HH12 ' A' ' 47' ' ' ARG . 60.5 m80 -129.06 122.91 30.97 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.896 0.379 . . . . 0.0 111.052 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -133.28 128.36 35.62 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.417 HD21 ' H ' ' A' ' 85' ' ' LEU . 1.6 pt? -99.04 140.38 33.27 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.582 -1.247 . . . . 0.0 112.711 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 86.0 mt -104.05 119.34 52.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 114.066 -1.425 . . . . 0.0 107.579 178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -99.35 144.34 28.57 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.432 ' HB ' HG12 ' A' ' 93' ' ' VAL . 8.8 t -129.33 153.06 48.22 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.28 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.19 -142.77 4.41 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.38 -22.36 29.34 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.559 2.172 . . . . 0.0 112.742 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -73.51 -50.36 21.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.871 0.843 . . . . 0.0 109.793 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 150.89 -125.08 1.83 Allowed Glycine 0 N--CA 1.422 -2.288 0 N-CA-C 107.505 -2.238 . . . . 0.0 107.505 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.432 HG12 ' HB ' ' A' ' 88' ' ' THR . 16.9 m -127.31 139.49 51.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 175.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.93 145.09 24.61 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.067 -0.396 . . . . 0.0 110.983 177.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.3 mt -75.79 140.58 17.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -57.47 -52.85 63.71 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -105.41 52.33 0.72 Allowed Glycine 0 CA--C 1.495 -1.189 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.821 -174.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.432 ' HA ' ' OG ' ' A' ' 120' ' ' SER . 6.7 p -86.52 123.06 71.64 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 123.764 0.332 . . . . 0.0 111.717 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -65.35 -32.12 51.14 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.644 2.229 . . . . 0.0 113.09 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.3 m -145.4 -19.14 0.48 Allowed 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.591 ' OE2' ' HB ' ' A' ' 119' ' ' ILE . 12.9 mp0 -54.5 128.66 61.04 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -176.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -85.33 -161.35 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.766 2.311 . . . . 0.0 110.572 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -87.19 129.42 34.96 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -103.74 161.49 13.88 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.64 -56.44 2.37 Favored Glycine 0 C--N 1.297 -1.584 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.295 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.9 m -116.05 151.46 35.49 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.07 -35.88 72.01 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.021 0.528 . . . . 0.0 110.671 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 m -51.86 -34.89 42.91 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.647 1.179 . . . . 0.0 112.119 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.84 -42.88 76.57 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.413 -176.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.456 HD11 ' N ' ' A' ' 111' ' ' VAL . 4.4 pp -73.49 -38.83 65.26 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.179 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.456 ' N ' HD11 ' A' ' 110' ' ' LEU . 75.2 t -59.81 -46.06 94.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.398 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.0 p -69.57 -37.97 77.22 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -79.85 -28.33 40.06 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.567 -176.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -77.28 -0.1 24.14 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.6 m -80.44 -18.47 48.7 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 170.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 64.7 mt -108.93 -59.53 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.795 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.9 m -113.97 99.43 50.39 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.539 -177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -90.7 107.57 0.32 Allowed 'Trans proline' 0 N--CA 1.443 -1.486 0 C-N-CA 122.895 2.397 . . . . 0.0 110.919 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.591 ' HB ' ' OE2' ' A' ' 101' ' ' GLU . 25.9 mt -95.18 -64.33 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.432 ' OG ' ' HA ' ' A' ' 98' ' ' CYS . 52.2 m -66.43 -35.39 80.18 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.42 0.629 . . . . 0.0 111.068 174.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -82.65 136.18 45.43 Favored Pre-proline 0 N--CA 1.439 -1.013 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.663 -176.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.97 -19.15 30.72 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.574 2.183 . . . . 0.0 112.256 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.455 ' SG ' HG12 ' A' ' 62' ' ' VAL . 28.5 p -144.13 163.63 33.03 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 25.3 p -71.23 157.69 37.69 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.381 0.61 . . . . 0.0 112.479 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.402 ' HB3' ' CE1' ' A' ' 44' ' ' PHE . 64.8 mt -83.64 115.16 22.02 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.212 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -94.81 104.31 16.22 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.0 mp -69.18 120.98 80.26 Favored Pre-proline 0 C--N 1.317 -0.819 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo . . . . . 0 C--N 1.36 1.164 0 C-N-CA 123.436 2.758 . . . . 0.0 113.091 -177.42 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 N--CA 1.437 -1.103 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.9 t -64.66 -44.65 89.73 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.288 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -4.53 3.53 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -81.95 -35.77 28.69 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.318 0.58 . . . . 0.0 109.511 174.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.408 ' CZ3' HD13 ' A' ' 46' ' ' ILE . 44.7 p-90 -109.46 -28.17 9.06 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -91.32 119.33 31.26 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.55 0.691 . . . . 0.0 110.734 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.42 99.15 5.87 Favored Pre-proline 0 C--N 1.297 -1.683 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.657 172.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.22 -25.11 26.82 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 123.006 2.471 . . . . 0.0 113.629 -171.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -93.96 13.32 23.16 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.433 -173.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.9 tp -92.02 145.52 24.46 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.7 t -99.47 172.31 7.4 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.215 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -55.89 -53.34 57.96 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.299 1.04 . . . . 0.0 112.005 -174.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -67.5 -33.96 76.17 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.1 0.476 . . . . 0.0 111.25 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -70.68 -33.11 70.57 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.221 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.6 -40.67 97.54 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.751 0.786 . . . . 0.0 109.506 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 70.0 mt -69.22 -37.56 76.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 114.755 -1.112 . . . . 0.0 109.582 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.51 -33.8 64.07 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.06 177.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.498 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 4.6 mm? -78.7 -55.73 4.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.105 0.479 . . . . 0.0 110.259 174.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 47.2 mt -59.75 -28.91 67.79 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -174.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -64.55 -28.07 69.39 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.924 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -95.9 -21.61 17.96 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.23 0.538 . . . . 0.0 110.475 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 35' ' ' LEU . 26.2 mtpp -77.91 150.34 34.09 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-O 121.021 0.439 . . . . 0.0 110.818 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -75.05 151.36 86.14 Favored Pre-proline 0 C--N 1.309 -1.187 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.566 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -52.1 121.99 9.8 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 123.429 2.753 . . . . 0.0 112.839 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.81 -23.36 7.03 Favored Glycine 0 N--CA 1.432 -1.627 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.2 145.08 44.45 Favored 'General case' 0 C--O 1.246 0.913 0 O-C-N 124.057 0.504 . . . . 0.0 110.513 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.466 ' CG ' HD12 ' A' ' 125' ' ' LEU . 12.7 p90 -142.83 171.96 13.34 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.34 -176.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -158.49 152.8 24.17 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 172.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.408 HD13 ' CZ3' ' A' ' 22' ' ' TRP . 55.8 mt -125.3 134.01 67.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.4 ptt-85 -133.38 -178.69 5.1 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -83.2 147.87 27.77 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.2 m -78.16 139.81 38.99 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.157 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -84.96 -36.07 21.62 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.9 m -69.2 -46.79 66.59 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.738 -176.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -131.1 146.41 52.35 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -87.11 148.97 25.0 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.67 23.05 70.96 Favored Glycine 0 CA--C 1.499 -0.962 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.59 137.1 43.45 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -110.52 121.85 46.32 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.68 114.56 3.95 Favored Glycine 0 N--CA 1.424 -2.112 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.276 -176.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 42.6 tp -94.0 123.62 37.48 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -112.91 122.15 46.78 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 176.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.4 tp -115.65 128.69 56.1 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.42 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 22.0 tptm -88.72 114.82 25.75 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 80' ' ' LEU . 29.3 m -108.61 171.73 2.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.76 -51.56 12.39 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.6 p -151.63 125.72 4.44 Favored Pre-proline 0 N--CA 1.431 -1.414 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.244 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.604 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 34.9 Cg_exo -60.1 -45.68 22.51 Favored 'Trans proline' 0 CA--C 1.577 2.652 0 C-N-CA 121.859 1.706 . . . . 0.0 111.506 169.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.604 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 46.5 Cg_endo -63.72 161.17 33.32 Favored 'Trans proline' 0 C--N 1.391 2.778 0 C-N-CA 122.934 2.423 . . . . 0.0 110.054 171.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.33 -40.89 45.64 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.42 2.08 . . . . 0.0 112.831 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.1 p -137.57 -17.97 1.27 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 65.33 33.47 9.02 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.059 0.944 . . . . 0.0 111.513 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -65.49 -45.7 68.84 Favored Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.452 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -74.29 103.72 1.73 Allowed 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 121.119 1.213 . . . . 0.0 109.148 169.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 56.0 t-105 -107.8 143.67 36.05 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.12 -175.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -134.93 8.72 3.52 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.77 51.23 4.11 Favored Glycine 0 CA--C 1.49 -1.48 0 C-N-CA 119.726 -1.226 . . . . 0.0 110.37 -175.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -91.32 119.09 68.77 Favored Pre-proline 0 N--CA 1.437 -1.107 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -49.66 146.66 14.86 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.818 3.012 . . . . 0.0 115.168 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -60.13 -21.03 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 CA-C-O 122.23 1.014 . . . . 0.0 109.794 174.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -69.65 -20.14 63.6 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.359 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -90.31 -7.86 52.31 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.651 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.411 ' O ' HG22 ' A' ' 62' ' ' VAL . 80.2 mt -83.53 -6.23 59.39 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 122.091 0.948 . . . . 0.0 108.844 177.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.8 t -85.87 134.25 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.27 174.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -111.05 130.7 55.52 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -109.71 122.86 48.44 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.049 0.452 . . . . 0.0 111.522 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -133.27 147.75 51.93 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 177.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -119.05 131.06 55.93 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 118.709 -1.196 . . . . 0.0 112.314 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.463 HG12 HG12 ' A' ' 95' ' ' ILE . 78.8 mt -87.7 118.23 33.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 178.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.553 ' OE1' ' HE2' ' A' ' 96' ' ' LYS . 39.8 mt-10 -98.97 138.9 35.41 Favored 'General case' 0 C--N 1.27 -2.867 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.481 ' HB ' HG11 ' A' ' 93' ' ' VAL . 7.2 t -120.43 116.66 25.89 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-O 121.989 0.899 . . . . 0.0 109.929 178.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -125.84 -166.69 12.33 Favored Glycine 0 N--CA 1.416 -2.651 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.483 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -68.49 -11.47 32.03 Favored 'Trans proline' 0 C--N 1.331 -0.351 0 C-N-CA 122.949 2.433 . . . . 0.0 113.173 -176.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.607 ' HD3' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -97.06 -17.16 20.16 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.911 179.513 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 136.19 -164.07 25.07 Favored Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -177.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.481 HG11 ' HB ' ' A' ' 88' ' ' THR . 8.3 m -104.97 148.41 9.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -164.81 157.89 16.89 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.233 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.653 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 60.5 mt -92.27 131.95 37.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.627 0.727 . . . . 0.0 112.008 -174.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.553 ' HE2' ' OE1' ' A' ' 87' ' ' GLU . 22.3 ttmm -88.78 132.87 34.44 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 172.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.49 7.1 7.71 Favored Glycine 0 C--N 1.308 -1.027 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -172.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.406 ' SG ' HG23 ' A' ' 119' ' ' ILE . 42.3 t -142.42 142.36 23.39 Favored Pre-proline 0 N--CA 1.428 -1.567 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -87.73 -13.92 3.84 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.264 1.976 . . . . 0.0 113.244 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.0 m -85.79 -82.76 0.18 Allowed 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.653 ' HG3' ' O ' ' A' ' 95' ' ' ILE . 28.2 mm-40 46.95 97.26 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 117.603 2.445 . . . . 0.0 117.603 174.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -81.63 147.79 15.72 Favored 'Trans proline' 0 N--CA 1.437 -1.845 0 C-N-CA 122.015 1.81 . . . . 0.0 108.926 172.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.418 ' CD2' ' HB2' ' A' ' 91' ' ' LYS . 87.3 m-85 -76.98 123.38 26.25 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.6 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 110' ' ' LEU . 59.9 m-85 -103.54 164.38 11.7 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.18 -53.5 2.49 Favored Glycine 0 C--N 1.305 -1.156 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.625 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 61.9 m -116.04 160.73 19.89 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 122.918 -0.166 . . . . 0.0 110.977 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.33 -35.17 79.5 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.938 0.399 . . . . 0.0 110.985 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -55.26 -30.82 60.84 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 123.912 0.885 . . . . 0.0 111.479 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.33 -49.33 69.85 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.419 -178.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.432 ' H ' HD12 ' A' ' 110' ' ' LEU 0.293 0.0 OUTLIER -72.52 -28.58 62.95 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.972 -179.78 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 73.4 t -63.65 -49.42 82.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 123.656 0.598 . . . . 0.0 110.076 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.0 t -68.45 -37.88 80.62 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.044 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -75.22 -40.57 59.0 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.462 ' HA ' ' O ' ' A' ' 117' ' ' SER . 25.4 m80 -67.7 -10.96 57.03 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.8 t -72.96 -32.09 65.0 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 175.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 62.4 mt -96.44 -53.5 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 19.8 m -114.77 103.57 54.74 Favored Pre-proline 0 N--CA 1.436 -1.141 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.633 -177.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -78.45 89.35 1.36 Allowed 'Trans proline' 0 N--CA 1.44 -1.657 0 C-N-CA 122.527 2.151 . . . . 0.0 110.922 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.406 HG23 ' SG ' ' A' ' 98' ' ' CYS . 43.5 mt -74.58 -66.57 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.56 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.5 t -85.11 -31.22 23.44 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.645 0.736 . . . . 0.0 110.111 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 69.5 mt -83.92 139.56 40.09 Favored Pre-proline 0 C--N 1.303 -1.444 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.377 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -76.81 -10.58 18.34 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.664 2.243 . . . . 0.0 112.893 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 45.1 t -137.37 160.83 37.97 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 39.3 m -70.61 136.0 48.86 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.466 HD12 ' CG ' ' A' ' 44' ' ' PHE . 23.9 tp -75.07 132.7 41.46 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.52 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.528 ' O ' ' HD3' ' A' ' 128' ' ' PRO . 36.6 mmt180 -118.07 128.81 55.12 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mp -95.26 106.31 25.25 Favored Pre-proline 0 C--N 1.312 -1.023 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 126' ' ' ARG . 33.6 Cg_exo . . . . . 0 N--CA 1.457 -0.652 0 C-N-CA 122.266 1.977 . . . . 0.0 111.988 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.9 p . . . . . 0 N--CA 1.434 -1.273 0 CA-C-O 122.02 0.914 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.9 m -75.9 -7.71 55.19 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.847 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.89 -16.56 53.26 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 119.936 -0.706 . . . . 0.0 111.695 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -69.75 -25.55 63.88 Favored 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -175.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 19.6 p-90 -113.25 -4.21 13.75 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.191 0.52 . . . . 0.0 111.917 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -107.45 114.32 28.25 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.786 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.66 96.97 3.53 Favored Pre-proline 0 C--N 1.295 -1.78 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.574 174.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -79.81 13.96 2.0 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.443 2.762 . . . . 0.0 114.038 -171.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -102.92 -6.58 22.3 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 120.859 0.361 . . . . 0.0 110.421 -176.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.458 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 75.9 mt -87.32 142.54 27.81 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.478 0.656 . . . . 0.0 111.762 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 87.3 p -89.17 177.81 6.53 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.983 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -63.05 -43.25 99.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -55.08 -48.2 73.86 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.316 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -70.31 -34.39 72.66 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.381 -178.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.2 -44.59 87.87 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.237 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 51.2 mt -66.64 -38.94 82.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.486 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.06 -40.37 89.21 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.377 0.608 . . . . 0.0 110.346 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -46.0 69.56 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.055 -179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 72.4 mt -74.86 -17.19 60.63 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -176.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -83.06 -11.28 58.18 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.149 -1.021 . . . . 0.0 110.37 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -93.91 -24.3 17.75 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.606 0.717 . . . . 0.0 109.454 175.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -99.91 164.52 11.98 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -72.49 156.91 89.84 Favored Pre-proline 0 C--N 1.287 -2.127 0 CA-C-N 112.177 -2.283 . . . . 0.0 112.749 -176.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -60.46 126.31 19.64 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.892 2.395 . . . . 0.0 111.379 175.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 112.96 -7.74 25.47 Favored Glycine 0 C--N 1.303 -1.25 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -176.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.49 150.3 32.98 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-N 115.534 -0.333 . . . . 0.0 110.341 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.493 ' CD1' HD12 ' A' ' 125' ' ' LEU . 9.8 p90 -149.25 167.63 25.5 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -155.97 148.72 24.04 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 171.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 63.2 mt -120.79 130.27 74.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-O 121.124 0.488 . . . . 0.0 110.656 -178.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -137.82 -176.96 4.6 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.044 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -62.66 134.39 56.25 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.8 t -74.57 136.38 42.09 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.371 0.605 . . . . 0.0 110.704 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -72.75 -27.06 61.8 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.325 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.2 m -81.13 -52.26 7.57 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.965 -175.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -137.73 145.26 42.28 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -175.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -82.98 151.92 25.66 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 173.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.03 9.96 81.52 Favored Glycine 0 C--N 1.305 -1.179 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.44 144.48 48.16 Favored 'General case' 0 N--CA 1.406 -2.648 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -116.9 126.34 52.83 Favored 'General case' 0 C--N 1.273 -2.749 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.419 ' O ' ' HD3' ' A' ' 47' ' ' ARG . . . -83.76 115.15 4.0 Favored Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.031 -177.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.7 tp -95.59 121.63 37.5 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 123.728 0.811 . . . . 0.0 109.03 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 44' ' ' PHE . . . -105.57 127.56 53.1 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 176.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -124.04 125.59 44.79 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -176.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.459 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 21.7 tptm -88.34 114.62 25.15 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.675 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.522 HG21 ' O ' ' A' ' 80' ' ' LEU . 20.0 m -96.85 167.61 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.07 -59.11 2.87 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 174.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.73 141.72 12.91 Favored Pre-proline 0 N--CA 1.428 -1.529 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.84 177.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.562 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 32.0 Cg_exo -59.47 -42.79 45.04 Favored 'Trans proline' 0 CA--C 1.573 2.454 0 C-N-CA 122.283 1.989 . . . . 0.0 112.61 174.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.562 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 39.7 Cg_endo -65.13 148.12 88.91 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 122.832 2.354 . . . . 0.0 109.77 172.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.79 -37.14 88.67 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.749 2.299 . . . . 0.0 113.048 -177.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.7 t -132.37 -11.07 3.22 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.949 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 69.83 31.99 3.31 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 124.345 1.058 . . . . 0.0 112.923 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -64.14 -43.75 74.95 Favored Pre-proline 0 CA--C 1.556 1.199 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.631 173.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -84.69 101.3 0.79 Allowed 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 121.446 1.43 . . . . 0.0 109.893 167.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 34.6 t-105 -92.53 146.66 23.51 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.909 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -121.82 -36.52 3.01 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.966 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.44 14.12 12.09 Favored Glycine 0 C--N 1.3 -1.466 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.31 -176.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -64.53 134.09 95.89 Favored Pre-proline 0 C--N 1.316 -0.865 0 C-N-CA 122.63 0.372 . . . . 0.0 110.701 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.1 173.19 14.91 Favored 'Trans proline' 0 C--O 1.245 0.844 0 C-N-CA 123.042 2.495 . . . . 0.0 113.855 -175.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -56.42 -30.31 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.478 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -58.78 -25.11 62.78 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 122.955 0.502 . . . . 0.0 112.238 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -92.05 -14.23 29.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.059 0.457 . . . . 0.0 110.56 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.522 ' O ' HG21 ' A' ' 62' ' ' VAL . 72.9 mt -81.95 -13.07 58.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 122.006 0.908 . . . . 0.0 108.642 178.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.2 t -94.91 111.37 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 175.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.403 ' NH2' ' HB3' ' A' ' 65' ' ' PRO . 32.4 mmt180 -85.19 147.46 26.59 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.428 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.9 m80 -126.13 123.21 37.79 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.586 0.708 . . . . 0.0 111.723 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -132.49 163.52 28.63 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 106.282 -1.748 . . . . 0.0 106.282 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -130.02 132.65 46.31 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.047 176.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 94' ' ' LYS . 75.1 mt -90.84 110.65 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.332 0 CA-C-N 114.48 -1.236 . . . . 0.0 107.668 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -100.2 152.69 19.98 Favored 'General case' 0 C--N 1.268 -2.954 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.481 ' HB ' HG13 ' A' ' 93' ' ' VAL . 4.3 t -134.14 148.82 51.01 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-O 121.214 0.531 . . . . 0.0 110.675 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.45 -159.51 11.15 Favored Glycine 0 N--CA 1.42 -2.384 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.37 -21.44 72.68 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.929 2.419 . . . . 0.0 112.939 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -88.83 -5.79 57.79 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.733 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 110.36 -147.56 17.44 Favored Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.481 HG13 ' HB ' ' A' ' 88' ' ' THR . 12.1 m -108.11 151.95 10.08 Favored 'Isoleucine or valine' 0 C--O 1.252 1.23 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 13.8 pttp -151.38 147.95 27.53 Favored 'General case' 0 C--N 1.311 -1.078 0 O-C-N 123.777 0.673 . . . . 0.0 109.859 -175.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.508 ' HB ' ' OE2' ' A' ' 101' ' ' GLU . 76.5 mt -101.46 108.38 23.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -75.36 119.06 18.94 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 120.984 0.421 . . . . 0.0 110.071 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 121.22 -2.74 11.47 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.072 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 24.1 p -70.93 152.9 94.96 Favored Pre-proline 0 C--N 1.317 -0.809 0 C-N-CA 123.026 0.53 . . . . 0.0 110.006 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -72.41 -52.64 0.17 Allowed 'Trans proline' 0 C--O 1.24 0.616 0 C-N-CA 121.729 1.619 . . . . 0.0 110.16 173.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.2 m -144.99 139.86 27.79 Favored 'General case' 0 N--CA 1.41 -2.467 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.508 ' OE2' ' HB ' ' A' ' 95' ' ' ILE . 38.3 tt0 -166.56 142.67 3.88 Favored Pre-proline 0 C--N 1.297 -1.713 0 O-C-N 123.479 0.487 . . . . 0.0 112.165 -176.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -92.71 160.62 2.83 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 123.171 2.581 . . . . 0.0 110.3 168.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -74.07 127.02 31.84 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -79.14 -72.59 0.38 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.023 0.439 . . . . 0.0 111.248 -176.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 148.91 -58.6 0.46 Allowed Glycine 0 C--N 1.309 -0.929 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.1 m -132.53 155.9 47.79 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.458 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 10.7 mp -53.11 -46.31 68.65 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.436 0.46 . . . . 0.0 111.164 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.4 m -53.83 -30.75 46.65 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.898 0.879 . . . . 0.0 112.458 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.58 -37.12 73.89 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 120.64 0.257 . . . . 0.0 111.288 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 107' ' ' LEU . 4.3 pp -80.35 -23.43 40.53 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.462 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 107' ' ' LEU . 70.8 t -71.44 -40.31 72.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.388 177.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.0 p -70.25 -22.86 62.84 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.029 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.573 ' HG2' ' H ' ' A' ' 114' ' ' HIS . 8.5 tt0 -95.2 -172.51 2.69 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 177.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.573 ' H ' ' HG2' ' A' ' 113' ' ' GLN . 57.2 m80 77.87 -26.07 0.19 Allowed 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.9 m -66.81 -41.9 86.79 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 173.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 65.8 mt -74.23 -66.25 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.404 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.7 m -125.75 118.79 24.26 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -78.75 101.09 1.42 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.238 1.959 . . . . 0.0 111.002 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 56.5 mt -95.02 -71.15 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.508 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.0 m -71.28 -30.2 65.99 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.343 0.592 . . . . 0.0 110.554 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 85.9 mt -101.49 148.81 35.74 Favored Pre-proline 0 C--N 1.304 -1.399 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.104 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -77.43 -29.29 4.89 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.007 1.805 . . . . 0.0 113.109 -178.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 79.9 m -114.8 155.03 27.51 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.81 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 64.7 m -62.68 122.72 16.57 Favored 'General case' 0 C--O 1.241 0.606 0 O-C-N 123.982 0.802 . . . . 0.0 109.645 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.493 HD12 ' CD1' ' A' ' 44' ' ' PHE . 27.4 tp -74.11 134.56 42.89 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.724 -173.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -117.96 129.03 55.36 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mp -93.29 132.98 29.24 Favored Pre-proline 0 C--O 1.193 -1.884 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -174.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 N--CA 1.488 1.185 0 C-N-CA 122.842 2.362 . . . . 0.0 112.898 179.123 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 35.0 p . . . . . 0 N--CA 1.408 -2.549 0 CA-C-O 120.659 0.266 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.401 ' HA ' ' CE2' ' A' ' 22' ' ' TRP . 48.3 p -53.38 -49.55 66.98 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -173.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -10.19 57.8 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 119.86 -0.736 . . . . 0.0 112.614 -177.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -83.34 -25.19 31.67 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.528 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.401 ' CE2' ' HA ' ' A' ' 19' ' ' SER . 27.0 p-90 -119.39 -22.09 7.19 Favored 'General case' 0 C--O 1.214 -0.795 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 52.1 t80 -90.97 112.77 24.8 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.775 -177.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.78 92.07 41.27 Favored Pre-proline 0 C--N 1.315 -0.929 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 175.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -57.64 -44.41 41.74 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 123.341 2.694 . . . . 0.0 115.942 -169.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -104.96 16.91 25.08 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.368 0.604 . . . . 0.0 111.364 -170.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.5 tp -74.62 146.25 42.6 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 85.4 p -93.0 166.66 12.26 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.96 -0.462 . . . . 0.0 110.257 -175.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -57.02 -49.41 75.88 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.939 0.399 . . . . 0.0 110.934 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -60.89 -34.82 75.24 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.296 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -75.87 -30.83 59.01 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.928 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.42 -43.14 77.81 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 75.8 mt -66.58 -40.22 85.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.624 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.21 -34.55 70.52 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.373 0.669 . . . . 0.0 111.104 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.72 -49.63 15.56 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.48 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 67.2 mt -68.49 -32.61 72.72 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -175.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -63.51 -21.54 66.38 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.065 0.459 . . . . 0.0 111.43 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -90.32 -10.14 45.18 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.275 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.65 -178.34 3.63 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.758 -174.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -99.96 160.72 26.47 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.111 -177.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -59.04 125.99 19.75 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 122.491 2.127 . . . . 0.0 111.673 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.51 -22.57 9.38 Favored Glycine 0 N--CA 1.43 -1.729 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.3 148.76 46.8 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.992 -0.374 . . . . 0.0 109.992 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -153.56 168.53 25.88 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.043 -175.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -153.15 152.43 31.26 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 172.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 23' ' ' TYR . 55.8 mt -121.98 133.19 69.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -127.02 -173.9 3.01 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -84.69 127.72 34.24 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 171.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.4 t -79.21 108.07 12.45 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -66.1 -6.53 13.48 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.75 -1.114 . . . . 0.0 113.912 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.1 p -77.62 -18.34 56.88 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.507 0.67 . . . . 0.0 110.977 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -135.83 -174.55 3.69 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -124.14 121.29 34.73 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.12 0.486 . . . . 0.0 109.918 172.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.04 43.65 8.05 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.37 159.33 41.36 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.529 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 50.5 m-85 -112.31 150.11 31.47 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.328 -176.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -126.76 116.45 2.5 Favored Glycine 0 C--N 1.282 -2.458 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 50.5 tp -94.77 123.24 38.11 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 123.144 0.578 . . . . 0.0 109.84 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -107.57 115.61 30.46 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 175.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.3 tp -110.79 127.52 55.41 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 123.491 0.494 . . . . 0.0 110.487 -177.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 26.7 tptp -88.64 115.49 26.2 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.4 m -106.96 164.91 4.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.66 -53.26 43.69 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.463 ' HB ' ' HG2' ' A' ' 66' ' ' PRO . 1.3 p -159.76 140.73 9.14 Favored Pre-proline 0 N--CA 1.423 -1.8 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 175.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.572 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 30.1 Cg_exo -56.7 -43.18 57.34 Favored 'Trans proline' 0 CA--C 1.571 2.327 0 C-N-CA 122.215 1.944 . . . . 0.0 112.704 175.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.572 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 43.5 Cg_endo -62.81 153.4 72.93 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.182 2.588 . . . . 0.0 110.426 171.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -57.31 -45.35 35.49 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.524 2.149 . . . . 0.0 112.632 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.9 m -133.44 1.32 3.42 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.511 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 60.16 38.22 20.36 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.828 0.851 . . . . 0.0 111.856 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -54.74 -49.74 89.77 Favored Pre-proline 0 CA--C 1.552 1.055 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.933 177.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -78.0 139.83 17.58 Favored 'Trans proline' 0 C--N 1.366 1.479 0 CA-C-N 120.253 1.126 . . . . 0.0 111.406 173.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -96.47 136.62 36.72 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -132.68 -12.22 3.02 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.038 0.447 . . . . 0.0 110.502 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.48 56.12 4.38 Favored Glycine 0 CA--C 1.493 -1.299 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -175.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -83.63 132.86 47.95 Favored Pre-proline 0 C--N 1.289 -2.024 0 C-N-CA 123.563 0.745 . . . . 0.0 111.395 -175.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -81.93 166.84 16.73 Favored 'Trans proline' 0 N--CA 1.445 -1.327 0 C-N-CA 122.122 1.881 . . . . 0.0 111.827 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.8 p -61.2 -24.47 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.486 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -65.26 -26.67 68.19 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.957 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -82.35 -27.73 32.01 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.109 0.48 . . . . 0.0 109.957 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.0 mt -74.72 -11.7 60.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.553 0.692 . . . . 0.0 110.367 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.2 t -103.15 118.47 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -100.36 129.78 46.38 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 -178.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -107.24 121.76 45.18 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 121.038 0.447 . . . . 0.0 109.8 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -127.79 118.37 23.61 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.2 pp -96.24 139.34 32.53 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.111 -177.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.529 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 76.9 mt -99.97 129.24 50.94 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 CA-C-N 114.402 -1.272 . . . . 0.0 107.935 -177.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.6 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 35.3 mt-10 -99.11 157.38 16.4 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -177.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 92' ' ' GLY . 4.4 t -147.54 128.89 14.84 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 175.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.39 -141.9 3.67 Favored Glycine 0 N--CA 1.426 -2.013 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.389 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.62 -47.63 25.72 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.723 2.949 . . . . 0.0 113.108 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -74.57 -60.73 2.15 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.584 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 167.46 -146.17 10.44 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 119.976 -1.107 . . . . 0.0 111.627 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.6 ' HA ' ' O ' ' A' ' 87' ' ' GLU . 22.0 m -104.9 149.36 8.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 O-C-N 124.007 0.475 . . . . 0.0 111.078 -175.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.89 157.64 3.04 Favored 'General case' 0 C--O 1.252 1.187 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 172.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 71.9 mt -76.17 129.15 37.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-O 121.959 0.885 . . . . 0.0 112.35 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -69.77 121.17 16.72 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.55 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 109.72 -1.16 30.47 Favored Glycine 0 C--N 1.306 -1.118 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 101' ' ' GLU . 37.9 t -108.81 110.26 61.12 Favored Pre-proline 0 N--CA 1.431 -1.396 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -96.45 21.24 0.43 Allowed 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.098 2.532 . . . . 0.0 112.671 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.5 m -138.13 31.91 2.4 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.852 0.834 . . . . 0.0 109.093 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.612 ' HB2' ' SG ' ' A' ' 98' ' ' CYS . 29.7 tt0 -134.46 123.5 16.49 Favored Pre-proline 0 N--CA 1.426 -1.675 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.588 -173.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.37 174.76 12.26 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.594 2.196 . . . . 0.0 112.076 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -86.25 129.03 34.98 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -106.93 172.78 6.63 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -98.41 -54.8 1.14 Allowed Glycine 0 C--N 1.304 -1.225 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.103 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.5 m -105.95 153.78 21.5 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 123.128 0.571 . . . . 0.0 110.028 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.428 HD21 ' CD2' ' A' ' 56' ' ' TYR . 92.6 mt -65.35 -36.19 83.25 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.049 0.452 . . . . 0.0 110.041 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.8 m -53.05 -29.25 28.84 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.001 0.92 . . . . 0.0 112.697 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.73 -41.83 74.75 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.405 HD13 ' H ' ' A' ' 110' ' ' LEU 0.306 0.0 OUTLIER -80.07 -32.36 39.31 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.215 177.285 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.407 ' HA ' ' CD2' ' A' ' 125' ' ' LEU . 67.6 t -57.08 -42.68 79.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.307 0.575 . . . . 0.0 110.91 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.8 p -72.15 -33.44 67.74 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.984 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -80.01 -36.35 36.02 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.502 ' HA ' ' O ' ' A' ' 117' ' ' SER . 27.9 m-70 -71.65 -5.47 33.89 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -174.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.8 m -73.33 -30.08 63.11 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 172.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.417 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 52.9 mt -101.03 -52.16 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.109 -177.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 38.8 t -111.72 95.87 30.11 Favored Pre-proline 0 N--CA 1.424 -1.773 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.036 -175.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 116' ' ' ILE . 5.8 Cg_endo -85.78 74.54 3.43 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 122.733 2.289 . . . . 0.0 109.942 178.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.1 mt -66.19 -56.24 15.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.861 -175.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.573 ' HB3' ' SG ' ' A' ' 98' ' ' CYS . 2.4 p -96.31 6.18 49.34 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.081 -177.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 69.2 mt -123.49 140.84 34.89 Favored Pre-proline 0 C--N 1.308 -1.199 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.755 -173.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.03 -8.44 15.45 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.576 2.184 . . . . 0.0 112.033 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 77.1 m -140.29 168.81 18.93 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 59.3 m -79.21 145.76 33.45 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 120.733 0.301 . . . . 0.0 110.27 -178.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.407 ' CD2' ' HA ' ' A' ' 111' ' ' VAL . 15.5 tp -85.6 108.73 18.12 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -106.65 107.47 18.5 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.54 0.686 . . . . 0.0 111.721 -174.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 58.2 mt -65.74 120.92 72.64 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.763 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 0 C--N 1.351 0.7 0 C-N-CA 122.246 1.964 . . . . 0.0 111.735 179.173 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.421 -1.915 0 CA-C-O 122.144 0.974 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.452 ' HA ' ' CE2' ' A' ' 22' ' ' TRP . 27.1 m -66.77 -22.25 66.04 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.501 177.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.72 0.46 5.54 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.882 -1.054 . . . . 0.0 113.076 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -94.52 -27.12 16.13 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 122.233 -0.292 . . . . 0.0 110.486 174.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.452 ' CE2' ' HA ' ' A' ' 19' ' ' SER . 31.0 p-90 -134.49 -8.24 2.52 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -170.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -96.75 114.39 26.03 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.029 -0.669 . . . . 0.0 111.327 -176.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -120.02 86.57 37.17 Favored Pre-proline 0 C--O 1.2 -1.528 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 176.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -54.11 -40.9 79.79 Favored 'Trans proline' 0 N--CA 1.479 0.628 0 C-N-CA 123.264 2.643 . . . . 0.0 115.936 -170.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -97.32 10.13 40.43 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -171.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.7 tp -75.61 136.81 40.47 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.454 0.645 . . . . 0.0 110.657 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.1 m -80.56 161.11 24.94 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.641 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -56.71 -51.42 68.87 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.275 0.63 . . . . 0.0 110.961 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -59.46 -44.66 92.93 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.583 0.706 . . . . 0.0 110.909 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -69.81 -30.53 68.07 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.863 -176.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.52 -36.97 82.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.667 0.746 . . . . 0.0 110.306 178.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 72.4 mt -69.73 -40.23 78.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.593 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.76 -33.31 73.86 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.789 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.87 -36.14 75.25 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.569 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.448 ' HB3' ' HG2' ' A' ' 61' ' ' LYS . 63.8 mt -87.85 -22.33 24.51 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -71.3 -9.42 58.09 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.571 0.7 . . . . 0.0 110.594 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -91.89 -25.18 19.06 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.43 174.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -106.71 155.58 19.52 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -169.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -66.07 156.5 84.16 Favored Pre-proline 0 C--N 1.32 -0.696 0 C-N-CA 125.334 1.454 . . . . 0.0 113.321 -172.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.24 111.96 1.26 Allowed 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 122.876 2.384 . . . . 0.0 111.045 175.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.05 -18.21 5.33 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -176.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.77 147.36 35.35 Favored 'General case' 0 C--O 1.251 1.146 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 177.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -153.17 169.48 22.9 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -175.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -160.35 154.33 22.98 Favored 'General case' 0 C--O 1.254 1.307 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 173.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 56.9 mt -126.8 137.61 57.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 123.354 0.409 . . . . 0.0 109.922 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.475 HH22 ' CD2' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -134.67 177.9 7.42 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 177.125 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -74.08 130.02 38.99 Favored 'General case' 0 C--O 1.249 1.034 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 175.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.0 t -82.56 92.76 7.17 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-O 121.526 0.679 . . . . 0.0 109.242 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -75.44 76.36 2.5 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-O 122.322 1.058 . . . . 0.0 108.782 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.5 t -161.87 -40.97 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 112.804 -1.998 . . . . 0.0 107.877 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -135.93 142.98 44.7 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -76.84 133.79 39.24 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.273 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.13 37.36 28.92 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.62 143.51 47.36 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -115.55 133.26 56.2 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.44 ' O ' ' HD3' ' A' ' 47' ' ' ARG . . . -97.83 119.14 6.32 Favored Glycine 0 C--N 1.283 -2.376 0 C-N-CA 119.836 -1.173 . . . . 0.0 112.018 -176.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 48.3 tp -97.4 136.08 38.36 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -122.04 129.97 52.88 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.4 tp -127.59 132.05 49.86 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 123.505 0.503 . . . . 0.0 110.957 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.448 ' HG2' ' HB3' ' A' ' 36' ' ' LEU . 0.7 OUTLIER -88.55 115.61 26.2 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 174.716 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.7 m -102.29 171.85 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.85 -56.09 6.36 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 p -152.57 137.6 11.03 Favored Pre-proline 0 N--CA 1.435 -1.204 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.477 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.642 ' HD2' ' CD ' ' A' ' 66' ' ' PRO . 16.6 Cg_exo -65.51 -44.7 8.14 Favored 'Trans proline' 0 CA--C 1.568 2.19 0 C-N-CA 121.625 1.55 . . . . 0.0 110.91 173.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.642 ' CD ' ' HD2' ' A' ' 65' ' ' PRO . 14.8 Cg_exo -71.14 165.6 31.9 Favored 'Trans proline' 0 C--N 1.397 3.098 0 C-N-CA 122.219 1.946 . . . . 0.0 109.87 168.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -50.58 -35.63 47.13 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.472 2.781 . . . . 0.0 112.953 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 65.2 m -151.7 -13.39 0.2 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 63.36 41.17 7.88 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.857 0.863 . . . . 0.0 111.835 175.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -58.88 -51.8 79.27 Favored Pre-proline 0 CA--C 1.553 1.082 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.269 171.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.4 127.91 21.17 Favored 'Trans proline' 0 C--N 1.387 2.578 0 C-N-CA 122.072 1.848 . . . . 0.0 112.049 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -98.98 139.48 34.56 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.195 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -136.79 16.43 3.08 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.173 0.589 . . . . 0.0 110.067 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.34 64.53 1.76 Allowed Glycine 0 CA--C 1.486 -1.752 0 N-CA-C 107.024 -2.43 . . . . 0.0 107.024 -172.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -104.58 103.19 38.55 Favored Pre-proline 0 C--N 1.301 -1.524 0 CA-C-N 114.953 -0.623 . . . . 0.0 110.358 -172.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.505 ' HB2' ' OE1' ' A' ' 78' ' ' GLU . 71.7 Cg_endo -78.8 175.53 10.88 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.052 1.835 . . . . 0.0 111.236 177.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 p -68.96 -28.2 38.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.568 0.699 . . . . 0.0 110.589 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.505 ' OE1' ' HB2' ' A' ' 76' ' ' PRO . 11.7 mp0 -66.52 -22.09 66.17 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.172 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -78.03 -18.16 56.18 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.651 0.738 . . . . 0.0 109.607 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.0 mt -84.13 -4.16 58.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.427 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.0 t -92.72 118.73 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -90.85 145.78 24.48 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.475 ' CD2' HH22 ' A' ' 47' ' ' ARG . 29.7 m80 -120.52 125.56 48.16 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.195 0.521 . . . . 0.0 111.793 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -138.32 131.96 30.87 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -104.83 142.36 34.86 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.893 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.6 mp -98.83 123.59 51.53 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.083 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.405 ' OE1' ' HD3' ' A' ' 96' ' ' LYS . 48.5 mt-10 -98.86 139.76 34.06 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.46 ' HB ' HG23 ' A' ' 93' ' ' VAL . 12.1 t -133.35 153.41 51.62 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.33 -152.21 11.33 Favored Glycine 0 N--CA 1.42 -2.415 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.73 -13.14 37.81 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.662 2.241 . . . . 0.0 112.669 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -86.62 -6.84 58.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.329 0.585 . . . . 0.0 110.6 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 109.42 -140.32 15.66 Favored Glycine 0 N--CA 1.427 -1.924 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.46 HG23 ' HB ' ' A' ' 88' ' ' THR . 12.5 p -132.28 126.3 55.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -146.77 140.99 26.25 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.391 -0.818 . . . . 0.0 112.969 -176.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.4 mt -72.04 126.75 33.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.562 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.405 ' HD3' ' OE1' ' A' ' 87' ' ' GLU . 25.7 tptp -76.01 97.91 4.15 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.498 ' O ' ' HD3' ' A' ' 99' ' ' PRO . . . 135.81 4.12 2.46 Favored Glycine 0 N--CA 1.425 -2.084 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.505 -176.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 46.0 t -93.23 104.79 13.09 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 97' ' ' GLY . 72.8 Cg_endo -89.64 -10.23 3.77 Favored 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 121.878 1.718 . . . . 0.0 112.419 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.4 t -71.16 -75.17 0.13 Allowed 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 176.32 103.9 0.1 Allowed Pre-proline 0 C--O 1.234 0.277 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.412 ' HB2' ' HB2' ' A' ' 94' ' ' LYS . 23.3 Cg_endo -96.25 -128.18 0.01 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.887 0 C-N-CA 122.841 2.361 . . . . 0.0 112.435 177.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 62.43 86.87 0.11 Allowed 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 125.55 1.54 . . . . 0.0 111.231 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -110.7 177.38 4.69 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 113.955 -1.475 . . . . 0.0 108.722 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -88.13 -48.01 4.22 Favored Glycine 0 C--N 1.314 -0.68 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.344 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.2 m -134.28 160.1 38.92 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 66.0 mt -56.84 -44.47 82.12 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.543 0.337 . . . . 0.0 111.389 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 32.3 t -54.91 -31.26 59.97 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.817 0.847 . . . . 0.0 111.102 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.33 -44.27 88.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.013 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.433 ' H ' HD11 ' A' ' 110' ' ' LEU 0.302 0.0 OUTLIER -80.26 -31.17 38.47 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 119.146 -1.021 . . . . 0.0 112.01 177.608 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.7 t -61.87 -54.2 37.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.169 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.1 t -70.5 -31.62 68.79 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -174.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -68.65 -25.91 65.06 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.726 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.418 ' CD2' ' H ' ' A' ' 119' ' ' ILE . 45.7 m80 -77.37 -0.98 27.76 Favored 'General case' 0 C--O 1.214 -0.814 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 35.1 m -78.42 -29.28 47.06 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 172.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 61.2 mt -96.66 -59.51 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.086 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.2 m -114.07 110.51 48.5 Favored Pre-proline 0 N--CA 1.428 -1.535 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.404 -175.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -75.13 98.37 1.16 Allowed 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 121.802 1.668 . . . . 0.0 109.603 174.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.418 ' H ' ' CD2' ' A' ' 114' ' ' HIS . 62.3 mt -91.67 -68.78 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.1 -176.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.0 t -90.37 -11.39 40.72 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.269 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 60.0 mt -117.69 144.44 34.35 Favored Pre-proline 0 C--N 1.295 -1.773 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -175.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -72.28 -24.01 20.23 Favored 'Trans proline' 0 N--CA 1.477 0.52 0 C-N-CA 122.767 2.311 . . . . 0.0 113.143 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 71.9 m -119.47 162.43 18.87 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 81.0 m -86.64 143.23 27.72 Favored 'General case' 0 N--CA 1.429 -1.522 0 O-C-N 123.467 0.479 . . . . 0.0 109.793 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 75.8 mt -76.44 118.82 19.52 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -95.08 98.83 10.94 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 13.8 mt -97.8 134.16 22.63 Favored Pre-proline 0 C--N 1.276 -2.616 0 CA-C-N 113.822 -1.536 . . . . 0.0 109.0 -172.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo . . . . . 0 N--CA 1.484 0.926 0 C-N-CA 123.265 2.643 . . . . 0.0 112.131 176.449 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.7 p . . . . . 0 N--CA 1.429 -1.493 0 CA-C-O 122.068 0.937 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.9 m -70.66 -33.97 71.53 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.819 -173.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -7.51 33.69 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.371 -178.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -74.74 -36.15 62.63 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.897 0.38 . . . . 0.0 110.711 177.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.403 ' CZ3' HD13 ' A' ' 46' ' ' ILE . 36.6 p-90 -103.56 -14.17 16.28 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.165 0.507 . . . . 0.0 111.789 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -94.31 112.58 24.38 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.471 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -127.08 91.62 46.29 Favored Pre-proline 0 C--N 1.312 -1.062 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 175.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.12 -7.67 21.43 Favored 'Trans proline' 0 C--N 1.331 -0.353 0 C-N-CA 122.377 2.051 . . . . 0.0 112.835 -175.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -100.37 -15.3 18.02 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.18 -176.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.5 tp -81.67 120.9 25.68 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.308 -168.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 m -76.72 165.43 24.74 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.939 -177.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -54.63 -50.99 66.8 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -174.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -65.82 -29.68 70.19 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.338 0.59 . . . . 0.0 111.384 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -77.09 -35.96 56.09 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.616 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.36 -41.38 98.84 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.765 176.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.406 ' HA ' HG23 ' A' ' 81' ' ' VAL . 87.0 mt -66.31 -45.33 89.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.86 177.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.07 -27.95 69.26 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.184 0.516 . . . . 0.0 111.911 178.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.44 -49.31 12.51 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 6.7 mp -70.33 -26.56 63.82 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -177.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -70.25 -13.14 62.04 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.446 0.641 . . . . 0.0 109.869 176.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -97.34 -32.72 11.74 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.495 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -85.54 -10.49 55.89 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -172.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.5 t70 73.1 148.59 0.12 Allowed Pre-proline 0 N--CA 1.506 2.339 0 O-C-N 123.532 0.52 . . . . 0.0 111.905 175.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 61' ' ' LYS . 88.1 Cg_exo -45.52 118.96 2.4 Favored 'Trans proline' 0 C--N 1.389 2.711 0 C-N-CA 123.726 2.95 . . . . 0.0 115.014 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.87 -35.25 2.22 Favored Glycine 0 N--CA 1.427 -1.959 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.039 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.98 144.1 50.62 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-O 121.153 0.501 . . . . 0.0 111.194 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -145.18 165.94 26.87 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -154.55 157.11 37.8 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 172.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.403 HD13 ' CZ3' ' A' ' 22' ' ' TRP . 65.5 mt -122.75 128.71 75.36 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.1 ptt-85 -121.72 179.69 4.4 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -95.49 130.99 42.13 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.1 m -89.78 136.95 32.74 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 120.762 0.315 . . . . 0.0 110.287 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -91.58 -23.55 19.86 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.1 t -71.93 -35.59 69.67 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.728 -176.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -128.43 149.38 50.59 Favored 'General case' 0 C--O 1.242 0.7 0 O-C-N 121.985 -0.447 . . . . 0.0 110.187 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -82.81 120.78 26.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.595 -176.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.58 29.97 57.08 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.565 178.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -113.86 133.84 55.17 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.446 ' CD2' HD23 ' A' ' 107' ' ' LEU . 44.7 m-85 -107.87 124.66 50.43 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.74 114.63 4.48 Favored Glycine 0 C--N 1.286 -2.211 0 C-N-CA 120.075 -1.059 . . . . 0.0 111.226 -176.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.3 tp -92.35 128.97 38.39 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -118.86 127.73 53.79 Favored 'General case' 0 C--N 1.282 -2.37 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 175.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.4 tp -123.01 131.85 53.88 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 123.522 0.514 . . . . 0.0 109.946 -177.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 41' ' ' PRO . 27.2 tptp -87.89 114.51 24.57 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.434 HG22 ' HE ' ' A' ' 82' ' ' ARG . 23.6 m -108.08 172.33 2.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.386 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.59 -48.63 21.49 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -163.21 143.72 7.16 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 123.142 0.577 . . . . 0.0 111.859 -178.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.579 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 37.4 Cg_exo -63.71 -46.97 7.88 Favored 'Trans proline' 0 CA--C 1.578 2.709 0 C-N-CA 121.774 1.65 . . . . 0.0 111.316 164.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.579 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 81.3 Cg_endo -71.66 171.22 16.82 Favored 'Trans proline' 0 C--N 1.398 3.146 0 C-N-CA 123.057 2.505 . . . . 0.0 109.05 171.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -66.45 -60.43 0.11 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 121.532 1.488 . . . . 0.0 112.205 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.1 p -123.23 -7.1 8.25 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.677 -178.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 64.19 33.73 11.54 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.225 1.01 . . . . 0.0 111.117 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.407 ' HB2' ' HD3' ' A' ' 71' ' ' PRO . 28.1 mt-30 -60.66 -46.97 97.19 Favored Pre-proline 0 CA--C 1.553 1.072 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.25 175.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.407 ' HD3' ' HB2' ' A' ' 70' ' ' GLN . 2.3 Cg_endo -84.99 108.01 1.13 Allowed 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 121.496 1.464 . . . . 0.0 109.539 172.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 49.0 t-105 -93.44 141.21 28.71 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.722 -176.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -119.26 -53.51 2.24 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.489 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 161.17 56.91 0.02 OUTLIER Glycine 0 CA--C 1.471 -2.7 0 N-CA-C 107.622 -2.191 . . . . 0.0 107.622 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -88.33 113.48 55.43 Favored Pre-proline 0 C--N 1.288 -2.098 0 CA-C-N 113.515 -1.342 . . . . 0.0 111.925 -171.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -85.66 164.42 10.64 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.195 1.93 . . . . 0.0 111.868 176.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.9 p -60.7 -19.73 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 121.597 0.713 . . . . 0.0 110.779 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -63.5 -21.72 66.48 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 123.951 0.9 . . . . 0.0 111.297 178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -92.82 -13.9 28.51 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 121.066 0.46 . . . . 0.0 110.902 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.9 mt -82.53 -8.54 59.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.968 0.89 . . . . 0.0 109.534 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.406 HG23 ' HA ' ' A' ' 33' ' ' ILE . 89.9 t -109.49 107.82 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.998 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 174.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.512 ' NH2' ' HA ' ' A' ' 65' ' ' PRO . 77.4 mtt180 -87.27 147.75 25.4 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.177 -177.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -123.73 122.61 38.52 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.14 -175.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -130.99 156.49 45.03 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.35 133.45 52.56 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.765 178.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.43 HG12 HG12 ' A' ' 95' ' ' ILE . 78.0 mt -94.31 113.98 30.0 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.432 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.203 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.83 128.22 46.96 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.496 ' HB ' HG11 ' A' ' 93' ' ' VAL . 9.3 t -99.62 115.82 30.3 Favored 'General case' 0 N--CA 1.413 -2.296 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 176.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -115.13 -170.08 16.18 Favored Glycine 0 N--CA 1.42 -2.414 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -177.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.65 -20.83 69.8 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.038 2.492 . . . . 0.0 112.92 -178.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -87.76 -39.74 14.66 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.923 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 158.97 -158.2 29.2 Favored Glycine 0 N--CA 1.431 -1.645 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 -177.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.496 HG11 ' HB ' ' A' ' 88' ' ' THR . 6.4 m -103.37 130.95 52.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -177.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.72 154.39 48.56 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.628 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.43 HG12 HG12 ' A' ' 86' ' ' ILE . 33.7 mt -94.06 130.42 43.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.439 0.638 . . . . 0.0 110.896 -174.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -102.03 143.77 31.46 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.337 176.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 105.1 8.15 36.72 Favored Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 -172.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 59.4 m -121.23 153.06 58.11 Favored Pre-proline 0 N--CA 1.423 -1.818 0 CA-C-N 114.105 -1.048 . . . . 0.0 109.395 -176.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -57.52 -58.39 0.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.153 1.902 . . . . 0.0 110.424 176.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.8 m -162.55 108.86 1.23 Allowed 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 122.839 0.456 . . . . 0.0 110.371 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.422 ' OE2' ' HB ' ' A' ' 119' ' ' ILE . 51.4 mt-10 -128.89 133.49 25.27 Favored Pre-proline 0 C--N 1.299 -1.593 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.96 176.53 6.04 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.603 2.869 . . . . 0.0 115.775 -170.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -87.79 113.48 23.49 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.642 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -90.48 161.75 15.37 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.98 -58.21 9.39 Favored Glycine 0 CA--C 1.509 -0.309 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.486 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.5 m -136.78 171.85 13.88 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.446 HD23 ' CD2' ' A' ' 56' ' ' TYR . 95.1 mt -53.5 -47.2 70.07 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.643 0.589 . . . . 0.0 110.654 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.7 m -52.95 -29.65 30.05 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.592 1.157 . . . . 0.0 112.747 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.43 -36.93 71.46 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 120.889 0.376 . . . . 0.0 111.306 -177.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 107' ' ' LEU . 4.2 pp -80.1 -21.66 43.02 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.599 0.714 . . . . 0.0 110.06 178.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 107' ' ' LEU . 88.1 t -70.68 -42.9 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.416 176.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.6 p -72.96 -44.55 60.99 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 122.16 -0.338 . . . . 0.0 111.349 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -77.76 12.33 1.74 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 35.0 p-80 -53.96 -35.1 61.42 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.182 1.393 . . . . 0.0 111.16 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 41.9 p -98.87 -4.06 33.89 Favored 'General case' 0 N--CA 1.401 -2.889 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.461 -172.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 52.2 mt -106.31 -42.79 6.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.25 -175.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.3 t -135.93 81.14 40.53 Favored Pre-proline 0 N--CA 1.435 -1.222 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.986 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -98.03 96.07 0.07 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.033 0 C-N-CA 122.425 2.083 . . . . 0.0 109.054 172.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.422 ' HB ' ' OE2' ' A' ' 101' ' ' GLU . 58.6 mt -90.89 -57.06 4.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.856 -175.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 27.6 t -91.76 -30.83 16.03 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.923 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.53 118.59 55.41 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.621 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.464 ' HG3' ' CZ ' ' A' ' 82' ' ' ARG . 89.4 Cg_endo -83.02 -3.89 11.14 Favored 'Trans proline' 0 C--O 1.243 0.735 0 C-N-CA 123.022 2.482 . . . . 0.0 112.265 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 84.8 m -145.32 149.26 34.5 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 79.0 m -88.93 148.4 23.83 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 58.7 mt -70.3 107.27 3.68 Favored 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.513 -175.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -80.2 99.78 7.97 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.859 -0.526 . . . . 0.0 110.168 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.451 ' H ' HD13 ' A' ' 127' ' ' ILE . 3.9 mp -71.12 121.77 85.11 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.79 -177.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 N--CA 1.491 1.345 0 C-N-CA 123.087 2.525 . . . . 0.0 113.381 -177.868 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.6 p . . . . . 0 N--CA 1.413 -2.296 0 CA-C-O 121.519 0.676 . . . . 0.0 110.314 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.417 ' HA ' ' NE1' ' A' ' 22' ' ' TRP . 18.4 m -73.01 -28.76 62.56 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.761 -177.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.28 -10.12 59.23 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.689 0.757 . . . . 0.0 110.769 177.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -76.92 -21.1 55.35 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.258 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.417 ' NE1' ' HA ' ' A' ' 19' ' ' SER . 47.0 p-90 -113.67 -31.46 6.47 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 177.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.478 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 42.1 t80 -86.26 116.85 24.7 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.001 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -125.81 84.85 60.14 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.425 ' HD3' ' CD2' ' A' ' 23' ' ' TYR . 9.3 Cg_endo -54.4 -46.59 32.31 Favored 'Trans proline' 0 C--N 1.333 -0.282 0 C-N-CA 122.786 2.324 . . . . 0.0 115.818 -171.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -97.84 13.86 29.09 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -173.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.544 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 15.2 tp -83.3 145.84 28.86 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.504 -178.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.2 t -96.89 169.65 9.7 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -58.81 -50.32 74.42 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 123.524 0.729 . . . . 0.0 111.736 -175.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -58.34 -40.29 81.78 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.122 0.487 . . . . 0.0 111.083 -177.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -74.98 -29.91 61.03 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.872 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.92 -43.48 83.22 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.966 -0.754 . . . . 0.0 108.966 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 77.3 mt -66.24 -39.12 83.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.248 177.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.52 -32.24 70.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.782 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.401 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 49.8 mt -73.15 -47.06 47.15 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.569 0.699 . . . . 0.0 110.61 173.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.505 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 67.8 mt -69.68 -18.36 63.55 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -177.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.406 ' HB3' HG23 ' A' ' 77' ' ' VAL . 21.0 ptmt -84.28 -0.67 53.29 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.346 0.593 . . . . 0.0 110.073 176.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -114.05 -43.12 3.27 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.111 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 35' ' ' LEU . 43.3 mtpt -74.77 162.99 28.17 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.421 -176.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -70.22 138.48 86.98 Favored Pre-proline 0 C--N 1.308 -1.204 0 C-N-CA 124.212 1.005 . . . . 0.0 111.827 -174.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -57.28 114.04 1.76 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.676 2.251 . . . . 0.0 111.413 175.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.27 -22.69 3.94 Favored Glycine 0 N--CA 1.425 -2.077 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 -174.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.42 158.55 28.67 Favored 'General case' 0 C--O 1.251 1.181 0 CA-C-N 115.029 -0.585 . . . . 0.0 109.908 177.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -152.47 176.23 11.89 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -175.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -156.38 154.83 31.14 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 170.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 23' ' ' TYR . 66.6 mt -125.02 130.54 73.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.544 ' HD2' ' O ' ' A' ' 27' ' ' LEU . 28.1 ptt85 -133.05 171.27 14.21 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -72.82 132.03 43.05 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 171.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.5 m -67.81 -32.77 73.56 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 -177.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 39.9 m-70 71.91 -39.59 0.45 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.321 1.048 . . . . 0.0 113.167 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.2 m -58.59 -41.44 85.76 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 123.795 0.838 . . . . 0.0 111.18 178.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.49 150.7 45.49 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -84.56 135.02 34.38 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.65 38.45 50.84 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -177.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.55 133.16 39.96 Favored 'General case' 0 C--O 1.249 1.028 0 CA-C-O 120.891 0.377 . . . . 0.0 110.394 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -116.73 126.83 53.71 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -91.39 114.15 4.45 Favored Glycine 0 C--N 1.288 -2.084 0 C-N-CA 120.148 -1.025 . . . . 0.0 111.324 -177.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.401 ' HB3' ' O ' ' A' ' 84' ' ' PHE . 2.2 tm? -92.08 117.77 30.16 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.65 115.73 30.43 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.4 tp -110.64 123.76 50.61 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.303 -177.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.505 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 22.3 tptm -91.23 114.35 26.85 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 176.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 80' ' ' LEU . 18.2 m -104.17 170.65 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.25 -58.28 5.13 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 p -161.85 124.15 1.73 Allowed Pre-proline 0 C--N 1.312 -1.06 0 C-N-CA 124.521 1.128 . . . . 0.0 108.713 176.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.573 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 35.6 Cg_exo -59.68 -47.1 17.22 Favored 'Trans proline' 0 CA--C 1.578 2.678 0 C-N-CA 121.688 1.592 . . . . 0.0 111.947 174.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.573 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 74.8 Cg_endo -73.46 153.29 49.87 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 123.19 2.593 . . . . 0.0 110.756 173.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -63.79 -46.92 7.81 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.402 2.068 . . . . 0.0 112.567 177.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.6 p -119.74 -8.28 9.92 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 66.8 36.57 4.49 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 124.414 1.086 . . . . 0.0 113.237 177.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.422 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 73.8 mt-30 -63.61 -48.85 79.77 Favored Pre-proline 0 CA--C 1.565 1.519 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.339 172.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 70' ' ' GLN . 18.3 Cg_endo -62.45 113.38 1.91 Allowed 'Trans proline' 0 C--N 1.389 2.709 0 C-N-CA 122.04 1.827 . . . . 0.0 111.919 173.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 57.0 t-105 -115.17 146.49 41.34 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.354 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -127.05 -28.82 2.84 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.834 0.35 . . . . 0.0 111.689 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 133.32 -41.71 1.45 Allowed Glycine 0 CA--C 1.489 -1.536 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 78' ' ' GLU . 5.2 m-20 -68.11 118.56 59.97 Favored Pre-proline 0 C--N 1.299 -1.623 0 C-N-CA 123.862 0.865 . . . . 0.0 109.839 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.21 -79.64 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 121.902 1.735 . . . . 0.0 112.722 177.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.406 HG23 ' HB3' ' A' ' 37' ' ' LYS . 3.2 p -73.74 -28.31 24.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 120.943 0.402 . . . . 0.0 111.624 -177.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 53.1 mp0 -68.28 -19.72 64.72 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -78.62 -36.25 44.39 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 171.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.494 ' O ' HG23 ' A' ' 62' ' ' VAL . 49.5 mt -75.87 -25.71 56.41 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.838 -176.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 89.9 t -88.92 116.25 30.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -101.36 130.81 47.62 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -109.84 126.17 53.54 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.222 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.401 ' O ' ' HB3' ' A' ' 58' ' ' LEU . 98.0 m-85 -133.15 123.14 25.13 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 176.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.9 pp -96.84 131.95 43.08 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 118.709 -1.196 . . . . 0.0 111.113 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 79.7 mt -92.35 122.58 43.93 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 C-N-CA 124.568 1.147 . . . . 0.0 108.98 -178.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -99.84 146.82 26.18 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.451 ' HB ' HG12 ' A' ' 93' ' ' VAL . 9.7 t -127.88 142.27 51.32 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.41 -158.36 7.95 Favored Glycine 0 N--CA 1.433 -1.508 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -177.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.15 3.85 4.8 Favored 'Trans proline' 0 N--CA 1.482 0.847 0 C-N-CA 122.914 2.409 . . . . 0.0 113.566 -174.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -111.71 -42.1 3.9 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.89 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 158.9 -154.5 25.59 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.451 HG12 ' HB ' ' A' ' 88' ' ' THR . 10.7 m -104.02 147.66 9.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -178.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.9 pttp -146.07 141.98 28.12 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -176.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.2 mt -85.65 131.68 33.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -67.58 101.76 1.06 Allowed 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 102.37 45.56 1.68 Allowed Glycine 0 N--CA 1.429 -1.831 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.735 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.432 ' HB2' ' CD ' ' A' ' 101' ' ' GLU . 24.4 p -115.57 124.25 30.25 Favored Pre-proline 0 C--N 1.312 -1.049 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 177.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.93 -44.06 2.17 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.54 2.16 . . . . 0.0 115.316 -175.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.9 m -120.36 -16.37 8.43 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.833 -172.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.432 ' CD ' ' HB2' ' A' ' 98' ' ' CYS . 5.4 mp0 -60.34 125.21 81.26 Favored Pre-proline 0 C--N 1.3 -1.56 0 C-N-CA 123.276 0.631 . . . . 0.0 112.27 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -87.05 -167.67 0.37 Allowed 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 123.128 2.552 . . . . 0.0 110.967 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -81.65 109.74 16.35 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -81.48 147.26 29.8 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -78.88 -23.66 63.63 Favored Glycine 0 C--N 1.302 -1.317 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.06 -178.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.8 p -143.62 161.31 38.85 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.411 ' O ' HG22 ' A' ' 111' ' ' VAL . 94.6 mt -71.29 -31.69 67.75 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 173.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 m -56.85 -40.12 75.54 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.651 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.36 -50.81 71.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.995 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.2 pp -68.77 -29.02 67.32 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.648 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 107' ' ' LEU . 49.5 t -64.93 -50.28 75.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.145 0.498 . . . . 0.0 110.391 177.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.7 t -72.49 -38.52 68.14 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.508 -177.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -73.61 -36.46 65.48 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -174.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -76.52 -0.66 23.91 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.3 m -75.01 -40.69 60.48 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 170.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 63.8 mt -86.24 -44.34 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.128 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.3 m -136.16 94.85 13.79 Favored Pre-proline 0 C--N 1.303 -1.444 0 O-C-N 122.104 -0.373 . . . . 0.0 111.295 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -86.77 108.04 0.77 Allowed 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 123.008 2.472 . . . . 0.0 109.983 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.429 ' HB ' ' OE2' ' A' ' 101' ' ' GLU . 33.9 mt -89.63 -73.54 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.285 -177.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.9 t -66.72 -34.02 76.93 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.215 0.531 . . . . 0.0 110.222 176.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 81.5 mt -71.57 124.79 91.47 Favored Pre-proline 0 C--N 1.311 -1.071 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.701 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -65.04 -20.61 63.76 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.437 2.758 . . . . 0.0 113.354 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 78.0 m -136.99 169.18 18.2 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 80.6 m -73.59 136.51 43.95 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 123.261 0.351 . . . . 0.0 111.045 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 22.7 tp -81.88 118.14 22.7 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -122.54 141.94 51.14 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.308 0.575 . . . . 0.0 111.273 -176.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.402 ' N ' HD11 ' A' ' 127' ' ' ILE . 2.8 mp -101.85 109.82 60.58 Favored Pre-proline 0 C--N 1.303 -1.422 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--N 1.324 -0.745 0 C-N-CA 121.74 1.627 . . . . 0.0 112.275 -178.882 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.7 p . . . . . 0 N--CA 1.435 -1.188 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.5 m -69.62 -24.13 63.6 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.972 -175.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.13 -9.93 59.73 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 120.443 -0.503 . . . . 0.0 112.347 -177.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -76.6 -49.83 15.35 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.205 0.526 . . . . 0.0 111.588 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.443 ' CZ3' HD13 ' A' ' 46' ' ' ILE . 29.6 p-90 -85.0 -12.95 52.09 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.768 -174.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -95.42 103.95 15.83 Favored 'General case' 0 N--CA 1.422 -1.831 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.683 -176.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.44 89.98 9.15 Favored Pre-proline 0 C--N 1.294 -1.844 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.099 174.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.73 18.79 0.81 Allowed 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 123.242 2.628 . . . . 0.0 112.411 -176.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -109.75 -3.73 16.55 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.79 -176.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.8 tp -101.19 130.61 47.31 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -172.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.0 m -79.45 170.68 16.23 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.593 0.757 . . . . 0.0 110.306 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -56.62 -53.71 54.51 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -69.85 -29.86 67.2 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.071 0.463 . . . . 0.0 110.654 -176.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -71.2 -33.42 69.92 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.686 176.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.4 -41.36 93.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.607 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 77.0 mt -67.3 -42.42 87.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.135 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.74 -28.78 67.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.857 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.71 -40.44 25.33 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.976 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.3 mp -86.73 -19.61 28.9 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -60.86 -36.56 79.48 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -92.92 3.01 56.49 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.307 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -99.4 169.58 9.23 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.708 0.766 . . . . 0.0 112.633 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -81.84 159.66 65.53 Favored Pre-proline 0 C--N 1.296 -1.722 0 C-N-CA 125.867 1.667 . . . . 0.0 111.368 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.02 111.88 2.79 Favored 'Trans proline' 0 C--N 1.36 1.172 0 C-N-CA 122.417 2.078 . . . . 0.0 110.32 176.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.88 -20.83 3.6 Favored Glycine 0 C--N 1.287 -2.159 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -176.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.01 136.49 48.4 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -151.75 173.04 15.21 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -177.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -155.91 158.05 37.32 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.443 HD13 ' CZ3' ' A' ' 22' ' ' TRP . 65.8 mt -122.54 116.25 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.081 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 174.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.1 ptt-85 -108.23 -175.02 2.66 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -100.03 128.4 46.12 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.423 ' C ' ' H ' ' A' ' 51' ' ' SER . 69.7 m -88.02 95.58 10.18 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.325 0.583 . . . . 0.0 110.162 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -73.86 11.98 0.77 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.775 0.797 . . . . 0.0 112.475 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.423 ' H ' ' C ' ' A' ' 49' ' ' SER . 32.9 t -86.81 -15.81 38.13 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 175.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -146.28 -171.54 3.75 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -125.23 134.94 52.15 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 171.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.18 22.85 56.39 Favored Glycine 0 C--N 1.308 -1.006 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -128.52 127.63 42.77 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -101.37 162.1 13.15 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.29 118.54 3.43 Favored Glycine 0 C--N 1.286 -2.229 0 C-N-CA 119.875 -1.155 . . . . 0.0 111.474 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -98.8 127.48 44.74 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -178.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -122.6 117.35 25.63 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.6 tp -110.29 128.08 55.34 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 123.719 0.637 . . . . 0.0 110.287 -176.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -88.69 114.08 24.93 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 177.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 80' ' ' LEU . 25.5 m -103.58 171.49 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.84 -60.35 2.74 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.401 ' HB ' ' HG2' ' A' ' 66' ' ' PRO . 2.1 p -159.32 141.93 10.21 Favored Pre-proline 0 N--CA 1.433 -1.276 0 C-N-CA 124.923 1.289 . . . . 0.0 108.478 176.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.601 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 36.3 Cg_exo -59.62 -44.33 32.68 Favored 'Trans proline' 0 CA--C 1.574 2.508 0 C-N-CA 121.75 1.633 . . . . 0.0 111.645 171.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.601 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 59.1 Cg_endo -68.99 146.95 66.68 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 122.68 2.254 . . . . 0.0 110.038 170.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -62.13 -42.03 31.93 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.695 2.263 . . . . 0.0 113.103 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.4 m -118.56 -18.99 8.95 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.86 0.362 . . . . 0.0 110.235 -177.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 67.68 24.44 8.41 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.168 0.987 . . . . 0.0 112.564 178.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -67.92 -38.35 14.07 Favored Pre-proline 0 CA--C 1.558 1.262 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.968 172.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -68.05 108.91 1.82 Allowed 'Trans proline' 0 C--N 1.38 2.224 0 C-N-CA 121.208 1.272 . . . . 0.0 109.119 167.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -131.33 145.72 51.98 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -175.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -138.4 -37.59 0.55 Allowed 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.871 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.81 -57.41 0.03 OUTLIER Glycine 0 CA--C 1.48 -2.109 0 N-CA-C 107.27 -2.332 . . . . 0.0 107.27 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 54.84 93.83 0.05 OUTLIER Pre-proline 0 N--CA 1.468 0.433 0 C-N-CA 125.104 1.362 . . . . 0.0 113.975 169.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -83.37 165.53 14.4 Favored 'Trans proline' 0 C--O 1.243 0.743 0 C-N-CA 122.504 2.136 . . . . 0.0 112.347 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 p -68.99 -27.2 34.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.594 0.711 . . . . 0.0 110.592 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -66.51 -15.95 63.77 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.349 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -85.11 -19.47 31.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.567 0.699 . . . . 0.0 109.471 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.425 ' O ' HG22 ' A' ' 62' ' ' VAL . 72.2 mt -80.71 -11.27 59.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.005 -178.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.0 t -100.59 108.84 23.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -87.18 131.54 34.15 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -177.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -105.08 125.63 51.19 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.259 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -140.88 131.46 25.48 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 176.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.32 154.66 17.14 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 117.878 -1.529 . . . . 0.0 110.963 176.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 78.5 mt -115.37 125.97 72.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.408 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.973 -176.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.486 ' CD ' ' HE2' ' A' ' 96' ' ' LYS . 47.4 mt-10 -105.86 138.39 42.13 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.423 ' HB ' HG23 ' A' ' 93' ' ' VAL . 5.6 t -121.45 147.51 45.65 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.52 -167.05 29.52 Favored Glycine 0 N--CA 1.423 -2.217 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.91 -14.21 35.53 Favored 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 123.637 2.891 . . . . 0.0 114.636 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -89.0 -24.66 22.32 Favored 'General case' 0 CA--C 1.5 -0.966 0 O-C-N 121.752 -0.592 . . . . 0.0 111.401 176.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 132.53 -160.12 23.64 Favored Glycine 0 N--CA 1.423 -2.19 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -177.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.544 HG13 ' H ' ' A' ' 105' ' ' GLY . 7.7 p -118.38 136.85 54.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -177.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.19 169.13 25.48 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 59.7 mt -85.77 143.07 12.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-O 120.86 0.362 . . . . 0.0 110.929 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.486 ' HE2' ' CD ' ' A' ' 87' ' ' GLU . 20.6 ttmm -99.17 140.57 33.14 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 172.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.08 43.06 4.19 Favored Glycine 0 CA--C 1.493 -1.303 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 24.5 p -129.73 157.61 76.11 Favored Pre-proline 0 N--CA 1.42 -1.968 0 CA-C-N 114.702 -0.749 . . . . 0.0 111.106 -171.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -65.56 -59.13 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 N-CA-C 107.72 -1.685 . . . . 0.0 107.72 167.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 67.0 m -164.32 125.57 2.2 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 124.522 1.129 . . . . 0.0 108.357 175.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.5 ' OE2' ' HB ' ' A' ' 119' ' ' ILE . 49.4 mm-40 -122.52 138.34 29.12 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.18 155.82 66.71 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.186 1.924 . . . . 0.0 110.688 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -91.59 99.48 12.39 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -64.62 -70.3 0.24 Allowed 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.353 0.597 . . . . 0.0 111.548 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.544 ' H ' HG13 ' A' ' 93' ' ' VAL . . . 145.17 -68.82 0.4 Allowed Glycine 0 C--N 1.3 -1.464 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 178.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.2 m -108.25 158.77 17.17 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.84 -36.53 82.54 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.4 t -64.81 -36.55 84.68 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.02 -47.36 83.39 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 175.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.3 tt -54.8 -50.79 67.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.113 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.445 ' HA ' HD22 ' A' ' 125' ' ' LEU . 69.1 t -61.55 -50.7 79.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.26 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.1 t -66.61 -31.68 72.53 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.171 0.51 . . . . 0.0 111.342 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -88.68 -18.97 26.79 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 121.711 -0.618 . . . . 0.0 112.657 -178.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -78.58 -9.36 59.33 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.137 0.494 . . . . 0.0 111.249 173.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.7 m -72.58 -27.62 62.3 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 170.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 35.2 mt -89.37 -60.14 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.575 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 27.0 m -120.57 99.17 47.86 Favored Pre-proline 0 N--CA 1.433 -1.324 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.968 -176.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -93.09 101.18 0.16 Allowed 'Trans proline' 0 N--CA 1.431 -2.169 0 C-N-CA 122.649 2.233 . . . . 0.0 109.482 172.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.5 ' HB ' ' OE2' ' A' ' 101' ' ' GLU . 63.8 mt -86.78 -62.36 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.12 -177.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.2 m -83.96 -16.88 42.49 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.273 0.559 . . . . 0.0 111.177 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.4 mt -90.12 123.7 65.19 Favored Pre-proline 0 C--N 1.305 -1.339 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -65.04 -30.19 56.52 Favored 'Trans proline' 0 N--CA 1.476 0.445 0 C-N-CA 122.808 2.339 . . . . 0.0 112.454 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 61.1 m -114.42 147.12 39.73 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.4 p -63.4 136.03 57.35 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.445 HD22 ' HA ' ' A' ' 111' ' ' VAL . 18.8 tp -79.76 86.43 5.34 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -93.55 124.29 37.45 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.393 -175.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mp -70.78 112.04 11.82 Favored Pre-proline 0 C--N 1.315 -0.905 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo . . . . . 0 C--N 1.345 0.391 0 C-N-CA 122.366 2.044 . . . . 0.0 112.107 -178.685 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.434 -1.271 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.8 m -100.32 -19.66 16.22 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.439 177.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.31 3.52 0.9 Allowed 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 -176.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -85.42 -40.27 16.62 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 14.7 p-90 -120.74 -8.94 9.41 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -172.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -92.19 110.84 22.23 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.653 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.43 ' HB3' HD13 ' A' ' 27' ' ' LEU . 1.3 mptp? -128.52 89.03 50.7 Favored Pre-proline 0 C--N 1.313 -0.988 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.41 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.09 -1.64 8.27 Favored 'Trans proline' 0 CA--C 1.552 1.395 0 C-N-CA 122.722 2.282 . . . . 0.0 114.649 -177.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -90.84 -21.73 21.32 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.312 0.577 . . . . 0.0 109.87 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.476 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 9.8 mp -86.22 142.28 28.7 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -174.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.3 m -111.31 178.09 4.45 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 174.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -47.05 -52.28 15.41 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -58.45 -43.46 88.85 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.773 0.829 . . . . 0.0 110.73 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -70.79 -32.59 69.74 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.373 -177.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.2 -41.23 86.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.413 0.625 . . . . 0.0 109.803 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 72.0 mt -66.33 -40.41 86.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.828 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.83 -29.5 68.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.202 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.03 -47.45 11.68 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 39' ' ' LYS . 72.6 mt -74.28 -19.44 60.49 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -176.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -72.01 -18.36 61.97 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.114 174.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -93.78 -35.54 12.71 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.386 178.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.407 ' HB2' ' HA ' ' A' ' 36' ' ' LEU . 24.2 mmmt -77.38 171.11 15.38 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -71.59 164.28 59.25 Favored Pre-proline 0 C--N 1.314 -0.96 0 C-N-CA 126.753 2.021 . . . . 0.0 111.71 -176.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -75.91 126.5 9.42 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 121.815 1.677 . . . . 0.0 108.37 169.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.02 -9.62 43.38 Favored Glycine 0 C--N 1.292 -1.915 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -175.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.08 155.61 26.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.446 ' CD1' HD22 ' A' ' 125' ' ' LEU . 15.0 p90 -156.56 170.8 21.54 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.763 -173.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -156.43 149.99 24.66 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 172.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 68.7 mt -121.05 129.59 75.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -139.94 172.44 12.77 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.503 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -75.52 137.15 40.68 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 t -86.33 129.57 34.81 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -90.86 -14.84 31.0 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.5 t -70.5 -45.58 65.37 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.409 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -134.7 142.71 46.88 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -85.71 138.22 32.27 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.9 21.46 50.11 Favored Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.26 144.85 48.62 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 115.537 -0.332 . . . . 0.0 110.22 -178.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -116.28 132.82 56.56 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.3 120.25 5.69 Favored Glycine 0 C--N 1.287 -2.151 0 C-N-CA 119.932 -1.127 . . . . 0.0 111.46 -177.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -95.82 120.49 36.18 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.406 ' HB1' HH12 ' A' ' 47' ' ' ARG . . . -112.76 125.04 53.89 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.442 HD12 ' HB3' ' A' ' 123' ' ' CYS . 3.4 tm? -123.66 126.8 47.22 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -178.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -89.2 114.79 26.15 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 80' ' ' LEU . 32.8 m -99.67 171.64 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.26 -47.2 36.55 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.4 p -156.06 129.57 4.54 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 124.347 1.059 . . . . 0.0 108.988 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.572 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 28.0 Cg_exo -62.43 -45.08 15.73 Favored 'Trans proline' 0 CA--C 1.57 2.308 0 C-N-CA 121.884 1.723 . . . . 0.0 113.017 174.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.572 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 37.4 Cg_endo -63.94 142.66 82.74 Favored 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 122.273 1.982 . . . . 0.0 110.396 174.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -61.53 -34.48 85.31 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 123.349 2.7 . . . . 0.0 113.861 -174.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.1 p -119.07 -42.22 2.71 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.463 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 72.37 7.47 5.66 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 124.82 1.248 . . . . 0.0 113.106 174.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.415 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 64.8 tt0 -72.53 -55.75 4.35 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-O 119.121 -0.466 . . . . 0.0 112.028 -178.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.415 ' HD3' ' HB3' ' A' ' 70' ' ' GLN . 6.9 Cg_endo -88.08 62.87 3.38 Favored 'Trans proline' 0 C--N 1.365 1.427 0 C-N-CA 121.461 1.44 . . . . 0.0 111.108 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -160.66 141.27 11.59 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 113.353 -1.749 . . . . 0.0 110.441 -176.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.83 80.16 0.63 Allowed 'General case' 0 N--CA 1.413 -2.298 0 CA-C-O 122.635 1.207 . . . . 0.0 110.429 169.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.17 40.88 0.49 Allowed Glycine 0 C--N 1.301 -1.393 0 CA-C-N 114.213 -1.358 . . . . 0.0 112.165 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -136.5 127.8 16.79 Favored Pre-proline 0 C--N 1.305 -1.337 0 CA-C-O 120.755 0.312 . . . . 0.0 111.054 -177.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -91.55 177.37 1.89 Allowed 'Trans proline' 0 N--CA 1.436 -1.875 0 C-N-CA 121.829 1.686 . . . . 0.0 109.4 168.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.7 p -58.89 -24.99 27.99 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-O 121.603 0.716 . . . . 0.0 111.632 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.7 -26.77 64.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.006 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -80.95 -16.68 52.82 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 121.144 0.497 . . . . 0.0 109.711 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.449 ' O ' HG21 ' A' ' 62' ' ' VAL . 77.4 mt -74.53 -12.59 60.51 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-O 121.68 0.753 . . . . 0.0 109.991 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 74.7 t -88.3 125.9 41.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 176.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -105.23 143.84 32.84 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -118.75 133.87 55.54 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -139.15 167.33 22.3 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.05 138.11 41.83 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.94 177.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.411 HG12 HG12 ' A' ' 95' ' ' ILE . 80.1 mt -97.03 114.82 34.99 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-N 114.187 -1.369 . . . . 0.0 107.395 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -99.62 137.23 38.39 Favored 'General case' 0 C--N 1.273 -2.727 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.477 ' HB ' HG13 ' A' ' 93' ' ' VAL . 6.1 t -113.06 143.44 44.33 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -155.83 -157.97 8.56 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -73.18 -14.28 25.81 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.224 1.949 . . . . 0.0 112.823 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.468 ' HD2' ' N ' ' A' ' 91' ' ' LYS . 0.1 OUTLIER -84.88 -28.77 25.76 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 121.519 0.675 . . . . 0.0 110.331 177.739 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 139.19 -147.5 19.26 Favored Glycine 0 N--CA 1.433 -1.562 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.477 HG13 ' HB ' ' A' ' 88' ' ' THR . 15.0 m -113.52 141.5 29.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.67 150.31 26.17 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.674 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.441 ' HB ' ' OE2' ' A' ' 101' ' ' GLU . 83.3 mt -86.14 133.76 28.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.704 0.764 . . . . 0.0 111.309 -176.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -93.01 124.17 36.8 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 173.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 113.94 42.6 0.84 Allowed Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -174.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 120' ' ' SER . 13.5 p -129.34 144.9 54.6 Favored Pre-proline 0 N--CA 1.428 -1.529 0 CA-C-N 115.421 -0.39 . . . . 0.0 110.123 -175.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -67.33 -28.13 39.88 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.395 2.064 . . . . 0.0 111.928 176.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.5 t -153.86 -89.87 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.441 ' OE2' ' HB ' ' A' ' 95' ' ' ILE . 28.2 tt0 65.78 133.03 0.04 OUTLIER Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 125.377 1.471 . . . . 0.0 112.986 173.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -79.2 172.58 14.53 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.412 2.075 . . . . 0.0 112.557 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -92.39 131.89 37.2 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 175.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -102.42 170.7 7.89 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -177.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -99.55 -52.69 1.19 Allowed Glycine 0 C--N 1.3 -1.447 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.5 m -111.72 153.85 25.86 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.476 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 64.4 mt -63.24 -36.68 84.45 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.4 m -54.23 -30.19 49.24 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.486 1.114 . . . . 0.0 112.158 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.53 -41.95 92.53 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.112 -177.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 107' ' ' LEU . 4.2 pp -77.0 -31.33 56.38 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.969 0.414 . . . . 0.0 110.081 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.427 ' HA ' ' CD1' ' A' ' 125' ' ' LEU . 55.3 t -59.5 -54.73 30.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.455 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.4 m -72.48 -25.71 61.52 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.905 -177.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -84.13 -36.99 22.53 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.988 -176.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -72.13 -5.22 33.96 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -177.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.6 m -74.37 -31.9 62.56 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.6 mt -94.93 -50.16 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.972 -178.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 45.3 m -132.88 96.75 17.67 Favored Pre-proline 0 C--N 1.31 -1.142 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.979 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -81.86 114.23 2.58 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.702 2.268 . . . . 0.0 109.715 176.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 65.3 mt -91.49 -64.69 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 120.771 0.32 . . . . 0.0 110.512 -176.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.505 ' HB3' ' HB3' ' A' ' 98' ' ' CYS . 2.3 p -74.95 -49.66 19.35 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.467 0.651 . . . . 0.0 110.263 176.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.9 mp -65.87 137.69 96.15 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.877 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -80.53 -9.8 13.45 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.637 2.225 . . . . 0.0 112.92 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.442 ' HB3' HD12 ' A' ' 60' ' ' LEU . 44.8 t -136.35 150.69 48.96 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -178.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 24.8 p -71.82 146.11 48.21 Favored 'General case' 0 C--O 1.252 1.198 0 O-C-N 123.775 0.672 . . . . 0.0 110.555 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.446 HD22 ' CD1' ' A' ' 44' ' ' PHE . 91.6 mt -77.81 128.19 33.61 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.388 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -106.4 103.04 12.41 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.406 HD11 ' N ' ' A' ' 127' ' ' ILE . 3.4 mp -88.69 122.58 69.15 Favored Pre-proline 0 C--N 1.313 -1.002 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.865 -176.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo . . . . . 0 C--N 1.358 1.05 0 C-N-CA 123.162 2.574 . . . . 0.0 112.116 -179.704 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.5 p . . . . . 0 N--CA 1.425 -1.683 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.4 m -56.8 -40.53 76.11 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.618 -177.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -60.0 -25.08 64.99 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -77.26 -27.82 53.31 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 120.876 0.369 . . . . 0.0 111.141 -177.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.0 p-90 -119.1 -17.97 8.83 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -176.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -94.42 110.22 22.02 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.657 -176.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.08 94.27 14.43 Favored Pre-proline 0 C--N 1.309 -1.188 0 C-N-CA 124.407 1.083 . . . . 0.0 108.644 174.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 47' ' ' ARG . 83.3 Cg_endo -75.0 -23.22 14.0 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.856 3.038 . . . . 0.0 117.463 -169.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -101.43 14.55 31.61 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 118.9 0.773 . . . . 0.0 111.167 -174.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.3 tp -88.66 135.3 33.57 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.6 m -82.87 163.54 21.08 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 122.341 -0.225 . . . . 0.0 110.971 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -52.88 -51.48 60.95 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -173.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -65.44 -37.35 86.63 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.414 0.626 . . . . 0.0 110.999 -176.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -72.08 -28.32 63.24 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.496 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.15 -45.18 74.25 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 175.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 77.1 mt -63.49 -35.1 71.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.52 177.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.99 -34.67 43.55 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.261 176.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.558 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 3.8 mm? -72.33 -50.41 27.05 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.502 0.667 . . . . 0.0 109.506 174.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.1 mp -70.64 -13.53 62.12 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -173.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -84.79 -1.25 56.12 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.543 0.687 . . . . 0.0 109.26 174.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -114.84 -30.44 6.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.876 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 35' ' ' LEU . 61.8 mmtt -80.28 -179.05 6.9 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -174.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -83.82 156.33 64.51 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.718 -177.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -66.16 115.08 3.28 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 121.922 1.748 . . . . 0.0 108.933 171.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 124.56 -17.56 7.34 Favored Glycine 0 C--N 1.297 -1.593 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -174.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.48 151.99 37.94 Favored 'General case' 0 C--O 1.249 1.06 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -154.44 174.87 14.3 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.333 -174.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -156.43 151.19 25.93 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 171.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.3 mt -120.22 129.66 75.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 19.9 ptt180 -119.51 172.74 7.43 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -100.56 127.28 46.99 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.1 m -107.53 119.43 39.41 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -173.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 -79.9 76.13 6.6 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.902 0.858 . . . . 0.0 108.971 174.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 t -136.2 -52.07 0.72 Allowed 'General case' 0 C--N 1.271 -2.805 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -128.86 168.97 15.16 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 176.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -88.58 121.74 31.28 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.361 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.81 50.97 7.41 Favored Glycine 0 N--CA 1.422 -2.263 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 86' ' ' ILE . . . -124.06 113.68 18.72 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.43 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 57.2 m-85 -98.78 125.14 44.05 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.296 -0.865 . . . . 0.0 108.707 -178.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.51 111.51 4.22 Favored Glycine 0 C--N 1.289 -2.033 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.318 -176.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 83' ' ' HIS . 38.9 tp -91.5 121.81 33.53 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -107.2 118.9 37.93 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 174.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.5 tp -114.73 130.88 56.9 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 123.496 0.497 . . . . 0.0 110.562 -177.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -90.66 113.71 25.83 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.52 ' HB ' ' SG ' ' A' ' 123' ' ' CYS . 17.7 m -98.25 162.13 2.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.6 -56.52 5.21 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 p -163.17 136.8 4.53 Favored Pre-proline 0 N--CA 1.425 -1.723 0 C-N-CA 126.883 2.073 . . . . 0.0 105.612 175.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.587 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 36.4 Cg_exo -59.81 -46.59 19.18 Favored 'Trans proline' 0 CA--C 1.572 2.419 0 C-N-CA 120.929 1.086 . . . . 0.0 111.339 172.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.587 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 67.3 Cg_endo -67.75 149.58 78.72 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 122.606 2.204 . . . . 0.0 110.13 172.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.01 -41.56 7.37 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.104 1.87 . . . . 0.0 112.435 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 33.1 t -110.78 -32.39 6.87 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.389 -177.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.467 ' HB1' ' HG2' ' A' ' 66' ' ' PRO . . . 64.82 38.16 6.86 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 123.86 0.864 . . . . 0.0 110.515 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -59.71 -44.54 97.54 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.018 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -70.25 95.56 0.6 Allowed 'Trans proline' 0 C--N 1.374 1.882 0 N-CA-C 108.746 -1.29 . . . . 0.0 108.746 167.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 56.4 t-105 -113.14 150.46 32.15 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.203 -173.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -137.61 -46.38 0.55 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 122.431 1.11 . . . . 0.0 108.032 176.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 146.57 -76.94 0.26 Allowed Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 107.323 -2.311 . . . . 0.0 107.323 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 72.95 135.35 0.05 OUTLIER Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 125.269 1.428 . . . . 0.0 111.265 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.56 156.02 59.38 Favored 'Trans proline' 0 C--O 1.239 0.533 0 C-N-CA 122.389 2.059 . . . . 0.0 110.947 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.8 p -62.01 -21.55 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.55 0.691 . . . . 0.0 110.281 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -66.05 -21.29 66.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.547 178.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -82.98 -28.18 29.91 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.252 0.549 . . . . 0.0 109.571 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.461 ' O ' HG22 ' A' ' 62' ' ' VAL . 2.8 mm? -84.92 -7.99 58.94 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.984 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.6 t -103.56 102.05 13.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 173.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -96.25 143.33 27.43 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.798 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.467 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 69.6 m80 -113.25 123.23 49.68 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.29 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -124.98 131.68 53.38 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.43 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 1.0 OUTLIER -102.98 132.19 49.41 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 118.756 -1.177 . . . . 0.0 112.666 179.737 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 55' ' ' ALA . 4.0 mp -87.64 125.24 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 175.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -99.39 125.83 45.16 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 92' ' ' GLY . 11.0 t -114.55 142.07 46.91 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 175.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.21 -138.3 4.4 Favored Glycine 0 N--CA 1.418 -2.516 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -67.84 -24.29 40.42 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.901 2.401 . . . . 0.0 113.971 -175.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -88.79 -17.85 28.94 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.583 0.706 . . . . 0.0 110.503 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 114.9 -152.51 18.09 Favored Glycine 0 N--CA 1.424 -2.166 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 -178.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.438 HG13 ' HB ' ' A' ' 88' ' ' THR . 6.3 m -104.79 125.99 59.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.82 150.87 26.52 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 121.804 -0.56 . . . . 0.0 109.966 177.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 75.8 mt -73.96 131.28 35.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 123.306 0.379 . . . . 0.0 110.961 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -72.89 119.59 17.34 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 123.976 0.91 . . . . 0.0 109.325 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.62 15.01 48.21 Favored Glycine 0 C--O 1.243 0.677 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.756 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 120' ' ' SER . 19.4 t -85.05 125.36 70.65 Favored Pre-proline 0 N--CA 1.435 -1.187 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -53.02 -28.71 41.4 Favored 'Trans proline' 0 N--CA 1.487 1.098 0 C-N-CA 123.69 2.927 . . . . 0.0 113.652 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.2 m -142.33 119.11 11.14 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 178.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -90.95 116.63 66.83 Favored Pre-proline 0 C--N 1.283 -2.321 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -82.1 -19.32 6.95 Favored 'Trans proline' 0 C--N 1.328 -0.551 0 C-N-CA 122.204 1.936 . . . . 0.0 114.193 -176.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 50.83 98.87 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.215 0 C-N-CA 126.667 1.987 . . . . 0.0 113.234 -176.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.423 ' CD2' ' HB3' ' A' ' 110' ' ' LEU . 77.8 m-85 -111.67 178.84 4.19 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.67 -30.73 2.52 Favored Glycine 0 C--N 1.305 -1.183 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.729 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.0 m -115.36 143.83 44.69 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.421 ' O ' HG22 ' A' ' 111' ' ' VAL . 57.9 mt -62.51 -43.07 99.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.6 t -60.92 -29.46 69.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.926 0.393 . . . . 0.0 110.925 -177.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.46 -43.09 98.35 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.518 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 111' ' ' VAL . 3.7 pp -76.3 -30.92 57.94 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.961 178.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.455 ' HA ' HD22 ' A' ' 125' ' ' LEU . 56.4 t -62.74 -51.65 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.69 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.6 t -65.31 -25.46 67.63 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.563 -176.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.457 ' HA ' ' OE1' ' A' ' 113' ' ' GLN . 9.3 mm-40 -85.27 -30.55 23.69 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.141 -0.623 . . . . 0.0 111.728 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 49.3 m80 -74.52 -6.66 49.68 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.062 0.458 . . . . 0.0 111.702 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.0 m -71.84 -29.99 64.98 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 173.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 60.3 mt -100.21 -53.01 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.664 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.7 m -120.8 96.29 48.76 Favored Pre-proline 0 N--CA 1.434 -1.256 0 CA-C-O 120.99 0.424 . . . . 0.0 111.727 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.445 ' HB2' ' O ' ' A' ' 121' ' ' LEU . 44.1 Cg_endo -75.1 101.64 1.5 Allowed 'Trans proline' 0 N--CA 1.43 -2.213 0 C-N-CA 121.324 1.349 . . . . 0.0 109.982 173.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 45.6 mt -76.6 -59.82 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.261 0.553 . . . . 0.0 109.925 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.49 ' HB2' ' SG ' ' A' ' 98' ' ' CYS . 21.5 t -84.51 -29.84 25.65 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.568 0.699 . . . . 0.0 109.482 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.445 ' O ' ' HB2' ' A' ' 118' ' ' PRO . 6.9 mp -80.69 142.8 53.49 Favored Pre-proline 0 C--N 1.299 -1.615 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.212 -175.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -82.89 -20.01 5.59 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.379 2.053 . . . . 0.0 112.02 176.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.52 ' SG ' ' HB ' ' A' ' 62' ' ' VAL . 83.8 m -126.72 160.52 30.58 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 60.3 m -72.6 140.79 48.24 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 123.545 0.528 . . . . 0.0 110.562 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.455 HD22 ' HA ' ' A' ' 111' ' ' VAL . 22.8 tp -85.74 102.38 13.59 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -110.07 119.65 39.95 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -173.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.4 mp -61.77 123.61 77.93 Favored Pre-proline 0 C--O 1.247 0.934 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.162 -176.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo . . . . . 0 C--N 1.359 1.101 0 C-N-CA 123.042 2.494 . . . . 0.0 112.477 179.728 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.6 p . . . . . 0 N--CA 1.419 -1.976 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.8 m -92.37 -43.45 9.23 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.771 -174.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.08 -5.13 8.81 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -176.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -78.26 -20.8 50.93 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.368 0.604 . . . . 0.0 109.553 175.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.465 ' CZ3' HD13 ' A' ' 46' ' ' ILE . 37.9 p-90 -122.83 -30.66 3.79 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.239 176.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.561 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 38.4 t80 -95.22 122.06 37.51 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 120.981 0.42 . . . . 0.0 110.516 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.25 104.79 2.41 Favored Pre-proline 0 C--N 1.306 -1.307 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.946 174.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.36 22.96 0.55 Allowed 'Trans proline' 0 N--CA 1.486 1.031 0 C-N-CA 123.738 2.959 . . . . 0.0 114.116 -174.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -98.97 -12.28 20.78 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.461 0.648 . . . . 0.0 109.481 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.531 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 3.8 mm? -92.86 130.33 38.49 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.565 -178.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.1 m -90.66 175.85 6.88 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 172.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -57.54 -46.89 83.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 118.219 0.463 . . . . 0.0 112.143 -178.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -66.85 -38.59 86.66 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.561 0.696 . . . . 0.0 110.492 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -66.57 -37.65 85.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.096 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.6 -41.73 90.98 Favored 'General case' 0 CA--C 1.509 -0.635 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.265 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 72.5 mt -63.17 -48.01 89.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.68 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.34 -30.13 71.32 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.374 0.607 . . . . 0.0 111.775 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.08 -49.03 11.38 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.463 -178.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.462 ' HG ' ' HB2' ' A' ' 61' ' ' LYS . 16.1 tp -80.13 -16.93 53.87 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.538 -173.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -63.06 -31.26 72.35 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 122.061 -0.399 . . . . 0.0 110.796 178.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -82.02 -14.48 55.87 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.835 0.826 . . . . 0.0 110.283 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -85.93 162.84 18.37 Favored 'General case' 0 C--O 1.254 1.331 0 CA-C-O 121.665 0.745 . . . . 0.0 111.382 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.08 144.02 98.25 Favored Pre-proline 0 C--N 1.305 -1.345 0 CA-C-N 113.728 -1.578 . . . . 0.0 111.531 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.22 111.16 1.71 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.87 1.714 . . . . 0.0 109.029 171.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.87 -20.7 6.35 Favored Glycine 0 N--CA 1.427 -1.961 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -172.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.25 154.47 30.97 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-O 120.973 0.416 . . . . 0.0 110.07 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -149.0 163.79 36.47 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.191 -176.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -146.04 146.92 31.14 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 171.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 23' ' ' TYR . 60.1 mt -120.36 137.61 53.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -143.25 -175.75 4.66 Favored 'General case' 0 C--N 1.28 -2.446 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.543 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -78.74 128.11 32.98 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 175.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.0 t -85.3 103.64 14.42 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -177.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -77.25 74.8 3.81 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-O 122.23 1.014 . . . . 0.0 109.861 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 72.3 m -157.1 -47.2 0.07 Allowed 'General case' 0 C--N 1.271 -2.836 0 CA-C-N 113.406 -1.724 . . . . 0.0 108.873 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -131.06 147.96 52.68 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -82.3 135.81 35.15 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.58 33.11 48.64 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -130.56 131.73 45.18 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.417 0.627 . . . . 0.0 109.706 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -111.48 123.69 50.75 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -85.1 124.84 6.93 Favored Glycine 0 C--N 1.295 -1.722 0 C-N-CA 119.971 -1.109 . . . . 0.0 111.801 -175.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -104.45 119.23 38.5 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.57 126.2 54.74 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -121.7 123.84 42.84 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.462 ' HB2' ' HG ' ' A' ' 36' ' ' LEU . 22.4 tptm -88.41 120.77 30.09 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.793 -178.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 80' ' ' LEU . 34.3 m -113.83 157.52 14.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 173.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.25 -38.06 71.95 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 p -158.37 132.22 4.97 Favored Pre-proline 0 N--CA 1.444 -0.729 0 C-N-CA 125.495 1.518 . . . . 0.0 107.737 176.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.564 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 23.4 Cg_exo -62.15 -44.02 21.43 Favored 'Trans proline' 0 CA--C 1.565 2.055 0 C-N-CA 122.068 1.845 . . . . 0.0 113.182 175.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.564 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 73.6 Cg_endo -70.91 160.7 48.53 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.722 2.282 . . . . 0.0 110.307 173.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -65.16 -54.17 0.7 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.074 1.85 . . . . 0.0 112.344 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.8 p -110.56 -27.59 8.89 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.087 -175.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.407 ' HB3' ' HG2' ' A' ' 66' ' ' PRO . . . 63.88 38.15 9.11 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 123.588 0.755 . . . . 0.0 109.501 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.425 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 34.5 tt0 -54.16 -51.56 76.38 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.959 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' A' ' 70' ' ' GLN . 2.4 Cg_endo -89.73 101.96 0.33 Allowed 'Trans proline' 0 N--CA 1.436 -1.903 0 C-N-CA 121.611 1.54 . . . . 0.0 111.158 175.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 47.4 t-105 -96.44 144.49 26.51 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -139.59 -41.44 0.45 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.147 0.499 . . . . 0.0 110.668 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.83 77.95 0.03 OUTLIER Glycine 0 CA--C 1.476 -2.379 0 N-CA-C 108.449 -1.861 . . . . 0.0 108.449 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -123.47 101.92 36.76 Favored Pre-proline 0 C--N 1.294 -1.824 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -173.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -88.78 -175.66 1.27 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.502 2.135 . . . . 0.0 114.245 -175.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.7 p -62.01 -23.85 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 115.077 -0.965 . . . . 0.0 113.306 -175.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.15 -23.92 67.66 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.681 0.277 . . . . 0.0 111.437 176.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -92.04 -30.07 16.24 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.486 ' O ' HG21 ' A' ' 62' ' ' VAL . 64.4 mt -66.41 -33.91 76.78 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.574 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 95.6 t -85.51 109.98 19.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 172.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -84.16 133.98 34.59 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -176.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.405 ' CD2' HH22 ' A' ' 47' ' ' ARG . 5.6 m80 -113.45 122.76 48.29 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -132.53 154.96 49.46 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 176.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -125.5 137.02 53.94 Favored 'General case' 0 C--N 1.283 -2.299 0 C-N-CA 118.631 -1.227 . . . . 0.0 110.93 176.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 86.0 mt -92.57 117.08 35.16 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.81 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.135 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.416 ' OE1' ' HE3' ' A' ' 96' ' ' LYS . 50.8 mt-10 -109.43 144.69 37.31 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.4 t -118.62 131.96 56.18 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.33 -144.73 4.17 Favored Glycine 0 N--CA 1.429 -1.78 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.385 -178.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -61.87 -44.15 22.14 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.868 2.379 . . . . 0.0 113.864 -177.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.463 ' HD2' ' N ' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -75.91 -41.93 50.44 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.917 -176.428 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.6 -154.94 25.94 Favored Glycine 0 N--CA 1.425 -2.069 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.8 p -111.94 126.09 69.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.56 178.12 8.84 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.755 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 58.8 mt -88.12 143.92 10.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 C-N-CA 123.598 0.759 . . . . 0.0 112.693 -169.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.416 ' HE3' ' OE1' ' A' ' 87' ' ' GLU . 25.0 ttmt -95.46 136.89 35.27 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 170.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.83 55.0 1.69 Allowed Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -175.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 11.9 p -135.31 154.28 78.57 Favored Pre-proline 0 C--N 1.311 -1.103 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -167.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -84.9 -56.54 0.02 OUTLIER 'Trans proline' 0 CA--C 1.558 1.69 0 C-N-CA 122.995 2.463 . . . . 0.0 112.633 173.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.0 m -149.88 131.54 14.94 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -177.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -140.46 140.08 21.98 Favored Pre-proline 0 C--N 1.297 -1.68 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.94 153.65 29.2 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.024 1.816 . . . . 0.0 107.694 166.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -92.98 112.32 24.24 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.46 -0.775 . . . . 0.0 110.797 -178.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.425 ' HE1' ' OE1' ' A' ' 113' ' ' GLN . 29.4 m-85 -89.0 157.43 18.37 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.11 -173.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -97.04 -27.67 9.25 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.556 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 53.8 m -141.69 157.29 45.24 Favored 'General case' 0 C--O 1.244 0.766 0 O-C-N 122.233 -0.569 . . . . 0.0 110.838 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.9 -35.12 72.51 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.449 0.7 . . . . 0.0 111.771 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.1 t -51.95 -31.21 27.95 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.85 0.86 . . . . 0.0 111.76 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.404 ' O ' ' HG3' ' A' ' 113' ' ' GLN . . . -73.7 -48.58 31.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 122.229 -0.295 . . . . 0.0 111.246 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 pp -67.7 -29.46 68.73 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.204 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 78.6 t -67.86 -48.65 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.32 176.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.5 p -68.51 -44.85 73.76 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.425 ' OE1' ' HE1' ' A' ' 104' ' ' PHE . 66.4 mt-30 -66.22 -41.53 89.95 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.718 -178.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.528 ' HA ' ' O ' ' A' ' 117' ' ' SER . 58.1 m80 -77.79 -9.94 59.29 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.7 t -76.05 -23.51 55.1 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 174.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 72.2 mt -99.94 -66.87 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.806 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 20.2 m -102.62 117.72 60.2 Favored Pre-proline 0 N--CA 1.433 -1.276 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.814 -175.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -82.35 88.96 1.22 Allowed 'Trans proline' 0 N--CA 1.439 -1.697 0 C-N-CA 121.882 1.721 . . . . 0.0 110.267 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 52.2 mt -88.63 -69.98 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.467 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.6 m -88.73 -6.73 57.23 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.117 0.484 . . . . 0.0 111.319 -178.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.7 mt -118.61 145.12 36.8 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -176.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.26 -36.51 45.77 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.947 2.431 . . . . 0.0 113.613 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 60.8 m -123.65 159.88 28.37 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 85.1 m -73.34 139.63 46.16 Favored 'General case' 0 N--CA 1.434 -1.246 0 O-C-N 123.686 0.616 . . . . 0.0 109.722 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.8 mt -65.37 110.79 2.76 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.583 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -89.38 95.36 10.25 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 174.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 58.6 mt -65.52 126.28 91.24 Favored Pre-proline 0 C--N 1.302 -1.484 0 CA-C-N 113.966 -1.47 . . . . 0.0 108.997 -178.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 N--CA 1.452 -0.915 0 C-N-CA 121.861 1.707 . . . . 0.0 110.223 176.698 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.1 p . . . . . 0 N--CA 1.435 -1.196 0 CA-C-O 121.868 0.842 . . . . 0.0 108.738 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.3 m -93.99 -33.31 13.49 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.627 -175.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -16.32 61.14 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.048 0.451 . . . . 0.0 111.672 -177.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -66.22 -40.06 90.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.506 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.406 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 11.8 p-90 -104.76 -5.67 21.04 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -94.11 113.16 25.06 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.961 -176.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.02 87.67 43.53 Favored Pre-proline 0 C--N 1.311 -1.109 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.5 178.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.14 -12.57 17.44 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.706 2.271 . . . . 0.0 115.254 -172.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -96.79 19.31 12.75 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.078 0.465 . . . . 0.0 111.27 -177.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.55 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 4.4 mm? -105.95 128.56 53.88 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.363 0.601 . . . . 0.0 112.25 -178.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.8 t -88.86 173.42 8.53 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 174.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.423 ' O ' HG13 ' A' ' 33' ' ' ILE . 11.0 ttm180 -48.96 -56.93 7.41 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.545 0.738 . . . . 0.0 112.36 -174.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -66.21 -37.3 85.23 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.999 -172.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -75.58 -32.08 60.22 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.269 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.57 89.96 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 175.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 29' ' ' ARG . 89.6 mt -59.99 -46.42 94.15 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.656 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.556 178.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.409 ' O ' ' HG2' ' A' ' 37' ' ' LYS . . . -59.02 -44.97 91.78 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 41.2 mt -64.87 -47.34 78.21 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.706 0.765 . . . . 0.0 111.593 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.484 ' HG ' ' HB2' ' A' ' 61' ' ' LYS . 51.5 tp -70.52 -38.14 74.22 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.291 -1.322 . . . . 0.0 113.835 -173.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 14.3 ptmm? -56.75 -30.57 63.72 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -175.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -98.73 8.8 44.53 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.53 0.681 . . . . 0.0 111.077 -177.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . 0.261 45.3 mtmt -84.15 -85.64 0.13 Allowed 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 119.18 -1.008 . . . . 0.0 113.382 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -173.48 136.9 0.71 Allowed Pre-proline 0 C--N 1.289 -2.024 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -176.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -58.56 107.3 0.33 Allowed 'Trans proline' 0 C--O 1.246 0.906 0 C-N-CA 122.519 2.146 . . . . 0.0 110.704 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.45 -25.82 4.73 Favored Glycine 0 N--CA 1.426 -1.972 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -175.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.407 ' O ' HD13 ' A' ' 36' ' ' LEU . . . -76.06 155.19 35.05 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-O 121.093 0.473 . . . . 0.0 110.362 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -146.2 178.33 8.31 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.431 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -156.64 149.46 23.79 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 169.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.406 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 61.1 mt -113.69 124.07 69.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.55 ' HD2' ' O ' ' A' ' 27' ' ' LEU . 39.1 ptt85 -117.28 -177.25 3.18 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.398 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -98.92 136.66 38.6 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.9 t -109.81 152.98 25.03 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.376 0.608 . . . . 0.0 112.212 -172.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -117.62 92.52 3.86 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-O 121.964 0.888 . . . . 0.0 108.884 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.4 m -153.85 -50.92 0.1 Allowed 'General case' 0 C--N 1.258 -3.401 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 177.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -130.88 143.32 50.64 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 104.068 -2.567 . . . . 0.0 104.068 171.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -81.22 120.46 24.92 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.52 30.63 4.88 Favored Glycine 0 C--N 1.295 -1.708 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -171.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -119.29 145.4 46.15 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.456 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 85.1 m-85 -115.55 143.06 45.88 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.31 123.03 7.67 Favored Glycine 0 C--N 1.285 -2.281 0 C-N-CA 119.995 -1.098 . . . . 0.0 110.432 -178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -99.61 119.87 38.77 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -114.41 121.93 45.08 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 176.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.8 tt -123.05 123.86 41.82 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -176.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.484 ' HB2' ' HG ' ' A' ' 36' ' ' LEU . 22.1 tptm -90.25 113.44 25.27 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 80' ' ' LEU . 17.9 m -99.02 171.26 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.02 -56.57 4.54 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 176.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.4 p -158.67 132.45 4.96 Favored Pre-proline 0 C--N 1.309 -1.189 0 C-N-CA 125.294 1.437 . . . . 0.0 108.287 177.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.556 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 35.7 Cg_exo -59.73 -42.14 48.99 Favored 'Trans proline' 0 CA--C 1.577 2.65 0 C-N-CA 121.376 1.384 . . . . 0.0 111.545 171.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.556 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 95.3 Cg_endo -76.89 172.25 16.53 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 122.991 2.46 . . . . 0.0 110.153 170.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.62 -44.91 43.57 Favored 'Trans proline' 0 C--N 1.362 1.241 0 C-N-CA 122.873 2.382 . . . . 0.0 112.633 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.5 m -143.49 -15.3 0.65 Allowed 'General case' 0 C--O 1.247 0.968 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.344 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.492 ' HB3' ' CG ' ' A' ' 66' ' ' PRO . . . 58.38 43.63 19.55 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 123.884 0.873 . . . . 0.0 108.688 -174.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -57.68 -48.23 97.57 Favored Pre-proline 0 N--CA 1.447 -0.606 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.819 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -76.41 87.6 1.43 Allowed 'Trans proline' 0 C--N 1.371 1.734 0 CA-C-N 120.495 1.212 . . . . 0.0 109.746 171.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 31.4 t-105 -81.78 141.52 33.43 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.674 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -122.9 -33.11 3.41 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.306 -0.958 . . . . 0.0 112.102 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.03 68.12 0.02 OUTLIER Glycine 0 CA--C 1.466 -2.976 0 N-CA-C 106.097 -2.801 . . . . 0.0 106.097 -176.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -104.4 110.9 64.94 Favored Pre-proline 0 C--N 1.284 -2.24 0 CA-C-N 113.381 -1.409 . . . . 0.0 111.215 -168.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -73.84 159.83 44.5 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.12 1.88 . . . . 0.0 111.437 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.408 ' HA ' HD23 ' A' ' 80' ' ' LEU . 8.6 p -62.99 -20.78 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.462 0.648 . . . . 0.0 110.676 -178.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -67.75 -13.32 62.02 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 124.065 0.946 . . . . 0.0 111.396 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -87.67 -38.36 15.93 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.461 ' O ' HG22 ' A' ' 62' ' ' VAL . 2.7 mm? -73.15 -27.57 61.74 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.866 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.2 t -86.18 110.08 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 171.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -91.78 134.27 34.89 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.408 -0.814 . . . . 0.0 108.853 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -114.26 122.5 46.93 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.298 0.57 . . . . 0.0 110.579 178.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -129.75 160.17 34.25 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -123.14 150.49 43.21 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.657 -1.217 . . . . 0.0 111.927 174.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.456 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 81.6 mt -108.81 131.1 60.41 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.792 0 CA-C-N 114.068 -1.424 . . . . 0.0 107.615 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -115.54 137.47 52.03 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 1.7 t -110.81 118.72 36.91 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 171.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -135.52 -148.09 5.57 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.85 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -71.25 -34.1 10.42 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 122.56 2.173 . . . . 0.0 113.875 -177.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -75.72 -26.49 57.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.129 0.49 . . . . 0.0 111.034 178.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 139.04 -153.52 22.82 Favored Glycine 0 N--CA 1.425 -2.087 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 88' ' ' THR . 13.9 p -112.04 130.87 64.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.23 170.01 23.22 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.418 ' HB ' ' SG ' ' A' ' 98' ' ' CYS . 64.1 mt -81.16 140.46 16.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -52.39 -53.05 49.95 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 123.601 0.761 . . . . 0.0 109.926 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.65 23.79 5.47 Favored Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 115.086 -0.961 . . . . 0.0 114.666 -176.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.418 ' SG ' ' HB ' ' A' ' 95' ' ' ILE . 31.1 p -116.02 103.09 53.71 Favored Pre-proline 0 N--CA 1.435 -1.2 0 CA-C-N 118.315 1.057 . . . . 0.0 110.551 174.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -100.6 28.47 0.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.124 2.549 . . . . 0.0 110.053 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.3 p -75.54 -78.71 0.11 Allowed 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.438 -176.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -166.68 -59.07 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -79.12 126.23 6.92 Favored 'Trans proline' 0 N--CA 1.44 -1.668 0 N-CA-C 115.813 1.428 . . . . 0.0 115.813 -165.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -97.72 121.03 39.15 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 168.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.548 ' CD2' ' HB3' ' A' ' 110' ' ' LEU . 60.0 m-85 -94.46 166.29 12.13 Favored 'General case' 0 C--N 1.289 -2.024 0 O-C-N 123.395 0.434 . . . . 0.0 111.177 -170.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.22 -36.78 6.93 Favored Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 121.108 -0.568 . . . . 0.0 111.991 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.9 m -140.98 169.41 17.68 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 122.497 -0.414 . . . . 0.0 109.943 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.454 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 94.8 mt -62.36 -40.05 95.17 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.107 0.563 . . . . 0.0 112.198 -176.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.0 t -52.53 -40.46 62.52 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.218 0.607 . . . . 0.0 112.037 -178.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.58 96.41 Favored 'General case' 0 C--O 1.247 0.954 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.548 ' HB3' ' CD2' ' A' ' 104' ' ' PHE . 4.4 pp -72.55 -28.73 63.01 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 120.912 0.387 . . . . 0.0 110.919 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 40.6 t -63.78 -54.59 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.132 177.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 45.9 m -65.28 -36.67 84.83 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.502 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -57.77 -48.18 80.39 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.434 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.466 ' HA ' ' O ' ' A' ' 117' ' ' SER . 71.6 m80 -87.53 -2.49 58.65 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.5 t -79.33 -31.15 43.03 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 67.4 mt -95.85 -58.96 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.424 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 21.6 m -111.57 105.3 56.71 Favored Pre-proline 0 N--CA 1.434 -1.247 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.835 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -75.29 85.35 1.57 Allowed 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 121.696 1.597 . . . . 0.0 110.076 175.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.0 mt -72.51 -73.85 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.908 -177.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.1 m -98.89 1.18 45.46 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.664 0.745 . . . . 0.0 111.318 -176.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.4 mt -105.29 137.6 19.3 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.78 -10.93 29.76 Favored 'Trans proline' 0 N--CA 1.485 1.023 0 C-N-CA 122.885 2.39 . . . . 0.0 113.701 -177.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 52.3 t -141.01 151.52 44.17 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 13.2 p -76.67 142.65 40.5 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 176.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 90.1 mt -73.02 120.17 18.27 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 123.741 0.651 . . . . 0.0 109.738 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -101.41 120.07 39.72 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mt -105.29 109.59 63.39 Favored Pre-proline 0 N--CA 1.429 -1.483 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 C--N 1.32 -0.949 0 C-N-CA 122.725 2.283 . . . . 0.0 113.08 -176.606 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.1 p . . . . . 0 CA--C 1.54 0.566 0 CA-C-O 122.417 1.103 . . . . 0.0 111.827 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 36.2 t -80.06 -21.56 43.26 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.27 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.95 -4.55 17.1 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -173.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -86.19 -12.09 50.72 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 122.114 -0.366 . . . . 0.0 110.78 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.429 ' CE3' ' HB2' ' A' ' 23' ' ' TYR . 53.3 p-90 -142.48 -28.95 0.58 Allowed 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -175.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.429 ' HB2' ' CE3' ' A' ' 22' ' ' TRP . 55.4 t80 -92.46 114.26 26.76 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.331 0.586 . . . . 0.0 112.535 -173.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.9 96.56 2.92 Favored Pre-proline 0 C--N 1.306 -1.314 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.816 172.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.95 3.78 6.7 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 123.26 2.64 . . . . 0.0 114.227 -173.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -85.11 -14.66 46.42 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.701 0.762 . . . . 0.0 109.504 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.3 tp -89.2 134.86 33.87 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.367 -169.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.8 t -92.27 177.5 6.13 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-O 120.875 0.369 . . . . 0.0 110.015 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.408 ' HA ' ' CZ ' ' A' ' 47' ' ' ARG . 17.1 ttm180 -54.48 -56.11 22.13 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 124.506 1.122 . . . . 0.0 113.4 -172.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -65.31 -40.59 93.97 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.386 0.612 . . . . 0.0 111.1 -174.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -65.45 -35.83 82.1 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.162 -177.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.33 -40.07 96.28 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.376 178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 73.4 mt -67.95 -41.23 84.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.197 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.11 -31.61 70.21 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.245 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.2 mt -79.81 -39.83 29.92 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.396 0.617 . . . . 0.0 111.707 175.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.9 tp -75.6 -28.74 59.0 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.065 -173.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.2 ptmm? -64.05 -15.07 58.69 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.31 0.576 . . . . 0.0 111.385 178.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -95.5 -13.63 24.36 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.316 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -99.27 174.32 6.36 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.919 0.39 . . . . 0.0 111.457 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -92.94 158.74 37.11 Favored Pre-proline 0 C--N 1.304 -1.376 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.061 -173.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -59.61 120.81 8.85 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 122.472 2.114 . . . . 0.0 110.873 175.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.81 -14.52 10.55 Favored Glycine 0 C--N 1.298 -1.543 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -176.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.75 151.67 27.36 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.459 ' CG ' HD23 ' A' ' 125' ' ' LEU . 22.5 p90 -152.16 162.03 41.74 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -175.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -150.48 147.32 27.36 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 174.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.417 HD13 ' CZ3' ' A' ' 22' ' ' TRP . 64.6 mt -118.96 127.29 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 CA-C-O 121.692 0.758 . . . . 0.0 109.673 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.408 ' CZ ' ' HA ' ' A' ' 29' ' ' ARG . 26.5 ptt-85 -125.3 -173.96 2.94 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -92.27 135.06 34.31 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 174.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 70.2 m -83.64 99.16 10.03 Favored 'General case' 0 N--CA 1.426 -1.631 0 C-N-CA 120.221 -0.591 . . . . 0.0 109.407 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -74.15 69.5 1.52 Allowed 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 121.98 0.895 . . . . 0.0 109.794 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.3 m -157.63 -36.46 0.07 Allowed 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 113.352 -1.749 . . . . 0.0 108.412 -177.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -133.4 166.98 21.27 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -110.89 130.12 55.68 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.78 24.5 38.26 Favored Glycine 0 C--N 1.304 -1.205 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.17 122.44 22.83 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-O 121.673 0.749 . . . . 0.0 110.146 -178.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -96.66 155.91 16.57 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -118.19 120.72 4.82 Favored Glycine 0 C--N 1.273 -2.952 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.45 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.2 tp -98.45 121.7 40.72 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 124.296 0.644 . . . . 0.0 109.275 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.15 112.93 25.37 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.7 tp -108.78 129.54 55.38 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 123.528 0.518 . . . . 0.0 109.7 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -88.83 119.3 29.21 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.7 m -108.38 165.71 4.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.32 -58.73 5.2 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.439 ' HB ' ' HG2' ' A' ' 66' ' ' PRO . 0.6 OUTLIER -164.64 145.47 6.41 Favored Pre-proline 0 C--N 1.314 -0.97 0 C-N-CA 123.545 0.738 . . . . 0.0 110.663 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.578 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 16.3 Cg_exo -63.05 -49.82 4.5 Favored 'Trans proline' 0 CA--C 1.571 2.344 0 C-N-CA 121.933 1.756 . . . . 0.0 109.44 168.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.578 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 15.9 Cg_endo -57.55 179.81 0.13 Allowed 'Trans proline' 0 C--N 1.392 2.831 0 C-N-CA 122.825 2.35 . . . . 0.0 110.841 162.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -71.82 -47.46 0.46 Allowed 'Trans proline' 0 C--N 1.357 1.001 0 N-CA-C 108.072 -1.549 . . . . 0.0 108.072 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 71.5 m -160.79 111.68 1.81 Allowed 'General case' 0 N--CA 1.407 -2.608 0 N-CA-C 103.442 -2.799 . . . . 0.0 103.442 171.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.423 ' H ' HG23 ' A' ' 64' ' ' THR . . . -58.41 76.15 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 124.031 0.932 . . . . 0.0 113.085 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -87.82 -47.43 0.47 Allowed Pre-proline 0 C--N 1.286 -2.156 0 CA-C-N 114.578 -1.192 . . . . 0.0 107.892 172.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -65.51 109.19 1.35 Allowed 'Trans proline' 0 C--N 1.377 2.05 0 N-CA-C 108.654 -1.325 . . . . 0.0 108.654 165.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -81.83 137.32 35.29 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.981 -175.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -126.17 -36.75 2.3 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.763 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 167.73 -48.34 0.24 Allowed Glycine 0 CA--C 1.467 -2.93 0 N-CA-C 107.335 -2.306 . . . . 0.0 107.335 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 39.49 78.38 0.37 Allowed Pre-proline 0 C--N 1.316 -0.87 0 C-N-CA 126.817 2.047 . . . . 0.0 114.647 168.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -75.38 163.2 34.95 Favored 'Trans proline' 0 C--O 1.242 0.701 0 C-N-CA 122.251 1.967 . . . . 0.0 111.518 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -67.11 -30.29 48.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 120.985 0.421 . . . . 0.0 111.182 -178.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -70.71 -18.77 62.8 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.202 0.525 . . . . 0.0 110.473 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -79.09 -22.77 44.76 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.6 mt -89.35 5.69 43.92 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.962 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.8 t -117.85 141.47 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -109.45 137.39 47.37 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -117.7 122.77 44.4 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 121.439 0.638 . . . . 0.0 111.669 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -135.57 143.38 45.62 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 177.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.9 mp -96.42 162.61 13.41 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.263 -1.375 . . . . 0.0 108.726 174.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 80.2 mt -125.13 110.83 25.69 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.014 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 174.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.455 ' OE1' ' HD3' ' A' ' 96' ' ' LYS . 30.1 mt-10 -99.72 148.93 23.84 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -175.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.423 ' HB ' HG22 ' A' ' 93' ' ' VAL . 5.3 t -135.56 141.86 45.25 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -149.74 -155.45 6.8 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.35 -27.22 84.45 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.17 2.58 . . . . 0.0 113.876 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.72 -48.68 16.1 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 120.739 0.305 . . . . 0.0 111.689 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.63 -144.12 8.99 Favored Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.423 HG22 ' HB ' ' A' ' 88' ' ' THR . 12.2 p -123.78 142.49 40.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.64 157.48 31.96 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.155 0.182 . . . . 0.0 111.214 -171.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 58.0 mt -81.56 136.8 22.35 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 CA-C-O 121.207 0.527 . . . . 0.0 110.891 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.455 ' HD3' ' OE1' ' A' ' 87' ' ' GLU . 43.5 tptt -83.38 135.2 34.79 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 124.492 1.117 . . . . 0.0 111.172 -176.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.68 34.55 13.31 Favored Glycine 0 CA--C 1.499 -0.94 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.118 176.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.592 ' SG ' ' HB3' ' A' ' 100' ' ' SER . 47.0 t -142.26 143.15 26.26 Favored Pre-proline 0 N--CA 1.425 -1.68 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -87.36 10.34 3.57 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 123.318 2.678 . . . . 0.0 110.64 177.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.592 ' HB3' ' SG ' ' A' ' 98' ' ' CYS . 40.5 t -125.47 -164.63 1.32 Allowed 'General case' 0 N--CA 1.393 -3.306 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 -178.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 68.4 100.53 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.794 0 C-N-CA 125.674 1.59 . . . . 0.0 112.295 -179.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.94 -162.99 0.15 Allowed 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 122.968 2.445 . . . . 0.0 111.654 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -94.33 96.53 9.61 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -78.32 161.22 27.37 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -76.36 -51.57 6.62 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.524 178.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 39.0 m -137.68 166.7 23.31 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.6 mp -58.72 -36.28 74.04 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 123.166 0.587 . . . . 0.0 110.98 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.1 m -51.21 -37.74 48.45 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.232 1.013 . . . . 0.0 111.482 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.14 -50.08 65.21 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.196 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 111' ' ' VAL . 4.1 pp -68.21 -35.06 77.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.879 0.371 . . . . 0.0 110.592 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.454 ' N ' HD12 ' A' ' 110' ' ' LEU . 47.9 t -58.31 -50.79 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.683 176.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 45.7 p -69.42 -22.78 63.66 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.409 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -88.79 -39.55 13.82 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.928 0.394 . . . . 0.0 111.405 -174.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -75.47 -0.84 21.51 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.7 m -74.56 -28.49 60.96 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 170.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 68.8 mt -97.95 -49.03 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.217 -178.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.9 m -121.71 99.83 44.38 Favored Pre-proline 0 N--CA 1.44 -0.959 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.174 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -81.47 100.89 1.17 Allowed 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.144 1.896 . . . . 0.0 109.727 174.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 65.0 mt -90.29 -73.8 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.135 -174.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.548 ' HB3' ' SG ' ' A' ' 98' ' ' CYS . 2.7 p -77.74 -27.41 50.45 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 122.038 0.923 . . . . 0.0 110.094 177.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.5 mt -83.12 129.68 60.12 Favored Pre-proline 0 N--CA 1.427 -1.587 0 CA-C-N 114.144 -1.389 . . . . 0.0 109.237 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -75.78 -4.33 15.06 Favored 'Trans proline' 0 N--CA 1.485 1.021 0 C-N-CA 122.893 2.395 . . . . 0.0 112.702 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 82.9 m -143.61 152.59 41.57 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . 0.43 ' SG ' ' HD3' ' A' ' 126' ' ' ARG . 21.5 p -82.07 148.63 28.48 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.952 0.406 . . . . 0.0 111.487 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.459 HD23 ' CG ' ' A' ' 44' ' ' PHE . 86.7 mt -74.19 117.42 15.98 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.43 ' HD3' ' SG ' ' A' ' 124' ' ' CYS . 24.2 mmm180 -104.41 109.73 21.71 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.241 0.543 . . . . 0.0 110.221 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mp -96.03 126.66 43.69 Favored Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo . . . . . 0 C--N 1.352 0.762 0 C-N-CA 122.408 2.072 . . . . 0.0 111.485 177.772 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.335 80.5 p . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 23' ' ' TYR . 20.0 m -62.66 -31.84 72.79 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.671 0.748 . . . . 0.0 109.483 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -10.64 33.64 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 177.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -98.38 -62.26 1.27 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.804 0.335 . . . . 0.0 111.093 176.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 24.8 p-90 -94.05 -8.65 39.17 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -171.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.481 ' HB3' ' O ' ' A' ' 19' ' ' SER . 70.2 t80 -100.5 120.0 39.35 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.865 -175.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -131.23 88.94 43.07 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 175.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.83 -31.82 67.55 Favored 'Trans proline' 0 N--CA 1.482 0.834 0 C-N-CA 122.482 2.121 . . . . 0.0 113.347 -172.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -84.74 -0.32 53.26 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 124.107 0.963 . . . . 0.0 112.776 -174.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.462 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 14.4 tp -85.76 152.37 23.1 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -176.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 t -110.28 174.86 5.66 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 120.628 0.251 . . . . 0.0 110.432 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 -56.91 -50.36 72.78 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -174.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -64.77 -32.01 73.5 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.126 0.488 . . . . 0.0 111.326 -175.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -74.83 -39.36 61.67 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.326 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.49 -43.44 93.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.395 0.617 . . . . 0.0 109.948 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 78.1 mt -65.62 -39.7 85.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.966 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.439 ' O ' ' HG2' ' A' ' 37' ' ' LYS . . . -57.71 -49.44 76.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.277 178.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.8 -36.29 82.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.075 0.464 . . . . 0.0 111.336 178.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.405 ' CD1' HD23 ' A' ' 45' ' ' LEU . 6.6 mp -81.2 -14.81 57.17 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -177.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 17.8 ptpt -80.28 -15.05 57.83 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.673 177.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -100.23 -3.72 30.92 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.187 176.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -101.38 174.63 5.89 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -176.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -91.53 144.65 29.91 Favored Pre-proline 0 C--N 1.305 -1.343 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.14 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.02 118.44 4.98 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.083 2.522 . . . . 0.0 112.094 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.37 -11.71 9.09 Favored Glycine 0 N--CA 1.435 -1.41 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -174.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.65 147.87 37.24 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -150.68 171.5 17.06 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -176.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.405 HD23 ' CD1' ' A' ' 36' ' ' LEU . 1.5 pt? -161.56 154.52 20.75 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 172.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.3 mt -121.48 134.92 63.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 121.061 0.457 . . . . 0.0 110.565 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.522 ' HG3' ' O ' ' A' ' 48' ' ' ASP . 23.8 ptt-85 -127.39 -173.69 2.97 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 177.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.522 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 13.1 t70 -82.4 150.75 26.94 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 174.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 70.8 m -66.25 -26.75 67.5 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 119.307 0.958 . . . . 0.0 112.12 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 35.4 t60 69.73 -46.75 0.59 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 124.909 1.284 . . . . 0.0 111.873 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.2 t -71.67 -33.5 68.91 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 123.775 0.83 . . . . 0.0 110.35 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -122.36 154.36 37.77 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -177.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -102.39 126.73 49.51 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 123.812 0.695 . . . . 0.0 110.41 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.13 22.67 34.57 Favored Glycine 0 C--N 1.308 -1.024 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -178.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.62 144.02 47.65 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 120.898 0.38 . . . . 0.0 110.162 -177.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -112.64 139.0 48.62 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -101.96 111.63 4.12 Favored Glycine 0 C--N 1.294 -1.797 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.378 -177.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 39.3 tp -91.31 130.49 37.17 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 123.88 0.872 . . . . 0.0 109.306 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -114.44 128.71 56.48 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 175.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.2 tp -122.27 129.54 52.3 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 123.553 0.533 . . . . 0.0 110.546 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -93.1 114.28 26.77 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 28.4 m -106.82 164.14 4.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 173.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.07 -59.24 3.02 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.9 p -149.22 141.73 15.36 Favored Pre-proline 0 N--CA 1.421 -1.877 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.568 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 39.1 Cg_exo -59.99 -44.71 28.1 Favored 'Trans proline' 0 CA--C 1.57 2.279 0 C-N-CA 121.675 1.583 . . . . 0.0 111.659 174.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.568 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 85.6 Cg_endo -75.78 149.72 33.98 Favored 'Trans proline' 0 C--N 1.381 2.272 0 C-N-CA 122.416 2.077 . . . . 0.0 109.559 171.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.18 -48.11 6.89 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.148 1.899 . . . . 0.0 112.629 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.9 p -116.71 -9.1 11.34 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.855 0.36 . . . . 0.0 111.363 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 59.4 44.05 15.64 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.562 -178.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -50.38 -52.33 55.8 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 113.902 -1.499 . . . . 0.0 110.787 175.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.45 93.43 0.98 Allowed 'Trans proline' 0 N--CA 1.441 -1.568 0 CA-C-N 120.308 1.146 . . . . 0.0 109.352 169.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 53.0 t-105 -86.55 137.16 32.73 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.562 -175.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -124.7 -42.12 2.09 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.206 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.24 56.39 1.0 Allowed Glycine 0 C--N 1.299 -1.524 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -89.94 139.93 27.57 Favored Pre-proline 0 C--N 1.306 -1.289 0 CA-C-N 115.091 -0.555 . . . . 0.0 109.855 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.19 167.93 26.06 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.893 2.395 . . . . 0.0 113.829 -175.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 p -59.53 -32.74 49.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.336 176.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 -65.1 -18.68 65.5 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.073 0.463 . . . . 0.0 110.881 177.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -92.4 -36.05 13.35 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.95 -35.8 82.33 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.156 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 89.6 t -70.71 113.04 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.515 ' HA ' ' NE ' ' A' ' 82' ' ' ARG . 1.7 mmp_? -87.25 144.6 26.74 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.795 -176.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -125.84 124.47 40.98 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 120.974 0.416 . . . . 0.0 110.352 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -132.13 132.86 43.63 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.442 ' HG ' ' HB2' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -97.06 140.59 31.35 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.972 -1.091 . . . . 0.0 112.229 177.029 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 77.4 mt -107.61 120.68 59.36 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.419 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -105.78 138.01 42.7 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -175.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.9 t -116.36 124.75 50.84 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.65 -162.66 9.52 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 -178.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.55 -31.82 49.9 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.205 2.603 . . . . 0.0 112.631 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -71.04 -21.88 62.21 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 175.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 132.63 -159.47 23.45 Favored Glycine 0 CA--C 1.488 -1.601 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.6 p -104.01 127.18 58.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.688 ' HG2' ' CD2' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -149.73 167.03 27.63 Favored 'General case' 0 C--O 1.201 -1.493 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.24 -171.665 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 66.6 mt -93.2 143.88 10.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.405 -176.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.442 ' HB2' ' HG ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -44.69 -46.56 10.37 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.675 1.59 . . . . 0.0 112.124 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -127.01 63.89 0.59 Allowed Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.44 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 11.1 p -85.05 122.85 74.1 Favored Pre-proline 0 C--N 1.304 -1.391 0 CA-C-O 120.678 0.275 . . . . 0.0 110.391 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -80.29 10.42 3.24 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 122.752 2.301 . . . . 0.0 113.365 -176.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.8 m -154.82 -162.46 1.38 Allowed 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -109.88 106.37 58.19 Favored Pre-proline 0 C--N 1.294 -1.816 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -175.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -89.42 -80.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.653 0 C-N-CA 122.066 1.844 . . . . 0.0 112.149 171.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.688 ' CD2' ' HG2' ' A' ' 94' ' ' LYS . 51.8 m-85 43.49 79.36 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 127.381 2.272 . . . . 0.0 112.805 178.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -107.08 -178.36 3.62 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.279 -177.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -86.35 -36.9 9.3 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.009 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.8 m -132.9 158.51 42.41 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 122.456 -0.438 . . . . 0.0 110.487 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 75.1 mt -55.21 -46.78 75.93 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 123.13 0.572 . . . . 0.0 111.463 178.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 24.3 p -54.6 -31.21 56.6 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 123.242 0.617 . . . . 0.0 112.401 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.18 -39.14 82.58 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.113 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.437 HD13 ' N ' ' A' ' 111' ' ' VAL . 3.8 pp -80.31 -29.81 38.13 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.687 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.437 ' N ' HD13 ' A' ' 110' ' ' LEU . 40.6 t -63.41 -54.48 32.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.629 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.7 m -68.64 -20.61 64.47 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.303 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -78.26 -40.82 35.94 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.646 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.507 ' HA ' ' O ' ' A' ' 117' ' ' SER . 66.8 m80 -80.18 3.02 21.99 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -174.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 10.7 p -86.15 -39.88 16.22 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 172.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.5 mt -84.01 -48.14 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.271 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 19.6 m -121.86 93.06 48.78 Favored Pre-proline 0 N--CA 1.425 -1.706 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.835 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.57 73.43 5.6 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.855 2.37 . . . . 0.0 110.873 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 67.5 mt -68.8 -60.8 2.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.13 -178.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.3 m -83.72 -49.96 8.62 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.551 -175.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -73.4 139.96 78.84 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.867 -177.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.88 -18.39 46.94 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 123.09 2.527 . . . . 0.0 111.994 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 43.6 t -127.94 154.75 45.21 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 4.0 p -71.61 145.01 49.26 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 177.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 74.2 mt -79.41 106.31 11.35 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -90.38 103.78 16.42 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.336 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.457 ' H ' HD12 ' A' ' 127' ' ' ILE . 1.8 mp -90.38 128.12 50.3 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo . . . . . 0 CA--C 1.531 0.373 0 C-N-CA 121.435 1.423 . . . . 0.0 110.21 174.507 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.518 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 2.0 p . . . . . 0 N--CA 1.425 -1.725 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.5 m -74.32 -36.17 63.68 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.313 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.77 -5.86 40.81 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.518 ' CD2' ' HA ' ' A' ' 18' ' ' THR . 25.6 m-85 -81.08 -24.12 38.0 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.079 175.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.464 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 54.0 p-90 -116.6 -32.28 5.24 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -93.16 114.54 27.07 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.217 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . 0.252 0.1 OUTLIER -155.24 98.28 2.37 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-O 121.711 0.767 . . . . 0.0 111.266 175.361 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -83.35 19.43 1.34 Allowed 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 124.047 3.165 . . . . 0.0 114.62 -173.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -99.43 -4.03 32.37 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.993 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.7 mp -92.99 140.96 28.92 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.817 0.818 . . . . 0.0 112.952 -177.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 m -90.05 177.26 6.5 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.043 -1.435 . . . . 0.0 107.707 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -50.49 -56.56 11.04 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.249 0.62 . . . . 0.0 110.635 177.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -65.86 -35.31 80.29 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.709 -175.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -66.94 -38.69 86.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.088 178.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.44 -42.07 99.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.577 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 82.9 mt -64.82 -45.83 93.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.107 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.406 ' HA ' ' CD ' ' A' ' 37' ' ' LYS . . . -59.83 -32.95 71.14 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.702 0.763 . . . . 0.0 111.83 178.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.14 -50.08 17.48 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.499 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 70.1 mt -71.09 -26.26 62.97 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -175.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.406 ' CD ' ' HA ' ' A' ' 34' ' ' ALA . 14.3 ptmm? -65.11 -24.49 67.44 Favored 'General case' 0 C--N 1.316 -0.883 0 O-C-N 121.908 -0.495 . . . . 0.0 110.567 178.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -84.37 -40.36 17.96 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.753 176.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.514 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -68.58 151.42 46.78 Favored 'General case' 0 C--O 1.248 1.015 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.222 -176.278 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -75.11 138.35 72.36 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.815 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -45.45 120.24 3.11 Favored 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 124.265 3.31 . . . . 0.0 114.121 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.87 -24.43 6.38 Favored Glycine 0 N--CA 1.434 -1.476 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -176.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.08 151.66 45.23 Favored 'General case' 0 C--O 1.249 1.031 0 CA-C-N 114.975 -0.613 . . . . 0.0 110.016 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -153.6 170.93 19.63 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 -175.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -147.42 145.7 29.31 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 171.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.464 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 60.7 mt -111.56 123.33 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.067 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -124.1 179.91 4.68 Favored 'General case' 0 C--N 1.275 -2.66 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 177.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -84.98 154.02 22.4 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 175.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.6 t -81.82 133.87 35.37 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -90.95 -22.89 20.62 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 121.833 0.825 . . . . 0.0 108.98 177.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.7 m -72.53 -52.82 13.99 Favored 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 114.347 -1.297 . . . . 0.0 109.784 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -126.77 138.55 53.38 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.33 0.585 . . . . 0.0 111.348 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -88.77 138.03 31.78 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 176.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.22 11.67 58.29 Favored Glycine 0 C--N 1.305 -1.143 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -172.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -135.3 153.88 51.73 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-N 114.631 -0.784 . . . . 0.0 109.111 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.459 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 52.6 m-85 -115.83 171.58 7.68 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 176.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.18 133.13 8.87 Favored Glycine 0 C--N 1.282 -2.437 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -111.22 115.61 29.66 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.34 125.36 50.51 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.487 HD23 ' SG ' ' A' ' 123' ' ' CYS . 50.4 tp -124.08 129.83 51.53 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 123.395 0.435 . . . . 0.0 111.782 -173.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.499 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 22.3 tptm -91.77 114.24 26.72 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 174.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 80' ' ' LEU . 24.3 m -101.64 171.08 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 175.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.61 -55.6 6.62 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.432 ' HB ' ' HG2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -159.18 142.98 10.94 Favored Pre-proline 0 N--CA 1.421 -1.892 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.508 -178.277 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.584 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 16.8 Cg_exo -61.46 -50.27 5.97 Favored 'Trans proline' 0 CA--C 1.555 1.542 0 C-N-CA 122.208 1.939 . . . . 0.0 110.094 172.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.584 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 10.8 Cg_endo -54.76 136.03 69.88 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 122.105 1.87 . . . . 0.0 109.653 163.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.19 -11.55 21.14 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.64 2.227 . . . . 0.0 112.674 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.4 p -130.1 -37.28 1.48 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.912 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.421 ' HA ' ' HB2' ' A' ' 66' ' ' PRO . . . 72.9 23.04 2.9 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 125.096 1.358 . . . . 0.0 111.989 178.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -62.91 -49.05 83.73 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.598 173.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.14 105.87 1.27 Allowed 'Trans proline' 0 C--N 1.386 2.502 0 C-N-CA 121.047 1.165 . . . . 0.0 110.126 170.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 68.2 t-105 -96.1 149.06 22.03 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.78 -175.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -133.62 -36.71 0.95 Allowed 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.878 175.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.36 34.38 29.28 Favored Glycine 0 CA--C 1.503 -0.685 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.9 p30 -90.28 153.8 46.6 Favored Pre-proline 0 C--N 1.298 -1.642 0 CA-C-N 114.163 -1.019 . . . . 0.0 111.127 -177.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_exo -34.51 146.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.366 1.499 1 C-N-CA 125.99 4.46 . . . . 0.0 117.684 -175.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.1 p -70.24 -13.97 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.221 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -64.9 -16.05 62.77 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.809 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -92.02 -24.81 19.08 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 121.114 0.483 . . . . 0.0 109.781 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.463 ' O ' HG23 ' A' ' 62' ' ' VAL . 79.1 mt -76.02 -26.06 56.3 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.013 0.911 . . . . 0.0 109.01 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.5 t -93.88 123.88 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 173.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.466 ' NE ' ' HA ' ' A' ' 82' ' ' ARG . 4.1 mmp_? -104.89 151.01 24.38 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -123.91 124.62 43.02 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.627 0.727 . . . . 0.0 111.772 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -128.13 170.38 13.02 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 pp -135.25 157.81 45.96 Favored 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.485 176.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.459 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 39.4 mt -111.34 123.68 67.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -173.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -102.77 129.55 49.46 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 123.733 0.813 . . . . 0.0 109.016 -176.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.6 t -116.77 132.76 56.61 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 120.928 0.394 . . . . 0.0 110.304 174.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.65 -159.82 8.34 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.56 -31.9 49.66 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.008 2.472 . . . . 0.0 113.713 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -80.57 -36.23 33.24 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.701 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 163.31 -163.15 35.38 Favored Glycine 0 N--CA 1.422 -2.238 0 C-N-CA 119.911 -1.138 . . . . 0.0 112.124 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.0 p -116.11 126.75 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.283 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.542 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 0.0 OUTLIER -151.27 173.88 13.95 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 116.048 -0.523 . . . . 0.0 112.388 -177.249 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.442 ' HB ' ' OG ' ' A' ' 120' ' ' SER . 70.2 mt -97.61 141.81 15.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-O 121.74 0.781 . . . . 0.0 112.975 -171.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -65.74 132.58 49.1 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 125.122 1.369 . . . . 0.0 108.926 174.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.42 -9.59 38.6 Favored Glycine 0 C--N 1.312 -0.778 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.568 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 37.8 t -142.24 141.04 20.17 Favored Pre-proline 0 N--CA 1.422 -1.866 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.58 -40.38 47.47 Favored 'Trans proline' 0 C--O 1.244 0.805 0 C-N-CA 121.555 1.504 . . . . 0.0 109.385 176.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.542 ' OG ' ' HB2' ' A' ' 94' ' ' LYS 0.38 1.8 p 49.41 67.36 0.9 Allowed 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 123.443 1.592 . . . . 0.0 114.06 -177.17 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.501 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 41.8 mt-10 -49.63 -36.72 18.59 Favored Pre-proline 0 C--N 1.303 -1.446 0 CA-C-N 111.525 -2.579 . . . . 0.0 115.652 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 101' ' ' GLU . 7.3 Cg_endo -53.6 -33.11 67.4 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.134 1.889 . . . . 0.0 114.732 177.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 48.75 99.58 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 126.211 1.805 . . . . 0.0 111.982 -172.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -74.31 139.39 44.17 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.745 -176.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.03 -42.25 20.26 Favored Glycine 0 C--N 1.304 -1.223 0 C-N-CA 120.042 -1.075 . . . . 0.0 110.706 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.8 m -133.22 159.89 38.87 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.417 ' O ' ' HB3' ' A' ' 110' ' ' LEU . 96.1 mt -58.61 -31.67 68.29 Favored 'General case' 0 C--O 1.215 -0.711 0 C-N-CA 123.626 0.77 . . . . 0.0 112.045 -178.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.9 m -61.27 -32.12 71.94 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-O 120.846 0.355 . . . . 0.0 111.589 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.5 -31.82 62.32 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.562 0.696 . . . . 0.0 109.555 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 107' ' ' LEU . 3.7 tt -67.62 -45.37 75.62 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.537 -1.21 . . . . 0.0 109.354 176.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.439 HG22 ' CE2' ' A' ' 22' ' ' TRP . 73.2 t -71.13 -39.11 73.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.137 -0.938 . . . . 0.0 113.177 -177.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.7 t -68.97 -21.81 64.15 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.151 0.5 . . . . 0.0 110.997 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -107.11 177.96 4.7 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.398 -178.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.51 ' HA ' ' O ' ' A' ' 117' ' ' SER . 7.0 m-70 73.48 -10.43 1.05 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.969 0.908 . . . . 0.0 113.21 -177.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.0 m -73.26 -32.8 64.9 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 169.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 61.2 mt -88.24 -62.23 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.859 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 26.6 t -116.54 99.96 53.13 Favored Pre-proline 0 N--CA 1.434 -1.238 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.32 99.12 1.08 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.78 2.32 . . . . 0.0 110.812 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.42 ' HB ' ' CE1' ' A' ' 114' ' ' HIS . 67.6 mt -99.51 -51.32 10.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.225 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.442 ' OG ' ' HB ' ' A' ' 95' ' ' ILE . 34.7 t -80.89 -42.35 21.59 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.644 -177.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -89.83 144.11 31.14 Favored Pre-proline 0 N--CA 1.434 -1.25 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.294 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -63.41 -32.21 71.79 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.987 2.458 . . . . 0.0 111.757 177.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.487 ' SG ' HD23 ' A' ' 60' ' ' LEU . 26.3 p -109.45 169.87 8.43 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 23.2 m -70.14 132.71 46.23 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 176.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 29.2 tp -82.37 131.98 35.22 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -136.39 128.14 29.07 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.0 mp -66.24 125.14 89.73 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo . . . . . 0 C--N 1.35 0.651 0 C-N-CA 122.049 1.833 . . . . 0.0 111.299 -179.253 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.496 -1.11 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.454 ' HD2' ' CD2' ' A' ' 3' ' ' HIS . 9.9 t60 -79.17 -42.4 26.2 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -176.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.454 ' CD2' ' HD2' ' A' ' 2' ' ' HIS . 94.5 m-70 -135.22 160.96 36.75 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -128.11 101.68 6.38 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -86.39 151.75 23.29 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -72.95 142.1 47.8 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 119.404 -0.919 . . . . 0.0 108.523 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 29.8 t60 -72.88 87.88 1.32 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.574 0.702 . . . . 0.0 111.48 -175.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.8 t -134.14 -2.2 2.87 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.3 m -105.22 6.51 33.02 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-O 121.819 0.819 . . . . 0.0 110.467 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.04 139.28 14.48 Favored Glycine 0 N--CA 1.423 -2.176 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.508 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 85.5 mt -106.7 159.33 16.3 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.7 t -104.48 96.49 10.25 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 11' ' ' LEU . 43.3 Cg_endo -95.19 145.13 1.42 Allowed 'Trans proline' 0 N--CA 1.438 -1.754 0 C-N-CA 122.389 2.059 . . . . 0.0 111.903 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -122.69 -50.72 1.95 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.58 61.95 4.14 Favored Glycine 0 CA--C 1.518 0.268 0 N-CA-C 115.098 0.799 . . . . 0.0 115.098 172.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.3 t -99.73 -1.6 37.38 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 122.088 0.947 . . . . 0.0 109.419 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -84.84 100.41 11.54 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 114.705 -1.134 . . . . 0.0 107.986 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.0 p -112.9 3.49 16.34 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.703 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.1 p -58.2 -45.0 88.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -174.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -13.25 62.11 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -74.48 -35.74 63.28 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.154 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.474 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 41.3 p-90 -110.36 -26.7 9.42 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 114.058 1.132 . . . . 0.0 114.058 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -90.81 113.32 25.44 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.316 0.579 . . . . 0.0 111.656 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.66 93.89 4.21 Favored Pre-proline 0 C--N 1.299 -1.627 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.846 174.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.43 -0.09 10.04 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 123.58 2.853 . . . . 0.0 114.334 -172.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -94.93 -1.54 52.35 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.088 0.471 . . . . 0.0 111.752 -173.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.524 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 73.3 mt -94.86 145.88 24.6 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.309 0.576 . . . . 0.0 111.746 -178.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.478 ' HA ' ' NH1' ' A' ' 47' ' ' ARG . 23.1 t -100.74 177.23 5.05 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.1 ttt180 -52.99 -53.4 50.57 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.654 0.782 . . . . 0.0 112.585 -173.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -64.0 -32.47 74.02 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.981 0.419 . . . . 0.0 111.411 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.414 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 15.7 mm-40 -73.03 -34.57 66.42 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.822 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.05 -44.94 83.13 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.414 0.626 . . . . 0.0 109.619 178.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.8 mt -63.93 -36.39 76.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.425 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.19 -36.04 72.49 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.481 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.458 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 4.4 mm? -75.78 -47.84 24.19 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.278 174.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.3 mt -66.42 -21.54 66.22 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -174.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -74.25 -5.24 40.89 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.417 0.627 . . . . 0.0 111.47 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -112.57 5.46 17.89 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.458 ' HG2' ' O ' ' A' ' 35' ' ' LEU . 31.3 mmmt -110.98 145.17 38.88 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.385 0.612 . . . . 0.0 110.992 -177.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -76.74 141.57 68.82 Favored Pre-proline 0 C--N 1.301 -1.531 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.221 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -47.64 118.9 3.28 Favored 'Trans proline' 0 C--N 1.364 1.375 0 C-N-CA 123.938 3.092 . . . . 0.0 113.467 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.24 -30.51 3.47 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.39 151.89 39.62 Favored 'General case' 0 C--O 1.253 1.239 0 CA-C-O 120.717 0.294 . . . . 0.0 110.54 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -147.32 175.9 10.42 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.671 -176.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -149.59 147.37 28.06 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 170.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.474 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 62.4 mt -112.19 122.21 66.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.524 ' HD2' ' O ' ' A' ' 27' ' ' LEU . 28.5 ptt85 -121.09 -173.94 2.72 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -95.22 153.51 17.63 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.5 t -97.39 132.35 43.19 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.95 0.881 . . . . 0.0 111.131 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -85.3 -14.79 45.45 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.803 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.7 m -78.53 -51.74 9.51 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.195 -175.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -128.98 144.22 51.12 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -73.76 132.93 43.14 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.01 31.65 25.55 Favored Glycine 0 N--CA 1.436 -1.367 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.146 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.0 145.97 49.98 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -113.72 134.47 54.73 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.83 118.02 5.15 Favored Glycine 0 N--CA 1.421 -2.356 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.042 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -96.69 118.29 32.84 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.98 119.75 40.3 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.0 tp -121.37 131.56 54.26 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.473 -176.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -88.81 113.99 24.96 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 175.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.468 HG21 ' O ' ' A' ' 80' ' ' LEU . 26.1 m -102.26 169.52 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.999 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.64 -57.6 4.0 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.87 118.81 2.15 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.134 0.974 . . . . 0.0 110.697 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.615 ' N ' ' HD3' ' A' ' 66' ' ' PRO . 21.5 Cg_endo -99.42 12.31 0.64 Allowed 'Trans proline' 0 CA--C 1.601 3.847 0 C-N-CA 122.84 2.36 . . . . 0.0 118.037 178.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.615 ' HD3' ' N ' ' A' ' 65' ' ' PRO . 2.0 Cg_endo -93.58 164.92 2.31 Favored 'Trans proline' 0 C--N 1.384 2.407 0 CA-C-N 123.051 2.125 . . . . 0.0 111.218 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -74.03 -22.16 17.43 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 121.861 1.707 . . . . 0.0 111.782 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.1 p -134.45 -43.2 0.77 Allowed 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.392 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 75.84 3.76 3.83 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.026 1.33 . . . . 0.0 112.982 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.42 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 34.9 tt0 -86.68 -52.44 0.43 Allowed Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 172.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.42 ' HD3' ' HB3' ' A' ' 70' ' ' GLN . 7.3 Cg_exo -76.02 107.09 2.39 Favored 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 121.317 1.344 . . . . 0.0 108.708 171.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 59.6 t-105 -117.56 135.42 53.97 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.934 -177.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -158.15 81.7 0.85 Allowed 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 114.616 -1.174 . . . . 0.0 108.609 174.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -169.94 -178.55 41.02 Favored Glycine 0 C--N 1.268 -3.208 0 CA-C-N 113.734 -1.575 . . . . 0.0 110.28 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -89.8 115.87 64.95 Favored Pre-proline 0 C--N 1.294 -1.829 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.545 ' O ' ' HG ' ' A' ' 80' ' ' LEU . 47.5 Cg_exo -32.47 -78.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 125.098 3.865 . . . . 0.0 117.048 -172.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -73.31 -30.08 29.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -174.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -71.23 -26.77 63.07 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.83 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.439 ' O ' ' HG3' ' A' ' 65' ' ' PRO . 4.9 tp60 -88.01 -18.06 29.82 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 121.139 0.495 . . . . 0.0 110.225 177.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 76' ' ' PRO . 91.1 mt -80.99 -12.01 59.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.482 0.658 . . . . 0.0 109.26 174.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.8 t -96.13 118.99 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -103.17 142.32 34.36 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.768 -177.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -123.36 122.08 37.41 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.387 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -126.72 170.09 12.49 Favored 'General case' 0 C--N 1.273 -2.728 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -135.86 135.38 39.73 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 118.767 -1.173 . . . . 0.0 112.119 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.591 ' CG2' ' HB ' ' A' ' 93' ' ' VAL . 59.5 mt -94.24 110.78 24.14 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 CA-C-N 114.014 -1.448 . . . . 0.0 107.408 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -105.57 121.22 43.52 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.831 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.498 ' HB ' ' CG1' ' A' ' 93' ' ' VAL . 1.4 t -94.95 118.68 32.21 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.691 0.758 . . . . 0.0 110.36 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -106.43 -157.99 21.74 Favored Glycine 0 N--CA 1.427 -1.946 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -66.4 -26.7 47.78 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.964 1.776 . . . . 0.0 110.528 176.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -73.74 -73.34 0.22 Allowed 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.167 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 179.02 -151.22 10.07 Favored Glycine 0 N--CA 1.423 -2.191 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.591 ' HB ' ' CG2' ' A' ' 86' ' ' ILE . 35.7 m -103.71 145.9 12.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 O-C-N 123.739 0.317 . . . . 0.0 110.865 -176.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.75 155.8 30.49 Favored 'General case' 0 C--O 1.259 1.565 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 176.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.503 HG12 HG12 ' A' ' 86' ' ' ILE . 59.4 mt -94.39 114.12 30.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.429 0.633 . . . . 0.0 111.765 -176.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -62.15 120.75 11.5 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.392 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.39 -28.61 2.44 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.573 ' SG ' HG21 ' A' ' 119' ' ' ILE . 49.6 t -112.98 132.1 22.5 Favored Pre-proline 0 N--CA 1.426 -1.656 0 CA-C-N 114.817 -0.691 . . . . 0.0 110.201 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -99.51 11.38 0.67 Allowed 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 122.628 2.219 . . . . 0.0 112.525 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.0 m -122.81 18.64 10.23 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.82 0.343 . . . . 0.0 111.087 -174.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -113.39 136.73 21.9 Favored Pre-proline 0 C--N 1.31 -1.111 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -174.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -82.33 -179.68 4.83 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.135 2.557 . . . . 0.0 113.292 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -98.93 108.55 21.26 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -76.44 -60.36 2.37 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.291 0.567 . . . . 0.0 110.21 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.456 ' H ' HG22 ' A' ' 93' ' ' VAL . . . 124.37 -66.53 0.52 Allowed Glycine 0 C--N 1.306 -1.131 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 177.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.7 m -93.61 150.62 20.28 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.13 -41.28 94.96 Favored 'General case' 0 C--O 1.216 -0.661 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.354 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 38.6 t -54.94 -31.37 60.39 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.229 0.612 . . . . 0.0 111.028 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.28 -49.28 74.67 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.378 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 111' ' ' VAL . 4.1 pp -75.01 -32.44 61.62 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 120.838 0.351 . . . . 0.0 110.936 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.453 ' N ' HD12 ' A' ' 110' ' ' LEU . 69.7 t -63.09 -44.66 99.63 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.821 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.569 178.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.3 t -73.28 -21.83 60.51 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.006 0.432 . . . . 0.0 111.819 177.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -83.42 -4.64 58.68 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 121.388 0.613 . . . . 0.0 110.085 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 125' ' ' LEU . 6.0 p80 -42.62 -50.4 5.42 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 126.694 1.997 . . . . 0.0 115.893 -173.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.4 t -103.7 4.78 35.74 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 121.438 0.637 . . . . 0.0 109.286 -172.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.5 mt -99.47 -48.54 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.8 m -141.27 86.21 11.38 Favored Pre-proline 0 N--CA 1.437 -1.103 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.459 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.88 89.49 1.13 Allowed 'Trans proline' 0 N--CA 1.44 -1.649 0 C-N-CA 121.681 1.587 . . . . 0.0 108.054 173.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.573 HG21 ' SG ' ' A' ' 98' ' ' CYS . 36.3 mt -90.28 -64.02 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.79 -174.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.8 t -73.4 -30.25 63.13 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 120.851 0.358 . . . . 0.0 111.073 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.66 127.21 73.65 Favored Pre-proline 0 N--CA 1.435 -1.203 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.417 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -69.23 -24.45 32.1 Favored 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 122.327 2.018 . . . . 0.0 111.457 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.421 ' SG ' ' HB ' ' A' ' 62' ' ' VAL . 83.4 m -114.74 145.73 41.76 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 53.4 m -64.16 111.88 2.77 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.124 0.488 . . . . 0.0 109.937 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 114' ' ' HIS . 27.9 tp -58.21 135.79 57.16 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 125.0 1.32 . . . . 0.0 110.041 -176.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.517 ' HD2' ' OD1' ' A' ' 131' ' ' ASP . 20.3 mmt180 -130.92 134.99 47.26 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.475 HG22 ' H ' ' A' ' 129' ' ' SER . 4.1 mp -80.96 136.15 50.93 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -53.58 -36.84 82.1 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.131 1.887 . . . . 0.0 112.129 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.475 ' H ' HG22 ' A' ' 127' ' ' ILE . 3.9 m -84.08 -33.43 24.39 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.025 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -133.38 124.9 28.0 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -173.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.517 ' OD1' ' HD2' ' A' ' 126' ' ' ARG . 13.8 t70 . . . . . 0 C--N 1.288 -2.075 0 CA-C-N 113.851 -1.522 . . . . 0.0 107.959 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 CA--C 1.504 -0.812 0 CA-C-O 120.895 0.378 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -117.82 117.11 28.41 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -88.91 113.06 24.04 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -66.62 148.55 51.75 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -173.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -79.54 117.24 20.3 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 174.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -61.92 -65.68 0.65 Allowed 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -129.4 -50.47 1.18 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.2 m 55.38 73.64 0.41 Allowed 'General case' 0 C--O 1.245 0.852 0 CA-C-O 122.19 0.995 . . . . 0.0 110.207 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.3 m -77.3 45.57 0.47 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.33 -1.305 . . . . 0.0 112.317 -175.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.49 47.62 3.66 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.0 mt -117.57 127.56 54.09 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.5 t -101.37 126.95 32.85 Favored Pre-proline 0 C--N 1.289 -2.038 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.02 107.25 2.06 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 122.422 2.081 . . . . 0.0 110.835 175.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -88.79 80.41 7.2 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 122.042 0.925 . . . . 0.0 109.653 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.3 52.64 0.53 Allowed Glycine 0 N--CA 1.427 -1.91 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 m -112.62 15.82 19.91 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.181 0.991 . . . . 0.0 108.907 -177.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -97.67 85.63 3.62 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.756 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.3 p -98.7 -0.06 43.61 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.317 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.5 m -45.46 -60.86 1.93 Allowed 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 125.853 1.661 . . . . 0.0 112.805 -173.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.417 ' HE2' ' CE2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -67.48 -12.69 60.9 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -176.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.417 ' CE2' ' HE2' ' A' ' 20' ' ' LYS . 74.6 m-85 -76.99 -23.24 52.29 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.419 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.417 ' CZ3' HD11 ' A' ' 46' ' ' ILE . 31.3 p-90 -121.0 -24.75 5.51 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 35.8 t80 -95.31 116.79 29.24 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.992 -0.442 . . . . 0.0 110.045 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.431 ' CB ' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -138.04 97.9 9.65 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.097 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.88 21.55 0.37 Allowed 'Trans proline' 0 CA--C 1.552 1.418 0 C-N-CA 123.326 2.684 . . . . 0.0 113.977 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -114.78 -20.44 10.62 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.241 0.543 . . . . 0.0 110.088 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.431 HD23 ' CB ' ' A' ' 24' ' ' LYS . 3.5 mm? -76.75 120.51 22.01 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.668 0.747 . . . . 0.0 111.355 -175.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.0 p -85.27 177.69 7.75 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.57 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -49.7 -55.85 12.34 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.079 0.952 . . . . 0.0 111.622 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -72.78 -32.45 65.6 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.98 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -70.77 -33.53 70.88 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.871 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.98 -42.51 99.86 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.576 0.703 . . . . 0.0 109.13 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 85.0 mt -65.27 -44.01 95.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.465 178.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.48 -28.64 68.5 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.375 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.03 -51.99 10.12 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.517 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 57.2 mt -72.84 -25.56 61.16 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -174.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -56.91 -33.8 67.31 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -89.51 -21.29 23.01 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.543 0.687 . . . . 0.0 110.77 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -78.62 164.77 24.36 Favored 'General case' 0 C--O 1.255 1.389 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -172.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.54 137.38 76.79 Favored Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 111.917 -2.401 . . . . 0.0 111.329 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -63.0 107.56 0.65 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.922 1.748 . . . . 0.0 109.342 170.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.46 -17.93 5.52 Favored Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 -175.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.37 154.96 27.4 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 120.644 0.259 . . . . 0.0 110.66 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.475 ' CG ' HD11 ' A' ' 125' ' ' LEU . 5.4 p90 -149.45 177.68 9.49 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.279 -174.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -155.31 147.09 23.26 Favored 'General case' 0 C--O 1.253 1.237 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 169.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 23' ' ' TYR . 63.2 mt -117.81 135.33 58.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.42 HH12 ' HB1' ' A' ' 59' ' ' ALA . 0.1 OUTLIER -144.73 162.45 36.7 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 174.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.07 131.88 48.69 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 173.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.433 ' HB3' ' O ' ' A' ' 52' ' ' PHE . 30.4 t -75.67 118.81 18.9 Favored 'General case' 0 N--CA 1.413 -2.312 0 C-N-CA 119.024 -1.071 . . . . 0.0 109.087 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 27.6 m-70 -77.24 -16.11 59.17 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.87 175.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.0 m -84.11 -46.79 11.58 Favored 'General case' 0 N--CA 1.408 -2.568 0 CA-C-N 114.229 -1.35 . . . . 0.0 109.535 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.433 ' O ' ' HB3' ' A' ' 49' ' ' SER . 89.9 m-85 -127.15 127.97 45.41 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-O 121.35 0.595 . . . . 0.0 111.095 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -83.61 128.03 34.2 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.658 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.22 15.75 52.63 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -177.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.74 160.81 36.99 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -122.4 129.88 52.53 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.95 115.58 4.14 Favored Glycine 0 C--N 1.293 -1.832 0 C-N-CA 119.968 -1.11 . . . . 0.0 111.302 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -93.29 119.56 32.58 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.42 ' HB1' HH12 ' A' ' 47' ' ' ARG . . . -114.53 129.76 56.69 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.431 HD22 ' SG ' ' A' ' 123' ' ' CYS . 58.9 tp -126.85 128.62 46.81 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 123.488 0.493 . . . . 0.0 110.801 -177.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.517 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 22.3 tptm -88.36 115.14 25.66 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 176.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.482 HG12 ' SG ' ' A' ' 123' ' ' CYS . 34.1 m -105.82 170.69 2.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.87 -48.48 12.33 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 p -167.29 120.97 0.79 Allowed Pre-proline 0 C--N 1.32 -0.681 0 C-N-CA 125.291 1.436 . . . . 0.0 109.025 178.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.561 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 28.2 Cg_exo -60.57 -46.84 15.65 Favored 'Trans proline' 0 CA--C 1.575 2.567 0 C-N-CA 121.149 1.232 . . . . 0.0 110.993 170.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.561 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 85.1 Cg_endo -77.73 158.66 31.72 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.86 2.374 . . . . 0.0 109.917 173.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -70.03 -54.16 0.22 Allowed 'Trans proline' 0 CA--C 1.551 1.357 0 C-N-CA 121.715 1.61 . . . . 0.0 112.189 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.1 m -104.86 -19.84 13.76 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.837 0.351 . . . . 0.0 110.906 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 66.98 34.7 5.07 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 124.169 0.987 . . . . 0.0 111.274 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -60.68 -44.29 94.78 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.857 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.62 82.39 0.73 Allowed 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 121.11 1.206 . . . . 0.0 111.285 173.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 36.4 t-105 -85.87 136.73 33.18 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.0 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.9 mtmm -127.06 6.66 6.53 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -173.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.03 24.58 44.11 Favored Glycine 0 CA--C 1.489 -1.543 0 N-CA-C 108.554 -1.819 . . . . 0.0 108.554 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -86.21 127.05 63.06 Favored Pre-proline 0 N--CA 1.423 -1.799 0 CA-C-N 113.744 -1.228 . . . . 0.0 111.308 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -96.26 -165.12 0.1 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.7 0 C-N-CA 122.938 2.425 . . . . 0.0 110.867 176.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.435 ' HA ' HD22 ' A' ' 80' ' ' LEU . 9.8 p -56.46 -21.3 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 123.633 0.773 . . . . 0.0 112.405 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -62.56 -33.63 75.33 Favored 'General case' 0 C--O 1.213 -0.819 0 C-N-CA 122.853 0.461 . . . . 0.0 110.909 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.62 -20.34 56.84 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 121.461 0.648 . . . . 0.0 109.819 -178.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 77' ' ' VAL . 3.5 mm? -81.03 -3.08 50.56 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.097 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.9 t -101.66 104.83 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.875 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 174.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -78.85 139.76 38.28 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -120.65 122.44 40.49 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-O 121.872 0.844 . . . . 0.0 111.688 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -131.41 170.74 14.25 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.48 136.82 41.58 Favored 'General case' 0 C--N 1.283 -2.325 0 C-N-CA 119.944 -0.703 . . . . 0.0 111.088 175.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 74.9 mt -91.43 114.72 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.632 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 30.7 mt-10 -99.75 140.08 34.47 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.503 ' HB ' HG12 ' A' ' 93' ' ' VAL . 1.3 t -116.17 127.46 54.81 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.439 0.638 . . . . 0.0 110.626 175.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.4 -169.97 14.01 Favored Glycine 0 N--CA 1.424 -2.163 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.2 -27.81 31.4 Favored 'Trans proline' 0 CA--C 1.553 1.43 0 C-N-CA 123.425 2.75 . . . . 0.0 114.858 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.472 ' HD2' ' N ' ' A' ' 91' ' ' LYS . 10.7 mptt -80.28 -21.32 42.8 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.073 0.463 . . . . 0.0 111.121 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.28 -149.07 16.88 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 87' ' ' GLU . 31.3 m -104.64 149.08 8.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.41 155.02 19.49 Favored 'General case' 0 C--O 1.251 1.147 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 71.6 mt -86.94 114.34 25.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.423 0.63 . . . . 0.0 111.311 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.537 ' HE2' ' CD ' ' A' ' 87' ' ' GLU . 19.4 ttmm -64.83 126.93 29.52 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.438 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 110.13 40.05 1.45 Allowed Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.4 ' HG ' ' HB2' ' A' ' 101' ' ' GLU . 35.5 t -142.33 132.4 12.44 Favored Pre-proline 0 N--CA 1.432 -1.33 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -178.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -86.8 8.11 4.57 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.602 2.202 . . . . 0.0 112.648 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.6 m -148.4 -148.0 0.24 Allowed 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.4 ' HB2' ' HG ' ' A' ' 98' ' ' CYS . 35.7 tt0 80.75 123.93 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.135 0 C-N-CA 124.963 1.305 . . . . 0.0 113.161 174.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.16 171.28 18.6 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.681 2.254 . . . . 0.0 111.74 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -95.59 132.38 40.79 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -108.25 154.68 21.42 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -178.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -95.4 -25.27 14.21 Favored Glycine 0 C--N 1.3 -1.42 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.772 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 11.1 m -122.65 144.62 49.01 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 90.2 mt -62.56 -37.83 87.69 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.196 0.522 . . . . 0.0 109.661 175.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.3 m -54.17 -34.44 60.49 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.593 1.157 . . . . 0.0 111.163 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.9 -39.32 83.62 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.7 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.474 HD13 ' N ' ' A' ' 111' ' ' VAL . 4.0 pp -76.2 -36.98 58.36 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.144 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.474 ' N ' HD13 ' A' ' 110' ' ' LEU . 43.0 t -55.9 -51.79 56.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.727 177.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.4 m -71.94 -26.71 62.39 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.967 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -83.46 -37.85 22.62 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -176.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -72.3 -6.17 41.31 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -174.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.8 m -75.26 -24.35 57.59 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 171.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 65.5 mt -101.61 -50.02 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.426 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.8 m -120.4 97.84 48.75 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.241 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.78 92.11 1.1 Allowed 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.473 2.115 . . . . 0.0 109.565 174.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 23.6 mt -84.97 -67.62 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.28 -174.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.8 p -77.67 -33.54 53.33 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.88 0.848 . . . . 0.0 110.338 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.6 mt -84.73 140.83 38.06 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.137 -177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.56 -11.3 15.69 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.863 2.375 . . . . 0.0 113.454 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.482 ' SG ' HG12 ' A' ' 62' ' ' VAL . 22.6 p -136.05 162.21 33.54 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 59.6 m -69.33 138.38 53.71 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 123.485 0.49 . . . . 0.0 110.021 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.475 HD11 ' CG ' ' A' ' 44' ' ' PHE . 19.6 tp -77.72 121.34 23.89 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.744 -175.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.46 ' NH2' ' HB3' ' A' ' 131' ' ' ASP . 7.7 tpt180 -95.76 114.47 26.21 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 123.51 0.724 . . . . 0.0 110.577 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 66.8 mt -81.15 121.97 81.05 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 175.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.07 -41.28 65.46 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 122.646 2.231 . . . . 0.0 113.681 -176.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.7 t -86.42 -5.62 59.12 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -175.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -112.31 80.02 1.29 Allowed 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 118.903 -1.119 . . . . 0.0 111.632 -175.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.46 ' HB3' ' NH2' ' A' ' 126' ' ' ARG . 32.0 t70 . . . . . 0 C--O 1.249 1.052 0 C-N-CA 127.063 2.145 . . . . 0.0 108.021 174.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.465 0.299 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -138.99 101.56 4.32 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.712 0.768 . . . . 0.0 111.067 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -105.88 -66.12 1.02 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -159.86 133.2 6.96 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -157.54 98.57 1.68 Allowed 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.423 0.63 . . . . 0.0 109.326 175.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -81.84 105.37 12.91 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.491 0.662 . . . . 0.0 109.614 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -146.61 92.5 2.16 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -177.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.7 m -66.16 153.84 41.32 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.127 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.1 m 70.78 -62.27 0.45 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.87 1.268 . . . . 0.0 111.805 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.8 83.84 1.51 Allowed Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 68.4 tp -73.99 -36.09 64.5 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.9 m -89.29 126.63 57.99 Favored Pre-proline 0 N--CA 1.429 -1.49 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.536 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -75.75 79.14 2.91 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.016 1.81 . . . . 0.0 109.701 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -80.3 91.87 5.69 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.548 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -134.93 23.51 3.52 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.5 m 56.42 58.05 4.49 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 123.896 0.878 . . . . 0.0 111.305 -176.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -74.2 116.28 14.67 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 177.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.0 p -92.78 -15.64 26.34 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -173.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.8 m -73.59 -33.06 64.44 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.609 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -61.46 -18.26 58.17 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -79.21 -26.91 42.53 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.522 ' CZ3' HD11 ' A' ' 46' ' ' ILE . 21.9 p-90 -131.91 -9.49 3.48 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -175.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -98.92 113.38 25.5 Favored 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.655 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.07 91.1 9.03 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.983 175.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.94 -17.08 46.4 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.904 2.403 . . . . 0.0 113.891 -175.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -71.86 -18.89 62.03 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.037 0.446 . . . . 0.0 111.294 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.9 tp -80.54 139.17 36.47 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.116 0.484 . . . . 0.0 110.61 -176.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.555 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 15.5 m -91.95 168.2 11.58 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.046 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -57.12 -51.68 68.31 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.067 0.947 . . . . 0.0 113.39 -175.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.87 -39.8 95.56 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 121.561 0.696 . . . . 0.0 110.985 -176.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.555 ' OE1' ' HB2' ' A' ' 28' ' ' SER . 21.1 mp0 -67.03 -40.12 87.13 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.862 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.93 -41.77 75.1 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 123.197 0.599 . . . . 0.0 111.627 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 60.1 mt -65.2 -35.67 75.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.867 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.1 -33.04 72.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.778 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.91 -40.52 65.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.043 0.449 . . . . 0.0 110.647 177.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 75.6 mt -76.16 -27.1 56.85 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -175.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -77.22 -3.37 39.32 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.551 0.691 . . . . 0.0 109.934 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -106.19 -5.29 19.38 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.747 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.509 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -119.74 170.2 9.43 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.111 0.482 . . . . 0.0 112.177 -175.244 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -85.85 160.31 53.0 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.294 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 61' ' ' LYS . 10.8 Cg_endo -56.11 127.47 26.17 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.775 2.316 . . . . 0.0 111.265 173.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.41 -24.01 8.28 Favored Glycine 0 N--CA 1.434 -1.446 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.56 146.61 40.32 Favored 'General case' 0 C--O 1.253 1.239 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -151.87 177.52 10.34 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 121.019 0.438 . . . . 0.0 110.119 -176.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -162.05 150.04 14.68 Favored 'General case' 0 C--O 1.251 1.152 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 173.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.522 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 68.6 mt -123.93 134.16 67.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.435 HH22 ' CD2' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -133.59 173.62 11.31 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.241 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -80.06 146.5 31.9 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.1 t -99.56 139.94 34.47 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.528 0.68 . . . . 0.0 111.682 -176.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -99.59 -8.5 24.41 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.476 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.5 t -76.38 -40.87 49.86 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -129.9 140.92 50.88 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -83.57 124.63 30.97 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.989 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.42 31.66 18.56 Favored Glycine 0 N--CA 1.435 -1.385 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -177.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.75 157.98 45.31 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.971 -0.615 . . . . 0.0 109.602 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -124.65 161.06 27.1 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.34 123.56 5.55 Favored Glycine 0 C--N 1.288 -2.091 0 C-N-CA 119.908 -1.139 . . . . 0.0 111.036 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 84' ' ' PHE . 2.2 tm? -101.68 130.51 48.06 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 123.947 0.899 . . . . 0.0 108.74 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -119.28 125.34 48.87 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.5 tp -119.88 131.3 55.21 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 123.686 0.616 . . . . 0.0 110.535 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 41' ' ' PRO . 22.3 tptm -88.5 116.05 26.45 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 80' ' ' LEU . 18.7 m -109.94 171.77 2.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.79 -60.07 2.54 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.4 p -150.81 138.38 12.1 Favored Pre-proline 0 C--N 1.308 -1.207 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.247 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.591 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 24.4 Cg_exo -61.46 -43.55 27.15 Favored 'Trans proline' 0 CA--C 1.577 2.67 0 C-N-CA 121.969 1.779 . . . . 0.0 111.854 171.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.591 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 56.4 Cg_endo -68.25 143.16 57.71 Favored 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 122.547 2.164 . . . . 0.0 110.105 170.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.88 -32.81 35.26 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.547 2.165 . . . . 0.0 112.644 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.9 t -114.27 -42.74 3.29 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.079 0.466 . . . . 0.0 110.096 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.444 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 74.56 -3.04 2.66 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.972 1.309 . . . . 0.0 112.134 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.412 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 8.6 tt0 -59.72 -50.09 88.57 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 171.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 70' ' ' GLN . 16.9 Cg_exo -70.56 101.23 1.0 Allowed 'Trans proline' 0 C--N 1.374 1.88 0 N-CA-C 106.615 -2.11 . . . . 0.0 106.615 164.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 46.3 t-105 -109.87 150.11 28.89 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.376 -172.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.466 ' HB3' ' HZ2' ' A' ' 73' ' ' LYS . 7.1 ttpm? -114.29 -63.0 1.51 Allowed 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.98 178.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 158.3 67.0 0.01 OUTLIER Glycine 0 CA--C 1.471 -2.718 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -118.94 121.51 30.44 Favored Pre-proline 0 C--N 1.285 -2.238 0 CA-C-N 114.695 -0.753 . . . . 0.0 109.971 -169.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -85.16 178.56 4.59 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.304 2.003 . . . . 0.0 112.129 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.0 p -57.31 -30.12 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 123.353 0.661 . . . . 0.0 112.681 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.3 mp0 -68.84 -19.74 64.27 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.975 -0.453 . . . . 0.0 111.46 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.588 HE21 ' HA ' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -84.69 -19.74 32.31 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.48 ' O ' HG23 ' A' ' 62' ' ' VAL . 46.7 mt -74.26 -17.47 60.87 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.8 t -87.74 112.58 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 173.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -98.55 131.5 44.72 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -176.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.435 ' CD2' HH22 ' A' ' 47' ' ' ARG . 36.0 m80 -105.07 124.5 49.64 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 121.402 0.62 . . . . 0.0 112.02 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.417 ' O ' ' HB3' ' A' ' 58' ' ' LEU . 93.9 m-85 -131.3 126.73 36.11 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 177.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.9 pp -99.1 144.49 28.18 Favored 'General case' 0 C--N 1.285 -2.228 0 C-N-CA 118.443 -1.303 . . . . 0.0 111.132 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 62.5 mt -105.82 135.23 44.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.367 -174.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.457 ' OE1' ' HA ' ' A' ' 96' ' ' LYS . 30.6 mt-10 -116.55 142.75 46.47 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -176.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.7 t -131.39 139.51 49.47 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 175.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.22 -161.04 11.56 Favored Glycine 0 N--CA 1.433 -1.502 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.29 -17.66 61.14 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.038 2.492 . . . . 0.0 113.88 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -79.72 -42.04 25.48 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 122.076 0.941 . . . . 0.0 109.217 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 146.71 -154.42 25.96 Favored Glycine 0 N--CA 1.422 -2.296 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.4 p -114.02 137.82 45.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.98 171.93 19.13 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.47 ' HB ' ' HB3' ' A' ' 98' ' ' CYS . 58.7 mt -90.54 143.85 10.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.457 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 17.0 tppt? -48.02 -45.63 32.11 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.576 1.151 . . . . 0.0 112.482 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -120.44 62.15 0.5 Allowed Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.812 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.47 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 19.7 p -98.7 127.8 34.53 Favored Pre-proline 0 C--N 1.299 -1.588 0 CA-C-O 120.931 0.396 . . . . 0.0 111.429 178.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -90.04 32.93 0.34 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.242 2.628 . . . . 0.0 110.13 174.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.1 t -92.69 -147.65 0.23 Allowed 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.418 ' H ' ' HD2' ' A' ' 102' ' ' PRO . 17.9 tp10 -152.62 -55.52 0.02 OUTLIER Pre-proline 0 C--N 1.289 -2.05 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.733 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.418 ' HD2' ' H ' ' A' ' 101' ' ' GLU . 88.5 Cg_endo -77.81 158.72 31.41 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 121.384 1.39 . . . . 0.0 113.155 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -100.21 157.13 16.81 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -114.02 165.28 12.78 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.7 -47.04 3.54 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.304 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.7 m -121.87 159.25 27.19 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.425 ' O ' HG23 ' A' ' 111' ' ' VAL . 95.2 mt -57.22 -45.73 83.57 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 122.815 0.446 . . . . 0.0 111.757 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 72.4 m -54.26 -29.36 46.61 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.73 -48.83 67.93 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.494 0.187 . . . . 0.0 110.601 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.88 -26.15 63.11 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.158 0.504 . . . . 0.0 110.642 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 107' ' ' LEU . 73.5 t -67.5 -51.69 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.299 176.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 28.6 t -68.25 -27.84 66.69 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.221 0.534 . . . . 0.0 110.467 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.495 ' NE2' ' HB2' ' A' ' 117' ' ' SER . 0.6 OUTLIER -63.28 -50.48 69.96 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.427 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -77.19 -0.37 24.84 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -176.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 7.1 m -75.55 -37.22 60.15 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.484 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 73.3 mt -101.31 -53.94 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.083 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.495 ' HB2' ' NE2' ' A' ' 113' ' ' GLN . 19.9 m -107.94 97.6 21.84 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 116' ' ' ILE . 5.8 Cg_exo -78.64 84.53 2.01 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 122.412 2.075 . . . . 0.0 110.388 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 68.8 mt -80.96 -54.67 9.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.556 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.7 m -92.39 -15.6 27.03 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.453 0.644 . . . . 0.0 110.524 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 71.7 mt -112.6 136.88 21.53 Favored Pre-proline 0 N--CA 1.428 -1.541 0 CA-C-N 115.435 -0.802 . . . . 0.0 108.907 -175.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.64 -5.84 16.41 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.537 2.158 . . . . 0.0 112.677 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 50.8 t -128.86 149.59 50.69 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 21.2 m -71.33 133.25 45.87 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 16.6 tp -77.77 138.02 38.77 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.247 -175.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -122.41 118.2 27.82 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.533 0.683 . . . . 0.0 111.95 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.512 HG22 ' H ' ' A' ' 129' ' ' SER . 2.7 mp -91.46 135.31 28.13 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -176.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.01 -27.47 79.48 Favored 'Trans proline' 0 N--CA 1.48 0.731 0 C-N-CA 122.053 1.835 . . . . 0.0 110.926 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.512 ' H ' HG22 ' A' ' 127' ' ' ILE . 15.7 t -81.03 -4.92 56.8 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.839 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.442 ' HD3' ' C ' ' A' ' 130' ' ' LYS . 11.4 tmtt? -106.15 119.62 39.69 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 . . . . . 0 C--N 1.296 -1.755 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 176.683 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.499 -1.012 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -125.75 122.58 36.66 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 176.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 72.82 149.35 0.1 Allowed 'General case' 0 C--O 1.249 1.064 0 C-N-CA 124.957 1.303 . . . . 0.0 110.547 -176.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -75.32 148.7 39.09 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 174.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.3 p80 -68.79 120.03 14.09 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 119.522 -0.871 . . . . 0.0 108.992 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -81.29 -20.02 41.72 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.465 ' CD2' ' HG ' ' A' ' 8' ' ' SER . 31.1 t60 70.9 113.69 0.05 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.066 1.746 . . . . 0.0 110.713 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.465 ' HG ' ' CD2' ' A' ' 7' ' ' HIS . 67.3 m 71.51 103.16 0.07 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.756 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.2 m -65.16 -48.84 72.09 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.413 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 12' ' ' VAL . . . -132.0 61.91 0.65 Allowed Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 178.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.4 mt 73.8 -14.83 0.62 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 125.272 1.429 . . . . 0.0 112.294 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.415 ' H ' ' C ' ' A' ' 10' ' ' GLY . 20.9 m -132.13 147.52 66.13 Favored Pre-proline 0 C--N 1.305 -1.353 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 173.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -52.01 -62.92 0.3 Allowed 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.79 2.327 . . . . 0.0 110.959 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 45.1 mtm180 -127.09 -74.52 0.59 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 170.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -146.2 -18.63 0.14 Allowed Glycine 0 N--CA 1.436 -1.342 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.288 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . 0.287 10.3 p 56.78 69.02 0.78 Allowed 'General case' 0 C--O 1.245 0.852 0 C-N-CA 124.375 1.07 . . . . 0.0 111.085 -175.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.458 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 11.5 m-20 -73.37 105.23 4.66 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-N 113.459 -1.701 . . . . 0.0 110.043 -178.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.9 p -86.38 -20.93 27.52 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-O 121.881 0.848 . . . . 0.0 110.788 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.422 ' HA ' ' CE2' ' A' ' 22' ' ' TRP . 14.8 m -68.31 -30.15 69.07 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 114.22 -1.354 . . . . 0.0 111.785 -177.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.458 ' HG2' ' O ' ' A' ' 17' ' ' ASP . 65.9 pttt -61.03 -22.29 64.41 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.542 ' CG ' ' HA ' ' A' ' 129' ' ' SER . 97.7 m-85 -76.71 -28.56 55.89 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.392 -177.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.422 ' CE2' ' HA ' ' A' ' 19' ' ' SER . 26.0 p-90 -116.54 -18.07 10.46 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -93.55 119.76 33.0 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.909 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.57 100.14 3.14 Favored Pre-proline 0 C--N 1.308 -1.234 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.246 173.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.72 -4.23 13.35 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.952 2.435 . . . . 0.0 113.471 -173.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -92.63 -12.11 32.47 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.014 -177.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.508 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 17.5 tp -86.47 124.02 32.33 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.0 m -75.9 173.24 11.44 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -173.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.4 tpp180 -57.84 -53.67 55.62 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.726 0.811 . . . . 0.0 110.935 -175.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -67.31 -30.55 70.43 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.278 -177.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -76.32 -35.9 58.55 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.276 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.93 97.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.595 0.712 . . . . 0.0 109.712 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 82.8 mt -66.71 -43.31 90.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.465 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.5 -30.9 70.0 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.501 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.33 -44.77 43.46 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.794 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 65.0 mt -74.3 -25.14 59.4 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -177.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -71.78 -19.02 62.07 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 121.665 -0.647 . . . . 0.0 110.285 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -89.21 -10.16 48.1 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.601 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.595 ' HE2' ' HA ' ' A' ' 39' ' ' LYS . 3.8 mmpt? -108.68 164.78 12.07 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -176.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.0 151.71 86.34 Favored Pre-proline 0 C--N 1.309 -1.171 0 CA-C-N 112.667 -2.06 . . . . 0.0 108.863 -175.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -61.04 131.37 36.58 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.636 1.557 . . . . 0.0 109.529 173.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.91 -13.2 31.98 Favored Glycine 0 C--N 1.302 -1.351 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.3 151.21 31.22 Favored 'General case' 0 C--O 1.246 0.898 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 31.9 p90 -154.73 164.72 38.37 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -175.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -152.31 157.12 40.9 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 172.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.6 mt -127.11 132.1 70.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.508 ' HD2' ' O ' ' A' ' 27' ' ' LEU . 7.2 ptm180 -127.87 153.77 46.25 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 175.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -60.07 127.41 31.74 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.3 t -77.51 119.18 20.74 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -86.87 -20.9 26.77 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 m -61.24 -49.93 75.13 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 112.883 -1.962 . . . . 0.0 110.237 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -125.55 133.27 52.37 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -82.73 121.93 27.52 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.785 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.86 23.67 14.89 Favored Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.23 152.1 51.64 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 121.147 0.499 . . . . 0.0 110.035 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -120.58 136.17 54.88 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.73 112.13 4.34 Favored Glycine 0 C--N 1.284 -2.309 0 C-N-CA 120.039 -1.077 . . . . 0.0 111.005 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 44.7 tp -87.05 130.42 34.49 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 44' ' ' PHE . . . -113.31 119.49 37.86 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 176.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.4 tp -115.68 130.17 56.75 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 123.65 0.594 . . . . 0.0 110.603 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 22.6 tptm -88.71 115.07 25.98 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.6 m -105.4 171.33 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 175.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.86 -54.39 10.24 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.6 p -160.22 142.98 9.91 Favored Pre-proline 0 C--N 1.319 -0.722 0 C-N-CA 124.753 1.221 . . . . 0.0 108.112 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.604 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 24.1 Cg_exo -62.57 -49.48 5.63 Favored 'Trans proline' 0 CA--C 1.576 2.579 0 C-N-CA 121.613 1.542 . . . . 0.0 111.386 169.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.604 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 69.3 Cg_endo -68.2 151.67 76.68 Favored 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 122.813 2.342 . . . . 0.0 109.866 173.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -59.09 -48.75 13.01 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.396 2.064 . . . . 0.0 112.617 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.6 p -118.57 -22.34 7.56 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.663 -177.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 67.42 34.77 4.56 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 124.056 0.943 . . . . 0.0 109.813 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -59.67 -51.18 82.8 Favored Pre-proline 0 CA--C 1.553 1.084 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.496 177.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -83.24 114.4 2.17 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 121.156 1.238 . . . . 0.0 110.025 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 38.7 t-105 -125.68 143.08 51.19 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 120.983 0.42 . . . . 0.0 110.215 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -127.54 -61.25 1.14 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 175.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -178.49 65.88 0.08 OUTLIER Glycine 0 CA--C 1.486 -1.758 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 177.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -82.32 130.36 59.78 Favored Pre-proline 0 C--N 1.297 -1.685 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -175.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.57 159.54 32.05 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.256 1.97 . . . . 0.0 113.096 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.6 p -66.22 -14.8 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 121.828 0.823 . . . . 0.0 110.392 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -68.73 -13.49 62.41 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.89 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -89.44 -25.27 21.58 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 121.04 0.447 . . . . 0.0 110.305 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 69.3 mt -74.92 -22.66 58.48 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.793 0.806 . . . . 0.0 109.156 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 98.1 t -100.4 127.36 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 174.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.501 ' HA ' ' NE ' ' A' ' 82' ' ' ARG . 3.5 mmp_? -107.32 139.88 41.11 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.941 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -116.1 122.71 45.94 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.248 0.547 . . . . 0.0 110.522 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -129.3 128.27 42.84 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.37 138.28 34.2 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 118.901 -1.12 . . . . 0.0 111.017 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.7 mt -102.56 119.12 50.47 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.079 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -101.64 143.88 31.05 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -176.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 92' ' ' GLY . 4.2 t -127.69 120.28 27.67 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-O 121.569 0.7 . . . . 0.0 110.229 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -140.67 -154.84 6.33 Favored Glycine 0 N--CA 1.435 -1.433 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.25 -15.82 28.34 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.118 1.878 . . . . 0.0 111.029 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -72.71 -27.89 62.33 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.415 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 122.83 -153.89 16.99 Favored Glycine 0 N--CA 1.426 -2.025 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -175.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.2 p -118.27 132.56 67.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.32 157.72 36.19 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.109 -178.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 98' ' ' CYS . 85.6 mt -72.42 140.55 17.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -78.85 128.72 33.72 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 108.69 -54.4 0.55 Allowed Glycine 0 N--CA 1.437 -1.237 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.458 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 49.7 t -139.88 121.92 9.89 Favored Pre-proline 0 N--CA 1.414 -2.273 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 176.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 98' ' ' CYS . 10.1 Cg_exo -73.09 -53.7 0.13 Allowed 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 121.741 1.628 . . . . 0.0 110.535 -177.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.2 t 156.21 -83.99 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 129.004 2.922 . . . . 0.0 103.263 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.541 ' HB2' ' HD3' ' A' ' 102' ' ' PRO . 45.7 mt-10 -144.5 -59.55 0.02 OUTLIER Pre-proline 0 N--CA 1.435 -1.202 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 173.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.541 ' HD3' ' HB2' ' A' ' 101' ' ' GLU . 16.6 Cg_endo -101.29 -172.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 121.345 1.363 . . . . 0.0 110.457 171.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -105.97 125.65 51.25 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 173.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.483 ' CD1' ' HB3' ' A' ' 110' ' ' LEU . 97.2 m-85 -84.59 172.64 11.43 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -172.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -101.4 -23.98 9.18 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.218 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.2 m -145.98 160.27 42.09 Favored 'General case' 0 C--O 1.247 0.954 0 O-C-N 122.289 -0.536 . . . . 0.0 110.658 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.92 -48.03 82.26 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 123.356 0.662 . . . . 0.0 112.589 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 m -54.61 -31.95 57.99 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.005 0.522 . . . . 0.0 112.02 -175.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.602 ' O ' ' HG2' ' A' ' 113' ' ' GLN . . . -63.8 -51.71 63.55 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.426 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.483 ' HB3' ' CD1' ' A' ' 104' ' ' PHE . 4.3 pp -70.2 -27.67 64.68 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.711 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.77 -53.22 44.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.742 178.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.1 t -64.35 -29.59 70.65 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.566 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.602 ' HG2' ' O ' ' A' ' 109' ' ' ALA . 81.3 mm-40 -68.01 -33.89 75.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.778 0.323 . . . . 0.0 110.905 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -82.1 -0.02 42.73 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 26.0 m -85.45 -21.73 28.6 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 172.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 67.6 mt -106.14 -49.1 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.653 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.2 m -120.43 102.12 45.73 Favored Pre-proline 0 C--N 1.302 -1.486 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.429 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.33 84.82 1.64 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.351 2.034 . . . . 0.0 109.942 175.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 72.5 mt -87.79 -67.53 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.935 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.2 m -85.03 -11.25 55.8 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.435 0.636 . . . . 0.0 110.936 -176.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 76.2 mt -120.16 137.89 26.48 Favored Pre-proline 0 N--CA 1.429 -1.479 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.493 -175.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -64.48 -34.03 54.98 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.621 2.214 . . . . 0.0 112.341 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 66.2 m -111.61 157.16 20.73 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 9.9 p -81.53 143.59 31.92 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 72.0 mt -78.01 119.12 21.0 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 123.109 0.256 . . . . 0.0 111.612 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -94.97 105.78 17.72 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 175.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.9 mt -78.0 121.87 84.65 Favored Pre-proline 0 C--N 1.301 -1.533 0 CA-C-N 115.305 -0.862 . . . . 0.0 112.063 -171.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -84.81 4.94 6.54 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 123.471 2.781 . . . . 0.0 112.513 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.542 ' HA ' ' CG ' ' A' ' 21' ' ' PHE . 13.9 m -72.69 85.65 1.2 Allowed 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.172 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -77.22 -166.53 0.74 Allowed 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 112.071 -2.331 . . . . 0.0 111.365 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.7 t70 . . . . . 0 C--N 1.289 -2.022 0 CA-C-N 114.172 -1.377 . . . . 0.0 107.657 179.866 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 ttm . . . . . 0 C--O 1.244 0.791 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -96.48 131.18 43.34 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 104.443 -2.428 . . . . 0.0 104.443 174.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 0.262 39.4 m-70 -72.31 -21.19 61.37 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -173.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -84.99 89.92 7.71 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 103.83 -2.656 . . . . 0.0 103.83 164.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -68.49 121.43 16.34 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.88 0.848 . . . . 0.0 112.738 -166.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -78.31 91.99 4.48 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.734 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -79.53 -83.56 0.09 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.681 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t 51.86 -102.98 0.14 Allowed 'General case' 0 C--O 1.253 1.284 0 O-C-N 124.303 1.002 . . . . 0.0 109.721 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.9 m 42.88 -148.62 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.466 1.107 . . . . 0.0 112.208 174.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.01 40.83 2.45 Favored Glycine 0 N--CA 1.427 -1.938 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 174.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.1 tt -95.91 -50.08 5.03 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.509 ' HB ' ' HD3' ' A' ' 13' ' ' PRO . 93.4 t -68.02 -58.89 7.12 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.47 176.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.509 ' HD3' ' HB ' ' A' ' 12' ' ' VAL . 23.9 Cg_endo -86.08 105.47 0.78 Allowed 'Trans proline' 0 C--N 1.371 1.715 0 N-CA-C 106.756 -2.055 . . . . 0.0 106.756 167.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -60.79 100.14 0.1 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -168.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -123.18 10.84 8.71 Favored Glycine 0 C--N 1.315 -0.627 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.8 p -106.15 22.92 14.9 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.517 -0.842 . . . . 0.0 110.79 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -55.71 106.85 0.28 Allowed 'General case' 0 N--CA 1.426 -1.673 0 C-N-CA 125.568 1.547 . . . . 0.0 110.982 -175.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.409 ' HA ' ' CE1' ' A' ' 21' ' ' PHE . 26.8 p 63.73 11.99 6.28 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 126.038 1.735 . . . . 0.0 112.977 175.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.2 m -101.11 -37.81 8.42 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.279 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -13.09 58.05 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.409 ' CE1' ' HA ' ' A' ' 18' ' ' THR . 96.9 m-85 -64.0 -50.79 67.14 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.232 0.539 . . . . 0.0 110.18 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 46.5 p-90 -109.89 -19.03 13.26 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -175.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -95.94 113.79 25.45 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.436 0.636 . . . . 0.0 111.61 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.81 94.55 5.43 Favored Pre-proline 0 C--N 1.303 -1.427 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.437 173.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -78.16 2.95 7.5 Favored 'Trans proline' 0 C--O 1.223 -0.24 0 C-N-CA 123.447 2.765 . . . . 0.0 115.23 -171.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -97.21 -3.22 41.25 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.066 -0.653 . . . . 0.0 111.885 -177.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.403 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 76.2 mt -91.42 134.03 34.97 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 120.946 0.403 . . . . 0.0 110.168 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.0 t -90.66 177.83 6.24 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.272 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -48.31 -57.48 5.94 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.863 1.265 . . . . 0.0 111.162 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.63 -32.03 73.38 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.829 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -75.55 -37.3 60.09 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.085 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.13 -42.63 95.21 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.603 0.716 . . . . 0.0 109.751 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 78.7 mt -66.57 -40.85 87.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.365 177.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.76 -27.32 67.88 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.522 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.29 -53.1 6.63 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 172.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 52.7 mt -61.89 -24.5 66.98 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -174.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -57.23 -35.53 69.81 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -102.22 6.66 40.76 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.637 0.732 . . . . 0.0 110.546 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -94.4 156.63 16.4 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.988 177.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.72 149.16 56.41 Favored Pre-proline 0 C--N 1.296 -1.757 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.6 -176.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 61' ' ' LYS . 78.3 Cg_exo -53.34 118.94 5.39 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.634 2.223 . . . . 0.0 111.098 175.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.94 -22.18 6.85 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -176.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.51 147.05 36.01 Favored 'General case' 0 C--O 1.247 0.926 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.473 ' CD1' HD23 ' A' ' 125' ' ' LEU . 33.0 p90 -150.6 165.59 32.88 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -175.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -151.72 150.9 30.72 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.7 mt -116.26 127.14 73.95 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.403 ' HD2' ' O ' ' A' ' 27' ' ' LEU . 50.1 ptt85 -125.44 170.98 10.86 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.92 -176.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -88.63 136.78 32.82 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 176.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.3 m -116.8 123.52 47.32 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 121.411 0.624 . . . . 0.0 112.345 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -84.88 80.51 9.25 Favored 'General case' 0 CA--C 1.487 -1.454 0 CA-C-O 122.304 1.05 . . . . 0.0 108.316 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.3 t -142.28 -62.24 0.44 Allowed 'General case' 0 C--N 1.268 -2.966 0 CA-C-N 113.128 -1.851 . . . . 0.0 107.271 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -126.83 161.77 27.43 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -78.51 121.12 24.17 Favored 'General case' 0 C--O 1.254 1.339 0 CA-C-O 121.182 0.515 . . . . 0.0 110.827 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.7 46.59 9.53 Favored Glycine 0 N--CA 1.437 -1.297 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.68 116.31 22.17 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 121.222 0.534 . . . . 0.0 109.738 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -103.12 118.29 36.47 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.39 122.47 6.48 Favored Glycine 0 C--N 1.277 -2.733 0 C-N-CA 119.839 -1.172 . . . . 0.0 111.239 -177.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 31.7 tp -93.94 124.55 38.02 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.64 121.32 44.76 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 60.3 tp -116.88 126.46 53.04 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 123.039 0.536 . . . . 0.0 110.501 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 21.9 tptm -89.0 115.68 26.74 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.7 m -110.11 170.36 3.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.58 -59.56 3.26 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.6 p -157.66 140.36 10.66 Favored Pre-proline 0 C--N 1.311 -1.071 0 C-N-CA 124.396 1.078 . . . . 0.0 108.204 177.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.569 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 31.3 Cg_exo -59.75 -44.14 33.27 Favored 'Trans proline' 0 CA--C 1.573 2.448 0 C-N-CA 121.999 1.799 . . . . 0.0 111.937 173.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.569 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 78.3 Cg_endo -70.89 154.17 63.4 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.402 2.068 . . . . 0.0 109.02 169.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.42 -47.56 1.0 Allowed 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 121.98 1.787 . . . . 0.0 112.11 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.4 p -103.06 -43.92 5.36 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.004 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.439 ' HB1' ' HG2' ' A' ' 66' ' ' PRO . . . 67.89 23.12 8.46 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.524 1.13 . . . . 0.0 110.602 -177.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -65.25 -47.16 71.73 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.42 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -57.99 120.82 8.97 Favored 'Trans proline' 0 C--N 1.376 1.992 0 N-CA-C 106.436 -2.179 . . . . 0.0 106.436 165.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -34.71 127.74 0.48 Allowed 'General case' 0 C--O 1.243 0.742 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -166.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -139.31 73.49 1.43 Allowed 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 113.899 -1.5 . . . . 0.0 108.88 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.96 48.06 1.0 Allowed Glycine 0 C--N 1.289 -2.047 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 175.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -98.8 146.62 31.96 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -176.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -50.24 157.43 3.07 Favored 'Trans proline' 0 C--O 1.246 0.919 0 C-N-CA 123.527 2.818 . . . . 0.0 114.011 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.5 p -61.94 -11.65 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.851 -178.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -62.03 -27.64 69.02 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 122.833 0.453 . . . . 0.0 110.687 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.402 ' HG2' ' HG2' ' A' ' 65' ' ' PRO . 7.7 tt0 -79.1 -33.59 44.27 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.019 0.438 . . . . 0.0 109.904 177.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.8 mt -72.15 -20.11 61.66 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.468 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 81.7 t -94.12 118.96 41.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 173.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -99.3 129.06 45.49 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 -178.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -106.43 122.92 47.25 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-O 121.28 0.562 . . . . 0.0 111.089 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -130.08 131.11 45.63 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 176.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.2 pp -102.99 140.6 37.05 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 118.32 -1.352 . . . . 0.0 111.584 -175.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.497 HG12 HG12 ' A' ' 95' ' ' ILE . 63.8 mt -102.18 126.1 56.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.587 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.519 ' OE2' ' HE2' ' A' ' 96' ' ' LYS . 38.5 mt-10 -103.53 146.02 29.15 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 92' ' ' GLY . 4.6 t -130.27 128.73 42.17 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 170.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.77 -137.22 2.22 Favored Glycine 0 N--CA 1.427 -1.95 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.829 -177.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.44 1.93 7.4 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.302 2.668 . . . . 0.0 113.721 -175.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -112.34 -20.6 11.76 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.722 0.772 . . . . 0.0 111.714 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 121.98 -154.26 16.76 Favored Glycine 0 CA--C 1.485 -1.819 0 N-CA-C 108.021 -2.032 . . . . 0.0 108.021 -177.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.5 p -107.92 127.1 64.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.55 ' HG2' ' CD2' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -158.02 151.54 23.52 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -172.713 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.497 HG12 HG12 ' A' ' 86' ' ' ILE . 60.3 mt -83.35 133.39 29.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.85 -177.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.519 ' HE2' ' OE2' ' A' ' 87' ' ' GLU . 18.2 ttmm -90.38 140.79 29.37 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.039 176.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.99 3.29 24.83 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -177.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 52.7 t -143.04 140.93 18.5 Favored Pre-proline 0 N--CA 1.422 -1.836 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -99.5 -2.49 0.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.539 2.159 . . . . 0.0 111.526 174.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.2 m -100.37 -10.28 21.38 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.396 -174.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -74.41 127.16 88.04 Favored Pre-proline 0 N--CA 1.426 -1.651 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -174.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.75 -177.4 3.11 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.376 2.051 . . . . 0.0 112.051 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.55 ' CD2' ' HG2' ' A' ' 94' ' ' LYS . 83.6 m-85 -110.88 119.1 37.96 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -106.14 174.49 5.86 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.645 -176.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -97.91 -39.87 3.71 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.913 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 51.1 m -128.45 162.17 27.8 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.73 -37.35 87.3 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 120.9 0.381 . . . . 0.0 110.271 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.0 m -51.59 -35.22 40.57 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.494 1.117 . . . . 0.0 112.04 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.67 -43.43 76.2 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.606 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 pp -74.55 -29.09 61.23 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.976 0.417 . . . . 0.0 111.175 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 75.6 t -64.77 -51.54 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.964 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.3 t -69.04 -31.97 71.14 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.427 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -63.98 -40.8 97.22 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.662 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.527 ' CD2' ' HA ' ' A' ' 118' ' ' PRO . 30.9 m80 -73.7 -3.88 30.96 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.9 m -82.8 -29.85 29.27 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 171.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.7 mt -90.83 -53.01 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.901 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.6 m -135.33 106.3 10.17 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.527 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 48.0 Cg_endo -78.73 100.9 1.4 Allowed 'Trans proline' 0 N--CA 1.437 -1.823 0 C-N-CA 121.413 1.409 . . . . 0.0 111.171 176.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 68.6 mt -84.07 -65.08 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.798 -176.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.7 m -85.98 -28.54 24.16 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.315 0.578 . . . . 0.0 111.415 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 63.6 mt -93.47 133.37 28.39 Favored Pre-proline 0 C--N 1.293 -1.868 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.146 -176.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.0 -13.47 31.57 Favored 'Trans proline' 0 N--CA 1.482 0.798 0 C-N-CA 123.092 2.528 . . . . 0.0 112.497 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 43.9 t -123.92 148.52 46.8 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . 0.5 ' SG ' ' HG3' ' A' ' 118' ' ' PRO . 45.6 m -73.29 147.16 44.78 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.473 HD23 ' CD1' ' A' ' 44' ' ' PHE . 44.5 mt -78.5 114.14 17.15 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.294 0.569 . . . . 0.0 111.452 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -97.17 96.64 8.57 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.1 mp -62.64 129.86 93.15 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -52.63 -42.97 58.85 Favored 'Trans proline' 0 C--N 1.36 1.172 0 C-N-CA 123.176 2.584 . . . . 0.0 112.67 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 20.4 m 59.05 11.79 2.13 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.039 1.336 . . . . 0.0 113.69 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -160.45 128.02 4.47 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 . . . . . 0 C--N 1.305 -1.366 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.406 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.3 mmm . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -121.26 139.76 52.97 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -116.76 171.34 7.95 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.623 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -84.14 110.01 18.17 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.492 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.427 ' HD1' ' HB3' ' A' ' 9' ' ' SER . 40.9 m80 -80.67 -52.2 7.83 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 176.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -137.34 27.79 2.81 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 69.7 m80 68.13 -66.5 0.22 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.805 1.242 . . . . 0.0 110.227 -171.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.7 m -83.93 85.97 7.24 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 172.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.427 ' HB3' ' HD1' ' A' ' 5' ' ' HIS . 13.0 m -93.93 95.35 9.01 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.163 -176.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.96 97.78 2.51 Favored Glycine 0 N--CA 1.427 -1.904 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -173.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.6 mt -75.82 105.79 7.04 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.33 0.586 . . . . 0.0 110.583 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.9 m -92.07 117.57 67.76 Favored Pre-proline 0 C--N 1.294 -1.818 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.167 175.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.31 -9.78 20.47 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 123.306 2.671 . . . . 0.0 113.83 -174.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.2 ptt180 -134.37 143.06 47.42 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 121.186 0.517 . . . . 0.0 111.896 -177.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -129.79 19.59 5.24 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.9 m -83.73 -15.19 49.55 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 122.087 0.946 . . . . 0.0 110.798 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.419 ' CG ' ' HZ1' ' A' ' 20' ' ' LYS . 21.0 p-10 -108.75 96.53 6.4 Favored 'General case' 0 C--N 1.268 -2.977 0 CA-C-N 113.727 -1.579 . . . . 0.0 109.029 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.3 p -95.53 -14.81 23.32 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.603 -171.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.9 m -68.97 -35.49 76.81 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.587 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.419 ' HZ1' ' CG ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -66.04 -11.09 45.89 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -177.002 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -76.22 -25.65 55.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.961 0.41 . . . . 0.0 110.264 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.51 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 37.0 p-90 -125.83 -26.1 3.53 Favored 'General case' 0 C--O 1.208 -1.082 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -176.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -84.43 111.29 19.33 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.599 -0.688 . . . . 0.0 111.022 -176.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -134.71 85.09 37.16 Favored Pre-proline 0 C--N 1.313 -0.978 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.48 -8.14 17.09 Favored 'Trans proline' 0 C--N 1.333 -0.264 0 C-N-CA 122.327 2.018 . . . . 0.0 113.538 -173.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -93.69 -5.36 48.71 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.318 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.8 tp -94.51 126.96 40.13 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -173.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.5 m -83.85 173.9 10.86 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.068 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -52.21 -55.28 22.13 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.23 1.012 . . . . 0.0 112.506 -175.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -55.7 -44.73 77.68 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.835 0.826 . . . . 0.0 110.684 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -73.39 -31.49 63.93 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 113.828 -1.533 . . . . 0.0 111.17 -174.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.39 74.76 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.447 0.641 . . . . 0.0 110.083 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 76.7 mt -68.13 -37.64 78.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.824 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.61 -32.48 70.45 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.645 175.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.424 ' O ' ' HB3' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -76.47 -47.86 21.52 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.28 -178.112 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.418 ' CD1' HD21 ' A' ' 45' ' ' LEU . 5.7 mp -75.2 -16.54 60.48 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -177.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -80.17 -8.82 59.61 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.326 174.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.424 ' HB3' ' O ' ' A' ' 35' ' ' LEU . 5.1 t70 -91.14 -41.2 11.15 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.017 177.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -91.59 179.56 5.62 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -176.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -86.86 153.45 54.89 Favored Pre-proline 0 C--N 1.31 -1.118 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 -172.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.09 122.78 12.15 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 122.24 1.96 . . . . 0.0 109.946 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.93 -24.89 5.36 Favored Glycine 0 N--CA 1.42 -2.378 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -175.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.8 148.93 39.88 Favored 'General case' 0 C--O 1.248 0.991 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.402 ' CE1' ' HB3' ' A' ' 125' ' ' LEU . 34.1 p90 -149.12 167.05 26.96 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -178.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.418 HD21 ' CD1' ' A' ' 36' ' ' LEU . 1.8 pt? -152.58 151.98 31.29 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 174.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.51 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 55.4 mt -113.12 113.34 43.77 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.404 HH12 ' CD2' ' A' ' 83' ' ' HIS . 15.1 ptt-85 -109.3 -173.82 2.36 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -90.48 129.46 36.65 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 172.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.1 t -82.65 107.45 15.29 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -78.29 75.04 4.82 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 122.459 1.123 . . . . 0.0 110.77 -175.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.3 m -150.61 -45.71 0.12 Allowed 'General case' 0 C--N 1.267 -2.989 0 CA-C-N 113.613 -1.63 . . . . 0.0 108.901 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -131.01 154.38 48.25 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -84.3 121.63 27.78 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.91 37.46 7.28 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.08 119.89 21.61 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -97.97 136.58 38.05 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -101.88 106.76 3.06 Favored Glycine 0 C--N 1.286 -2.218 0 C-N-CA 120.324 -0.941 . . . . 0.0 110.984 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -85.14 117.87 24.36 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 82' ' ' ARG . . . -115.03 125.67 53.84 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.9 tp -120.7 127.1 51.72 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 123.958 0.786 . . . . 0.0 109.446 -177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -88.96 114.74 25.91 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.455 HG12 ' SG ' ' A' ' 123' ' ' CYS . 33.3 m -104.25 169.37 2.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.219 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.88 -43.38 25.1 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 p -160.89 123.01 1.74 Allowed Pre-proline 0 C--N 1.32 -0.707 0 C-N-CA 124.93 1.292 . . . . 0.0 109.534 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.566 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 23.9 Cg_exo -64.85 -47.49 5.0 Favored 'Trans proline' 0 CA--C 1.566 2.101 0 C-N-CA 121.916 1.744 . . . . 0.0 112.232 172.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.566 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 58.1 Cg_endo -71.79 134.17 23.32 Favored 'Trans proline' 0 C--N 1.384 2.425 0 C-N-CA 121.626 1.551 . . . . 0.0 109.959 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.88 -24.47 33.86 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.806 2.337 . . . . 0.0 113.01 -176.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.4 t -115.38 -37.8 3.95 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.465 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 64.34 32.06 12.41 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.957 0.903 . . . . 0.0 112.965 174.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -63.03 -46.17 86.79 Favored Pre-proline 0 CA--C 1.557 1.234 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -56.4 123.04 12.87 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 121.804 1.669 . . . . 0.0 112.089 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -108.88 132.43 54.05 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.051 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -147.26 7.87 0.91 Allowed 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 124.413 1.085 . . . . 0.0 109.536 177.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.54 117.63 0.76 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -172.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -108.74 107.23 59.91 Favored Pre-proline 0 C--N 1.296 -1.742 0 CA-C-O 121.333 0.587 . . . . 0.0 111.256 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -85.42 148.15 10.05 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.12 1.88 . . . . 0.0 109.972 174.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.2 p -53.37 -25.54 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 123.612 0.765 . . . . 0.0 112.722 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -70.71 -27.02 63.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.237 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.2 -31.55 62.69 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.35 -4.48 33.63 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.493 -177.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 73.6 t -91.89 119.13 38.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 6.2 mmp_? -93.26 149.57 21.13 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.404 ' CD2' HH12 ' A' ' 47' ' ' ARG . 60.5 m80 -129.06 122.91 30.97 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.896 0.379 . . . . 0.0 111.052 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -133.28 128.36 35.62 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.417 HD21 ' H ' ' A' ' 85' ' ' LEU . 1.6 pt? -99.04 140.38 33.27 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.582 -1.247 . . . . 0.0 112.711 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 86.0 mt -104.05 119.34 52.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 114.066 -1.425 . . . . 0.0 107.579 178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -99.35 144.34 28.57 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.432 ' HB ' HG12 ' A' ' 93' ' ' VAL . 8.8 t -129.33 153.06 48.22 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.28 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.19 -142.77 4.41 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.38 -22.36 29.34 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.559 2.172 . . . . 0.0 112.742 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -73.51 -50.36 21.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.871 0.843 . . . . 0.0 109.793 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 150.89 -125.08 1.83 Allowed Glycine 0 N--CA 1.422 -2.288 0 N-CA-C 107.505 -2.238 . . . . 0.0 107.505 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.432 HG12 ' HB ' ' A' ' 88' ' ' THR . 16.9 m -127.31 139.49 51.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 175.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.93 145.09 24.61 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.067 -0.396 . . . . 0.0 110.983 177.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.3 mt -75.79 140.58 17.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -57.47 -52.85 63.71 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -105.41 52.33 0.72 Allowed Glycine 0 CA--C 1.495 -1.189 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.821 -174.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.432 ' HA ' ' OG ' ' A' ' 120' ' ' SER . 6.7 p -86.52 123.06 71.64 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 123.764 0.332 . . . . 0.0 111.717 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -65.35 -32.12 51.14 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.644 2.229 . . . . 0.0 113.09 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.3 m -145.4 -19.14 0.48 Allowed 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.591 ' OE2' ' HB ' ' A' ' 119' ' ' ILE . 12.9 mp0 -54.5 128.66 61.04 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -176.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -85.33 -161.35 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.766 2.311 . . . . 0.0 110.572 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -87.19 129.42 34.96 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -103.74 161.49 13.88 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.64 -56.44 2.37 Favored Glycine 0 C--N 1.297 -1.584 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.295 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.9 m -116.05 151.46 35.49 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.07 -35.88 72.01 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.021 0.528 . . . . 0.0 110.671 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 m -51.86 -34.89 42.91 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.647 1.179 . . . . 0.0 112.119 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.84 -42.88 76.57 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.413 -176.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.456 HD11 ' N ' ' A' ' 111' ' ' VAL . 4.4 pp -73.49 -38.83 65.26 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.179 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.456 ' N ' HD11 ' A' ' 110' ' ' LEU . 75.2 t -59.81 -46.06 94.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.398 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.0 p -69.57 -37.97 77.22 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -79.85 -28.33 40.06 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.567 -176.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -77.28 -0.1 24.14 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.6 m -80.44 -18.47 48.7 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 170.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 64.7 mt -108.93 -59.53 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.795 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.9 m -113.97 99.43 50.39 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.539 -177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -90.7 107.57 0.32 Allowed 'Trans proline' 0 N--CA 1.443 -1.486 0 C-N-CA 122.895 2.397 . . . . 0.0 110.919 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.591 ' HB ' ' OE2' ' A' ' 101' ' ' GLU . 25.9 mt -95.18 -64.33 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.432 ' OG ' ' HA ' ' A' ' 98' ' ' CYS . 52.2 m -66.43 -35.39 80.18 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.42 0.629 . . . . 0.0 111.068 174.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -82.65 136.18 45.43 Favored Pre-proline 0 N--CA 1.439 -1.013 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.663 -176.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.97 -19.15 30.72 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.574 2.183 . . . . 0.0 112.256 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.455 ' SG ' HG12 ' A' ' 62' ' ' VAL . 28.5 p -144.13 163.63 33.03 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 25.3 p -71.23 157.69 37.69 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.381 0.61 . . . . 0.0 112.479 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.402 ' HB3' ' CE1' ' A' ' 44' ' ' PHE . 64.8 mt -83.64 115.16 22.02 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.212 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -94.81 104.31 16.22 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.0 mp -69.18 120.98 80.26 Favored Pre-proline 0 C--N 1.317 -0.819 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -45.26 -50.43 9.01 Favored 'Trans proline' 0 C--N 1.36 1.164 0 C-N-CA 123.436 2.758 . . . . 0.0 113.091 -177.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.9 m 58.95 18.26 6.07 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.206 1.002 . . . . 0.0 111.443 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.438 ' C ' ' HD3' ' A' ' 130' ' ' LYS . 12.1 tmtt? -144.69 132.49 21.23 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 33.9 t70 . . . . . 0 C--N 1.294 -1.804 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.262 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.9 mmm . . . . . 0 CA--C 1.502 -0.87 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -131.64 170.32 14.93 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 123.637 0.775 . . . . 0.0 109.213 177.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.4 p80 -96.67 -21.09 17.82 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.137 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -136.26 143.21 44.13 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 177.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -124.68 167.63 14.28 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.752 -176.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -96.45 108.7 21.29 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 176.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -82.09 125.84 31.32 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.345 -175.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.9 m -126.27 155.3 42.14 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.356 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.6 m -94.77 98.28 10.65 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.17 80.08 0.68 Allowed Glycine 0 N--CA 1.429 -1.83 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.512 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -157.46 167.43 30.23 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 p -115.58 105.95 51.16 Favored Pre-proline 0 C--N 1.295 -1.787 0 CA-C-O 121.14 0.495 . . . . 0.0 110.889 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.61 114.46 3.31 Favored 'Trans proline' 0 C--O 1.247 0.961 0 C-N-CA 122.44 2.094 . . . . 0.0 110.266 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 63.9 mtt85 -92.18 173.2 7.95 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.504 -176.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.22 53.35 4.76 Favored Glycine 0 CA--C 1.487 -1.699 0 N-CA-C 114.384 0.514 . . . . 0.0 114.384 -171.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.2 m 50.89 53.32 13.23 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 124.413 1.085 . . . . 0.0 111.529 176.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -74.32 90.68 2.14 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.535 0.683 . . . . 0.0 110.325 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.8 p -109.92 -10.74 14.72 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -174.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.9 t -64.66 -44.65 89.73 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.288 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -4.53 3.53 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -81.95 -35.77 28.69 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.318 0.58 . . . . 0.0 109.511 174.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.408 ' CZ3' HD13 ' A' ' 46' ' ' ILE . 44.7 p-90 -109.46 -28.17 9.06 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -91.32 119.33 31.26 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.55 0.691 . . . . 0.0 110.734 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.42 99.15 5.87 Favored Pre-proline 0 C--N 1.297 -1.683 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.657 172.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.22 -25.11 26.82 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 123.006 2.471 . . . . 0.0 113.629 -171.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -93.96 13.32 23.16 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.433 -173.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.9 tp -92.02 145.52 24.46 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.7 t -99.47 172.31 7.4 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.215 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -55.89 -53.34 57.96 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.299 1.04 . . . . 0.0 112.005 -174.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -67.5 -33.96 76.17 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.1 0.476 . . . . 0.0 111.25 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -70.68 -33.11 70.57 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.221 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.6 -40.67 97.54 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.751 0.786 . . . . 0.0 109.506 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 70.0 mt -69.22 -37.56 76.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 114.755 -1.112 . . . . 0.0 109.582 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.51 -33.8 64.07 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.06 177.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.498 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 4.6 mm? -78.7 -55.73 4.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.105 0.479 . . . . 0.0 110.259 174.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 47.2 mt -59.75 -28.91 67.79 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -174.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -64.55 -28.07 69.39 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.924 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -95.9 -21.61 17.96 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.23 0.538 . . . . 0.0 110.475 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 35' ' ' LEU . 26.2 mtpp -77.91 150.34 34.09 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-O 121.021 0.439 . . . . 0.0 110.818 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -75.05 151.36 86.14 Favored Pre-proline 0 C--N 1.309 -1.187 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.566 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -52.1 121.99 9.8 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 123.429 2.753 . . . . 0.0 112.839 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.81 -23.36 7.03 Favored Glycine 0 N--CA 1.432 -1.627 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.2 145.08 44.45 Favored 'General case' 0 C--O 1.246 0.913 0 O-C-N 124.057 0.504 . . . . 0.0 110.513 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.466 ' CG ' HD12 ' A' ' 125' ' ' LEU . 12.7 p90 -142.83 171.96 13.34 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.34 -176.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -158.49 152.8 24.17 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 172.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.408 HD13 ' CZ3' ' A' ' 22' ' ' TRP . 55.8 mt -125.3 134.01 67.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.4 ptt-85 -133.38 -178.69 5.1 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -83.2 147.87 27.77 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.2 m -78.16 139.81 38.99 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.157 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -84.96 -36.07 21.62 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.9 m -69.2 -46.79 66.59 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.738 -176.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -131.1 146.41 52.35 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -87.11 148.97 25.0 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.67 23.05 70.96 Favored Glycine 0 CA--C 1.499 -0.962 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.59 137.1 43.45 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -110.52 121.85 46.32 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.68 114.56 3.95 Favored Glycine 0 N--CA 1.424 -2.112 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.276 -176.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 42.6 tp -94.0 123.62 37.48 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -112.91 122.15 46.78 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 176.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.4 tp -115.65 128.69 56.1 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.42 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 22.0 tptm -88.72 114.82 25.75 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 80' ' ' LEU . 29.3 m -108.61 171.73 2.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.76 -51.56 12.39 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.6 p -151.63 125.72 4.44 Favored Pre-proline 0 N--CA 1.431 -1.414 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.244 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.604 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 34.9 Cg_exo -60.1 -45.68 22.51 Favored 'Trans proline' 0 CA--C 1.577 2.652 0 C-N-CA 121.859 1.706 . . . . 0.0 111.506 169.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.604 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 46.5 Cg_endo -63.72 161.17 33.32 Favored 'Trans proline' 0 C--N 1.391 2.778 0 C-N-CA 122.934 2.423 . . . . 0.0 110.054 171.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.33 -40.89 45.64 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.42 2.08 . . . . 0.0 112.831 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.1 p -137.57 -17.97 1.27 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 65.33 33.47 9.02 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.059 0.944 . . . . 0.0 111.513 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -65.49 -45.7 68.84 Favored Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.452 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -74.29 103.72 1.73 Allowed 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 121.119 1.213 . . . . 0.0 109.148 169.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 56.0 t-105 -107.8 143.67 36.05 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.12 -175.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -134.93 8.72 3.52 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.77 51.23 4.11 Favored Glycine 0 CA--C 1.49 -1.48 0 C-N-CA 119.726 -1.226 . . . . 0.0 110.37 -175.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -91.32 119.09 68.77 Favored Pre-proline 0 N--CA 1.437 -1.107 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -49.66 146.66 14.86 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.818 3.012 . . . . 0.0 115.168 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -60.13 -21.03 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 CA-C-O 122.23 1.014 . . . . 0.0 109.794 174.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -69.65 -20.14 63.6 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.359 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -90.31 -7.86 52.31 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.651 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.411 ' O ' HG22 ' A' ' 62' ' ' VAL . 80.2 mt -83.53 -6.23 59.39 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 122.091 0.948 . . . . 0.0 108.844 177.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.8 t -85.87 134.25 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.27 174.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -111.05 130.7 55.52 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -109.71 122.86 48.44 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.049 0.452 . . . . 0.0 111.522 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -133.27 147.75 51.93 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 177.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -119.05 131.06 55.93 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 118.709 -1.196 . . . . 0.0 112.314 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.463 HG12 HG12 ' A' ' 95' ' ' ILE . 78.8 mt -87.7 118.23 33.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 178.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.553 ' OE1' ' HE2' ' A' ' 96' ' ' LYS . 39.8 mt-10 -98.97 138.9 35.41 Favored 'General case' 0 C--N 1.27 -2.867 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.481 ' HB ' HG11 ' A' ' 93' ' ' VAL . 7.2 t -120.43 116.66 25.89 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-O 121.989 0.899 . . . . 0.0 109.929 178.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -125.84 -166.69 12.33 Favored Glycine 0 N--CA 1.416 -2.651 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.483 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -68.49 -11.47 32.03 Favored 'Trans proline' 0 C--N 1.331 -0.351 0 C-N-CA 122.949 2.433 . . . . 0.0 113.173 -176.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.607 ' HD3' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -97.06 -17.16 20.16 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.911 179.513 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 136.19 -164.07 25.07 Favored Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -177.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.481 HG11 ' HB ' ' A' ' 88' ' ' THR . 8.3 m -104.97 148.41 9.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -164.81 157.89 16.89 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.233 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.653 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 60.5 mt -92.27 131.95 37.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.627 0.727 . . . . 0.0 112.008 -174.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.553 ' HE2' ' OE1' ' A' ' 87' ' ' GLU . 22.3 ttmm -88.78 132.87 34.44 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 172.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.49 7.1 7.71 Favored Glycine 0 C--N 1.308 -1.027 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -172.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.406 ' SG ' HG23 ' A' ' 119' ' ' ILE . 42.3 t -142.42 142.36 23.39 Favored Pre-proline 0 N--CA 1.428 -1.567 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -87.73 -13.92 3.84 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.264 1.976 . . . . 0.0 113.244 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.0 m -85.79 -82.76 0.18 Allowed 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.653 ' HG3' ' O ' ' A' ' 95' ' ' ILE . 28.2 mm-40 46.95 97.26 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 117.603 2.445 . . . . 0.0 117.603 174.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -81.63 147.79 15.72 Favored 'Trans proline' 0 N--CA 1.437 -1.845 0 C-N-CA 122.015 1.81 . . . . 0.0 108.926 172.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.418 ' CD2' ' HB2' ' A' ' 91' ' ' LYS . 87.3 m-85 -76.98 123.38 26.25 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.6 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 110' ' ' LEU . 59.9 m-85 -103.54 164.38 11.7 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.18 -53.5 2.49 Favored Glycine 0 C--N 1.305 -1.156 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.625 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 61.9 m -116.04 160.73 19.89 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 122.918 -0.166 . . . . 0.0 110.977 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.33 -35.17 79.5 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.938 0.399 . . . . 0.0 110.985 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -55.26 -30.82 60.84 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 123.912 0.885 . . . . 0.0 111.479 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.33 -49.33 69.85 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.419 -178.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.432 ' H ' HD12 ' A' ' 110' ' ' LEU 0.293 0.0 OUTLIER -72.52 -28.58 62.95 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.972 -179.78 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 73.4 t -63.65 -49.42 82.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 123.656 0.598 . . . . 0.0 110.076 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.0 t -68.45 -37.88 80.62 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.044 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -75.22 -40.57 59.0 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.462 ' HA ' ' O ' ' A' ' 117' ' ' SER . 25.4 m80 -67.7 -10.96 57.03 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.8 t -72.96 -32.09 65.0 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 175.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 62.4 mt -96.44 -53.5 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 19.8 m -114.77 103.57 54.74 Favored Pre-proline 0 N--CA 1.436 -1.141 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.633 -177.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -78.45 89.35 1.36 Allowed 'Trans proline' 0 N--CA 1.44 -1.657 0 C-N-CA 122.527 2.151 . . . . 0.0 110.922 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.406 HG23 ' SG ' ' A' ' 98' ' ' CYS . 43.5 mt -74.58 -66.57 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.56 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.5 t -85.11 -31.22 23.44 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.645 0.736 . . . . 0.0 110.111 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 69.5 mt -83.92 139.56 40.09 Favored Pre-proline 0 C--N 1.303 -1.444 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.377 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -76.81 -10.58 18.34 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.664 2.243 . . . . 0.0 112.893 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 45.1 t -137.37 160.83 37.97 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 39.3 m -70.61 136.0 48.86 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.466 HD12 ' CG ' ' A' ' 44' ' ' PHE . 23.9 tp -75.07 132.7 41.46 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.52 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.528 ' O ' ' HD3' ' A' ' 128' ' ' PRO . 36.6 mmt180 -118.07 128.81 55.12 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mp -95.26 106.31 25.25 Favored Pre-proline 0 C--N 1.312 -1.023 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 126' ' ' ARG . 33.6 Cg_exo -62.75 -34.06 74.43 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.266 1.977 . . . . 0.0 111.988 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 34.1 t 70.93 17.05 6.4 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.554 1.141 . . . . 0.0 108.899 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -140.73 163.66 32.31 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 30.0 t70 . . . . . 0 C--N 1.292 -1.933 0 O-C-N 123.825 0.703 . . . . 0.0 110.207 -178.65 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.507 -0.685 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -121.99 -176.61 3.38 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -90.43 -14.11 33.53 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.925 0.869 . . . . 0.0 108.694 175.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -100.55 145.51 28.24 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 175.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -93.64 157.03 16.38 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -175.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -85.55 122.78 30.16 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -114.0 91.87 3.78 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.778 -178.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.8 m 65.12 -53.77 0.33 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 175.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.7 m -120.97 144.52 48.45 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -175.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.31 -175.94 39.54 Favored Glycine 0 N--CA 1.438 -1.186 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.72 120.39 14.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.032 0.444 . . . . 0.0 110.444 178.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.7 m -114.92 149.38 42.36 Favored Pre-proline 0 C--N 1.292 -1.907 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.319 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.03 19.41 1.03 Allowed 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.829 2.352 . . . . 0.0 112.187 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -115.19 121.81 44.11 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 160.26 30.08 0.02 OUTLIER Glycine 0 C--N 1.294 -1.786 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.233 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.8 t -103.69 40.46 1.42 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 177.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -113.6 137.48 51.52 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.19 -1.368 . . . . 0.0 107.318 -176.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.9 p -84.68 -1.07 55.63 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-O 122.02 0.914 . . . . 0.0 111.195 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.9 m -75.9 -7.71 55.19 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.847 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.89 -16.56 53.26 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 119.936 -0.706 . . . . 0.0 111.695 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -69.75 -25.55 63.88 Favored 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -175.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 19.6 p-90 -113.25 -4.21 13.75 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.191 0.52 . . . . 0.0 111.917 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -107.45 114.32 28.25 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.786 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.66 96.97 3.53 Favored Pre-proline 0 C--N 1.295 -1.78 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.574 174.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -79.81 13.96 2.0 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.443 2.762 . . . . 0.0 114.038 -171.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -102.92 -6.58 22.3 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 120.859 0.361 . . . . 0.0 110.421 -176.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.458 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 75.9 mt -87.32 142.54 27.81 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.478 0.656 . . . . 0.0 111.762 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 87.3 p -89.17 177.81 6.53 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.983 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -63.05 -43.25 99.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -55.08 -48.2 73.86 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.316 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -70.31 -34.39 72.66 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.381 -178.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.2 -44.59 87.87 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.237 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 51.2 mt -66.64 -38.94 82.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.486 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.06 -40.37 89.21 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.377 0.608 . . . . 0.0 110.346 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -46.0 69.56 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.055 -179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 72.4 mt -74.86 -17.19 60.63 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -176.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -83.06 -11.28 58.18 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.149 -1.021 . . . . 0.0 110.37 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -93.91 -24.3 17.75 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.606 0.717 . . . . 0.0 109.454 175.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -99.91 164.52 11.98 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -72.49 156.91 89.84 Favored Pre-proline 0 C--N 1.287 -2.127 0 CA-C-N 112.177 -2.283 . . . . 0.0 112.749 -176.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -60.46 126.31 19.64 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.892 2.395 . . . . 0.0 111.379 175.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 112.96 -7.74 25.47 Favored Glycine 0 C--N 1.303 -1.25 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -176.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.49 150.3 32.98 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-N 115.534 -0.333 . . . . 0.0 110.341 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.493 ' CD1' HD12 ' A' ' 125' ' ' LEU . 9.8 p90 -149.25 167.63 25.5 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -155.97 148.72 24.04 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 171.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 63.2 mt -120.79 130.27 74.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-O 121.124 0.488 . . . . 0.0 110.656 -178.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -137.82 -176.96 4.6 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.044 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -62.66 134.39 56.25 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.8 t -74.57 136.38 42.09 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.371 0.605 . . . . 0.0 110.704 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -72.75 -27.06 61.8 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.325 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.2 m -81.13 -52.26 7.57 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.965 -175.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -137.73 145.26 42.28 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -175.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -82.98 151.92 25.66 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 173.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.03 9.96 81.52 Favored Glycine 0 C--N 1.305 -1.179 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.44 144.48 48.16 Favored 'General case' 0 N--CA 1.406 -2.648 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -116.9 126.34 52.83 Favored 'General case' 0 C--N 1.273 -2.749 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.419 ' O ' ' HD3' ' A' ' 47' ' ' ARG . . . -83.76 115.15 4.0 Favored Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.031 -177.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.7 tp -95.59 121.63 37.5 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 123.728 0.811 . . . . 0.0 109.03 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 44' ' ' PHE . . . -105.57 127.56 53.1 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 176.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -124.04 125.59 44.79 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -176.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.459 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 21.7 tptm -88.34 114.62 25.15 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.675 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.522 HG21 ' O ' ' A' ' 80' ' ' LEU . 20.0 m -96.85 167.61 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.07 -59.11 2.87 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 174.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.73 141.72 12.91 Favored Pre-proline 0 N--CA 1.428 -1.529 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.84 177.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.562 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 32.0 Cg_exo -59.47 -42.79 45.04 Favored 'Trans proline' 0 CA--C 1.573 2.454 0 C-N-CA 122.283 1.989 . . . . 0.0 112.61 174.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.562 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 39.7 Cg_endo -65.13 148.12 88.91 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 122.832 2.354 . . . . 0.0 109.77 172.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.79 -37.14 88.67 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.749 2.299 . . . . 0.0 113.048 -177.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.7 t -132.37 -11.07 3.22 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.949 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 69.83 31.99 3.31 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 124.345 1.058 . . . . 0.0 112.923 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -64.14 -43.75 74.95 Favored Pre-proline 0 CA--C 1.556 1.199 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.631 173.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -84.69 101.3 0.79 Allowed 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 121.446 1.43 . . . . 0.0 109.893 167.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 34.6 t-105 -92.53 146.66 23.51 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.909 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -121.82 -36.52 3.01 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.966 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.44 14.12 12.09 Favored Glycine 0 C--N 1.3 -1.466 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.31 -176.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -64.53 134.09 95.89 Favored Pre-proline 0 C--N 1.316 -0.865 0 C-N-CA 122.63 0.372 . . . . 0.0 110.701 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.1 173.19 14.91 Favored 'Trans proline' 0 C--O 1.245 0.844 0 C-N-CA 123.042 2.495 . . . . 0.0 113.855 -175.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -56.42 -30.31 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.478 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -58.78 -25.11 62.78 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 122.955 0.502 . . . . 0.0 112.238 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -92.05 -14.23 29.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.059 0.457 . . . . 0.0 110.56 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.522 ' O ' HG21 ' A' ' 62' ' ' VAL . 72.9 mt -81.95 -13.07 58.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 122.006 0.908 . . . . 0.0 108.642 178.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.2 t -94.91 111.37 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 175.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.403 ' NH2' ' HB3' ' A' ' 65' ' ' PRO . 32.4 mmt180 -85.19 147.46 26.59 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.428 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.9 m80 -126.13 123.21 37.79 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.586 0.708 . . . . 0.0 111.723 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -132.49 163.52 28.63 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 106.282 -1.748 . . . . 0.0 106.282 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -130.02 132.65 46.31 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.047 176.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 94' ' ' LYS . 75.1 mt -90.84 110.65 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.332 0 CA-C-N 114.48 -1.236 . . . . 0.0 107.668 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -100.2 152.69 19.98 Favored 'General case' 0 C--N 1.268 -2.954 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.481 ' HB ' HG13 ' A' ' 93' ' ' VAL . 4.3 t -134.14 148.82 51.01 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-O 121.214 0.531 . . . . 0.0 110.675 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.45 -159.51 11.15 Favored Glycine 0 N--CA 1.42 -2.384 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.37 -21.44 72.68 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.929 2.419 . . . . 0.0 112.939 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -88.83 -5.79 57.79 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.733 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 110.36 -147.56 17.44 Favored Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.481 HG13 ' HB ' ' A' ' 88' ' ' THR . 12.1 m -108.11 151.95 10.08 Favored 'Isoleucine or valine' 0 C--O 1.252 1.23 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 13.8 pttp -151.38 147.95 27.53 Favored 'General case' 0 C--N 1.311 -1.078 0 O-C-N 123.777 0.673 . . . . 0.0 109.859 -175.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.508 ' HB ' ' OE2' ' A' ' 101' ' ' GLU . 76.5 mt -101.46 108.38 23.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -75.36 119.06 18.94 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 120.984 0.421 . . . . 0.0 110.071 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 121.22 -2.74 11.47 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.072 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 24.1 p -70.93 152.9 94.96 Favored Pre-proline 0 C--N 1.317 -0.809 0 C-N-CA 123.026 0.53 . . . . 0.0 110.006 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -72.41 -52.64 0.17 Allowed 'Trans proline' 0 C--O 1.24 0.616 0 C-N-CA 121.729 1.619 . . . . 0.0 110.16 173.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.2 m -144.99 139.86 27.79 Favored 'General case' 0 N--CA 1.41 -2.467 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.508 ' OE2' ' HB ' ' A' ' 95' ' ' ILE . 38.3 tt0 -166.56 142.67 3.88 Favored Pre-proline 0 C--N 1.297 -1.713 0 O-C-N 123.479 0.487 . . . . 0.0 112.165 -176.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -92.71 160.62 2.83 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 123.171 2.581 . . . . 0.0 110.3 168.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -74.07 127.02 31.84 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -79.14 -72.59 0.38 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.023 0.439 . . . . 0.0 111.248 -176.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 148.91 -58.6 0.46 Allowed Glycine 0 C--N 1.309 -0.929 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.1 m -132.53 155.9 47.79 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.458 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 10.7 mp -53.11 -46.31 68.65 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.436 0.46 . . . . 0.0 111.164 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.4 m -53.83 -30.75 46.65 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.898 0.879 . . . . 0.0 112.458 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.58 -37.12 73.89 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 120.64 0.257 . . . . 0.0 111.288 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 107' ' ' LEU . 4.3 pp -80.35 -23.43 40.53 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.462 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 107' ' ' LEU . 70.8 t -71.44 -40.31 72.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.388 177.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.0 p -70.25 -22.86 62.84 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.029 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.573 ' HG2' ' H ' ' A' ' 114' ' ' HIS . 8.5 tt0 -95.2 -172.51 2.69 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 177.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.573 ' H ' ' HG2' ' A' ' 113' ' ' GLN . 57.2 m80 77.87 -26.07 0.19 Allowed 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.9 m -66.81 -41.9 86.79 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 173.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 65.8 mt -74.23 -66.25 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.404 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.7 m -125.75 118.79 24.26 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -78.75 101.09 1.42 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.238 1.959 . . . . 0.0 111.002 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 56.5 mt -95.02 -71.15 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.508 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.0 m -71.28 -30.2 65.99 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.343 0.592 . . . . 0.0 110.554 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 85.9 mt -101.49 148.81 35.74 Favored Pre-proline 0 C--N 1.304 -1.399 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.104 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -77.43 -29.29 4.89 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.007 1.805 . . . . 0.0 113.109 -178.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 79.9 m -114.8 155.03 27.51 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.81 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 64.7 m -62.68 122.72 16.57 Favored 'General case' 0 C--O 1.241 0.606 0 O-C-N 123.982 0.802 . . . . 0.0 109.645 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.493 HD12 ' CD1' ' A' ' 44' ' ' PHE . 27.4 tp -74.11 134.56 42.89 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.724 -173.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -117.96 129.03 55.36 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.407 HG22 ' H ' ' A' ' 129' ' ' SER . 3.4 mp -93.29 132.98 29.24 Favored Pre-proline 0 C--O 1.193 -1.884 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -174.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.32 -32.51 81.56 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 C-N-CA 122.842 2.362 . . . . 0.0 112.898 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.407 ' H ' HG22 ' A' ' 127' ' ' ILE . 6.8 m -61.49 -29.82 70.22 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.847 0.859 . . . . 0.0 111.188 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 130' ' ' LYS . 6.9 tmtm? -151.32 92.2 1.76 Allowed 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.4 t70 . . . . . 0 C--N 1.284 -2.258 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 179.359 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.9 mtm . . . . . 0 N--CA 1.468 0.464 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -86.54 147.72 25.83 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 174.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -97.36 116.84 30.32 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.2 t60 73.22 142.41 0.06 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.214 1.006 . . . . 0.0 113.533 178.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 67.0 t60 -171.21 86.15 0.09 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.083 -1.417 . . . . 0.0 107.981 170.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.428 ' CE1' ' HB2' ' A' ' 8' ' ' SER . 13.6 t-80 -112.79 126.35 55.33 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -47.19 -54.14 11.43 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.081 0.952 . . . . 0.0 111.312 -177.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.428 ' HB2' ' CE1' ' A' ' 6' ' ' HIS . 4.5 m -68.64 -17.95 64.2 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -175.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.7 m -106.04 7.83 32.05 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.823 0.344 . . . . 0.0 110.813 -177.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.08 -31.49 0.33 Allowed Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.224 -0.989 . . . . 0.0 112.672 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 36.0 tp 60.07 45.11 12.3 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 122.59 1.186 . . . . 0.0 108.569 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.6 t -118.87 94.02 47.36 Favored Pre-proline 0 N--CA 1.437 -1.119 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.038 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -94.5 91.6 0.12 Allowed 'Trans proline' 0 N--CA 1.428 -2.351 0 C-N-CA 122.433 2.089 . . . . 0.0 110.587 175.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -87.9 -57.53 2.9 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 177.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -94.22 -90.26 1.65 Allowed Glycine 0 N--CA 1.407 -3.267 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 175.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.4 m 56.55 23.87 8.09 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 122.118 0.961 . . . . 0.0 110.498 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -119.85 155.66 32.2 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.457 -175.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 35.0 p -109.11 -7.2 15.36 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.739 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.401 ' HA ' ' CE2' ' A' ' 22' ' ' TRP . 48.3 p -53.38 -49.55 66.98 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -173.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -10.19 57.8 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 119.86 -0.736 . . . . 0.0 112.614 -177.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -83.34 -25.19 31.67 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.528 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.401 ' CE2' ' HA ' ' A' ' 19' ' ' SER . 27.0 p-90 -119.39 -22.09 7.19 Favored 'General case' 0 C--O 1.214 -0.795 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 52.1 t80 -90.97 112.77 24.8 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.775 -177.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.78 92.07 41.27 Favored Pre-proline 0 C--N 1.315 -0.929 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 175.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -57.64 -44.41 41.74 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 123.341 2.694 . . . . 0.0 115.942 -169.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -104.96 16.91 25.08 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.368 0.604 . . . . 0.0 111.364 -170.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.5 tp -74.62 146.25 42.6 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 85.4 p -93.0 166.66 12.26 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.96 -0.462 . . . . 0.0 110.257 -175.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -57.02 -49.41 75.88 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.939 0.399 . . . . 0.0 110.934 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -60.89 -34.82 75.24 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.296 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -75.87 -30.83 59.01 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.928 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.42 -43.14 77.81 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 75.8 mt -66.58 -40.22 85.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.624 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.21 -34.55 70.52 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.373 0.669 . . . . 0.0 111.104 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.72 -49.63 15.56 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.48 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 67.2 mt -68.49 -32.61 72.72 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -175.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -63.51 -21.54 66.38 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.065 0.459 . . . . 0.0 111.43 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -90.32 -10.14 45.18 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.275 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.65 -178.34 3.63 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.758 -174.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -99.96 160.72 26.47 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.111 -177.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -59.04 125.99 19.75 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 122.491 2.127 . . . . 0.0 111.673 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.51 -22.57 9.38 Favored Glycine 0 N--CA 1.43 -1.729 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.3 148.76 46.8 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.992 -0.374 . . . . 0.0 109.992 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -153.56 168.53 25.88 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.043 -175.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -153.15 152.43 31.26 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 172.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 23' ' ' TYR . 55.8 mt -121.98 133.19 69.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -127.02 -173.9 3.01 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -84.69 127.72 34.24 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 171.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.4 t -79.21 108.07 12.45 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -66.1 -6.53 13.48 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.75 -1.114 . . . . 0.0 113.912 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.1 p -77.62 -18.34 56.88 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.507 0.67 . . . . 0.0 110.977 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -135.83 -174.55 3.69 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -124.14 121.29 34.73 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.12 0.486 . . . . 0.0 109.918 172.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.04 43.65 8.05 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.37 159.33 41.36 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.529 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 50.5 m-85 -112.31 150.11 31.47 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.328 -176.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -126.76 116.45 2.5 Favored Glycine 0 C--N 1.282 -2.458 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 50.5 tp -94.77 123.24 38.11 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 123.144 0.578 . . . . 0.0 109.84 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -107.57 115.61 30.46 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 175.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.3 tp -110.79 127.52 55.41 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 123.491 0.494 . . . . 0.0 110.487 -177.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 26.7 tptp -88.64 115.49 26.2 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.4 m -106.96 164.91 4.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.66 -53.26 43.69 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.463 ' HB ' ' HG2' ' A' ' 66' ' ' PRO . 1.3 p -159.76 140.73 9.14 Favored Pre-proline 0 N--CA 1.423 -1.8 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 175.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.572 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 30.1 Cg_exo -56.7 -43.18 57.34 Favored 'Trans proline' 0 CA--C 1.571 2.327 0 C-N-CA 122.215 1.944 . . . . 0.0 112.704 175.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.572 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 43.5 Cg_endo -62.81 153.4 72.93 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.182 2.588 . . . . 0.0 110.426 171.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -57.31 -45.35 35.49 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.524 2.149 . . . . 0.0 112.632 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.9 m -133.44 1.32 3.42 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.511 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 60.16 38.22 20.36 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.828 0.851 . . . . 0.0 111.856 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -54.74 -49.74 89.77 Favored Pre-proline 0 CA--C 1.552 1.055 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.933 177.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -78.0 139.83 17.58 Favored 'Trans proline' 0 C--N 1.366 1.479 0 CA-C-N 120.253 1.126 . . . . 0.0 111.406 173.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -96.47 136.62 36.72 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -132.68 -12.22 3.02 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.038 0.447 . . . . 0.0 110.502 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.48 56.12 4.38 Favored Glycine 0 CA--C 1.493 -1.299 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -175.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -83.63 132.86 47.95 Favored Pre-proline 0 C--N 1.289 -2.024 0 C-N-CA 123.563 0.745 . . . . 0.0 111.395 -175.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -81.93 166.84 16.73 Favored 'Trans proline' 0 N--CA 1.445 -1.327 0 C-N-CA 122.122 1.881 . . . . 0.0 111.827 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.8 p -61.2 -24.47 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.486 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -65.26 -26.67 68.19 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.957 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -82.35 -27.73 32.01 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.109 0.48 . . . . 0.0 109.957 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.0 mt -74.72 -11.7 60.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.553 0.692 . . . . 0.0 110.367 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.2 t -103.15 118.47 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -100.36 129.78 46.38 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 -178.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -107.24 121.76 45.18 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 121.038 0.447 . . . . 0.0 109.8 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -127.79 118.37 23.61 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.2 pp -96.24 139.34 32.53 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.111 -177.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.529 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 76.9 mt -99.97 129.24 50.94 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 CA-C-N 114.402 -1.272 . . . . 0.0 107.935 -177.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.6 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 35.3 mt-10 -99.11 157.38 16.4 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -177.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 92' ' ' GLY . 4.4 t -147.54 128.89 14.84 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 175.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.39 -141.9 3.67 Favored Glycine 0 N--CA 1.426 -2.013 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.389 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.62 -47.63 25.72 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.723 2.949 . . . . 0.0 113.108 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -74.57 -60.73 2.15 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.584 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 167.46 -146.17 10.44 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 119.976 -1.107 . . . . 0.0 111.627 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.6 ' HA ' ' O ' ' A' ' 87' ' ' GLU . 22.0 m -104.9 149.36 8.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 O-C-N 124.007 0.475 . . . . 0.0 111.078 -175.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.89 157.64 3.04 Favored 'General case' 0 C--O 1.252 1.187 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 172.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 71.9 mt -76.17 129.15 37.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-O 121.959 0.885 . . . . 0.0 112.35 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -69.77 121.17 16.72 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.55 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 109.72 -1.16 30.47 Favored Glycine 0 C--N 1.306 -1.118 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 101' ' ' GLU . 37.9 t -108.81 110.26 61.12 Favored Pre-proline 0 N--CA 1.431 -1.396 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -96.45 21.24 0.43 Allowed 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.098 2.532 . . . . 0.0 112.671 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.5 m -138.13 31.91 2.4 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.852 0.834 . . . . 0.0 109.093 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.612 ' HB2' ' SG ' ' A' ' 98' ' ' CYS . 29.7 tt0 -134.46 123.5 16.49 Favored Pre-proline 0 N--CA 1.426 -1.675 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.588 -173.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.37 174.76 12.26 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.594 2.196 . . . . 0.0 112.076 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -86.25 129.03 34.98 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -106.93 172.78 6.63 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -98.41 -54.8 1.14 Allowed Glycine 0 C--N 1.304 -1.225 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.103 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.5 m -105.95 153.78 21.5 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 123.128 0.571 . . . . 0.0 110.028 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.428 HD21 ' CD2' ' A' ' 56' ' ' TYR . 92.6 mt -65.35 -36.19 83.25 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.049 0.452 . . . . 0.0 110.041 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.8 m -53.05 -29.25 28.84 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.001 0.92 . . . . 0.0 112.697 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.73 -41.83 74.75 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.405 HD13 ' H ' ' A' ' 110' ' ' LEU 0.306 0.0 OUTLIER -80.07 -32.36 39.31 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.215 177.285 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.407 ' HA ' ' CD2' ' A' ' 125' ' ' LEU . 67.6 t -57.08 -42.68 79.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.307 0.575 . . . . 0.0 110.91 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.8 p -72.15 -33.44 67.74 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.984 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -80.01 -36.35 36.02 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.502 ' HA ' ' O ' ' A' ' 117' ' ' SER . 27.9 m-70 -71.65 -5.47 33.89 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -174.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.8 m -73.33 -30.08 63.11 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 172.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.417 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 52.9 mt -101.03 -52.16 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.109 -177.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 38.8 t -111.72 95.87 30.11 Favored Pre-proline 0 N--CA 1.424 -1.773 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.036 -175.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 116' ' ' ILE . 5.8 Cg_endo -85.78 74.54 3.43 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 122.733 2.289 . . . . 0.0 109.942 178.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.1 mt -66.19 -56.24 15.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.861 -175.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.573 ' HB3' ' SG ' ' A' ' 98' ' ' CYS . 2.4 p -96.31 6.18 49.34 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.081 -177.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 69.2 mt -123.49 140.84 34.89 Favored Pre-proline 0 C--N 1.308 -1.199 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.755 -173.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.03 -8.44 15.45 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.576 2.184 . . . . 0.0 112.033 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 77.1 m -140.29 168.81 18.93 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 59.3 m -79.21 145.76 33.45 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 120.733 0.301 . . . . 0.0 110.27 -178.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.407 ' CD2' ' HA ' ' A' ' 111' ' ' VAL . 15.5 tp -85.6 108.73 18.12 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -106.65 107.47 18.5 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.54 0.686 . . . . 0.0 111.721 -174.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 58.2 mt -65.74 120.92 72.64 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.763 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.7 -60.95 0.21 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.246 1.964 . . . . 0.0 111.735 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.4 t 60.31 18.37 7.94 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.193 0.997 . . . . 0.0 110.631 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -148.66 143.38 26.46 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.651 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 . . . . . 0 C--N 1.298 -1.655 0 C-N-CA 124.223 1.009 . . . . 0.0 109.234 175.615 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 ttm . . . . . 0 C--O 1.233 0.233 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -95.54 -11.69 26.98 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -175.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -83.99 112.93 20.63 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 173.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 82.1 t60 66.56 104.77 0.04 OUTLIER 'General case' 0 C--O 1.238 0.461 0 O-C-N 124.309 1.005 . . . . 0.0 111.183 -176.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -125.61 88.77 2.92 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.904 0.859 . . . . 0.0 110.684 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -78.75 -69.71 0.55 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.994 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -121.5 35.12 4.97 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 122.673 1.225 . . . . 0.0 108.178 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.8 t -88.69 84.59 6.71 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 174.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.6 p -109.56 104.76 13.85 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.976 -174.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.83 -35.93 43.76 Favored Glycine 0 CA--C 1.496 -1.118 0 N-CA-C 108.195 -1.962 . . . . 0.0 108.195 174.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.09 98.15 7.9 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 174.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.1 m -77.44 154.93 81.77 Favored Pre-proline 0 C--N 1.308 -1.23 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.466 -176.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.71 154.26 74.6 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 122.513 2.142 . . . . 0.0 110.915 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -64.79 118.17 8.59 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.366 -176.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.4 -33.48 5.52 Favored Glycine 0 N--CA 1.429 -1.801 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.988 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.7 m 57.7 33.66 23.51 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.902 0.881 . . . . 0.0 110.902 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -72.2 100.39 2.57 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 122.594 1.188 . . . . 0.0 112.297 -175.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.2 t -125.93 -4.83 6.9 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.512 177.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.452 ' HA ' ' CE2' ' A' ' 22' ' ' TRP . 27.1 m -66.77 -22.25 66.04 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.501 177.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.72 0.46 5.54 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.882 -1.054 . . . . 0.0 113.076 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -94.52 -27.12 16.13 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 122.233 -0.292 . . . . 0.0 110.486 174.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.452 ' CE2' ' HA ' ' A' ' 19' ' ' SER . 31.0 p-90 -134.49 -8.24 2.52 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -170.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -96.75 114.39 26.03 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.029 -0.669 . . . . 0.0 111.327 -176.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -120.02 86.57 37.17 Favored Pre-proline 0 C--O 1.2 -1.528 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 176.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -54.11 -40.9 79.79 Favored 'Trans proline' 0 N--CA 1.479 0.628 0 C-N-CA 123.264 2.643 . . . . 0.0 115.936 -170.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -97.32 10.13 40.43 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -171.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.7 tp -75.61 136.81 40.47 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.454 0.645 . . . . 0.0 110.657 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.1 m -80.56 161.11 24.94 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.641 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -56.71 -51.42 68.87 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.275 0.63 . . . . 0.0 110.961 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -59.46 -44.66 92.93 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.583 0.706 . . . . 0.0 110.909 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -69.81 -30.53 68.07 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.863 -176.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.52 -36.97 82.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.667 0.746 . . . . 0.0 110.306 178.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 72.4 mt -69.73 -40.23 78.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.593 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.76 -33.31 73.86 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.789 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.87 -36.14 75.25 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.569 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.448 ' HB3' ' HG2' ' A' ' 61' ' ' LYS . 63.8 mt -87.85 -22.33 24.51 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -71.3 -9.42 58.09 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.571 0.7 . . . . 0.0 110.594 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -91.89 -25.18 19.06 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.43 174.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -106.71 155.58 19.52 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -169.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -66.07 156.5 84.16 Favored Pre-proline 0 C--N 1.32 -0.696 0 C-N-CA 125.334 1.454 . . . . 0.0 113.321 -172.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.24 111.96 1.26 Allowed 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 122.876 2.384 . . . . 0.0 111.045 175.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.05 -18.21 5.33 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -176.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.77 147.36 35.35 Favored 'General case' 0 C--O 1.251 1.146 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 177.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -153.17 169.48 22.9 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -175.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -160.35 154.33 22.98 Favored 'General case' 0 C--O 1.254 1.307 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 173.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 56.9 mt -126.8 137.61 57.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 123.354 0.409 . . . . 0.0 109.922 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.475 HH22 ' CD2' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -134.67 177.9 7.42 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 177.125 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -74.08 130.02 38.99 Favored 'General case' 0 C--O 1.249 1.034 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 175.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.0 t -82.56 92.76 7.17 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-O 121.526 0.679 . . . . 0.0 109.242 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -75.44 76.36 2.5 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-O 122.322 1.058 . . . . 0.0 108.782 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.5 t -161.87 -40.97 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 112.804 -1.998 . . . . 0.0 107.877 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -135.93 142.98 44.7 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -76.84 133.79 39.24 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.273 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.13 37.36 28.92 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.62 143.51 47.36 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -115.55 133.26 56.2 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.44 ' O ' ' HD3' ' A' ' 47' ' ' ARG . . . -97.83 119.14 6.32 Favored Glycine 0 C--N 1.283 -2.376 0 C-N-CA 119.836 -1.173 . . . . 0.0 112.018 -176.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 48.3 tp -97.4 136.08 38.36 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -122.04 129.97 52.88 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.4 tp -127.59 132.05 49.86 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 123.505 0.503 . . . . 0.0 110.957 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.448 ' HG2' ' HB3' ' A' ' 36' ' ' LEU . 0.7 OUTLIER -88.55 115.61 26.2 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 174.716 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.7 m -102.29 171.85 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.85 -56.09 6.36 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 p -152.57 137.6 11.03 Favored Pre-proline 0 N--CA 1.435 -1.204 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.477 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.642 ' HD2' ' CD ' ' A' ' 66' ' ' PRO . 16.6 Cg_exo -65.51 -44.7 8.14 Favored 'Trans proline' 0 CA--C 1.568 2.19 0 C-N-CA 121.625 1.55 . . . . 0.0 110.91 173.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.642 ' CD ' ' HD2' ' A' ' 65' ' ' PRO . 14.8 Cg_exo -71.14 165.6 31.9 Favored 'Trans proline' 0 C--N 1.397 3.098 0 C-N-CA 122.219 1.946 . . . . 0.0 109.87 168.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -50.58 -35.63 47.13 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.472 2.781 . . . . 0.0 112.953 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 65.2 m -151.7 -13.39 0.2 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 63.36 41.17 7.88 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.857 0.863 . . . . 0.0 111.835 175.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -58.88 -51.8 79.27 Favored Pre-proline 0 CA--C 1.553 1.082 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.269 171.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.4 127.91 21.17 Favored 'Trans proline' 0 C--N 1.387 2.578 0 C-N-CA 122.072 1.848 . . . . 0.0 112.049 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -98.98 139.48 34.56 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.195 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -136.79 16.43 3.08 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.173 0.589 . . . . 0.0 110.067 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.34 64.53 1.76 Allowed Glycine 0 CA--C 1.486 -1.752 0 N-CA-C 107.024 -2.43 . . . . 0.0 107.024 -172.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -104.58 103.19 38.55 Favored Pre-proline 0 C--N 1.301 -1.524 0 CA-C-N 114.953 -0.623 . . . . 0.0 110.358 -172.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.505 ' HB2' ' OE1' ' A' ' 78' ' ' GLU . 71.7 Cg_endo -78.8 175.53 10.88 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.052 1.835 . . . . 0.0 111.236 177.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 p -68.96 -28.2 38.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.568 0.699 . . . . 0.0 110.589 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.505 ' OE1' ' HB2' ' A' ' 76' ' ' PRO . 11.7 mp0 -66.52 -22.09 66.17 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.172 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -78.03 -18.16 56.18 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.651 0.738 . . . . 0.0 109.607 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.0 mt -84.13 -4.16 58.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.427 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.0 t -92.72 118.73 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -90.85 145.78 24.48 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.475 ' CD2' HH22 ' A' ' 47' ' ' ARG . 29.7 m80 -120.52 125.56 48.16 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.195 0.521 . . . . 0.0 111.793 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -138.32 131.96 30.87 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -104.83 142.36 34.86 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.893 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.6 mp -98.83 123.59 51.53 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.083 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.405 ' OE1' ' HD3' ' A' ' 96' ' ' LYS . 48.5 mt-10 -98.86 139.76 34.06 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.46 ' HB ' HG23 ' A' ' 93' ' ' VAL . 12.1 t -133.35 153.41 51.62 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.33 -152.21 11.33 Favored Glycine 0 N--CA 1.42 -2.415 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.73 -13.14 37.81 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.662 2.241 . . . . 0.0 112.669 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -86.62 -6.84 58.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.329 0.585 . . . . 0.0 110.6 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 109.42 -140.32 15.66 Favored Glycine 0 N--CA 1.427 -1.924 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.46 HG23 ' HB ' ' A' ' 88' ' ' THR . 12.5 p -132.28 126.3 55.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -146.77 140.99 26.25 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.391 -0.818 . . . . 0.0 112.969 -176.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.4 mt -72.04 126.75 33.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.562 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.405 ' HD3' ' OE1' ' A' ' 87' ' ' GLU . 25.7 tptp -76.01 97.91 4.15 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.498 ' O ' ' HD3' ' A' ' 99' ' ' PRO . . . 135.81 4.12 2.46 Favored Glycine 0 N--CA 1.425 -2.084 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.505 -176.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 46.0 t -93.23 104.79 13.09 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 97' ' ' GLY . 72.8 Cg_endo -89.64 -10.23 3.77 Favored 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 121.878 1.718 . . . . 0.0 112.419 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.4 t -71.16 -75.17 0.13 Allowed 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 176.32 103.9 0.1 Allowed Pre-proline 0 C--O 1.234 0.277 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.412 ' HB2' ' HB2' ' A' ' 94' ' ' LYS . 23.3 Cg_endo -96.25 -128.18 0.01 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.887 0 C-N-CA 122.841 2.361 . . . . 0.0 112.435 177.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 62.43 86.87 0.11 Allowed 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 125.55 1.54 . . . . 0.0 111.231 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -110.7 177.38 4.69 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 113.955 -1.475 . . . . 0.0 108.722 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -88.13 -48.01 4.22 Favored Glycine 0 C--N 1.314 -0.68 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.344 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.2 m -134.28 160.1 38.92 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 66.0 mt -56.84 -44.47 82.12 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.543 0.337 . . . . 0.0 111.389 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 32.3 t -54.91 -31.26 59.97 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.817 0.847 . . . . 0.0 111.102 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.33 -44.27 88.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.013 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.433 ' H ' HD11 ' A' ' 110' ' ' LEU 0.302 0.0 OUTLIER -80.26 -31.17 38.47 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 119.146 -1.021 . . . . 0.0 112.01 177.608 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.7 t -61.87 -54.2 37.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.169 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.1 t -70.5 -31.62 68.79 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -174.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -68.65 -25.91 65.06 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.726 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.418 ' CD2' ' H ' ' A' ' 119' ' ' ILE . 45.7 m80 -77.37 -0.98 27.76 Favored 'General case' 0 C--O 1.214 -0.814 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 35.1 m -78.42 -29.28 47.06 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 172.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 61.2 mt -96.66 -59.51 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.086 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.2 m -114.07 110.51 48.5 Favored Pre-proline 0 N--CA 1.428 -1.535 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.404 -175.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -75.13 98.37 1.16 Allowed 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 121.802 1.668 . . . . 0.0 109.603 174.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.418 ' H ' ' CD2' ' A' ' 114' ' ' HIS . 62.3 mt -91.67 -68.78 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.1 -176.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.0 t -90.37 -11.39 40.72 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.269 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 60.0 mt -117.69 144.44 34.35 Favored Pre-proline 0 C--N 1.295 -1.773 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -175.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -72.28 -24.01 20.23 Favored 'Trans proline' 0 N--CA 1.477 0.52 0 C-N-CA 122.767 2.311 . . . . 0.0 113.143 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 71.9 m -119.47 162.43 18.87 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 81.0 m -86.64 143.23 27.72 Favored 'General case' 0 N--CA 1.429 -1.522 0 O-C-N 123.467 0.479 . . . . 0.0 109.793 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 75.8 mt -76.44 118.82 19.52 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -95.08 98.83 10.94 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.445 HG23 ' H ' ' A' ' 129' ' ' SER . 13.8 mt -97.8 134.16 22.63 Favored Pre-proline 0 C--N 1.276 -2.616 0 CA-C-N 113.822 -1.536 . . . . 0.0 109.0 -172.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -57.57 -20.75 43.06 Favored 'Trans proline' 0 N--CA 1.484 0.926 0 C-N-CA 123.265 2.643 . . . . 0.0 112.131 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.445 ' H ' HG23 ' A' ' 127' ' ' ILE . 22.5 t -64.17 -33.72 76.44 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.267 176.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -108.24 119.57 39.88 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -176.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.6 t70 . . . . . 0 C--N 1.294 -1.821 0 CA-C-O 118.493 -0.765 . . . . 0.0 109.645 -179.941 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 CA--C 1.509 -0.634 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -90.21 129.63 36.44 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 173.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 -91.09 -22.3 20.78 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-O 121.159 0.504 . . . . 0.0 110.274 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -114.51 131.57 56.6 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.176 -176.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -92.64 101.31 13.72 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -106.97 -51.72 2.88 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.963 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -106.68 -15.98 14.62 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.974 0.416 . . . . 0.0 111.4 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.9 t -88.64 103.39 15.88 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 175.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.0 m -89.55 -28.79 19.36 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.555 -177.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.06 -126.77 10.53 Favored Glycine 0 N--CA 1.438 -1.188 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -175.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -121.72 86.58 2.6 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 120.941 0.4 . . . . 0.0 109.971 176.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.9 t -80.15 -66.67 0.25 Allowed Pre-proline 0 CA--C 1.546 0.814 0 CA-C-O 119.104 -0.474 . . . . 0.0 111.53 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -70.03 -37.1 8.96 Favored 'Trans proline' 0 C--N 1.376 2.005 0 CA-C-N 120.412 1.183 . . . . 0.0 112.002 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 53.39 175.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 126.446 1.899 . . . . 0.0 111.998 -176.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -135.83 -119.43 1.89 Allowed Glycine 0 N--CA 1.408 -3.197 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 176.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.0 m -136.06 19.04 3.21 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -85.97 81.74 8.39 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.566 -179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.7 p -113.01 2.35 15.71 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 122.068 0.937 . . . . 0.0 109.989 -177.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.9 m -70.66 -33.97 71.53 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.819 -173.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -7.51 33.69 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.371 -178.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -74.74 -36.15 62.63 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.897 0.38 . . . . 0.0 110.711 177.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.403 ' CZ3' HD13 ' A' ' 46' ' ' ILE . 36.6 p-90 -103.56 -14.17 16.28 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.165 0.507 . . . . 0.0 111.789 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -94.31 112.58 24.38 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.471 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -127.08 91.62 46.29 Favored Pre-proline 0 C--N 1.312 -1.062 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 175.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.12 -7.67 21.43 Favored 'Trans proline' 0 C--N 1.331 -0.353 0 C-N-CA 122.377 2.051 . . . . 0.0 112.835 -175.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -100.37 -15.3 18.02 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.18 -176.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.5 tp -81.67 120.9 25.68 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.308 -168.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 m -76.72 165.43 24.74 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.939 -177.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -54.63 -50.99 66.8 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -174.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -65.82 -29.68 70.19 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.338 0.59 . . . . 0.0 111.384 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -77.09 -35.96 56.09 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.616 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.36 -41.38 98.84 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.765 176.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.406 ' HA ' HG23 ' A' ' 81' ' ' VAL . 87.0 mt -66.31 -45.33 89.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.86 177.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.07 -27.95 69.26 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.184 0.516 . . . . 0.0 111.911 178.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.44 -49.31 12.51 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 6.7 mp -70.33 -26.56 63.82 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -177.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -70.25 -13.14 62.04 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.446 0.641 . . . . 0.0 109.869 176.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -97.34 -32.72 11.74 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.495 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -85.54 -10.49 55.89 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -172.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.5 t70 73.1 148.59 0.12 Allowed Pre-proline 0 N--CA 1.506 2.339 0 O-C-N 123.532 0.52 . . . . 0.0 111.905 175.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 61' ' ' LYS . 88.1 Cg_exo -45.52 118.96 2.4 Favored 'Trans proline' 0 C--N 1.389 2.711 0 C-N-CA 123.726 2.95 . . . . 0.0 115.014 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.87 -35.25 2.22 Favored Glycine 0 N--CA 1.427 -1.959 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.039 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.98 144.1 50.62 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-O 121.153 0.501 . . . . 0.0 111.194 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -145.18 165.94 26.87 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -154.55 157.11 37.8 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 172.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.403 HD13 ' CZ3' ' A' ' 22' ' ' TRP . 65.5 mt -122.75 128.71 75.36 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.1 ptt-85 -121.72 179.69 4.4 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -95.49 130.99 42.13 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.1 m -89.78 136.95 32.74 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 120.762 0.315 . . . . 0.0 110.287 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -91.58 -23.55 19.86 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.1 t -71.93 -35.59 69.67 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.728 -176.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -128.43 149.38 50.59 Favored 'General case' 0 C--O 1.242 0.7 0 O-C-N 121.985 -0.447 . . . . 0.0 110.187 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -82.81 120.78 26.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.595 -176.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.58 29.97 57.08 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.565 178.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -113.86 133.84 55.17 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.446 ' CD2' HD23 ' A' ' 107' ' ' LEU . 44.7 m-85 -107.87 124.66 50.43 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.74 114.63 4.48 Favored Glycine 0 C--N 1.286 -2.211 0 C-N-CA 120.075 -1.059 . . . . 0.0 111.226 -176.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.3 tp -92.35 128.97 38.39 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -118.86 127.73 53.79 Favored 'General case' 0 C--N 1.282 -2.37 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 175.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.4 tp -123.01 131.85 53.88 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 123.522 0.514 . . . . 0.0 109.946 -177.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 41' ' ' PRO . 27.2 tptp -87.89 114.51 24.57 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.434 HG22 ' HE ' ' A' ' 82' ' ' ARG . 23.6 m -108.08 172.33 2.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.386 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.59 -48.63 21.49 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -163.21 143.72 7.16 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 123.142 0.577 . . . . 0.0 111.859 -178.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.579 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 37.4 Cg_exo -63.71 -46.97 7.88 Favored 'Trans proline' 0 CA--C 1.578 2.709 0 C-N-CA 121.774 1.65 . . . . 0.0 111.316 164.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.579 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 81.3 Cg_endo -71.66 171.22 16.82 Favored 'Trans proline' 0 C--N 1.398 3.146 0 C-N-CA 123.057 2.505 . . . . 0.0 109.05 171.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -66.45 -60.43 0.11 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 121.532 1.488 . . . . 0.0 112.205 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.1 p -123.23 -7.1 8.25 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.677 -178.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 64.19 33.73 11.54 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.225 1.01 . . . . 0.0 111.117 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.407 ' HB2' ' HD3' ' A' ' 71' ' ' PRO . 28.1 mt-30 -60.66 -46.97 97.19 Favored Pre-proline 0 CA--C 1.553 1.072 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.25 175.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.407 ' HD3' ' HB2' ' A' ' 70' ' ' GLN . 2.3 Cg_endo -84.99 108.01 1.13 Allowed 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 121.496 1.464 . . . . 0.0 109.539 172.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 49.0 t-105 -93.44 141.21 28.71 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.722 -176.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -119.26 -53.51 2.24 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.489 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 161.17 56.91 0.02 OUTLIER Glycine 0 CA--C 1.471 -2.7 0 N-CA-C 107.622 -2.191 . . . . 0.0 107.622 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -88.33 113.48 55.43 Favored Pre-proline 0 C--N 1.288 -2.098 0 CA-C-N 113.515 -1.342 . . . . 0.0 111.925 -171.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -85.66 164.42 10.64 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.195 1.93 . . . . 0.0 111.868 176.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.9 p -60.7 -19.73 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 121.597 0.713 . . . . 0.0 110.779 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -63.5 -21.72 66.48 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 123.951 0.9 . . . . 0.0 111.297 178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -92.82 -13.9 28.51 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 121.066 0.46 . . . . 0.0 110.902 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.9 mt -82.53 -8.54 59.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.968 0.89 . . . . 0.0 109.534 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.406 HG23 ' HA ' ' A' ' 33' ' ' ILE . 89.9 t -109.49 107.82 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.998 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 174.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.512 ' NH2' ' HA ' ' A' ' 65' ' ' PRO . 77.4 mtt180 -87.27 147.75 25.4 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.177 -177.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -123.73 122.61 38.52 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.14 -175.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -130.99 156.49 45.03 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.35 133.45 52.56 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.765 178.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.43 HG12 HG12 ' A' ' 95' ' ' ILE . 78.0 mt -94.31 113.98 30.0 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.432 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.203 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.83 128.22 46.96 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.496 ' HB ' HG11 ' A' ' 93' ' ' VAL . 9.3 t -99.62 115.82 30.3 Favored 'General case' 0 N--CA 1.413 -2.296 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 176.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -115.13 -170.08 16.18 Favored Glycine 0 N--CA 1.42 -2.414 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -177.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.65 -20.83 69.8 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.038 2.492 . . . . 0.0 112.92 -178.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -87.76 -39.74 14.66 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.923 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 158.97 -158.2 29.2 Favored Glycine 0 N--CA 1.431 -1.645 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 -177.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.496 HG11 ' HB ' ' A' ' 88' ' ' THR . 6.4 m -103.37 130.95 52.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -177.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.72 154.39 48.56 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.628 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.43 HG12 HG12 ' A' ' 86' ' ' ILE . 33.7 mt -94.06 130.42 43.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.439 0.638 . . . . 0.0 110.896 -174.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -102.03 143.77 31.46 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.337 176.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 105.1 8.15 36.72 Favored Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 -172.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 59.4 m -121.23 153.06 58.11 Favored Pre-proline 0 N--CA 1.423 -1.818 0 CA-C-N 114.105 -1.048 . . . . 0.0 109.395 -176.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -57.52 -58.39 0.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.153 1.902 . . . . 0.0 110.424 176.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.8 m -162.55 108.86 1.23 Allowed 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 122.839 0.456 . . . . 0.0 110.371 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.422 ' OE2' ' HB ' ' A' ' 119' ' ' ILE . 51.4 mt-10 -128.89 133.49 25.27 Favored Pre-proline 0 C--N 1.299 -1.593 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.96 176.53 6.04 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.603 2.869 . . . . 0.0 115.775 -170.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -87.79 113.48 23.49 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.642 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -90.48 161.75 15.37 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.98 -58.21 9.39 Favored Glycine 0 CA--C 1.509 -0.309 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.486 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.5 m -136.78 171.85 13.88 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.446 HD23 ' CD2' ' A' ' 56' ' ' TYR . 95.1 mt -53.5 -47.2 70.07 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.643 0.589 . . . . 0.0 110.654 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.7 m -52.95 -29.65 30.05 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.592 1.157 . . . . 0.0 112.747 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.43 -36.93 71.46 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 120.889 0.376 . . . . 0.0 111.306 -177.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 107' ' ' LEU . 4.2 pp -80.1 -21.66 43.02 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.599 0.714 . . . . 0.0 110.06 178.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 107' ' ' LEU . 88.1 t -70.68 -42.9 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.416 176.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.6 p -72.96 -44.55 60.99 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 122.16 -0.338 . . . . 0.0 111.349 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -77.76 12.33 1.74 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 35.0 p-80 -53.96 -35.1 61.42 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.182 1.393 . . . . 0.0 111.16 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 41.9 p -98.87 -4.06 33.89 Favored 'General case' 0 N--CA 1.401 -2.889 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.461 -172.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 52.2 mt -106.31 -42.79 6.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.25 -175.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.3 t -135.93 81.14 40.53 Favored Pre-proline 0 N--CA 1.435 -1.222 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.986 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -98.03 96.07 0.07 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.033 0 C-N-CA 122.425 2.083 . . . . 0.0 109.054 172.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.422 ' HB ' ' OE2' ' A' ' 101' ' ' GLU . 58.6 mt -90.89 -57.06 4.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.856 -175.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 27.6 t -91.76 -30.83 16.03 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.923 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.53 118.59 55.41 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.621 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.464 ' HG3' ' CZ ' ' A' ' 82' ' ' ARG . 89.4 Cg_endo -83.02 -3.89 11.14 Favored 'Trans proline' 0 C--O 1.243 0.735 0 C-N-CA 123.022 2.482 . . . . 0.0 112.265 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 84.8 m -145.32 149.26 34.5 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 79.0 m -88.93 148.4 23.83 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 58.7 mt -70.3 107.27 3.68 Favored 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.513 -175.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -80.2 99.78 7.97 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.859 -0.526 . . . . 0.0 110.168 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.451 ' H ' HD13 ' A' ' 127' ' ' ILE . 3.9 mp -71.12 121.77 85.11 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.79 -177.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.47 -15.17 41.44 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 123.087 2.525 . . . . 0.0 113.381 -177.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.426 ' H ' HG23 ' A' ' 127' ' ' ILE . 23.2 t -103.73 -6.45 21.5 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.59 -1.187 . . . . 0.0 111.859 -178.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.424 ' HB2' ' HB ' ' A' ' 127' ' ' ILE . 74.8 mmtt -124.7 139.4 53.89 Favored 'General case' 0 CA--C 1.489 -1.368 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.895 -176.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.1 t70 . . . . . 0 C--N 1.285 -2.238 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.661 179.128 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.464 0.236 0 CA-C-O 120.442 0.163 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -100.87 132.9 46.05 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.2 p-80 -103.96 158.53 16.35 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.015 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -72.49 132.13 43.45 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 173.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -91.59 -13.36 32.1 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.29 0.567 . . . . 0.0 111.516 -175.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -139.01 168.15 20.47 Favored 'General case' 0 C--O 1.25 1.115 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 176.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -110.05 166.37 11.0 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 120.839 0.352 . . . . 0.0 110.562 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 64.6 m -154.21 120.33 5.35 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.0 t -73.69 -33.53 64.45 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.518 177.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.79 -67.86 3.49 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.349 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.5 tp -85.05 67.25 10.13 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 122.374 1.083 . . . . 0.0 111.558 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.8 t -117.35 -58.22 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.793 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 173.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -79.2 141.02 16.0 Favored 'Trans proline' 0 N--CA 1.434 -1.972 0 N-CA-C 109.86 -0.861 . . . . 0.0 109.86 169.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -94.46 -41.1 9.55 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 176.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.12 -105.02 0.33 Allowed Glycine 0 N--CA 1.417 -2.574 0 CA-C-N 113.711 -1.586 . . . . 0.0 109.605 175.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.402 ' C ' ' H ' ' A' ' 18' ' ' THR . 44.8 m -93.67 46.85 1.2 Allowed 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.919 0.866 . . . . 0.0 110.9 -177.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -79.02 28.56 0.22 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.12 1.368 . . . . 0.0 111.947 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.402 ' H ' ' C ' ' A' ' 16' ' ' SER . 3.6 p -93.47 19.67 8.14 Favored 'General case' 0 C--N 1.273 -2.756 0 CA-C-O 121.519 0.676 . . . . 0.0 110.314 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.417 ' HA ' ' NE1' ' A' ' 22' ' ' TRP . 18.4 m -73.01 -28.76 62.56 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.761 -177.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.28 -10.12 59.23 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.689 0.757 . . . . 0.0 110.769 177.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -76.92 -21.1 55.35 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.258 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.417 ' NE1' ' HA ' ' A' ' 19' ' ' SER . 47.0 p-90 -113.67 -31.46 6.47 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 177.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.478 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 42.1 t80 -86.26 116.85 24.7 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.001 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -125.81 84.85 60.14 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.425 ' HD3' ' CD2' ' A' ' 23' ' ' TYR . 9.3 Cg_endo -54.4 -46.59 32.31 Favored 'Trans proline' 0 C--N 1.333 -0.282 0 C-N-CA 122.786 2.324 . . . . 0.0 115.818 -171.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -97.84 13.86 29.09 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -173.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.544 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 15.2 tp -83.3 145.84 28.86 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.504 -178.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.2 t -96.89 169.65 9.7 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -58.81 -50.32 74.42 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 123.524 0.729 . . . . 0.0 111.736 -175.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -58.34 -40.29 81.78 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.122 0.487 . . . . 0.0 111.083 -177.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -74.98 -29.91 61.03 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.872 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.92 -43.48 83.22 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.966 -0.754 . . . . 0.0 108.966 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 77.3 mt -66.24 -39.12 83.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.248 177.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.52 -32.24 70.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.782 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.401 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 49.8 mt -73.15 -47.06 47.15 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.569 0.699 . . . . 0.0 110.61 173.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.505 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 67.8 mt -69.68 -18.36 63.55 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -177.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.406 ' HB3' HG23 ' A' ' 77' ' ' VAL . 21.0 ptmt -84.28 -0.67 53.29 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.346 0.593 . . . . 0.0 110.073 176.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -114.05 -43.12 3.27 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.111 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 35' ' ' LEU . 43.3 mtpt -74.77 162.99 28.17 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.421 -176.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -70.22 138.48 86.98 Favored Pre-proline 0 C--N 1.308 -1.204 0 C-N-CA 124.212 1.005 . . . . 0.0 111.827 -174.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -57.28 114.04 1.76 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.676 2.251 . . . . 0.0 111.413 175.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.27 -22.69 3.94 Favored Glycine 0 N--CA 1.425 -2.077 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 -174.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.42 158.55 28.67 Favored 'General case' 0 C--O 1.251 1.181 0 CA-C-N 115.029 -0.585 . . . . 0.0 109.908 177.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -152.47 176.23 11.89 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -175.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -156.38 154.83 31.14 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 170.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 23' ' ' TYR . 66.6 mt -125.02 130.54 73.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.544 ' HD2' ' O ' ' A' ' 27' ' ' LEU . 28.1 ptt85 -133.05 171.27 14.21 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -72.82 132.03 43.05 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 171.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.5 m -67.81 -32.77 73.56 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 -177.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 39.9 m-70 71.91 -39.59 0.45 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.321 1.048 . . . . 0.0 113.167 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.2 m -58.59 -41.44 85.76 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 123.795 0.838 . . . . 0.0 111.18 178.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.49 150.7 45.49 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -84.56 135.02 34.38 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.65 38.45 50.84 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -177.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.55 133.16 39.96 Favored 'General case' 0 C--O 1.249 1.028 0 CA-C-O 120.891 0.377 . . . . 0.0 110.394 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -116.73 126.83 53.71 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -91.39 114.15 4.45 Favored Glycine 0 C--N 1.288 -2.084 0 C-N-CA 120.148 -1.025 . . . . 0.0 111.324 -177.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.401 ' HB3' ' O ' ' A' ' 84' ' ' PHE . 2.2 tm? -92.08 117.77 30.16 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.65 115.73 30.43 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.4 tp -110.64 123.76 50.61 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.303 -177.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.505 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 22.3 tptm -91.23 114.35 26.85 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 176.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 80' ' ' LEU . 18.2 m -104.17 170.65 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.25 -58.28 5.13 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 p -161.85 124.15 1.73 Allowed Pre-proline 0 C--N 1.312 -1.06 0 C-N-CA 124.521 1.128 . . . . 0.0 108.713 176.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.573 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 35.6 Cg_exo -59.68 -47.1 17.22 Favored 'Trans proline' 0 CA--C 1.578 2.678 0 C-N-CA 121.688 1.592 . . . . 0.0 111.947 174.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.573 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 74.8 Cg_endo -73.46 153.29 49.87 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 123.19 2.593 . . . . 0.0 110.756 173.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -63.79 -46.92 7.81 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.402 2.068 . . . . 0.0 112.567 177.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.6 p -119.74 -8.28 9.92 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 66.8 36.57 4.49 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 124.414 1.086 . . . . 0.0 113.237 177.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.422 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 73.8 mt-30 -63.61 -48.85 79.77 Favored Pre-proline 0 CA--C 1.565 1.519 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.339 172.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 70' ' ' GLN . 18.3 Cg_endo -62.45 113.38 1.91 Allowed 'Trans proline' 0 C--N 1.389 2.709 0 C-N-CA 122.04 1.827 . . . . 0.0 111.919 173.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 57.0 t-105 -115.17 146.49 41.34 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.354 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -127.05 -28.82 2.84 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.834 0.35 . . . . 0.0 111.689 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 133.32 -41.71 1.45 Allowed Glycine 0 CA--C 1.489 -1.536 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 78' ' ' GLU . 5.2 m-20 -68.11 118.56 59.97 Favored Pre-proline 0 C--N 1.299 -1.623 0 C-N-CA 123.862 0.865 . . . . 0.0 109.839 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.21 -79.64 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 121.902 1.735 . . . . 0.0 112.722 177.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.406 HG23 ' HB3' ' A' ' 37' ' ' LYS . 3.2 p -73.74 -28.31 24.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 120.943 0.402 . . . . 0.0 111.624 -177.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 53.1 mp0 -68.28 -19.72 64.72 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -78.62 -36.25 44.39 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 171.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.494 ' O ' HG23 ' A' ' 62' ' ' VAL . 49.5 mt -75.87 -25.71 56.41 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.838 -176.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 89.9 t -88.92 116.25 30.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -101.36 130.81 47.62 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -109.84 126.17 53.54 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.222 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.401 ' O ' ' HB3' ' A' ' 58' ' ' LEU . 98.0 m-85 -133.15 123.14 25.13 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 176.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.9 pp -96.84 131.95 43.08 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 118.709 -1.196 . . . . 0.0 111.113 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 79.7 mt -92.35 122.58 43.93 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 C-N-CA 124.568 1.147 . . . . 0.0 108.98 -178.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -99.84 146.82 26.18 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.451 ' HB ' HG12 ' A' ' 93' ' ' VAL . 9.7 t -127.88 142.27 51.32 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.41 -158.36 7.95 Favored Glycine 0 N--CA 1.433 -1.508 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -177.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.15 3.85 4.8 Favored 'Trans proline' 0 N--CA 1.482 0.847 0 C-N-CA 122.914 2.409 . . . . 0.0 113.566 -174.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -111.71 -42.1 3.9 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.89 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 158.9 -154.5 25.59 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.451 HG12 ' HB ' ' A' ' 88' ' ' THR . 10.7 m -104.02 147.66 9.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -178.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.9 pttp -146.07 141.98 28.12 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -176.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.2 mt -85.65 131.68 33.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -67.58 101.76 1.06 Allowed 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 102.37 45.56 1.68 Allowed Glycine 0 N--CA 1.429 -1.831 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.735 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.432 ' HB2' ' CD ' ' A' ' 101' ' ' GLU . 24.4 p -115.57 124.25 30.25 Favored Pre-proline 0 C--N 1.312 -1.049 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 177.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.93 -44.06 2.17 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.54 2.16 . . . . 0.0 115.316 -175.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.9 m -120.36 -16.37 8.43 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.833 -172.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.432 ' CD ' ' HB2' ' A' ' 98' ' ' CYS . 5.4 mp0 -60.34 125.21 81.26 Favored Pre-proline 0 C--N 1.3 -1.56 0 C-N-CA 123.276 0.631 . . . . 0.0 112.27 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -87.05 -167.67 0.37 Allowed 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 123.128 2.552 . . . . 0.0 110.967 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -81.65 109.74 16.35 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -81.48 147.26 29.8 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -78.88 -23.66 63.63 Favored Glycine 0 C--N 1.302 -1.317 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.06 -178.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.8 p -143.62 161.31 38.85 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.411 ' O ' HG22 ' A' ' 111' ' ' VAL . 94.6 mt -71.29 -31.69 67.75 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 173.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 m -56.85 -40.12 75.54 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.651 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.36 -50.81 71.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.995 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.2 pp -68.77 -29.02 67.32 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.648 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 107' ' ' LEU . 49.5 t -64.93 -50.28 75.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.145 0.498 . . . . 0.0 110.391 177.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.7 t -72.49 -38.52 68.14 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.508 -177.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -73.61 -36.46 65.48 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -174.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -76.52 -0.66 23.91 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.3 m -75.01 -40.69 60.48 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 170.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 63.8 mt -86.24 -44.34 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.128 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.3 m -136.16 94.85 13.79 Favored Pre-proline 0 C--N 1.303 -1.444 0 O-C-N 122.104 -0.373 . . . . 0.0 111.295 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -86.77 108.04 0.77 Allowed 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 123.008 2.472 . . . . 0.0 109.983 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.429 ' HB ' ' OE2' ' A' ' 101' ' ' GLU . 33.9 mt -89.63 -73.54 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.285 -177.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.9 t -66.72 -34.02 76.93 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.215 0.531 . . . . 0.0 110.222 176.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 81.5 mt -71.57 124.79 91.47 Favored Pre-proline 0 C--N 1.311 -1.071 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.701 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -65.04 -20.61 63.76 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.437 2.758 . . . . 0.0 113.354 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 78.0 m -136.99 169.18 18.2 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 80.6 m -73.59 136.51 43.95 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 123.261 0.351 . . . . 0.0 111.045 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 22.7 tp -81.88 118.14 22.7 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -122.54 141.94 51.14 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.308 0.575 . . . . 0.0 111.273 -176.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.402 ' N ' HD11 ' A' ' 127' ' ' ILE . 2.8 mp -101.85 109.82 60.58 Favored Pre-proline 0 C--N 1.303 -1.422 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -74.44 -27.99 10.65 Favored 'Trans proline' 0 C--N 1.324 -0.745 0 C-N-CA 121.74 1.627 . . . . 0.0 112.275 -178.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.3 m -76.53 -16.36 59.64 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.679 -1.146 . . . . 0.0 113.109 -175.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.422 ' HD3' ' C ' ' A' ' 130' ' ' LYS . 12.2 tmtt? -149.74 128.19 12.24 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -177.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.403 ' N ' ' HD3' ' A' ' 130' ' ' LYS . 27.2 t70 . . . . . 0 C--N 1.288 -2.077 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 174.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 CA--C 1.507 -0.693 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 -97.93 115.75 28.76 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -131.19 160.79 33.79 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 39.2 m80 69.72 173.16 0.3 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.242 1.017 . . . . 0.0 111.907 176.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -141.56 100.99 3.89 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -126.99 -58.07 1.3 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.452 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 71.82 130.55 0.04 OUTLIER 'General case' 0 C--O 1.242 0.708 0 O-C-N 124.44 1.087 . . . . 0.0 112.31 -177.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.3 m -82.53 108.32 15.84 Favored 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 m -51.96 94.62 0.01 OUTLIER 'General case' 0 C--O 1.241 0.646 0 C-N-CA 125.002 1.321 . . . . 0.0 112.906 -176.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.1 90.51 0.47 Allowed Glycine 0 N--CA 1.436 -1.333 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.3 tp -178.98 -80.04 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.1 m -148.75 145.03 19.01 Favored Pre-proline 0 C--N 1.309 -1.179 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -47.5 -47.14 18.62 Favored 'Trans proline' 0 N--CA 1.476 0.481 0 C-N-CA 123.609 2.873 . . . . 0.0 113.935 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -98.44 19.36 14.59 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.326 0.584 . . . . 0.0 111.596 -176.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -130.88 39.36 1.8 Allowed Glycine 0 CA--C 1.496 -1.152 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.6 t -102.0 28.71 5.54 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -134.52 135.86 42.66 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.804 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.7 p -107.29 5.33 27.46 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -177.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.5 m -69.62 -24.13 63.6 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.972 -175.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.13 -9.93 59.73 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 120.443 -0.503 . . . . 0.0 112.347 -177.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -76.6 -49.83 15.35 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.205 0.526 . . . . 0.0 111.588 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.443 ' CZ3' HD13 ' A' ' 46' ' ' ILE . 29.6 p-90 -85.0 -12.95 52.09 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.768 -174.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -95.42 103.95 15.83 Favored 'General case' 0 N--CA 1.422 -1.831 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.683 -176.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.44 89.98 9.15 Favored Pre-proline 0 C--N 1.294 -1.844 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.099 174.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.73 18.79 0.81 Allowed 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 123.242 2.628 . . . . 0.0 112.411 -176.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -109.75 -3.73 16.55 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.79 -176.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.8 tp -101.19 130.61 47.31 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -172.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.0 m -79.45 170.68 16.23 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.593 0.757 . . . . 0.0 110.306 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -56.62 -53.71 54.51 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -69.85 -29.86 67.2 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.071 0.463 . . . . 0.0 110.654 -176.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -71.2 -33.42 69.92 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.686 176.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.4 -41.36 93.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.607 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 77.0 mt -67.3 -42.42 87.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.135 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.74 -28.78 67.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.857 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.71 -40.44 25.33 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.976 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.3 mp -86.73 -19.61 28.9 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -60.86 -36.56 79.48 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -92.92 3.01 56.49 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.307 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -99.4 169.58 9.23 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.708 0.766 . . . . 0.0 112.633 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -81.84 159.66 65.53 Favored Pre-proline 0 C--N 1.296 -1.722 0 C-N-CA 125.867 1.667 . . . . 0.0 111.368 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.02 111.88 2.79 Favored 'Trans proline' 0 C--N 1.36 1.172 0 C-N-CA 122.417 2.078 . . . . 0.0 110.32 176.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.88 -20.83 3.6 Favored Glycine 0 C--N 1.287 -2.159 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -176.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.01 136.49 48.4 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -151.75 173.04 15.21 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -177.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -155.91 158.05 37.32 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.443 HD13 ' CZ3' ' A' ' 22' ' ' TRP . 65.8 mt -122.54 116.25 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.081 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 174.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.1 ptt-85 -108.23 -175.02 2.66 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -100.03 128.4 46.12 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.423 ' C ' ' H ' ' A' ' 51' ' ' SER . 69.7 m -88.02 95.58 10.18 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.325 0.583 . . . . 0.0 110.162 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -73.86 11.98 0.77 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.775 0.797 . . . . 0.0 112.475 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.423 ' H ' ' C ' ' A' ' 49' ' ' SER . 32.9 t -86.81 -15.81 38.13 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 175.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -146.28 -171.54 3.75 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -125.23 134.94 52.15 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 171.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.18 22.85 56.39 Favored Glycine 0 C--N 1.308 -1.006 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -128.52 127.63 42.77 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -101.37 162.1 13.15 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.29 118.54 3.43 Favored Glycine 0 C--N 1.286 -2.229 0 C-N-CA 119.875 -1.155 . . . . 0.0 111.474 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -98.8 127.48 44.74 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -178.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -122.6 117.35 25.63 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.6 tp -110.29 128.08 55.34 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 123.719 0.637 . . . . 0.0 110.287 -176.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -88.69 114.08 24.93 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 177.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 80' ' ' LEU . 25.5 m -103.58 171.49 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.84 -60.35 2.74 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.401 ' HB ' ' HG2' ' A' ' 66' ' ' PRO . 2.1 p -159.32 141.93 10.21 Favored Pre-proline 0 N--CA 1.433 -1.276 0 C-N-CA 124.923 1.289 . . . . 0.0 108.478 176.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.601 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 36.3 Cg_exo -59.62 -44.33 32.68 Favored 'Trans proline' 0 CA--C 1.574 2.508 0 C-N-CA 121.75 1.633 . . . . 0.0 111.645 171.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.601 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 59.1 Cg_endo -68.99 146.95 66.68 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 122.68 2.254 . . . . 0.0 110.038 170.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -62.13 -42.03 31.93 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.695 2.263 . . . . 0.0 113.103 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.4 m -118.56 -18.99 8.95 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.86 0.362 . . . . 0.0 110.235 -177.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 67.68 24.44 8.41 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.168 0.987 . . . . 0.0 112.564 178.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -67.92 -38.35 14.07 Favored Pre-proline 0 CA--C 1.558 1.262 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.968 172.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -68.05 108.91 1.82 Allowed 'Trans proline' 0 C--N 1.38 2.224 0 C-N-CA 121.208 1.272 . . . . 0.0 109.119 167.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -131.33 145.72 51.98 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -175.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -138.4 -37.59 0.55 Allowed 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.871 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.81 -57.41 0.03 OUTLIER Glycine 0 CA--C 1.48 -2.109 0 N-CA-C 107.27 -2.332 . . . . 0.0 107.27 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 54.84 93.83 0.05 OUTLIER Pre-proline 0 N--CA 1.468 0.433 0 C-N-CA 125.104 1.362 . . . . 0.0 113.975 169.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -83.37 165.53 14.4 Favored 'Trans proline' 0 C--O 1.243 0.743 0 C-N-CA 122.504 2.136 . . . . 0.0 112.347 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 p -68.99 -27.2 34.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.594 0.711 . . . . 0.0 110.592 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -66.51 -15.95 63.77 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.349 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -85.11 -19.47 31.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.567 0.699 . . . . 0.0 109.471 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.425 ' O ' HG22 ' A' ' 62' ' ' VAL . 72.2 mt -80.71 -11.27 59.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.005 -178.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.0 t -100.59 108.84 23.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -87.18 131.54 34.15 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -177.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -105.08 125.63 51.19 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.259 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -140.88 131.46 25.48 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 176.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.32 154.66 17.14 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 117.878 -1.529 . . . . 0.0 110.963 176.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 78.5 mt -115.37 125.97 72.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.408 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.973 -176.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.486 ' CD ' ' HE2' ' A' ' 96' ' ' LYS . 47.4 mt-10 -105.86 138.39 42.13 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.423 ' HB ' HG23 ' A' ' 93' ' ' VAL . 5.6 t -121.45 147.51 45.65 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.52 -167.05 29.52 Favored Glycine 0 N--CA 1.423 -2.217 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.91 -14.21 35.53 Favored 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 123.637 2.891 . . . . 0.0 114.636 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -89.0 -24.66 22.32 Favored 'General case' 0 CA--C 1.5 -0.966 0 O-C-N 121.752 -0.592 . . . . 0.0 111.401 176.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 132.53 -160.12 23.64 Favored Glycine 0 N--CA 1.423 -2.19 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -177.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.544 HG13 ' H ' ' A' ' 105' ' ' GLY . 7.7 p -118.38 136.85 54.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -177.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.19 169.13 25.48 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 59.7 mt -85.77 143.07 12.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-O 120.86 0.362 . . . . 0.0 110.929 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.486 ' HE2' ' CD ' ' A' ' 87' ' ' GLU . 20.6 ttmm -99.17 140.57 33.14 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 172.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.08 43.06 4.19 Favored Glycine 0 CA--C 1.493 -1.303 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 24.5 p -129.73 157.61 76.11 Favored Pre-proline 0 N--CA 1.42 -1.968 0 CA-C-N 114.702 -0.749 . . . . 0.0 111.106 -171.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -65.56 -59.13 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 N-CA-C 107.72 -1.685 . . . . 0.0 107.72 167.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 67.0 m -164.32 125.57 2.2 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 124.522 1.129 . . . . 0.0 108.357 175.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.5 ' OE2' ' HB ' ' A' ' 119' ' ' ILE . 49.4 mm-40 -122.52 138.34 29.12 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.18 155.82 66.71 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.186 1.924 . . . . 0.0 110.688 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -91.59 99.48 12.39 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -64.62 -70.3 0.24 Allowed 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.353 0.597 . . . . 0.0 111.548 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.544 ' H ' HG13 ' A' ' 93' ' ' VAL . . . 145.17 -68.82 0.4 Allowed Glycine 0 C--N 1.3 -1.464 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 178.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.2 m -108.25 158.77 17.17 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.84 -36.53 82.54 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.4 t -64.81 -36.55 84.68 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.02 -47.36 83.39 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 175.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.3 tt -54.8 -50.79 67.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.113 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.445 ' HA ' HD22 ' A' ' 125' ' ' LEU . 69.1 t -61.55 -50.7 79.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.26 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.1 t -66.61 -31.68 72.53 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.171 0.51 . . . . 0.0 111.342 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -88.68 -18.97 26.79 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 121.711 -0.618 . . . . 0.0 112.657 -178.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -78.58 -9.36 59.33 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.137 0.494 . . . . 0.0 111.249 173.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.7 m -72.58 -27.62 62.3 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 170.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 35.2 mt -89.37 -60.14 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.575 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 27.0 m -120.57 99.17 47.86 Favored Pre-proline 0 N--CA 1.433 -1.324 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.968 -176.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -93.09 101.18 0.16 Allowed 'Trans proline' 0 N--CA 1.431 -2.169 0 C-N-CA 122.649 2.233 . . . . 0.0 109.482 172.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.5 ' HB ' ' OE2' ' A' ' 101' ' ' GLU . 63.8 mt -86.78 -62.36 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.12 -177.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.2 m -83.96 -16.88 42.49 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.273 0.559 . . . . 0.0 111.177 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.4 mt -90.12 123.7 65.19 Favored Pre-proline 0 C--N 1.305 -1.339 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -65.04 -30.19 56.52 Favored 'Trans proline' 0 N--CA 1.476 0.445 0 C-N-CA 122.808 2.339 . . . . 0.0 112.454 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 61.1 m -114.42 147.12 39.73 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.4 p -63.4 136.03 57.35 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.445 HD22 ' HA ' ' A' ' 111' ' ' VAL . 18.8 tp -79.76 86.43 5.34 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -93.55 124.29 37.45 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.393 -175.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mp -70.78 112.04 11.82 Favored Pre-proline 0 C--N 1.315 -0.905 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -68.17 -31.89 28.47 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.366 2.044 . . . . 0.0 112.107 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 34.4 t 71.9 0.6 3.59 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.596 1.158 . . . . 0.0 111.057 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? -128.56 123.57 33.77 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.4 t70 . . . . . 0 C--O 1.258 1.507 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 177.26 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mmm . . . . . 0 N--CA 1.467 0.42 0 CA-C-O 120.403 0.144 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -72.11 117.36 13.64 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.382 -0.199 . . . . 0.0 111.474 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 39.9 m-70 70.89 18.4 6.08 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.326 1.05 . . . . 0.0 111.292 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -163.22 83.87 0.49 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.745 178.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -156.37 125.63 6.14 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.453 178.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -156.21 169.26 24.95 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -78.63 154.87 29.88 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.4 m -54.34 -37.14 64.55 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -175.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.1 m -87.19 -13.71 43.19 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.31 -72.72 1.4 Allowed Glycine 0 C--O 1.241 0.549 0 N-CA-C 111.613 -0.595 . . . . 0.0 111.613 -176.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.6 tp -171.96 -53.62 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 124.524 1.129 . . . . 0.0 108.829 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.2 t 61.03 81.23 0.24 Allowed Pre-proline 0 N--CA 1.473 0.688 0 C-N-CA 124.727 1.211 . . . . 0.0 109.895 -176.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -85.32 30.44 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.722 2.282 . . . . 0.0 113.529 -173.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -105.38 76.47 1.22 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.582 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -108.55 -3.24 32.77 Favored Glycine 0 CA--C 1.493 -1.308 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.276 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.5 p -101.41 13.84 33.81 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.78 0.8 . . . . 0.0 110.915 -176.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.509 ' O ' ' HE2' ' A' ' 20' ' ' LYS . 2.0 m-20 -95.35 118.92 32.95 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.926 -177.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.63 7.05 15.92 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -174.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.8 m -100.32 -19.66 16.22 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.439 177.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.509 ' HE2' ' O ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -66.31 3.52 0.9 Allowed 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 -176.469 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -85.42 -40.27 16.62 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 14.7 p-90 -120.74 -8.94 9.41 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -172.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -92.19 110.84 22.23 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.653 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.43 ' HB3' HD13 ' A' ' 27' ' ' LEU . 1.3 mptp? -128.52 89.03 50.7 Favored Pre-proline 0 C--N 1.313 -0.988 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.41 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.09 -1.64 8.27 Favored 'Trans proline' 0 CA--C 1.552 1.395 0 C-N-CA 122.722 2.282 . . . . 0.0 114.649 -177.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -90.84 -21.73 21.32 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.312 0.577 . . . . 0.0 109.87 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.476 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 9.8 mp -86.22 142.28 28.7 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -174.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.3 m -111.31 178.09 4.45 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 174.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -47.05 -52.28 15.41 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -58.45 -43.46 88.85 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.773 0.829 . . . . 0.0 110.73 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -70.79 -32.59 69.74 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.373 -177.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.2 -41.23 86.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.413 0.625 . . . . 0.0 109.803 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 72.0 mt -66.33 -40.41 86.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.828 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.83 -29.5 68.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.202 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.03 -47.45 11.68 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 39' ' ' LYS . 72.6 mt -74.28 -19.44 60.49 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -176.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -72.01 -18.36 61.97 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.114 174.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -93.78 -35.54 12.71 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.386 178.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.407 ' HB2' ' HA ' ' A' ' 36' ' ' LEU . 24.2 mmmt -77.38 171.11 15.38 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -71.59 164.28 59.25 Favored Pre-proline 0 C--N 1.314 -0.96 0 C-N-CA 126.753 2.021 . . . . 0.0 111.71 -176.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -75.91 126.5 9.42 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 121.815 1.677 . . . . 0.0 108.37 169.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.02 -9.62 43.38 Favored Glycine 0 C--N 1.292 -1.915 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -175.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.08 155.61 26.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.446 ' CD1' HD22 ' A' ' 125' ' ' LEU . 15.0 p90 -156.56 170.8 21.54 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.763 -173.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -156.43 149.99 24.66 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 172.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 68.7 mt -121.05 129.59 75.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -139.94 172.44 12.77 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.503 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -75.52 137.15 40.68 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 t -86.33 129.57 34.81 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -90.86 -14.84 31.0 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.5 t -70.5 -45.58 65.37 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.409 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -134.7 142.71 46.88 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -85.71 138.22 32.27 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.9 21.46 50.11 Favored Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.26 144.85 48.62 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 115.537 -0.332 . . . . 0.0 110.22 -178.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -116.28 132.82 56.56 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.3 120.25 5.69 Favored Glycine 0 C--N 1.287 -2.151 0 C-N-CA 119.932 -1.127 . . . . 0.0 111.46 -177.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -95.82 120.49 36.18 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.406 ' HB1' HH12 ' A' ' 47' ' ' ARG . . . -112.76 125.04 53.89 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.442 HD12 ' HB3' ' A' ' 123' ' ' CYS . 3.4 tm? -123.66 126.8 47.22 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -178.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -89.2 114.79 26.15 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 80' ' ' LEU . 32.8 m -99.67 171.64 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.26 -47.2 36.55 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.4 p -156.06 129.57 4.54 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 124.347 1.059 . . . . 0.0 108.988 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.572 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 28.0 Cg_exo -62.43 -45.08 15.73 Favored 'Trans proline' 0 CA--C 1.57 2.308 0 C-N-CA 121.884 1.723 . . . . 0.0 113.017 174.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.572 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 37.4 Cg_endo -63.94 142.66 82.74 Favored 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 122.273 1.982 . . . . 0.0 110.396 174.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -61.53 -34.48 85.31 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 123.349 2.7 . . . . 0.0 113.861 -174.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.1 p -119.07 -42.22 2.71 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.463 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 72.37 7.47 5.66 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 124.82 1.248 . . . . 0.0 113.106 174.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.415 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 64.8 tt0 -72.53 -55.75 4.35 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-O 119.121 -0.466 . . . . 0.0 112.028 -178.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.415 ' HD3' ' HB3' ' A' ' 70' ' ' GLN . 6.9 Cg_endo -88.08 62.87 3.38 Favored 'Trans proline' 0 C--N 1.365 1.427 0 C-N-CA 121.461 1.44 . . . . 0.0 111.108 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -160.66 141.27 11.59 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 113.353 -1.749 . . . . 0.0 110.441 -176.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.83 80.16 0.63 Allowed 'General case' 0 N--CA 1.413 -2.298 0 CA-C-O 122.635 1.207 . . . . 0.0 110.429 169.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.17 40.88 0.49 Allowed Glycine 0 C--N 1.301 -1.393 0 CA-C-N 114.213 -1.358 . . . . 0.0 112.165 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -136.5 127.8 16.79 Favored Pre-proline 0 C--N 1.305 -1.337 0 CA-C-O 120.755 0.312 . . . . 0.0 111.054 -177.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -91.55 177.37 1.89 Allowed 'Trans proline' 0 N--CA 1.436 -1.875 0 C-N-CA 121.829 1.686 . . . . 0.0 109.4 168.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.7 p -58.89 -24.99 27.99 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-O 121.603 0.716 . . . . 0.0 111.632 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.7 -26.77 64.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.006 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -80.95 -16.68 52.82 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 121.144 0.497 . . . . 0.0 109.711 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.449 ' O ' HG21 ' A' ' 62' ' ' VAL . 77.4 mt -74.53 -12.59 60.51 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-O 121.68 0.753 . . . . 0.0 109.991 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 74.7 t -88.3 125.9 41.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 176.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -105.23 143.84 32.84 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -118.75 133.87 55.54 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -139.15 167.33 22.3 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.05 138.11 41.83 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.94 177.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.411 HG12 HG12 ' A' ' 95' ' ' ILE . 80.1 mt -97.03 114.82 34.99 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-N 114.187 -1.369 . . . . 0.0 107.395 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -99.62 137.23 38.39 Favored 'General case' 0 C--N 1.273 -2.727 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.477 ' HB ' HG13 ' A' ' 93' ' ' VAL . 6.1 t -113.06 143.44 44.33 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -155.83 -157.97 8.56 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -73.18 -14.28 25.81 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.224 1.949 . . . . 0.0 112.823 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.468 ' HD2' ' N ' ' A' ' 91' ' ' LYS . 0.1 OUTLIER -84.88 -28.77 25.76 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 121.519 0.675 . . . . 0.0 110.331 177.739 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 139.19 -147.5 19.26 Favored Glycine 0 N--CA 1.433 -1.562 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.477 HG13 ' HB ' ' A' ' 88' ' ' THR . 15.0 m -113.52 141.5 29.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.67 150.31 26.17 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.674 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.441 ' HB ' ' OE2' ' A' ' 101' ' ' GLU . 83.3 mt -86.14 133.76 28.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.704 0.764 . . . . 0.0 111.309 -176.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -93.01 124.17 36.8 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 173.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 113.94 42.6 0.84 Allowed Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -174.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 120' ' ' SER . 13.5 p -129.34 144.9 54.6 Favored Pre-proline 0 N--CA 1.428 -1.529 0 CA-C-N 115.421 -0.39 . . . . 0.0 110.123 -175.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -67.33 -28.13 39.88 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.395 2.064 . . . . 0.0 111.928 176.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.5 t -153.86 -89.87 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.441 ' OE2' ' HB ' ' A' ' 95' ' ' ILE . 28.2 tt0 65.78 133.03 0.04 OUTLIER Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 125.377 1.471 . . . . 0.0 112.986 173.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -79.2 172.58 14.53 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.412 2.075 . . . . 0.0 112.557 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -92.39 131.89 37.2 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 175.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -102.42 170.7 7.89 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -177.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -99.55 -52.69 1.19 Allowed Glycine 0 C--N 1.3 -1.447 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.5 m -111.72 153.85 25.86 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.476 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 64.4 mt -63.24 -36.68 84.45 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.4 m -54.23 -30.19 49.24 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.486 1.114 . . . . 0.0 112.158 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.53 -41.95 92.53 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.112 -177.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 107' ' ' LEU . 4.2 pp -77.0 -31.33 56.38 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.969 0.414 . . . . 0.0 110.081 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.427 ' HA ' ' CD1' ' A' ' 125' ' ' LEU . 55.3 t -59.5 -54.73 30.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.455 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.4 m -72.48 -25.71 61.52 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.905 -177.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -84.13 -36.99 22.53 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.988 -176.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -72.13 -5.22 33.96 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -177.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.6 m -74.37 -31.9 62.56 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.6 mt -94.93 -50.16 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.972 -178.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 45.3 m -132.88 96.75 17.67 Favored Pre-proline 0 C--N 1.31 -1.142 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.979 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -81.86 114.23 2.58 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.702 2.268 . . . . 0.0 109.715 176.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 65.3 mt -91.49 -64.69 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 120.771 0.32 . . . . 0.0 110.512 -176.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.505 ' HB3' ' HB3' ' A' ' 98' ' ' CYS . 2.3 p -74.95 -49.66 19.35 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.467 0.651 . . . . 0.0 110.263 176.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.9 mp -65.87 137.69 96.15 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.877 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -80.53 -9.8 13.45 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.637 2.225 . . . . 0.0 112.92 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.442 ' HB3' HD12 ' A' ' 60' ' ' LEU . 44.8 t -136.35 150.69 48.96 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -178.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 24.8 p -71.82 146.11 48.21 Favored 'General case' 0 C--O 1.252 1.198 0 O-C-N 123.775 0.672 . . . . 0.0 110.555 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.446 HD22 ' CD1' ' A' ' 44' ' ' PHE . 91.6 mt -77.81 128.19 33.61 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.388 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -106.4 103.04 12.41 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.406 HD11 ' N ' ' A' ' 127' ' ' ILE . 3.4 mp -88.69 122.58 69.15 Favored Pre-proline 0 C--N 1.313 -1.002 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.865 -176.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.05 -35.37 90.16 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 123.162 2.574 . . . . 0.0 112.116 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.0 m 67.19 -25.63 0.12 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 126.008 1.723 . . . . 0.0 115.281 175.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -110.82 121.79 46.23 Favored 'General case' 0 N--CA 1.434 -1.253 0 O-C-N 121.789 -0.569 . . . . 0.0 111.559 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.9 t70 . . . . . 0 C--N 1.303 -1.44 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 173.206 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 ttm . . . . . 0 CA--C 1.516 -0.343 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -79.24 -90.22 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -179.76 126.83 0.08 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -170.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -132.92 -83.35 0.47 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -111.9 -5.45 14.35 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -176.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -103.77 114.07 28.05 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -73.86 116.6 14.66 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.785 0.802 . . . . 0.0 111.766 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.9 m -92.0 42.43 1.1 Allowed 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.674 0.75 . . . . 0.0 109.832 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.2 m -135.41 164.17 28.38 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.32 -92.27 1.34 Allowed Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -157.78 149.72 22.09 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.8 t -118.6 99.95 51.31 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 174.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.61 138.27 19.1 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.721 2.281 . . . . 0.0 112.892 -175.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -109.67 141.46 42.2 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.023 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.75 35.04 72.93 Favored Glycine 0 N--CA 1.44 -1.05 0 O-C-N 123.428 0.455 . . . . 0.0 112.328 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.3 m -79.0 -18.03 54.36 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 122.18 0.991 . . . . 0.0 110.206 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -122.57 129.65 52.16 Favored 'General case' 0 C--N 1.274 -2.697 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.418 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.5 p -118.55 12.23 13.12 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.4 m -56.8 -40.53 76.11 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.618 -177.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -60.0 -25.08 64.99 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -77.26 -27.82 53.31 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 120.876 0.369 . . . . 0.0 111.141 -177.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.0 p-90 -119.1 -17.97 8.83 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -176.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -94.42 110.22 22.02 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.657 -176.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.08 94.27 14.43 Favored Pre-proline 0 C--N 1.309 -1.188 0 C-N-CA 124.407 1.083 . . . . 0.0 108.644 174.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 47' ' ' ARG . 83.3 Cg_endo -75.0 -23.22 14.0 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.856 3.038 . . . . 0.0 117.463 -169.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -101.43 14.55 31.61 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 118.9 0.773 . . . . 0.0 111.167 -174.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.3 tp -88.66 135.3 33.57 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.6 m -82.87 163.54 21.08 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 122.341 -0.225 . . . . 0.0 110.971 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -52.88 -51.48 60.95 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -173.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -65.44 -37.35 86.63 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.414 0.626 . . . . 0.0 110.999 -176.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -72.08 -28.32 63.24 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.496 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.15 -45.18 74.25 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 175.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 77.1 mt -63.49 -35.1 71.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.52 177.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.99 -34.67 43.55 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.261 176.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.558 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 3.8 mm? -72.33 -50.41 27.05 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.502 0.667 . . . . 0.0 109.506 174.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.1 mp -70.64 -13.53 62.12 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -173.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -84.79 -1.25 56.12 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.543 0.687 . . . . 0.0 109.26 174.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -114.84 -30.44 6.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.876 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 35' ' ' LEU . 61.8 mmtt -80.28 -179.05 6.9 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -174.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -83.82 156.33 64.51 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.718 -177.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -66.16 115.08 3.28 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 121.922 1.748 . . . . 0.0 108.933 171.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 124.56 -17.56 7.34 Favored Glycine 0 C--N 1.297 -1.593 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -174.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.48 151.99 37.94 Favored 'General case' 0 C--O 1.249 1.06 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -154.44 174.87 14.3 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.333 -174.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -156.43 151.19 25.93 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 171.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.3 mt -120.22 129.66 75.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 19.9 ptt180 -119.51 172.74 7.43 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -100.56 127.28 46.99 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.1 m -107.53 119.43 39.41 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -173.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 -79.9 76.13 6.6 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.902 0.858 . . . . 0.0 108.971 174.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 t -136.2 -52.07 0.72 Allowed 'General case' 0 C--N 1.271 -2.805 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -128.86 168.97 15.16 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 176.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -88.58 121.74 31.28 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.361 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.81 50.97 7.41 Favored Glycine 0 N--CA 1.422 -2.263 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 86' ' ' ILE . . . -124.06 113.68 18.72 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.43 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 57.2 m-85 -98.78 125.14 44.05 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.296 -0.865 . . . . 0.0 108.707 -178.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.51 111.51 4.22 Favored Glycine 0 C--N 1.289 -2.033 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.318 -176.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 83' ' ' HIS . 38.9 tp -91.5 121.81 33.53 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -107.2 118.9 37.93 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 174.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.5 tp -114.73 130.88 56.9 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 123.496 0.497 . . . . 0.0 110.562 -177.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -90.66 113.71 25.83 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.52 ' HB ' ' SG ' ' A' ' 123' ' ' CYS . 17.7 m -98.25 162.13 2.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.6 -56.52 5.21 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 p -163.17 136.8 4.53 Favored Pre-proline 0 N--CA 1.425 -1.723 0 C-N-CA 126.883 2.073 . . . . 0.0 105.612 175.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.587 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 36.4 Cg_exo -59.81 -46.59 19.18 Favored 'Trans proline' 0 CA--C 1.572 2.419 0 C-N-CA 120.929 1.086 . . . . 0.0 111.339 172.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.587 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 67.3 Cg_endo -67.75 149.58 78.72 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 122.606 2.204 . . . . 0.0 110.13 172.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.01 -41.56 7.37 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.104 1.87 . . . . 0.0 112.435 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 33.1 t -110.78 -32.39 6.87 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.389 -177.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.467 ' HB1' ' HG2' ' A' ' 66' ' ' PRO . . . 64.82 38.16 6.86 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 123.86 0.864 . . . . 0.0 110.515 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -59.71 -44.54 97.54 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.018 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -70.25 95.56 0.6 Allowed 'Trans proline' 0 C--N 1.374 1.882 0 N-CA-C 108.746 -1.29 . . . . 0.0 108.746 167.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 56.4 t-105 -113.14 150.46 32.15 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.203 -173.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -137.61 -46.38 0.55 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 122.431 1.11 . . . . 0.0 108.032 176.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 146.57 -76.94 0.26 Allowed Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 107.323 -2.311 . . . . 0.0 107.323 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 72.95 135.35 0.05 OUTLIER Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 125.269 1.428 . . . . 0.0 111.265 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.56 156.02 59.38 Favored 'Trans proline' 0 C--O 1.239 0.533 0 C-N-CA 122.389 2.059 . . . . 0.0 110.947 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.8 p -62.01 -21.55 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.55 0.691 . . . . 0.0 110.281 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -66.05 -21.29 66.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.547 178.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -82.98 -28.18 29.91 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.252 0.549 . . . . 0.0 109.571 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.461 ' O ' HG22 ' A' ' 62' ' ' VAL . 2.8 mm? -84.92 -7.99 58.94 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.984 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.6 t -103.56 102.05 13.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 173.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -96.25 143.33 27.43 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.798 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.467 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 69.6 m80 -113.25 123.23 49.68 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.29 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -124.98 131.68 53.38 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.43 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 1.0 OUTLIER -102.98 132.19 49.41 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 118.756 -1.177 . . . . 0.0 112.666 179.737 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 55' ' ' ALA . 4.0 mp -87.64 125.24 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 175.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -99.39 125.83 45.16 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 92' ' ' GLY . 11.0 t -114.55 142.07 46.91 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 175.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.21 -138.3 4.4 Favored Glycine 0 N--CA 1.418 -2.516 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -67.84 -24.29 40.42 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.901 2.401 . . . . 0.0 113.971 -175.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -88.79 -17.85 28.94 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.583 0.706 . . . . 0.0 110.503 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 114.9 -152.51 18.09 Favored Glycine 0 N--CA 1.424 -2.166 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 -178.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.438 HG13 ' HB ' ' A' ' 88' ' ' THR . 6.3 m -104.79 125.99 59.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.82 150.87 26.52 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 121.804 -0.56 . . . . 0.0 109.966 177.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 75.8 mt -73.96 131.28 35.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 123.306 0.379 . . . . 0.0 110.961 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -72.89 119.59 17.34 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 123.976 0.91 . . . . 0.0 109.325 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.62 15.01 48.21 Favored Glycine 0 C--O 1.243 0.677 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.756 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 120' ' ' SER . 19.4 t -85.05 125.36 70.65 Favored Pre-proline 0 N--CA 1.435 -1.187 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -53.02 -28.71 41.4 Favored 'Trans proline' 0 N--CA 1.487 1.098 0 C-N-CA 123.69 2.927 . . . . 0.0 113.652 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.2 m -142.33 119.11 11.14 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 178.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -90.95 116.63 66.83 Favored Pre-proline 0 C--N 1.283 -2.321 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -82.1 -19.32 6.95 Favored 'Trans proline' 0 C--N 1.328 -0.551 0 C-N-CA 122.204 1.936 . . . . 0.0 114.193 -176.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 50.83 98.87 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.215 0 C-N-CA 126.667 1.987 . . . . 0.0 113.234 -176.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.423 ' CD2' ' HB3' ' A' ' 110' ' ' LEU . 77.8 m-85 -111.67 178.84 4.19 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.67 -30.73 2.52 Favored Glycine 0 C--N 1.305 -1.183 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.729 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.0 m -115.36 143.83 44.69 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.421 ' O ' HG22 ' A' ' 111' ' ' VAL . 57.9 mt -62.51 -43.07 99.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.6 t -60.92 -29.46 69.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.926 0.393 . . . . 0.0 110.925 -177.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.46 -43.09 98.35 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.518 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 111' ' ' VAL . 3.7 pp -76.3 -30.92 57.94 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.961 178.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.455 ' HA ' HD22 ' A' ' 125' ' ' LEU . 56.4 t -62.74 -51.65 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.69 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.6 t -65.31 -25.46 67.63 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.563 -176.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.457 ' HA ' ' OE1' ' A' ' 113' ' ' GLN . 9.3 mm-40 -85.27 -30.55 23.69 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.141 -0.623 . . . . 0.0 111.728 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 49.3 m80 -74.52 -6.66 49.68 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.062 0.458 . . . . 0.0 111.702 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.0 m -71.84 -29.99 64.98 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 173.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 60.3 mt -100.21 -53.01 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.664 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.7 m -120.8 96.29 48.76 Favored Pre-proline 0 N--CA 1.434 -1.256 0 CA-C-O 120.99 0.424 . . . . 0.0 111.727 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.445 ' HB2' ' O ' ' A' ' 121' ' ' LEU . 44.1 Cg_endo -75.1 101.64 1.5 Allowed 'Trans proline' 0 N--CA 1.43 -2.213 0 C-N-CA 121.324 1.349 . . . . 0.0 109.982 173.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 45.6 mt -76.6 -59.82 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.261 0.553 . . . . 0.0 109.925 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.49 ' HB2' ' SG ' ' A' ' 98' ' ' CYS . 21.5 t -84.51 -29.84 25.65 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.568 0.699 . . . . 0.0 109.482 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.445 ' O ' ' HB2' ' A' ' 118' ' ' PRO . 6.9 mp -80.69 142.8 53.49 Favored Pre-proline 0 C--N 1.299 -1.615 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.212 -175.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -82.89 -20.01 5.59 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.379 2.053 . . . . 0.0 112.02 176.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.52 ' SG ' ' HB ' ' A' ' 62' ' ' VAL . 83.8 m -126.72 160.52 30.58 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 60.3 m -72.6 140.79 48.24 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 123.545 0.528 . . . . 0.0 110.562 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.455 HD22 ' HA ' ' A' ' 111' ' ' VAL . 22.8 tp -85.74 102.38 13.59 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -110.07 119.65 39.95 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -173.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.4 mp -61.77 123.61 77.93 Favored Pre-proline 0 C--O 1.247 0.934 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.162 -176.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -54.87 -50.9 11.7 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 123.042 2.494 . . . . 0.0 112.477 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.9 m 59.27 18.22 6.44 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.5 1.12 . . . . 0.0 112.191 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.404 ' HZ2' ' HB2' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -165.41 175.18 9.31 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 -177.764 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.261 1.667 0 O-C-N 124.499 1.124 . . . . 0.0 112.265 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.5 mmt . . . . . 0 CA--C 1.504 -0.825 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -71.01 -63.72 1.05 Allowed 'General case' 0 C--N 1.323 -0.547 0 O-C-N 123.552 0.533 . . . . 0.0 112.337 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -89.49 -55.31 3.71 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.032 0.444 . . . . 0.0 110.874 -175.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -166.02 -177.21 4.1 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 -176.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -64.26 116.88 6.44 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 172.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -75.03 17.78 0.21 Allowed 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -168.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 35.7 m170 -85.83 127.4 34.56 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 175.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 56.2 m 69.82 19.24 7.18 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 123.949 0.781 . . . . 0.0 110.761 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.6 t -71.39 -45.97 61.47 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.551 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.29 172.65 13.78 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 83.8 mt -100.27 104.25 15.72 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 177.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.4 t 63.63 77.32 0.32 Allowed Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -170.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.69 109.56 0.6 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.229 2.619 . . . . 0.0 112.602 -175.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -148.74 172.01 15.3 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -122.43 -110.36 2.05 Favored Glycine 0 N--CA 1.418 -2.55 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 175.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.2 p -100.08 7.11 44.88 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.816 0.817 . . . . 0.0 111.181 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -100.69 108.78 20.72 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.151 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.6 p -115.1 18.41 16.29 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 115.208 -0.905 . . . . 0.0 108.599 175.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.8 m -92.37 -43.45 9.23 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.771 -174.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.08 -5.13 8.81 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -176.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -78.26 -20.8 50.93 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.368 0.604 . . . . 0.0 109.553 175.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.465 ' CZ3' HD13 ' A' ' 46' ' ' ILE . 37.9 p-90 -122.83 -30.66 3.79 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.239 176.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.561 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 38.4 t80 -95.22 122.06 37.51 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 120.981 0.42 . . . . 0.0 110.516 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.25 104.79 2.41 Favored Pre-proline 0 C--N 1.306 -1.307 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.946 174.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.36 22.96 0.55 Allowed 'Trans proline' 0 N--CA 1.486 1.031 0 C-N-CA 123.738 2.959 . . . . 0.0 114.116 -174.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -98.97 -12.28 20.78 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.461 0.648 . . . . 0.0 109.481 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.531 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 3.8 mm? -92.86 130.33 38.49 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.565 -178.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.1 m -90.66 175.85 6.88 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 172.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -57.54 -46.89 83.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 118.219 0.463 . . . . 0.0 112.143 -178.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -66.85 -38.59 86.66 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.561 0.696 . . . . 0.0 110.492 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -66.57 -37.65 85.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.096 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.6 -41.73 90.98 Favored 'General case' 0 CA--C 1.509 -0.635 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.265 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 72.5 mt -63.17 -48.01 89.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.68 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.34 -30.13 71.32 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.374 0.607 . . . . 0.0 111.775 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.08 -49.03 11.38 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.463 -178.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.462 ' HG ' ' HB2' ' A' ' 61' ' ' LYS . 16.1 tp -80.13 -16.93 53.87 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.538 -173.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -63.06 -31.26 72.35 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 122.061 -0.399 . . . . 0.0 110.796 178.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -82.02 -14.48 55.87 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.835 0.826 . . . . 0.0 110.283 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -85.93 162.84 18.37 Favored 'General case' 0 C--O 1.254 1.331 0 CA-C-O 121.665 0.745 . . . . 0.0 111.382 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.08 144.02 98.25 Favored Pre-proline 0 C--N 1.305 -1.345 0 CA-C-N 113.728 -1.578 . . . . 0.0 111.531 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.22 111.16 1.71 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.87 1.714 . . . . 0.0 109.029 171.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.87 -20.7 6.35 Favored Glycine 0 N--CA 1.427 -1.961 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -172.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.25 154.47 30.97 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-O 120.973 0.416 . . . . 0.0 110.07 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -149.0 163.79 36.47 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.191 -176.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -146.04 146.92 31.14 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 171.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 23' ' ' TYR . 60.1 mt -120.36 137.61 53.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -143.25 -175.75 4.66 Favored 'General case' 0 C--N 1.28 -2.446 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.543 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -78.74 128.11 32.98 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 175.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.0 t -85.3 103.64 14.42 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -177.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -77.25 74.8 3.81 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-O 122.23 1.014 . . . . 0.0 109.861 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 72.3 m -157.1 -47.2 0.07 Allowed 'General case' 0 C--N 1.271 -2.836 0 CA-C-N 113.406 -1.724 . . . . 0.0 108.873 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -131.06 147.96 52.68 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -82.3 135.81 35.15 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.58 33.11 48.64 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -130.56 131.73 45.18 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.417 0.627 . . . . 0.0 109.706 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -111.48 123.69 50.75 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -85.1 124.84 6.93 Favored Glycine 0 C--N 1.295 -1.722 0 C-N-CA 119.971 -1.109 . . . . 0.0 111.801 -175.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -104.45 119.23 38.5 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.57 126.2 54.74 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -121.7 123.84 42.84 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.462 ' HB2' ' HG ' ' A' ' 36' ' ' LEU . 22.4 tptm -88.41 120.77 30.09 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.793 -178.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 80' ' ' LEU . 34.3 m -113.83 157.52 14.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 173.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.25 -38.06 71.95 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 p -158.37 132.22 4.97 Favored Pre-proline 0 N--CA 1.444 -0.729 0 C-N-CA 125.495 1.518 . . . . 0.0 107.737 176.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.564 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 23.4 Cg_exo -62.15 -44.02 21.43 Favored 'Trans proline' 0 CA--C 1.565 2.055 0 C-N-CA 122.068 1.845 . . . . 0.0 113.182 175.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.564 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 73.6 Cg_endo -70.91 160.7 48.53 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.722 2.282 . . . . 0.0 110.307 173.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -65.16 -54.17 0.7 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.074 1.85 . . . . 0.0 112.344 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.8 p -110.56 -27.59 8.89 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.087 -175.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.407 ' HB3' ' HG2' ' A' ' 66' ' ' PRO . . . 63.88 38.15 9.11 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 123.588 0.755 . . . . 0.0 109.501 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.425 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 34.5 tt0 -54.16 -51.56 76.38 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.959 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' A' ' 70' ' ' GLN . 2.4 Cg_endo -89.73 101.96 0.33 Allowed 'Trans proline' 0 N--CA 1.436 -1.903 0 C-N-CA 121.611 1.54 . . . . 0.0 111.158 175.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 47.4 t-105 -96.44 144.49 26.51 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -139.59 -41.44 0.45 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.147 0.499 . . . . 0.0 110.668 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.83 77.95 0.03 OUTLIER Glycine 0 CA--C 1.476 -2.379 0 N-CA-C 108.449 -1.861 . . . . 0.0 108.449 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -123.47 101.92 36.76 Favored Pre-proline 0 C--N 1.294 -1.824 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -173.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -88.78 -175.66 1.27 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.502 2.135 . . . . 0.0 114.245 -175.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.7 p -62.01 -23.85 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 115.077 -0.965 . . . . 0.0 113.306 -175.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.15 -23.92 67.66 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.681 0.277 . . . . 0.0 111.437 176.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -92.04 -30.07 16.24 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.486 ' O ' HG21 ' A' ' 62' ' ' VAL . 64.4 mt -66.41 -33.91 76.78 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.574 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 95.6 t -85.51 109.98 19.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 172.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -84.16 133.98 34.59 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -176.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.405 ' CD2' HH22 ' A' ' 47' ' ' ARG . 5.6 m80 -113.45 122.76 48.29 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -132.53 154.96 49.46 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 176.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -125.5 137.02 53.94 Favored 'General case' 0 C--N 1.283 -2.299 0 C-N-CA 118.631 -1.227 . . . . 0.0 110.93 176.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 86.0 mt -92.57 117.08 35.16 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.81 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.135 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.416 ' OE1' ' HE3' ' A' ' 96' ' ' LYS . 50.8 mt-10 -109.43 144.69 37.31 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.4 t -118.62 131.96 56.18 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.33 -144.73 4.17 Favored Glycine 0 N--CA 1.429 -1.78 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.385 -178.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -61.87 -44.15 22.14 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.868 2.379 . . . . 0.0 113.864 -177.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.463 ' HD2' ' N ' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -75.91 -41.93 50.44 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.917 -176.428 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.6 -154.94 25.94 Favored Glycine 0 N--CA 1.425 -2.069 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.8 p -111.94 126.09 69.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.56 178.12 8.84 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.755 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 58.8 mt -88.12 143.92 10.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 C-N-CA 123.598 0.759 . . . . 0.0 112.693 -169.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.416 ' HE3' ' OE1' ' A' ' 87' ' ' GLU . 25.0 ttmt -95.46 136.89 35.27 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 170.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.83 55.0 1.69 Allowed Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -175.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 11.9 p -135.31 154.28 78.57 Favored Pre-proline 0 C--N 1.311 -1.103 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -167.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -84.9 -56.54 0.02 OUTLIER 'Trans proline' 0 CA--C 1.558 1.69 0 C-N-CA 122.995 2.463 . . . . 0.0 112.633 173.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.0 m -149.88 131.54 14.94 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -177.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -140.46 140.08 21.98 Favored Pre-proline 0 C--N 1.297 -1.68 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.94 153.65 29.2 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.024 1.816 . . . . 0.0 107.694 166.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -92.98 112.32 24.24 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.46 -0.775 . . . . 0.0 110.797 -178.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.425 ' HE1' ' OE1' ' A' ' 113' ' ' GLN . 29.4 m-85 -89.0 157.43 18.37 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.11 -173.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -97.04 -27.67 9.25 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.556 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 53.8 m -141.69 157.29 45.24 Favored 'General case' 0 C--O 1.244 0.766 0 O-C-N 122.233 -0.569 . . . . 0.0 110.838 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.9 -35.12 72.51 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.449 0.7 . . . . 0.0 111.771 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.1 t -51.95 -31.21 27.95 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.85 0.86 . . . . 0.0 111.76 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.404 ' O ' ' HG3' ' A' ' 113' ' ' GLN . . . -73.7 -48.58 31.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 122.229 -0.295 . . . . 0.0 111.246 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 pp -67.7 -29.46 68.73 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.204 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 78.6 t -67.86 -48.65 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.32 176.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.5 p -68.51 -44.85 73.76 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.425 ' OE1' ' HE1' ' A' ' 104' ' ' PHE . 66.4 mt-30 -66.22 -41.53 89.95 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.718 -178.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.528 ' HA ' ' O ' ' A' ' 117' ' ' SER . 58.1 m80 -77.79 -9.94 59.29 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.7 t -76.05 -23.51 55.1 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 174.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 72.2 mt -99.94 -66.87 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.806 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 20.2 m -102.62 117.72 60.2 Favored Pre-proline 0 N--CA 1.433 -1.276 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.814 -175.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -82.35 88.96 1.22 Allowed 'Trans proline' 0 N--CA 1.439 -1.697 0 C-N-CA 121.882 1.721 . . . . 0.0 110.267 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 52.2 mt -88.63 -69.98 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.467 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.6 m -88.73 -6.73 57.23 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.117 0.484 . . . . 0.0 111.319 -178.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.7 mt -118.61 145.12 36.8 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -176.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.26 -36.51 45.77 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.947 2.431 . . . . 0.0 113.613 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 60.8 m -123.65 159.88 28.37 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 85.1 m -73.34 139.63 46.16 Favored 'General case' 0 N--CA 1.434 -1.246 0 O-C-N 123.686 0.616 . . . . 0.0 109.722 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.8 mt -65.37 110.79 2.76 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.583 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -89.38 95.36 10.25 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 174.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 58.6 mt -65.52 126.28 91.24 Favored Pre-proline 0 C--N 1.302 -1.484 0 CA-C-N 113.966 -1.47 . . . . 0.0 108.997 -178.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.11 -63.31 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.861 1.707 . . . . 0.0 110.223 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 34.5 t 67.12 -44.74 0.46 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.056 1.342 . . . . 0.0 112.666 177.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -113.17 -166.21 1.06 Allowed 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 123.932 0.893 . . . . 0.0 109.988 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 C--N 1.295 -1.785 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.761 179.889 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ppp? . . . . . 0 CA--C 1.51 -0.581 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -149.3 -58.49 0.21 Allowed 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.7 m170 53.44 81.81 0.09 Allowed 'General case' 0 C--O 1.243 0.717 0 O-C-N 124.212 0.945 . . . . 0.0 112.205 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -66.1 -53.32 39.43 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.93 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -91.24 80.71 5.56 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.09 0.471 . . . . 0.0 111.234 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -97.49 71.01 2.29 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 174.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -176.24 173.24 2.19 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 113.162 -1.836 . . . . 0.0 106.156 -176.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.1 m -93.33 157.38 16.27 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.048 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.7 m -64.3 107.89 1.45 Allowed 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 121.31 0.576 . . . . 0.0 109.786 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.15 -25.06 1.26 Allowed Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -176.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 33.3 tp -89.66 27.16 1.57 Allowed 'General case' 0 CA--C 1.55 0.946 0 CA-C-O 122.289 1.042 . . . . 0.0 109.962 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.6 t -106.82 132.72 20.68 Favored Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -55.38 106.96 0.21 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 122.54 2.16 . . . . 0.0 110.489 175.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.561 ' HD2' ' O ' ' A' ' 17' ' ' ASP . 28.9 ttm180 -99.82 -23.85 14.85 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.287 -172.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.97 33.26 5.84 Favored Glycine 0 N--CA 1.434 -1.49 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.619 -176.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.6 m 52.94 43.62 31.43 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.115 0.966 . . . . 0.0 111.908 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.561 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 11.6 t70 -117.41 139.82 50.38 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.214 -176.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.1 p -133.84 18.23 3.85 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.868 0.842 . . . . 0.0 108.738 172.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.3 m -93.99 -33.31 13.49 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.627 -175.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -16.32 61.14 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.048 0.451 . . . . 0.0 111.672 -177.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -66.22 -40.06 90.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.506 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.406 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 11.8 p-90 -104.76 -5.67 21.04 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -94.11 113.16 25.06 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.961 -176.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.02 87.67 43.53 Favored Pre-proline 0 C--N 1.311 -1.109 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.5 178.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.14 -12.57 17.44 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.706 2.271 . . . . 0.0 115.254 -172.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -96.79 19.31 12.75 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.078 0.465 . . . . 0.0 111.27 -177.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.55 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 4.4 mm? -105.95 128.56 53.88 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.363 0.601 . . . . 0.0 112.25 -178.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.8 t -88.86 173.42 8.53 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 174.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.423 ' O ' HG13 ' A' ' 33' ' ' ILE . 11.0 ttm180 -48.96 -56.93 7.41 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.545 0.738 . . . . 0.0 112.36 -174.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -66.21 -37.3 85.23 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.999 -172.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -75.58 -32.08 60.22 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.269 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.57 89.96 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 175.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 29' ' ' ARG . 89.6 mt -59.99 -46.42 94.15 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.656 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.556 178.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.409 ' O ' ' HG2' ' A' ' 37' ' ' LYS . . . -59.02 -44.97 91.78 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 41.2 mt -64.87 -47.34 78.21 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.706 0.765 . . . . 0.0 111.593 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.484 ' HG ' ' HB2' ' A' ' 61' ' ' LYS . 51.5 tp -70.52 -38.14 74.22 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.291 -1.322 . . . . 0.0 113.835 -173.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 14.3 ptmm? -56.75 -30.57 63.72 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -175.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -98.73 8.8 44.53 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.53 0.681 . . . . 0.0 111.077 -177.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . 0.261 45.3 mtmt -84.15 -85.64 0.13 Allowed 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 119.18 -1.008 . . . . 0.0 113.382 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -173.48 136.9 0.71 Allowed Pre-proline 0 C--N 1.289 -2.024 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -176.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -58.56 107.3 0.33 Allowed 'Trans proline' 0 C--O 1.246 0.906 0 C-N-CA 122.519 2.146 . . . . 0.0 110.704 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.45 -25.82 4.73 Favored Glycine 0 N--CA 1.426 -1.972 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -175.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.407 ' O ' HD13 ' A' ' 36' ' ' LEU . . . -76.06 155.19 35.05 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-O 121.093 0.473 . . . . 0.0 110.362 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -146.2 178.33 8.31 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.431 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -156.64 149.46 23.79 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 169.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.406 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 61.1 mt -113.69 124.07 69.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.55 ' HD2' ' O ' ' A' ' 27' ' ' LEU . 39.1 ptt85 -117.28 -177.25 3.18 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.398 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -98.92 136.66 38.6 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.9 t -109.81 152.98 25.03 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.376 0.608 . . . . 0.0 112.212 -172.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -117.62 92.52 3.86 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-O 121.964 0.888 . . . . 0.0 108.884 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.4 m -153.85 -50.92 0.1 Allowed 'General case' 0 C--N 1.258 -3.401 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 177.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -130.88 143.32 50.64 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 104.068 -2.567 . . . . 0.0 104.068 171.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -81.22 120.46 24.92 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.52 30.63 4.88 Favored Glycine 0 C--N 1.295 -1.708 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -171.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -119.29 145.4 46.15 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.456 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 85.1 m-85 -115.55 143.06 45.88 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.31 123.03 7.67 Favored Glycine 0 C--N 1.285 -2.281 0 C-N-CA 119.995 -1.098 . . . . 0.0 110.432 -178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -99.61 119.87 38.77 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -114.41 121.93 45.08 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 176.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.8 tt -123.05 123.86 41.82 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -176.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.484 ' HB2' ' HG ' ' A' ' 36' ' ' LEU . 22.1 tptm -90.25 113.44 25.27 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 80' ' ' LEU . 17.9 m -99.02 171.26 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.02 -56.57 4.54 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 176.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.4 p -158.67 132.45 4.96 Favored Pre-proline 0 C--N 1.309 -1.189 0 C-N-CA 125.294 1.437 . . . . 0.0 108.287 177.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.556 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 35.7 Cg_exo -59.73 -42.14 48.99 Favored 'Trans proline' 0 CA--C 1.577 2.65 0 C-N-CA 121.376 1.384 . . . . 0.0 111.545 171.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.556 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 95.3 Cg_endo -76.89 172.25 16.53 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 122.991 2.46 . . . . 0.0 110.153 170.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.62 -44.91 43.57 Favored 'Trans proline' 0 C--N 1.362 1.241 0 C-N-CA 122.873 2.382 . . . . 0.0 112.633 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.5 m -143.49 -15.3 0.65 Allowed 'General case' 0 C--O 1.247 0.968 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.344 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.492 ' HB3' ' CG ' ' A' ' 66' ' ' PRO . . . 58.38 43.63 19.55 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 123.884 0.873 . . . . 0.0 108.688 -174.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -57.68 -48.23 97.57 Favored Pre-proline 0 N--CA 1.447 -0.606 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.819 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -76.41 87.6 1.43 Allowed 'Trans proline' 0 C--N 1.371 1.734 0 CA-C-N 120.495 1.212 . . . . 0.0 109.746 171.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 31.4 t-105 -81.78 141.52 33.43 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.674 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -122.9 -33.11 3.41 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.306 -0.958 . . . . 0.0 112.102 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.03 68.12 0.02 OUTLIER Glycine 0 CA--C 1.466 -2.976 0 N-CA-C 106.097 -2.801 . . . . 0.0 106.097 -176.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -104.4 110.9 64.94 Favored Pre-proline 0 C--N 1.284 -2.24 0 CA-C-N 113.381 -1.409 . . . . 0.0 111.215 -168.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -73.84 159.83 44.5 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.12 1.88 . . . . 0.0 111.437 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.408 ' HA ' HD23 ' A' ' 80' ' ' LEU . 8.6 p -62.99 -20.78 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.462 0.648 . . . . 0.0 110.676 -178.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -67.75 -13.32 62.02 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 124.065 0.946 . . . . 0.0 111.396 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -87.67 -38.36 15.93 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.461 ' O ' HG22 ' A' ' 62' ' ' VAL . 2.7 mm? -73.15 -27.57 61.74 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.866 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.2 t -86.18 110.08 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 171.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -91.78 134.27 34.89 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.408 -0.814 . . . . 0.0 108.853 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -114.26 122.5 46.93 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.298 0.57 . . . . 0.0 110.579 178.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -129.75 160.17 34.25 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -123.14 150.49 43.21 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.657 -1.217 . . . . 0.0 111.927 174.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.456 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 81.6 mt -108.81 131.1 60.41 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.792 0 CA-C-N 114.068 -1.424 . . . . 0.0 107.615 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -115.54 137.47 52.03 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 1.7 t -110.81 118.72 36.91 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 171.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -135.52 -148.09 5.57 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.85 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -71.25 -34.1 10.42 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 122.56 2.173 . . . . 0.0 113.875 -177.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -75.72 -26.49 57.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.129 0.49 . . . . 0.0 111.034 178.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 139.04 -153.52 22.82 Favored Glycine 0 N--CA 1.425 -2.087 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 88' ' ' THR . 13.9 p -112.04 130.87 64.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.23 170.01 23.22 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.418 ' HB ' ' SG ' ' A' ' 98' ' ' CYS . 64.1 mt -81.16 140.46 16.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -52.39 -53.05 49.95 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 123.601 0.761 . . . . 0.0 109.926 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.65 23.79 5.47 Favored Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 115.086 -0.961 . . . . 0.0 114.666 -176.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.418 ' SG ' ' HB ' ' A' ' 95' ' ' ILE . 31.1 p -116.02 103.09 53.71 Favored Pre-proline 0 N--CA 1.435 -1.2 0 CA-C-N 118.315 1.057 . . . . 0.0 110.551 174.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -100.6 28.47 0.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.124 2.549 . . . . 0.0 110.053 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.3 p -75.54 -78.71 0.11 Allowed 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.438 -176.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -166.68 -59.07 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -79.12 126.23 6.92 Favored 'Trans proline' 0 N--CA 1.44 -1.668 0 N-CA-C 115.813 1.428 . . . . 0.0 115.813 -165.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -97.72 121.03 39.15 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 168.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.548 ' CD2' ' HB3' ' A' ' 110' ' ' LEU . 60.0 m-85 -94.46 166.29 12.13 Favored 'General case' 0 C--N 1.289 -2.024 0 O-C-N 123.395 0.434 . . . . 0.0 111.177 -170.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.22 -36.78 6.93 Favored Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 121.108 -0.568 . . . . 0.0 111.991 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.9 m -140.98 169.41 17.68 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 122.497 -0.414 . . . . 0.0 109.943 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.454 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 94.8 mt -62.36 -40.05 95.17 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.107 0.563 . . . . 0.0 112.198 -176.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.0 t -52.53 -40.46 62.52 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.218 0.607 . . . . 0.0 112.037 -178.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.58 96.41 Favored 'General case' 0 C--O 1.247 0.954 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.548 ' HB3' ' CD2' ' A' ' 104' ' ' PHE . 4.4 pp -72.55 -28.73 63.01 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 120.912 0.387 . . . . 0.0 110.919 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 40.6 t -63.78 -54.59 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.132 177.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 45.9 m -65.28 -36.67 84.83 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.502 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -57.77 -48.18 80.39 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.434 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.466 ' HA ' ' O ' ' A' ' 117' ' ' SER . 71.6 m80 -87.53 -2.49 58.65 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.5 t -79.33 -31.15 43.03 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 67.4 mt -95.85 -58.96 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.424 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 21.6 m -111.57 105.3 56.71 Favored Pre-proline 0 N--CA 1.434 -1.247 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.835 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -75.29 85.35 1.57 Allowed 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 121.696 1.597 . . . . 0.0 110.076 175.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.0 mt -72.51 -73.85 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.908 -177.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.1 m -98.89 1.18 45.46 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.664 0.745 . . . . 0.0 111.318 -176.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.4 mt -105.29 137.6 19.3 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.78 -10.93 29.76 Favored 'Trans proline' 0 N--CA 1.485 1.023 0 C-N-CA 122.885 2.39 . . . . 0.0 113.701 -177.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 52.3 t -141.01 151.52 44.17 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 13.2 p -76.67 142.65 40.5 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 176.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 90.1 mt -73.02 120.17 18.27 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 123.741 0.651 . . . . 0.0 109.738 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -101.41 120.07 39.72 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mt -105.29 109.59 63.39 Favored Pre-proline 0 N--CA 1.429 -1.483 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -84.68 -5.11 9.95 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 C-N-CA 122.725 2.283 . . . . 0.0 113.08 -176.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.4 m 60.6 26.47 16.17 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 124.898 1.279 . . . . 0.0 110.117 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.4 149.43 26.13 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 114.211 -1.359 . . . . 0.0 107.804 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.3 t70 . . . . . 0 C--N 1.262 -3.21 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.263 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.6 ttm . . . . . 0 CA--C 1.52 -0.187 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -117.45 140.46 49.56 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -83.43 -21.39 32.96 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.272 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -77.19 130.15 36.9 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 174.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -82.05 -15.48 53.41 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.046 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.4 m80 62.47 77.44 0.33 Allowed 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.036 0.934 . . . . 0.0 109.415 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -84.72 170.25 13.45 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.141 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.5 m -76.11 15.98 0.49 Allowed 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 m -68.88 -34.21 75.05 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 173.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.34 42.58 2.12 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 49.2 tp -88.96 104.87 17.37 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.6 m -79.35 148.18 70.01 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -45.25 -59.53 1.13 Allowed 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 123.672 2.915 . . . . 0.0 112.338 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -134.43 -49.63 0.78 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.5 12.13 25.58 Favored Glycine 0 CA--C 1.494 -1.251 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.08 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.7 m -89.39 13.4 13.73 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.774 0.797 . . . . 0.0 110.762 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.458 ' O ' ' HD2' ' A' ' 20' ' ' LYS . 18.6 m-20 -112.48 139.76 47.79 Favored 'General case' 0 CA--C 1.478 -1.819 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.1 p -83.1 15.29 2.89 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 122.417 1.103 . . . . 0.0 111.827 -175.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 36.2 t -80.06 -21.56 43.26 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.27 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.458 ' HD2' ' O ' ' A' ' 17' ' ' ASP . 0.1 OUTLIER -68.95 -4.55 17.1 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -173.887 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -86.19 -12.09 50.72 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 122.114 -0.366 . . . . 0.0 110.78 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.429 ' CE3' ' HB2' ' A' ' 23' ' ' TYR . 53.3 p-90 -142.48 -28.95 0.58 Allowed 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -175.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.429 ' HB2' ' CE3' ' A' ' 22' ' ' TRP . 55.4 t80 -92.46 114.26 26.76 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.331 0.586 . . . . 0.0 112.535 -173.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.9 96.56 2.92 Favored Pre-proline 0 C--N 1.306 -1.314 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.816 172.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.95 3.78 6.7 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 123.26 2.64 . . . . 0.0 114.227 -173.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -85.11 -14.66 46.42 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.701 0.762 . . . . 0.0 109.504 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.3 tp -89.2 134.86 33.87 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.367 -169.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.8 t -92.27 177.5 6.13 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-O 120.875 0.369 . . . . 0.0 110.015 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.408 ' HA ' ' CZ ' ' A' ' 47' ' ' ARG . 17.1 ttm180 -54.48 -56.11 22.13 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 124.506 1.122 . . . . 0.0 113.4 -172.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -65.31 -40.59 93.97 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.386 0.612 . . . . 0.0 111.1 -174.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -65.45 -35.83 82.1 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.162 -177.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.33 -40.07 96.28 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.376 178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 73.4 mt -67.95 -41.23 84.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.197 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.11 -31.61 70.21 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.245 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.2 mt -79.81 -39.83 29.92 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.396 0.617 . . . . 0.0 111.707 175.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.9 tp -75.6 -28.74 59.0 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.065 -173.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.2 ptmm? -64.05 -15.07 58.69 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.31 0.576 . . . . 0.0 111.385 178.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -95.5 -13.63 24.36 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.316 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -99.27 174.32 6.36 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.919 0.39 . . . . 0.0 111.457 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -92.94 158.74 37.11 Favored Pre-proline 0 C--N 1.304 -1.376 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.061 -173.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -59.61 120.81 8.85 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 122.472 2.114 . . . . 0.0 110.873 175.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.81 -14.52 10.55 Favored Glycine 0 C--N 1.298 -1.543 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -176.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.75 151.67 27.36 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.459 ' CG ' HD23 ' A' ' 125' ' ' LEU . 22.5 p90 -152.16 162.03 41.74 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -175.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -150.48 147.32 27.36 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 174.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.417 HD13 ' CZ3' ' A' ' 22' ' ' TRP . 64.6 mt -118.96 127.29 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 CA-C-O 121.692 0.758 . . . . 0.0 109.673 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.408 ' CZ ' ' HA ' ' A' ' 29' ' ' ARG . 26.5 ptt-85 -125.3 -173.96 2.94 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -92.27 135.06 34.31 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 174.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 70.2 m -83.64 99.16 10.03 Favored 'General case' 0 N--CA 1.426 -1.631 0 C-N-CA 120.221 -0.591 . . . . 0.0 109.407 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -74.15 69.5 1.52 Allowed 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 121.98 0.895 . . . . 0.0 109.794 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.3 m -157.63 -36.46 0.07 Allowed 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 113.352 -1.749 . . . . 0.0 108.412 -177.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -133.4 166.98 21.27 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -110.89 130.12 55.68 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.78 24.5 38.26 Favored Glycine 0 C--N 1.304 -1.205 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.17 122.44 22.83 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-O 121.673 0.749 . . . . 0.0 110.146 -178.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -96.66 155.91 16.57 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -118.19 120.72 4.82 Favored Glycine 0 C--N 1.273 -2.952 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.45 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.2 tp -98.45 121.7 40.72 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 124.296 0.644 . . . . 0.0 109.275 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.15 112.93 25.37 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.7 tp -108.78 129.54 55.38 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 123.528 0.518 . . . . 0.0 109.7 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -88.83 119.3 29.21 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.7 m -108.38 165.71 4.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.32 -58.73 5.2 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.439 ' HB ' ' HG2' ' A' ' 66' ' ' PRO . 0.6 OUTLIER -164.64 145.47 6.41 Favored Pre-proline 0 C--N 1.314 -0.97 0 C-N-CA 123.545 0.738 . . . . 0.0 110.663 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.578 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 16.3 Cg_exo -63.05 -49.82 4.5 Favored 'Trans proline' 0 CA--C 1.571 2.344 0 C-N-CA 121.933 1.756 . . . . 0.0 109.44 168.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.578 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 15.9 Cg_endo -57.55 179.81 0.13 Allowed 'Trans proline' 0 C--N 1.392 2.831 0 C-N-CA 122.825 2.35 . . . . 0.0 110.841 162.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -71.82 -47.46 0.46 Allowed 'Trans proline' 0 C--N 1.357 1.001 0 N-CA-C 108.072 -1.549 . . . . 0.0 108.072 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 71.5 m -160.79 111.68 1.81 Allowed 'General case' 0 N--CA 1.407 -2.608 0 N-CA-C 103.442 -2.799 . . . . 0.0 103.442 171.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.423 ' H ' HG23 ' A' ' 64' ' ' THR . . . -58.41 76.15 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 124.031 0.932 . . . . 0.0 113.085 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -87.82 -47.43 0.47 Allowed Pre-proline 0 C--N 1.286 -2.156 0 CA-C-N 114.578 -1.192 . . . . 0.0 107.892 172.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -65.51 109.19 1.35 Allowed 'Trans proline' 0 C--N 1.377 2.05 0 N-CA-C 108.654 -1.325 . . . . 0.0 108.654 165.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -81.83 137.32 35.29 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.981 -175.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -126.17 -36.75 2.3 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.763 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 167.73 -48.34 0.24 Allowed Glycine 0 CA--C 1.467 -2.93 0 N-CA-C 107.335 -2.306 . . . . 0.0 107.335 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 39.49 78.38 0.37 Allowed Pre-proline 0 C--N 1.316 -0.87 0 C-N-CA 126.817 2.047 . . . . 0.0 114.647 168.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -75.38 163.2 34.95 Favored 'Trans proline' 0 C--O 1.242 0.701 0 C-N-CA 122.251 1.967 . . . . 0.0 111.518 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -67.11 -30.29 48.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 120.985 0.421 . . . . 0.0 111.182 -178.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -70.71 -18.77 62.8 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.202 0.525 . . . . 0.0 110.473 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -79.09 -22.77 44.76 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.6 mt -89.35 5.69 43.92 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.962 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.8 t -117.85 141.47 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -109.45 137.39 47.37 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -117.7 122.77 44.4 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 121.439 0.638 . . . . 0.0 111.669 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -135.57 143.38 45.62 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 177.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.9 mp -96.42 162.61 13.41 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.263 -1.375 . . . . 0.0 108.726 174.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 80.2 mt -125.13 110.83 25.69 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.014 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 174.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.455 ' OE1' ' HD3' ' A' ' 96' ' ' LYS . 30.1 mt-10 -99.72 148.93 23.84 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -175.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.423 ' HB ' HG22 ' A' ' 93' ' ' VAL . 5.3 t -135.56 141.86 45.25 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -149.74 -155.45 6.8 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.35 -27.22 84.45 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.17 2.58 . . . . 0.0 113.876 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.72 -48.68 16.1 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 120.739 0.305 . . . . 0.0 111.689 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.63 -144.12 8.99 Favored Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.423 HG22 ' HB ' ' A' ' 88' ' ' THR . 12.2 p -123.78 142.49 40.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.64 157.48 31.96 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.155 0.182 . . . . 0.0 111.214 -171.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 58.0 mt -81.56 136.8 22.35 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 CA-C-O 121.207 0.527 . . . . 0.0 110.891 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.455 ' HD3' ' OE1' ' A' ' 87' ' ' GLU . 43.5 tptt -83.38 135.2 34.79 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 124.492 1.117 . . . . 0.0 111.172 -176.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.68 34.55 13.31 Favored Glycine 0 CA--C 1.499 -0.94 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.118 176.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.592 ' SG ' ' HB3' ' A' ' 100' ' ' SER . 47.0 t -142.26 143.15 26.26 Favored Pre-proline 0 N--CA 1.425 -1.68 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -87.36 10.34 3.57 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 123.318 2.678 . . . . 0.0 110.64 177.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.592 ' HB3' ' SG ' ' A' ' 98' ' ' CYS . 40.5 t -125.47 -164.63 1.32 Allowed 'General case' 0 N--CA 1.393 -3.306 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 -178.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 68.4 100.53 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.794 0 C-N-CA 125.674 1.59 . . . . 0.0 112.295 -179.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.94 -162.99 0.15 Allowed 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 122.968 2.445 . . . . 0.0 111.654 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -94.33 96.53 9.61 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -78.32 161.22 27.37 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -76.36 -51.57 6.62 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.524 178.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 39.0 m -137.68 166.7 23.31 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.6 mp -58.72 -36.28 74.04 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 123.166 0.587 . . . . 0.0 110.98 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.1 m -51.21 -37.74 48.45 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.232 1.013 . . . . 0.0 111.482 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.14 -50.08 65.21 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.196 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 111' ' ' VAL . 4.1 pp -68.21 -35.06 77.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.879 0.371 . . . . 0.0 110.592 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.454 ' N ' HD12 ' A' ' 110' ' ' LEU . 47.9 t -58.31 -50.79 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.683 176.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 45.7 p -69.42 -22.78 63.66 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.409 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -88.79 -39.55 13.82 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.928 0.394 . . . . 0.0 111.405 -174.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -75.47 -0.84 21.51 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.7 m -74.56 -28.49 60.96 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 170.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 68.8 mt -97.95 -49.03 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.217 -178.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.9 m -121.71 99.83 44.38 Favored Pre-proline 0 N--CA 1.44 -0.959 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.174 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -81.47 100.89 1.17 Allowed 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.144 1.896 . . . . 0.0 109.727 174.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 65.0 mt -90.29 -73.8 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.135 -174.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.548 ' HB3' ' SG ' ' A' ' 98' ' ' CYS . 2.7 p -77.74 -27.41 50.45 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 122.038 0.923 . . . . 0.0 110.094 177.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.5 mt -83.12 129.68 60.12 Favored Pre-proline 0 N--CA 1.427 -1.587 0 CA-C-N 114.144 -1.389 . . . . 0.0 109.237 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -75.78 -4.33 15.06 Favored 'Trans proline' 0 N--CA 1.485 1.021 0 C-N-CA 122.893 2.395 . . . . 0.0 112.702 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 82.9 m -143.61 152.59 41.57 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . 0.43 ' SG ' ' HD3' ' A' ' 126' ' ' ARG . 21.5 p -82.07 148.63 28.48 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.952 0.406 . . . . 0.0 111.487 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.459 HD23 ' CG ' ' A' ' 44' ' ' PHE . 86.7 mt -74.19 117.42 15.98 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.43 ' HD3' ' SG ' ' A' ' 124' ' ' CYS . 24.2 mmm180 -104.41 109.73 21.71 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.241 0.543 . . . . 0.0 110.221 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mp -96.03 126.66 43.69 Favored Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -64.09 -29.79 65.65 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.408 2.072 . . . . 0.0 111.485 177.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 19.8 t 78.1 -36.29 0.21 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.678 1.591 . . . . 0.0 111.681 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -133.33 -171.43 2.69 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 120.947 0.404 . . . . 0.0 110.206 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 . . . . . 0 C--N 1.297 -1.683 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -179.827 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptm . . . . . 0 C--O 1.235 0.318 0 CA-C-O 120.507 0.194 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -118.88 0.97 11.48 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 174.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -139.53 -168.75 2.54 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.9 m80 64.36 35.71 9.56 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 122.068 0.937 . . . . 0.0 109.226 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -66.11 133.66 51.17 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.559 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.451 ' HA ' ' O ' ' A' ' 9' ' ' SER . 57.6 m-70 68.71 19.0 8.63 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.207 1.003 . . . . 0.0 112.148 178.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -59.14 -31.03 68.59 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.407 0.622 . . . . 0.0 111.635 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.5 t -169.15 -39.16 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 6' ' ' HIS . 5.3 m -77.36 93.04 3.99 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 170.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.5 -97.23 0.21 Allowed Glycine 0 N--CA 1.428 -1.857 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -89.05 113.54 24.67 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.842 0.353 . . . . 0.0 111.617 -176.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -103.96 127.4 29.4 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 175.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -86.78 21.18 1.1 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.112 2.542 . . . . 0.0 113.215 -177.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -79.75 127.25 31.97 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.0 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.73 34.46 6.57 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -177.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.547 ' HA ' ' OG ' ' A' ' 108' ' ' SER . 45.4 p -87.27 17.16 4.54 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 121.906 0.86 . . . . 0.0 110.895 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -84.44 -168.83 2.33 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.675 -176.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.335 80.5 p 76.54 -4.71 2.31 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 127.483 2.313 . . . . 0.0 114.967 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 23' ' ' TYR . 20.0 m -62.66 -31.84 72.79 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.671 0.748 . . . . 0.0 109.483 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -10.64 33.64 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 177.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -98.38 -62.26 1.27 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.804 0.335 . . . . 0.0 111.093 176.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 24.8 p-90 -94.05 -8.65 39.17 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -171.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.481 ' HB3' ' O ' ' A' ' 19' ' ' SER . 70.2 t80 -100.5 120.0 39.35 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.865 -175.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -131.23 88.94 43.07 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 175.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.83 -31.82 67.55 Favored 'Trans proline' 0 N--CA 1.482 0.834 0 C-N-CA 122.482 2.121 . . . . 0.0 113.347 -172.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -84.74 -0.32 53.26 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 124.107 0.963 . . . . 0.0 112.776 -174.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.462 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 14.4 tp -85.76 152.37 23.1 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -176.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 t -110.28 174.86 5.66 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 120.628 0.251 . . . . 0.0 110.432 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 -56.91 -50.36 72.78 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -174.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -64.77 -32.01 73.5 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.126 0.488 . . . . 0.0 111.326 -175.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -74.83 -39.36 61.67 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.326 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.49 -43.44 93.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.395 0.617 . . . . 0.0 109.948 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 78.1 mt -65.62 -39.7 85.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.966 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.439 ' O ' ' HG2' ' A' ' 37' ' ' LYS . . . -57.71 -49.44 76.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.277 178.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.8 -36.29 82.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.075 0.464 . . . . 0.0 111.336 178.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.405 ' CD1' HD23 ' A' ' 45' ' ' LEU . 6.6 mp -81.2 -14.81 57.17 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -177.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 17.8 ptpt -80.28 -15.05 57.83 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.673 177.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -100.23 -3.72 30.92 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.187 176.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -101.38 174.63 5.89 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -176.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -91.53 144.65 29.91 Favored Pre-proline 0 C--N 1.305 -1.343 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.14 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.02 118.44 4.98 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.083 2.522 . . . . 0.0 112.094 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.37 -11.71 9.09 Favored Glycine 0 N--CA 1.435 -1.41 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -174.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.65 147.87 37.24 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -150.68 171.5 17.06 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -176.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.405 HD23 ' CD1' ' A' ' 36' ' ' LEU . 1.5 pt? -161.56 154.52 20.75 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 172.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.3 mt -121.48 134.92 63.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 121.061 0.457 . . . . 0.0 110.565 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.522 ' HG3' ' O ' ' A' ' 48' ' ' ASP . 23.8 ptt-85 -127.39 -173.69 2.97 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 177.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.522 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 13.1 t70 -82.4 150.75 26.94 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 174.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 70.8 m -66.25 -26.75 67.5 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 119.307 0.958 . . . . 0.0 112.12 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 35.4 t60 69.73 -46.75 0.59 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 124.909 1.284 . . . . 0.0 111.873 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.2 t -71.67 -33.5 68.91 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 123.775 0.83 . . . . 0.0 110.35 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -122.36 154.36 37.77 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -177.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -102.39 126.73 49.51 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 123.812 0.695 . . . . 0.0 110.41 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.13 22.67 34.57 Favored Glycine 0 C--N 1.308 -1.024 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -178.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.62 144.02 47.65 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 120.898 0.38 . . . . 0.0 110.162 -177.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -112.64 139.0 48.62 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -101.96 111.63 4.12 Favored Glycine 0 C--N 1.294 -1.797 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.378 -177.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 39.3 tp -91.31 130.49 37.17 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 123.88 0.872 . . . . 0.0 109.306 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -114.44 128.71 56.48 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 175.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.2 tp -122.27 129.54 52.3 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 123.553 0.533 . . . . 0.0 110.546 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -93.1 114.28 26.77 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 28.4 m -106.82 164.14 4.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 173.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.07 -59.24 3.02 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.9 p -149.22 141.73 15.36 Favored Pre-proline 0 N--CA 1.421 -1.877 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.568 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 39.1 Cg_exo -59.99 -44.71 28.1 Favored 'Trans proline' 0 CA--C 1.57 2.279 0 C-N-CA 121.675 1.583 . . . . 0.0 111.659 174.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.568 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 85.6 Cg_endo -75.78 149.72 33.98 Favored 'Trans proline' 0 C--N 1.381 2.272 0 C-N-CA 122.416 2.077 . . . . 0.0 109.559 171.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.18 -48.11 6.89 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.148 1.899 . . . . 0.0 112.629 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.9 p -116.71 -9.1 11.34 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.855 0.36 . . . . 0.0 111.363 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 59.4 44.05 15.64 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.562 -178.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -50.38 -52.33 55.8 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 113.902 -1.499 . . . . 0.0 110.787 175.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.45 93.43 0.98 Allowed 'Trans proline' 0 N--CA 1.441 -1.568 0 CA-C-N 120.308 1.146 . . . . 0.0 109.352 169.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 53.0 t-105 -86.55 137.16 32.73 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.562 -175.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -124.7 -42.12 2.09 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.206 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.24 56.39 1.0 Allowed Glycine 0 C--N 1.299 -1.524 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -89.94 139.93 27.57 Favored Pre-proline 0 C--N 1.306 -1.289 0 CA-C-N 115.091 -0.555 . . . . 0.0 109.855 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.19 167.93 26.06 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.893 2.395 . . . . 0.0 113.829 -175.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 p -59.53 -32.74 49.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.336 176.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 -65.1 -18.68 65.5 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.073 0.463 . . . . 0.0 110.881 177.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -92.4 -36.05 13.35 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.95 -35.8 82.33 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.156 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 89.6 t -70.71 113.04 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.515 ' HA ' ' NE ' ' A' ' 82' ' ' ARG . 1.7 mmp_? -87.25 144.6 26.74 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.795 -176.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -125.84 124.47 40.98 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 120.974 0.416 . . . . 0.0 110.352 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -132.13 132.86 43.63 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.442 ' HG ' ' HB2' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -97.06 140.59 31.35 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.972 -1.091 . . . . 0.0 112.229 177.029 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 77.4 mt -107.61 120.68 59.36 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.419 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -105.78 138.01 42.7 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -175.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.9 t -116.36 124.75 50.84 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.65 -162.66 9.52 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 -178.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.55 -31.82 49.9 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.205 2.603 . . . . 0.0 112.631 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -71.04 -21.88 62.21 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 175.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 132.63 -159.47 23.45 Favored Glycine 0 CA--C 1.488 -1.601 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.6 p -104.01 127.18 58.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.688 ' HG2' ' CD2' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -149.73 167.03 27.63 Favored 'General case' 0 C--O 1.201 -1.493 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.24 -171.665 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 66.6 mt -93.2 143.88 10.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.405 -176.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.442 ' HB2' ' HG ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -44.69 -46.56 10.37 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.675 1.59 . . . . 0.0 112.124 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -127.01 63.89 0.59 Allowed Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.44 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 11.1 p -85.05 122.85 74.1 Favored Pre-proline 0 C--N 1.304 -1.391 0 CA-C-O 120.678 0.275 . . . . 0.0 110.391 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -80.29 10.42 3.24 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 122.752 2.301 . . . . 0.0 113.365 -176.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.8 m -154.82 -162.46 1.38 Allowed 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -109.88 106.37 58.19 Favored Pre-proline 0 C--N 1.294 -1.816 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -175.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -89.42 -80.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.653 0 C-N-CA 122.066 1.844 . . . . 0.0 112.149 171.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.688 ' CD2' ' HG2' ' A' ' 94' ' ' LYS . 51.8 m-85 43.49 79.36 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 127.381 2.272 . . . . 0.0 112.805 178.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -107.08 -178.36 3.62 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.279 -177.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -86.35 -36.9 9.3 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.009 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.8 m -132.9 158.51 42.41 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 122.456 -0.438 . . . . 0.0 110.487 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 75.1 mt -55.21 -46.78 75.93 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 123.13 0.572 . . . . 0.0 111.463 178.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.547 ' OG ' ' HA ' ' A' ' 16' ' ' SER . 24.3 p -54.6 -31.21 56.6 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 123.242 0.617 . . . . 0.0 112.401 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.18 -39.14 82.58 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.113 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.437 HD13 ' N ' ' A' ' 111' ' ' VAL . 3.8 pp -80.31 -29.81 38.13 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.687 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.437 ' N ' HD13 ' A' ' 110' ' ' LEU . 40.6 t -63.41 -54.48 32.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.629 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.7 m -68.64 -20.61 64.47 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.303 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -78.26 -40.82 35.94 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.646 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.507 ' HA ' ' O ' ' A' ' 117' ' ' SER . 66.8 m80 -80.18 3.02 21.99 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -174.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 10.7 p -86.15 -39.88 16.22 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 172.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.5 mt -84.01 -48.14 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.271 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 19.6 m -121.86 93.06 48.78 Favored Pre-proline 0 N--CA 1.425 -1.706 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.835 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.57 73.43 5.6 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.855 2.37 . . . . 0.0 110.873 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 67.5 mt -68.8 -60.8 2.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.13 -178.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.3 m -83.72 -49.96 8.62 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.551 -175.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -73.4 139.96 78.84 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.867 -177.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.88 -18.39 46.94 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 123.09 2.527 . . . . 0.0 111.994 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 43.6 t -127.94 154.75 45.21 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 4.0 p -71.61 145.01 49.26 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 177.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 74.2 mt -79.41 106.31 11.35 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -90.38 103.78 16.42 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.336 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.457 ' H ' HD12 ' A' ' 127' ' ' ILE . 1.8 mp -90.38 128.12 50.3 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -73.91 -29.59 10.08 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 121.435 1.423 . . . . 0.0 110.21 174.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.4 m -80.96 -1.53 44.07 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 125.203 1.401 . . . . 0.0 113.243 -175.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.428 ' HB3' ' HB ' ' A' ' 127' ' ' ILE . 17.6 tppt? -140.19 145.86 37.99 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 . . . . . 0 C--N 1.29 -2.01 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.936 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.34 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.494 ' CD2' ' HD1' ' A' ' 5' ' ' HIS . 52.7 m80 -90.37 106.47 18.52 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.059 0.457 . . . . 0.0 111.776 -177.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -96.32 -49.65 5.11 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -119.22 -50.24 2.36 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.069 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.494 ' HD1' ' CD2' ' A' ' 2' ' ' HIS . 18.9 t60 69.05 88.97 0.11 Allowed 'General case' 0 C--O 1.242 0.686 0 O-C-N 124.486 1.116 . . . . 0.0 109.615 -175.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -110.6 114.4 27.76 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.917 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 48.83 72.76 0.26 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.259 1.423 . . . . 0.0 111.95 175.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.471 ' HB2' ' CE1' ' A' ' 5' ' ' HIS . 19.9 m -134.59 77.3 1.68 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.687 0.756 . . . . 0.0 110.03 178.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.6 t -166.4 156.3 11.85 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.61 104.46 3.15 Favored Glycine 0 N--CA 1.423 -2.173 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.94 114.85 18.22 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 176.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.2 t -115.69 100.22 53.32 Favored Pre-proline 0 C--N 1.294 -1.84 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -176.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.85 85.29 1.65 Allowed 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.194 1.93 . . . . 0.0 109.871 177.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 73.33 -52.39 0.7 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.508 1.523 . . . . 0.0 111.254 -176.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 177.03 -97.76 0.11 Allowed Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 107.907 -2.077 . . . . 0.0 107.907 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.436 ' C ' ' H ' ' A' ' 18' ' ' THR . 14.1 t -135.46 24.67 3.46 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 173.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.93 24.0 0.79 Allowed 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 112.527 -2.124 . . . . 0.0 109.296 -177.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.518 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 2.0 p -76.07 -10.65 59.59 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -174.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.5 m -74.32 -36.17 63.68 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.313 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.77 -5.86 40.81 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.518 ' CD2' ' HA ' ' A' ' 18' ' ' THR . 25.6 m-85 -81.08 -24.12 38.0 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.079 175.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.464 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 54.0 p-90 -116.6 -32.28 5.24 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -93.16 114.54 27.07 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.217 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . 0.252 0.1 OUTLIER -155.24 98.28 2.37 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-O 121.711 0.767 . . . . 0.0 111.266 175.361 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -83.35 19.43 1.34 Allowed 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 124.047 3.165 . . . . 0.0 114.62 -173.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -99.43 -4.03 32.37 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.993 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.7 mp -92.99 140.96 28.92 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.817 0.818 . . . . 0.0 112.952 -177.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 m -90.05 177.26 6.5 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.043 -1.435 . . . . 0.0 107.707 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -50.49 -56.56 11.04 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.249 0.62 . . . . 0.0 110.635 177.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -65.86 -35.31 80.29 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.709 -175.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -66.94 -38.69 86.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.088 178.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.44 -42.07 99.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.577 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 82.9 mt -64.82 -45.83 93.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.107 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.406 ' HA ' ' CD ' ' A' ' 37' ' ' LYS . . . -59.83 -32.95 71.14 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.702 0.763 . . . . 0.0 111.83 178.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.14 -50.08 17.48 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.499 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 70.1 mt -71.09 -26.26 62.97 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -175.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.406 ' CD ' ' HA ' ' A' ' 34' ' ' ALA . 14.3 ptmm? -65.11 -24.49 67.44 Favored 'General case' 0 C--N 1.316 -0.883 0 O-C-N 121.908 -0.495 . . . . 0.0 110.567 178.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -84.37 -40.36 17.96 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.753 176.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.514 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -68.58 151.42 46.78 Favored 'General case' 0 C--O 1.248 1.015 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.222 -176.278 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -75.11 138.35 72.36 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.815 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -45.45 120.24 3.11 Favored 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 124.265 3.31 . . . . 0.0 114.121 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.87 -24.43 6.38 Favored Glycine 0 N--CA 1.434 -1.476 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -176.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.08 151.66 45.23 Favored 'General case' 0 C--O 1.249 1.031 0 CA-C-N 114.975 -0.613 . . . . 0.0 110.016 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -153.6 170.93 19.63 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 -175.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -147.42 145.7 29.31 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 171.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.464 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 60.7 mt -111.56 123.33 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.067 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -124.1 179.91 4.68 Favored 'General case' 0 C--N 1.275 -2.66 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 177.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -84.98 154.02 22.4 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 175.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.6 t -81.82 133.87 35.37 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -90.95 -22.89 20.62 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 121.833 0.825 . . . . 0.0 108.98 177.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.7 m -72.53 -52.82 13.99 Favored 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 114.347 -1.297 . . . . 0.0 109.784 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -126.77 138.55 53.38 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.33 0.585 . . . . 0.0 111.348 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -88.77 138.03 31.78 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 176.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.22 11.67 58.29 Favored Glycine 0 C--N 1.305 -1.143 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -172.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -135.3 153.88 51.73 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-N 114.631 -0.784 . . . . 0.0 109.111 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.459 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 52.6 m-85 -115.83 171.58 7.68 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 176.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.18 133.13 8.87 Favored Glycine 0 C--N 1.282 -2.437 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -111.22 115.61 29.66 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.34 125.36 50.51 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.487 HD23 ' SG ' ' A' ' 123' ' ' CYS . 50.4 tp -124.08 129.83 51.53 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 123.395 0.435 . . . . 0.0 111.782 -173.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.499 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 22.3 tptm -91.77 114.24 26.72 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 174.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 80' ' ' LEU . 24.3 m -101.64 171.08 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 175.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.61 -55.6 6.62 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.432 ' HB ' ' HG2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -159.18 142.98 10.94 Favored Pre-proline 0 N--CA 1.421 -1.892 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.508 -178.277 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.584 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 16.8 Cg_exo -61.46 -50.27 5.97 Favored 'Trans proline' 0 CA--C 1.555 1.542 0 C-N-CA 122.208 1.939 . . . . 0.0 110.094 172.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.584 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 10.8 Cg_endo -54.76 136.03 69.88 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 122.105 1.87 . . . . 0.0 109.653 163.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.19 -11.55 21.14 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.64 2.227 . . . . 0.0 112.674 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.4 p -130.1 -37.28 1.48 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.912 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.421 ' HA ' ' HB2' ' A' ' 66' ' ' PRO . . . 72.9 23.04 2.9 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 125.096 1.358 . . . . 0.0 111.989 178.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -62.91 -49.05 83.73 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.598 173.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.14 105.87 1.27 Allowed 'Trans proline' 0 C--N 1.386 2.502 0 C-N-CA 121.047 1.165 . . . . 0.0 110.126 170.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 68.2 t-105 -96.1 149.06 22.03 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.78 -175.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -133.62 -36.71 0.95 Allowed 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.878 175.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.36 34.38 29.28 Favored Glycine 0 CA--C 1.503 -0.685 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.9 p30 -90.28 153.8 46.6 Favored Pre-proline 0 C--N 1.298 -1.642 0 CA-C-N 114.163 -1.019 . . . . 0.0 111.127 -177.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_exo -34.51 146.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.366 1.499 1 C-N-CA 125.99 4.46 . . . . 0.0 117.684 -175.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.1 p -70.24 -13.97 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.221 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -64.9 -16.05 62.77 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.809 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -92.02 -24.81 19.08 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 121.114 0.483 . . . . 0.0 109.781 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.463 ' O ' HG23 ' A' ' 62' ' ' VAL . 79.1 mt -76.02 -26.06 56.3 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.013 0.911 . . . . 0.0 109.01 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.5 t -93.88 123.88 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 173.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.466 ' NE ' ' HA ' ' A' ' 82' ' ' ARG . 4.1 mmp_? -104.89 151.01 24.38 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -123.91 124.62 43.02 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.627 0.727 . . . . 0.0 111.772 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -128.13 170.38 13.02 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 pp -135.25 157.81 45.96 Favored 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.485 176.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.459 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 39.4 mt -111.34 123.68 67.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -173.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -102.77 129.55 49.46 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 123.733 0.813 . . . . 0.0 109.016 -176.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.6 t -116.77 132.76 56.61 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 120.928 0.394 . . . . 0.0 110.304 174.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.65 -159.82 8.34 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.56 -31.9 49.66 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.008 2.472 . . . . 0.0 113.713 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -80.57 -36.23 33.24 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.701 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 163.31 -163.15 35.38 Favored Glycine 0 N--CA 1.422 -2.238 0 C-N-CA 119.911 -1.138 . . . . 0.0 112.124 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.0 p -116.11 126.75 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.283 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.542 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 0.0 OUTLIER -151.27 173.88 13.95 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 116.048 -0.523 . . . . 0.0 112.388 -177.249 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.442 ' HB ' ' OG ' ' A' ' 120' ' ' SER . 70.2 mt -97.61 141.81 15.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-O 121.74 0.781 . . . . 0.0 112.975 -171.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -65.74 132.58 49.1 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 125.122 1.369 . . . . 0.0 108.926 174.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.42 -9.59 38.6 Favored Glycine 0 C--N 1.312 -0.778 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.568 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 37.8 t -142.24 141.04 20.17 Favored Pre-proline 0 N--CA 1.422 -1.866 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.58 -40.38 47.47 Favored 'Trans proline' 0 C--O 1.244 0.805 0 C-N-CA 121.555 1.504 . . . . 0.0 109.385 176.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.542 ' OG ' ' HB2' ' A' ' 94' ' ' LYS 0.38 1.8 p 49.41 67.36 0.9 Allowed 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 123.443 1.592 . . . . 0.0 114.06 -177.17 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.501 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 41.8 mt-10 -49.63 -36.72 18.59 Favored Pre-proline 0 C--N 1.303 -1.446 0 CA-C-N 111.525 -2.579 . . . . 0.0 115.652 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 101' ' ' GLU . 7.3 Cg_endo -53.6 -33.11 67.4 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.134 1.889 . . . . 0.0 114.732 177.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 48.75 99.58 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 126.211 1.805 . . . . 0.0 111.982 -172.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -74.31 139.39 44.17 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.745 -176.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.03 -42.25 20.26 Favored Glycine 0 C--N 1.304 -1.223 0 C-N-CA 120.042 -1.075 . . . . 0.0 110.706 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.8 m -133.22 159.89 38.87 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.417 ' O ' ' HB3' ' A' ' 110' ' ' LEU . 96.1 mt -58.61 -31.67 68.29 Favored 'General case' 0 C--O 1.215 -0.711 0 C-N-CA 123.626 0.77 . . . . 0.0 112.045 -178.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.9 m -61.27 -32.12 71.94 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-O 120.846 0.355 . . . . 0.0 111.589 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.5 -31.82 62.32 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.562 0.696 . . . . 0.0 109.555 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 107' ' ' LEU . 3.7 tt -67.62 -45.37 75.62 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.537 -1.21 . . . . 0.0 109.354 176.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.439 HG22 ' CE2' ' A' ' 22' ' ' TRP . 73.2 t -71.13 -39.11 73.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.137 -0.938 . . . . 0.0 113.177 -177.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.7 t -68.97 -21.81 64.15 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.151 0.5 . . . . 0.0 110.997 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -107.11 177.96 4.7 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.398 -178.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.51 ' HA ' ' O ' ' A' ' 117' ' ' SER . 7.0 m-70 73.48 -10.43 1.05 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.969 0.908 . . . . 0.0 113.21 -177.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.0 m -73.26 -32.8 64.9 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 169.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 61.2 mt -88.24 -62.23 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.859 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 26.6 t -116.54 99.96 53.13 Favored Pre-proline 0 N--CA 1.434 -1.238 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.32 99.12 1.08 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.78 2.32 . . . . 0.0 110.812 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.42 ' HB ' ' CE1' ' A' ' 114' ' ' HIS . 67.6 mt -99.51 -51.32 10.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.225 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.442 ' OG ' ' HB ' ' A' ' 95' ' ' ILE . 34.7 t -80.89 -42.35 21.59 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.644 -177.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -89.83 144.11 31.14 Favored Pre-proline 0 N--CA 1.434 -1.25 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.294 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -63.41 -32.21 71.79 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.987 2.458 . . . . 0.0 111.757 177.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.487 ' SG ' HD23 ' A' ' 60' ' ' LEU . 26.3 p -109.45 169.87 8.43 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 23.2 m -70.14 132.71 46.23 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 176.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 29.2 tp -82.37 131.98 35.22 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -136.39 128.14 29.07 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.0 mp -66.24 125.14 89.73 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -61.29 -50.34 6.06 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.049 1.833 . . . . 0.0 111.299 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.479 ' HA ' ' CG ' ' A' ' 21' ' ' PHE . 65.6 p 56.18 13.21 1.14 Allowed 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.124 1.769 . . . . 0.0 114.403 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.49 ' HD3' ' C ' ' A' ' 130' ' ' LYS . 11.5 tmtt? -166.66 116.71 0.92 Allowed 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 . . . . . 0 C--N 1.301 -1.521 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 173.669 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.0 p . . . . . 0 N--CA 1.446 -0.666 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.1 p -58.2 -45.0 88.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -174.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -13.25 62.11 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -74.48 -35.74 63.28 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.154 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.491 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 41.3 p-90 -110.36 -26.7 9.42 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 114.058 1.132 . . . . 0.0 114.058 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -90.81 113.32 25.44 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.316 0.579 . . . . 0.0 111.656 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.66 93.89 4.21 Favored Pre-proline 0 C--N 1.299 -1.627 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.846 174.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 47' ' ' ARG . 97.0 Cg_endo -76.43 -0.09 10.04 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 123.58 2.853 . . . . 0.0 114.334 -172.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -94.93 -1.54 52.35 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.088 0.471 . . . . 0.0 111.752 -173.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.533 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 73.3 mt -94.86 145.88 24.6 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.309 0.576 . . . . 0.0 111.746 -178.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.455 ' HA ' ' NH1' ' A' ' 47' ' ' ARG . 23.1 t -100.74 177.23 5.05 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.1 ttt180 -52.99 -53.4 50.57 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.654 0.782 . . . . 0.0 112.585 -173.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -64.0 -32.47 74.02 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.981 0.419 . . . . 0.0 111.411 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.426 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 15.7 mm-40 -73.03 -34.57 66.42 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.822 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.05 -44.94 83.13 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.414 0.626 . . . . 0.0 109.619 178.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.8 mt -63.93 -36.39 76.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.425 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.19 -36.04 72.49 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.481 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 4.4 mm? -75.78 -47.84 24.19 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.278 174.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.3 mt -66.42 -21.54 66.22 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -174.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -74.25 -5.24 40.89 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.417 0.627 . . . . 0.0 111.47 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -112.57 5.46 17.89 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 35' ' ' LEU . 31.3 mmmt -110.98 145.17 38.88 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.385 0.612 . . . . 0.0 110.992 -177.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -76.74 141.57 68.82 Favored Pre-proline 0 C--N 1.301 -1.531 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.221 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -47.64 118.9 3.28 Favored 'Trans proline' 0 C--N 1.364 1.375 0 C-N-CA 123.938 3.092 . . . . 0.0 113.467 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.24 -30.51 3.47 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.39 151.89 39.62 Favored 'General case' 0 C--O 1.253 1.239 0 CA-C-O 120.717 0.294 . . . . 0.0 110.54 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -147.32 175.9 10.42 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.671 -176.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -149.59 147.37 28.06 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 170.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.491 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 62.4 mt -112.19 122.21 66.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.533 ' HD2' ' O ' ' A' ' 27' ' ' LEU . 28.5 ptt85 -121.09 -173.94 2.72 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -95.22 153.51 17.63 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.5 t -97.39 132.35 43.19 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.95 0.881 . . . . 0.0 111.131 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -85.3 -14.79 45.45 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.803 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.7 m -78.53 -51.74 9.51 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.195 -175.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -128.98 144.22 51.12 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -73.76 132.93 43.14 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.01 31.65 25.55 Favored Glycine 0 N--CA 1.436 -1.367 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.146 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.0 145.97 49.98 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.424 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 87.3 m-85 -113.72 134.47 54.73 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.83 118.02 5.15 Favored Glycine 0 N--CA 1.421 -2.356 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.042 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -96.69 118.29 32.84 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.98 119.75 40.3 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.0 tp -121.37 131.56 54.26 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.473 -176.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -88.81 113.99 24.96 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 175.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 80' ' ' LEU . 26.1 m -102.26 169.52 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.999 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.64 -57.6 4.0 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.87 118.81 2.15 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.134 0.974 . . . . 0.0 110.697 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.613 ' N ' ' HD3' ' A' ' 66' ' ' PRO . 21.5 Cg_endo -99.42 12.31 0.64 Allowed 'Trans proline' 0 CA--C 1.601 3.847 0 C-N-CA 122.84 2.36 . . . . 0.0 118.037 178.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.613 ' HD3' ' N ' ' A' ' 65' ' ' PRO . 2.0 Cg_endo -93.58 164.92 2.31 Favored 'Trans proline' 0 C--N 1.384 2.407 0 CA-C-N 123.051 2.125 . . . . 0.0 111.218 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -74.03 -22.16 17.43 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 121.861 1.707 . . . . 0.0 111.782 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.1 p -134.45 -43.2 0.77 Allowed 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.392 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.437 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 75.84 3.76 3.83 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.026 1.33 . . . . 0.0 112.982 177.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.461 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 34.9 tt0 -86.68 -52.44 0.43 Allowed Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 172.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.461 ' HD3' ' HB3' ' A' ' 70' ' ' GLN . 7.3 Cg_exo -76.02 107.09 2.39 Favored 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 121.317 1.344 . . . . 0.0 108.708 171.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 59.6 t-105 -117.56 135.42 53.97 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.934 -177.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -158.15 81.7 0.85 Allowed 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 114.616 -1.174 . . . . 0.0 108.609 174.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -169.94 -178.55 41.02 Favored Glycine 0 C--N 1.268 -3.208 0 CA-C-N 113.734 -1.575 . . . . 0.0 110.28 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -89.8 115.87 64.95 Favored Pre-proline 0 C--N 1.294 -1.829 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.55 ' O ' ' HG ' ' A' ' 80' ' ' LEU . 47.5 Cg_exo -32.47 -78.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 125.098 3.865 . . . . 0.0 117.048 -172.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -73.31 -30.08 29.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -174.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -71.23 -26.77 63.07 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.83 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.468 ' OE1' ' HA ' ' A' ' 79' ' ' GLN . 4.9 tp60 -88.01 -18.06 29.82 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 121.139 0.495 . . . . 0.0 110.225 177.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 76' ' ' PRO . 91.1 mt -80.99 -12.01 59.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.482 0.658 . . . . 0.0 109.26 174.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.8 t -96.13 118.99 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -103.17 142.32 34.36 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.768 -177.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -123.36 122.08 37.41 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.387 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -126.72 170.09 12.49 Favored 'General case' 0 C--N 1.273 -2.728 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -135.86 135.38 39.73 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 118.767 -1.173 . . . . 0.0 112.119 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.594 ' CG2' ' HB ' ' A' ' 93' ' ' VAL . 59.5 mt -94.24 110.78 24.14 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 CA-C-N 114.014 -1.448 . . . . 0.0 107.408 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -105.57 121.22 43.52 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.831 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.716 ' HB ' HG12 ' A' ' 93' ' ' VAL . 1.4 t -94.95 118.68 32.21 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.691 0.758 . . . . 0.0 110.36 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -106.43 -157.99 21.74 Favored Glycine 0 N--CA 1.427 -1.946 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -66.4 -26.7 47.78 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.964 1.776 . . . . 0.0 110.528 176.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -73.74 -73.34 0.22 Allowed 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.167 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 179.02 -151.22 10.07 Favored Glycine 0 N--CA 1.423 -2.191 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.716 HG12 ' HB ' ' A' ' 88' ' ' THR . 35.7 m -103.71 145.9 12.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 O-C-N 123.739 0.317 . . . . 0.0 110.865 -176.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.75 155.8 30.49 Favored 'General case' 0 C--O 1.259 1.565 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 176.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.58 HG12 HG12 ' A' ' 86' ' ' ILE . 59.4 mt -94.39 114.12 30.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.429 0.633 . . . . 0.0 111.765 -176.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -62.15 120.75 11.5 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.392 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.39 -28.61 2.44 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.61 ' SG ' HG22 ' A' ' 119' ' ' ILE . 49.6 t -112.98 132.1 22.5 Favored Pre-proline 0 N--CA 1.426 -1.656 0 CA-C-N 114.817 -0.691 . . . . 0.0 110.201 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 98' ' ' CYS . 95.4 Cg_endo -99.51 11.38 0.67 Allowed 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 122.628 2.219 . . . . 0.0 112.525 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.0 m -122.81 18.64 10.23 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.82 0.343 . . . . 0.0 111.087 -174.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -113.39 136.73 21.9 Favored Pre-proline 0 C--N 1.31 -1.111 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -174.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -82.33 -179.68 4.83 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.135 2.557 . . . . 0.0 113.292 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -98.93 108.55 21.26 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -76.44 -60.36 2.37 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.291 0.567 . . . . 0.0 110.21 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.609 ' H ' HG22 ' A' ' 93' ' ' VAL . . . 124.37 -66.53 0.52 Allowed Glycine 0 C--N 1.306 -1.131 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 177.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.7 m -93.61 150.62 20.28 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.13 -41.28 94.96 Favored 'General case' 0 C--O 1.216 -0.661 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.354 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 38.6 t -54.94 -31.37 60.39 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.229 0.612 . . . . 0.0 111.028 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.28 -49.28 74.67 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.378 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.452 HD12 ' N ' ' A' ' 111' ' ' VAL . 4.1 pp -75.01 -32.44 61.62 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 120.838 0.351 . . . . 0.0 110.936 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.452 ' N ' HD12 ' A' ' 110' ' ' LEU . 69.7 t -63.09 -44.66 99.63 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.821 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.569 178.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.3 t -73.28 -21.83 60.51 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.006 0.432 . . . . 0.0 111.819 177.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -83.42 -4.64 58.68 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 121.388 0.613 . . . . 0.0 110.085 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 125' ' ' LEU . 6.0 p80 -42.62 -50.4 5.42 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 126.694 1.997 . . . . 0.0 115.893 -173.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.4 t -103.7 4.78 35.74 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 121.438 0.637 . . . . 0.0 109.286 -172.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.5 mt -99.47 -48.54 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.8 m -141.27 86.21 11.38 Favored Pre-proline 0 N--CA 1.437 -1.103 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.459 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.88 89.49 1.13 Allowed 'Trans proline' 0 N--CA 1.44 -1.649 0 C-N-CA 121.681 1.587 . . . . 0.0 108.054 173.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.61 HG22 ' SG ' ' A' ' 98' ' ' CYS . 36.3 mt -90.28 -64.02 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.79 -174.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.4 ' HA ' ' HB2' ' A' ' 98' ' ' CYS . 7.8 t -73.4 -30.25 63.13 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 120.851 0.358 . . . . 0.0 111.073 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.66 127.21 73.65 Favored Pre-proline 0 N--CA 1.435 -1.203 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.417 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -69.23 -24.45 32.1 Favored 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 122.327 2.018 . . . . 0.0 111.457 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.415 ' SG ' ' HB ' ' A' ' 62' ' ' VAL . 83.4 m -114.74 145.73 41.76 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 53.4 m -64.16 111.88 2.77 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.124 0.488 . . . . 0.0 109.937 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 114' ' ' HIS . 27.9 tp -58.21 135.79 57.16 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 125.0 1.32 . . . . 0.0 110.041 -176.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -130.92 134.99 47.26 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.1 mp -80.96 136.15 50.93 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo . . . . . 0 CA--C 1.543 0.928 0 C-N-CA 122.131 1.887 . . . . 0.0 112.129 177.367 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.3 p . . . . . 0 N--CA 1.435 -1.18 0 CA-C-O 120.774 0.321 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.5 m -45.46 -60.86 1.93 Allowed 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 125.853 1.661 . . . . 0.0 112.805 -173.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.41 ' HE2' ' CE2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -67.48 -12.69 60.9 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -176.616 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.41 ' CE2' ' HE2' ' A' ' 20' ' ' LYS . 74.6 m-85 -76.99 -23.24 52.29 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.419 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.434 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 31.3 p-90 -121.0 -24.75 5.51 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.506 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 35.8 t80 -95.31 116.79 29.24 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.992 -0.442 . . . . 0.0 110.045 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.488 ' CB ' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -138.04 97.9 9.65 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.097 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.88 21.55 0.37 Allowed 'Trans proline' 0 CA--C 1.552 1.418 0 C-N-CA 123.326 2.684 . . . . 0.0 113.977 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -114.78 -20.44 10.62 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.241 0.543 . . . . 0.0 110.088 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.488 HD23 ' CB ' ' A' ' 24' ' ' LYS . 3.5 mm? -76.75 120.51 22.01 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.668 0.747 . . . . 0.0 111.355 -175.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.0 p -85.27 177.69 7.75 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.57 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -49.7 -55.85 12.34 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.079 0.952 . . . . 0.0 111.622 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -72.78 -32.45 65.6 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.98 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -70.77 -33.53 70.88 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.871 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.98 -42.51 99.86 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.576 0.703 . . . . 0.0 109.13 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 85.0 mt -65.27 -44.01 95.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.465 178.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.48 -28.64 68.5 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.375 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.03 -51.99 10.12 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 57.2 mt -72.84 -25.56 61.16 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -174.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -56.91 -33.8 67.31 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -89.51 -21.29 23.01 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.543 0.687 . . . . 0.0 110.77 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -78.62 164.77 24.36 Favored 'General case' 0 C--O 1.255 1.389 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -172.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.54 137.38 76.79 Favored Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 111.917 -2.401 . . . . 0.0 111.329 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -63.0 107.56 0.65 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.922 1.748 . . . . 0.0 109.342 170.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.46 -17.93 5.52 Favored Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 -175.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.37 154.96 27.4 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 120.644 0.259 . . . . 0.0 110.66 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.485 ' CG ' HD11 ' A' ' 125' ' ' LEU . 5.4 p90 -149.45 177.68 9.49 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.279 -174.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -155.31 147.09 23.26 Favored 'General case' 0 C--O 1.253 1.237 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 169.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 23' ' ' TYR . 63.2 mt -117.81 135.33 58.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.442 HH12 ' HB2' ' A' ' 59' ' ' ALA . 0.1 OUTLIER -144.73 162.45 36.7 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 174.871 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.07 131.88 48.69 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 173.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.433 ' HB3' ' O ' ' A' ' 52' ' ' PHE . 30.4 t -75.67 118.81 18.9 Favored 'General case' 0 N--CA 1.413 -2.312 0 C-N-CA 119.024 -1.071 . . . . 0.0 109.087 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 27.6 m-70 -77.24 -16.11 59.17 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.87 175.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.0 m -84.11 -46.79 11.58 Favored 'General case' 0 N--CA 1.408 -2.568 0 CA-C-N 114.229 -1.35 . . . . 0.0 109.535 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.433 ' O ' ' HB3' ' A' ' 49' ' ' SER . 89.9 m-85 -127.15 127.97 45.41 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-O 121.35 0.595 . . . . 0.0 111.095 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -83.61 128.03 34.2 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.658 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.22 15.75 52.63 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -177.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.74 160.81 36.99 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -122.4 129.88 52.53 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.95 115.58 4.14 Favored Glycine 0 C--N 1.293 -1.832 0 C-N-CA 119.968 -1.11 . . . . 0.0 111.302 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -93.29 119.56 32.58 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.442 ' HB2' HH12 ' A' ' 47' ' ' ARG . . . -114.53 129.76 56.69 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.42 HD21 ' SG ' ' A' ' 123' ' ' CYS . 58.9 tp -126.85 128.62 46.81 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 123.488 0.493 . . . . 0.0 110.801 -177.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 22.3 tptm -88.36 115.14 25.66 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 176.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.489 HG12 ' SG ' ' A' ' 123' ' ' CYS . 34.1 m -105.82 170.69 2.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.87 -48.48 12.33 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 p -167.29 120.97 0.79 Allowed Pre-proline 0 C--N 1.32 -0.681 0 C-N-CA 125.291 1.436 . . . . 0.0 109.025 178.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.63 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 28.2 Cg_exo -60.57 -46.84 15.65 Favored 'Trans proline' 0 CA--C 1.575 2.567 0 C-N-CA 121.149 1.232 . . . . 0.0 110.993 170.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.63 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 85.1 Cg_endo -77.73 158.66 31.72 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.86 2.374 . . . . 0.0 109.917 173.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -70.03 -54.16 0.22 Allowed 'Trans proline' 0 CA--C 1.551 1.357 0 C-N-CA 121.715 1.61 . . . . 0.0 112.189 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.1 m -104.86 -19.84 13.76 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.837 0.351 . . . . 0.0 110.906 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 66.98 34.7 5.07 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 124.169 0.987 . . . . 0.0 111.274 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -60.68 -44.29 94.78 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.857 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.62 82.39 0.73 Allowed 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 121.11 1.206 . . . . 0.0 111.285 173.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 36.4 t-105 -85.87 136.73 33.18 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.0 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.9 mtmm -127.06 6.66 6.53 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -173.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.03 24.58 44.11 Favored Glycine 0 CA--C 1.489 -1.543 0 N-CA-C 108.554 -1.819 . . . . 0.0 108.554 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -86.21 127.05 63.06 Favored Pre-proline 0 N--CA 1.423 -1.799 0 CA-C-N 113.744 -1.228 . . . . 0.0 111.308 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -96.26 -165.12 0.1 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.7 0 C-N-CA 122.938 2.425 . . . . 0.0 110.867 176.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.463 ' HA ' HD23 ' A' ' 80' ' ' LEU . 9.8 p -56.46 -21.3 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 123.633 0.773 . . . . 0.0 112.405 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -62.56 -33.63 75.33 Favored 'General case' 0 C--O 1.213 -0.819 0 C-N-CA 122.853 0.461 . . . . 0.0 110.909 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.62 -20.34 56.84 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 121.461 0.648 . . . . 0.0 109.819 -178.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 77' ' ' VAL . 3.5 mm? -81.03 -3.08 50.56 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.097 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.9 t -101.66 104.83 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.875 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 174.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -78.85 139.76 38.28 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -120.65 122.44 40.49 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-O 121.872 0.844 . . . . 0.0 111.688 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -131.41 170.74 14.25 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.48 136.82 41.58 Favored 'General case' 0 C--N 1.283 -2.325 0 C-N-CA 119.944 -0.703 . . . . 0.0 111.088 175.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.429 HG12 HG12 ' A' ' 95' ' ' ILE . 74.9 mt -91.43 114.72 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.632 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 178.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.548 ' CD ' ' HE2' ' A' ' 96' ' ' LYS . 30.7 mt-10 -99.75 140.08 34.47 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.737 ' HB ' HG12 ' A' ' 93' ' ' VAL . 1.3 t -116.17 127.46 54.81 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.439 0.638 . . . . 0.0 110.626 175.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.4 -169.97 14.01 Favored Glycine 0 N--CA 1.424 -2.163 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.2 -27.81 31.4 Favored 'Trans proline' 0 CA--C 1.553 1.43 0 C-N-CA 123.425 2.75 . . . . 0.0 114.858 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.48 ' HD2' ' N ' ' A' ' 91' ' ' LYS . 10.7 mptt -80.28 -21.32 42.8 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.073 0.463 . . . . 0.0 111.121 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.28 -149.07 16.88 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.737 HG12 ' HB ' ' A' ' 88' ' ' THR . 31.3 m -104.64 149.08 8.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.41 155.02 19.49 Favored 'General case' 0 C--O 1.251 1.147 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.429 HG12 HG12 ' A' ' 86' ' ' ILE . 71.6 mt -86.94 114.34 25.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.423 0.63 . . . . 0.0 111.311 -176.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.548 ' HE2' ' CD ' ' A' ' 87' ' ' GLU . 19.4 ttmm -64.83 126.93 29.52 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.438 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 110.13 40.05 1.45 Allowed Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 120' ' ' SER . 35.5 t -142.33 132.4 12.44 Favored Pre-proline 0 N--CA 1.432 -1.33 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -178.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -86.8 8.11 4.57 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.602 2.202 . . . . 0.0 112.648 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.6 m -148.4 -148.0 0.24 Allowed 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 80.75 123.93 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.135 0 C-N-CA 124.963 1.305 . . . . 0.0 113.161 174.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.16 171.28 18.6 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.681 2.254 . . . . 0.0 111.74 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -95.59 132.38 40.79 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -108.25 154.68 21.42 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -178.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -95.4 -25.27 14.21 Favored Glycine 0 C--N 1.3 -1.42 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.772 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 11.1 m -122.65 144.62 49.01 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 90.2 mt -62.56 -37.83 87.69 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.196 0.522 . . . . 0.0 109.661 175.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.3 m -54.17 -34.44 60.49 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.593 1.157 . . . . 0.0 111.163 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.9 -39.32 83.62 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.7 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.48 HD12 ' N ' ' A' ' 111' ' ' VAL . 4.0 pp -76.2 -36.98 58.36 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.144 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.48 ' N ' HD12 ' A' ' 110' ' ' LEU . 43.0 t -55.9 -51.79 56.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.727 177.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.4 m -71.94 -26.71 62.39 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.967 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -83.46 -37.85 22.62 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -176.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -72.3 -6.17 41.31 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -174.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.8 m -75.26 -24.35 57.59 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 171.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 65.5 mt -101.61 -50.02 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.426 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.8 m -120.4 97.84 48.75 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.241 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.78 92.11 1.1 Allowed 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.473 2.115 . . . . 0.0 109.565 174.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 23.6 mt -84.97 -67.62 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.28 -174.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.444 ' HB3' ' HB2' ' A' ' 98' ' ' CYS . 4.8 p -77.67 -33.54 53.33 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.88 0.848 . . . . 0.0 110.338 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.418 HD22 HD22 ' A' ' 60' ' ' LEU . 49.6 mt -84.73 140.83 38.06 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.137 -177.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.56 -11.3 15.69 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.863 2.375 . . . . 0.0 113.454 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.489 ' SG ' HG12 ' A' ' 62' ' ' VAL . 22.6 p -136.05 162.21 33.54 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 59.6 m -69.33 138.38 53.71 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 123.485 0.49 . . . . 0.0 110.021 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.485 HD11 ' CG ' ' A' ' 44' ' ' PHE . 19.6 tp -77.72 121.34 23.89 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.744 -175.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -95.76 114.47 26.21 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 123.51 0.724 . . . . 0.0 110.577 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 66.8 mt -81.15 121.97 81.05 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 175.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 CA--C 1.535 0.528 0 C-N-CA 122.646 2.231 . . . . 0.0 113.681 -176.319 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.0 p . . . . . 0 N--CA 1.425 -1.69 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.8 m -73.59 -33.06 64.44 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.609 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -61.46 -18.26 58.17 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -79.21 -26.91 42.53 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.539 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 21.9 p-90 -131.91 -9.49 3.48 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -175.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -98.92 113.38 25.5 Favored 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.655 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.07 91.1 9.03 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.983 175.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.94 -17.08 46.4 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.904 2.403 . . . . 0.0 113.891 -175.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -71.86 -18.89 62.03 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.037 0.446 . . . . 0.0 111.294 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.9 tp -80.54 139.17 36.47 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.116 0.484 . . . . 0.0 110.61 -176.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.575 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 15.5 m -91.95 168.2 11.58 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.046 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -57.12 -51.68 68.31 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.067 0.947 . . . . 0.0 113.39 -175.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.87 -39.8 95.56 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 121.561 0.696 . . . . 0.0 110.985 -176.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.575 ' OE1' ' HB2' ' A' ' 28' ' ' SER . 21.1 mp0 -67.03 -40.12 87.13 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.862 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.93 -41.77 75.1 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 123.197 0.599 . . . . 0.0 111.627 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 60.1 mt -65.2 -35.67 75.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.867 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.1 -33.04 72.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.778 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.91 -40.52 65.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.043 0.449 . . . . 0.0 110.647 177.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.465 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 75.6 mt -76.16 -27.1 56.85 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -175.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -77.22 -3.37 39.32 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.551 0.691 . . . . 0.0 109.934 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -106.19 -5.29 19.38 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.747 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.552 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -119.74 170.2 9.43 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.111 0.482 . . . . 0.0 112.177 -175.244 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -85.85 160.31 53.0 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.294 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 61' ' ' LYS . 10.8 Cg_endo -56.11 127.47 26.17 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.775 2.316 . . . . 0.0 111.265 173.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.41 -24.01 8.28 Favored Glycine 0 N--CA 1.434 -1.446 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.56 146.61 40.32 Favored 'General case' 0 C--O 1.253 1.239 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -151.87 177.52 10.34 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 121.019 0.438 . . . . 0.0 110.119 -176.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -162.05 150.04 14.68 Favored 'General case' 0 C--O 1.251 1.152 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 173.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.539 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 68.6 mt -123.93 134.16 67.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.458 HH22 ' CD2' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -133.59 173.62 11.31 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.241 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -80.06 146.5 31.9 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.1 t -99.56 139.94 34.47 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.528 0.68 . . . . 0.0 111.682 -176.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -99.59 -8.5 24.41 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.476 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.5 t -76.38 -40.87 49.86 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -129.9 140.92 50.88 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -83.57 124.63 30.97 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.989 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.42 31.66 18.56 Favored Glycine 0 N--CA 1.435 -1.385 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -177.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.75 157.98 45.31 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.971 -0.615 . . . . 0.0 109.602 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -124.65 161.06 27.1 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.34 123.56 5.55 Favored Glycine 0 C--N 1.288 -2.091 0 C-N-CA 119.908 -1.139 . . . . 0.0 111.036 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 84' ' ' PHE . 2.2 tm? -101.68 130.51 48.06 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 123.947 0.899 . . . . 0.0 108.74 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.41 ' HB2' HH12 ' A' ' 47' ' ' ARG . . . -119.28 125.34 48.87 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 175.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.5 tp -119.88 131.3 55.21 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 123.686 0.616 . . . . 0.0 110.535 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 41' ' ' PRO . 22.3 tptm -88.5 116.05 26.45 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 80' ' ' LEU . 18.7 m -109.94 171.77 2.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.79 -60.07 2.54 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.4 p -150.81 138.38 12.1 Favored Pre-proline 0 C--N 1.308 -1.207 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.247 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.678 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 24.4 Cg_exo -61.46 -43.55 27.15 Favored 'Trans proline' 0 CA--C 1.577 2.67 0 C-N-CA 121.969 1.779 . . . . 0.0 111.854 171.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.678 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 56.4 Cg_endo -68.25 143.16 57.71 Favored 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 122.547 2.164 . . . . 0.0 110.105 170.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.88 -32.81 35.26 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.547 2.165 . . . . 0.0 112.644 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.9 t -114.27 -42.74 3.29 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.079 0.466 . . . . 0.0 110.096 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.593 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 74.56 -3.04 2.66 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.972 1.309 . . . . 0.0 112.134 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.461 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 56.9 tt0 -59.72 -50.09 88.57 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 171.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.461 ' HD3' ' HB3' ' A' ' 70' ' ' GLN . 16.9 Cg_exo -70.56 101.23 1.0 Allowed 'Trans proline' 0 C--N 1.374 1.88 0 N-CA-C 106.615 -2.11 . . . . 0.0 106.615 164.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 46.3 t-105 -109.87 150.11 28.89 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.376 -172.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -114.29 -63.0 1.51 Allowed 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.98 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 158.3 67.0 0.01 OUTLIER Glycine 0 CA--C 1.471 -2.718 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -118.94 121.51 30.44 Favored Pre-proline 0 C--N 1.285 -2.238 0 CA-C-N 114.695 -0.753 . . . . 0.0 109.971 -169.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -85.16 178.56 4.59 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.304 2.003 . . . . 0.0 112.129 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.0 p -57.31 -30.12 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 123.353 0.661 . . . . 0.0 112.681 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.3 mp0 -68.84 -19.74 64.27 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.975 -0.453 . . . . 0.0 111.46 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -84.69 -19.74 32.31 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.487 ' O ' HG22 ' A' ' 62' ' ' VAL . 46.7 mt -74.26 -17.47 60.87 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.8 t -87.74 112.58 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 173.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -98.55 131.5 44.72 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -176.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.458 ' CD2' HH22 ' A' ' 47' ' ' ARG . 36.0 m80 -105.07 124.5 49.64 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 121.402 0.62 . . . . 0.0 112.02 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.417 ' O ' ' HB3' ' A' ' 58' ' ' LEU . 93.9 m-85 -131.3 126.73 36.11 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 177.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.9 pp -99.1 144.49 28.18 Favored 'General case' 0 C--N 1.285 -2.228 0 C-N-CA 118.443 -1.303 . . . . 0.0 111.132 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 62.5 mt -105.82 135.23 44.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.367 -174.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.452 ' OE1' ' HA ' ' A' ' 96' ' ' LYS . 30.6 mt-10 -116.55 142.75 46.47 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -176.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.428 ' HB ' HG23 ' A' ' 93' ' ' VAL . 4.7 t -131.39 139.51 49.47 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 175.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.22 -161.04 11.56 Favored Glycine 0 N--CA 1.433 -1.502 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.29 -17.66 61.14 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.038 2.492 . . . . 0.0 113.88 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.419 ' HD2' ' H ' ' A' ' 91' ' ' LYS . 9.7 mptt -79.72 -42.04 25.48 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 122.076 0.941 . . . . 0.0 109.217 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 146.71 -154.42 25.96 Favored Glycine 0 N--CA 1.422 -2.296 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.428 HG23 ' HB ' ' A' ' 88' ' ' THR . 12.4 p -114.02 137.82 45.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.98 171.93 19.13 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.503 ' HB ' ' HB3' ' A' ' 98' ' ' CYS . 58.7 mt -90.54 143.85 10.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 17.0 tppt? -48.02 -45.63 32.11 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.576 1.151 . . . . 0.0 112.482 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -120.44 62.15 0.5 Allowed Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.812 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.503 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 19.7 p -98.7 127.8 34.53 Favored Pre-proline 0 C--N 1.299 -1.588 0 CA-C-O 120.931 0.396 . . . . 0.0 111.429 178.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -90.04 32.93 0.34 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.242 2.628 . . . . 0.0 110.13 174.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.1 t -92.69 -147.65 0.23 Allowed 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.538 ' H ' ' HD2' ' A' ' 102' ' ' PRO . 17.9 tp10 -152.62 -55.52 0.02 OUTLIER Pre-proline 0 C--N 1.289 -2.05 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.733 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.538 ' HD2' ' H ' ' A' ' 101' ' ' GLU . 88.5 Cg_endo -77.81 158.72 31.41 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 121.384 1.39 . . . . 0.0 113.155 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -100.21 157.13 16.81 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -114.02 165.28 12.78 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.7 -47.04 3.54 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.304 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.7 m -121.87 159.25 27.19 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 111' ' ' VAL . 95.2 mt -57.22 -45.73 83.57 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 122.815 0.446 . . . . 0.0 111.757 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 72.4 m -54.26 -29.36 46.61 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.73 -48.83 67.93 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.494 0.187 . . . . 0.0 110.601 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.88 -26.15 63.11 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.158 0.504 . . . . 0.0 110.642 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 107' ' ' LEU . 73.5 t -67.5 -51.69 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.299 176.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 28.6 t -68.25 -27.84 66.69 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.221 0.534 . . . . 0.0 110.467 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.505 ' NE2' ' HB2' ' A' ' 117' ' ' SER . 0.6 OUTLIER -63.28 -50.48 69.96 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.427 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -77.19 -0.37 24.84 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -176.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 7.1 m -75.55 -37.22 60.15 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.486 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 73.3 mt -101.31 -53.94 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.083 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.505 ' HB2' ' NE2' ' A' ' 113' ' ' GLN . 19.9 m -107.94 97.6 21.84 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 116' ' ' ILE . 5.8 Cg_exo -78.64 84.53 2.01 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 122.412 2.075 . . . . 0.0 110.388 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 68.8 mt -80.96 -54.67 9.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.556 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.7 m -92.39 -15.6 27.03 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.453 0.644 . . . . 0.0 110.524 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 71.7 mt -112.6 136.88 21.53 Favored Pre-proline 0 N--CA 1.428 -1.541 0 CA-C-N 115.435 -0.802 . . . . 0.0 108.907 -175.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.476 ' HG2' HG11 ' A' ' 62' ' ' VAL . 71.7 Cg_endo -76.64 -5.84 16.41 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.537 2.158 . . . . 0.0 112.677 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 50.8 t -128.86 149.59 50.69 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 21.2 m -71.33 133.25 45.87 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 16.6 tp -77.77 138.02 38.77 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.247 -175.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 126' ' ' ARG . 23.3 mmt180 -122.41 118.2 27.82 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.533 0.683 . . . . 0.0 111.95 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.526 ' H ' HD12 ' A' ' 127' ' ' ILE . 2.7 mp -91.46 135.31 28.13 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -176.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo . . . . . 0 N--CA 1.48 0.731 0 C-N-CA 122.053 1.835 . . . . 0.0 110.926 175.719 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.9 p . . . . . 0 N--CA 1.428 -1.573 0 CA-C-O 121.881 0.848 . . . . 0.0 110.788 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.432 ' HA ' ' CE2' ' A' ' 22' ' ' TRP . 14.8 m -68.31 -30.15 69.07 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 114.22 -1.354 . . . . 0.0 111.785 -177.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -61.03 -22.29 64.41 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -176.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -76.71 -28.56 55.89 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.392 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.432 ' CE2' ' HA ' ' A' ' 19' ' ' SER . 26.0 p-90 -116.54 -18.07 10.46 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -93.55 119.76 33.0 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.909 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.57 100.14 3.14 Favored Pre-proline 0 C--N 1.308 -1.234 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.246 173.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.484 ' HA ' ' HB2' ' A' ' 47' ' ' ARG . 98.1 Cg_endo -79.72 -4.23 13.35 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.952 2.435 . . . . 0.0 113.471 -173.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -92.63 -12.11 32.47 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.014 -177.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.521 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 17.5 tp -86.47 124.02 32.33 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.0 m -75.9 173.24 11.44 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -173.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.4 tpp180 -57.84 -53.67 55.62 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.726 0.811 . . . . 0.0 110.935 -175.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -67.31 -30.55 70.43 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.278 -177.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -76.32 -35.9 58.55 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.276 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.93 97.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.595 0.712 . . . . 0.0 109.712 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 82.8 mt -66.71 -43.31 90.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.465 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.5 -30.9 70.0 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.501 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.33 -44.77 43.46 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.794 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.49 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 65.0 mt -74.3 -25.14 59.4 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -177.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -71.78 -19.02 62.07 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 121.665 -0.647 . . . . 0.0 110.285 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -89.21 -10.16 48.1 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.601 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.671 ' HE2' ' HA ' ' A' ' 39' ' ' LYS . 3.8 mmpt? -108.68 164.78 12.07 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -176.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.0 151.71 86.34 Favored Pre-proline 0 C--N 1.309 -1.171 0 CA-C-N 112.667 -2.06 . . . . 0.0 108.863 -175.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -61.04 131.37 36.58 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.636 1.557 . . . . 0.0 109.529 173.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.91 -13.2 31.98 Favored Glycine 0 C--N 1.302 -1.351 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.3 151.21 31.22 Favored 'General case' 0 C--O 1.246 0.898 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -154.73 164.72 38.37 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -175.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -152.31 157.12 40.9 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 172.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.402 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 57.6 mt -127.11 132.1 70.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.521 ' HD2' ' O ' ' A' ' 27' ' ' LEU . 7.2 ptm180 -127.87 153.77 46.25 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 175.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -60.07 127.41 31.74 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.3 t -77.51 119.18 20.74 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -86.87 -20.9 26.77 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 m -61.24 -49.93 75.13 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 112.883 -1.962 . . . . 0.0 110.237 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -125.55 133.27 52.37 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -82.73 121.93 27.52 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.785 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.86 23.67 14.89 Favored Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.23 152.1 51.64 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 121.147 0.499 . . . . 0.0 110.035 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -120.58 136.17 54.88 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.73 112.13 4.34 Favored Glycine 0 C--N 1.284 -2.309 0 C-N-CA 120.039 -1.077 . . . . 0.0 111.005 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 44.7 tp -87.05 130.42 34.49 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -113.31 119.49 37.86 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 176.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.4 tp -115.68 130.17 56.75 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 123.65 0.594 . . . . 0.0 110.603 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.49 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 22.6 tptm -88.71 115.07 25.98 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.6 m -105.4 171.33 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 175.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.86 -54.39 10.24 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.6 p -160.22 142.98 9.91 Favored Pre-proline 0 C--N 1.319 -0.722 0 C-N-CA 124.753 1.221 . . . . 0.0 108.112 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.67 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 24.1 Cg_exo -62.57 -49.48 5.63 Favored 'Trans proline' 0 CA--C 1.576 2.579 0 C-N-CA 121.613 1.542 . . . . 0.0 111.386 169.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.67 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 69.3 Cg_endo -68.2 151.67 76.68 Favored 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 122.813 2.342 . . . . 0.0 109.866 173.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -59.09 -48.75 13.01 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.396 2.064 . . . . 0.0 112.617 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.6 p -118.57 -22.34 7.56 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.663 -177.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.429 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 67.42 34.77 4.56 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 124.056 0.943 . . . . 0.0 109.813 -177.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.426 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 64.5 tt0 -59.67 -51.18 82.8 Favored Pre-proline 0 CA--C 1.553 1.084 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.496 177.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.426 ' HD3' ' HB3' ' A' ' 70' ' ' GLN . 4.4 Cg_endo -83.24 114.4 2.17 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 121.156 1.238 . . . . 0.0 110.025 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 38.7 t-105 -125.68 143.08 51.19 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 120.983 0.42 . . . . 0.0 110.215 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -127.54 -61.25 1.14 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 175.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -178.49 65.88 0.08 OUTLIER Glycine 0 CA--C 1.486 -1.758 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 177.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -82.32 130.36 59.78 Favored Pre-proline 0 C--N 1.297 -1.685 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -175.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.57 159.54 32.05 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.256 1.97 . . . . 0.0 113.096 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.6 p -66.22 -14.8 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 121.828 0.823 . . . . 0.0 110.392 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -68.73 -13.49 62.41 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.89 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.434 ' HB3' ' HG2' ' A' ' 65' ' ' PRO . 81.9 mm-40 -89.44 -25.27 21.58 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 121.04 0.447 . . . . 0.0 110.305 176.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.447 HD23 ' HD3' ' A' ' 65' ' ' PRO . 69.3 mt -74.92 -22.66 58.48 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.793 0.806 . . . . 0.0 109.156 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.434 HG13 HD12 ' A' ' 36' ' ' LEU . 98.1 t -100.4 127.36 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 174.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.499 ' NE ' ' HA ' ' A' ' 82' ' ' ARG . 3.5 mmp_? -107.32 139.88 41.11 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.941 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -116.1 122.71 45.94 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.248 0.547 . . . . 0.0 110.522 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -129.3 128.27 42.84 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.406 ' H ' HD23 ' A' ' 85' ' ' LEU . 0.9 OUTLIER -96.37 138.28 34.2 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 118.901 -1.12 . . . . 0.0 111.017 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.7 mt -102.56 119.12 50.47 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.079 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -101.64 143.88 31.05 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -176.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.475 ' HB ' HG23 ' A' ' 93' ' ' VAL . 4.2 t -127.69 120.28 27.67 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-O 121.569 0.7 . . . . 0.0 110.229 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -140.67 -154.84 6.33 Favored Glycine 0 N--CA 1.435 -1.433 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.25 -15.82 28.34 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.118 1.878 . . . . 0.0 111.029 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -72.71 -27.89 62.33 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.415 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 122.83 -153.89 16.99 Favored Glycine 0 N--CA 1.426 -2.025 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -175.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.475 HG23 ' HB ' ' A' ' 88' ' ' THR . 13.2 p -118.27 132.56 67.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.32 157.72 36.19 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.109 -178.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 98' ' ' CYS . 85.6 mt -72.42 140.55 17.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -78.85 128.72 33.72 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 108.69 -54.4 0.55 Allowed Glycine 0 N--CA 1.437 -1.237 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.471 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 49.7 t -139.88 121.92 9.89 Favored Pre-proline 0 N--CA 1.414 -2.273 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 176.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -73.09 -53.7 0.13 Allowed 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 121.741 1.628 . . . . 0.0 110.535 -177.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.2 t 156.21 -83.99 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 129.004 2.922 . . . . 0.0 103.263 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.652 ' HB2' ' HD3' ' A' ' 102' ' ' PRO . 45.7 mt-10 -144.5 -59.55 0.02 OUTLIER Pre-proline 0 N--CA 1.435 -1.202 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 173.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.652 ' HD3' ' HB2' ' A' ' 101' ' ' GLU . 16.6 Cg_endo -101.29 -172.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 121.345 1.363 . . . . 0.0 110.457 171.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -105.97 125.65 51.25 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 173.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.491 ' CD1' ' HB3' ' A' ' 110' ' ' LEU . 97.2 m-85 -84.59 172.64 11.43 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -172.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -101.4 -23.98 9.18 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.218 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.2 m -145.98 160.27 42.09 Favored 'General case' 0 C--O 1.247 0.954 0 O-C-N 122.289 -0.536 . . . . 0.0 110.658 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.92 -48.03 82.26 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 123.356 0.662 . . . . 0.0 112.589 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 m -54.61 -31.95 57.99 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.005 0.522 . . . . 0.0 112.02 -175.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.612 ' O ' ' HG2' ' A' ' 113' ' ' GLN . . . -63.8 -51.71 63.55 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.426 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.491 ' HB3' ' CD1' ' A' ' 104' ' ' PHE . 4.3 pp -70.2 -27.67 64.68 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.711 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.77 -53.22 44.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.742 178.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.1 t -64.35 -29.59 70.65 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.566 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.612 ' HG2' ' O ' ' A' ' 109' ' ' ALA . 81.3 mm-40 -68.01 -33.89 75.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.778 0.323 . . . . 0.0 110.905 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -82.1 -0.02 42.73 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 26.0 m -85.45 -21.73 28.6 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 172.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 67.6 mt -106.14 -49.1 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.653 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.2 m -120.43 102.12 45.73 Favored Pre-proline 0 C--N 1.302 -1.486 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.429 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.33 84.82 1.64 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.351 2.034 . . . . 0.0 109.942 175.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 72.5 mt -87.79 -67.53 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.935 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.2 m -85.03 -11.25 55.8 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.435 0.636 . . . . 0.0 110.936 -176.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 76.2 mt -120.16 137.89 26.48 Favored Pre-proline 0 N--CA 1.429 -1.479 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.493 -175.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -64.48 -34.03 54.98 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.621 2.214 . . . . 0.0 112.341 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 66.2 m -111.61 157.16 20.73 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 9.9 p -81.53 143.59 31.92 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 72.0 mt -78.01 119.12 21.0 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 123.109 0.256 . . . . 0.0 111.612 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -94.97 105.78 17.72 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 175.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.9 mt -78.0 121.87 84.65 Favored Pre-proline 0 C--N 1.301 -1.533 0 CA-C-N 115.305 -0.862 . . . . 0.0 112.063 -171.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 C--N 1.357 1.001 0 C-N-CA 123.471 2.781 . . . . 0.0 112.513 -179.195 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.417 ' HA ' ' CE1' ' A' ' 21' ' ' PHE . 26.8 p . . . . . 0 N--CA 1.451 -0.406 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.2 m -101.11 -37.81 8.42 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.279 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -13.09 58.05 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.417 ' CE1' ' HA ' ' A' ' 18' ' ' THR . 96.9 m-85 -64.0 -50.79 67.14 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.232 0.539 . . . . 0.0 110.18 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.408 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 46.5 p-90 -109.89 -19.03 13.26 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -175.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -95.94 113.79 25.45 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.436 0.636 . . . . 0.0 111.61 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.81 94.55 5.43 Favored Pre-proline 0 C--N 1.303 -1.427 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.437 173.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -78.16 2.95 7.5 Favored 'Trans proline' 0 C--O 1.223 -0.24 0 C-N-CA 123.447 2.765 . . . . 0.0 115.23 -171.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -97.21 -3.22 41.25 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.066 -0.653 . . . . 0.0 111.885 -177.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.413 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 76.2 mt -91.42 134.03 34.97 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 120.946 0.403 . . . . 0.0 110.168 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.0 t -90.66 177.83 6.24 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.272 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -48.31 -57.48 5.94 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.863 1.265 . . . . 0.0 111.162 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.63 -32.03 73.38 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.829 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -75.55 -37.3 60.09 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.085 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.13 -42.63 95.21 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.603 0.716 . . . . 0.0 109.751 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 78.7 mt -66.57 -40.85 87.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.365 177.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.76 -27.32 67.88 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.522 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.4 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 4.5 mm? -81.29 -53.1 6.63 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 172.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.489 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 52.7 mt -61.89 -24.5 66.98 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -174.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -57.23 -35.53 69.81 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -102.22 6.66 40.76 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.637 0.732 . . . . 0.0 110.546 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 35' ' ' LEU . 75.6 mmtt -94.4 156.63 16.4 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.988 177.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.72 149.16 56.41 Favored Pre-proline 0 C--N 1.296 -1.757 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.6 -176.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 61' ' ' LYS . 78.3 Cg_exo -53.34 118.94 5.39 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.634 2.223 . . . . 0.0 111.098 175.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.94 -22.18 6.85 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -176.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.51 147.05 36.01 Favored 'General case' 0 C--O 1.247 0.926 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.451 ' CD1' HD22 ' A' ' 125' ' ' LEU . 33.0 p90 -150.6 165.59 32.88 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -175.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -151.72 150.9 30.72 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.408 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 57.7 mt -116.26 127.14 73.95 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.413 ' HD2' ' O ' ' A' ' 27' ' ' LEU . 50.1 ptt85 -125.44 170.98 10.86 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.92 -176.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -88.63 136.78 32.82 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 176.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.3 m -116.8 123.52 47.32 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 121.411 0.624 . . . . 0.0 112.345 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -84.88 80.51 9.25 Favored 'General case' 0 CA--C 1.487 -1.454 0 CA-C-O 122.304 1.05 . . . . 0.0 108.316 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.3 t -142.28 -62.24 0.44 Allowed 'General case' 0 C--N 1.268 -2.966 0 CA-C-N 113.128 -1.851 . . . . 0.0 107.271 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -126.83 161.77 27.43 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -78.51 121.12 24.17 Favored 'General case' 0 C--O 1.254 1.339 0 CA-C-O 121.182 0.515 . . . . 0.0 110.827 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.7 46.59 9.53 Favored Glycine 0 N--CA 1.437 -1.297 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.68 116.31 22.17 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 121.222 0.534 . . . . 0.0 109.738 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -103.12 118.29 36.47 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.39 122.47 6.48 Favored Glycine 0 C--N 1.277 -2.733 0 C-N-CA 119.839 -1.172 . . . . 0.0 111.239 -177.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 31.7 tp -93.94 124.55 38.02 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.64 121.32 44.76 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 60.3 tp -116.88 126.46 53.04 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 123.039 0.536 . . . . 0.0 110.501 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 21.9 tptm -89.0 115.68 26.74 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.7 m -110.11 170.36 3.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.58 -59.56 3.26 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.6 p -157.66 140.36 10.66 Favored Pre-proline 0 C--N 1.311 -1.071 0 C-N-CA 124.396 1.078 . . . . 0.0 108.204 177.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.647 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 31.3 Cg_exo -59.75 -44.14 33.27 Favored 'Trans proline' 0 CA--C 1.573 2.448 0 C-N-CA 121.999 1.799 . . . . 0.0 111.937 173.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.647 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 78.3 Cg_endo -70.89 154.17 63.4 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.402 2.068 . . . . 0.0 109.02 169.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.42 -47.56 1.0 Allowed 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 121.98 1.787 . . . . 0.0 112.11 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.4 p -103.06 -43.92 5.36 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.004 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.546 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 67.89 23.12 8.46 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.524 1.13 . . . . 0.0 110.602 -177.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -65.25 -47.16 71.73 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.42 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -57.99 120.82 8.97 Favored 'Trans proline' 0 C--N 1.376 1.992 0 N-CA-C 106.436 -2.179 . . . . 0.0 106.436 165.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -34.71 127.74 0.48 Allowed 'General case' 0 C--O 1.243 0.742 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -166.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -139.31 73.49 1.43 Allowed 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 113.899 -1.5 . . . . 0.0 108.88 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.96 48.06 1.0 Allowed Glycine 0 C--N 1.289 -2.047 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 175.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -98.8 146.62 31.96 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -176.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -50.24 157.43 3.07 Favored 'Trans proline' 0 C--O 1.246 0.919 0 C-N-CA 123.527 2.818 . . . . 0.0 114.011 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.5 p -61.94 -11.65 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.851 -178.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -62.03 -27.64 69.02 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 122.833 0.453 . . . . 0.0 110.687 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.47 ' HG2' ' HG2' ' A' ' 65' ' ' PRO . 7.7 tt0 -79.1 -33.59 44.27 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.019 0.438 . . . . 0.0 109.904 177.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.8 mt -72.15 -20.11 61.66 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.468 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 81.7 t -94.12 118.96 41.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 173.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -99.3 129.06 45.49 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 -178.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -106.43 122.92 47.25 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-O 121.28 0.562 . . . . 0.0 111.089 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -130.08 131.11 45.63 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 176.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.2 pp -102.99 140.6 37.05 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 118.32 -1.352 . . . . 0.0 111.584 -175.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.545 HG12 HG12 ' A' ' 95' ' ' ILE . 63.8 mt -102.18 126.1 56.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.587 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.524 ' OE2' ' HE2' ' A' ' 96' ' ' LYS . 38.5 mt-10 -103.53 146.02 29.15 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 92' ' ' GLY . 4.6 t -130.27 128.73 42.17 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 170.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.77 -137.22 2.22 Favored Glycine 0 N--CA 1.427 -1.95 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.829 -177.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.44 1.93 7.4 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.302 2.668 . . . . 0.0 113.721 -175.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -112.34 -20.6 11.76 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.722 0.772 . . . . 0.0 111.714 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 121.98 -154.26 16.76 Favored Glycine 0 CA--C 1.485 -1.819 0 N-CA-C 108.021 -2.032 . . . . 0.0 108.021 -177.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.5 p -107.92 127.1 64.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.59 ' HG2' ' CD2' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -158.02 151.54 23.52 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -172.713 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.545 HG12 HG12 ' A' ' 86' ' ' ILE . 60.3 mt -83.35 133.39 29.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.85 -177.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.524 ' HE2' ' OE2' ' A' ' 87' ' ' GLU . 18.2 ttmm -90.38 140.79 29.37 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.039 176.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.99 3.29 24.83 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -177.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 52.7 t -143.04 140.93 18.5 Favored Pre-proline 0 N--CA 1.422 -1.836 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 98' ' ' CYS . 19.4 Cg_endo -99.5 -2.49 0.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.539 2.159 . . . . 0.0 111.526 174.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.2 m -100.37 -10.28 21.38 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.396 -174.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 8.1 tp10 -74.41 127.16 88.04 Favored Pre-proline 0 N--CA 1.426 -1.651 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -174.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 101' ' ' GLU . 6.1 Cg_exo -73.75 -177.4 3.11 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.376 2.051 . . . . 0.0 112.051 177.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.59 ' CD2' ' HG2' ' A' ' 94' ' ' LYS . 83.6 m-85 -110.88 119.1 37.96 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -106.14 174.49 5.86 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.645 -176.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -97.91 -39.87 3.71 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.913 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 51.1 m -128.45 162.17 27.8 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.73 -37.35 87.3 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 120.9 0.381 . . . . 0.0 110.271 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.0 m -51.59 -35.22 40.57 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.494 1.117 . . . . 0.0 112.04 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.67 -43.43 76.2 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.606 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 pp -74.55 -29.09 61.23 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.976 0.417 . . . . 0.0 111.175 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 75.6 t -64.77 -51.54 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.964 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.3 t -69.04 -31.97 71.14 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.427 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -63.98 -40.8 97.22 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.662 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.572 ' CD2' ' HA ' ' A' ' 118' ' ' PRO . 30.9 m80 -73.7 -3.88 30.96 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.9 m -82.8 -29.85 29.27 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 171.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.7 mt -90.83 -53.01 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.901 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.6 m -135.33 106.3 10.17 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.572 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 48.0 Cg_endo -78.73 100.9 1.4 Allowed 'Trans proline' 0 N--CA 1.437 -1.823 0 C-N-CA 121.413 1.409 . . . . 0.0 111.171 176.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 68.6 mt -84.07 -65.08 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.798 -176.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.7 m -85.98 -28.54 24.16 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.315 0.578 . . . . 0.0 111.415 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 63.6 mt -93.47 133.37 28.39 Favored Pre-proline 0 C--N 1.293 -1.868 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.146 -176.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.0 -13.47 31.57 Favored 'Trans proline' 0 N--CA 1.482 0.798 0 C-N-CA 123.092 2.528 . . . . 0.0 112.497 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 43.9 t -123.92 148.52 46.8 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.508 ' SG ' ' HG3' ' A' ' 118' ' ' PRO . 45.6 m -73.29 147.16 44.78 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.451 HD22 ' CD1' ' A' ' 44' ' ' PHE . 44.5 mt -78.5 114.14 17.15 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.294 0.569 . . . . 0.0 111.452 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -97.17 96.64 8.57 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.1 mp -62.64 129.86 93.15 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo . . . . . 0 C--N 1.36 1.172 0 C-N-CA 123.176 2.584 . . . . 0.0 112.67 179.68 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.3 p . . . . . 0 N--CA 1.429 -1.508 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.9 m -68.97 -35.49 76.81 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.587 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.04 -11.09 45.89 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -177.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -76.22 -25.65 55.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.961 0.41 . . . . 0.0 110.264 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.529 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 37.0 p-90 -125.83 -26.1 3.53 Favored 'General case' 0 C--O 1.208 -1.082 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -176.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -84.43 111.29 19.33 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.599 -0.688 . . . . 0.0 111.022 -176.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -134.71 85.09 37.16 Favored Pre-proline 0 C--N 1.313 -0.978 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.48 -8.14 17.09 Favored 'Trans proline' 0 C--N 1.333 -0.264 0 C-N-CA 122.327 2.018 . . . . 0.0 113.538 -173.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -93.69 -5.36 48.71 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.318 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.8 tp -94.51 126.96 40.13 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -173.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.5 m -83.85 173.9 10.86 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.068 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -52.21 -55.28 22.13 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.23 1.012 . . . . 0.0 112.506 -175.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -55.7 -44.73 77.68 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.835 0.826 . . . . 0.0 110.684 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -73.39 -31.49 63.93 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 113.828 -1.533 . . . . 0.0 111.17 -174.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.39 74.76 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.447 0.641 . . . . 0.0 110.083 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 76.7 mt -68.13 -37.64 78.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.824 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.61 -32.48 70.45 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.645 175.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.432 ' O ' ' HB3' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -76.47 -47.86 21.52 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.28 -178.112 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.44 HD13 HD22 ' A' ' 45' ' ' LEU . 5.7 mp -75.2 -16.54 60.48 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -177.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -80.17 -8.82 59.61 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.326 174.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 35' ' ' LEU . 5.1 t70 -91.14 -41.2 11.15 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.017 177.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -91.59 179.56 5.62 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -176.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -86.86 153.45 54.89 Favored Pre-proline 0 C--N 1.31 -1.118 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 -172.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.09 122.78 12.15 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 122.24 1.96 . . . . 0.0 109.946 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.93 -24.89 5.36 Favored Glycine 0 N--CA 1.42 -2.378 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -175.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.8 148.93 39.88 Favored 'General case' 0 C--O 1.248 0.991 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.408 ' CE1' ' HB3' ' A' ' 125' ' ' LEU . 34.1 p90 -149.12 167.05 26.96 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -178.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.44 HD22 HD13 ' A' ' 36' ' ' LEU . 1.8 pt? -152.58 151.98 31.29 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 174.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.529 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 55.4 mt -113.12 113.34 43.77 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.1 ptt-85 -109.3 -173.82 2.36 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -90.48 129.46 36.65 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 172.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.1 t -82.65 107.45 15.29 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -78.29 75.04 4.82 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 122.459 1.123 . . . . 0.0 110.77 -175.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.3 m -150.61 -45.71 0.12 Allowed 'General case' 0 C--N 1.267 -2.989 0 CA-C-N 113.613 -1.63 . . . . 0.0 108.901 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -131.01 154.38 48.25 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -84.3 121.63 27.78 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.91 37.46 7.28 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.08 119.89 21.61 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.415 ' HB3' ' CG2' ' A' ' 46' ' ' ILE . 63.6 m-85 -97.97 136.58 38.05 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -101.88 106.76 3.06 Favored Glycine 0 C--N 1.286 -2.218 0 C-N-CA 120.324 -0.941 . . . . 0.0 110.984 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -85.14 117.87 24.36 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 82' ' ' ARG . . . -115.03 125.67 53.84 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.9 tp -120.7 127.1 51.72 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 123.958 0.786 . . . . 0.0 109.446 -177.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -88.96 114.74 25.91 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.447 HG12 ' SG ' ' A' ' 123' ' ' CYS . 33.3 m -104.25 169.37 2.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.219 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.88 -43.38 25.1 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 p -160.89 123.01 1.74 Allowed Pre-proline 0 C--N 1.32 -0.707 0 C-N-CA 124.93 1.292 . . . . 0.0 109.534 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.653 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 23.9 Cg_exo -64.85 -47.49 5.0 Favored 'Trans proline' 0 CA--C 1.566 2.101 0 C-N-CA 121.916 1.744 . . . . 0.0 112.232 172.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.714 ' HG2' ' HB2' ' A' ' 69' ' ' ALA . 58.1 Cg_endo -71.79 134.17 23.32 Favored 'Trans proline' 0 C--N 1.384 2.425 0 C-N-CA 121.626 1.551 . . . . 0.0 109.959 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.88 -24.47 33.86 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.806 2.337 . . . . 0.0 113.01 -176.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.4 t -115.38 -37.8 3.95 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.714 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 64.34 32.06 12.41 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.957 0.903 . . . . 0.0 112.965 174.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -63.03 -46.17 86.79 Favored Pre-proline 0 CA--C 1.557 1.234 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -56.4 123.04 12.87 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 121.804 1.669 . . . . 0.0 112.089 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -108.88 132.43 54.05 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.051 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -147.26 7.87 0.91 Allowed 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 124.413 1.085 . . . . 0.0 109.536 177.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.54 117.63 0.76 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -172.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -108.74 107.23 59.91 Favored Pre-proline 0 C--N 1.296 -1.742 0 CA-C-O 121.333 0.587 . . . . 0.0 111.256 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -85.42 148.15 10.05 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.12 1.88 . . . . 0.0 109.972 174.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.2 p -53.37 -25.54 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 123.612 0.765 . . . . 0.0 112.722 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -70.71 -27.02 63.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.237 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.2 -31.55 62.69 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.35 -4.48 33.63 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.493 -177.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 73.6 t -91.89 119.13 38.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 6.2 mmp_? -93.26 149.57 21.13 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -129.06 122.91 30.97 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.896 0.379 . . . . 0.0 111.052 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -133.28 128.36 35.62 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.505 HD23 ' H ' ' A' ' 85' ' ' LEU . 1.6 pt? -99.04 140.38 33.27 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.582 -1.247 . . . . 0.0 112.711 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.422 HG12 HG12 ' A' ' 95' ' ' ILE . 86.0 mt -104.05 119.34 52.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 114.066 -1.425 . . . . 0.0 107.579 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -99.35 144.34 28.57 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.471 ' HB ' HG12 ' A' ' 93' ' ' VAL . 8.8 t -129.33 153.06 48.22 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.28 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.19 -142.77 4.41 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.38 -22.36 29.34 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.559 2.172 . . . . 0.0 112.742 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -73.51 -50.36 21.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.871 0.843 . . . . 0.0 109.793 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 150.89 -125.08 1.83 Allowed Glycine 0 N--CA 1.422 -2.288 0 N-CA-C 107.505 -2.238 . . . . 0.0 107.505 -177.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.471 HG12 ' HB ' ' A' ' 88' ' ' THR . 16.9 m -127.31 139.49 51.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 175.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.93 145.09 24.61 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.067 -0.396 . . . . 0.0 110.983 177.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.422 HG12 HG12 ' A' ' 86' ' ' ILE . 60.3 mt -75.79 140.58 17.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -57.47 -52.85 63.71 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -105.41 52.33 0.72 Allowed Glycine 0 CA--C 1.495 -1.189 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.821 -174.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.432 ' HA ' ' OG ' ' A' ' 120' ' ' SER . 6.7 p -86.52 123.06 71.64 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 123.764 0.332 . . . . 0.0 111.717 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -65.35 -32.12 51.14 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.644 2.229 . . . . 0.0 113.09 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.3 m -145.4 -19.14 0.48 Allowed 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.6 ' OE2' ' HB ' ' A' ' 119' ' ' ILE . 12.9 mp0 -54.5 128.66 61.04 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -176.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -85.33 -161.35 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.766 2.311 . . . . 0.0 110.572 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -87.19 129.42 34.96 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -103.74 161.49 13.88 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.64 -56.44 2.37 Favored Glycine 0 C--N 1.297 -1.584 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.295 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.9 m -116.05 151.46 35.49 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.07 -35.88 72.01 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.021 0.528 . . . . 0.0 110.671 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 m -51.86 -34.89 42.91 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.647 1.179 . . . . 0.0 112.119 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.84 -42.88 76.57 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.413 -176.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 111' ' ' VAL . 4.4 pp -73.49 -38.83 65.26 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.179 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.461 ' N ' HD12 ' A' ' 110' ' ' LEU . 75.2 t -59.81 -46.06 94.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.398 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.0 p -69.57 -37.97 77.22 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -79.85 -28.33 40.06 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.567 -176.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -77.28 -0.1 24.14 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.6 m -80.44 -18.47 48.7 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 170.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 64.7 mt -108.93 -59.53 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.795 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.9 m -113.97 99.43 50.39 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.539 -177.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -90.7 107.57 0.32 Allowed 'Trans proline' 0 N--CA 1.443 -1.486 0 C-N-CA 122.895 2.397 . . . . 0.0 110.919 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.6 ' HB ' ' OE2' ' A' ' 101' ' ' GLU . 25.9 mt -95.18 -64.33 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.432 ' OG ' ' HA ' ' A' ' 98' ' ' CYS . 52.2 m -66.43 -35.39 80.18 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.42 0.629 . . . . 0.0 111.068 174.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -82.65 136.18 45.43 Favored Pre-proline 0 N--CA 1.439 -1.013 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.663 -176.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.97 -19.15 30.72 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.574 2.183 . . . . 0.0 112.256 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.447 ' SG ' HG12 ' A' ' 62' ' ' VAL . 28.5 p -144.13 163.63 33.03 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 25.3 p -71.23 157.69 37.69 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.381 0.61 . . . . 0.0 112.479 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.408 ' HB3' ' CE1' ' A' ' 44' ' ' PHE . 64.8 mt -83.64 115.16 22.02 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.212 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -94.81 104.31 16.22 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.0 mp -69.18 120.98 80.26 Favored Pre-proline 0 C--N 1.317 -0.819 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo . . . . . 0 C--N 1.36 1.164 0 C-N-CA 123.436 2.758 . . . . 0.0 113.091 -177.42 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 N--CA 1.437 -1.103 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.9 t -64.66 -44.65 89.73 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.288 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -4.53 3.53 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -81.95 -35.77 28.69 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.318 0.58 . . . . 0.0 109.511 174.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.434 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 44.7 p-90 -109.46 -28.17 9.06 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -91.32 119.33 31.26 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.55 0.691 . . . . 0.0 110.734 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.42 99.15 5.87 Favored Pre-proline 0 C--N 1.297 -1.683 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.657 172.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.22 -25.11 26.82 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 123.006 2.471 . . . . 0.0 113.629 -171.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -93.96 13.32 23.16 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.433 -173.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.9 tp -92.02 145.52 24.46 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.7 t -99.47 172.31 7.4 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.215 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -55.89 -53.34 57.96 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.299 1.04 . . . . 0.0 112.005 -174.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -67.5 -33.96 76.17 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.1 0.476 . . . . 0.0 111.25 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -70.68 -33.11 70.57 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.221 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.6 -40.67 97.54 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.751 0.786 . . . . 0.0 109.506 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 70.0 mt -69.22 -37.56 76.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 114.755 -1.112 . . . . 0.0 109.582 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.51 -33.8 64.07 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.06 177.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.507 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 4.6 mm? -78.7 -55.73 4.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.105 0.479 . . . . 0.0 110.259 174.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 47.2 mt -59.75 -28.91 67.79 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -174.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -64.55 -28.07 69.39 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.924 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -95.9 -21.61 17.96 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.23 0.538 . . . . 0.0 110.475 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' A' ' 35' ' ' LEU . 26.2 mtpp -77.91 150.34 34.09 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-O 121.021 0.439 . . . . 0.0 110.818 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -75.05 151.36 86.14 Favored Pre-proline 0 C--N 1.309 -1.187 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.566 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -52.1 121.99 9.8 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 123.429 2.753 . . . . 0.0 112.839 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.81 -23.36 7.03 Favored Glycine 0 N--CA 1.432 -1.627 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.2 145.08 44.45 Favored 'General case' 0 C--O 1.246 0.913 0 O-C-N 124.057 0.504 . . . . 0.0 110.513 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.493 ' CG ' HD11 ' A' ' 125' ' ' LEU . 12.7 p90 -142.83 171.96 13.34 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.34 -176.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -158.49 152.8 24.17 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 172.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.434 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 55.8 mt -125.3 134.01 67.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.4 ptt-85 -133.38 -178.69 5.1 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -83.2 147.87 27.77 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.2 m -78.16 139.81 38.99 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.157 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -84.96 -36.07 21.62 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.9 m -69.2 -46.79 66.59 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.738 -176.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -131.1 146.41 52.35 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -87.11 148.97 25.0 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.67 23.05 70.96 Favored Glycine 0 CA--C 1.499 -0.962 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.59 137.1 43.45 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -110.52 121.85 46.32 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.68 114.56 3.95 Favored Glycine 0 N--CA 1.424 -2.112 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.276 -176.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 42.6 tp -94.0 123.62 37.48 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -112.91 122.15 46.78 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 176.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.4 tp -115.65 128.69 56.1 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.42 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 22.0 tptm -88.72 114.82 25.75 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 80' ' ' LEU . 29.3 m -108.61 171.73 2.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.76 -51.56 12.39 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.6 p -151.63 125.72 4.44 Favored Pre-proline 0 N--CA 1.431 -1.414 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.244 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.65 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 34.9 Cg_exo -60.1 -45.68 22.51 Favored 'Trans proline' 0 CA--C 1.577 2.652 0 C-N-CA 121.859 1.706 . . . . 0.0 111.506 169.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.65 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 46.5 Cg_endo -63.72 161.17 33.32 Favored 'Trans proline' 0 C--N 1.391 2.778 0 C-N-CA 122.934 2.423 . . . . 0.0 110.054 171.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.33 -40.89 45.64 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.42 2.08 . . . . 0.0 112.831 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.1 p -137.57 -17.97 1.27 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.435 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 65.33 33.47 9.02 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.059 0.944 . . . . 0.0 111.513 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -65.49 -45.7 68.84 Favored Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.452 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -74.29 103.72 1.73 Allowed 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 121.119 1.213 . . . . 0.0 109.148 169.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 56.0 t-105 -107.8 143.67 36.05 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.12 -175.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -134.93 8.72 3.52 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.77 51.23 4.11 Favored Glycine 0 CA--C 1.49 -1.48 0 C-N-CA 119.726 -1.226 . . . . 0.0 110.37 -175.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -91.32 119.09 68.77 Favored Pre-proline 0 N--CA 1.437 -1.107 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -49.66 146.66 14.86 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.818 3.012 . . . . 0.0 115.168 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.485 HG23 HD12 ' A' ' 80' ' ' LEU . 7.5 p -60.13 -21.03 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 CA-C-O 122.23 1.014 . . . . 0.0 109.794 174.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -69.65 -20.14 63.6 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.359 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -90.31 -7.86 52.31 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.651 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.485 HD12 HG23 ' A' ' 77' ' ' VAL . 80.2 mt -83.53 -6.23 59.39 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 122.091 0.948 . . . . 0.0 108.844 177.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.8 t -85.87 134.25 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.27 174.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -111.05 130.7 55.52 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -109.71 122.86 48.44 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.049 0.452 . . . . 0.0 111.522 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -133.27 147.75 51.93 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 177.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -119.05 131.06 55.93 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 118.709 -1.196 . . . . 0.0 112.314 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.55 HG12 HG12 ' A' ' 95' ' ' ILE . 78.8 mt -87.7 118.23 33.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 178.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.558 ' OE1' ' HE2' ' A' ' 96' ' ' LYS . 39.8 mt-10 -98.97 138.9 35.41 Favored 'General case' 0 C--N 1.27 -2.867 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.539 ' HB ' HG12 ' A' ' 93' ' ' VAL . 7.2 t -120.43 116.66 25.89 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-O 121.989 0.899 . . . . 0.0 109.929 178.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -125.84 -166.69 12.33 Favored Glycine 0 N--CA 1.416 -2.651 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.483 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -68.49 -11.47 32.03 Favored 'Trans proline' 0 C--N 1.331 -0.351 0 C-N-CA 122.949 2.433 . . . . 0.0 113.173 -176.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.529 ' HD3' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -97.06 -17.16 20.16 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.911 179.513 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 136.19 -164.07 25.07 Favored Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -177.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.539 HG12 ' HB ' ' A' ' 88' ' ' THR . 8.3 m -104.97 148.41 9.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.492 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -164.81 157.89 16.89 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.233 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.661 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 60.5 mt -92.27 131.95 37.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.627 0.727 . . . . 0.0 112.008 -174.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.558 ' HE2' ' OE1' ' A' ' 87' ' ' GLU . 22.3 ttmm -88.78 132.87 34.44 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 172.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.49 7.1 7.71 Favored Glycine 0 C--N 1.308 -1.027 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -172.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.415 ' SG ' HG22 ' A' ' 119' ' ' ILE . 42.3 t -142.42 142.36 23.39 Favored Pre-proline 0 N--CA 1.428 -1.567 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -87.73 -13.92 3.84 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.264 1.976 . . . . 0.0 113.244 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.0 m -85.79 -82.76 0.18 Allowed 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.661 ' HG3' ' O ' ' A' ' 95' ' ' ILE . 28.2 mm-40 46.95 97.26 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 117.603 2.445 . . . . 0.0 117.603 174.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -81.63 147.79 15.72 Favored 'Trans proline' 0 N--CA 1.437 -1.845 0 C-N-CA 122.015 1.81 . . . . 0.0 108.926 172.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -76.98 123.38 26.25 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.6 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.429 ' CE2' ' HB3' ' A' ' 110' ' ' LEU . 59.9 m-85 -103.54 164.38 11.7 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.18 -53.5 2.49 Favored Glycine 0 C--N 1.305 -1.156 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.625 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 61.9 m -116.04 160.73 19.89 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 122.918 -0.166 . . . . 0.0 110.977 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.33 -35.17 79.5 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.938 0.399 . . . . 0.0 110.985 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -55.26 -30.82 60.84 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 123.912 0.885 . . . . 0.0 111.479 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.33 -49.33 69.85 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.419 -178.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.589 ' H ' HD13 ' A' ' 110' ' ' LEU 0.293 0.0 OUTLIER -72.52 -28.58 62.95 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.972 -179.78 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 73.4 t -63.65 -49.42 82.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 123.656 0.598 . . . . 0.0 110.076 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.0 t -68.45 -37.88 80.62 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.044 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -75.22 -40.57 59.0 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.472 ' HA ' ' O ' ' A' ' 117' ' ' SER . 25.4 m80 -67.7 -10.96 57.03 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.8 t -72.96 -32.09 65.0 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 175.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 62.4 mt -96.44 -53.5 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 19.8 m -114.77 103.57 54.74 Favored Pre-proline 0 N--CA 1.436 -1.141 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.633 -177.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -78.45 89.35 1.36 Allowed 'Trans proline' 0 N--CA 1.44 -1.657 0 C-N-CA 122.527 2.151 . . . . 0.0 110.922 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.415 HG22 ' SG ' ' A' ' 98' ' ' CYS . 43.5 mt -74.58 -66.57 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.56 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.5 t -85.11 -31.22 23.44 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.645 0.736 . . . . 0.0 110.111 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 69.5 mt -83.92 139.56 40.09 Favored Pre-proline 0 C--N 1.303 -1.444 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.377 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -76.81 -10.58 18.34 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.664 2.243 . . . . 0.0 112.893 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 45.1 t -137.37 160.83 37.97 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 39.3 m -70.61 136.0 48.86 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.493 HD11 ' CG ' ' A' ' 44' ' ' PHE . 23.9 tp -75.07 132.7 41.46 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.52 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.543 ' O ' ' HD3' ' A' ' 128' ' ' PRO . 36.6 mmt180 -118.07 128.81 55.12 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mp -95.26 106.31 25.25 Favored Pre-proline 0 C--N 1.312 -1.023 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.543 ' HD3' ' O ' ' A' ' 126' ' ' ARG . 33.6 Cg_exo . . . . . 0 N--CA 1.457 -0.652 0 C-N-CA 122.266 1.977 . . . . 0.0 111.988 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.9 p . . . . . 0 N--CA 1.434 -1.273 0 CA-C-O 122.02 0.914 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.9 m -75.9 -7.71 55.19 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.847 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.89 -16.56 53.26 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 119.936 -0.706 . . . . 0.0 111.695 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -69.75 -25.55 63.88 Favored 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -175.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 19.6 p-90 -113.25 -4.21 13.75 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.191 0.52 . . . . 0.0 111.917 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -107.45 114.32 28.25 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.786 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.66 96.97 3.53 Favored Pre-proline 0 C--N 1.295 -1.78 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.574 174.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.517 ' HA ' ' HB2' ' A' ' 47' ' ' ARG . 66.3 Cg_endo -79.81 13.96 2.0 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.443 2.762 . . . . 0.0 114.038 -171.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -102.92 -6.58 22.3 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 120.859 0.361 . . . . 0.0 110.421 -176.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.477 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 75.9 mt -87.32 142.54 27.81 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.478 0.656 . . . . 0.0 111.762 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 87.3 p -89.17 177.81 6.53 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.983 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -63.05 -43.25 99.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -55.08 -48.2 73.86 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.316 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -70.31 -34.39 72.66 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.381 -178.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.451 ' HA ' HD11 ' A' ' 45' ' ' LEU . . . -65.2 -44.59 87.87 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.237 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 51.2 mt -66.64 -38.94 82.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.486 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.06 -40.37 89.21 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.377 0.608 . . . . 0.0 110.346 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -46.0 69.56 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.055 -179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 72.4 mt -74.86 -17.19 60.63 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -176.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.401 ' HB3' HG21 ' A' ' 77' ' ' VAL . 18.4 ptpt -83.06 -11.28 58.18 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.149 -1.021 . . . . 0.0 110.37 177.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -93.91 -24.3 17.75 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.606 0.717 . . . . 0.0 109.454 175.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -99.91 164.52 11.98 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -72.49 156.91 89.84 Favored Pre-proline 0 C--N 1.287 -2.127 0 CA-C-N 112.177 -2.283 . . . . 0.0 112.749 -176.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -60.46 126.31 19.64 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.892 2.395 . . . . 0.0 111.379 175.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 112.96 -7.74 25.47 Favored Glycine 0 C--N 1.303 -1.25 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -176.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.49 150.3 32.98 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-N 115.534 -0.333 . . . . 0.0 110.341 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.527 ' CD1' HD11 ' A' ' 125' ' ' LEU . 9.8 p90 -149.25 167.63 25.5 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.451 HD11 ' HA ' ' A' ' 32' ' ' ALA . 2.5 pt? -155.97 148.72 24.04 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 171.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.406 ' CG2' ' HB3' ' A' ' 56' ' ' TYR . 63.2 mt -120.79 130.27 74.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-O 121.124 0.488 . . . . 0.0 110.656 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.517 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -137.82 -176.96 4.6 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.044 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -62.66 134.39 56.25 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.8 t -74.57 136.38 42.09 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.371 0.605 . . . . 0.0 110.704 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -72.75 -27.06 61.8 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.325 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.2 m -81.13 -52.26 7.57 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.965 -175.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -137.73 145.26 42.28 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -175.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -82.98 151.92 25.66 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 173.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.03 9.96 81.52 Favored Glycine 0 C--N 1.305 -1.179 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.44 144.48 48.16 Favored 'General case' 0 N--CA 1.406 -2.648 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.406 ' HB3' ' CG2' ' A' ' 46' ' ' ILE . 76.6 m-85 -116.9 126.34 52.83 Favored 'General case' 0 C--N 1.273 -2.749 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.433 ' O ' ' HD3' ' A' ' 47' ' ' ARG . . . -83.76 115.15 4.0 Favored Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.031 -177.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.7 tp -95.59 121.63 37.5 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 123.728 0.811 . . . . 0.0 109.03 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.57 127.56 53.1 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -124.04 125.59 44.79 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -176.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.495 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 21.7 tptm -88.34 114.62 25.15 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.675 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 80' ' ' LEU . 20.0 m -96.85 167.61 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.07 -59.11 2.87 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 174.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.4 ' HB ' ' HG2' ' A' ' 66' ' ' PRO . 0.6 OUTLIER -155.73 141.72 12.91 Favored Pre-proline 0 N--CA 1.428 -1.529 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.84 177.349 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.65 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 32.0 Cg_exo -59.47 -42.79 45.04 Favored 'Trans proline' 0 CA--C 1.573 2.454 0 C-N-CA 122.283 1.989 . . . . 0.0 112.61 174.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.65 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 39.7 Cg_endo -65.13 148.12 88.91 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 122.832 2.354 . . . . 0.0 109.77 172.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.79 -37.14 88.67 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.749 2.299 . . . . 0.0 113.048 -177.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.7 t -132.37 -11.07 3.22 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.949 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.455 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 69.83 31.99 3.31 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 124.345 1.058 . . . . 0.0 112.923 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -64.14 -43.75 74.95 Favored Pre-proline 0 CA--C 1.556 1.199 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.631 173.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -84.69 101.3 0.79 Allowed 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 121.446 1.43 . . . . 0.0 109.893 167.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 34.6 t-105 -92.53 146.66 23.51 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.909 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -121.82 -36.52 3.01 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.966 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.44 14.12 12.09 Favored Glycine 0 C--N 1.3 -1.466 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.31 -176.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -64.53 134.09 95.89 Favored Pre-proline 0 C--N 1.316 -0.865 0 C-N-CA 122.63 0.372 . . . . 0.0 110.701 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.1 173.19 14.91 Favored 'Trans proline' 0 C--O 1.245 0.844 0 C-N-CA 123.042 2.495 . . . . 0.0 113.855 -175.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.401 HG21 ' HB3' ' A' ' 37' ' ' LYS . 2.1 p -56.42 -30.31 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.478 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -58.78 -25.11 62.78 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 122.955 0.502 . . . . 0.0 112.238 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -92.05 -14.23 29.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.059 0.457 . . . . 0.0 110.56 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.528 ' O ' HG22 ' A' ' 62' ' ' VAL . 72.9 mt -81.95 -13.07 58.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 122.006 0.908 . . . . 0.0 108.642 178.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.2 t -94.91 111.37 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 175.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.412 ' NH2' ' HB3' ' A' ' 65' ' ' PRO . 32.4 mmt180 -85.19 147.46 26.59 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.428 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.9 m80 -126.13 123.21 37.79 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.586 0.708 . . . . 0.0 111.723 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -132.49 163.52 28.63 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 106.282 -1.748 . . . . 0.0 106.282 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -130.02 132.65 46.31 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.047 176.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 94' ' ' LYS . 75.1 mt -90.84 110.65 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.332 0 CA-C-N 114.48 -1.236 . . . . 0.0 107.668 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -100.2 152.69 19.98 Favored 'General case' 0 C--N 1.268 -2.954 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.507 ' HB ' HG12 ' A' ' 93' ' ' VAL . 4.3 t -134.14 148.82 51.01 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-O 121.214 0.531 . . . . 0.0 110.675 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.45 -159.51 11.15 Favored Glycine 0 N--CA 1.42 -2.384 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.37 -21.44 72.68 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.929 2.419 . . . . 0.0 112.939 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -88.83 -5.79 57.79 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.733 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 110.36 -147.56 17.44 Favored Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.507 HG12 ' HB ' ' A' ' 88' ' ' THR . 12.1 m -108.11 151.95 10.08 Favored 'Isoleucine or valine' 0 C--O 1.252 1.23 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 13.8 pttp -151.38 147.95 27.53 Favored 'General case' 0 C--N 1.311 -1.078 0 O-C-N 123.777 0.673 . . . . 0.0 109.859 -175.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.517 ' HB ' ' OE2' ' A' ' 101' ' ' GLU . 76.5 mt -101.46 108.38 23.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -75.36 119.06 18.94 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 120.984 0.421 . . . . 0.0 110.071 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 121.22 -2.74 11.47 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.072 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 24.1 p -70.93 152.9 94.96 Favored Pre-proline 0 C--N 1.317 -0.809 0 C-N-CA 123.026 0.53 . . . . 0.0 110.006 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -72.41 -52.64 0.17 Allowed 'Trans proline' 0 C--O 1.24 0.616 0 C-N-CA 121.729 1.619 . . . . 0.0 110.16 173.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.2 m -144.99 139.86 27.79 Favored 'General case' 0 N--CA 1.41 -2.467 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.517 ' OE2' ' HB ' ' A' ' 95' ' ' ILE . 38.3 tt0 -166.56 142.67 3.88 Favored Pre-proline 0 C--N 1.297 -1.713 0 O-C-N 123.479 0.487 . . . . 0.0 112.165 -176.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -92.71 160.62 2.83 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 123.171 2.581 . . . . 0.0 110.3 168.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -74.07 127.02 31.84 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -79.14 -72.59 0.38 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.023 0.439 . . . . 0.0 111.248 -176.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.44 ' H ' HG22 ' A' ' 93' ' ' VAL . . . 148.91 -58.6 0.46 Allowed Glycine 0 C--N 1.309 -0.929 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.1 m -132.53 155.9 47.79 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.475 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 10.7 mp -53.11 -46.31 68.65 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.436 0.46 . . . . 0.0 111.164 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.4 m -53.83 -30.75 46.65 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.898 0.879 . . . . 0.0 112.458 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.58 -37.12 73.89 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 120.64 0.257 . . . . 0.0 111.288 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 107' ' ' LEU . 4.3 pp -80.35 -23.43 40.53 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.462 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 107' ' ' LEU . 70.8 t -71.44 -40.31 72.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.388 177.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.0 p -70.25 -22.86 62.84 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.029 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.625 ' HG2' ' H ' ' A' ' 114' ' ' HIS . 8.5 tt0 -95.2 -172.51 2.69 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 177.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.625 ' H ' ' HG2' ' A' ' 113' ' ' GLN . 57.2 m80 77.87 -26.07 0.19 Allowed 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.9 m -66.81 -41.9 86.79 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 173.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 65.8 mt -74.23 -66.25 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.404 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.7 m -125.75 118.79 24.26 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -78.75 101.09 1.42 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.238 1.959 . . . . 0.0 111.002 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 56.5 mt -95.02 -71.15 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.508 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.0 m -71.28 -30.2 65.99 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.343 0.592 . . . . 0.0 110.554 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 85.9 mt -101.49 148.81 35.74 Favored Pre-proline 0 C--N 1.304 -1.399 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.104 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 1.7 Cg_endo -77.43 -29.29 4.89 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.007 1.805 . . . . 0.0 113.109 -178.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 79.9 m -114.8 155.03 27.51 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.81 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 64.7 m -62.68 122.72 16.57 Favored 'General case' 0 C--O 1.241 0.606 0 O-C-N 123.982 0.802 . . . . 0.0 109.645 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.527 HD11 ' CD1' ' A' ' 44' ' ' PHE . 27.4 tp -74.11 134.56 42.89 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.724 -173.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -117.96 129.03 55.36 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 127' ' ' ILE . 3.4 mp -93.29 132.98 29.24 Favored Pre-proline 0 C--O 1.193 -1.884 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -174.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 N--CA 1.488 1.185 0 C-N-CA 122.842 2.362 . . . . 0.0 112.898 179.123 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 35.0 p . . . . . 0 N--CA 1.408 -2.549 0 CA-C-O 120.659 0.266 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.407 ' HA ' ' CE2' ' A' ' 22' ' ' TRP . 48.3 p -53.38 -49.55 66.98 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -173.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -10.19 57.8 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 119.86 -0.736 . . . . 0.0 112.614 -177.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -83.34 -25.19 31.67 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.528 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.407 ' CE2' ' HA ' ' A' ' 19' ' ' SER . 27.0 p-90 -119.39 -22.09 7.19 Favored 'General case' 0 C--O 1.214 -0.795 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 52.1 t80 -90.97 112.77 24.8 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.775 -177.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.78 92.07 41.27 Favored Pre-proline 0 C--N 1.315 -0.929 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 175.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -57.64 -44.41 41.74 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 123.341 2.694 . . . . 0.0 115.942 -169.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -104.96 16.91 25.08 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.368 0.604 . . . . 0.0 111.364 -170.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.5 tp -74.62 146.25 42.6 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 85.4 p -93.0 166.66 12.26 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.96 -0.462 . . . . 0.0 110.257 -175.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -57.02 -49.41 75.88 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.939 0.399 . . . . 0.0 110.934 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -60.89 -34.82 75.24 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.296 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -75.87 -30.83 59.01 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.928 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.42 -43.14 77.81 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 75.8 mt -66.58 -40.22 85.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.624 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.21 -34.55 70.52 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.373 0.669 . . . . 0.0 111.104 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.72 -49.63 15.56 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.526 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 67.2 mt -68.49 -32.61 72.72 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -175.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -63.51 -21.54 66.38 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.065 0.459 . . . . 0.0 111.43 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -90.32 -10.14 45.18 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.275 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.65 -178.34 3.63 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.758 -174.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -99.96 160.72 26.47 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.111 -177.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -59.04 125.99 19.75 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 122.491 2.127 . . . . 0.0 111.673 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.51 -22.57 9.38 Favored Glycine 0 N--CA 1.43 -1.729 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.3 148.76 46.8 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.992 -0.374 . . . . 0.0 109.992 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.402 ' HB2' HD11 ' A' ' 58' ' ' LEU . 43.2 p90 -153.56 168.53 25.88 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.043 -175.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -153.15 152.43 31.26 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 172.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 23' ' ' TYR . 55.8 mt -121.98 133.19 69.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -127.02 -173.9 3.01 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -84.69 127.72 34.24 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 171.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.4 t -79.21 108.07 12.45 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -66.1 -6.53 13.48 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.75 -1.114 . . . . 0.0 113.912 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.1 p -77.62 -18.34 56.88 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.507 0.67 . . . . 0.0 110.977 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -135.83 -174.55 3.69 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -124.14 121.29 34.73 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.12 0.486 . . . . 0.0 109.918 172.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.04 43.65 8.05 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.37 159.33 41.36 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.563 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 50.5 m-85 -112.31 150.11 31.47 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.328 -176.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 85' ' ' LEU . . . -126.76 116.45 2.5 Favored Glycine 0 C--N 1.282 -2.458 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.402 HD11 ' HB2' ' A' ' 44' ' ' PHE . 50.5 tp -94.77 123.24 38.11 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 123.144 0.578 . . . . 0.0 109.84 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -107.57 115.61 30.46 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 175.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.3 tp -110.79 127.52 55.41 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 123.491 0.494 . . . . 0.0 110.487 -177.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.526 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 26.7 tptp -88.64 115.49 26.2 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.426 HG11 ' HG2' ' A' ' 122' ' ' PRO . 31.4 m -106.96 164.91 4.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.66 -53.26 43.69 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.489 ' HB ' ' HG2' ' A' ' 66' ' ' PRO . 1.3 p -159.76 140.73 9.14 Favored Pre-proline 0 N--CA 1.423 -1.8 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 175.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.6 ' CD ' ' HD2' ' A' ' 66' ' ' PRO . 30.1 Cg_exo -56.7 -43.18 57.34 Favored 'Trans proline' 0 CA--C 1.571 2.327 0 C-N-CA 122.215 1.944 . . . . 0.0 112.704 175.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.6 ' HD2' ' CD ' ' A' ' 65' ' ' PRO . 43.5 Cg_endo -62.81 153.4 72.93 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.182 2.588 . . . . 0.0 110.426 171.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -57.31 -45.35 35.49 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.524 2.149 . . . . 0.0 112.632 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.9 m -133.44 1.32 3.42 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.511 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 60.16 38.22 20.36 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.828 0.851 . . . . 0.0 111.856 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -54.74 -49.74 89.77 Favored Pre-proline 0 CA--C 1.552 1.055 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.933 177.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -78.0 139.83 17.58 Favored 'Trans proline' 0 C--N 1.366 1.479 0 CA-C-N 120.253 1.126 . . . . 0.0 111.406 173.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -96.47 136.62 36.72 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -132.68 -12.22 3.02 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.038 0.447 . . . . 0.0 110.502 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.48 56.12 4.38 Favored Glycine 0 CA--C 1.493 -1.299 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -175.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -83.63 132.86 47.95 Favored Pre-proline 0 C--N 1.289 -2.024 0 C-N-CA 123.563 0.745 . . . . 0.0 111.395 -175.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -81.93 166.84 16.73 Favored 'Trans proline' 0 N--CA 1.445 -1.327 0 C-N-CA 122.122 1.881 . . . . 0.0 111.827 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.8 p -61.2 -24.47 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.486 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -65.26 -26.67 68.19 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.957 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.422 ' HG2' ' HG2' ' A' ' 65' ' ' PRO . 47.2 tt0 -82.35 -27.73 32.01 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.109 0.48 . . . . 0.0 109.957 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.0 mt -74.72 -11.7 60.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.553 0.692 . . . . 0.0 110.367 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.2 t -103.15 118.47 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -100.36 129.78 46.38 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 -178.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -107.24 121.76 45.18 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 121.038 0.447 . . . . 0.0 109.8 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -127.79 118.37 23.61 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.412 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 4.2 pp -96.24 139.34 32.53 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.111 -177.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.563 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 76.9 mt -99.97 129.24 50.94 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 CA-C-N 114.402 -1.272 . . . . 0.0 107.935 -177.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.598 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 35.3 mt-10 -99.11 157.38 16.4 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -177.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.703 ' HB ' HG12 ' A' ' 93' ' ' VAL . 4.4 t -147.54 128.89 14.84 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 175.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.39 -141.9 3.67 Favored Glycine 0 N--CA 1.426 -2.013 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.389 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.62 -47.63 25.72 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.723 2.949 . . . . 0.0 113.108 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -74.57 -60.73 2.15 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 167.46 -146.17 10.44 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 119.976 -1.107 . . . . 0.0 111.627 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.703 HG12 ' HB ' ' A' ' 88' ' ' THR . 22.0 m -104.9 149.36 8.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 O-C-N 124.007 0.475 . . . . 0.0 111.078 -175.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.89 157.64 3.04 Favored 'General case' 0 C--O 1.252 1.187 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 172.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.496 HG12 HG12 ' A' ' 86' ' ' ILE . 71.9 mt -76.17 129.15 37.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-O 121.959 0.885 . . . . 0.0 112.35 -178.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -69.77 121.17 16.72 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.55 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 109.72 -1.16 30.47 Favored Glycine 0 C--N 1.306 -1.118 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.627 ' SG ' ' HB2' ' A' ' 101' ' ' GLU . 37.9 t -108.81 110.26 61.12 Favored Pre-proline 0 N--CA 1.431 -1.396 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -96.45 21.24 0.43 Allowed 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.098 2.532 . . . . 0.0 112.671 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.5 m -138.13 31.91 2.4 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.852 0.834 . . . . 0.0 109.093 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.627 ' HB2' ' SG ' ' A' ' 98' ' ' CYS . 29.7 tt0 -134.46 123.5 16.49 Favored Pre-proline 0 N--CA 1.426 -1.675 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.588 -173.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.37 174.76 12.26 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.594 2.196 . . . . 0.0 112.076 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -86.25 129.03 34.98 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -106.93 172.78 6.63 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -98.41 -54.8 1.14 Allowed Glycine 0 C--N 1.304 -1.225 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.103 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.5 m -105.95 153.78 21.5 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 123.128 0.571 . . . . 0.0 110.028 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.429 HD21 ' CD2' ' A' ' 56' ' ' TYR . 92.6 mt -65.35 -36.19 83.25 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.049 0.452 . . . . 0.0 110.041 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.8 m -53.05 -29.25 28.84 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.001 0.92 . . . . 0.0 112.697 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.73 -41.83 74.75 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.552 ' H ' HD13 ' A' ' 110' ' ' LEU 0.306 0.0 OUTLIER -80.07 -32.36 39.31 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.215 177.285 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.455 ' HA ' HD23 ' A' ' 125' ' ' LEU . 67.6 t -57.08 -42.68 79.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.307 0.575 . . . . 0.0 110.91 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.8 p -72.15 -33.44 67.74 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.984 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -80.01 -36.35 36.02 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.509 ' HA ' ' O ' ' A' ' 117' ' ' SER . 27.9 m-70 -71.65 -5.47 33.89 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -174.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.8 m -73.33 -30.08 63.11 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 172.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.425 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 52.9 mt -101.03 -52.16 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.109 -177.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 38.8 t -111.72 95.87 30.11 Favored Pre-proline 0 N--CA 1.424 -1.773 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.036 -175.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 116' ' ' ILE . 5.8 Cg_endo -85.78 74.54 3.43 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 122.733 2.289 . . . . 0.0 109.942 178.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.1 mt -66.19 -56.24 15.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.861 -175.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.563 ' HB3' ' SG ' ' A' ' 98' ' ' CYS . 2.4 p -96.31 6.18 49.34 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.081 -177.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 69.2 mt -123.49 140.84 34.89 Favored Pre-proline 0 C--N 1.308 -1.199 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.755 -173.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.426 ' HG2' HG11 ' A' ' 62' ' ' VAL . 72.4 Cg_endo -79.03 -8.44 15.45 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.576 2.184 . . . . 0.0 112.033 177.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 77.1 m -140.29 168.81 18.93 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 59.3 m -79.21 145.76 33.45 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 120.733 0.301 . . . . 0.0 110.27 -178.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 111' ' ' VAL . 15.5 tp -85.6 108.73 18.12 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -106.65 107.47 18.5 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.54 0.686 . . . . 0.0 111.721 -174.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 58.2 mt -65.74 120.92 72.64 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.763 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 0 C--N 1.351 0.7 0 C-N-CA 122.246 1.964 . . . . 0.0 111.735 179.173 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.421 -1.915 0 CA-C-O 122.144 0.974 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.464 ' HA ' ' CE2' ' A' ' 22' ' ' TRP . 27.1 m -66.77 -22.25 66.04 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.501 177.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.72 0.46 5.54 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.882 -1.054 . . . . 0.0 113.076 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -94.52 -27.12 16.13 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 122.233 -0.292 . . . . 0.0 110.486 174.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.464 ' CE2' ' HA ' ' A' ' 19' ' ' SER . 31.0 p-90 -134.49 -8.24 2.52 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -170.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -96.75 114.39 26.03 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.029 -0.669 . . . . 0.0 111.327 -176.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -120.02 86.57 37.17 Favored Pre-proline 0 C--O 1.2 -1.528 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 176.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -54.11 -40.9 79.79 Favored 'Trans proline' 0 N--CA 1.479 0.628 0 C-N-CA 123.264 2.643 . . . . 0.0 115.936 -170.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -97.32 10.13 40.43 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -171.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.7 tp -75.61 136.81 40.47 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.454 0.645 . . . . 0.0 110.657 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.1 m -80.56 161.11 24.94 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.641 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.413 ' HA ' HH21 ' A' ' 47' ' ' ARG . 28.2 ttm180 -56.71 -51.42 68.87 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.275 0.63 . . . . 0.0 110.961 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -59.46 -44.66 92.93 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.583 0.706 . . . . 0.0 110.909 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -69.81 -30.53 68.07 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.863 -176.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.52 -36.97 82.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.667 0.746 . . . . 0.0 110.306 178.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 72.4 mt -69.73 -40.23 78.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.593 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.76 -33.31 73.86 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.789 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.87 -36.14 75.25 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.569 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.547 ' HB3' ' HG2' ' A' ' 61' ' ' LYS . 63.8 mt -87.85 -22.33 24.51 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -71.3 -9.42 58.09 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.571 0.7 . . . . 0.0 110.594 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -91.89 -25.18 19.06 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.43 174.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -106.71 155.58 19.52 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -169.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -66.07 156.5 84.16 Favored Pre-proline 0 C--N 1.32 -0.696 0 C-N-CA 125.334 1.454 . . . . 0.0 113.321 -172.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.24 111.96 1.26 Allowed 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 122.876 2.384 . . . . 0.0 111.045 175.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.05 -18.21 5.33 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -176.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.77 147.36 35.35 Favored 'General case' 0 C--O 1.251 1.146 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 177.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.401 ' HB2' HD11 ' A' ' 58' ' ' LEU . 25.0 p90 -153.17 169.48 22.9 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -175.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -160.35 154.33 22.98 Favored 'General case' 0 C--O 1.254 1.307 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 173.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 56.9 mt -126.8 137.61 57.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 123.354 0.409 . . . . 0.0 109.922 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.505 HH22 ' CD2' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -134.67 177.9 7.42 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 177.125 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -74.08 130.02 38.99 Favored 'General case' 0 C--O 1.249 1.034 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 175.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.0 t -82.56 92.76 7.17 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-O 121.526 0.679 . . . . 0.0 109.242 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -75.44 76.36 2.5 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-O 122.322 1.058 . . . . 0.0 108.782 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.5 t -161.87 -40.97 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 112.804 -1.998 . . . . 0.0 107.877 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -135.93 142.98 44.7 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -76.84 133.79 39.24 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.273 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.13 37.36 28.92 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.62 143.51 47.36 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -115.55 133.26 56.2 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.449 ' O ' ' HD3' ' A' ' 47' ' ' ARG . . . -97.83 119.14 6.32 Favored Glycine 0 C--N 1.283 -2.376 0 C-N-CA 119.836 -1.173 . . . . 0.0 112.018 -176.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.401 HD11 ' HB2' ' A' ' 44' ' ' PHE . 48.3 tp -97.4 136.08 38.36 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.422 ' HB2' HH12 ' A' ' 47' ' ' ARG . . . -122.04 129.97 52.88 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 173.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.4 tp -127.59 132.05 49.86 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 123.505 0.503 . . . . 0.0 110.957 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.547 ' HG2' ' HB3' ' A' ' 36' ' ' LEU . 0.7 OUTLIER -88.55 115.61 26.2 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 174.716 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.7 m -102.29 171.85 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.85 -56.09 6.36 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 p -152.57 137.6 11.03 Favored Pre-proline 0 N--CA 1.435 -1.204 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.477 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.501 ' HD2' ' CD ' ' A' ' 66' ' ' PRO . 16.6 Cg_exo -65.51 -44.7 8.14 Favored 'Trans proline' 0 CA--C 1.568 2.19 0 C-N-CA 121.625 1.55 . . . . 0.0 110.91 173.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.501 ' CD ' ' HD2' ' A' ' 65' ' ' PRO . 14.8 Cg_exo -71.14 165.6 31.9 Favored 'Trans proline' 0 C--N 1.397 3.098 0 C-N-CA 122.219 1.946 . . . . 0.0 109.87 168.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -50.58 -35.63 47.13 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.472 2.781 . . . . 0.0 112.953 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 65.2 m -151.7 -13.39 0.2 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 63.36 41.17 7.88 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.857 0.863 . . . . 0.0 111.835 175.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.403 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 22.0 mp0 -58.88 -51.8 79.27 Favored Pre-proline 0 CA--C 1.553 1.082 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.269 171.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 70' ' ' GLN . 30.2 Cg_endo -63.4 127.91 21.17 Favored 'Trans proline' 0 C--N 1.387 2.578 0 C-N-CA 122.072 1.848 . . . . 0.0 112.049 176.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -98.98 139.48 34.56 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.195 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -136.79 16.43 3.08 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.173 0.589 . . . . 0.0 110.067 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.34 64.53 1.76 Allowed Glycine 0 CA--C 1.486 -1.752 0 N-CA-C 107.024 -2.43 . . . . 0.0 107.024 -172.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -104.58 103.19 38.55 Favored Pre-proline 0 C--N 1.301 -1.524 0 CA-C-N 114.953 -0.623 . . . . 0.0 110.358 -172.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.516 ' HB2' ' OE1' ' A' ' 78' ' ' GLU . 71.7 Cg_endo -78.8 175.53 10.88 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.052 1.835 . . . . 0.0 111.236 177.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 p -68.96 -28.2 38.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.568 0.699 . . . . 0.0 110.589 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.516 ' OE1' ' HB2' ' A' ' 76' ' ' PRO . 11.7 mp0 -66.52 -22.09 66.17 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.172 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -78.03 -18.16 56.18 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.651 0.738 . . . . 0.0 109.607 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.0 mt -84.13 -4.16 58.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.427 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.0 t -92.72 118.73 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -90.85 145.78 24.48 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.505 ' CD2' HH22 ' A' ' 47' ' ' ARG . 29.7 m80 -120.52 125.56 48.16 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.195 0.521 . . . . 0.0 111.793 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -138.32 131.96 30.87 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.484 HD23 ' H ' ' A' ' 85' ' ' LEU . 1.6 pt? -104.83 142.36 34.86 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.893 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.442 ' CG2' HG22 ' A' ' 93' ' ' VAL . 4.6 mp -98.83 123.59 51.53 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.083 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.414 ' OE1' ' HD3' ' A' ' 96' ' ' LYS . 48.5 mt-10 -98.86 139.76 34.06 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.502 ' HB ' HG23 ' A' ' 93' ' ' VAL . 12.1 t -133.35 153.41 51.62 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.33 -152.21 11.33 Favored Glycine 0 N--CA 1.42 -2.415 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.73 -13.14 37.81 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.662 2.241 . . . . 0.0 112.669 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -86.62 -6.84 58.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.329 0.585 . . . . 0.0 110.6 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 109.42 -140.32 15.66 Favored Glycine 0 N--CA 1.427 -1.924 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.502 HG23 ' HB ' ' A' ' 88' ' ' THR . 12.5 p -132.28 126.3 55.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -146.77 140.99 26.25 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.391 -0.818 . . . . 0.0 112.969 -176.84 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.4 mt -72.04 126.75 33.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.562 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.414 ' HD3' ' OE1' ' A' ' 87' ' ' GLU . 25.7 tptp -76.01 97.91 4.15 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.511 ' O ' ' HD3' ' A' ' 99' ' ' PRO . . . 135.81 4.12 2.46 Favored Glycine 0 N--CA 1.425 -2.084 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.505 -176.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 46.0 t -93.23 104.79 13.09 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 97' ' ' GLY . 72.8 Cg_endo -89.64 -10.23 3.77 Favored 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 121.878 1.718 . . . . 0.0 112.419 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.4 t -71.16 -75.17 0.13 Allowed 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 176.32 103.9 0.1 Allowed Pre-proline 0 C--O 1.234 0.277 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.499 ' HB2' ' HB2' ' A' ' 94' ' ' LYS . 23.3 Cg_endo -96.25 -128.18 0.01 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.887 0 C-N-CA 122.841 2.361 . . . . 0.0 112.435 177.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.42 ' H ' ' HB2' ' A' ' 102' ' ' PRO . 89.2 m-85 62.43 86.87 0.11 Allowed 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 125.55 1.54 . . . . 0.0 111.231 -175.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -110.7 177.38 4.69 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 113.955 -1.475 . . . . 0.0 108.722 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -88.13 -48.01 4.22 Favored Glycine 0 C--N 1.314 -0.68 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.344 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.2 m -134.28 160.1 38.92 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 66.0 mt -56.84 -44.47 82.12 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.543 0.337 . . . . 0.0 111.389 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 32.3 t -54.91 -31.26 59.97 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.817 0.847 . . . . 0.0 111.102 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.33 -44.27 88.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.013 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.56 ' H ' HD13 ' A' ' 110' ' ' LEU 0.302 0.0 OUTLIER -80.26 -31.17 38.47 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 119.146 -1.021 . . . . 0.0 112.01 177.608 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.7 t -61.87 -54.2 37.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.169 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.1 t -70.5 -31.62 68.79 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -174.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -68.65 -25.91 65.06 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.726 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.465 ' CD2' ' H ' ' A' ' 119' ' ' ILE . 45.7 m80 -77.37 -0.98 27.76 Favored 'General case' 0 C--O 1.214 -0.814 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 35.1 m -78.42 -29.28 47.06 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 172.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 61.2 mt -96.66 -59.51 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.086 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.2 m -114.07 110.51 48.5 Favored Pre-proline 0 N--CA 1.428 -1.535 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.404 -175.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -75.13 98.37 1.16 Allowed 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 121.802 1.668 . . . . 0.0 109.603 174.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.465 ' H ' ' CD2' ' A' ' 114' ' ' HIS . 62.3 mt -91.67 -68.78 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.1 -176.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.0 t -90.37 -11.39 40.72 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.269 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 60.0 mt -117.69 144.44 34.35 Favored Pre-proline 0 C--N 1.295 -1.773 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -175.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -72.28 -24.01 20.23 Favored 'Trans proline' 0 N--CA 1.477 0.52 0 C-N-CA 122.767 2.311 . . . . 0.0 113.143 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 71.9 m -119.47 162.43 18.87 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 81.0 m -86.64 143.23 27.72 Favored 'General case' 0 N--CA 1.429 -1.522 0 O-C-N 123.467 0.479 . . . . 0.0 109.793 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 75.8 mt -76.44 118.82 19.52 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -95.08 98.83 10.94 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 13.8 mt -97.8 134.16 22.63 Favored Pre-proline 0 C--N 1.276 -2.616 0 CA-C-N 113.822 -1.536 . . . . 0.0 109.0 -172.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo . . . . . 0 N--CA 1.484 0.926 0 C-N-CA 123.265 2.643 . . . . 0.0 112.131 176.449 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.7 p . . . . . 0 N--CA 1.429 -1.493 0 CA-C-O 122.068 0.937 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.9 m -70.66 -33.97 71.53 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.819 -173.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -7.51 33.69 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.371 -178.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -74.74 -36.15 62.63 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.897 0.38 . . . . 0.0 110.711 177.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.44 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 36.6 p-90 -103.56 -14.17 16.28 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.165 0.507 . . . . 0.0 111.789 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -94.31 112.58 24.38 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.471 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -127.08 91.62 46.29 Favored Pre-proline 0 C--N 1.312 -1.062 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 175.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.12 -7.67 21.43 Favored 'Trans proline' 0 C--N 1.331 -0.353 0 C-N-CA 122.377 2.051 . . . . 0.0 112.835 -175.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -100.37 -15.3 18.02 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.18 -176.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.5 tp -81.67 120.9 25.68 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.308 -168.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 m -76.72 165.43 24.74 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.939 -177.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -54.63 -50.99 66.8 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -174.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -65.82 -29.68 70.19 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.338 0.59 . . . . 0.0 111.384 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -77.09 -35.96 56.09 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.616 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.36 -41.38 98.84 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.765 176.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.442 ' HA ' HG21 ' A' ' 81' ' ' VAL . 87.0 mt -66.31 -45.33 89.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.86 177.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.07 -27.95 69.26 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.184 0.516 . . . . 0.0 111.911 178.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.44 -49.31 12.51 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 6.7 mp -70.33 -26.56 63.82 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -177.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -70.25 -13.14 62.04 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.446 0.641 . . . . 0.0 109.869 176.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -97.34 -32.72 11.74 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.495 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -85.54 -10.49 55.89 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -172.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.5 t70 73.1 148.59 0.12 Allowed Pre-proline 0 N--CA 1.506 2.339 0 O-C-N 123.532 0.52 . . . . 0.0 111.905 175.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' A' ' 61' ' ' LYS . 88.1 Cg_exo -45.52 118.96 2.4 Favored 'Trans proline' 0 C--N 1.389 2.711 0 C-N-CA 123.726 2.95 . . . . 0.0 115.014 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.87 -35.25 2.22 Favored Glycine 0 N--CA 1.427 -1.959 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.039 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.98 144.1 50.62 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-O 121.153 0.501 . . . . 0.0 111.194 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -145.18 165.94 26.87 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -154.55 157.11 37.8 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 172.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.44 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 65.5 mt -122.75 128.71 75.36 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.1 ptt-85 -121.72 179.69 4.4 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -95.49 130.99 42.13 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.1 m -89.78 136.95 32.74 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 120.762 0.315 . . . . 0.0 110.287 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -91.58 -23.55 19.86 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.1 t -71.93 -35.59 69.67 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.728 -176.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -128.43 149.38 50.59 Favored 'General case' 0 C--O 1.242 0.7 0 O-C-N 121.985 -0.447 . . . . 0.0 110.187 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -82.81 120.78 26.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.595 -176.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.58 29.97 57.08 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.565 178.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -113.86 133.84 55.17 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.454 ' CD2' HD21 ' A' ' 107' ' ' LEU . 44.7 m-85 -107.87 124.66 50.43 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.74 114.63 4.48 Favored Glycine 0 C--N 1.286 -2.211 0 C-N-CA 120.075 -1.059 . . . . 0.0 111.226 -176.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.3 tp -92.35 128.97 38.39 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -118.86 127.73 53.79 Favored 'General case' 0 C--N 1.282 -2.37 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 175.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.4 tp -123.01 131.85 53.88 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 123.522 0.514 . . . . 0.0 109.946 -177.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 41' ' ' PRO . 27.2 tptp -87.89 114.51 24.57 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.411 HG21 ' HE ' ' A' ' 82' ' ' ARG . 23.6 m -108.08 172.33 2.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.386 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.59 -48.63 21.49 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -163.21 143.72 7.16 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 123.142 0.577 . . . . 0.0 111.859 -178.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.67 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 37.4 Cg_exo -63.71 -46.97 7.88 Favored 'Trans proline' 0 CA--C 1.578 2.709 0 C-N-CA 121.774 1.65 . . . . 0.0 111.316 164.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.67 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 81.3 Cg_endo -71.66 171.22 16.82 Favored 'Trans proline' 0 C--N 1.398 3.146 0 C-N-CA 123.057 2.505 . . . . 0.0 109.05 171.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -66.45 -60.43 0.11 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 121.532 1.488 . . . . 0.0 112.205 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.1 p -123.23 -7.1 8.25 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.677 -178.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 64.19 33.73 11.54 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.225 1.01 . . . . 0.0 111.117 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.422 ' HB2' ' HD3' ' A' ' 71' ' ' PRO . 28.1 mt-30 -60.66 -46.97 97.19 Favored Pre-proline 0 CA--C 1.553 1.072 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.25 175.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 70' ' ' GLN . 2.3 Cg_endo -84.99 108.01 1.13 Allowed 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 121.496 1.464 . . . . 0.0 109.539 172.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 49.0 t-105 -93.44 141.21 28.71 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.722 -176.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -119.26 -53.51 2.24 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.489 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 161.17 56.91 0.02 OUTLIER Glycine 0 CA--C 1.471 -2.7 0 N-CA-C 107.622 -2.191 . . . . 0.0 107.622 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -88.33 113.48 55.43 Favored Pre-proline 0 C--N 1.288 -2.098 0 CA-C-N 113.515 -1.342 . . . . 0.0 111.925 -171.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -85.66 164.42 10.64 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.195 1.93 . . . . 0.0 111.868 176.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.9 p -60.7 -19.73 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 121.597 0.713 . . . . 0.0 110.779 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -63.5 -21.72 66.48 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 123.951 0.9 . . . . 0.0 111.297 178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -92.82 -13.9 28.51 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 121.066 0.46 . . . . 0.0 110.902 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.9 mt -82.53 -8.54 59.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.968 0.89 . . . . 0.0 109.534 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.442 HG21 ' HA ' ' A' ' 33' ' ' ILE . 89.9 t -109.49 107.82 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.998 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 174.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.517 ' NH2' ' HA ' ' A' ' 65' ' ' PRO . 77.4 mtt180 -87.27 147.75 25.4 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.177 -177.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -123.73 122.61 38.52 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.14 -175.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -130.99 156.49 45.03 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.403 ' HG ' ' HB3' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -125.35 133.45 52.56 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.765 178.741 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.494 HG12 HG12 ' A' ' 95' ' ' ILE . 78.0 mt -94.31 113.98 30.0 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.432 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.203 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.83 128.22 46.96 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.599 ' HB ' HG12 ' A' ' 93' ' ' VAL . 9.3 t -99.62 115.82 30.3 Favored 'General case' 0 N--CA 1.413 -2.296 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 176.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -115.13 -170.08 16.18 Favored Glycine 0 N--CA 1.42 -2.414 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -177.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.65 -20.83 69.8 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.038 2.492 . . . . 0.0 112.92 -178.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -87.76 -39.74 14.66 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.923 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 158.97 -158.2 29.2 Favored Glycine 0 N--CA 1.431 -1.645 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 -177.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.599 HG12 ' HB ' ' A' ' 88' ' ' THR . 6.4 m -103.37 130.95 52.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -177.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.72 154.39 48.56 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.628 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.494 HG12 HG12 ' A' ' 86' ' ' ILE . 33.7 mt -94.06 130.42 43.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.439 0.638 . . . . 0.0 110.896 -174.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.403 ' HB3' ' HG ' ' A' ' 85' ' ' LEU . 33.1 ttmt -102.03 143.77 31.46 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.337 176.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 105.1 8.15 36.72 Favored Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 -172.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 59.4 m -121.23 153.06 58.11 Favored Pre-proline 0 N--CA 1.423 -1.818 0 CA-C-N 114.105 -1.048 . . . . 0.0 109.395 -176.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -57.52 -58.39 0.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.153 1.902 . . . . 0.0 110.424 176.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.8 m -162.55 108.86 1.23 Allowed 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 122.839 0.456 . . . . 0.0 110.371 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.461 ' HG2' ' HB ' ' A' ' 119' ' ' ILE . 51.4 mt-10 -128.89 133.49 25.27 Favored Pre-proline 0 C--N 1.299 -1.593 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.96 176.53 6.04 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.603 2.869 . . . . 0.0 115.775 -170.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -87.79 113.48 23.49 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.642 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -90.48 161.75 15.37 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.98 -58.21 9.39 Favored Glycine 0 CA--C 1.509 -0.309 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.486 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.5 m -136.78 171.85 13.88 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.454 HD21 ' CD2' ' A' ' 56' ' ' TYR . 95.1 mt -53.5 -47.2 70.07 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.643 0.589 . . . . 0.0 110.654 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.7 m -52.95 -29.65 30.05 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.592 1.157 . . . . 0.0 112.747 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.43 -36.93 71.46 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 120.889 0.376 . . . . 0.0 111.306 -177.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 107' ' ' LEU . 4.2 pp -80.1 -21.66 43.02 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.599 0.714 . . . . 0.0 110.06 178.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 107' ' ' LEU . 88.1 t -70.68 -42.9 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.416 176.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.6 p -72.96 -44.55 60.99 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 122.16 -0.338 . . . . 0.0 111.349 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -77.76 12.33 1.74 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.423 ' HB2' ' H ' ' A' ' 125' ' ' LEU . 35.0 p-80 -53.96 -35.1 61.42 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.182 1.393 . . . . 0.0 111.16 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 41.9 p -98.87 -4.06 33.89 Favored 'General case' 0 N--CA 1.401 -2.889 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.461 -172.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 52.2 mt -106.31 -42.79 6.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.25 -175.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.3 t -135.93 81.14 40.53 Favored Pre-proline 0 N--CA 1.435 -1.222 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.986 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -98.03 96.07 0.07 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.033 0 C-N-CA 122.425 2.083 . . . . 0.0 109.054 172.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.461 ' HB ' ' HG2' ' A' ' 101' ' ' GLU . 58.6 mt -90.89 -57.06 4.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.856 -175.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 27.6 t -91.76 -30.83 16.03 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.923 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.53 118.59 55.41 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.621 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.475 ' HG3' ' CZ ' ' A' ' 82' ' ' ARG . 89.4 Cg_endo -83.02 -3.89 11.14 Favored 'Trans proline' 0 C--O 1.243 0.735 0 C-N-CA 123.022 2.482 . . . . 0.0 112.265 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 84.8 m -145.32 149.26 34.5 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 79.0 m -88.93 148.4 23.83 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.423 ' H ' ' HB2' ' A' ' 114' ' ' HIS . 58.7 mt -70.3 107.27 3.68 Favored 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.513 -175.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -80.2 99.78 7.97 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.859 -0.526 . . . . 0.0 110.168 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.574 ' H ' HD12 ' A' ' 127' ' ' ILE . 3.9 mp -71.12 121.77 85.11 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.79 -177.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 N--CA 1.491 1.345 0 C-N-CA 123.087 2.525 . . . . 0.0 113.381 -177.868 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.6 p . . . . . 0 N--CA 1.413 -2.296 0 CA-C-O 121.519 0.676 . . . . 0.0 110.314 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.428 ' HA ' ' NE1' ' A' ' 22' ' ' TRP . 18.4 m -73.01 -28.76 62.56 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.761 -177.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.421 ' HD3' ' H ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -71.28 -10.12 59.23 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.689 0.757 . . . . 0.0 110.769 177.184 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -76.92 -21.1 55.35 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.258 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.428 ' NE1' ' HA ' ' A' ' 19' ' ' SER . 47.0 p-90 -113.67 -31.46 6.47 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 177.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.476 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 42.1 t80 -86.26 116.85 24.7 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.001 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -125.81 84.85 60.14 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.416 ' HD3' ' CD2' ' A' ' 23' ' ' TYR . 9.3 Cg_endo -54.4 -46.59 32.31 Favored 'Trans proline' 0 C--N 1.333 -0.282 0 C-N-CA 122.786 2.324 . . . . 0.0 115.818 -171.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -97.84 13.86 29.09 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -173.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.561 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 15.2 tp -83.3 145.84 28.86 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.504 -178.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.2 t -96.89 169.65 9.7 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -58.81 -50.32 74.42 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 123.524 0.729 . . . . 0.0 111.736 -175.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -58.34 -40.29 81.78 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.122 0.487 . . . . 0.0 111.083 -177.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -74.98 -29.91 61.03 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.872 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.92 -43.48 83.22 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.966 -0.754 . . . . 0.0 108.966 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 77.3 mt -66.24 -39.12 83.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.248 177.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.52 -32.24 70.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.782 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.404 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 49.8 mt -73.15 -47.06 47.15 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.569 0.699 . . . . 0.0 110.61 173.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.557 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 67.8 mt -69.68 -18.36 63.55 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -177.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.447 ' HB3' HG21 ' A' ' 77' ' ' VAL . 21.0 ptmt -84.28 -0.67 53.29 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.346 0.593 . . . . 0.0 110.073 176.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -114.05 -43.12 3.27 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.111 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 35' ' ' LEU . 43.3 mtpt -74.77 162.99 28.17 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.421 -176.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -70.22 138.48 86.98 Favored Pre-proline 0 C--N 1.308 -1.204 0 C-N-CA 124.212 1.005 . . . . 0.0 111.827 -174.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -57.28 114.04 1.76 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.676 2.251 . . . . 0.0 111.413 175.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.27 -22.69 3.94 Favored Glycine 0 N--CA 1.425 -2.077 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 -174.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.42 158.55 28.67 Favored 'General case' 0 C--O 1.251 1.181 0 CA-C-N 115.029 -0.585 . . . . 0.0 109.908 177.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -152.47 176.23 11.89 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -175.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -156.38 154.83 31.14 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 170.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 23' ' ' TYR . 66.6 mt -125.02 130.54 73.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.561 ' HD2' ' O ' ' A' ' 27' ' ' LEU . 28.1 ptt85 -133.05 171.27 14.21 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -72.82 132.03 43.05 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 171.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.5 m -67.81 -32.77 73.56 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 -177.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 60.9 m80 71.91 -39.59 0.45 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.321 1.048 . . . . 0.0 113.167 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.2 m -58.59 -41.44 85.76 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 123.795 0.838 . . . . 0.0 111.18 178.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.49 150.7 45.49 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -84.56 135.02 34.38 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.65 38.45 50.84 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -177.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.55 133.16 39.96 Favored 'General case' 0 C--O 1.249 1.028 0 CA-C-O 120.891 0.377 . . . . 0.0 110.394 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.403 ' HB3' ' CG2' ' A' ' 46' ' ' ILE . 47.3 m-85 -116.73 126.83 53.71 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -91.39 114.15 4.45 Favored Glycine 0 C--N 1.288 -2.084 0 C-N-CA 120.148 -1.025 . . . . 0.0 111.324 -177.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.401 ' HB3' ' O ' ' A' ' 84' ' ' PHE . 2.2 tm? -92.08 117.77 30.16 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.65 115.73 30.43 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.4 tp -110.64 123.76 50.61 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.303 -177.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.557 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 22.3 tptm -91.23 114.35 26.85 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 176.022 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 80' ' ' LEU . 18.2 m -104.17 170.65 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.25 -58.28 5.13 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 p -161.85 124.15 1.73 Allowed Pre-proline 0 C--N 1.312 -1.06 0 C-N-CA 124.521 1.128 . . . . 0.0 108.713 176.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.627 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 35.6 Cg_exo -59.68 -47.1 17.22 Favored 'Trans proline' 0 CA--C 1.578 2.678 0 C-N-CA 121.688 1.592 . . . . 0.0 111.947 174.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.627 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 74.8 Cg_endo -73.46 153.29 49.87 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 123.19 2.593 . . . . 0.0 110.756 173.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -63.79 -46.92 7.81 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.402 2.068 . . . . 0.0 112.567 177.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.6 p -119.74 -8.28 9.92 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.401 ' HA ' ' CG ' ' A' ' 66' ' ' PRO . . . 66.8 36.57 4.49 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 124.414 1.086 . . . . 0.0 113.237 177.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.424 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 73.8 mt-30 -63.61 -48.85 79.77 Favored Pre-proline 0 CA--C 1.565 1.519 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.339 172.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 70' ' ' GLN . 18.3 Cg_endo -62.45 113.38 1.91 Allowed 'Trans proline' 0 C--N 1.389 2.709 0 C-N-CA 122.04 1.827 . . . . 0.0 111.919 173.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 57.0 t-105 -115.17 146.49 41.34 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.354 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -127.05 -28.82 2.84 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.834 0.35 . . . . 0.0 111.689 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 133.32 -41.71 1.45 Allowed Glycine 0 CA--C 1.489 -1.536 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.541 ' HB3' ' HB2' ' A' ' 78' ' ' GLU . 5.2 m-20 -68.11 118.56 59.97 Favored Pre-proline 0 C--N 1.299 -1.623 0 C-N-CA 123.862 0.865 . . . . 0.0 109.839 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 75' ' ' ASP . 5.7 Cg_exo -77.21 -79.64 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 121.902 1.735 . . . . 0.0 112.722 177.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 37' ' ' LYS . 3.2 p -73.74 -28.31 24.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 120.943 0.402 . . . . 0.0 111.624 -177.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.541 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 53.1 mp0 -68.28 -19.72 64.72 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.416 ' HG2' ' HB2' ' A' ' 75' ' ' ASP . 8.0 mm100 -78.62 -36.25 44.39 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 171.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.503 ' O ' HG22 ' A' ' 62' ' ' VAL . 49.5 mt -75.87 -25.71 56.41 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.838 -176.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 89.9 t -88.92 116.25 30.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -101.36 130.81 47.62 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -109.84 126.17 53.54 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.222 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.401 ' O ' ' HB3' ' A' ' 58' ' ' LEU . 98.0 m-85 -133.15 123.14 25.13 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 176.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.9 pp -96.84 131.95 43.08 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 118.709 -1.196 . . . . 0.0 111.113 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 79.7 mt -92.35 122.58 43.93 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 C-N-CA 124.568 1.147 . . . . 0.0 108.98 -178.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -99.84 146.82 26.18 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.482 ' HB ' HG12 ' A' ' 93' ' ' VAL . 9.7 t -127.88 142.27 51.32 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.41 -158.36 7.95 Favored Glycine 0 N--CA 1.433 -1.508 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -177.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.15 3.85 4.8 Favored 'Trans proline' 0 N--CA 1.482 0.847 0 C-N-CA 122.914 2.409 . . . . 0.0 113.566 -174.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -111.71 -42.1 3.9 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.89 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 158.9 -154.5 25.59 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.482 HG12 ' HB ' ' A' ' 88' ' ' THR . 10.7 m -104.02 147.66 9.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -178.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.9 pttp -146.07 141.98 28.12 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -176.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.2 mt -85.65 131.68 33.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -67.58 101.76 1.06 Allowed 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 102.37 45.56 1.68 Allowed Glycine 0 N--CA 1.429 -1.831 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.735 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.444 ' HB2' ' CD ' ' A' ' 101' ' ' GLU . 24.4 p -115.57 124.25 30.25 Favored Pre-proline 0 C--N 1.312 -1.049 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 177.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.93 -44.06 2.17 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.54 2.16 . . . . 0.0 115.316 -175.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.9 m -120.36 -16.37 8.43 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.833 -172.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.444 ' CD ' ' HB2' ' A' ' 98' ' ' CYS . 5.4 mp0 -60.34 125.21 81.26 Favored Pre-proline 0 C--N 1.3 -1.56 0 C-N-CA 123.276 0.631 . . . . 0.0 112.27 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -87.05 -167.67 0.37 Allowed 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 123.128 2.552 . . . . 0.0 110.967 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -81.65 109.74 16.35 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -81.48 147.26 29.8 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -78.88 -23.66 63.63 Favored Glycine 0 C--N 1.302 -1.317 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.06 -178.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.8 p -143.62 161.31 38.85 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.418 ' O ' HG23 ' A' ' 111' ' ' VAL . 94.6 mt -71.29 -31.69 67.75 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 173.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 m -56.85 -40.12 75.54 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.651 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.36 -50.81 71.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.995 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.2 pp -68.77 -29.02 67.32 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.648 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 107' ' ' LEU . 49.5 t -64.93 -50.28 75.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.145 0.498 . . . . 0.0 110.391 177.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.7 t -72.49 -38.52 68.14 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.508 -177.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -73.61 -36.46 65.48 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -174.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -76.52 -0.66 23.91 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.3 m -75.01 -40.69 60.48 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 170.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 63.8 mt -86.24 -44.34 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.128 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.3 m -136.16 94.85 13.79 Favored Pre-proline 0 C--N 1.303 -1.444 0 O-C-N 122.104 -0.373 . . . . 0.0 111.295 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -86.77 108.04 0.77 Allowed 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 123.008 2.472 . . . . 0.0 109.983 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.438 ' HB ' ' OE2' ' A' ' 101' ' ' GLU . 33.9 mt -89.63 -73.54 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.285 -177.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.9 t -66.72 -34.02 76.93 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.215 0.531 . . . . 0.0 110.222 176.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 81.5 mt -71.57 124.79 91.47 Favored Pre-proline 0 C--N 1.311 -1.071 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.701 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -65.04 -20.61 63.76 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.437 2.758 . . . . 0.0 113.354 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 78.0 m -136.99 169.18 18.2 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 80.6 m -73.59 136.51 43.95 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 123.261 0.351 . . . . 0.0 111.045 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 111' ' ' VAL . 22.7 tp -81.88 118.14 22.7 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -122.54 141.94 51.14 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.308 0.575 . . . . 0.0 111.273 -176.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.405 ' N ' HD12 ' A' ' 127' ' ' ILE . 2.8 mp -101.85 109.82 60.58 Favored Pre-proline 0 C--N 1.303 -1.422 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--N 1.324 -0.745 0 C-N-CA 121.74 1.627 . . . . 0.0 112.275 -178.882 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.7 p . . . . . 0 N--CA 1.435 -1.188 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.5 m -69.62 -24.13 63.6 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.972 -175.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.46 ' HD3' ' H ' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -81.13 -9.93 59.73 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 120.443 -0.503 . . . . 0.0 112.347 -177.658 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -76.6 -49.83 15.35 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.205 0.526 . . . . 0.0 111.588 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.454 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 29.6 p-90 -85.0 -12.95 52.09 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.768 -174.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -95.42 103.95 15.83 Favored 'General case' 0 N--CA 1.422 -1.831 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.683 -176.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.44 89.98 9.15 Favored Pre-proline 0 C--N 1.294 -1.844 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.099 174.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.73 18.79 0.81 Allowed 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 123.242 2.628 . . . . 0.0 112.411 -176.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -109.75 -3.73 16.55 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.79 -176.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.8 tp -101.19 130.61 47.31 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -172.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.0 m -79.45 170.68 16.23 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.593 0.757 . . . . 0.0 110.306 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -56.62 -53.71 54.51 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -69.85 -29.86 67.2 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.071 0.463 . . . . 0.0 110.654 -176.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -71.2 -33.42 69.92 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.686 176.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.4 -41.36 93.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.607 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 77.0 mt -67.3 -42.42 87.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.135 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.74 -28.78 67.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.857 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.71 -40.44 25.33 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.976 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.3 mp -86.73 -19.61 28.9 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -60.86 -36.56 79.48 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -92.92 3.01 56.49 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.307 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -99.4 169.58 9.23 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.708 0.766 . . . . 0.0 112.633 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -81.84 159.66 65.53 Favored Pre-proline 0 C--N 1.296 -1.722 0 C-N-CA 125.867 1.667 . . . . 0.0 111.368 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.02 111.88 2.79 Favored 'Trans proline' 0 C--N 1.36 1.172 0 C-N-CA 122.417 2.078 . . . . 0.0 110.32 176.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.88 -20.83 3.6 Favored Glycine 0 C--N 1.287 -2.159 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -176.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.01 136.49 48.4 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -151.75 173.04 15.21 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -177.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -155.91 158.05 37.32 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.454 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 65.8 mt -122.54 116.25 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.081 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 174.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.1 ptt-85 -108.23 -175.02 2.66 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -100.03 128.4 46.12 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.7 m -88.02 95.58 10.18 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.325 0.583 . . . . 0.0 110.162 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -73.86 11.98 0.77 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.775 0.797 . . . . 0.0 112.475 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.9 t -86.81 -15.81 38.13 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -146.28 -171.54 3.75 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -125.23 134.94 52.15 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 171.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.18 22.85 56.39 Favored Glycine 0 C--N 1.308 -1.006 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -128.52 127.63 42.77 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -101.37 162.1 13.15 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.29 118.54 3.43 Favored Glycine 0 C--N 1.286 -2.229 0 C-N-CA 119.875 -1.155 . . . . 0.0 111.474 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -98.8 127.48 44.74 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -178.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -122.6 117.35 25.63 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.6 tp -110.29 128.08 55.34 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 123.719 0.637 . . . . 0.0 110.287 -176.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -88.69 114.08 24.93 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 177.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 80' ' ' LEU . 25.5 m -103.58 171.49 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.84 -60.35 2.74 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.409 ' HB ' ' HG2' ' A' ' 66' ' ' PRO . 2.1 p -159.32 141.93 10.21 Favored Pre-proline 0 N--CA 1.433 -1.276 0 C-N-CA 124.923 1.289 . . . . 0.0 108.478 176.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.653 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 36.3 Cg_exo -59.62 -44.33 32.68 Favored 'Trans proline' 0 CA--C 1.574 2.508 0 C-N-CA 121.75 1.633 . . . . 0.0 111.645 171.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.653 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 59.1 Cg_endo -68.99 146.95 66.68 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 122.68 2.254 . . . . 0.0 110.038 170.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 66' ' ' PRO . 34.3 Cg_exo -62.13 -42.03 31.93 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.695 2.263 . . . . 0.0 113.103 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.4 m -118.56 -18.99 8.95 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.86 0.362 . . . . 0.0 110.235 -177.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.447 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 67.68 24.44 8.41 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.168 0.987 . . . . 0.0 112.564 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -67.92 -38.35 14.07 Favored Pre-proline 0 CA--C 1.558 1.262 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.968 172.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -68.05 108.91 1.82 Allowed 'Trans proline' 0 C--N 1.38 2.224 0 C-N-CA 121.208 1.272 . . . . 0.0 109.119 167.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -131.33 145.72 51.98 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -175.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -138.4 -37.59 0.55 Allowed 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.871 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.81 -57.41 0.03 OUTLIER Glycine 0 CA--C 1.48 -2.109 0 N-CA-C 107.27 -2.332 . . . . 0.0 107.27 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 54.84 93.83 0.05 OUTLIER Pre-proline 0 N--CA 1.468 0.433 0 C-N-CA 125.104 1.362 . . . . 0.0 113.975 169.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -83.37 165.53 14.4 Favored 'Trans proline' 0 C--O 1.243 0.743 0 C-N-CA 122.504 2.136 . . . . 0.0 112.347 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 p -68.99 -27.2 34.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.594 0.711 . . . . 0.0 110.592 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -66.51 -15.95 63.77 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.349 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -85.11 -19.47 31.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.567 0.699 . . . . 0.0 109.471 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.426 ' O ' HG22 ' A' ' 62' ' ' VAL . 72.2 mt -80.71 -11.27 59.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.005 -178.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.0 t -100.59 108.84 23.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -87.18 131.54 34.15 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -177.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -105.08 125.63 51.19 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.259 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -140.88 131.46 25.48 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 176.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.32 154.66 17.14 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 117.878 -1.529 . . . . 0.0 110.963 176.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.406 ' CG2' HG22 ' A' ' 93' ' ' VAL . 78.5 mt -115.37 125.97 72.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.408 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.973 -176.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.499 ' CD ' ' HE2' ' A' ' 96' ' ' LYS . 47.4 mt-10 -105.86 138.39 42.13 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.616 ' HB ' HG23 ' A' ' 93' ' ' VAL . 5.6 t -121.45 147.51 45.65 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.52 -167.05 29.52 Favored Glycine 0 N--CA 1.423 -2.217 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.91 -14.21 35.53 Favored 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 123.637 2.891 . . . . 0.0 114.636 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -89.0 -24.66 22.32 Favored 'General case' 0 CA--C 1.5 -0.966 0 O-C-N 121.752 -0.592 . . . . 0.0 111.401 176.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 132.53 -160.12 23.64 Favored Glycine 0 N--CA 1.423 -2.19 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -177.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.706 HG12 ' H ' ' A' ' 105' ' ' GLY . 7.7 p -118.38 136.85 54.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -177.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.19 169.13 25.48 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.424 ' HB ' ' HG3' ' A' ' 101' ' ' GLU . 59.7 mt -85.77 143.07 12.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-O 120.86 0.362 . . . . 0.0 110.929 -177.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.499 ' HE2' ' CD ' ' A' ' 87' ' ' GLU . 20.6 ttmm -99.17 140.57 33.14 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 172.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.08 43.06 4.19 Favored Glycine 0 CA--C 1.493 -1.303 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 24.5 p -129.73 157.61 76.11 Favored Pre-proline 0 N--CA 1.42 -1.968 0 CA-C-N 114.702 -0.749 . . . . 0.0 111.106 -171.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -65.56 -59.13 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 N-CA-C 107.72 -1.685 . . . . 0.0 107.72 167.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 67.0 m -164.32 125.57 2.2 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 124.522 1.129 . . . . 0.0 108.357 175.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.506 ' OE2' ' HB ' ' A' ' 119' ' ' ILE . 49.4 mm-40 -122.52 138.34 29.12 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.18 155.82 66.71 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.186 1.924 . . . . 0.0 110.688 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -91.59 99.48 12.39 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -64.62 -70.3 0.24 Allowed 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.353 0.597 . . . . 0.0 111.548 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.706 ' H ' HG12 ' A' ' 93' ' ' VAL . . . 145.17 -68.82 0.4 Allowed Glycine 0 C--N 1.3 -1.464 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 178.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.2 m -108.25 158.77 17.17 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.84 -36.53 82.54 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.4 t -64.81 -36.55 84.68 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.02 -47.36 83.39 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 175.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.3 tt -54.8 -50.79 67.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.113 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.518 ' HA ' HD23 ' A' ' 125' ' ' LEU . 69.1 t -61.55 -50.7 79.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.26 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.1 t -66.61 -31.68 72.53 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.171 0.51 . . . . 0.0 111.342 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -88.68 -18.97 26.79 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 121.711 -0.618 . . . . 0.0 112.657 -178.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -78.58 -9.36 59.33 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.137 0.494 . . . . 0.0 111.249 173.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.7 m -72.58 -27.62 62.3 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 170.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 35.2 mt -89.37 -60.14 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.575 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 27.0 m -120.57 99.17 47.86 Favored Pre-proline 0 N--CA 1.433 -1.324 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.968 -176.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -93.09 101.18 0.16 Allowed 'Trans proline' 0 N--CA 1.431 -2.169 0 C-N-CA 122.649 2.233 . . . . 0.0 109.482 172.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.506 ' HB ' ' OE2' ' A' ' 101' ' ' GLU . 63.8 mt -86.78 -62.36 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.12 -177.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.2 m -83.96 -16.88 42.49 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.273 0.559 . . . . 0.0 111.177 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.4 mt -90.12 123.7 65.19 Favored Pre-proline 0 C--N 1.305 -1.339 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -65.04 -30.19 56.52 Favored 'Trans proline' 0 N--CA 1.476 0.445 0 C-N-CA 122.808 2.339 . . . . 0.0 112.454 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 61.1 m -114.42 147.12 39.73 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.4 p -63.4 136.03 57.35 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 111' ' ' VAL . 18.8 tp -79.76 86.43 5.34 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -93.55 124.29 37.45 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.393 -175.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.461 ' H ' HD12 ' A' ' 127' ' ' ILE . 3.4 mp -70.78 112.04 11.82 Favored Pre-proline 0 C--N 1.315 -0.905 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo . . . . . 0 C--N 1.345 0.391 0 C-N-CA 122.366 2.044 . . . . 0.0 112.107 -178.685 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.434 -1.271 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.8 m -100.32 -19.66 16.22 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.439 177.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.31 3.52 0.9 Allowed 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 -176.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -85.42 -40.27 16.62 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 14.7 p-90 -120.74 -8.94 9.41 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -172.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -92.19 110.84 22.23 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.653 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.55 ' HB3' HD13 ' A' ' 27' ' ' LEU . 1.3 mptp? -128.52 89.03 50.7 Favored Pre-proline 0 C--N 1.313 -0.988 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.41 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.09 -1.64 8.27 Favored 'Trans proline' 0 CA--C 1.552 1.395 0 C-N-CA 122.722 2.282 . . . . 0.0 114.649 -177.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -90.84 -21.73 21.32 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.312 0.577 . . . . 0.0 109.87 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.55 HD13 ' HB3' ' A' ' 24' ' ' LYS . 9.8 mp -86.22 142.28 28.7 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -174.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.3 m -111.31 178.09 4.45 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 174.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -47.05 -52.28 15.41 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -58.45 -43.46 88.85 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.773 0.829 . . . . 0.0 110.73 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -70.79 -32.59 69.74 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.373 -177.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.2 -41.23 86.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.413 0.625 . . . . 0.0 109.803 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 72.0 mt -66.33 -40.41 86.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.828 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.83 -29.5 68.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.202 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.03 -47.45 11.68 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.444 HD12 HG13 ' A' ' 81' ' ' VAL . 72.6 mt -74.28 -19.44 60.49 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -176.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -72.01 -18.36 61.97 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.114 174.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -93.78 -35.54 12.71 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.386 178.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 36' ' ' LEU . 24.2 mmmt -77.38 171.11 15.38 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -71.59 164.28 59.25 Favored Pre-proline 0 C--N 1.314 -0.96 0 C-N-CA 126.753 2.021 . . . . 0.0 111.71 -176.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -75.91 126.5 9.42 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 121.815 1.677 . . . . 0.0 108.37 169.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.02 -9.62 43.38 Favored Glycine 0 C--N 1.292 -1.915 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -175.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.08 155.61 26.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.439 ' CG ' HD22 ' A' ' 125' ' ' LEU . 15.0 p90 -156.56 170.8 21.54 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.763 -173.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -156.43 149.99 24.66 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 172.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 68.7 mt -121.05 129.59 75.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -139.94 172.44 12.77 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.503 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -75.52 137.15 40.68 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 t -86.33 129.57 34.81 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -90.86 -14.84 31.0 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.5 t -70.5 -45.58 65.37 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.409 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -134.7 142.71 46.88 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -85.71 138.22 32.27 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.9 21.46 50.11 Favored Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.26 144.85 48.62 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 115.537 -0.332 . . . . 0.0 110.22 -178.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -116.28 132.82 56.56 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.3 120.25 5.69 Favored Glycine 0 C--N 1.287 -2.151 0 C-N-CA 119.932 -1.127 . . . . 0.0 111.46 -177.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -95.82 120.49 36.18 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.4 ' HB2' HH12 ' A' ' 47' ' ' ARG . . . -112.76 125.04 53.89 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.515 HD11 ' HB3' ' A' ' 123' ' ' CYS . 3.4 tm? -123.66 126.8 47.22 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -178.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -89.2 114.79 26.15 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 80' ' ' LEU . 32.8 m -99.67 171.64 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.26 -47.2 36.55 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.4 p -156.06 129.57 4.54 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 124.347 1.059 . . . . 0.0 108.988 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.651 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 28.0 Cg_exo -62.43 -45.08 15.73 Favored 'Trans proline' 0 CA--C 1.57 2.308 0 C-N-CA 121.884 1.723 . . . . 0.0 113.017 174.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.757 ' HG2' ' HB2' ' A' ' 69' ' ' ALA . 37.4 Cg_endo -63.94 142.66 82.74 Favored 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 122.273 1.982 . . . . 0.0 110.396 174.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -61.53 -34.48 85.31 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 123.349 2.7 . . . . 0.0 113.861 -174.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.1 p -119.07 -42.22 2.71 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.757 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 72.37 7.47 5.66 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 124.82 1.248 . . . . 0.0 113.106 174.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.443 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 64.8 tt0 -72.53 -55.75 4.35 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-O 119.121 -0.466 . . . . 0.0 112.028 -178.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 70' ' ' GLN . 6.9 Cg_endo -88.08 62.87 3.38 Favored 'Trans proline' 0 C--N 1.365 1.427 0 C-N-CA 121.461 1.44 . . . . 0.0 111.108 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.416 ' HE1' ' HB3' ' A' ' 75' ' ' ASP . 59.7 t-105 -160.66 141.27 11.59 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 113.353 -1.749 . . . . 0.0 110.441 -176.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.83 80.16 0.63 Allowed 'General case' 0 N--CA 1.413 -2.298 0 CA-C-O 122.635 1.207 . . . . 0.0 110.429 169.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.17 40.88 0.49 Allowed Glycine 0 C--N 1.301 -1.393 0 CA-C-N 114.213 -1.358 . . . . 0.0 112.165 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.416 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 6.9 p-10 -136.5 127.8 16.79 Favored Pre-proline 0 C--N 1.305 -1.337 0 CA-C-O 120.755 0.312 . . . . 0.0 111.054 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 79' ' ' GLN . 8.4 Cg_endo -91.55 177.37 1.89 Allowed 'Trans proline' 0 N--CA 1.436 -1.875 0 C-N-CA 121.829 1.686 . . . . 0.0 109.4 168.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.7 p -58.89 -24.99 27.99 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-O 121.603 0.716 . . . . 0.0 111.632 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.7 -26.77 64.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.006 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.461 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 8.5 tp-100 -80.95 -16.68 52.82 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 121.144 0.497 . . . . 0.0 109.711 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.453 ' O ' HG22 ' A' ' 62' ' ' VAL . 77.4 mt -74.53 -12.59 60.51 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-O 121.68 0.753 . . . . 0.0 109.991 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.444 HG13 HD12 ' A' ' 36' ' ' LEU . 74.7 t -88.3 125.9 41.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 176.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.404 ' NE ' ' HA ' ' A' ' 82' ' ' ARG . 3.9 mmp_? -105.23 143.84 32.84 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -118.75 133.87 55.54 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -139.15 167.33 22.3 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.05 138.11 41.83 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.94 177.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.522 HG12 HG12 ' A' ' 95' ' ' ILE . 80.1 mt -97.03 114.82 34.99 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-N 114.187 -1.369 . . . . 0.0 107.395 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -99.62 137.23 38.39 Favored 'General case' 0 C--N 1.273 -2.727 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.542 ' HB ' HG12 ' A' ' 93' ' ' VAL . 6.1 t -113.06 143.44 44.33 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -155.83 -157.97 8.56 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -73.18 -14.28 25.81 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.224 1.949 . . . . 0.0 112.823 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.467 ' HD2' ' N ' ' A' ' 91' ' ' LYS . 0.1 OUTLIER -84.88 -28.77 25.76 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 121.519 0.675 . . . . 0.0 110.331 177.739 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 139.19 -147.5 19.26 Favored Glycine 0 N--CA 1.433 -1.562 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.542 HG12 ' HB ' ' A' ' 88' ' ' THR . 15.0 m -113.52 141.5 29.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.67 150.31 26.17 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.674 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.522 HG12 HG12 ' A' ' 86' ' ' ILE . 83.3 mt -86.14 133.76 28.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.704 0.764 . . . . 0.0 111.309 -176.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -93.01 124.17 36.8 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 173.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 113.94 42.6 0.84 Allowed Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -174.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 120' ' ' SER . 13.5 p -129.34 144.9 54.6 Favored Pre-proline 0 N--CA 1.428 -1.529 0 CA-C-N 115.421 -0.39 . . . . 0.0 110.123 -175.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -67.33 -28.13 39.88 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.395 2.064 . . . . 0.0 111.928 176.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.5 t -153.86 -89.87 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.441 ' OE2' ' HB ' ' A' ' 95' ' ' ILE . 28.2 tt0 65.78 133.03 0.04 OUTLIER Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 125.377 1.471 . . . . 0.0 112.986 173.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -79.2 172.58 14.53 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.412 2.075 . . . . 0.0 112.557 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -92.39 131.89 37.2 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 175.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -102.42 170.7 7.89 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -177.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -99.55 -52.69 1.19 Allowed Glycine 0 C--N 1.3 -1.447 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.5 m -111.72 153.85 25.86 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.491 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 64.4 mt -63.24 -36.68 84.45 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.4 m -54.23 -30.19 49.24 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.486 1.114 . . . . 0.0 112.158 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.53 -41.95 92.53 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.112 -177.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 107' ' ' LEU . 4.2 pp -77.0 -31.33 56.38 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.969 0.414 . . . . 0.0 110.081 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.442 ' HA ' ' CD1' ' A' ' 125' ' ' LEU . 55.3 t -59.5 -54.73 30.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.455 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.4 m -72.48 -25.71 61.52 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.905 -177.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -84.13 -36.99 22.53 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.988 -176.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -72.13 -5.22 33.96 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -177.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.6 m -74.37 -31.9 62.56 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.6 mt -94.93 -50.16 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.972 -178.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 45.3 m -132.88 96.75 17.67 Favored Pre-proline 0 C--N 1.31 -1.142 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.979 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -81.86 114.23 2.58 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.702 2.268 . . . . 0.0 109.715 176.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 65.3 mt -91.49 -64.69 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 120.771 0.32 . . . . 0.0 110.512 -176.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.56 ' HB3' ' HB3' ' A' ' 98' ' ' CYS . 2.3 p -74.95 -49.66 19.35 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.467 0.651 . . . . 0.0 110.263 176.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.404 ' CD2' HD21 ' A' ' 125' ' ' LEU . 7.9 mp -65.87 137.69 96.15 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.877 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -80.53 -9.8 13.45 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.637 2.225 . . . . 0.0 112.92 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.515 ' HB3' HD11 ' A' ' 60' ' ' LEU . 44.8 t -136.35 150.69 48.96 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -178.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 24.8 p -71.82 146.11 48.21 Favored 'General case' 0 C--O 1.252 1.198 0 O-C-N 123.775 0.672 . . . . 0.0 110.555 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.442 ' CD1' ' HA ' ' A' ' 111' ' ' VAL . 91.6 mt -77.81 128.19 33.61 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.388 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -106.4 103.04 12.41 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 127' ' ' ILE . 3.4 mp -88.69 122.58 69.15 Favored Pre-proline 0 C--N 1.313 -1.002 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.865 -176.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo . . . . . 0 C--N 1.358 1.05 0 C-N-CA 123.162 2.574 . . . . 0.0 112.116 -179.704 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.5 p . . . . . 0 N--CA 1.425 -1.683 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.4 m -56.8 -40.53 76.11 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.618 -177.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -60.0 -25.08 64.99 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -178.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -77.26 -27.82 53.31 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 120.876 0.369 . . . . 0.0 111.141 -177.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.0 p-90 -119.1 -17.97 8.83 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -176.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -94.42 110.22 22.02 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.657 -176.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.08 94.27 14.43 Favored Pre-proline 0 C--N 1.309 -1.188 0 C-N-CA 124.407 1.083 . . . . 0.0 108.644 174.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 47' ' ' ARG . 83.3 Cg_endo -75.0 -23.22 14.0 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.856 3.038 . . . . 0.0 117.463 -169.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -101.43 14.55 31.61 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 118.9 0.773 . . . . 0.0 111.167 -174.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.3 tp -88.66 135.3 33.57 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.6 m -82.87 163.54 21.08 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 122.341 -0.225 . . . . 0.0 110.971 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -52.88 -51.48 60.95 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -173.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -65.44 -37.35 86.63 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.414 0.626 . . . . 0.0 110.999 -176.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -72.08 -28.32 63.24 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.496 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.15 -45.18 74.25 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 175.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.458 HG23 HG21 ' A' ' 81' ' ' VAL . 77.1 mt -63.49 -35.1 71.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.52 177.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.99 -34.67 43.55 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.261 176.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.558 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 3.8 mm? -72.33 -50.41 27.05 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.502 0.667 . . . . 0.0 109.506 174.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.1 mp -70.64 -13.53 62.12 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -173.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -84.79 -1.25 56.12 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.543 0.687 . . . . 0.0 109.26 174.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -114.84 -30.44 6.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.876 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 35' ' ' LEU . 61.8 mmtt -80.28 -179.05 6.9 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -174.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -83.82 156.33 64.51 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.718 -177.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -66.16 115.08 3.28 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 121.922 1.748 . . . . 0.0 108.933 171.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 124.56 -17.56 7.34 Favored Glycine 0 C--N 1.297 -1.593 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -174.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.48 151.99 37.94 Favored 'General case' 0 C--O 1.249 1.06 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -154.44 174.87 14.3 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.333 -174.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -156.43 151.19 25.93 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 171.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.3 mt -120.22 129.66 75.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 19.9 ptt180 -119.51 172.74 7.43 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -100.56 127.28 46.99 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.1 m -107.53 119.43 39.41 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -173.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 -79.9 76.13 6.6 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.902 0.858 . . . . 0.0 108.971 174.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 t -136.2 -52.07 0.72 Allowed 'General case' 0 C--N 1.271 -2.805 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -128.86 168.97 15.16 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 176.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -88.58 121.74 31.28 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.361 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.81 50.97 7.41 Favored Glycine 0 N--CA 1.422 -2.263 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 86' ' ' ILE . . . -124.06 113.68 18.72 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.427 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 57.2 m-85 -98.78 125.14 44.05 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.296 -0.865 . . . . 0.0 108.707 -178.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.51 111.51 4.22 Favored Glycine 0 C--N 1.289 -2.033 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.318 -176.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 83' ' ' HIS . 38.9 tp -91.5 121.81 33.53 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -107.2 118.9 37.93 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 174.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.5 tp -114.73 130.88 56.9 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 123.496 0.497 . . . . 0.0 110.562 -177.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -90.66 113.71 25.83 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.516 ' HB ' ' SG ' ' A' ' 123' ' ' CYS . 17.7 m -98.25 162.13 2.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.6 -56.52 5.21 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 p -163.17 136.8 4.53 Favored Pre-proline 0 N--CA 1.425 -1.723 0 C-N-CA 126.883 2.073 . . . . 0.0 105.612 175.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.671 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 36.4 Cg_exo -59.81 -46.59 19.18 Favored 'Trans proline' 0 CA--C 1.572 2.419 0 C-N-CA 120.929 1.086 . . . . 0.0 111.339 172.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.671 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 67.3 Cg_endo -67.75 149.58 78.72 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 122.606 2.204 . . . . 0.0 110.13 172.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.01 -41.56 7.37 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.104 1.87 . . . . 0.0 112.435 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 33.1 t -110.78 -32.39 6.87 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.389 -177.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.586 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 64.82 38.16 6.86 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 123.86 0.864 . . . . 0.0 110.515 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -59.71 -44.54 97.54 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.018 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -70.25 95.56 0.6 Allowed 'Trans proline' 0 C--N 1.374 1.882 0 N-CA-C 108.746 -1.29 . . . . 0.0 108.746 167.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 56.4 t-105 -113.14 150.46 32.15 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.203 -173.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -137.61 -46.38 0.55 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 122.431 1.11 . . . . 0.0 108.032 176.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 146.57 -76.94 0.26 Allowed Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 107.323 -2.311 . . . . 0.0 107.323 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 72.95 135.35 0.05 OUTLIER Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 125.269 1.428 . . . . 0.0 111.265 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.56 156.02 59.38 Favored 'Trans proline' 0 C--O 1.239 0.533 0 C-N-CA 122.389 2.059 . . . . 0.0 110.947 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.8 p -62.01 -21.55 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.55 0.691 . . . . 0.0 110.281 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -66.05 -21.29 66.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.547 178.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -82.98 -28.18 29.91 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.252 0.549 . . . . 0.0 109.571 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.469 ' O ' HG22 ' A' ' 62' ' ' VAL . 2.8 mm? -84.92 -7.99 58.94 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.984 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.458 HG21 HG23 ' A' ' 33' ' ' ILE . 92.6 t -103.56 102.05 13.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 173.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -96.25 143.33 27.43 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.798 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.471 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 69.6 m80 -113.25 123.23 49.68 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.29 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -124.98 131.68 53.38 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 1.0 OUTLIER -102.98 132.19 49.41 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 118.756 -1.177 . . . . 0.0 112.666 179.737 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 55' ' ' ALA . 4.0 mp -87.64 125.24 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 175.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -99.39 125.83 45.16 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 92' ' ' GLY . 11.0 t -114.55 142.07 46.91 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 175.318 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.21 -138.3 4.4 Favored Glycine 0 N--CA 1.418 -2.516 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -67.84 -24.29 40.42 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.901 2.401 . . . . 0.0 113.971 -175.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -88.79 -17.85 28.94 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.583 0.706 . . . . 0.0 110.503 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.536 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 114.9 -152.51 18.09 Favored Glycine 0 N--CA 1.424 -2.166 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 -178.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.476 HG12 ' HB ' ' A' ' 88' ' ' THR . 6.3 m -104.79 125.99 59.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.82 150.87 26.52 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 121.804 -0.56 . . . . 0.0 109.966 177.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 75.8 mt -73.96 131.28 35.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 123.306 0.379 . . . . 0.0 110.961 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -72.89 119.59 17.34 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 123.976 0.91 . . . . 0.0 109.325 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.62 15.01 48.21 Favored Glycine 0 C--O 1.243 0.677 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.756 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.501 ' SG ' ' HB2' ' A' ' 120' ' ' SER . 19.4 t -85.05 125.36 70.65 Favored Pre-proline 0 N--CA 1.435 -1.187 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -53.02 -28.71 41.4 Favored 'Trans proline' 0 N--CA 1.487 1.098 0 C-N-CA 123.69 2.927 . . . . 0.0 113.652 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.2 m -142.33 119.11 11.14 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 178.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -90.95 116.63 66.83 Favored Pre-proline 0 C--N 1.283 -2.321 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -82.1 -19.32 6.95 Favored 'Trans proline' 0 C--N 1.328 -0.551 0 C-N-CA 122.204 1.936 . . . . 0.0 114.193 -176.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 50.83 98.87 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.215 0 C-N-CA 126.667 1.987 . . . . 0.0 113.234 -176.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.426 ' CD2' ' HB3' ' A' ' 110' ' ' LEU . 77.8 m-85 -111.67 178.84 4.19 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.67 -30.73 2.52 Favored Glycine 0 C--N 1.305 -1.183 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.729 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.0 m -115.36 143.83 44.69 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.426 ' O ' HG23 ' A' ' 111' ' ' VAL . 57.9 mt -62.51 -43.07 99.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.6 t -60.92 -29.46 69.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.926 0.393 . . . . 0.0 110.925 -177.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.46 -43.09 98.35 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.518 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.458 HD23 HG23 ' A' ' 93' ' ' VAL . 3.7 pp -76.3 -30.92 57.94 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.961 178.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.528 ' HA ' HD23 ' A' ' 125' ' ' LEU . 56.4 t -62.74 -51.65 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.69 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.6 t -65.31 -25.46 67.63 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.563 -176.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.482 ' HA ' ' OE1' ' A' ' 113' ' ' GLN . 9.3 mm-40 -85.27 -30.55 23.69 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.141 -0.623 . . . . 0.0 111.728 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 49.3 m80 -74.52 -6.66 49.68 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.062 0.458 . . . . 0.0 111.702 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.0 m -71.84 -29.99 64.98 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 173.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 60.3 mt -100.21 -53.01 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.664 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.7 m -120.8 96.29 48.76 Favored Pre-proline 0 N--CA 1.434 -1.256 0 CA-C-O 120.99 0.424 . . . . 0.0 111.727 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.451 ' HB2' ' O ' ' A' ' 121' ' ' LEU . 44.1 Cg_endo -75.1 101.64 1.5 Allowed 'Trans proline' 0 N--CA 1.43 -2.213 0 C-N-CA 121.324 1.349 . . . . 0.0 109.982 173.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 45.6 mt -76.6 -59.82 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.261 0.553 . . . . 0.0 109.925 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.501 ' HB2' ' SG ' ' A' ' 98' ' ' CYS . 21.5 t -84.51 -29.84 25.65 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.568 0.699 . . . . 0.0 109.482 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.451 ' O ' ' HB2' ' A' ' 118' ' ' PRO . 6.9 mp -80.69 142.8 53.49 Favored Pre-proline 0 C--N 1.299 -1.615 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.212 -175.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -82.89 -20.01 5.59 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.379 2.053 . . . . 0.0 112.02 176.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.516 ' SG ' ' HB ' ' A' ' 62' ' ' VAL . 83.8 m -126.72 160.52 30.58 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 60.3 m -72.6 140.79 48.24 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 123.545 0.528 . . . . 0.0 110.562 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.528 HD23 ' HA ' ' A' ' 111' ' ' VAL . 22.8 tp -85.74 102.38 13.59 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -110.07 119.65 39.95 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -173.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.4 mp -61.77 123.61 77.93 Favored Pre-proline 0 C--O 1.247 0.934 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.162 -176.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo . . . . . 0 C--N 1.359 1.101 0 C-N-CA 123.042 2.494 . . . . 0.0 112.477 179.728 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.6 p . . . . . 0 N--CA 1.419 -1.976 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.8 m -92.37 -43.45 9.23 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.771 -174.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.08 -5.13 8.81 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -176.027 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -78.26 -20.8 50.93 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.368 0.604 . . . . 0.0 109.553 175.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.484 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 37.9 p-90 -122.83 -30.66 3.79 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.239 176.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 38.4 t80 -95.22 122.06 37.51 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 120.981 0.42 . . . . 0.0 110.516 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.25 104.79 2.41 Favored Pre-proline 0 C--N 1.306 -1.307 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.946 174.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.36 22.96 0.55 Allowed 'Trans proline' 0 N--CA 1.486 1.031 0 C-N-CA 123.738 2.959 . . . . 0.0 114.116 -174.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -98.97 -12.28 20.78 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.461 0.648 . . . . 0.0 109.481 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.537 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 3.8 mm? -92.86 130.33 38.49 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.565 -178.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.1 m -90.66 175.85 6.88 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 172.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -57.54 -46.89 83.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 118.219 0.463 . . . . 0.0 112.143 -178.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -66.85 -38.59 86.66 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.561 0.696 . . . . 0.0 110.492 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -66.57 -37.65 85.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.096 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.6 -41.73 90.98 Favored 'General case' 0 CA--C 1.509 -0.635 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.265 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 72.5 mt -63.17 -48.01 89.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.68 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.412 ' HA ' ' CD ' ' A' ' 37' ' ' LYS . . . -63.34 -30.13 71.32 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.374 0.607 . . . . 0.0 111.775 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.08 -49.03 11.38 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.463 -178.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.528 ' HG ' ' HB2' ' A' ' 61' ' ' LYS . 16.1 tp -80.13 -16.93 53.87 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.538 -173.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.433 ' HB2' HG21 ' A' ' 77' ' ' VAL . 14.9 ptmm? -63.06 -31.26 72.35 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 122.061 -0.399 . . . . 0.0 110.796 178.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -82.02 -14.48 55.87 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.835 0.826 . . . . 0.0 110.283 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -85.93 162.84 18.37 Favored 'General case' 0 C--O 1.254 1.331 0 CA-C-O 121.665 0.745 . . . . 0.0 111.382 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.08 144.02 98.25 Favored Pre-proline 0 C--N 1.305 -1.345 0 CA-C-N 113.728 -1.578 . . . . 0.0 111.531 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.22 111.16 1.71 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.87 1.714 . . . . 0.0 109.029 171.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.87 -20.7 6.35 Favored Glycine 0 N--CA 1.427 -1.961 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -172.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.25 154.47 30.97 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-O 120.973 0.416 . . . . 0.0 110.07 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.402 ' CG ' HD22 ' A' ' 125' ' ' LEU . 26.1 p90 -149.0 163.79 36.47 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.191 -176.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -146.04 146.92 31.14 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 171.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 23' ' ' TYR . 60.1 mt -120.36 137.61 53.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.537 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -143.25 -175.75 4.66 Favored 'General case' 0 C--N 1.28 -2.446 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.543 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -78.74 128.11 32.98 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 175.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.408 ' HB2' ' N ' ' A' ' 57' ' ' GLY . 21.0 t -85.3 103.64 14.42 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -177.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -77.25 74.8 3.81 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-O 122.23 1.014 . . . . 0.0 109.861 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 72.3 m -157.1 -47.2 0.07 Allowed 'General case' 0 C--N 1.271 -2.836 0 CA-C-N 113.406 -1.724 . . . . 0.0 108.873 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -131.06 147.96 52.68 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -82.3 135.81 35.15 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.58 33.11 48.64 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -130.56 131.73 45.18 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.417 0.627 . . . . 0.0 109.706 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -111.48 123.69 50.75 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.408 ' N ' ' HB2' ' A' ' 49' ' ' SER . . . -85.1 124.84 6.93 Favored Glycine 0 C--N 1.295 -1.722 0 C-N-CA 119.971 -1.109 . . . . 0.0 111.801 -175.204 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -104.45 119.23 38.5 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.57 126.2 54.74 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -121.7 123.84 42.84 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.528 ' HB2' ' HG ' ' A' ' 36' ' ' LEU . 22.4 tptm -88.41 120.77 30.09 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.793 -178.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 80' ' ' LEU . 34.3 m -113.83 157.52 14.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 173.152 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.25 -38.06 71.95 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 p -158.37 132.22 4.97 Favored Pre-proline 0 N--CA 1.444 -0.729 0 C-N-CA 125.495 1.518 . . . . 0.0 107.737 176.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.631 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 23.4 Cg_exo -62.15 -44.02 21.43 Favored 'Trans proline' 0 CA--C 1.565 2.055 0 C-N-CA 122.068 1.845 . . . . 0.0 113.182 175.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.631 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 73.6 Cg_endo -70.91 160.7 48.53 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.722 2.282 . . . . 0.0 110.307 173.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -65.16 -54.17 0.7 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.074 1.85 . . . . 0.0 112.344 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.8 p -110.56 -27.59 8.89 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.087 -175.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.478 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 63.88 38.15 9.11 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 123.588 0.755 . . . . 0.0 109.501 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.459 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 34.5 tt0 -54.16 -51.56 76.38 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.959 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.459 ' HD3' ' HB3' ' A' ' 70' ' ' GLN . 2.4 Cg_endo -89.73 101.96 0.33 Allowed 'Trans proline' 0 N--CA 1.436 -1.903 0 C-N-CA 121.611 1.54 . . . . 0.0 111.158 175.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 47.4 t-105 -96.44 144.49 26.51 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -139.59 -41.44 0.45 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.147 0.499 . . . . 0.0 110.668 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.83 77.95 0.03 OUTLIER Glycine 0 CA--C 1.476 -2.379 0 N-CA-C 108.449 -1.861 . . . . 0.0 108.449 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -123.47 101.92 36.76 Favored Pre-proline 0 C--N 1.294 -1.824 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -173.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -88.78 -175.66 1.27 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.502 2.135 . . . . 0.0 114.245 -175.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.433 HG21 ' HB2' ' A' ' 37' ' ' LYS . 9.7 p -62.01 -23.85 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 115.077 -0.965 . . . . 0.0 113.306 -175.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.15 -23.92 67.66 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.681 0.277 . . . . 0.0 111.437 176.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.416 ' HG2' ' HG2' ' A' ' 65' ' ' PRO . 8.3 tt0 -92.04 -30.07 16.24 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 178.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.491 ' O ' HG22 ' A' ' 62' ' ' VAL . 64.4 mt -66.41 -33.91 76.78 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.574 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 95.6 t -85.51 109.98 19.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 172.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -84.16 133.98 34.59 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -176.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.431 ' CD2' HH22 ' A' ' 47' ' ' ARG . 5.6 m80 -113.45 122.76 48.29 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -132.53 154.96 49.46 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 176.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -125.5 137.02 53.94 Favored 'General case' 0 C--N 1.283 -2.299 0 C-N-CA 118.631 -1.227 . . . . 0.0 110.93 176.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 86.0 mt -92.57 117.08 35.16 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.81 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.135 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.422 ' OE1' ' HE3' ' A' ' 96' ' ' LYS . 50.8 mt-10 -109.43 144.69 37.31 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.41 ' HB ' HG23 ' A' ' 93' ' ' VAL . 3.4 t -118.62 131.96 56.18 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.33 -144.73 4.17 Favored Glycine 0 N--CA 1.429 -1.78 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.385 -178.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -61.87 -44.15 22.14 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.868 2.379 . . . . 0.0 113.864 -177.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.464 ' HD2' ' N ' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -75.91 -41.93 50.44 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.917 -176.428 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.6 -154.94 25.94 Favored Glycine 0 N--CA 1.425 -2.069 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.41 HG23 ' HB ' ' A' ' 88' ' ' THR . 8.8 p -111.94 126.09 69.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.41 ' HG2' ' OE1' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -162.56 178.12 8.84 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.755 -178.375 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 58.8 mt -88.12 143.92 10.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 C-N-CA 123.598 0.759 . . . . 0.0 112.693 -169.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.422 ' HE3' ' OE1' ' A' ' 87' ' ' GLU . 25.0 ttmt -95.46 136.89 35.27 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 170.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.83 55.0 1.69 Allowed Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -175.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.463 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 11.9 p -135.31 154.28 78.57 Favored Pre-proline 0 C--N 1.311 -1.103 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -167.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 98' ' ' CYS . 2.2 Cg_endo -84.9 -56.54 0.02 OUTLIER 'Trans proline' 0 CA--C 1.558 1.69 0 C-N-CA 122.995 2.463 . . . . 0.0 112.633 173.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.0 m -149.88 131.54 14.94 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -177.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.41 ' OE1' ' HG2' ' A' ' 94' ' ' LYS . 43.9 mt-10 -140.46 140.08 21.98 Favored Pre-proline 0 C--N 1.297 -1.68 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.94 153.65 29.2 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.024 1.816 . . . . 0.0 107.694 166.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -92.98 112.32 24.24 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.46 -0.775 . . . . 0.0 110.797 -178.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.424 ' HE1' ' OE1' ' A' ' 113' ' ' GLN . 29.4 m-85 -89.0 157.43 18.37 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.11 -173.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -97.04 -27.67 9.25 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.556 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 53.8 m -141.69 157.29 45.24 Favored 'General case' 0 C--O 1.244 0.766 0 O-C-N 122.233 -0.569 . . . . 0.0 110.838 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.9 -35.12 72.51 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.449 0.7 . . . . 0.0 111.771 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.1 t -51.95 -31.21 27.95 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.85 0.86 . . . . 0.0 111.76 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.409 ' O ' ' HG3' ' A' ' 113' ' ' GLN . . . -73.7 -48.58 31.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 122.229 -0.295 . . . . 0.0 111.246 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 pp -67.7 -29.46 68.73 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.204 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 78.6 t -67.86 -48.65 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.32 176.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.5 p -68.51 -44.85 73.76 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.424 ' OE1' ' HE1' ' A' ' 104' ' ' PHE . 66.4 mt-30 -66.22 -41.53 89.95 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.718 -178.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.532 ' HA ' ' O ' ' A' ' 117' ' ' SER . 58.1 m80 -77.79 -9.94 59.29 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.7 t -76.05 -23.51 55.1 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 174.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 72.2 mt -99.94 -66.87 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.806 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.532 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 20.2 m -102.62 117.72 60.2 Favored Pre-proline 0 N--CA 1.433 -1.276 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.814 -175.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -82.35 88.96 1.22 Allowed 'Trans proline' 0 N--CA 1.439 -1.697 0 C-N-CA 121.882 1.721 . . . . 0.0 110.267 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 52.2 mt -88.63 -69.98 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.467 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.6 m -88.73 -6.73 57.23 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.117 0.484 . . . . 0.0 111.319 -178.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.7 mt -118.61 145.12 36.8 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -176.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.26 -36.51 45.77 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.947 2.431 . . . . 0.0 113.613 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 60.8 m -123.65 159.88 28.37 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 85.1 m -73.34 139.63 46.16 Favored 'General case' 0 N--CA 1.434 -1.246 0 O-C-N 123.686 0.616 . . . . 0.0 109.722 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.402 HD22 ' CG ' ' A' ' 44' ' ' PHE . 84.8 mt -65.37 110.79 2.76 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.583 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -89.38 95.36 10.25 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 174.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 58.6 mt -65.52 126.28 91.24 Favored Pre-proline 0 C--N 1.302 -1.484 0 CA-C-N 113.966 -1.47 . . . . 0.0 108.997 -178.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 N--CA 1.452 -0.915 0 C-N-CA 121.861 1.707 . . . . 0.0 110.223 176.698 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.1 p . . . . . 0 N--CA 1.435 -1.196 0 CA-C-O 121.868 0.842 . . . . 0.0 108.738 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.3 m -93.99 -33.31 13.49 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.627 -175.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -16.32 61.14 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.048 0.451 . . . . 0.0 111.672 -177.181 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -66.22 -40.06 90.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.506 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.416 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 11.8 p-90 -104.76 -5.67 21.04 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -94.11 113.16 25.06 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.961 -176.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.411 ' HB3' HD23 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -132.02 87.67 43.53 Favored Pre-proline 0 C--N 1.311 -1.109 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.5 178.622 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.14 -12.57 17.44 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.706 2.271 . . . . 0.0 115.254 -172.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -96.79 19.31 12.75 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.078 0.465 . . . . 0.0 111.27 -177.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.56 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 4.4 mm? -105.95 128.56 53.88 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.363 0.601 . . . . 0.0 112.25 -178.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.8 t -88.86 173.42 8.53 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 174.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.417 ' O ' HG13 ' A' ' 33' ' ' ILE . 11.0 ttm180 -48.96 -56.93 7.41 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.545 0.738 . . . . 0.0 112.36 -174.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -66.21 -37.3 85.23 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.999 -172.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -75.58 -32.08 60.22 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.269 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.57 89.96 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 175.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 29' ' ' ARG . 89.6 mt -59.99 -46.42 94.15 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.656 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.556 178.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' A' ' 37' ' ' LYS . . . -59.02 -44.97 91.78 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 41.2 mt -64.87 -47.34 78.21 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.706 0.765 . . . . 0.0 111.593 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.566 ' HG ' ' HB2' ' A' ' 61' ' ' LYS . 51.5 tp -70.52 -38.14 74.22 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.291 -1.322 . . . . 0.0 113.835 -173.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 14.3 ptmm? -56.75 -30.57 63.72 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -175.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -98.73 8.8 44.53 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.53 0.681 . . . . 0.0 111.077 -177.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . 0.261 45.3 mtmt -84.15 -85.64 0.13 Allowed 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 119.18 -1.008 . . . . 0.0 113.382 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -173.48 136.9 0.71 Allowed Pre-proline 0 C--N 1.289 -2.024 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -176.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -58.56 107.3 0.33 Allowed 'Trans proline' 0 C--O 1.246 0.906 0 C-N-CA 122.519 2.146 . . . . 0.0 110.704 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.45 -25.82 4.73 Favored Glycine 0 N--CA 1.426 -1.972 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -175.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.421 ' O ' HD11 ' A' ' 36' ' ' LEU . . . -76.06 155.19 35.05 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-O 121.093 0.473 . . . . 0.0 110.362 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -146.2 178.33 8.31 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.431 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -156.64 149.46 23.79 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 169.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.416 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 61.1 mt -113.69 124.07 69.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.56 ' HD2' ' O ' ' A' ' 27' ' ' LEU . 39.1 ptt85 -117.28 -177.25 3.18 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.398 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -98.92 136.66 38.6 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.9 t -109.81 152.98 25.03 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.376 0.608 . . . . 0.0 112.212 -172.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -117.62 92.52 3.86 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-O 121.964 0.888 . . . . 0.0 108.884 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.4 m -153.85 -50.92 0.1 Allowed 'General case' 0 C--N 1.258 -3.401 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 177.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -130.88 143.32 50.64 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 104.068 -2.567 . . . . 0.0 104.068 171.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -81.22 120.46 24.92 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.52 30.63 4.88 Favored Glycine 0 C--N 1.295 -1.708 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -171.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -119.29 145.4 46.15 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.491 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 85.1 m-85 -115.55 143.06 45.88 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.31 123.03 7.67 Favored Glycine 0 C--N 1.285 -2.281 0 C-N-CA 119.995 -1.098 . . . . 0.0 110.432 -178.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -99.61 119.87 38.77 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -114.41 121.93 45.08 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 176.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.8 tt -123.05 123.86 41.82 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -176.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.566 ' HB2' ' HG ' ' A' ' 36' ' ' LEU . 22.1 tptm -90.25 113.44 25.27 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 80' ' ' LEU . 17.9 m -99.02 171.26 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.02 -56.57 4.54 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 176.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.411 ' HA ' HD12 ' A' ' 80' ' ' LEU . 9.4 p -158.67 132.45 4.96 Favored Pre-proline 0 C--N 1.309 -1.189 0 C-N-CA 125.294 1.437 . . . . 0.0 108.287 177.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.61 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 35.7 Cg_exo -59.73 -42.14 48.99 Favored 'Trans proline' 0 CA--C 1.577 2.65 0 C-N-CA 121.376 1.384 . . . . 0.0 111.545 171.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.61 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 95.3 Cg_endo -76.89 172.25 16.53 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 122.991 2.46 . . . . 0.0 110.153 170.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.62 -44.91 43.57 Favored 'Trans proline' 0 C--N 1.362 1.241 0 C-N-CA 122.873 2.382 . . . . 0.0 112.633 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.5 m -143.49 -15.3 0.65 Allowed 'General case' 0 C--O 1.247 0.968 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.344 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.478 ' HB2' ' CG ' ' A' ' 66' ' ' PRO . . . 58.38 43.63 19.55 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 123.884 0.873 . . . . 0.0 108.688 -174.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -57.68 -48.23 97.57 Favored Pre-proline 0 N--CA 1.447 -0.606 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.819 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -76.41 87.6 1.43 Allowed 'Trans proline' 0 C--N 1.371 1.734 0 CA-C-N 120.495 1.212 . . . . 0.0 109.746 171.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 31.4 t-105 -81.78 141.52 33.43 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.674 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -122.9 -33.11 3.41 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.306 -0.958 . . . . 0.0 112.102 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.03 68.12 0.02 OUTLIER Glycine 0 CA--C 1.466 -2.976 0 N-CA-C 106.097 -2.801 . . . . 0.0 106.097 -176.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -104.4 110.9 64.94 Favored Pre-proline 0 C--N 1.284 -2.24 0 CA-C-N 113.381 -1.409 . . . . 0.0 111.215 -168.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -73.84 159.83 44.5 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.12 1.88 . . . . 0.0 111.437 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.456 ' HA ' HD23 ' A' ' 80' ' ' LEU . 8.6 p -62.99 -20.78 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.462 0.648 . . . . 0.0 110.676 -178.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -67.75 -13.32 62.02 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 124.065 0.946 . . . . 0.0 111.396 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -87.67 -38.36 15.93 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.47 ' O ' HG22 ' A' ' 62' ' ' VAL . 2.7 mm? -73.15 -27.57 61.74 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.866 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.501 HG13 HD23 ' A' ' 36' ' ' LEU . 69.2 t -86.18 110.08 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 171.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -91.78 134.27 34.89 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.408 -0.814 . . . . 0.0 108.853 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -114.26 122.5 46.93 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.298 0.57 . . . . 0.0 110.579 178.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -129.75 160.17 34.25 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -123.14 150.49 43.21 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.657 -1.217 . . . . 0.0 111.927 174.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.491 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 81.6 mt -108.81 131.1 60.41 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.792 0 CA-C-N 114.068 -1.424 . . . . 0.0 107.615 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -115.54 137.47 52.03 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 1.7 t -110.81 118.72 36.91 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 171.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -135.52 -148.09 5.57 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.85 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -71.25 -34.1 10.42 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 122.56 2.173 . . . . 0.0 113.875 -177.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -75.72 -26.49 57.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.129 0.49 . . . . 0.0 111.034 178.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 139.04 -153.52 22.82 Favored Glycine 0 N--CA 1.425 -2.087 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 88' ' ' THR . 13.9 p -112.04 130.87 64.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.23 170.01 23.22 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.425 ' HB ' ' SG ' ' A' ' 98' ' ' CYS . 64.1 mt -81.16 140.46 16.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -52.39 -53.05 49.95 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 123.601 0.761 . . . . 0.0 109.926 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.65 23.79 5.47 Favored Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 115.086 -0.961 . . . . 0.0 114.666 -176.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.425 ' SG ' ' HB ' ' A' ' 95' ' ' ILE . 31.1 p -116.02 103.09 53.71 Favored Pre-proline 0 N--CA 1.435 -1.2 0 CA-C-N 118.315 1.057 . . . . 0.0 110.551 174.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -100.6 28.47 0.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.124 2.549 . . . . 0.0 110.053 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.3 p -75.54 -78.71 0.11 Allowed 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.438 -176.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -166.68 -59.07 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -79.12 126.23 6.92 Favored 'Trans proline' 0 N--CA 1.44 -1.668 0 N-CA-C 115.813 1.428 . . . . 0.0 115.813 -165.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -97.72 121.03 39.15 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 168.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.556 ' CD2' ' HB3' ' A' ' 110' ' ' LEU . 60.0 m-85 -94.46 166.29 12.13 Favored 'General case' 0 C--N 1.289 -2.024 0 O-C-N 123.395 0.434 . . . . 0.0 111.177 -170.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.22 -36.78 6.93 Favored Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 121.108 -0.568 . . . . 0.0 111.991 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.9 m -140.98 169.41 17.68 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 122.497 -0.414 . . . . 0.0 109.943 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.471 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 94.8 mt -62.36 -40.05 95.17 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.107 0.563 . . . . 0.0 112.198 -176.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.0 t -52.53 -40.46 62.52 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.218 0.607 . . . . 0.0 112.037 -178.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.58 96.41 Favored 'General case' 0 C--O 1.247 0.954 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.556 ' HB3' ' CD2' ' A' ' 104' ' ' PHE . 4.4 pp -72.55 -28.73 63.01 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 120.912 0.387 . . . . 0.0 110.919 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 40.6 t -63.78 -54.59 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.132 177.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 45.9 m -65.28 -36.67 84.83 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.502 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -57.77 -48.18 80.39 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.434 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.474 ' HA ' ' O ' ' A' ' 117' ' ' SER . 71.6 m80 -87.53 -2.49 58.65 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.5 t -79.33 -31.15 43.03 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 67.4 mt -95.85 -58.96 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.424 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 21.6 m -111.57 105.3 56.71 Favored Pre-proline 0 N--CA 1.434 -1.247 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.835 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -75.29 85.35 1.57 Allowed 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 121.696 1.597 . . . . 0.0 110.076 175.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.0 mt -72.51 -73.85 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.908 -177.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.1 m -98.89 1.18 45.46 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.664 0.745 . . . . 0.0 111.318 -176.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.4 mt -105.29 137.6 19.3 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.78 -10.93 29.76 Favored 'Trans proline' 0 N--CA 1.485 1.023 0 C-N-CA 122.885 2.39 . . . . 0.0 113.701 -177.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 52.3 t -141.01 151.52 44.17 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 13.2 p -76.67 142.65 40.5 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 176.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 90.1 mt -73.02 120.17 18.27 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 123.741 0.651 . . . . 0.0 109.738 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -101.41 120.07 39.72 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mt -105.29 109.59 63.39 Favored Pre-proline 0 N--CA 1.429 -1.483 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 C--N 1.32 -0.949 0 C-N-CA 122.725 2.283 . . . . 0.0 113.08 -176.606 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.1 p . . . . . 0 CA--C 1.54 0.566 0 CA-C-O 122.417 1.103 . . . . 0.0 111.827 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 36.2 t -80.06 -21.56 43.26 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.27 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.95 -4.55 17.1 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -173.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -86.19 -12.09 50.72 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 122.114 -0.366 . . . . 0.0 110.78 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.444 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 53.3 p-90 -142.48 -28.95 0.58 Allowed 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -175.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.435 ' HB2' ' CE3' ' A' ' 22' ' ' TRP . 55.4 t80 -92.46 114.26 26.76 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.331 0.586 . . . . 0.0 112.535 -173.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.9 96.56 2.92 Favored Pre-proline 0 C--N 1.306 -1.314 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.816 172.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.95 3.78 6.7 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 123.26 2.64 . . . . 0.0 114.227 -173.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -85.11 -14.66 46.42 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.701 0.762 . . . . 0.0 109.504 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.3 tp -89.2 134.86 33.87 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.367 -169.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.8 t -92.27 177.5 6.13 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-O 120.875 0.369 . . . . 0.0 110.015 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.401 ' HA ' ' CZ ' ' A' ' 47' ' ' ARG . 17.1 ttm180 -54.48 -56.11 22.13 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 124.506 1.122 . . . . 0.0 113.4 -172.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -65.31 -40.59 93.97 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.386 0.612 . . . . 0.0 111.1 -174.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -65.45 -35.83 82.1 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.162 -177.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.33 -40.07 96.28 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.376 178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 73.4 mt -67.95 -41.23 84.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.197 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.11 -31.61 70.21 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.245 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.2 mt -79.81 -39.83 29.92 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.396 0.617 . . . . 0.0 111.707 175.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.9 tp -75.6 -28.74 59.0 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.065 -173.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.2 ptmm? -64.05 -15.07 58.69 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.31 0.576 . . . . 0.0 111.385 178.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -95.5 -13.63 24.36 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.316 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -99.27 174.32 6.36 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.919 0.39 . . . . 0.0 111.457 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -92.94 158.74 37.11 Favored Pre-proline 0 C--N 1.304 -1.376 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.061 -173.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -59.61 120.81 8.85 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 122.472 2.114 . . . . 0.0 110.873 175.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.81 -14.52 10.55 Favored Glycine 0 C--N 1.298 -1.543 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -176.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.75 151.67 27.36 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.462 ' CG ' HD22 ' A' ' 125' ' ' LEU . 22.5 p90 -152.16 162.03 41.74 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -175.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -150.48 147.32 27.36 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 174.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.444 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 64.6 mt -118.96 127.29 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 CA-C-O 121.692 0.758 . . . . 0.0 109.673 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.41 HH22 ' CD2' ' A' ' 83' ' ' HIS . 26.5 ptt-85 -125.3 -173.96 2.94 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -92.27 135.06 34.31 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 174.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 70.2 m -83.64 99.16 10.03 Favored 'General case' 0 N--CA 1.426 -1.631 0 C-N-CA 120.221 -0.591 . . . . 0.0 109.407 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -74.15 69.5 1.52 Allowed 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 121.98 0.895 . . . . 0.0 109.794 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.3 m -157.63 -36.46 0.07 Allowed 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 113.352 -1.749 . . . . 0.0 108.412 -177.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -133.4 166.98 21.27 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -110.89 130.12 55.68 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.78 24.5 38.26 Favored Glycine 0 C--N 1.304 -1.205 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.418 ' HB1' HD23 ' A' ' 85' ' ' LEU . . . -134.17 122.44 22.83 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-O 121.673 0.749 . . . . 0.0 110.146 -178.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -96.66 155.91 16.57 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -118.19 120.72 4.82 Favored Glycine 0 C--N 1.273 -2.952 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.45 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.2 tp -98.45 121.7 40.72 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 124.296 0.644 . . . . 0.0 109.275 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.15 112.93 25.37 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.7 tp -108.78 129.54 55.38 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 123.528 0.518 . . . . 0.0 109.7 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -88.83 119.3 29.21 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.7 m -108.38 165.71 4.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.32 -58.73 5.2 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.516 HG21 ' H ' ' A' ' 69' ' ' ALA . 0.6 OUTLIER -164.64 145.47 6.41 Favored Pre-proline 0 C--N 1.314 -0.97 0 C-N-CA 123.545 0.738 . . . . 0.0 110.663 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.569 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 16.3 Cg_exo -63.05 -49.82 4.5 Favored 'Trans proline' 0 CA--C 1.571 2.344 0 C-N-CA 121.933 1.756 . . . . 0.0 109.44 168.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.569 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 15.9 Cg_endo -57.55 179.81 0.13 Allowed 'Trans proline' 0 C--N 1.392 2.831 0 C-N-CA 122.825 2.35 . . . . 0.0 110.841 162.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -71.82 -47.46 0.46 Allowed 'Trans proline' 0 C--N 1.357 1.001 0 N-CA-C 108.072 -1.549 . . . . 0.0 108.072 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 71.5 m -160.79 111.68 1.81 Allowed 'General case' 0 N--CA 1.407 -2.608 0 N-CA-C 103.442 -2.799 . . . . 0.0 103.442 171.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.516 ' H ' HG21 ' A' ' 64' ' ' THR . . . -58.41 76.15 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 124.031 0.932 . . . . 0.0 113.085 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.467 ' H ' ' HD2' ' A' ' 71' ' ' PRO . 51.4 tt0 -87.82 -47.43 0.47 Allowed Pre-proline 0 C--N 1.286 -2.156 0 CA-C-N 114.578 -1.192 . . . . 0.0 107.892 172.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.467 ' HD2' ' H ' ' A' ' 70' ' ' GLN . 20.2 Cg_endo -65.51 109.19 1.35 Allowed 'Trans proline' 0 C--N 1.377 2.05 0 N-CA-C 108.654 -1.325 . . . . 0.0 108.654 165.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -81.83 137.32 35.29 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.981 -175.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -126.17 -36.75 2.3 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.763 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 167.73 -48.34 0.24 Allowed Glycine 0 CA--C 1.467 -2.93 0 N-CA-C 107.335 -2.306 . . . . 0.0 107.335 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 39.49 78.38 0.37 Allowed Pre-proline 0 C--N 1.316 -0.87 0 C-N-CA 126.817 2.047 . . . . 0.0 114.647 168.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -75.38 163.2 34.95 Favored 'Trans proline' 0 C--O 1.242 0.701 0 C-N-CA 122.251 1.967 . . . . 0.0 111.518 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -67.11 -30.29 48.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 120.985 0.421 . . . . 0.0 111.182 -178.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -70.71 -18.77 62.8 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.202 0.525 . . . . 0.0 110.473 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -79.09 -22.77 44.76 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.6 mt -89.35 5.69 43.92 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.962 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.8 t -117.85 141.47 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -109.45 137.39 47.37 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.41 ' CD2' HH22 ' A' ' 47' ' ' ARG . 26.8 m80 -117.7 122.77 44.4 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 121.439 0.638 . . . . 0.0 111.669 178.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -135.57 143.38 45.62 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 177.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.418 HD23 ' HB1' ' A' ' 55' ' ' ALA . 3.9 mp -96.42 162.61 13.41 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.263 -1.375 . . . . 0.0 108.726 174.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 80.2 mt -125.13 110.83 25.69 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.014 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 174.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.462 ' OE1' ' HD3' ' A' ' 96' ' ' LYS . 30.1 mt-10 -99.72 148.93 23.84 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -175.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.565 ' HB ' HG23 ' A' ' 93' ' ' VAL . 5.3 t -135.56 141.86 45.25 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -149.74 -155.45 6.8 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.35 -27.22 84.45 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.17 2.58 . . . . 0.0 113.876 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.72 -48.68 16.1 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 120.739 0.305 . . . . 0.0 111.689 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.63 -144.12 8.99 Favored Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.565 HG23 ' HB ' ' A' ' 88' ' ' THR . 12.2 p -123.78 142.49 40.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.64 157.48 31.96 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.155 0.182 . . . . 0.0 111.214 -171.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 58.0 mt -81.56 136.8 22.35 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 CA-C-O 121.207 0.527 . . . . 0.0 110.891 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.462 ' HD3' ' OE1' ' A' ' 87' ' ' GLU . 43.5 tptt -83.38 135.2 34.79 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 124.492 1.117 . . . . 0.0 111.172 -176.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.68 34.55 13.31 Favored Glycine 0 CA--C 1.499 -0.94 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.118 176.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.6 ' SG ' ' HB3' ' A' ' 100' ' ' SER . 47.0 t -142.26 143.15 26.26 Favored Pre-proline 0 N--CA 1.425 -1.68 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -87.36 10.34 3.57 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 123.318 2.678 . . . . 0.0 110.64 177.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.6 ' HB3' ' SG ' ' A' ' 98' ' ' CYS . 40.5 t -125.47 -164.63 1.32 Allowed 'General case' 0 N--CA 1.393 -3.306 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 -178.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 68.4 100.53 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.794 0 C-N-CA 125.674 1.59 . . . . 0.0 112.295 -179.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.94 -162.99 0.15 Allowed 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 122.968 2.445 . . . . 0.0 111.654 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -94.33 96.53 9.61 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -78.32 161.22 27.37 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -76.36 -51.57 6.62 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.524 178.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 39.0 m -137.68 166.7 23.31 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.6 mp -58.72 -36.28 74.04 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 123.166 0.587 . . . . 0.0 110.98 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.1 m -51.21 -37.74 48.45 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.232 1.013 . . . . 0.0 111.482 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.14 -50.08 65.21 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.196 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.457 HD12 ' N ' ' A' ' 111' ' ' VAL . 4.1 pp -68.21 -35.06 77.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.879 0.371 . . . . 0.0 110.592 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.457 ' N ' HD12 ' A' ' 110' ' ' LEU . 47.9 t -58.31 -50.79 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.683 176.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 45.7 p -69.42 -22.78 63.66 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.409 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -88.79 -39.55 13.82 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.928 0.394 . . . . 0.0 111.405 -174.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -75.47 -0.84 21.51 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.7 m -74.56 -28.49 60.96 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 170.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 68.8 mt -97.95 -49.03 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.217 -178.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.9 m -121.71 99.83 44.38 Favored Pre-proline 0 N--CA 1.44 -0.959 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.174 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -81.47 100.89 1.17 Allowed 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.144 1.896 . . . . 0.0 109.727 174.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 65.0 mt -90.29 -73.8 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.135 -174.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.549 ' HB3' ' SG ' ' A' ' 98' ' ' CYS . 2.7 p -77.74 -27.41 50.45 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 122.038 0.923 . . . . 0.0 110.094 177.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.5 mt -83.12 129.68 60.12 Favored Pre-proline 0 N--CA 1.427 -1.587 0 CA-C-N 114.144 -1.389 . . . . 0.0 109.237 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -75.78 -4.33 15.06 Favored 'Trans proline' 0 N--CA 1.485 1.021 0 C-N-CA 122.893 2.395 . . . . 0.0 112.702 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 82.9 m -143.61 152.59 41.57 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.449 ' SG ' ' HD3' ' A' ' 126' ' ' ARG . 21.5 p -82.07 148.63 28.48 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.952 0.406 . . . . 0.0 111.487 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.462 HD22 ' CG ' ' A' ' 44' ' ' PHE . 86.7 mt -74.19 117.42 15.98 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.449 ' HD3' ' SG ' ' A' ' 124' ' ' CYS . 24.2 mmm180 -104.41 109.73 21.71 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.241 0.543 . . . . 0.0 110.221 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mp -96.03 126.66 43.69 Favored Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo . . . . . 0 C--N 1.352 0.762 0 C-N-CA 122.408 2.072 . . . . 0.0 111.485 177.772 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.335 80.5 p . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.491 ' O ' ' HB3' ' A' ' 23' ' ' TYR . 20.0 m -62.66 -31.84 72.79 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.671 0.748 . . . . 0.0 109.483 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -10.64 33.64 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 177.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -98.38 -62.26 1.27 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.804 0.335 . . . . 0.0 111.093 176.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 24.8 p-90 -94.05 -8.65 39.17 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -171.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.491 ' HB3' ' O ' ' A' ' 19' ' ' SER . 70.2 t80 -100.5 120.0 39.35 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.865 -175.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -131.23 88.94 43.07 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 175.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.83 -31.82 67.55 Favored 'Trans proline' 0 N--CA 1.482 0.834 0 C-N-CA 122.482 2.121 . . . . 0.0 113.347 -172.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 42.4 p-80 -84.74 -0.32 53.26 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 124.107 0.963 . . . . 0.0 112.776 -174.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.462 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 14.4 tp -85.76 152.37 23.1 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -176.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 t -110.28 174.86 5.66 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 120.628 0.251 . . . . 0.0 110.432 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 -56.91 -50.36 72.78 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -174.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -64.77 -32.01 73.5 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.126 0.488 . . . . 0.0 111.326 -175.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -74.83 -39.36 61.67 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.326 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.49 -43.44 93.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.395 0.617 . . . . 0.0 109.948 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 78.1 mt -65.62 -39.7 85.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.966 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.455 ' O ' ' HG2' ' A' ' 37' ' ' LYS . . . -57.71 -49.44 76.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.277 178.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.8 -36.29 82.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.075 0.464 . . . . 0.0 111.336 178.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.419 ' CD1' HD22 ' A' ' 45' ' ' LEU . 6.6 mp -81.2 -14.81 57.17 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -177.283 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.489 ' HB3' HG21 ' A' ' 77' ' ' VAL . 17.8 ptpt -80.28 -15.05 57.83 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.673 177.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -100.23 -3.72 30.92 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.187 176.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -101.38 174.63 5.89 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -176.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -91.53 144.65 29.91 Favored Pre-proline 0 C--N 1.305 -1.343 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.14 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.02 118.44 4.98 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.083 2.522 . . . . 0.0 112.094 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.37 -11.71 9.09 Favored Glycine 0 N--CA 1.435 -1.41 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -174.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.65 147.87 37.24 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.405 ' HB2' HD11 ' A' ' 58' ' ' LEU . 36.1 p90 -150.68 171.5 17.06 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -176.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.419 HD22 ' CD1' ' A' ' 36' ' ' LEU . 1.5 pt? -161.56 154.52 20.75 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 172.208 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.3 mt -121.48 134.92 63.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 121.061 0.457 . . . . 0.0 110.565 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.533 ' HG3' ' O ' ' A' ' 48' ' ' ASP . 23.8 ptt-85 -127.39 -173.69 2.97 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 177.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.533 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 13.1 t70 -82.4 150.75 26.94 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 174.033 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 70.8 m -66.25 -26.75 67.5 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 119.307 0.958 . . . . 0.0 112.12 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 35.4 t60 69.73 -46.75 0.59 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 124.909 1.284 . . . . 0.0 111.873 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.2 t -71.67 -33.5 68.91 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 123.775 0.83 . . . . 0.0 110.35 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -122.36 154.36 37.77 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -177.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -102.39 126.73 49.51 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 123.812 0.695 . . . . 0.0 110.41 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.13 22.67 34.57 Favored Glycine 0 C--N 1.308 -1.024 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -178.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.62 144.02 47.65 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 120.898 0.38 . . . . 0.0 110.162 -177.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -112.64 139.0 48.62 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -101.96 111.63 4.12 Favored Glycine 0 C--N 1.294 -1.797 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.378 -177.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.405 HD11 ' HB2' ' A' ' 44' ' ' PHE . 39.3 tp -91.31 130.49 37.17 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 123.88 0.872 . . . . 0.0 109.306 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -114.44 128.71 56.48 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 175.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.2 tp -122.27 129.54 52.3 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 123.553 0.533 . . . . 0.0 110.546 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -93.1 114.28 26.77 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 28.4 m -106.82 164.14 4.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 173.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.07 -59.24 3.02 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.9 p -149.22 141.73 15.36 Favored Pre-proline 0 N--CA 1.421 -1.877 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.629 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 39.1 Cg_exo -59.99 -44.71 28.1 Favored 'Trans proline' 0 CA--C 1.57 2.279 0 C-N-CA 121.675 1.583 . . . . 0.0 111.659 174.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.629 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 85.6 Cg_endo -75.78 149.72 33.98 Favored 'Trans proline' 0 C--N 1.381 2.272 0 C-N-CA 122.416 2.077 . . . . 0.0 109.559 171.094 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.18 -48.11 6.89 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.148 1.899 . . . . 0.0 112.629 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.9 p -116.71 -9.1 11.34 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.855 0.36 . . . . 0.0 111.363 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 59.4 44.05 15.64 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.562 -178.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -50.38 -52.33 55.8 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 113.902 -1.499 . . . . 0.0 110.787 175.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.45 93.43 0.98 Allowed 'Trans proline' 0 N--CA 1.441 -1.568 0 CA-C-N 120.308 1.146 . . . . 0.0 109.352 169.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 53.0 t-105 -86.55 137.16 32.73 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.562 -175.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -124.7 -42.12 2.09 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.206 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.24 56.39 1.0 Allowed Glycine 0 C--N 1.299 -1.524 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -89.94 139.93 27.57 Favored Pre-proline 0 C--N 1.306 -1.289 0 CA-C-N 115.091 -0.555 . . . . 0.0 109.855 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.19 167.93 26.06 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.893 2.395 . . . . 0.0 113.829 -175.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.489 HG21 ' HB3' ' A' ' 37' ' ' LYS . 2.3 p -59.53 -32.74 49.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.336 176.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 -65.1 -18.68 65.5 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.073 0.463 . . . . 0.0 110.881 177.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -92.4 -36.05 13.35 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.95 -35.8 82.33 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.156 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 89.6 t -70.71 113.04 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.516 ' NE ' ' HA ' ' A' ' 82' ' ' ARG . 1.7 mmp_? -87.25 144.6 26.74 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.795 -176.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -125.84 124.47 40.98 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 120.974 0.416 . . . . 0.0 110.352 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -132.13 132.86 43.63 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.482 ' HG ' ' HB2' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -97.06 140.59 31.35 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.972 -1.091 . . . . 0.0 112.229 177.029 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 77.4 mt -107.61 120.68 59.36 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.419 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -105.78 138.01 42.7 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -175.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.435 ' HB ' HG23 ' A' ' 93' ' ' VAL . 3.9 t -116.36 124.75 50.84 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.65 -162.66 9.52 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 -178.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.55 -31.82 49.9 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.205 2.603 . . . . 0.0 112.631 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -71.04 -21.88 62.21 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 175.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 132.63 -159.47 23.45 Favored Glycine 0 CA--C 1.488 -1.601 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.435 HG23 ' HB ' ' A' ' 88' ' ' THR . 14.6 p -104.01 127.18 58.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.711 ' HG2' ' CD2' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -149.73 167.03 27.63 Favored 'General case' 0 C--O 1.201 -1.493 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.24 -171.665 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 66.6 mt -93.2 143.88 10.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.405 -176.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.482 ' HB2' ' HG ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -44.69 -46.56 10.37 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.675 1.59 . . . . 0.0 112.124 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -127.01 63.89 0.59 Allowed Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.44 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 11.1 p -85.05 122.85 74.1 Favored Pre-proline 0 C--N 1.304 -1.391 0 CA-C-O 120.678 0.275 . . . . 0.0 110.391 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -80.29 10.42 3.24 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 122.752 2.301 . . . . 0.0 113.365 -176.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.8 m -154.82 -162.46 1.38 Allowed 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.436 ' HG3' ' CD1' ' A' ' 103' ' ' TYR . 37.2 tt0 -109.88 106.37 58.19 Favored Pre-proline 0 C--N 1.294 -1.816 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -175.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -89.42 -80.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.653 0 C-N-CA 122.066 1.844 . . . . 0.0 112.149 171.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.711 ' CD2' ' HG2' ' A' ' 94' ' ' LYS . 51.8 m-85 43.49 79.36 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 127.381 2.272 . . . . 0.0 112.805 178.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.411 ' O ' HG12 ' A' ' 93' ' ' VAL . 98.0 m-85 -107.08 -178.36 3.62 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.279 -177.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -86.35 -36.9 9.3 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.009 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.8 m -132.9 158.51 42.41 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 122.456 -0.438 . . . . 0.0 110.487 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 75.1 mt -55.21 -46.78 75.93 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 123.13 0.572 . . . . 0.0 111.463 178.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 24.3 p -54.6 -31.21 56.6 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 123.242 0.617 . . . . 0.0 112.401 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.18 -39.14 82.58 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.113 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 111' ' ' VAL . 3.8 pp -80.31 -29.81 38.13 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.687 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.437 ' N ' HD12 ' A' ' 110' ' ' LEU . 40.6 t -63.41 -54.48 32.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.629 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.7 m -68.64 -20.61 64.47 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.303 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -78.26 -40.82 35.94 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.646 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.515 ' HA ' ' O ' ' A' ' 117' ' ' SER . 66.8 m80 -80.18 3.02 21.99 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -174.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 125' ' ' LEU . 10.7 p -86.15 -39.88 16.22 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 172.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.5 mt -84.01 -48.14 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.271 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 19.6 m -121.86 93.06 48.78 Favored Pre-proline 0 N--CA 1.425 -1.706 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.835 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.57 73.43 5.6 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.855 2.37 . . . . 0.0 110.873 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 67.5 mt -68.8 -60.8 2.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.13 -178.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.3 m -83.72 -49.96 8.62 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.551 -175.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -73.4 139.96 78.84 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.867 -177.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.88 -18.39 46.94 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 123.09 2.527 . . . . 0.0 111.994 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 43.6 t -127.94 154.75 45.21 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 4.0 p -71.61 145.01 49.26 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 177.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.401 ' O ' ' HB3' ' A' ' 115' ' ' SER . 74.2 mt -79.41 106.31 11.35 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -90.38 103.78 16.42 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.336 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.547 ' H ' HD12 ' A' ' 127' ' ' ILE . 1.8 mp -90.38 128.12 50.3 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo . . . . . 0 CA--C 1.531 0.373 0 C-N-CA 121.435 1.423 . . . . 0.0 110.21 174.507 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.553 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 2.0 p . . . . . 0 N--CA 1.425 -1.725 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.5 m -74.32 -36.17 63.68 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.313 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.77 -5.86 40.81 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.553 ' CD2' ' HA ' ' A' ' 18' ' ' THR . 25.6 m-85 -81.08 -24.12 38.0 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.079 175.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.476 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 54.0 p-90 -116.6 -32.28 5.24 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -93.16 114.54 27.07 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.217 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . 0.252 0.1 OUTLIER -155.24 98.28 2.37 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-O 121.711 0.767 . . . . 0.0 111.266 175.361 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -83.35 19.43 1.34 Allowed 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 124.047 3.165 . . . . 0.0 114.62 -173.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -99.43 -4.03 32.37 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.993 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.7 mp -92.99 140.96 28.92 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.817 0.818 . . . . 0.0 112.952 -177.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 m -90.05 177.26 6.5 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.043 -1.435 . . . . 0.0 107.707 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -50.49 -56.56 11.04 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.249 0.62 . . . . 0.0 110.635 177.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -65.86 -35.31 80.29 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.709 -175.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -66.94 -38.69 86.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.088 178.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.44 -42.07 99.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.577 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 82.9 mt -64.82 -45.83 93.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.107 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.421 ' HA ' ' CD ' ' A' ' 37' ' ' LYS . . . -59.83 -32.95 71.14 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.702 0.763 . . . . 0.0 111.83 178.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.14 -50.08 17.48 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 70.1 mt -71.09 -26.26 62.97 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -175.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.421 ' CD ' ' HA ' ' A' ' 34' ' ' ALA . 14.3 ptmm? -65.11 -24.49 67.44 Favored 'General case' 0 C--N 1.316 -0.883 0 O-C-N 121.908 -0.495 . . . . 0.0 110.567 178.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -84.37 -40.36 17.96 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.753 176.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.574 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -68.58 151.42 46.78 Favored 'General case' 0 C--O 1.248 1.015 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.222 -176.278 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -75.11 138.35 72.36 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.815 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -45.45 120.24 3.11 Favored 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 124.265 3.31 . . . . 0.0 114.121 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.87 -24.43 6.38 Favored Glycine 0 N--CA 1.434 -1.476 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -176.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.08 151.66 45.23 Favored 'General case' 0 C--O 1.249 1.031 0 CA-C-N 114.975 -0.613 . . . . 0.0 110.016 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.419 ' HZ ' HG13 ' A' ' 111' ' ' VAL . 23.6 p90 -153.6 170.93 19.63 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 -175.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -147.42 145.7 29.31 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 171.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.476 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 60.7 mt -111.56 123.33 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.067 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -124.1 179.91 4.68 Favored 'General case' 0 C--N 1.275 -2.66 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 177.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -84.98 154.02 22.4 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 175.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.6 t -81.82 133.87 35.37 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -90.95 -22.89 20.62 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 121.833 0.825 . . . . 0.0 108.98 177.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.7 m -72.53 -52.82 13.99 Favored 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 114.347 -1.297 . . . . 0.0 109.784 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -126.77 138.55 53.38 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.33 0.585 . . . . 0.0 111.348 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -88.77 138.03 31.78 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 176.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.22 11.67 58.29 Favored Glycine 0 C--N 1.305 -1.143 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -172.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -135.3 153.88 51.73 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-N 114.631 -0.784 . . . . 0.0 109.111 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.5 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 52.6 m-85 -115.83 171.58 7.68 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 176.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.18 133.13 8.87 Favored Glycine 0 C--N 1.282 -2.437 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -111.22 115.61 29.66 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.34 125.36 50.51 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.493 HD21 ' SG ' ' A' ' 123' ' ' CYS . 50.4 tp -124.08 129.83 51.53 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 123.395 0.435 . . . . 0.0 111.782 -173.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.562 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 22.3 tptm -91.77 114.24 26.72 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 174.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 80' ' ' LEU . 24.3 m -101.64 171.08 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 175.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.61 -55.6 6.62 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.44 ' HB ' ' HG2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -159.18 142.98 10.94 Favored Pre-proline 0 N--CA 1.421 -1.892 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.508 -178.277 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.595 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 16.8 Cg_exo -61.46 -50.27 5.97 Favored 'Trans proline' 0 CA--C 1.555 1.542 0 C-N-CA 122.208 1.939 . . . . 0.0 110.094 172.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.595 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 10.8 Cg_endo -54.76 136.03 69.88 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 122.105 1.87 . . . . 0.0 109.653 163.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.19 -11.55 21.14 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.64 2.227 . . . . 0.0 112.674 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.4 p -130.1 -37.28 1.48 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.912 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.437 ' HA ' ' HB2' ' A' ' 66' ' ' PRO . . . 72.9 23.04 2.9 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 125.096 1.358 . . . . 0.0 111.989 178.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -62.91 -49.05 83.73 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.598 173.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.14 105.87 1.27 Allowed 'Trans proline' 0 C--N 1.386 2.502 0 C-N-CA 121.047 1.165 . . . . 0.0 110.126 170.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 68.2 t-105 -96.1 149.06 22.03 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.78 -175.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -133.62 -36.71 0.95 Allowed 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.878 175.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.36 34.38 29.28 Favored Glycine 0 CA--C 1.503 -0.685 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.9 p30 -90.28 153.8 46.6 Favored Pre-proline 0 C--N 1.298 -1.642 0 CA-C-N 114.163 -1.019 . . . . 0.0 111.127 -177.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_exo -34.51 146.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.366 1.499 1 C-N-CA 125.99 4.46 . . . . 0.0 117.684 -175.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.1 p -70.24 -13.97 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.221 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -64.9 -16.05 62.77 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.809 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -92.02 -24.81 19.08 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 121.114 0.483 . . . . 0.0 109.781 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.483 HD23 ' HD3' ' A' ' 65' ' ' PRO . 79.1 mt -76.02 -26.06 56.3 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.013 0.911 . . . . 0.0 109.01 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.5 t -93.88 123.88 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 173.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.477 ' NE ' ' HA ' ' A' ' 82' ' ' ARG . 4.1 mmp_? -104.89 151.01 24.38 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -123.91 124.62 43.02 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.627 0.727 . . . . 0.0 111.772 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -128.13 170.38 13.02 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 pp -135.25 157.81 45.96 Favored 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.485 176.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.5 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 39.4 mt -111.34 123.68 67.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -173.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -102.77 129.55 49.46 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 123.733 0.813 . . . . 0.0 109.016 -176.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.512 ' HB ' HG23 ' A' ' 93' ' ' VAL . 2.6 t -116.77 132.76 56.61 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 120.928 0.394 . . . . 0.0 110.304 174.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.65 -159.82 8.34 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.56 -31.9 49.66 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.008 2.472 . . . . 0.0 113.713 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -80.57 -36.23 33.24 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.701 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 163.31 -163.15 35.38 Favored Glycine 0 N--CA 1.422 -2.238 0 C-N-CA 119.911 -1.138 . . . . 0.0 112.124 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.512 HG23 ' HB ' ' A' ' 88' ' ' THR . 14.0 p -116.11 126.75 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.283 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.561 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 0.0 OUTLIER -151.27 173.88 13.95 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 116.048 -0.523 . . . . 0.0 112.388 -177.249 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.45 ' HB ' ' OG ' ' A' ' 120' ' ' SER . 70.2 mt -97.61 141.81 15.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-O 121.74 0.781 . . . . 0.0 112.975 -171.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -65.74 132.58 49.1 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 125.122 1.369 . . . . 0.0 108.926 174.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.42 -9.59 38.6 Favored Glycine 0 C--N 1.312 -0.778 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.568 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 37.8 t -142.24 141.04 20.17 Favored Pre-proline 0 N--CA 1.422 -1.866 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.58 -40.38 47.47 Favored 'Trans proline' 0 C--O 1.244 0.805 0 C-N-CA 121.555 1.504 . . . . 0.0 109.385 176.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.561 ' OG ' ' HB2' ' A' ' 94' ' ' LYS 0.38 1.8 p 49.41 67.36 0.9 Allowed 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 123.443 1.592 . . . . 0.0 114.06 -177.17 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.505 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 41.8 mt-10 -49.63 -36.72 18.59 Favored Pre-proline 0 C--N 1.303 -1.446 0 CA-C-N 111.525 -2.579 . . . . 0.0 115.652 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 101' ' ' GLU . 7.3 Cg_endo -53.6 -33.11 67.4 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.134 1.889 . . . . 0.0 114.732 177.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 48.75 99.58 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 126.211 1.805 . . . . 0.0 111.982 -172.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -74.31 139.39 44.17 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.745 -176.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.03 -42.25 20.26 Favored Glycine 0 C--N 1.304 -1.223 0 C-N-CA 120.042 -1.075 . . . . 0.0 110.706 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.8 m -133.22 159.89 38.87 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.421 ' O ' ' HB3' ' A' ' 110' ' ' LEU . 96.1 mt -58.61 -31.67 68.29 Favored 'General case' 0 C--O 1.215 -0.711 0 C-N-CA 123.626 0.77 . . . . 0.0 112.045 -178.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.9 m -61.27 -32.12 71.94 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-O 120.846 0.355 . . . . 0.0 111.589 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.5 -31.82 62.32 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.562 0.696 . . . . 0.0 109.555 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.421 ' HB3' ' O ' ' A' ' 107' ' ' LEU . 3.7 tt -67.62 -45.37 75.62 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.537 -1.21 . . . . 0.0 109.354 176.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.446 HG21 ' CE2' ' A' ' 22' ' ' TRP . 73.2 t -71.13 -39.11 73.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.137 -0.938 . . . . 0.0 113.177 -177.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.7 t -68.97 -21.81 64.15 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.151 0.5 . . . . 0.0 110.997 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -107.11 177.96 4.7 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.398 -178.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.532 ' HA ' ' O ' ' A' ' 117' ' ' SER . 7.0 m-70 73.48 -10.43 1.05 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.969 0.908 . . . . 0.0 113.21 -177.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.0 m -73.26 -32.8 64.9 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 169.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 61.2 mt -88.24 -62.23 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.859 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.532 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 26.6 t -116.54 99.96 53.13 Favored Pre-proline 0 N--CA 1.434 -1.238 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.32 99.12 1.08 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.78 2.32 . . . . 0.0 110.812 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.434 ' HB ' ' CE1' ' A' ' 114' ' ' HIS . 67.6 mt -99.51 -51.32 10.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.225 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.45 ' OG ' ' HB ' ' A' ' 95' ' ' ILE . 34.7 t -80.89 -42.35 21.59 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.644 -177.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.425 HD12 HD22 ' A' ' 60' ' ' LEU . 1.8 mm? -89.83 144.11 31.14 Favored Pre-proline 0 N--CA 1.434 -1.25 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.294 -178.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -63.41 -32.21 71.79 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.987 2.458 . . . . 0.0 111.757 177.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.493 ' SG ' HD21 ' A' ' 60' ' ' LEU . 26.3 p -109.45 169.87 8.43 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 23.2 m -70.14 132.71 46.23 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 176.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 29.2 tp -82.37 131.98 35.22 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -136.39 128.14 29.07 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.455 ' H ' HD12 ' A' ' 127' ' ' ILE . 3.0 mp -66.24 125.14 89.73 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo . . . . . 0 C--N 1.35 0.651 0 C-N-CA 122.049 1.833 . . . . 0.0 111.299 -179.253 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.496 -1.11 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -79.17 -42.4 26.2 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -176.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -135.22 160.96 36.75 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -128.11 101.68 6.38 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -86.39 151.75 23.29 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -72.95 142.1 47.8 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 119.404 -0.919 . . . . 0.0 108.523 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 29.8 t60 -72.88 87.88 1.32 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.574 0.702 . . . . 0.0 111.48 -175.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.8 t -134.14 -2.2 2.87 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.3 m -105.22 6.51 33.02 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-O 121.819 0.819 . . . . 0.0 110.467 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.04 139.28 14.48 Favored Glycine 0 N--CA 1.423 -2.176 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.519 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 85.5 mt -106.7 159.33 16.3 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.7 t -104.48 96.49 10.25 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.519 ' HD3' ' O ' ' A' ' 11' ' ' LEU . 43.3 Cg_endo -95.19 145.13 1.42 Allowed 'Trans proline' 0 N--CA 1.438 -1.754 0 C-N-CA 122.389 2.059 . . . . 0.0 111.903 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -122.69 -50.72 1.95 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.58 61.95 4.14 Favored Glycine 0 CA--C 1.518 0.268 0 N-CA-C 115.098 0.799 . . . . 0.0 115.098 172.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.3 t -99.73 -1.6 37.38 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 122.088 0.947 . . . . 0.0 109.419 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -84.84 100.41 11.54 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 114.705 -1.134 . . . . 0.0 107.986 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.0 p -112.9 3.49 16.34 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.703 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.1 p -58.2 -45.0 88.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -174.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -13.25 62.11 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -74.48 -35.74 63.28 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.154 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.491 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 41.3 p-90 -110.36 -26.7 9.42 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 114.058 1.132 . . . . 0.0 114.058 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -90.81 113.32 25.44 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.316 0.579 . . . . 0.0 111.656 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.66 93.89 4.21 Favored Pre-proline 0 C--N 1.299 -1.627 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.846 174.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 47' ' ' ARG . 97.0 Cg_endo -76.43 -0.09 10.04 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 123.58 2.853 . . . . 0.0 114.334 -172.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -94.93 -1.54 52.35 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.088 0.471 . . . . 0.0 111.752 -173.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.533 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 73.3 mt -94.86 145.88 24.6 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.309 0.576 . . . . 0.0 111.746 -178.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.455 ' HA ' ' NH1' ' A' ' 47' ' ' ARG . 23.1 t -100.74 177.23 5.05 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.1 ttt180 -52.99 -53.4 50.57 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.654 0.782 . . . . 0.0 112.585 -173.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -64.0 -32.47 74.02 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.981 0.419 . . . . 0.0 111.411 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.426 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 15.7 mm-40 -73.03 -34.57 66.42 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.822 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.05 -44.94 83.13 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.414 0.626 . . . . 0.0 109.619 178.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.8 mt -63.93 -36.39 76.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.425 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.19 -36.04 72.49 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.481 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 4.4 mm? -75.78 -47.84 24.19 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.278 174.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.3 mt -66.42 -21.54 66.22 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -174.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -74.25 -5.24 40.89 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.417 0.627 . . . . 0.0 111.47 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -112.57 5.46 17.89 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 35' ' ' LEU . 31.3 mmmt -110.98 145.17 38.88 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.385 0.612 . . . . 0.0 110.992 -177.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -76.74 141.57 68.82 Favored Pre-proline 0 C--N 1.301 -1.531 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.221 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -47.64 118.9 3.28 Favored 'Trans proline' 0 C--N 1.364 1.375 0 C-N-CA 123.938 3.092 . . . . 0.0 113.467 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.24 -30.51 3.47 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.39 151.89 39.62 Favored 'General case' 0 C--O 1.253 1.239 0 CA-C-O 120.717 0.294 . . . . 0.0 110.54 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -147.32 175.9 10.42 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.671 -176.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -149.59 147.37 28.06 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 170.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.491 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 62.4 mt -112.19 122.21 66.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.533 ' HD2' ' O ' ' A' ' 27' ' ' LEU . 28.5 ptt85 -121.09 -173.94 2.72 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -95.22 153.51 17.63 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.5 t -97.39 132.35 43.19 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.95 0.881 . . . . 0.0 111.131 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -85.3 -14.79 45.45 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.803 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.7 m -78.53 -51.74 9.51 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.195 -175.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -128.98 144.22 51.12 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -73.76 132.93 43.14 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.01 31.65 25.55 Favored Glycine 0 N--CA 1.436 -1.367 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.146 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.0 145.97 49.98 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.424 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 87.3 m-85 -113.72 134.47 54.73 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.83 118.02 5.15 Favored Glycine 0 N--CA 1.421 -2.356 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.042 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -96.69 118.29 32.84 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.98 119.75 40.3 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.0 tp -121.37 131.56 54.26 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.473 -176.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -88.81 113.99 24.96 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 175.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 80' ' ' LEU . 26.1 m -102.26 169.52 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.999 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.64 -57.6 4.0 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.87 118.81 2.15 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.134 0.974 . . . . 0.0 110.697 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.613 ' N ' ' HD3' ' A' ' 66' ' ' PRO . 21.5 Cg_endo -99.42 12.31 0.64 Allowed 'Trans proline' 0 CA--C 1.601 3.847 0 C-N-CA 122.84 2.36 . . . . 0.0 118.037 178.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.613 ' HD3' ' N ' ' A' ' 65' ' ' PRO . 2.0 Cg_endo -93.58 164.92 2.31 Favored 'Trans proline' 0 C--N 1.384 2.407 0 CA-C-N 123.051 2.125 . . . . 0.0 111.218 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -74.03 -22.16 17.43 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 121.861 1.707 . . . . 0.0 111.782 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.1 p -134.45 -43.2 0.77 Allowed 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.392 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.437 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 75.84 3.76 3.83 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.026 1.33 . . . . 0.0 112.982 177.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.461 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 34.9 tt0 -86.68 -52.44 0.43 Allowed Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 172.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.461 ' HD3' ' HB3' ' A' ' 70' ' ' GLN . 7.3 Cg_exo -76.02 107.09 2.39 Favored 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 121.317 1.344 . . . . 0.0 108.708 171.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 59.6 t-105 -117.56 135.42 53.97 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.934 -177.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -158.15 81.7 0.85 Allowed 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 114.616 -1.174 . . . . 0.0 108.609 174.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -169.94 -178.55 41.02 Favored Glycine 0 C--N 1.268 -3.208 0 CA-C-N 113.734 -1.575 . . . . 0.0 110.28 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -89.8 115.87 64.95 Favored Pre-proline 0 C--N 1.294 -1.829 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.55 ' O ' ' HG ' ' A' ' 80' ' ' LEU . 47.5 Cg_exo -32.47 -78.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 125.098 3.865 . . . . 0.0 117.048 -172.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -73.31 -30.08 29.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -174.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -71.23 -26.77 63.07 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.83 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.468 ' OE1' ' HA ' ' A' ' 79' ' ' GLN . 4.9 tp60 -88.01 -18.06 29.82 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 121.139 0.495 . . . . 0.0 110.225 177.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 76' ' ' PRO . 91.1 mt -80.99 -12.01 59.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.482 0.658 . . . . 0.0 109.26 174.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.8 t -96.13 118.99 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -103.17 142.32 34.36 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.768 -177.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -123.36 122.08 37.41 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.387 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -126.72 170.09 12.49 Favored 'General case' 0 C--N 1.273 -2.728 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -135.86 135.38 39.73 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 118.767 -1.173 . . . . 0.0 112.119 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.594 ' CG2' ' HB ' ' A' ' 93' ' ' VAL . 59.5 mt -94.24 110.78 24.14 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 CA-C-N 114.014 -1.448 . . . . 0.0 107.408 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -105.57 121.22 43.52 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.831 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.716 ' HB ' HG12 ' A' ' 93' ' ' VAL . 1.4 t -94.95 118.68 32.21 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.691 0.758 . . . . 0.0 110.36 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -106.43 -157.99 21.74 Favored Glycine 0 N--CA 1.427 -1.946 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -66.4 -26.7 47.78 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.964 1.776 . . . . 0.0 110.528 176.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -73.74 -73.34 0.22 Allowed 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.167 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 179.02 -151.22 10.07 Favored Glycine 0 N--CA 1.423 -2.191 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.716 HG12 ' HB ' ' A' ' 88' ' ' THR . 35.7 m -103.71 145.9 12.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 O-C-N 123.739 0.317 . . . . 0.0 110.865 -176.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.75 155.8 30.49 Favored 'General case' 0 C--O 1.259 1.565 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 176.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.58 HG12 HG12 ' A' ' 86' ' ' ILE . 59.4 mt -94.39 114.12 30.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.429 0.633 . . . . 0.0 111.765 -176.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -62.15 120.75 11.5 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.392 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.39 -28.61 2.44 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.61 ' SG ' HG22 ' A' ' 119' ' ' ILE . 49.6 t -112.98 132.1 22.5 Favored Pre-proline 0 N--CA 1.426 -1.656 0 CA-C-N 114.817 -0.691 . . . . 0.0 110.201 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 98' ' ' CYS . 95.4 Cg_endo -99.51 11.38 0.67 Allowed 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 122.628 2.219 . . . . 0.0 112.525 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.0 m -122.81 18.64 10.23 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.82 0.343 . . . . 0.0 111.087 -174.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -113.39 136.73 21.9 Favored Pre-proline 0 C--N 1.31 -1.111 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -174.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -82.33 -179.68 4.83 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.135 2.557 . . . . 0.0 113.292 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -98.93 108.55 21.26 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -76.44 -60.36 2.37 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.291 0.567 . . . . 0.0 110.21 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.609 ' H ' HG22 ' A' ' 93' ' ' VAL . . . 124.37 -66.53 0.52 Allowed Glycine 0 C--N 1.306 -1.131 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 177.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.7 m -93.61 150.62 20.28 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.13 -41.28 94.96 Favored 'General case' 0 C--O 1.216 -0.661 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.354 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 38.6 t -54.94 -31.37 60.39 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.229 0.612 . . . . 0.0 111.028 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.28 -49.28 74.67 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.378 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.452 HD12 ' N ' ' A' ' 111' ' ' VAL . 4.1 pp -75.01 -32.44 61.62 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 120.838 0.351 . . . . 0.0 110.936 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.452 ' N ' HD12 ' A' ' 110' ' ' LEU . 69.7 t -63.09 -44.66 99.63 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.821 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.569 178.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.3 t -73.28 -21.83 60.51 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.006 0.432 . . . . 0.0 111.819 177.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -83.42 -4.64 58.68 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 121.388 0.613 . . . . 0.0 110.085 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 125' ' ' LEU . 6.0 p80 -42.62 -50.4 5.42 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 126.694 1.997 . . . . 0.0 115.893 -173.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.4 t -103.7 4.78 35.74 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 121.438 0.637 . . . . 0.0 109.286 -172.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.5 mt -99.47 -48.54 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.8 m -141.27 86.21 11.38 Favored Pre-proline 0 N--CA 1.437 -1.103 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.459 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.88 89.49 1.13 Allowed 'Trans proline' 0 N--CA 1.44 -1.649 0 C-N-CA 121.681 1.587 . . . . 0.0 108.054 173.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.61 HG22 ' SG ' ' A' ' 98' ' ' CYS . 36.3 mt -90.28 -64.02 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.79 -174.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.4 ' HA ' ' HB2' ' A' ' 98' ' ' CYS . 7.8 t -73.4 -30.25 63.13 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 120.851 0.358 . . . . 0.0 111.073 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.66 127.21 73.65 Favored Pre-proline 0 N--CA 1.435 -1.203 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.417 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -69.23 -24.45 32.1 Favored 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 122.327 2.018 . . . . 0.0 111.457 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.415 ' SG ' ' HB ' ' A' ' 62' ' ' VAL . 83.4 m -114.74 145.73 41.76 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 53.4 m -64.16 111.88 2.77 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.124 0.488 . . . . 0.0 109.937 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 114' ' ' HIS . 27.9 tp -58.21 135.79 57.16 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 125.0 1.32 . . . . 0.0 110.041 -176.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.513 ' HD2' ' OD1' ' A' ' 131' ' ' ASP . 20.3 mmt180 -130.92 134.99 47.26 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.576 HG22 ' H ' ' A' ' 129' ' ' SER . 4.1 mp -80.96 136.15 50.93 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -53.58 -36.84 82.1 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.131 1.887 . . . . 0.0 112.129 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.576 ' H ' HG22 ' A' ' 127' ' ' ILE . 3.9 m -84.08 -33.43 24.39 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.025 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -133.38 124.9 28.0 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -173.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.513 ' OD1' ' HD2' ' A' ' 126' ' ' ARG . 13.8 t70 . . . . . 0 C--N 1.288 -2.075 0 CA-C-N 113.851 -1.522 . . . . 0.0 107.959 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 CA--C 1.504 -0.812 0 CA-C-O 120.895 0.378 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -117.82 117.11 28.41 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -88.91 113.06 24.04 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -66.62 148.55 51.75 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -173.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -79.54 117.24 20.3 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 174.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -61.92 -65.68 0.65 Allowed 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -129.4 -50.47 1.18 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.2 m 55.38 73.64 0.41 Allowed 'General case' 0 C--O 1.245 0.852 0 CA-C-O 122.19 0.995 . . . . 0.0 110.207 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.3 m -77.3 45.57 0.47 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.33 -1.305 . . . . 0.0 112.317 -175.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.49 47.62 3.66 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.0 mt -117.57 127.56 54.09 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.5 t -101.37 126.95 32.85 Favored Pre-proline 0 C--N 1.289 -2.038 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.02 107.25 2.06 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 122.422 2.081 . . . . 0.0 110.835 175.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -88.79 80.41 7.2 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 122.042 0.925 . . . . 0.0 109.653 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.3 52.64 0.53 Allowed Glycine 0 N--CA 1.427 -1.91 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 m -112.62 15.82 19.91 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.181 0.991 . . . . 0.0 108.907 -177.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -97.67 85.63 3.62 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.756 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.3 p -98.7 -0.06 43.61 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.317 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.5 m -45.46 -60.86 1.93 Allowed 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 125.853 1.661 . . . . 0.0 112.805 -173.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.41 ' HE2' ' CE2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -67.48 -12.69 60.9 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -176.616 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.41 ' CE2' ' HE2' ' A' ' 20' ' ' LYS . 74.6 m-85 -76.99 -23.24 52.29 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.419 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.434 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 31.3 p-90 -121.0 -24.75 5.51 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.506 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 35.8 t80 -95.31 116.79 29.24 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.992 -0.442 . . . . 0.0 110.045 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.488 ' CB ' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -138.04 97.9 9.65 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.097 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.88 21.55 0.37 Allowed 'Trans proline' 0 CA--C 1.552 1.418 0 C-N-CA 123.326 2.684 . . . . 0.0 113.977 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -114.78 -20.44 10.62 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.241 0.543 . . . . 0.0 110.088 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.488 HD23 ' CB ' ' A' ' 24' ' ' LYS . 3.5 mm? -76.75 120.51 22.01 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.668 0.747 . . . . 0.0 111.355 -175.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.0 p -85.27 177.69 7.75 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.57 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -49.7 -55.85 12.34 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.079 0.952 . . . . 0.0 111.622 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -72.78 -32.45 65.6 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.98 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -70.77 -33.53 70.88 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.871 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.98 -42.51 99.86 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.576 0.703 . . . . 0.0 109.13 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 85.0 mt -65.27 -44.01 95.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.465 178.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.48 -28.64 68.5 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.375 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.03 -51.99 10.12 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 57.2 mt -72.84 -25.56 61.16 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -174.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -56.91 -33.8 67.31 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -89.51 -21.29 23.01 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.543 0.687 . . . . 0.0 110.77 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -78.62 164.77 24.36 Favored 'General case' 0 C--O 1.255 1.389 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -172.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.54 137.38 76.79 Favored Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 111.917 -2.401 . . . . 0.0 111.329 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -63.0 107.56 0.65 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.922 1.748 . . . . 0.0 109.342 170.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.46 -17.93 5.52 Favored Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 -175.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.37 154.96 27.4 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 120.644 0.259 . . . . 0.0 110.66 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.485 ' CG ' HD11 ' A' ' 125' ' ' LEU . 5.4 p90 -149.45 177.68 9.49 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.279 -174.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -155.31 147.09 23.26 Favored 'General case' 0 C--O 1.253 1.237 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 169.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 23' ' ' TYR . 63.2 mt -117.81 135.33 58.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.442 HH12 ' HB2' ' A' ' 59' ' ' ALA . 0.1 OUTLIER -144.73 162.45 36.7 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 174.871 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.07 131.88 48.69 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 173.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.433 ' HB3' ' O ' ' A' ' 52' ' ' PHE . 30.4 t -75.67 118.81 18.9 Favored 'General case' 0 N--CA 1.413 -2.312 0 C-N-CA 119.024 -1.071 . . . . 0.0 109.087 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 27.6 m-70 -77.24 -16.11 59.17 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.87 175.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.0 m -84.11 -46.79 11.58 Favored 'General case' 0 N--CA 1.408 -2.568 0 CA-C-N 114.229 -1.35 . . . . 0.0 109.535 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.433 ' O ' ' HB3' ' A' ' 49' ' ' SER . 89.9 m-85 -127.15 127.97 45.41 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-O 121.35 0.595 . . . . 0.0 111.095 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -83.61 128.03 34.2 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.658 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.22 15.75 52.63 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -177.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.74 160.81 36.99 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -122.4 129.88 52.53 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.95 115.58 4.14 Favored Glycine 0 C--N 1.293 -1.832 0 C-N-CA 119.968 -1.11 . . . . 0.0 111.302 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -93.29 119.56 32.58 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.442 ' HB2' HH12 ' A' ' 47' ' ' ARG . . . -114.53 129.76 56.69 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.42 HD21 ' SG ' ' A' ' 123' ' ' CYS . 58.9 tp -126.85 128.62 46.81 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 123.488 0.493 . . . . 0.0 110.801 -177.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 22.3 tptm -88.36 115.14 25.66 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 176.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.489 HG12 ' SG ' ' A' ' 123' ' ' CYS . 34.1 m -105.82 170.69 2.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.87 -48.48 12.33 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 p -167.29 120.97 0.79 Allowed Pre-proline 0 C--N 1.32 -0.681 0 C-N-CA 125.291 1.436 . . . . 0.0 109.025 178.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.63 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 28.2 Cg_exo -60.57 -46.84 15.65 Favored 'Trans proline' 0 CA--C 1.575 2.567 0 C-N-CA 121.149 1.232 . . . . 0.0 110.993 170.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.63 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 85.1 Cg_endo -77.73 158.66 31.72 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.86 2.374 . . . . 0.0 109.917 173.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -70.03 -54.16 0.22 Allowed 'Trans proline' 0 CA--C 1.551 1.357 0 C-N-CA 121.715 1.61 . . . . 0.0 112.189 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.1 m -104.86 -19.84 13.76 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.837 0.351 . . . . 0.0 110.906 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 66.98 34.7 5.07 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 124.169 0.987 . . . . 0.0 111.274 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -60.68 -44.29 94.78 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.857 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.62 82.39 0.73 Allowed 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 121.11 1.206 . . . . 0.0 111.285 173.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 36.4 t-105 -85.87 136.73 33.18 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.0 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.9 mtmm -127.06 6.66 6.53 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -173.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.03 24.58 44.11 Favored Glycine 0 CA--C 1.489 -1.543 0 N-CA-C 108.554 -1.819 . . . . 0.0 108.554 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -86.21 127.05 63.06 Favored Pre-proline 0 N--CA 1.423 -1.799 0 CA-C-N 113.744 -1.228 . . . . 0.0 111.308 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -96.26 -165.12 0.1 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.7 0 C-N-CA 122.938 2.425 . . . . 0.0 110.867 176.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.463 ' HA ' HD23 ' A' ' 80' ' ' LEU . 9.8 p -56.46 -21.3 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 123.633 0.773 . . . . 0.0 112.405 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -62.56 -33.63 75.33 Favored 'General case' 0 C--O 1.213 -0.819 0 C-N-CA 122.853 0.461 . . . . 0.0 110.909 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.62 -20.34 56.84 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 121.461 0.648 . . . . 0.0 109.819 -178.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 77' ' ' VAL . 3.5 mm? -81.03 -3.08 50.56 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.097 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.9 t -101.66 104.83 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.875 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 174.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -78.85 139.76 38.28 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -120.65 122.44 40.49 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-O 121.872 0.844 . . . . 0.0 111.688 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -131.41 170.74 14.25 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.48 136.82 41.58 Favored 'General case' 0 C--N 1.283 -2.325 0 C-N-CA 119.944 -0.703 . . . . 0.0 111.088 175.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.429 HG12 HG12 ' A' ' 95' ' ' ILE . 74.9 mt -91.43 114.72 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.632 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 178.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.548 ' CD ' ' HE2' ' A' ' 96' ' ' LYS . 30.7 mt-10 -99.75 140.08 34.47 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.737 ' HB ' HG12 ' A' ' 93' ' ' VAL . 1.3 t -116.17 127.46 54.81 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.439 0.638 . . . . 0.0 110.626 175.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.4 -169.97 14.01 Favored Glycine 0 N--CA 1.424 -2.163 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.2 -27.81 31.4 Favored 'Trans proline' 0 CA--C 1.553 1.43 0 C-N-CA 123.425 2.75 . . . . 0.0 114.858 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.48 ' HD2' ' N ' ' A' ' 91' ' ' LYS . 10.7 mptt -80.28 -21.32 42.8 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.073 0.463 . . . . 0.0 111.121 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.28 -149.07 16.88 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.737 HG12 ' HB ' ' A' ' 88' ' ' THR . 31.3 m -104.64 149.08 8.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.41 155.02 19.49 Favored 'General case' 0 C--O 1.251 1.147 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.429 HG12 HG12 ' A' ' 86' ' ' ILE . 71.6 mt -86.94 114.34 25.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.423 0.63 . . . . 0.0 111.311 -176.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.548 ' HE2' ' CD ' ' A' ' 87' ' ' GLU . 19.4 ttmm -64.83 126.93 29.52 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.438 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 110.13 40.05 1.45 Allowed Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 120' ' ' SER . 35.5 t -142.33 132.4 12.44 Favored Pre-proline 0 N--CA 1.432 -1.33 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -178.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -86.8 8.11 4.57 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.602 2.202 . . . . 0.0 112.648 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.6 m -148.4 -148.0 0.24 Allowed 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 80.75 123.93 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.135 0 C-N-CA 124.963 1.305 . . . . 0.0 113.161 174.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.16 171.28 18.6 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.681 2.254 . . . . 0.0 111.74 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -95.59 132.38 40.79 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -108.25 154.68 21.42 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -178.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -95.4 -25.27 14.21 Favored Glycine 0 C--N 1.3 -1.42 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.772 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 11.1 m -122.65 144.62 49.01 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 90.2 mt -62.56 -37.83 87.69 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.196 0.522 . . . . 0.0 109.661 175.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.3 m -54.17 -34.44 60.49 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.593 1.157 . . . . 0.0 111.163 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.9 -39.32 83.62 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.7 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.48 HD12 ' N ' ' A' ' 111' ' ' VAL . 4.0 pp -76.2 -36.98 58.36 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.144 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.48 ' N ' HD12 ' A' ' 110' ' ' LEU . 43.0 t -55.9 -51.79 56.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.727 177.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.4 m -71.94 -26.71 62.39 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.967 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -83.46 -37.85 22.62 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -176.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -72.3 -6.17 41.31 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -174.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.8 m -75.26 -24.35 57.59 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 171.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 65.5 mt -101.61 -50.02 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.426 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.8 m -120.4 97.84 48.75 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.241 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.78 92.11 1.1 Allowed 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.473 2.115 . . . . 0.0 109.565 174.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 23.6 mt -84.97 -67.62 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.28 -174.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.444 ' HB3' ' HB2' ' A' ' 98' ' ' CYS . 4.8 p -77.67 -33.54 53.33 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.88 0.848 . . . . 0.0 110.338 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.418 HD22 HD22 ' A' ' 60' ' ' LEU . 49.6 mt -84.73 140.83 38.06 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.137 -177.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.56 -11.3 15.69 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.863 2.375 . . . . 0.0 113.454 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.489 ' SG ' HG12 ' A' ' 62' ' ' VAL . 22.6 p -136.05 162.21 33.54 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 59.6 m -69.33 138.38 53.71 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 123.485 0.49 . . . . 0.0 110.021 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.485 HD11 ' CG ' ' A' ' 44' ' ' PHE . 19.6 tp -77.72 121.34 23.89 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.744 -175.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 131' ' ' ASP . 7.7 tpt180 -95.76 114.47 26.21 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 123.51 0.724 . . . . 0.0 110.577 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 66.8 mt -81.15 121.97 81.05 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 175.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.07 -41.28 65.46 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 122.646 2.231 . . . . 0.0 113.681 -176.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.7 t -86.42 -5.62 59.12 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -175.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -112.31 80.02 1.29 Allowed 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 118.903 -1.119 . . . . 0.0 111.632 -175.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.488 ' HB3' ' CZ ' ' A' ' 126' ' ' ARG . 32.0 t70 . . . . . 0 C--O 1.249 1.052 0 C-N-CA 127.063 2.145 . . . . 0.0 108.021 174.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.465 0.299 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -138.99 101.56 4.32 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.712 0.768 . . . . 0.0 111.067 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -105.88 -66.12 1.02 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -159.86 133.2 6.96 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -157.54 98.57 1.68 Allowed 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.423 0.63 . . . . 0.0 109.326 175.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -81.84 105.37 12.91 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.491 0.662 . . . . 0.0 109.614 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -146.61 92.5 2.16 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -177.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.7 m -66.16 153.84 41.32 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.127 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.1 m 70.78 -62.27 0.45 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.87 1.268 . . . . 0.0 111.805 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.8 83.84 1.51 Allowed Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 68.4 tp -73.99 -36.09 64.5 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.9 m -89.29 126.63 57.99 Favored Pre-proline 0 N--CA 1.429 -1.49 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.536 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -75.75 79.14 2.91 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.016 1.81 . . . . 0.0 109.701 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -80.3 91.87 5.69 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.548 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -134.93 23.51 3.52 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.5 m 56.42 58.05 4.49 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 123.896 0.878 . . . . 0.0 111.305 -176.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -74.2 116.28 14.67 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 177.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.0 p -92.78 -15.64 26.34 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -173.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.8 m -73.59 -33.06 64.44 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.609 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -61.46 -18.26 58.17 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -79.21 -26.91 42.53 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.539 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 21.9 p-90 -131.91 -9.49 3.48 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -175.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -98.92 113.38 25.5 Favored 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.655 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.07 91.1 9.03 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.983 175.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.94 -17.08 46.4 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.904 2.403 . . . . 0.0 113.891 -175.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -71.86 -18.89 62.03 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.037 0.446 . . . . 0.0 111.294 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.9 tp -80.54 139.17 36.47 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.116 0.484 . . . . 0.0 110.61 -176.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.575 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 15.5 m -91.95 168.2 11.58 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.046 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -57.12 -51.68 68.31 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.067 0.947 . . . . 0.0 113.39 -175.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.87 -39.8 95.56 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 121.561 0.696 . . . . 0.0 110.985 -176.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.575 ' OE1' ' HB2' ' A' ' 28' ' ' SER . 21.1 mp0 -67.03 -40.12 87.13 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.862 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.93 -41.77 75.1 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 123.197 0.599 . . . . 0.0 111.627 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 60.1 mt -65.2 -35.67 75.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.867 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.1 -33.04 72.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.778 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.91 -40.52 65.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.043 0.449 . . . . 0.0 110.647 177.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.465 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 75.6 mt -76.16 -27.1 56.85 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -175.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -77.22 -3.37 39.32 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.551 0.691 . . . . 0.0 109.934 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -106.19 -5.29 19.38 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.747 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.552 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -119.74 170.2 9.43 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.111 0.482 . . . . 0.0 112.177 -175.244 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -85.85 160.31 53.0 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.294 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 61' ' ' LYS . 10.8 Cg_endo -56.11 127.47 26.17 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.775 2.316 . . . . 0.0 111.265 173.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.41 -24.01 8.28 Favored Glycine 0 N--CA 1.434 -1.446 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.56 146.61 40.32 Favored 'General case' 0 C--O 1.253 1.239 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -151.87 177.52 10.34 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 121.019 0.438 . . . . 0.0 110.119 -176.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -162.05 150.04 14.68 Favored 'General case' 0 C--O 1.251 1.152 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 173.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.539 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 68.6 mt -123.93 134.16 67.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.458 HH22 ' CD2' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -133.59 173.62 11.31 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.241 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -80.06 146.5 31.9 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.1 t -99.56 139.94 34.47 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.528 0.68 . . . . 0.0 111.682 -176.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -99.59 -8.5 24.41 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.476 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.5 t -76.38 -40.87 49.86 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -129.9 140.92 50.88 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -83.57 124.63 30.97 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.989 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.42 31.66 18.56 Favored Glycine 0 N--CA 1.435 -1.385 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -177.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.75 157.98 45.31 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.971 -0.615 . . . . 0.0 109.602 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -124.65 161.06 27.1 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.34 123.56 5.55 Favored Glycine 0 C--N 1.288 -2.091 0 C-N-CA 119.908 -1.139 . . . . 0.0 111.036 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 84' ' ' PHE . 2.2 tm? -101.68 130.51 48.06 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 123.947 0.899 . . . . 0.0 108.74 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.41 ' HB2' HH12 ' A' ' 47' ' ' ARG . . . -119.28 125.34 48.87 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 175.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.5 tp -119.88 131.3 55.21 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 123.686 0.616 . . . . 0.0 110.535 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 41' ' ' PRO . 22.3 tptm -88.5 116.05 26.45 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 80' ' ' LEU . 18.7 m -109.94 171.77 2.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.79 -60.07 2.54 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.4 p -150.81 138.38 12.1 Favored Pre-proline 0 C--N 1.308 -1.207 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.247 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.678 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 24.4 Cg_exo -61.46 -43.55 27.15 Favored 'Trans proline' 0 CA--C 1.577 2.67 0 C-N-CA 121.969 1.779 . . . . 0.0 111.854 171.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.678 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 56.4 Cg_endo -68.25 143.16 57.71 Favored 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 122.547 2.164 . . . . 0.0 110.105 170.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.88 -32.81 35.26 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.547 2.165 . . . . 0.0 112.644 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.9 t -114.27 -42.74 3.29 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.079 0.466 . . . . 0.0 110.096 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.593 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 74.56 -3.04 2.66 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.972 1.309 . . . . 0.0 112.134 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.461 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 56.9 tt0 -59.72 -50.09 88.57 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 171.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.461 ' HD3' ' HB3' ' A' ' 70' ' ' GLN . 16.9 Cg_exo -70.56 101.23 1.0 Allowed 'Trans proline' 0 C--N 1.374 1.88 0 N-CA-C 106.615 -2.11 . . . . 0.0 106.615 164.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 46.3 t-105 -109.87 150.11 28.89 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.376 -172.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -114.29 -63.0 1.51 Allowed 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.98 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 158.3 67.0 0.01 OUTLIER Glycine 0 CA--C 1.471 -2.718 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -118.94 121.51 30.44 Favored Pre-proline 0 C--N 1.285 -2.238 0 CA-C-N 114.695 -0.753 . . . . 0.0 109.971 -169.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -85.16 178.56 4.59 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.304 2.003 . . . . 0.0 112.129 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.0 p -57.31 -30.12 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 123.353 0.661 . . . . 0.0 112.681 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.3 mp0 -68.84 -19.74 64.27 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.975 -0.453 . . . . 0.0 111.46 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -84.69 -19.74 32.31 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.487 ' O ' HG22 ' A' ' 62' ' ' VAL . 46.7 mt -74.26 -17.47 60.87 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.8 t -87.74 112.58 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 173.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -98.55 131.5 44.72 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -176.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.458 ' CD2' HH22 ' A' ' 47' ' ' ARG . 36.0 m80 -105.07 124.5 49.64 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 121.402 0.62 . . . . 0.0 112.02 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.417 ' O ' ' HB3' ' A' ' 58' ' ' LEU . 93.9 m-85 -131.3 126.73 36.11 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 177.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.9 pp -99.1 144.49 28.18 Favored 'General case' 0 C--N 1.285 -2.228 0 C-N-CA 118.443 -1.303 . . . . 0.0 111.132 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 62.5 mt -105.82 135.23 44.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.367 -174.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.452 ' OE1' ' HA ' ' A' ' 96' ' ' LYS . 30.6 mt-10 -116.55 142.75 46.47 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -176.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.428 ' HB ' HG23 ' A' ' 93' ' ' VAL . 4.7 t -131.39 139.51 49.47 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 175.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.22 -161.04 11.56 Favored Glycine 0 N--CA 1.433 -1.502 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.29 -17.66 61.14 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.038 2.492 . . . . 0.0 113.88 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.419 ' HD2' ' H ' ' A' ' 91' ' ' LYS . 9.7 mptt -79.72 -42.04 25.48 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 122.076 0.941 . . . . 0.0 109.217 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 146.71 -154.42 25.96 Favored Glycine 0 N--CA 1.422 -2.296 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.428 HG23 ' HB ' ' A' ' 88' ' ' THR . 12.4 p -114.02 137.82 45.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.98 171.93 19.13 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.503 ' HB ' ' HB3' ' A' ' 98' ' ' CYS . 58.7 mt -90.54 143.85 10.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 17.0 tppt? -48.02 -45.63 32.11 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.576 1.151 . . . . 0.0 112.482 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -120.44 62.15 0.5 Allowed Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.812 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.503 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 19.7 p -98.7 127.8 34.53 Favored Pre-proline 0 C--N 1.299 -1.588 0 CA-C-O 120.931 0.396 . . . . 0.0 111.429 178.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -90.04 32.93 0.34 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.242 2.628 . . . . 0.0 110.13 174.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.1 t -92.69 -147.65 0.23 Allowed 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.538 ' H ' ' HD2' ' A' ' 102' ' ' PRO . 17.9 tp10 -152.62 -55.52 0.02 OUTLIER Pre-proline 0 C--N 1.289 -2.05 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.733 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.538 ' HD2' ' H ' ' A' ' 101' ' ' GLU . 88.5 Cg_endo -77.81 158.72 31.41 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 121.384 1.39 . . . . 0.0 113.155 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -100.21 157.13 16.81 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -114.02 165.28 12.78 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.7 -47.04 3.54 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.304 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.7 m -121.87 159.25 27.19 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 111' ' ' VAL . 95.2 mt -57.22 -45.73 83.57 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 122.815 0.446 . . . . 0.0 111.757 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 72.4 m -54.26 -29.36 46.61 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.73 -48.83 67.93 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.494 0.187 . . . . 0.0 110.601 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.88 -26.15 63.11 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.158 0.504 . . . . 0.0 110.642 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 107' ' ' LEU . 73.5 t -67.5 -51.69 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.299 176.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 28.6 t -68.25 -27.84 66.69 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.221 0.534 . . . . 0.0 110.467 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.505 ' NE2' ' HB2' ' A' ' 117' ' ' SER . 0.6 OUTLIER -63.28 -50.48 69.96 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.427 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -77.19 -0.37 24.84 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -176.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 7.1 m -75.55 -37.22 60.15 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.486 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 73.3 mt -101.31 -53.94 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.083 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.505 ' HB2' ' NE2' ' A' ' 113' ' ' GLN . 19.9 m -107.94 97.6 21.84 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 116' ' ' ILE . 5.8 Cg_exo -78.64 84.53 2.01 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 122.412 2.075 . . . . 0.0 110.388 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 68.8 mt -80.96 -54.67 9.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.556 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.7 m -92.39 -15.6 27.03 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.453 0.644 . . . . 0.0 110.524 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 71.7 mt -112.6 136.88 21.53 Favored Pre-proline 0 N--CA 1.428 -1.541 0 CA-C-N 115.435 -0.802 . . . . 0.0 108.907 -175.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.476 ' HG2' HG11 ' A' ' 62' ' ' VAL . 71.7 Cg_endo -76.64 -5.84 16.41 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.537 2.158 . . . . 0.0 112.677 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 50.8 t -128.86 149.59 50.69 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 21.2 m -71.33 133.25 45.87 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 16.6 tp -77.77 138.02 38.77 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.247 -175.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 126' ' ' ARG . 23.3 mmt180 -122.41 118.2 27.82 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.533 0.683 . . . . 0.0 111.95 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.612 HG22 ' H ' ' A' ' 129' ' ' SER . 2.7 mp -91.46 135.31 28.13 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -176.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.01 -27.47 79.48 Favored 'Trans proline' 0 N--CA 1.48 0.731 0 C-N-CA 122.053 1.835 . . . . 0.0 110.926 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.612 ' H ' HG22 ' A' ' 127' ' ' ILE . 15.7 t -81.03 -4.92 56.8 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.839 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.447 ' HD3' ' C ' ' A' ' 130' ' ' LYS . 11.4 tmtt? -106.15 119.62 39.69 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 . . . . . 0 C--N 1.296 -1.755 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 176.683 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.499 -1.012 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -125.75 122.58 36.66 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 176.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 72.82 149.35 0.1 Allowed 'General case' 0 C--O 1.249 1.064 0 C-N-CA 124.957 1.303 . . . . 0.0 110.547 -176.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -75.32 148.7 39.09 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 174.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.3 p80 -68.79 120.03 14.09 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 119.522 -0.871 . . . . 0.0 108.992 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -81.29 -20.02 41.72 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 70.9 113.69 0.05 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.066 1.746 . . . . 0.0 110.713 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.3 m 71.51 103.16 0.07 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.756 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.2 m -65.16 -48.84 72.09 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.413 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.0 61.91 0.65 Allowed Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 178.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.4 mt 73.8 -14.83 0.62 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 125.272 1.429 . . . . 0.0 112.294 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.9 m -132.13 147.52 66.13 Favored Pre-proline 0 C--N 1.305 -1.353 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 173.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -52.01 -62.92 0.3 Allowed 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.79 2.327 . . . . 0.0 110.959 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 45.1 mtm180 -127.09 -74.52 0.59 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 170.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -146.2 -18.63 0.14 Allowed Glycine 0 N--CA 1.436 -1.342 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.288 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . 0.287 10.3 p 56.78 69.02 0.78 Allowed 'General case' 0 C--O 1.245 0.852 0 C-N-CA 124.375 1.07 . . . . 0.0 111.085 -175.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 11.5 m-20 -73.37 105.23 4.66 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-N 113.459 -1.701 . . . . 0.0 110.043 -178.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.9 p -86.38 -20.93 27.52 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-O 121.881 0.848 . . . . 0.0 110.788 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.432 ' HA ' ' CE2' ' A' ' 22' ' ' TRP . 14.8 m -68.31 -30.15 69.07 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 114.22 -1.354 . . . . 0.0 111.785 -177.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 17' ' ' ASP . 65.9 pttt -61.03 -22.29 64.41 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.545 ' CG ' ' HA ' ' A' ' 129' ' ' SER . 97.7 m-85 -76.71 -28.56 55.89 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.392 -177.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.432 ' CE2' ' HA ' ' A' ' 19' ' ' SER . 26.0 p-90 -116.54 -18.07 10.46 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -93.55 119.76 33.0 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.909 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.57 100.14 3.14 Favored Pre-proline 0 C--N 1.308 -1.234 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.246 173.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.484 ' HA ' ' HB2' ' A' ' 47' ' ' ARG . 98.1 Cg_endo -79.72 -4.23 13.35 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.952 2.435 . . . . 0.0 113.471 -173.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -92.63 -12.11 32.47 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.014 -177.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.521 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 17.5 tp -86.47 124.02 32.33 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.0 m -75.9 173.24 11.44 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -173.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.4 tpp180 -57.84 -53.67 55.62 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.726 0.811 . . . . 0.0 110.935 -175.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -67.31 -30.55 70.43 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.278 -177.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -76.32 -35.9 58.55 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.276 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.93 97.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.595 0.712 . . . . 0.0 109.712 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 82.8 mt -66.71 -43.31 90.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.465 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.5 -30.9 70.0 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.501 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.33 -44.77 43.46 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.794 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.49 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 65.0 mt -74.3 -25.14 59.4 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -177.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -71.78 -19.02 62.07 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 121.665 -0.647 . . . . 0.0 110.285 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -89.21 -10.16 48.1 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.601 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.671 ' HE2' ' HA ' ' A' ' 39' ' ' LYS . 3.8 mmpt? -108.68 164.78 12.07 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -176.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.0 151.71 86.34 Favored Pre-proline 0 C--N 1.309 -1.171 0 CA-C-N 112.667 -2.06 . . . . 0.0 108.863 -175.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -61.04 131.37 36.58 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.636 1.557 . . . . 0.0 109.529 173.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.91 -13.2 31.98 Favored Glycine 0 C--N 1.302 -1.351 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.3 151.21 31.22 Favored 'General case' 0 C--O 1.246 0.898 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -154.73 164.72 38.37 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -175.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -152.31 157.12 40.9 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 172.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.402 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 57.6 mt -127.11 132.1 70.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.521 ' HD2' ' O ' ' A' ' 27' ' ' LEU . 7.2 ptm180 -127.87 153.77 46.25 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 175.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -60.07 127.41 31.74 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.3 t -77.51 119.18 20.74 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -86.87 -20.9 26.77 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 m -61.24 -49.93 75.13 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 112.883 -1.962 . . . . 0.0 110.237 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -125.55 133.27 52.37 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -82.73 121.93 27.52 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.785 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.86 23.67 14.89 Favored Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.23 152.1 51.64 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 121.147 0.499 . . . . 0.0 110.035 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -120.58 136.17 54.88 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.73 112.13 4.34 Favored Glycine 0 C--N 1.284 -2.309 0 C-N-CA 120.039 -1.077 . . . . 0.0 111.005 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 44.7 tp -87.05 130.42 34.49 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -113.31 119.49 37.86 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 176.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.4 tp -115.68 130.17 56.75 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 123.65 0.594 . . . . 0.0 110.603 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.49 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 22.6 tptm -88.71 115.07 25.98 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.6 m -105.4 171.33 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 175.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.86 -54.39 10.24 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.6 p -160.22 142.98 9.91 Favored Pre-proline 0 C--N 1.319 -0.722 0 C-N-CA 124.753 1.221 . . . . 0.0 108.112 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.67 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 24.1 Cg_exo -62.57 -49.48 5.63 Favored 'Trans proline' 0 CA--C 1.576 2.579 0 C-N-CA 121.613 1.542 . . . . 0.0 111.386 169.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.67 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 69.3 Cg_endo -68.2 151.67 76.68 Favored 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 122.813 2.342 . . . . 0.0 109.866 173.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -59.09 -48.75 13.01 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.396 2.064 . . . . 0.0 112.617 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.6 p -118.57 -22.34 7.56 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.663 -177.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.429 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 67.42 34.77 4.56 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 124.056 0.943 . . . . 0.0 109.813 -177.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.426 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 64.5 tt0 -59.67 -51.18 82.8 Favored Pre-proline 0 CA--C 1.553 1.084 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.496 177.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.426 ' HD3' ' HB3' ' A' ' 70' ' ' GLN . 4.4 Cg_endo -83.24 114.4 2.17 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 121.156 1.238 . . . . 0.0 110.025 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 38.7 t-105 -125.68 143.08 51.19 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 120.983 0.42 . . . . 0.0 110.215 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -127.54 -61.25 1.14 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 175.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -178.49 65.88 0.08 OUTLIER Glycine 0 CA--C 1.486 -1.758 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 177.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -82.32 130.36 59.78 Favored Pre-proline 0 C--N 1.297 -1.685 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -175.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.57 159.54 32.05 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.256 1.97 . . . . 0.0 113.096 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.6 p -66.22 -14.8 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 121.828 0.823 . . . . 0.0 110.392 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -68.73 -13.49 62.41 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.89 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.434 ' HB3' ' HG2' ' A' ' 65' ' ' PRO . 81.9 mm-40 -89.44 -25.27 21.58 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 121.04 0.447 . . . . 0.0 110.305 176.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.447 HD23 ' HD3' ' A' ' 65' ' ' PRO . 69.3 mt -74.92 -22.66 58.48 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.793 0.806 . . . . 0.0 109.156 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.434 HG13 HD12 ' A' ' 36' ' ' LEU . 98.1 t -100.4 127.36 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 174.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.499 ' NE ' ' HA ' ' A' ' 82' ' ' ARG . 3.5 mmp_? -107.32 139.88 41.11 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.941 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -116.1 122.71 45.94 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.248 0.547 . . . . 0.0 110.522 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -129.3 128.27 42.84 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.406 ' H ' HD23 ' A' ' 85' ' ' LEU . 0.9 OUTLIER -96.37 138.28 34.2 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 118.901 -1.12 . . . . 0.0 111.017 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.7 mt -102.56 119.12 50.47 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.079 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -101.64 143.88 31.05 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -176.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.475 ' HB ' HG23 ' A' ' 93' ' ' VAL . 4.2 t -127.69 120.28 27.67 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-O 121.569 0.7 . . . . 0.0 110.229 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -140.67 -154.84 6.33 Favored Glycine 0 N--CA 1.435 -1.433 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.25 -15.82 28.34 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.118 1.878 . . . . 0.0 111.029 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -72.71 -27.89 62.33 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.415 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 122.83 -153.89 16.99 Favored Glycine 0 N--CA 1.426 -2.025 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -175.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.475 HG23 ' HB ' ' A' ' 88' ' ' THR . 13.2 p -118.27 132.56 67.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.32 157.72 36.19 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.109 -178.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 98' ' ' CYS . 85.6 mt -72.42 140.55 17.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -78.85 128.72 33.72 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 108.69 -54.4 0.55 Allowed Glycine 0 N--CA 1.437 -1.237 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.471 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 49.7 t -139.88 121.92 9.89 Favored Pre-proline 0 N--CA 1.414 -2.273 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 176.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -73.09 -53.7 0.13 Allowed 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 121.741 1.628 . . . . 0.0 110.535 -177.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.2 t 156.21 -83.99 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 129.004 2.922 . . . . 0.0 103.263 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.652 ' HB2' ' HD3' ' A' ' 102' ' ' PRO . 45.7 mt-10 -144.5 -59.55 0.02 OUTLIER Pre-proline 0 N--CA 1.435 -1.202 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 173.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.652 ' HD3' ' HB2' ' A' ' 101' ' ' GLU . 16.6 Cg_endo -101.29 -172.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 121.345 1.363 . . . . 0.0 110.457 171.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -105.97 125.65 51.25 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 173.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.491 ' CD1' ' HB3' ' A' ' 110' ' ' LEU . 97.2 m-85 -84.59 172.64 11.43 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -172.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -101.4 -23.98 9.18 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.218 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.2 m -145.98 160.27 42.09 Favored 'General case' 0 C--O 1.247 0.954 0 O-C-N 122.289 -0.536 . . . . 0.0 110.658 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.92 -48.03 82.26 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 123.356 0.662 . . . . 0.0 112.589 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 m -54.61 -31.95 57.99 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.005 0.522 . . . . 0.0 112.02 -175.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.612 ' O ' ' HG2' ' A' ' 113' ' ' GLN . . . -63.8 -51.71 63.55 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.426 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.491 ' HB3' ' CD1' ' A' ' 104' ' ' PHE . 4.3 pp -70.2 -27.67 64.68 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.711 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.77 -53.22 44.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.742 178.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.1 t -64.35 -29.59 70.65 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.566 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.612 ' HG2' ' O ' ' A' ' 109' ' ' ALA . 81.3 mm-40 -68.01 -33.89 75.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.778 0.323 . . . . 0.0 110.905 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -82.1 -0.02 42.73 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 26.0 m -85.45 -21.73 28.6 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 172.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 67.6 mt -106.14 -49.1 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.653 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.2 m -120.43 102.12 45.73 Favored Pre-proline 0 C--N 1.302 -1.486 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.429 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.33 84.82 1.64 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.351 2.034 . . . . 0.0 109.942 175.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 72.5 mt -87.79 -67.53 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.935 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.2 m -85.03 -11.25 55.8 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.435 0.636 . . . . 0.0 110.936 -176.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 76.2 mt -120.16 137.89 26.48 Favored Pre-proline 0 N--CA 1.429 -1.479 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.493 -175.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -64.48 -34.03 54.98 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.621 2.214 . . . . 0.0 112.341 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 66.2 m -111.61 157.16 20.73 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 9.9 p -81.53 143.59 31.92 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 72.0 mt -78.01 119.12 21.0 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 123.109 0.256 . . . . 0.0 111.612 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -94.97 105.78 17.72 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 175.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.509 HG22 ' H ' ' A' ' 129' ' ' SER . 50.9 mt -78.0 121.87 84.65 Favored Pre-proline 0 C--N 1.301 -1.533 0 CA-C-N 115.305 -0.862 . . . . 0.0 112.063 -171.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -84.81 4.94 6.54 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 123.471 2.781 . . . . 0.0 112.513 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.545 ' HA ' ' CG ' ' A' ' 21' ' ' PHE . 13.9 m -72.69 85.65 1.2 Allowed 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.172 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -77.22 -166.53 0.74 Allowed 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 112.071 -2.331 . . . . 0.0 111.365 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.7 t70 . . . . . 0 C--N 1.289 -2.022 0 CA-C-N 114.172 -1.377 . . . . 0.0 107.657 179.866 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 ttm . . . . . 0 C--O 1.244 0.791 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 62.7 t-80 -96.48 131.18 43.34 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 104.443 -2.428 . . . . 0.0 104.443 174.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 0.262 39.4 m-70 -72.31 -21.19 61.37 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -173.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -84.99 89.92 7.71 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 103.83 -2.656 . . . . 0.0 103.83 164.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.432 ' HD1' ' CD2' ' A' ' 7' ' ' HIS . 9.7 t-80 -68.49 121.43 16.34 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.88 0.848 . . . . 0.0 112.738 -166.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -78.31 91.99 4.48 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.734 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.432 ' CD2' ' HD1' ' A' ' 5' ' ' HIS . 58.8 m80 -79.53 -83.56 0.09 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.681 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t 51.86 -102.98 0.14 Allowed 'General case' 0 C--O 1.253 1.284 0 O-C-N 124.303 1.002 . . . . 0.0 109.721 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.9 m 42.88 -148.62 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.466 1.107 . . . . 0.0 112.208 174.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.01 40.83 2.45 Favored Glycine 0 N--CA 1.427 -1.938 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 174.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.1 tt -95.91 -50.08 5.03 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.589 ' HB ' ' HD3' ' A' ' 13' ' ' PRO . 93.4 t -68.02 -58.89 7.12 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.47 176.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.589 ' HD3' ' HB ' ' A' ' 12' ' ' VAL . 23.9 Cg_endo -86.08 105.47 0.78 Allowed 'Trans proline' 0 C--N 1.371 1.715 0 N-CA-C 106.756 -2.055 . . . . 0.0 106.756 167.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -60.79 100.14 0.1 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -168.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -123.18 10.84 8.71 Favored Glycine 0 C--N 1.315 -0.627 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.8 p -106.15 22.92 14.9 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.517 -0.842 . . . . 0.0 110.79 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -55.71 106.85 0.28 Allowed 'General case' 0 N--CA 1.426 -1.673 0 C-N-CA 125.568 1.547 . . . . 0.0 110.982 -175.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.417 ' HA ' ' CE1' ' A' ' 21' ' ' PHE . 26.8 p 63.73 11.99 6.28 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 126.038 1.735 . . . . 0.0 112.977 175.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.2 m -101.11 -37.81 8.42 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.279 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -13.09 58.05 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.417 ' CE1' ' HA ' ' A' ' 18' ' ' THR . 96.9 m-85 -64.0 -50.79 67.14 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.232 0.539 . . . . 0.0 110.18 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.408 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 46.5 p-90 -109.89 -19.03 13.26 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -175.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -95.94 113.79 25.45 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.436 0.636 . . . . 0.0 111.61 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.81 94.55 5.43 Favored Pre-proline 0 C--N 1.303 -1.427 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.437 173.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -78.16 2.95 7.5 Favored 'Trans proline' 0 C--O 1.223 -0.24 0 C-N-CA 123.447 2.765 . . . . 0.0 115.23 -171.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -97.21 -3.22 41.25 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.066 -0.653 . . . . 0.0 111.885 -177.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.413 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 76.2 mt -91.42 134.03 34.97 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 120.946 0.403 . . . . 0.0 110.168 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.0 t -90.66 177.83 6.24 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.272 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -48.31 -57.48 5.94 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.863 1.265 . . . . 0.0 111.162 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.63 -32.03 73.38 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.829 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -75.55 -37.3 60.09 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.085 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.13 -42.63 95.21 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.603 0.716 . . . . 0.0 109.751 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 78.7 mt -66.57 -40.85 87.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.365 177.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.76 -27.32 67.88 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.522 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.4 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 4.5 mm? -81.29 -53.1 6.63 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 172.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.489 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 52.7 mt -61.89 -24.5 66.98 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -174.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -57.23 -35.53 69.81 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -102.22 6.66 40.76 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.637 0.732 . . . . 0.0 110.546 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 35' ' ' LEU . 75.6 mmtt -94.4 156.63 16.4 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.988 177.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.72 149.16 56.41 Favored Pre-proline 0 C--N 1.296 -1.757 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.6 -176.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 61' ' ' LYS . 78.3 Cg_exo -53.34 118.94 5.39 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.634 2.223 . . . . 0.0 111.098 175.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.94 -22.18 6.85 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -176.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.51 147.05 36.01 Favored 'General case' 0 C--O 1.247 0.926 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.451 ' CD1' HD22 ' A' ' 125' ' ' LEU . 33.0 p90 -150.6 165.59 32.88 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -175.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -151.72 150.9 30.72 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.408 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 57.7 mt -116.26 127.14 73.95 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.413 ' HD2' ' O ' ' A' ' 27' ' ' LEU . 50.1 ptt85 -125.44 170.98 10.86 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.92 -176.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -88.63 136.78 32.82 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 176.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.3 m -116.8 123.52 47.32 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 121.411 0.624 . . . . 0.0 112.345 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -84.88 80.51 9.25 Favored 'General case' 0 CA--C 1.487 -1.454 0 CA-C-O 122.304 1.05 . . . . 0.0 108.316 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.3 t -142.28 -62.24 0.44 Allowed 'General case' 0 C--N 1.268 -2.966 0 CA-C-N 113.128 -1.851 . . . . 0.0 107.271 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -126.83 161.77 27.43 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -78.51 121.12 24.17 Favored 'General case' 0 C--O 1.254 1.339 0 CA-C-O 121.182 0.515 . . . . 0.0 110.827 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.7 46.59 9.53 Favored Glycine 0 N--CA 1.437 -1.297 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.68 116.31 22.17 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 121.222 0.534 . . . . 0.0 109.738 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -103.12 118.29 36.47 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.39 122.47 6.48 Favored Glycine 0 C--N 1.277 -2.733 0 C-N-CA 119.839 -1.172 . . . . 0.0 111.239 -177.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 31.7 tp -93.94 124.55 38.02 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.64 121.32 44.76 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 60.3 tp -116.88 126.46 53.04 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 123.039 0.536 . . . . 0.0 110.501 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 21.9 tptm -89.0 115.68 26.74 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.7 m -110.11 170.36 3.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.58 -59.56 3.26 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.6 p -157.66 140.36 10.66 Favored Pre-proline 0 C--N 1.311 -1.071 0 C-N-CA 124.396 1.078 . . . . 0.0 108.204 177.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.647 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 31.3 Cg_exo -59.75 -44.14 33.27 Favored 'Trans proline' 0 CA--C 1.573 2.448 0 C-N-CA 121.999 1.799 . . . . 0.0 111.937 173.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.647 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 78.3 Cg_endo -70.89 154.17 63.4 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.402 2.068 . . . . 0.0 109.02 169.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.42 -47.56 1.0 Allowed 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 121.98 1.787 . . . . 0.0 112.11 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.4 p -103.06 -43.92 5.36 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.004 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.546 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 67.89 23.12 8.46 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.524 1.13 . . . . 0.0 110.602 -177.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -65.25 -47.16 71.73 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.42 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -57.99 120.82 8.97 Favored 'Trans proline' 0 C--N 1.376 1.992 0 N-CA-C 106.436 -2.179 . . . . 0.0 106.436 165.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -34.71 127.74 0.48 Allowed 'General case' 0 C--O 1.243 0.742 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -166.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -139.31 73.49 1.43 Allowed 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 113.899 -1.5 . . . . 0.0 108.88 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.96 48.06 1.0 Allowed Glycine 0 C--N 1.289 -2.047 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 175.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -98.8 146.62 31.96 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -176.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -50.24 157.43 3.07 Favored 'Trans proline' 0 C--O 1.246 0.919 0 C-N-CA 123.527 2.818 . . . . 0.0 114.011 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.5 p -61.94 -11.65 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.851 -178.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -62.03 -27.64 69.02 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 122.833 0.453 . . . . 0.0 110.687 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.47 ' HG2' ' HG2' ' A' ' 65' ' ' PRO . 7.7 tt0 -79.1 -33.59 44.27 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.019 0.438 . . . . 0.0 109.904 177.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.8 mt -72.15 -20.11 61.66 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.468 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 81.7 t -94.12 118.96 41.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 173.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -99.3 129.06 45.49 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 -178.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -106.43 122.92 47.25 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-O 121.28 0.562 . . . . 0.0 111.089 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -130.08 131.11 45.63 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 176.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.2 pp -102.99 140.6 37.05 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 118.32 -1.352 . . . . 0.0 111.584 -175.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.545 HG12 HG12 ' A' ' 95' ' ' ILE . 63.8 mt -102.18 126.1 56.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.587 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.524 ' OE2' ' HE2' ' A' ' 96' ' ' LYS . 38.5 mt-10 -103.53 146.02 29.15 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 92' ' ' GLY . 4.6 t -130.27 128.73 42.17 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 170.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.77 -137.22 2.22 Favored Glycine 0 N--CA 1.427 -1.95 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.829 -177.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.44 1.93 7.4 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.302 2.668 . . . . 0.0 113.721 -175.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -112.34 -20.6 11.76 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.722 0.772 . . . . 0.0 111.714 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 121.98 -154.26 16.76 Favored Glycine 0 CA--C 1.485 -1.819 0 N-CA-C 108.021 -2.032 . . . . 0.0 108.021 -177.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.5 p -107.92 127.1 64.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.59 ' HG2' ' CD2' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -158.02 151.54 23.52 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -172.713 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.545 HG12 HG12 ' A' ' 86' ' ' ILE . 60.3 mt -83.35 133.39 29.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.85 -177.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.524 ' HE2' ' OE2' ' A' ' 87' ' ' GLU . 18.2 ttmm -90.38 140.79 29.37 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.039 176.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.99 3.29 24.83 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -177.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 52.7 t -143.04 140.93 18.5 Favored Pre-proline 0 N--CA 1.422 -1.836 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 98' ' ' CYS . 19.4 Cg_endo -99.5 -2.49 0.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.539 2.159 . . . . 0.0 111.526 174.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.2 m -100.37 -10.28 21.38 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.396 -174.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 8.1 tp10 -74.41 127.16 88.04 Favored Pre-proline 0 N--CA 1.426 -1.651 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -174.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 101' ' ' GLU . 6.1 Cg_exo -73.75 -177.4 3.11 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.376 2.051 . . . . 0.0 112.051 177.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.59 ' CD2' ' HG2' ' A' ' 94' ' ' LYS . 83.6 m-85 -110.88 119.1 37.96 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -106.14 174.49 5.86 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.645 -176.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -97.91 -39.87 3.71 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.913 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 51.1 m -128.45 162.17 27.8 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.73 -37.35 87.3 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 120.9 0.381 . . . . 0.0 110.271 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.0 m -51.59 -35.22 40.57 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.494 1.117 . . . . 0.0 112.04 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.67 -43.43 76.2 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.606 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 pp -74.55 -29.09 61.23 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.976 0.417 . . . . 0.0 111.175 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 75.6 t -64.77 -51.54 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.964 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.3 t -69.04 -31.97 71.14 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.427 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -63.98 -40.8 97.22 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.662 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.572 ' CD2' ' HA ' ' A' ' 118' ' ' PRO . 30.9 m80 -73.7 -3.88 30.96 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.9 m -82.8 -29.85 29.27 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 171.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.7 mt -90.83 -53.01 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.901 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.6 m -135.33 106.3 10.17 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.572 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 48.0 Cg_endo -78.73 100.9 1.4 Allowed 'Trans proline' 0 N--CA 1.437 -1.823 0 C-N-CA 121.413 1.409 . . . . 0.0 111.171 176.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 68.6 mt -84.07 -65.08 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.798 -176.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.7 m -85.98 -28.54 24.16 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.315 0.578 . . . . 0.0 111.415 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 63.6 mt -93.47 133.37 28.39 Favored Pre-proline 0 C--N 1.293 -1.868 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.146 -176.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.0 -13.47 31.57 Favored 'Trans proline' 0 N--CA 1.482 0.798 0 C-N-CA 123.092 2.528 . . . . 0.0 112.497 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 43.9 t -123.92 148.52 46.8 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.508 ' SG ' ' HG3' ' A' ' 118' ' ' PRO . 45.6 m -73.29 147.16 44.78 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.451 HD22 ' CD1' ' A' ' 44' ' ' PHE . 44.5 mt -78.5 114.14 17.15 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.294 0.569 . . . . 0.0 111.452 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -97.17 96.64 8.57 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.1 mp -62.64 129.86 93.15 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -52.63 -42.97 58.85 Favored 'Trans proline' 0 C--N 1.36 1.172 0 C-N-CA 123.176 2.584 . . . . 0.0 112.67 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 20.4 m 59.05 11.79 2.13 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.039 1.336 . . . . 0.0 113.69 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -160.45 128.02 4.47 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 . . . . . 0 C--N 1.305 -1.366 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.406 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.3 mmm . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -121.26 139.76 52.97 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -116.76 171.34 7.95 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.623 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -84.14 110.01 18.17 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.492 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -80.67 -52.2 7.83 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 176.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -137.34 27.79 2.81 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 69.7 m80 68.13 -66.5 0.22 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.805 1.242 . . . . 0.0 110.227 -171.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.7 m -83.93 85.97 7.24 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 172.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.0 m -93.93 95.35 9.01 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.163 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.96 97.78 2.51 Favored Glycine 0 N--CA 1.427 -1.904 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -173.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.6 mt -75.82 105.79 7.04 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.33 0.586 . . . . 0.0 110.583 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.9 m -92.07 117.57 67.76 Favored Pre-proline 0 C--N 1.294 -1.818 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.167 175.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.31 -9.78 20.47 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 123.306 2.671 . . . . 0.0 113.83 -174.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.2 ptt180 -134.37 143.06 47.42 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 121.186 0.517 . . . . 0.0 111.896 -177.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -129.79 19.59 5.24 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.9 m -83.73 -15.19 49.55 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 122.087 0.946 . . . . 0.0 110.798 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -108.75 96.53 6.4 Favored 'General case' 0 C--N 1.268 -2.977 0 CA-C-N 113.727 -1.579 . . . . 0.0 109.029 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.3 p -95.53 -14.81 23.32 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.603 -171.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.9 m -68.97 -35.49 76.81 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.587 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.04 -11.09 45.89 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -177.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -76.22 -25.65 55.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.961 0.41 . . . . 0.0 110.264 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.529 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 37.0 p-90 -125.83 -26.1 3.53 Favored 'General case' 0 C--O 1.208 -1.082 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -176.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -84.43 111.29 19.33 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.599 -0.688 . . . . 0.0 111.022 -176.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -134.71 85.09 37.16 Favored Pre-proline 0 C--N 1.313 -0.978 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.48 -8.14 17.09 Favored 'Trans proline' 0 C--N 1.333 -0.264 0 C-N-CA 122.327 2.018 . . . . 0.0 113.538 -173.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -93.69 -5.36 48.71 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.318 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.8 tp -94.51 126.96 40.13 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -173.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.5 m -83.85 173.9 10.86 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.068 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -52.21 -55.28 22.13 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.23 1.012 . . . . 0.0 112.506 -175.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -55.7 -44.73 77.68 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.835 0.826 . . . . 0.0 110.684 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -73.39 -31.49 63.93 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 113.828 -1.533 . . . . 0.0 111.17 -174.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.39 74.76 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.447 0.641 . . . . 0.0 110.083 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 76.7 mt -68.13 -37.64 78.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.824 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.61 -32.48 70.45 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.645 175.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.432 ' O ' ' HB3' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -76.47 -47.86 21.52 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.28 -178.112 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.44 HD13 HD22 ' A' ' 45' ' ' LEU . 5.7 mp -75.2 -16.54 60.48 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -177.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -80.17 -8.82 59.61 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.326 174.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 35' ' ' LEU . 5.1 t70 -91.14 -41.2 11.15 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.017 177.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -91.59 179.56 5.62 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -176.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -86.86 153.45 54.89 Favored Pre-proline 0 C--N 1.31 -1.118 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 -172.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.09 122.78 12.15 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 122.24 1.96 . . . . 0.0 109.946 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.93 -24.89 5.36 Favored Glycine 0 N--CA 1.42 -2.378 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -175.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.8 148.93 39.88 Favored 'General case' 0 C--O 1.248 0.991 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.408 ' CE1' ' HB3' ' A' ' 125' ' ' LEU . 34.1 p90 -149.12 167.05 26.96 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -178.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.44 HD22 HD13 ' A' ' 36' ' ' LEU . 1.8 pt? -152.58 151.98 31.29 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 174.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.529 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 55.4 mt -113.12 113.34 43.77 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.1 ptt-85 -109.3 -173.82 2.36 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -90.48 129.46 36.65 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 172.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.1 t -82.65 107.45 15.29 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -78.29 75.04 4.82 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 122.459 1.123 . . . . 0.0 110.77 -175.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.3 m -150.61 -45.71 0.12 Allowed 'General case' 0 C--N 1.267 -2.989 0 CA-C-N 113.613 -1.63 . . . . 0.0 108.901 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -131.01 154.38 48.25 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -84.3 121.63 27.78 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.91 37.46 7.28 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.08 119.89 21.61 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.415 ' HB3' ' CG2' ' A' ' 46' ' ' ILE . 63.6 m-85 -97.97 136.58 38.05 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -101.88 106.76 3.06 Favored Glycine 0 C--N 1.286 -2.218 0 C-N-CA 120.324 -0.941 . . . . 0.0 110.984 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -85.14 117.87 24.36 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 82' ' ' ARG . . . -115.03 125.67 53.84 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.9 tp -120.7 127.1 51.72 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 123.958 0.786 . . . . 0.0 109.446 -177.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -88.96 114.74 25.91 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.447 HG12 ' SG ' ' A' ' 123' ' ' CYS . 33.3 m -104.25 169.37 2.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.219 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.88 -43.38 25.1 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 p -160.89 123.01 1.74 Allowed Pre-proline 0 C--N 1.32 -0.707 0 C-N-CA 124.93 1.292 . . . . 0.0 109.534 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.653 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 23.9 Cg_exo -64.85 -47.49 5.0 Favored 'Trans proline' 0 CA--C 1.566 2.101 0 C-N-CA 121.916 1.744 . . . . 0.0 112.232 172.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.714 ' HG2' ' HB2' ' A' ' 69' ' ' ALA . 58.1 Cg_endo -71.79 134.17 23.32 Favored 'Trans proline' 0 C--N 1.384 2.425 0 C-N-CA 121.626 1.551 . . . . 0.0 109.959 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.88 -24.47 33.86 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.806 2.337 . . . . 0.0 113.01 -176.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.4 t -115.38 -37.8 3.95 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.714 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 64.34 32.06 12.41 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.957 0.903 . . . . 0.0 112.965 174.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -63.03 -46.17 86.79 Favored Pre-proline 0 CA--C 1.557 1.234 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -56.4 123.04 12.87 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 121.804 1.669 . . . . 0.0 112.089 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -108.88 132.43 54.05 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.051 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -147.26 7.87 0.91 Allowed 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 124.413 1.085 . . . . 0.0 109.536 177.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.54 117.63 0.76 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -172.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -108.74 107.23 59.91 Favored Pre-proline 0 C--N 1.296 -1.742 0 CA-C-O 121.333 0.587 . . . . 0.0 111.256 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -85.42 148.15 10.05 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.12 1.88 . . . . 0.0 109.972 174.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.2 p -53.37 -25.54 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 123.612 0.765 . . . . 0.0 112.722 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -70.71 -27.02 63.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.237 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.2 -31.55 62.69 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.35 -4.48 33.63 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.493 -177.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 73.6 t -91.89 119.13 38.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 6.2 mmp_? -93.26 149.57 21.13 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -129.06 122.91 30.97 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.896 0.379 . . . . 0.0 111.052 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -133.28 128.36 35.62 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.505 HD23 ' H ' ' A' ' 85' ' ' LEU . 1.6 pt? -99.04 140.38 33.27 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.582 -1.247 . . . . 0.0 112.711 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.422 HG12 HG12 ' A' ' 95' ' ' ILE . 86.0 mt -104.05 119.34 52.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 114.066 -1.425 . . . . 0.0 107.579 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -99.35 144.34 28.57 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.471 ' HB ' HG12 ' A' ' 93' ' ' VAL . 8.8 t -129.33 153.06 48.22 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.28 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.19 -142.77 4.41 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.38 -22.36 29.34 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.559 2.172 . . . . 0.0 112.742 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -73.51 -50.36 21.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.871 0.843 . . . . 0.0 109.793 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 150.89 -125.08 1.83 Allowed Glycine 0 N--CA 1.422 -2.288 0 N-CA-C 107.505 -2.238 . . . . 0.0 107.505 -177.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.471 HG12 ' HB ' ' A' ' 88' ' ' THR . 16.9 m -127.31 139.49 51.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 175.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.93 145.09 24.61 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.067 -0.396 . . . . 0.0 110.983 177.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.422 HG12 HG12 ' A' ' 86' ' ' ILE . 60.3 mt -75.79 140.58 17.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -57.47 -52.85 63.71 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -105.41 52.33 0.72 Allowed Glycine 0 CA--C 1.495 -1.189 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.821 -174.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.432 ' HA ' ' OG ' ' A' ' 120' ' ' SER . 6.7 p -86.52 123.06 71.64 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 123.764 0.332 . . . . 0.0 111.717 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -65.35 -32.12 51.14 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.644 2.229 . . . . 0.0 113.09 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.3 m -145.4 -19.14 0.48 Allowed 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.6 ' OE2' ' HB ' ' A' ' 119' ' ' ILE . 12.9 mp0 -54.5 128.66 61.04 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -176.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -85.33 -161.35 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.766 2.311 . . . . 0.0 110.572 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -87.19 129.42 34.96 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -103.74 161.49 13.88 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.64 -56.44 2.37 Favored Glycine 0 C--N 1.297 -1.584 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.295 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.9 m -116.05 151.46 35.49 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.07 -35.88 72.01 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.021 0.528 . . . . 0.0 110.671 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 m -51.86 -34.89 42.91 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.647 1.179 . . . . 0.0 112.119 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.84 -42.88 76.57 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.413 -176.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 111' ' ' VAL . 4.4 pp -73.49 -38.83 65.26 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.179 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.461 ' N ' HD12 ' A' ' 110' ' ' LEU . 75.2 t -59.81 -46.06 94.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.398 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.0 p -69.57 -37.97 77.22 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -79.85 -28.33 40.06 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.567 -176.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -77.28 -0.1 24.14 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.6 m -80.44 -18.47 48.7 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 170.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 64.7 mt -108.93 -59.53 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.795 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.9 m -113.97 99.43 50.39 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.539 -177.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -90.7 107.57 0.32 Allowed 'Trans proline' 0 N--CA 1.443 -1.486 0 C-N-CA 122.895 2.397 . . . . 0.0 110.919 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.6 ' HB ' ' OE2' ' A' ' 101' ' ' GLU . 25.9 mt -95.18 -64.33 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.432 ' OG ' ' HA ' ' A' ' 98' ' ' CYS . 52.2 m -66.43 -35.39 80.18 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.42 0.629 . . . . 0.0 111.068 174.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -82.65 136.18 45.43 Favored Pre-proline 0 N--CA 1.439 -1.013 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.663 -176.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.97 -19.15 30.72 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.574 2.183 . . . . 0.0 112.256 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.447 ' SG ' HG12 ' A' ' 62' ' ' VAL . 28.5 p -144.13 163.63 33.03 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 25.3 p -71.23 157.69 37.69 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.381 0.61 . . . . 0.0 112.479 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.408 ' HB3' ' CE1' ' A' ' 44' ' ' PHE . 64.8 mt -83.64 115.16 22.02 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.212 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -94.81 104.31 16.22 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.0 mp -69.18 120.98 80.26 Favored Pre-proline 0 C--N 1.317 -0.819 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -45.26 -50.43 9.01 Favored 'Trans proline' 0 C--N 1.36 1.164 0 C-N-CA 123.436 2.758 . . . . 0.0 113.091 -177.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.9 m 58.95 18.26 6.07 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.206 1.002 . . . . 0.0 111.443 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.439 ' HD3' ' C ' ' A' ' 130' ' ' LYS . 12.1 tmtt? -144.69 132.49 21.23 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 33.9 t70 . . . . . 0 C--N 1.294 -1.804 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.262 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.9 mmm . . . . . 0 CA--C 1.502 -0.87 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -131.64 170.32 14.93 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 123.637 0.775 . . . . 0.0 109.213 177.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.4 p80 -96.67 -21.09 17.82 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.137 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -136.26 143.21 44.13 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 177.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -124.68 167.63 14.28 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.752 -176.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -96.45 108.7 21.29 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 176.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -82.09 125.84 31.32 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.345 -175.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.9 m -126.27 155.3 42.14 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.356 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.6 m -94.77 98.28 10.65 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.17 80.08 0.68 Allowed Glycine 0 N--CA 1.429 -1.83 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.512 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -157.46 167.43 30.23 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 p -115.58 105.95 51.16 Favored Pre-proline 0 C--N 1.295 -1.787 0 CA-C-O 121.14 0.495 . . . . 0.0 110.889 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.61 114.46 3.31 Favored 'Trans proline' 0 C--O 1.247 0.961 0 C-N-CA 122.44 2.094 . . . . 0.0 110.266 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 63.9 mtt85 -92.18 173.2 7.95 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.504 -176.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.22 53.35 4.76 Favored Glycine 0 CA--C 1.487 -1.699 0 N-CA-C 114.384 0.514 . . . . 0.0 114.384 -171.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.2 m 50.89 53.32 13.23 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 124.413 1.085 . . . . 0.0 111.529 176.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -74.32 90.68 2.14 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.535 0.683 . . . . 0.0 110.325 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.8 p -109.92 -10.74 14.72 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -174.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.9 t -64.66 -44.65 89.73 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.288 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -4.53 3.53 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -81.95 -35.77 28.69 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.318 0.58 . . . . 0.0 109.511 174.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.434 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 44.7 p-90 -109.46 -28.17 9.06 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -91.32 119.33 31.26 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.55 0.691 . . . . 0.0 110.734 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.42 99.15 5.87 Favored Pre-proline 0 C--N 1.297 -1.683 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.657 172.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.22 -25.11 26.82 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 123.006 2.471 . . . . 0.0 113.629 -171.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -93.96 13.32 23.16 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.433 -173.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.9 tp -92.02 145.52 24.46 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.7 t -99.47 172.31 7.4 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.215 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -55.89 -53.34 57.96 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.299 1.04 . . . . 0.0 112.005 -174.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -67.5 -33.96 76.17 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.1 0.476 . . . . 0.0 111.25 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -70.68 -33.11 70.57 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.221 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.6 -40.67 97.54 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.751 0.786 . . . . 0.0 109.506 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 70.0 mt -69.22 -37.56 76.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 114.755 -1.112 . . . . 0.0 109.582 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.51 -33.8 64.07 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.06 177.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.507 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 4.6 mm? -78.7 -55.73 4.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.105 0.479 . . . . 0.0 110.259 174.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 47.2 mt -59.75 -28.91 67.79 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -174.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -64.55 -28.07 69.39 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.924 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -95.9 -21.61 17.96 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.23 0.538 . . . . 0.0 110.475 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' A' ' 35' ' ' LEU . 26.2 mtpp -77.91 150.34 34.09 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-O 121.021 0.439 . . . . 0.0 110.818 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -75.05 151.36 86.14 Favored Pre-proline 0 C--N 1.309 -1.187 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.566 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -52.1 121.99 9.8 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 123.429 2.753 . . . . 0.0 112.839 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.81 -23.36 7.03 Favored Glycine 0 N--CA 1.432 -1.627 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.2 145.08 44.45 Favored 'General case' 0 C--O 1.246 0.913 0 O-C-N 124.057 0.504 . . . . 0.0 110.513 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.493 ' CG ' HD11 ' A' ' 125' ' ' LEU . 12.7 p90 -142.83 171.96 13.34 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.34 -176.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -158.49 152.8 24.17 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 172.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.434 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 55.8 mt -125.3 134.01 67.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.4 ptt-85 -133.38 -178.69 5.1 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -83.2 147.87 27.77 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.2 m -78.16 139.81 38.99 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.157 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -84.96 -36.07 21.62 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.9 m -69.2 -46.79 66.59 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.738 -176.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -131.1 146.41 52.35 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -87.11 148.97 25.0 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.67 23.05 70.96 Favored Glycine 0 CA--C 1.499 -0.962 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.59 137.1 43.45 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -110.52 121.85 46.32 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.68 114.56 3.95 Favored Glycine 0 N--CA 1.424 -2.112 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.276 -176.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 42.6 tp -94.0 123.62 37.48 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -112.91 122.15 46.78 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 176.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.4 tp -115.65 128.69 56.1 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.42 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 22.0 tptm -88.72 114.82 25.75 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 80' ' ' LEU . 29.3 m -108.61 171.73 2.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.76 -51.56 12.39 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.6 p -151.63 125.72 4.44 Favored Pre-proline 0 N--CA 1.431 -1.414 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.244 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.65 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 34.9 Cg_exo -60.1 -45.68 22.51 Favored 'Trans proline' 0 CA--C 1.577 2.652 0 C-N-CA 121.859 1.706 . . . . 0.0 111.506 169.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.65 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 46.5 Cg_endo -63.72 161.17 33.32 Favored 'Trans proline' 0 C--N 1.391 2.778 0 C-N-CA 122.934 2.423 . . . . 0.0 110.054 171.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.33 -40.89 45.64 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.42 2.08 . . . . 0.0 112.831 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.1 p -137.57 -17.97 1.27 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.435 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 65.33 33.47 9.02 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.059 0.944 . . . . 0.0 111.513 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -65.49 -45.7 68.84 Favored Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.452 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -74.29 103.72 1.73 Allowed 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 121.119 1.213 . . . . 0.0 109.148 169.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 56.0 t-105 -107.8 143.67 36.05 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.12 -175.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -134.93 8.72 3.52 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.77 51.23 4.11 Favored Glycine 0 CA--C 1.49 -1.48 0 C-N-CA 119.726 -1.226 . . . . 0.0 110.37 -175.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -91.32 119.09 68.77 Favored Pre-proline 0 N--CA 1.437 -1.107 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -49.66 146.66 14.86 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.818 3.012 . . . . 0.0 115.168 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.485 HG23 HD12 ' A' ' 80' ' ' LEU . 7.5 p -60.13 -21.03 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 CA-C-O 122.23 1.014 . . . . 0.0 109.794 174.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -69.65 -20.14 63.6 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.359 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -90.31 -7.86 52.31 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.651 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.485 HD12 HG23 ' A' ' 77' ' ' VAL . 80.2 mt -83.53 -6.23 59.39 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 122.091 0.948 . . . . 0.0 108.844 177.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.8 t -85.87 134.25 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.27 174.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -111.05 130.7 55.52 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -109.71 122.86 48.44 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.049 0.452 . . . . 0.0 111.522 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -133.27 147.75 51.93 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 177.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -119.05 131.06 55.93 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 118.709 -1.196 . . . . 0.0 112.314 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.55 HG12 HG12 ' A' ' 95' ' ' ILE . 78.8 mt -87.7 118.23 33.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 178.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.558 ' OE1' ' HE2' ' A' ' 96' ' ' LYS . 39.8 mt-10 -98.97 138.9 35.41 Favored 'General case' 0 C--N 1.27 -2.867 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.539 ' HB ' HG12 ' A' ' 93' ' ' VAL . 7.2 t -120.43 116.66 25.89 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-O 121.989 0.899 . . . . 0.0 109.929 178.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -125.84 -166.69 12.33 Favored Glycine 0 N--CA 1.416 -2.651 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.483 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -68.49 -11.47 32.03 Favored 'Trans proline' 0 C--N 1.331 -0.351 0 C-N-CA 122.949 2.433 . . . . 0.0 113.173 -176.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.529 ' HD3' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -97.06 -17.16 20.16 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.911 179.513 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 136.19 -164.07 25.07 Favored Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -177.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.539 HG12 ' HB ' ' A' ' 88' ' ' THR . 8.3 m -104.97 148.41 9.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.492 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -164.81 157.89 16.89 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.233 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.661 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 60.5 mt -92.27 131.95 37.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.627 0.727 . . . . 0.0 112.008 -174.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.558 ' HE2' ' OE1' ' A' ' 87' ' ' GLU . 22.3 ttmm -88.78 132.87 34.44 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 172.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.49 7.1 7.71 Favored Glycine 0 C--N 1.308 -1.027 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -172.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.415 ' SG ' HG22 ' A' ' 119' ' ' ILE . 42.3 t -142.42 142.36 23.39 Favored Pre-proline 0 N--CA 1.428 -1.567 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -87.73 -13.92 3.84 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.264 1.976 . . . . 0.0 113.244 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.0 m -85.79 -82.76 0.18 Allowed 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.661 ' HG3' ' O ' ' A' ' 95' ' ' ILE . 28.2 mm-40 46.95 97.26 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 117.603 2.445 . . . . 0.0 117.603 174.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -81.63 147.79 15.72 Favored 'Trans proline' 0 N--CA 1.437 -1.845 0 C-N-CA 122.015 1.81 . . . . 0.0 108.926 172.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -76.98 123.38 26.25 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.6 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.429 ' CE2' ' HB3' ' A' ' 110' ' ' LEU . 59.9 m-85 -103.54 164.38 11.7 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.18 -53.5 2.49 Favored Glycine 0 C--N 1.305 -1.156 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.625 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 61.9 m -116.04 160.73 19.89 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 122.918 -0.166 . . . . 0.0 110.977 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.33 -35.17 79.5 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.938 0.399 . . . . 0.0 110.985 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -55.26 -30.82 60.84 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 123.912 0.885 . . . . 0.0 111.479 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.33 -49.33 69.85 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.419 -178.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.589 ' H ' HD13 ' A' ' 110' ' ' LEU 0.293 0.0 OUTLIER -72.52 -28.58 62.95 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.972 -179.78 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 73.4 t -63.65 -49.42 82.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 123.656 0.598 . . . . 0.0 110.076 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.0 t -68.45 -37.88 80.62 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.044 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -75.22 -40.57 59.0 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.472 ' HA ' ' O ' ' A' ' 117' ' ' SER . 25.4 m80 -67.7 -10.96 57.03 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.8 t -72.96 -32.09 65.0 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 175.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 62.4 mt -96.44 -53.5 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 19.8 m -114.77 103.57 54.74 Favored Pre-proline 0 N--CA 1.436 -1.141 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.633 -177.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -78.45 89.35 1.36 Allowed 'Trans proline' 0 N--CA 1.44 -1.657 0 C-N-CA 122.527 2.151 . . . . 0.0 110.922 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.415 HG22 ' SG ' ' A' ' 98' ' ' CYS . 43.5 mt -74.58 -66.57 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.56 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.5 t -85.11 -31.22 23.44 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.645 0.736 . . . . 0.0 110.111 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 69.5 mt -83.92 139.56 40.09 Favored Pre-proline 0 C--N 1.303 -1.444 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.377 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -76.81 -10.58 18.34 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.664 2.243 . . . . 0.0 112.893 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 45.1 t -137.37 160.83 37.97 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 39.3 m -70.61 136.0 48.86 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.493 HD11 ' CG ' ' A' ' 44' ' ' PHE . 23.9 tp -75.07 132.7 41.46 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.52 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.543 ' O ' ' HD3' ' A' ' 128' ' ' PRO . 36.6 mmt180 -118.07 128.81 55.12 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mp -95.26 106.31 25.25 Favored Pre-proline 0 C--N 1.312 -1.023 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.543 ' HD3' ' O ' ' A' ' 126' ' ' ARG . 33.6 Cg_exo -62.75 -34.06 74.43 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.266 1.977 . . . . 0.0 111.988 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 34.1 t 70.93 17.05 6.4 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.554 1.141 . . . . 0.0 108.899 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -140.73 163.66 32.31 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 30.0 t70 . . . . . 0 C--N 1.292 -1.933 0 O-C-N 123.825 0.703 . . . . 0.0 110.207 -178.65 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.507 -0.685 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -121.99 -176.61 3.38 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -90.43 -14.11 33.53 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.925 0.869 . . . . 0.0 108.694 175.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -100.55 145.51 28.24 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 175.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -93.64 157.03 16.38 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -175.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -85.55 122.78 30.16 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.5 m80 -114.0 91.87 3.78 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.778 -178.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.8 m 65.12 -53.77 0.33 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 175.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.7 m -120.97 144.52 48.45 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -175.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.31 -175.94 39.54 Favored Glycine 0 N--CA 1.438 -1.186 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.72 120.39 14.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.032 0.444 . . . . 0.0 110.444 178.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.7 m -114.92 149.38 42.36 Favored Pre-proline 0 C--N 1.292 -1.907 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.319 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.03 19.41 1.03 Allowed 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.829 2.352 . . . . 0.0 112.187 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -115.19 121.81 44.11 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 160.26 30.08 0.02 OUTLIER Glycine 0 C--N 1.294 -1.786 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.233 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.8 t -103.69 40.46 1.42 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 177.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -113.6 137.48 51.52 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.19 -1.368 . . . . 0.0 107.318 -176.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.9 p -84.68 -1.07 55.63 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-O 122.02 0.914 . . . . 0.0 111.195 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.9 m -75.9 -7.71 55.19 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.847 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.89 -16.56 53.26 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 119.936 -0.706 . . . . 0.0 111.695 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -69.75 -25.55 63.88 Favored 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -175.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 19.6 p-90 -113.25 -4.21 13.75 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.191 0.52 . . . . 0.0 111.917 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -107.45 114.32 28.25 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.786 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.66 96.97 3.53 Favored Pre-proline 0 C--N 1.295 -1.78 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.574 174.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.517 ' HA ' ' HB2' ' A' ' 47' ' ' ARG . 66.3 Cg_endo -79.81 13.96 2.0 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.443 2.762 . . . . 0.0 114.038 -171.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -102.92 -6.58 22.3 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 120.859 0.361 . . . . 0.0 110.421 -176.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.477 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 75.9 mt -87.32 142.54 27.81 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.478 0.656 . . . . 0.0 111.762 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 87.3 p -89.17 177.81 6.53 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.983 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -63.05 -43.25 99.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -55.08 -48.2 73.86 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.316 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -70.31 -34.39 72.66 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.381 -178.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.451 ' HA ' HD11 ' A' ' 45' ' ' LEU . . . -65.2 -44.59 87.87 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.237 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 51.2 mt -66.64 -38.94 82.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.486 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.06 -40.37 89.21 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.377 0.608 . . . . 0.0 110.346 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -46.0 69.56 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.055 -179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 72.4 mt -74.86 -17.19 60.63 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -176.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.401 ' HB3' HG21 ' A' ' 77' ' ' VAL . 18.4 ptpt -83.06 -11.28 58.18 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.149 -1.021 . . . . 0.0 110.37 177.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -93.91 -24.3 17.75 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.606 0.717 . . . . 0.0 109.454 175.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -99.91 164.52 11.98 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -72.49 156.91 89.84 Favored Pre-proline 0 C--N 1.287 -2.127 0 CA-C-N 112.177 -2.283 . . . . 0.0 112.749 -176.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -60.46 126.31 19.64 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.892 2.395 . . . . 0.0 111.379 175.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 112.96 -7.74 25.47 Favored Glycine 0 C--N 1.303 -1.25 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -176.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.49 150.3 32.98 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-N 115.534 -0.333 . . . . 0.0 110.341 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.527 ' CD1' HD11 ' A' ' 125' ' ' LEU . 9.8 p90 -149.25 167.63 25.5 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.451 HD11 ' HA ' ' A' ' 32' ' ' ALA . 2.5 pt? -155.97 148.72 24.04 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 171.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.406 ' CG2' ' HB3' ' A' ' 56' ' ' TYR . 63.2 mt -120.79 130.27 74.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-O 121.124 0.488 . . . . 0.0 110.656 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.517 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -137.82 -176.96 4.6 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.044 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -62.66 134.39 56.25 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.8 t -74.57 136.38 42.09 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.371 0.605 . . . . 0.0 110.704 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -72.75 -27.06 61.8 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.325 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.2 m -81.13 -52.26 7.57 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.965 -175.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -137.73 145.26 42.28 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -175.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -82.98 151.92 25.66 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 173.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.03 9.96 81.52 Favored Glycine 0 C--N 1.305 -1.179 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.44 144.48 48.16 Favored 'General case' 0 N--CA 1.406 -2.648 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.406 ' HB3' ' CG2' ' A' ' 46' ' ' ILE . 76.6 m-85 -116.9 126.34 52.83 Favored 'General case' 0 C--N 1.273 -2.749 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.433 ' O ' ' HD3' ' A' ' 47' ' ' ARG . . . -83.76 115.15 4.0 Favored Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.031 -177.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.7 tp -95.59 121.63 37.5 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 123.728 0.811 . . . . 0.0 109.03 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.57 127.56 53.1 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -124.04 125.59 44.79 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -176.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.495 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 21.7 tptm -88.34 114.62 25.15 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.675 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 80' ' ' LEU . 20.0 m -96.85 167.61 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.07 -59.11 2.87 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 174.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.4 ' HB ' ' HG2' ' A' ' 66' ' ' PRO . 0.6 OUTLIER -155.73 141.72 12.91 Favored Pre-proline 0 N--CA 1.428 -1.529 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.84 177.349 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.65 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 32.0 Cg_exo -59.47 -42.79 45.04 Favored 'Trans proline' 0 CA--C 1.573 2.454 0 C-N-CA 122.283 1.989 . . . . 0.0 112.61 174.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.65 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 39.7 Cg_endo -65.13 148.12 88.91 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 122.832 2.354 . . . . 0.0 109.77 172.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.79 -37.14 88.67 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.749 2.299 . . . . 0.0 113.048 -177.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.7 t -132.37 -11.07 3.22 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.949 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.455 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 69.83 31.99 3.31 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 124.345 1.058 . . . . 0.0 112.923 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -64.14 -43.75 74.95 Favored Pre-proline 0 CA--C 1.556 1.199 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.631 173.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -84.69 101.3 0.79 Allowed 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 121.446 1.43 . . . . 0.0 109.893 167.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 34.6 t-105 -92.53 146.66 23.51 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.909 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -121.82 -36.52 3.01 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.966 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.44 14.12 12.09 Favored Glycine 0 C--N 1.3 -1.466 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.31 -176.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -64.53 134.09 95.89 Favored Pre-proline 0 C--N 1.316 -0.865 0 C-N-CA 122.63 0.372 . . . . 0.0 110.701 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.1 173.19 14.91 Favored 'Trans proline' 0 C--O 1.245 0.844 0 C-N-CA 123.042 2.495 . . . . 0.0 113.855 -175.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.401 HG21 ' HB3' ' A' ' 37' ' ' LYS . 2.1 p -56.42 -30.31 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.478 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -58.78 -25.11 62.78 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 122.955 0.502 . . . . 0.0 112.238 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -92.05 -14.23 29.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.059 0.457 . . . . 0.0 110.56 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.528 ' O ' HG22 ' A' ' 62' ' ' VAL . 72.9 mt -81.95 -13.07 58.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 122.006 0.908 . . . . 0.0 108.642 178.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.2 t -94.91 111.37 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 175.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.412 ' NH2' ' HB3' ' A' ' 65' ' ' PRO . 32.4 mmt180 -85.19 147.46 26.59 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.428 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.9 m80 -126.13 123.21 37.79 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.586 0.708 . . . . 0.0 111.723 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -132.49 163.52 28.63 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 106.282 -1.748 . . . . 0.0 106.282 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -130.02 132.65 46.31 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.047 176.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 94' ' ' LYS . 75.1 mt -90.84 110.65 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.332 0 CA-C-N 114.48 -1.236 . . . . 0.0 107.668 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -100.2 152.69 19.98 Favored 'General case' 0 C--N 1.268 -2.954 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.507 ' HB ' HG12 ' A' ' 93' ' ' VAL . 4.3 t -134.14 148.82 51.01 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-O 121.214 0.531 . . . . 0.0 110.675 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.45 -159.51 11.15 Favored Glycine 0 N--CA 1.42 -2.384 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.37 -21.44 72.68 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.929 2.419 . . . . 0.0 112.939 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -88.83 -5.79 57.79 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.733 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 110.36 -147.56 17.44 Favored Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.507 HG12 ' HB ' ' A' ' 88' ' ' THR . 12.1 m -108.11 151.95 10.08 Favored 'Isoleucine or valine' 0 C--O 1.252 1.23 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 13.8 pttp -151.38 147.95 27.53 Favored 'General case' 0 C--N 1.311 -1.078 0 O-C-N 123.777 0.673 . . . . 0.0 109.859 -175.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.517 ' HB ' ' OE2' ' A' ' 101' ' ' GLU . 76.5 mt -101.46 108.38 23.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -75.36 119.06 18.94 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 120.984 0.421 . . . . 0.0 110.071 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 121.22 -2.74 11.47 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.072 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 24.1 p -70.93 152.9 94.96 Favored Pre-proline 0 C--N 1.317 -0.809 0 C-N-CA 123.026 0.53 . . . . 0.0 110.006 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -72.41 -52.64 0.17 Allowed 'Trans proline' 0 C--O 1.24 0.616 0 C-N-CA 121.729 1.619 . . . . 0.0 110.16 173.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.2 m -144.99 139.86 27.79 Favored 'General case' 0 N--CA 1.41 -2.467 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.517 ' OE2' ' HB ' ' A' ' 95' ' ' ILE . 38.3 tt0 -166.56 142.67 3.88 Favored Pre-proline 0 C--N 1.297 -1.713 0 O-C-N 123.479 0.487 . . . . 0.0 112.165 -176.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -92.71 160.62 2.83 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 123.171 2.581 . . . . 0.0 110.3 168.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -74.07 127.02 31.84 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -79.14 -72.59 0.38 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.023 0.439 . . . . 0.0 111.248 -176.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.44 ' H ' HG22 ' A' ' 93' ' ' VAL . . . 148.91 -58.6 0.46 Allowed Glycine 0 C--N 1.309 -0.929 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.1 m -132.53 155.9 47.79 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.475 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 10.7 mp -53.11 -46.31 68.65 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.436 0.46 . . . . 0.0 111.164 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.4 m -53.83 -30.75 46.65 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.898 0.879 . . . . 0.0 112.458 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.58 -37.12 73.89 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 120.64 0.257 . . . . 0.0 111.288 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 107' ' ' LEU . 4.3 pp -80.35 -23.43 40.53 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.462 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 107' ' ' LEU . 70.8 t -71.44 -40.31 72.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.388 177.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.0 p -70.25 -22.86 62.84 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.029 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.625 ' HG2' ' H ' ' A' ' 114' ' ' HIS . 8.5 tt0 -95.2 -172.51 2.69 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 177.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.625 ' H ' ' HG2' ' A' ' 113' ' ' GLN . 57.2 m80 77.87 -26.07 0.19 Allowed 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.9 m -66.81 -41.9 86.79 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 173.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 65.8 mt -74.23 -66.25 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.404 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.7 m -125.75 118.79 24.26 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -78.75 101.09 1.42 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.238 1.959 . . . . 0.0 111.002 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 56.5 mt -95.02 -71.15 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.508 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.0 m -71.28 -30.2 65.99 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.343 0.592 . . . . 0.0 110.554 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 85.9 mt -101.49 148.81 35.74 Favored Pre-proline 0 C--N 1.304 -1.399 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.104 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 1.7 Cg_endo -77.43 -29.29 4.89 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.007 1.805 . . . . 0.0 113.109 -178.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 79.9 m -114.8 155.03 27.51 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.81 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 64.7 m -62.68 122.72 16.57 Favored 'General case' 0 C--O 1.241 0.606 0 O-C-N 123.982 0.802 . . . . 0.0 109.645 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.527 HD11 ' CD1' ' A' ' 44' ' ' PHE . 27.4 tp -74.11 134.56 42.89 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.724 -173.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -117.96 129.03 55.36 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.493 HG22 ' H ' ' A' ' 129' ' ' SER . 3.4 mp -93.29 132.98 29.24 Favored Pre-proline 0 C--O 1.193 -1.884 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -174.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.32 -32.51 81.56 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 C-N-CA 122.842 2.362 . . . . 0.0 112.898 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.493 ' H ' HG22 ' A' ' 127' ' ' ILE . 6.8 m -61.49 -29.82 70.22 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.847 0.859 . . . . 0.0 111.188 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.486 ' HD3' ' O ' ' A' ' 130' ' ' LYS . 6.9 tmtm? -151.32 92.2 1.76 Allowed 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.4 t70 . . . . . 0 C--N 1.284 -2.258 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 179.359 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.9 mtm . . . . . 0 N--CA 1.468 0.464 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -86.54 147.72 25.83 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 174.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -97.36 116.84 30.32 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.2 t60 73.22 142.41 0.06 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.214 1.006 . . . . 0.0 113.533 178.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 67.0 t60 -171.21 86.15 0.09 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.083 -1.417 . . . . 0.0 107.981 170.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.423 ' CE1' ' HB2' ' A' ' 8' ' ' SER . 13.6 t-80 -112.79 126.35 55.33 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -47.19 -54.14 11.43 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.081 0.952 . . . . 0.0 111.312 -177.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.423 ' HB2' ' CE1' ' A' ' 6' ' ' HIS . 4.5 m -68.64 -17.95 64.2 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -175.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.7 m -106.04 7.83 32.05 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.823 0.344 . . . . 0.0 110.813 -177.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.08 -31.49 0.33 Allowed Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.224 -0.989 . . . . 0.0 112.672 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 36.0 tp 60.07 45.11 12.3 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 122.59 1.186 . . . . 0.0 108.569 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.6 t -118.87 94.02 47.36 Favored Pre-proline 0 N--CA 1.437 -1.119 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.038 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -94.5 91.6 0.12 Allowed 'Trans proline' 0 N--CA 1.428 -2.351 0 C-N-CA 122.433 2.089 . . . . 0.0 110.587 175.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -87.9 -57.53 2.9 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 177.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -94.22 -90.26 1.65 Allowed Glycine 0 N--CA 1.407 -3.267 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 175.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.4 m 56.55 23.87 8.09 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 122.118 0.961 . . . . 0.0 110.498 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -119.85 155.66 32.2 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.457 -175.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 35.0 p -109.11 -7.2 15.36 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.739 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.407 ' HA ' ' CE2' ' A' ' 22' ' ' TRP . 48.3 p -53.38 -49.55 66.98 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -173.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -10.19 57.8 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 119.86 -0.736 . . . . 0.0 112.614 -177.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -83.34 -25.19 31.67 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.528 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.407 ' CE2' ' HA ' ' A' ' 19' ' ' SER . 27.0 p-90 -119.39 -22.09 7.19 Favored 'General case' 0 C--O 1.214 -0.795 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 52.1 t80 -90.97 112.77 24.8 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.775 -177.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.78 92.07 41.27 Favored Pre-proline 0 C--N 1.315 -0.929 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 175.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -57.64 -44.41 41.74 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 123.341 2.694 . . . . 0.0 115.942 -169.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -104.96 16.91 25.08 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.368 0.604 . . . . 0.0 111.364 -170.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.5 tp -74.62 146.25 42.6 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 85.4 p -93.0 166.66 12.26 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.96 -0.462 . . . . 0.0 110.257 -175.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -57.02 -49.41 75.88 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.939 0.399 . . . . 0.0 110.934 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -60.89 -34.82 75.24 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.296 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -75.87 -30.83 59.01 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.928 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.42 -43.14 77.81 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 75.8 mt -66.58 -40.22 85.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.624 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.21 -34.55 70.52 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.373 0.669 . . . . 0.0 111.104 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.72 -49.63 15.56 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.526 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 67.2 mt -68.49 -32.61 72.72 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -175.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -63.51 -21.54 66.38 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.065 0.459 . . . . 0.0 111.43 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -90.32 -10.14 45.18 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.275 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.65 -178.34 3.63 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.758 -174.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -99.96 160.72 26.47 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.111 -177.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -59.04 125.99 19.75 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 122.491 2.127 . . . . 0.0 111.673 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.51 -22.57 9.38 Favored Glycine 0 N--CA 1.43 -1.729 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.3 148.76 46.8 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.992 -0.374 . . . . 0.0 109.992 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.402 ' HB2' HD11 ' A' ' 58' ' ' LEU . 43.2 p90 -153.56 168.53 25.88 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.043 -175.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -153.15 152.43 31.26 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 172.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 23' ' ' TYR . 55.8 mt -121.98 133.19 69.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -127.02 -173.9 3.01 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -84.69 127.72 34.24 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 171.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.4 t -79.21 108.07 12.45 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -66.1 -6.53 13.48 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.75 -1.114 . . . . 0.0 113.912 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.1 p -77.62 -18.34 56.88 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.507 0.67 . . . . 0.0 110.977 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -135.83 -174.55 3.69 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -124.14 121.29 34.73 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.12 0.486 . . . . 0.0 109.918 172.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.04 43.65 8.05 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.37 159.33 41.36 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.563 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 50.5 m-85 -112.31 150.11 31.47 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.328 -176.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 85' ' ' LEU . . . -126.76 116.45 2.5 Favored Glycine 0 C--N 1.282 -2.458 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.402 HD11 ' HB2' ' A' ' 44' ' ' PHE . 50.5 tp -94.77 123.24 38.11 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 123.144 0.578 . . . . 0.0 109.84 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -107.57 115.61 30.46 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 175.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.3 tp -110.79 127.52 55.41 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 123.491 0.494 . . . . 0.0 110.487 -177.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.526 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 26.7 tptp -88.64 115.49 26.2 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.426 HG11 ' HG2' ' A' ' 122' ' ' PRO . 31.4 m -106.96 164.91 4.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.66 -53.26 43.69 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.489 ' HB ' ' HG2' ' A' ' 66' ' ' PRO . 1.3 p -159.76 140.73 9.14 Favored Pre-proline 0 N--CA 1.423 -1.8 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 175.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.6 ' CD ' ' HD2' ' A' ' 66' ' ' PRO . 30.1 Cg_exo -56.7 -43.18 57.34 Favored 'Trans proline' 0 CA--C 1.571 2.327 0 C-N-CA 122.215 1.944 . . . . 0.0 112.704 175.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.6 ' HD2' ' CD ' ' A' ' 65' ' ' PRO . 43.5 Cg_endo -62.81 153.4 72.93 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.182 2.588 . . . . 0.0 110.426 171.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -57.31 -45.35 35.49 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.524 2.149 . . . . 0.0 112.632 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.9 m -133.44 1.32 3.42 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.511 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 60.16 38.22 20.36 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.828 0.851 . . . . 0.0 111.856 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -54.74 -49.74 89.77 Favored Pre-proline 0 CA--C 1.552 1.055 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.933 177.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -78.0 139.83 17.58 Favored 'Trans proline' 0 C--N 1.366 1.479 0 CA-C-N 120.253 1.126 . . . . 0.0 111.406 173.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -96.47 136.62 36.72 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -132.68 -12.22 3.02 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.038 0.447 . . . . 0.0 110.502 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.48 56.12 4.38 Favored Glycine 0 CA--C 1.493 -1.299 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -175.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -83.63 132.86 47.95 Favored Pre-proline 0 C--N 1.289 -2.024 0 C-N-CA 123.563 0.745 . . . . 0.0 111.395 -175.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -81.93 166.84 16.73 Favored 'Trans proline' 0 N--CA 1.445 -1.327 0 C-N-CA 122.122 1.881 . . . . 0.0 111.827 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.8 p -61.2 -24.47 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.486 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -65.26 -26.67 68.19 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.957 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.422 ' HG2' ' HG2' ' A' ' 65' ' ' PRO . 47.2 tt0 -82.35 -27.73 32.01 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.109 0.48 . . . . 0.0 109.957 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.0 mt -74.72 -11.7 60.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.553 0.692 . . . . 0.0 110.367 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.2 t -103.15 118.47 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -100.36 129.78 46.38 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 -178.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -107.24 121.76 45.18 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 121.038 0.447 . . . . 0.0 109.8 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -127.79 118.37 23.61 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.412 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 4.2 pp -96.24 139.34 32.53 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.111 -177.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.563 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 76.9 mt -99.97 129.24 50.94 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 CA-C-N 114.402 -1.272 . . . . 0.0 107.935 -177.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.598 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 35.3 mt-10 -99.11 157.38 16.4 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -177.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.703 ' HB ' HG12 ' A' ' 93' ' ' VAL . 4.4 t -147.54 128.89 14.84 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 175.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.39 -141.9 3.67 Favored Glycine 0 N--CA 1.426 -2.013 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.389 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.62 -47.63 25.72 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.723 2.949 . . . . 0.0 113.108 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -74.57 -60.73 2.15 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 167.46 -146.17 10.44 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 119.976 -1.107 . . . . 0.0 111.627 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.703 HG12 ' HB ' ' A' ' 88' ' ' THR . 22.0 m -104.9 149.36 8.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 O-C-N 124.007 0.475 . . . . 0.0 111.078 -175.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.89 157.64 3.04 Favored 'General case' 0 C--O 1.252 1.187 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 172.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.496 HG12 HG12 ' A' ' 86' ' ' ILE . 71.9 mt -76.17 129.15 37.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-O 121.959 0.885 . . . . 0.0 112.35 -178.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -69.77 121.17 16.72 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.55 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 109.72 -1.16 30.47 Favored Glycine 0 C--N 1.306 -1.118 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.627 ' SG ' ' HB2' ' A' ' 101' ' ' GLU . 37.9 t -108.81 110.26 61.12 Favored Pre-proline 0 N--CA 1.431 -1.396 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -96.45 21.24 0.43 Allowed 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.098 2.532 . . . . 0.0 112.671 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.5 m -138.13 31.91 2.4 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.852 0.834 . . . . 0.0 109.093 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.627 ' HB2' ' SG ' ' A' ' 98' ' ' CYS . 29.7 tt0 -134.46 123.5 16.49 Favored Pre-proline 0 N--CA 1.426 -1.675 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.588 -173.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.37 174.76 12.26 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.594 2.196 . . . . 0.0 112.076 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -86.25 129.03 34.98 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -106.93 172.78 6.63 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -98.41 -54.8 1.14 Allowed Glycine 0 C--N 1.304 -1.225 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.103 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.5 m -105.95 153.78 21.5 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 123.128 0.571 . . . . 0.0 110.028 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.429 HD21 ' CD2' ' A' ' 56' ' ' TYR . 92.6 mt -65.35 -36.19 83.25 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.049 0.452 . . . . 0.0 110.041 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.8 m -53.05 -29.25 28.84 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.001 0.92 . . . . 0.0 112.697 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.73 -41.83 74.75 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.552 ' H ' HD13 ' A' ' 110' ' ' LEU 0.306 0.0 OUTLIER -80.07 -32.36 39.31 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.215 177.285 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.455 ' HA ' HD23 ' A' ' 125' ' ' LEU . 67.6 t -57.08 -42.68 79.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.307 0.575 . . . . 0.0 110.91 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.8 p -72.15 -33.44 67.74 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.984 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -80.01 -36.35 36.02 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.509 ' HA ' ' O ' ' A' ' 117' ' ' SER . 27.9 m-70 -71.65 -5.47 33.89 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -174.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.8 m -73.33 -30.08 63.11 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 172.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.425 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 52.9 mt -101.03 -52.16 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.109 -177.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 38.8 t -111.72 95.87 30.11 Favored Pre-proline 0 N--CA 1.424 -1.773 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.036 -175.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 116' ' ' ILE . 5.8 Cg_endo -85.78 74.54 3.43 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 122.733 2.289 . . . . 0.0 109.942 178.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.1 mt -66.19 -56.24 15.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.861 -175.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.563 ' HB3' ' SG ' ' A' ' 98' ' ' CYS . 2.4 p -96.31 6.18 49.34 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.081 -177.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 69.2 mt -123.49 140.84 34.89 Favored Pre-proline 0 C--N 1.308 -1.199 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.755 -173.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.426 ' HG2' HG11 ' A' ' 62' ' ' VAL . 72.4 Cg_endo -79.03 -8.44 15.45 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.576 2.184 . . . . 0.0 112.033 177.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 77.1 m -140.29 168.81 18.93 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 59.3 m -79.21 145.76 33.45 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 120.733 0.301 . . . . 0.0 110.27 -178.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 111' ' ' VAL . 15.5 tp -85.6 108.73 18.12 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -106.65 107.47 18.5 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.54 0.686 . . . . 0.0 111.721 -174.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 58.2 mt -65.74 120.92 72.64 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.763 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.7 -60.95 0.21 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.246 1.964 . . . . 0.0 111.735 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.4 t 60.31 18.37 7.94 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.193 0.997 . . . . 0.0 110.631 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -148.66 143.38 26.46 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.651 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 . . . . . 0 C--N 1.298 -1.655 0 C-N-CA 124.223 1.009 . . . . 0.0 109.234 175.615 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 ttm . . . . . 0 C--O 1.233 0.233 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -95.54 -11.69 26.98 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -175.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -83.99 112.93 20.63 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 173.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 82.1 t60 66.56 104.77 0.04 OUTLIER 'General case' 0 C--O 1.238 0.461 0 O-C-N 124.309 1.005 . . . . 0.0 111.183 -176.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -125.61 88.77 2.92 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.904 0.859 . . . . 0.0 110.684 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -78.75 -69.71 0.55 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.994 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -121.5 35.12 4.97 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 122.673 1.225 . . . . 0.0 108.178 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.8 t -88.69 84.59 6.71 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 174.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.6 p -109.56 104.76 13.85 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.976 -174.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.83 -35.93 43.76 Favored Glycine 0 CA--C 1.496 -1.118 0 N-CA-C 108.195 -1.962 . . . . 0.0 108.195 174.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.09 98.15 7.9 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 174.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.1 m -77.44 154.93 81.77 Favored Pre-proline 0 C--N 1.308 -1.23 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.466 -176.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.71 154.26 74.6 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 122.513 2.142 . . . . 0.0 110.915 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -64.79 118.17 8.59 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.366 -176.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.4 -33.48 5.52 Favored Glycine 0 N--CA 1.429 -1.801 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.988 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.7 m 57.7 33.66 23.51 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.902 0.881 . . . . 0.0 110.902 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -72.2 100.39 2.57 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 122.594 1.188 . . . . 0.0 112.297 -175.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.2 t -125.93 -4.83 6.9 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.512 177.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.464 ' HA ' ' CE2' ' A' ' 22' ' ' TRP . 27.1 m -66.77 -22.25 66.04 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.501 177.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.72 0.46 5.54 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.882 -1.054 . . . . 0.0 113.076 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -94.52 -27.12 16.13 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 122.233 -0.292 . . . . 0.0 110.486 174.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.464 ' CE2' ' HA ' ' A' ' 19' ' ' SER . 31.0 p-90 -134.49 -8.24 2.52 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -170.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -96.75 114.39 26.03 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.029 -0.669 . . . . 0.0 111.327 -176.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -120.02 86.57 37.17 Favored Pre-proline 0 C--O 1.2 -1.528 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 176.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -54.11 -40.9 79.79 Favored 'Trans proline' 0 N--CA 1.479 0.628 0 C-N-CA 123.264 2.643 . . . . 0.0 115.936 -170.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -97.32 10.13 40.43 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -171.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.7 tp -75.61 136.81 40.47 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.454 0.645 . . . . 0.0 110.657 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.1 m -80.56 161.11 24.94 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.641 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.413 ' HA ' HH21 ' A' ' 47' ' ' ARG . 28.2 ttm180 -56.71 -51.42 68.87 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.275 0.63 . . . . 0.0 110.961 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -59.46 -44.66 92.93 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.583 0.706 . . . . 0.0 110.909 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -69.81 -30.53 68.07 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.863 -176.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.52 -36.97 82.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.667 0.746 . . . . 0.0 110.306 178.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 72.4 mt -69.73 -40.23 78.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.593 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.76 -33.31 73.86 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.789 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.87 -36.14 75.25 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.569 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.547 ' HB3' ' HG2' ' A' ' 61' ' ' LYS . 63.8 mt -87.85 -22.33 24.51 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -71.3 -9.42 58.09 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.571 0.7 . . . . 0.0 110.594 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -91.89 -25.18 19.06 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.43 174.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -106.71 155.58 19.52 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -169.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -66.07 156.5 84.16 Favored Pre-proline 0 C--N 1.32 -0.696 0 C-N-CA 125.334 1.454 . . . . 0.0 113.321 -172.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.24 111.96 1.26 Allowed 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 122.876 2.384 . . . . 0.0 111.045 175.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.05 -18.21 5.33 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -176.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.77 147.36 35.35 Favored 'General case' 0 C--O 1.251 1.146 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 177.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.401 ' HB2' HD11 ' A' ' 58' ' ' LEU . 25.0 p90 -153.17 169.48 22.9 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -175.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -160.35 154.33 22.98 Favored 'General case' 0 C--O 1.254 1.307 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 173.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 56.9 mt -126.8 137.61 57.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 123.354 0.409 . . . . 0.0 109.922 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.505 HH22 ' CD2' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -134.67 177.9 7.42 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 177.125 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -74.08 130.02 38.99 Favored 'General case' 0 C--O 1.249 1.034 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 175.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.0 t -82.56 92.76 7.17 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-O 121.526 0.679 . . . . 0.0 109.242 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -75.44 76.36 2.5 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-O 122.322 1.058 . . . . 0.0 108.782 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.5 t -161.87 -40.97 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 112.804 -1.998 . . . . 0.0 107.877 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -135.93 142.98 44.7 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -76.84 133.79 39.24 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.273 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.13 37.36 28.92 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.62 143.51 47.36 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -115.55 133.26 56.2 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.449 ' O ' ' HD3' ' A' ' 47' ' ' ARG . . . -97.83 119.14 6.32 Favored Glycine 0 C--N 1.283 -2.376 0 C-N-CA 119.836 -1.173 . . . . 0.0 112.018 -176.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.401 HD11 ' HB2' ' A' ' 44' ' ' PHE . 48.3 tp -97.4 136.08 38.36 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.422 ' HB2' HH12 ' A' ' 47' ' ' ARG . . . -122.04 129.97 52.88 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 173.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.4 tp -127.59 132.05 49.86 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 123.505 0.503 . . . . 0.0 110.957 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.547 ' HG2' ' HB3' ' A' ' 36' ' ' LEU . 0.7 OUTLIER -88.55 115.61 26.2 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 174.716 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.7 m -102.29 171.85 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.85 -56.09 6.36 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 p -152.57 137.6 11.03 Favored Pre-proline 0 N--CA 1.435 -1.204 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.477 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.501 ' HD2' ' CD ' ' A' ' 66' ' ' PRO . 16.6 Cg_exo -65.51 -44.7 8.14 Favored 'Trans proline' 0 CA--C 1.568 2.19 0 C-N-CA 121.625 1.55 . . . . 0.0 110.91 173.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.501 ' CD ' ' HD2' ' A' ' 65' ' ' PRO . 14.8 Cg_exo -71.14 165.6 31.9 Favored 'Trans proline' 0 C--N 1.397 3.098 0 C-N-CA 122.219 1.946 . . . . 0.0 109.87 168.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -50.58 -35.63 47.13 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.472 2.781 . . . . 0.0 112.953 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 65.2 m -151.7 -13.39 0.2 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 63.36 41.17 7.88 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.857 0.863 . . . . 0.0 111.835 175.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.403 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 22.0 mp0 -58.88 -51.8 79.27 Favored Pre-proline 0 CA--C 1.553 1.082 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.269 171.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 70' ' ' GLN . 30.2 Cg_endo -63.4 127.91 21.17 Favored 'Trans proline' 0 C--N 1.387 2.578 0 C-N-CA 122.072 1.848 . . . . 0.0 112.049 176.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -98.98 139.48 34.56 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.195 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -136.79 16.43 3.08 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.173 0.589 . . . . 0.0 110.067 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.34 64.53 1.76 Allowed Glycine 0 CA--C 1.486 -1.752 0 N-CA-C 107.024 -2.43 . . . . 0.0 107.024 -172.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -104.58 103.19 38.55 Favored Pre-proline 0 C--N 1.301 -1.524 0 CA-C-N 114.953 -0.623 . . . . 0.0 110.358 -172.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.516 ' HB2' ' OE1' ' A' ' 78' ' ' GLU . 71.7 Cg_endo -78.8 175.53 10.88 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.052 1.835 . . . . 0.0 111.236 177.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 p -68.96 -28.2 38.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.568 0.699 . . . . 0.0 110.589 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.516 ' OE1' ' HB2' ' A' ' 76' ' ' PRO . 11.7 mp0 -66.52 -22.09 66.17 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.172 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -78.03 -18.16 56.18 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.651 0.738 . . . . 0.0 109.607 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.0 mt -84.13 -4.16 58.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.427 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.0 t -92.72 118.73 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -90.85 145.78 24.48 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.505 ' CD2' HH22 ' A' ' 47' ' ' ARG . 29.7 m80 -120.52 125.56 48.16 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.195 0.521 . . . . 0.0 111.793 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -138.32 131.96 30.87 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.484 HD23 ' H ' ' A' ' 85' ' ' LEU . 1.6 pt? -104.83 142.36 34.86 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.893 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.442 ' CG2' HG22 ' A' ' 93' ' ' VAL . 4.6 mp -98.83 123.59 51.53 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.083 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.414 ' OE1' ' HD3' ' A' ' 96' ' ' LYS . 48.5 mt-10 -98.86 139.76 34.06 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.502 ' HB ' HG23 ' A' ' 93' ' ' VAL . 12.1 t -133.35 153.41 51.62 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.33 -152.21 11.33 Favored Glycine 0 N--CA 1.42 -2.415 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.73 -13.14 37.81 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.662 2.241 . . . . 0.0 112.669 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -86.62 -6.84 58.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.329 0.585 . . . . 0.0 110.6 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 109.42 -140.32 15.66 Favored Glycine 0 N--CA 1.427 -1.924 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.502 HG23 ' HB ' ' A' ' 88' ' ' THR . 12.5 p -132.28 126.3 55.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -146.77 140.99 26.25 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.391 -0.818 . . . . 0.0 112.969 -176.84 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.4 mt -72.04 126.75 33.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.562 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.414 ' HD3' ' OE1' ' A' ' 87' ' ' GLU . 25.7 tptp -76.01 97.91 4.15 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.511 ' O ' ' HD3' ' A' ' 99' ' ' PRO . . . 135.81 4.12 2.46 Favored Glycine 0 N--CA 1.425 -2.084 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.505 -176.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 46.0 t -93.23 104.79 13.09 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 97' ' ' GLY . 72.8 Cg_endo -89.64 -10.23 3.77 Favored 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 121.878 1.718 . . . . 0.0 112.419 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.4 t -71.16 -75.17 0.13 Allowed 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 176.32 103.9 0.1 Allowed Pre-proline 0 C--O 1.234 0.277 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.499 ' HB2' ' HB2' ' A' ' 94' ' ' LYS . 23.3 Cg_endo -96.25 -128.18 0.01 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.887 0 C-N-CA 122.841 2.361 . . . . 0.0 112.435 177.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.42 ' H ' ' HB2' ' A' ' 102' ' ' PRO . 89.2 m-85 62.43 86.87 0.11 Allowed 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 125.55 1.54 . . . . 0.0 111.231 -175.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -110.7 177.38 4.69 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 113.955 -1.475 . . . . 0.0 108.722 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -88.13 -48.01 4.22 Favored Glycine 0 C--N 1.314 -0.68 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.344 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.2 m -134.28 160.1 38.92 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 66.0 mt -56.84 -44.47 82.12 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.543 0.337 . . . . 0.0 111.389 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 32.3 t -54.91 -31.26 59.97 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.817 0.847 . . . . 0.0 111.102 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.33 -44.27 88.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.013 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.56 ' H ' HD13 ' A' ' 110' ' ' LEU 0.302 0.0 OUTLIER -80.26 -31.17 38.47 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 119.146 -1.021 . . . . 0.0 112.01 177.608 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.7 t -61.87 -54.2 37.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.169 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.1 t -70.5 -31.62 68.79 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -174.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -68.65 -25.91 65.06 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.726 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.465 ' CD2' ' H ' ' A' ' 119' ' ' ILE . 45.7 m80 -77.37 -0.98 27.76 Favored 'General case' 0 C--O 1.214 -0.814 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 35.1 m -78.42 -29.28 47.06 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 172.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 61.2 mt -96.66 -59.51 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.086 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.2 m -114.07 110.51 48.5 Favored Pre-proline 0 N--CA 1.428 -1.535 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.404 -175.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -75.13 98.37 1.16 Allowed 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 121.802 1.668 . . . . 0.0 109.603 174.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.465 ' H ' ' CD2' ' A' ' 114' ' ' HIS . 62.3 mt -91.67 -68.78 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.1 -176.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.0 t -90.37 -11.39 40.72 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.269 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 60.0 mt -117.69 144.44 34.35 Favored Pre-proline 0 C--N 1.295 -1.773 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -175.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -72.28 -24.01 20.23 Favored 'Trans proline' 0 N--CA 1.477 0.52 0 C-N-CA 122.767 2.311 . . . . 0.0 113.143 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 71.9 m -119.47 162.43 18.87 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 81.0 m -86.64 143.23 27.72 Favored 'General case' 0 N--CA 1.429 -1.522 0 O-C-N 123.467 0.479 . . . . 0.0 109.793 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 75.8 mt -76.44 118.82 19.52 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -95.08 98.83 10.94 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.543 HG22 ' H ' ' A' ' 129' ' ' SER . 13.8 mt -97.8 134.16 22.63 Favored Pre-proline 0 C--N 1.276 -2.616 0 CA-C-N 113.822 -1.536 . . . . 0.0 109.0 -172.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -57.57 -20.75 43.06 Favored 'Trans proline' 0 N--CA 1.484 0.926 0 C-N-CA 123.265 2.643 . . . . 0.0 112.131 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.543 ' H ' HG22 ' A' ' 127' ' ' ILE . 22.5 t -64.17 -33.72 76.44 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.267 176.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -108.24 119.57 39.88 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -176.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.6 t70 . . . . . 0 C--N 1.294 -1.821 0 CA-C-O 118.493 -0.765 . . . . 0.0 109.645 -179.941 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 CA--C 1.509 -0.634 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -90.21 129.63 36.44 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 173.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 -91.09 -22.3 20.78 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-O 121.159 0.504 . . . . 0.0 110.274 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -114.51 131.57 56.6 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.176 -176.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -92.64 101.31 13.72 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -106.97 -51.72 2.88 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.963 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -106.68 -15.98 14.62 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.974 0.416 . . . . 0.0 111.4 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.9 t -88.64 103.39 15.88 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 175.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.0 m -89.55 -28.79 19.36 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.555 -177.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.06 -126.77 10.53 Favored Glycine 0 N--CA 1.438 -1.188 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -175.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -121.72 86.58 2.6 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 120.941 0.4 . . . . 0.0 109.971 176.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.438 ' HB ' ' HD3' ' A' ' 13' ' ' PRO . 61.9 t -80.15 -66.67 0.25 Allowed Pre-proline 0 CA--C 1.546 0.814 0 CA-C-O 119.104 -0.474 . . . . 0.0 111.53 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.438 ' HD3' ' HB ' ' A' ' 12' ' ' VAL . 51.9 Cg_endo -70.03 -37.1 8.96 Favored 'Trans proline' 0 C--N 1.376 2.005 0 CA-C-N 120.412 1.183 . . . . 0.0 112.002 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 53.39 175.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 126.446 1.899 . . . . 0.0 111.998 -176.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -135.83 -119.43 1.89 Allowed Glycine 0 N--CA 1.408 -3.197 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 176.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.0 m -136.06 19.04 3.21 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -85.97 81.74 8.39 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.566 -179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.7 p -113.01 2.35 15.71 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 122.068 0.937 . . . . 0.0 109.989 -177.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.9 m -70.66 -33.97 71.53 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.819 -173.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -7.51 33.69 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.371 -178.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -74.74 -36.15 62.63 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.897 0.38 . . . . 0.0 110.711 177.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.44 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 36.6 p-90 -103.56 -14.17 16.28 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.165 0.507 . . . . 0.0 111.789 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -94.31 112.58 24.38 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.471 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -127.08 91.62 46.29 Favored Pre-proline 0 C--N 1.312 -1.062 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 175.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.12 -7.67 21.43 Favored 'Trans proline' 0 C--N 1.331 -0.353 0 C-N-CA 122.377 2.051 . . . . 0.0 112.835 -175.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -100.37 -15.3 18.02 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.18 -176.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.5 tp -81.67 120.9 25.68 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.308 -168.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 m -76.72 165.43 24.74 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.939 -177.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -54.63 -50.99 66.8 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -174.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -65.82 -29.68 70.19 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.338 0.59 . . . . 0.0 111.384 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -77.09 -35.96 56.09 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.616 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.36 -41.38 98.84 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.765 176.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.442 ' HA ' HG21 ' A' ' 81' ' ' VAL . 87.0 mt -66.31 -45.33 89.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.86 177.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.07 -27.95 69.26 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.184 0.516 . . . . 0.0 111.911 178.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.44 -49.31 12.51 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 6.7 mp -70.33 -26.56 63.82 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -177.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -70.25 -13.14 62.04 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.446 0.641 . . . . 0.0 109.869 176.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -97.34 -32.72 11.74 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.495 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -85.54 -10.49 55.89 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -172.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.5 t70 73.1 148.59 0.12 Allowed Pre-proline 0 N--CA 1.506 2.339 0 O-C-N 123.532 0.52 . . . . 0.0 111.905 175.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' A' ' 61' ' ' LYS . 88.1 Cg_exo -45.52 118.96 2.4 Favored 'Trans proline' 0 C--N 1.389 2.711 0 C-N-CA 123.726 2.95 . . . . 0.0 115.014 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.87 -35.25 2.22 Favored Glycine 0 N--CA 1.427 -1.959 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.039 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.98 144.1 50.62 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-O 121.153 0.501 . . . . 0.0 111.194 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -145.18 165.94 26.87 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -154.55 157.11 37.8 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 172.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.44 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 65.5 mt -122.75 128.71 75.36 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.1 ptt-85 -121.72 179.69 4.4 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -95.49 130.99 42.13 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.1 m -89.78 136.95 32.74 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 120.762 0.315 . . . . 0.0 110.287 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -91.58 -23.55 19.86 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.1 t -71.93 -35.59 69.67 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.728 -176.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -128.43 149.38 50.59 Favored 'General case' 0 C--O 1.242 0.7 0 O-C-N 121.985 -0.447 . . . . 0.0 110.187 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -82.81 120.78 26.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.595 -176.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.58 29.97 57.08 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.565 178.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -113.86 133.84 55.17 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.454 ' CD2' HD21 ' A' ' 107' ' ' LEU . 44.7 m-85 -107.87 124.66 50.43 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.74 114.63 4.48 Favored Glycine 0 C--N 1.286 -2.211 0 C-N-CA 120.075 -1.059 . . . . 0.0 111.226 -176.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.3 tp -92.35 128.97 38.39 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -118.86 127.73 53.79 Favored 'General case' 0 C--N 1.282 -2.37 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 175.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.4 tp -123.01 131.85 53.88 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 123.522 0.514 . . . . 0.0 109.946 -177.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 41' ' ' PRO . 27.2 tptp -87.89 114.51 24.57 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.411 HG21 ' HE ' ' A' ' 82' ' ' ARG . 23.6 m -108.08 172.33 2.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.386 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.59 -48.63 21.49 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -163.21 143.72 7.16 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 123.142 0.577 . . . . 0.0 111.859 -178.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.67 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 37.4 Cg_exo -63.71 -46.97 7.88 Favored 'Trans proline' 0 CA--C 1.578 2.709 0 C-N-CA 121.774 1.65 . . . . 0.0 111.316 164.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.67 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 81.3 Cg_endo -71.66 171.22 16.82 Favored 'Trans proline' 0 C--N 1.398 3.146 0 C-N-CA 123.057 2.505 . . . . 0.0 109.05 171.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -66.45 -60.43 0.11 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 121.532 1.488 . . . . 0.0 112.205 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.1 p -123.23 -7.1 8.25 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.677 -178.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 64.19 33.73 11.54 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.225 1.01 . . . . 0.0 111.117 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.422 ' HB2' ' HD3' ' A' ' 71' ' ' PRO . 28.1 mt-30 -60.66 -46.97 97.19 Favored Pre-proline 0 CA--C 1.553 1.072 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.25 175.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 70' ' ' GLN . 2.3 Cg_endo -84.99 108.01 1.13 Allowed 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 121.496 1.464 . . . . 0.0 109.539 172.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 49.0 t-105 -93.44 141.21 28.71 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.722 -176.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -119.26 -53.51 2.24 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.489 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 161.17 56.91 0.02 OUTLIER Glycine 0 CA--C 1.471 -2.7 0 N-CA-C 107.622 -2.191 . . . . 0.0 107.622 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -88.33 113.48 55.43 Favored Pre-proline 0 C--N 1.288 -2.098 0 CA-C-N 113.515 -1.342 . . . . 0.0 111.925 -171.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -85.66 164.42 10.64 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.195 1.93 . . . . 0.0 111.868 176.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.9 p -60.7 -19.73 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 121.597 0.713 . . . . 0.0 110.779 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -63.5 -21.72 66.48 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 123.951 0.9 . . . . 0.0 111.297 178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -92.82 -13.9 28.51 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 121.066 0.46 . . . . 0.0 110.902 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.9 mt -82.53 -8.54 59.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.968 0.89 . . . . 0.0 109.534 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.442 HG21 ' HA ' ' A' ' 33' ' ' ILE . 89.9 t -109.49 107.82 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.998 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 174.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.517 ' NH2' ' HA ' ' A' ' 65' ' ' PRO . 77.4 mtt180 -87.27 147.75 25.4 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.177 -177.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -123.73 122.61 38.52 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.14 -175.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -130.99 156.49 45.03 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.403 ' HG ' ' HB3' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -125.35 133.45 52.56 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.765 178.741 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.494 HG12 HG12 ' A' ' 95' ' ' ILE . 78.0 mt -94.31 113.98 30.0 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.432 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.203 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.83 128.22 46.96 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.599 ' HB ' HG12 ' A' ' 93' ' ' VAL . 9.3 t -99.62 115.82 30.3 Favored 'General case' 0 N--CA 1.413 -2.296 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 176.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -115.13 -170.08 16.18 Favored Glycine 0 N--CA 1.42 -2.414 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -177.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.65 -20.83 69.8 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.038 2.492 . . . . 0.0 112.92 -178.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -87.76 -39.74 14.66 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.923 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 158.97 -158.2 29.2 Favored Glycine 0 N--CA 1.431 -1.645 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 -177.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.599 HG12 ' HB ' ' A' ' 88' ' ' THR . 6.4 m -103.37 130.95 52.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -177.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.72 154.39 48.56 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.628 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.494 HG12 HG12 ' A' ' 86' ' ' ILE . 33.7 mt -94.06 130.42 43.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.439 0.638 . . . . 0.0 110.896 -174.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.403 ' HB3' ' HG ' ' A' ' 85' ' ' LEU . 33.1 ttmt -102.03 143.77 31.46 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.337 176.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 105.1 8.15 36.72 Favored Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 -172.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 59.4 m -121.23 153.06 58.11 Favored Pre-proline 0 N--CA 1.423 -1.818 0 CA-C-N 114.105 -1.048 . . . . 0.0 109.395 -176.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -57.52 -58.39 0.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.153 1.902 . . . . 0.0 110.424 176.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.8 m -162.55 108.86 1.23 Allowed 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 122.839 0.456 . . . . 0.0 110.371 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.461 ' HG2' ' HB ' ' A' ' 119' ' ' ILE . 51.4 mt-10 -128.89 133.49 25.27 Favored Pre-proline 0 C--N 1.299 -1.593 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.96 176.53 6.04 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.603 2.869 . . . . 0.0 115.775 -170.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -87.79 113.48 23.49 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.642 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -90.48 161.75 15.37 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.98 -58.21 9.39 Favored Glycine 0 CA--C 1.509 -0.309 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.486 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.5 m -136.78 171.85 13.88 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.454 HD21 ' CD2' ' A' ' 56' ' ' TYR . 95.1 mt -53.5 -47.2 70.07 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.643 0.589 . . . . 0.0 110.654 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.7 m -52.95 -29.65 30.05 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.592 1.157 . . . . 0.0 112.747 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.43 -36.93 71.46 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 120.889 0.376 . . . . 0.0 111.306 -177.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 107' ' ' LEU . 4.2 pp -80.1 -21.66 43.02 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.599 0.714 . . . . 0.0 110.06 178.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 107' ' ' LEU . 88.1 t -70.68 -42.9 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.416 176.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.6 p -72.96 -44.55 60.99 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 122.16 -0.338 . . . . 0.0 111.349 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -77.76 12.33 1.74 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.423 ' HB2' ' H ' ' A' ' 125' ' ' LEU . 35.0 p-80 -53.96 -35.1 61.42 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.182 1.393 . . . . 0.0 111.16 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 41.9 p -98.87 -4.06 33.89 Favored 'General case' 0 N--CA 1.401 -2.889 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.461 -172.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 52.2 mt -106.31 -42.79 6.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.25 -175.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.3 t -135.93 81.14 40.53 Favored Pre-proline 0 N--CA 1.435 -1.222 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.986 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -98.03 96.07 0.07 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.033 0 C-N-CA 122.425 2.083 . . . . 0.0 109.054 172.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.461 ' HB ' ' HG2' ' A' ' 101' ' ' GLU . 58.6 mt -90.89 -57.06 4.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.856 -175.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 27.6 t -91.76 -30.83 16.03 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.923 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.53 118.59 55.41 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.621 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.475 ' HG3' ' CZ ' ' A' ' 82' ' ' ARG . 89.4 Cg_endo -83.02 -3.89 11.14 Favored 'Trans proline' 0 C--O 1.243 0.735 0 C-N-CA 123.022 2.482 . . . . 0.0 112.265 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 84.8 m -145.32 149.26 34.5 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 79.0 m -88.93 148.4 23.83 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.423 ' H ' ' HB2' ' A' ' 114' ' ' HIS . 58.7 mt -70.3 107.27 3.68 Favored 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.513 -175.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -80.2 99.78 7.97 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.859 -0.526 . . . . 0.0 110.168 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.574 ' H ' HD12 ' A' ' 127' ' ' ILE . 3.9 mp -71.12 121.77 85.11 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.79 -177.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.47 -15.17 41.44 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 123.087 2.525 . . . . 0.0 113.381 -177.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.537 ' H ' HG22 ' A' ' 127' ' ' ILE . 23.2 t -103.73 -6.45 21.5 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.59 -1.187 . . . . 0.0 111.859 -178.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.44 ' HB2' ' HB ' ' A' ' 127' ' ' ILE . 74.8 mmtt -124.7 139.4 53.89 Favored 'General case' 0 CA--C 1.489 -1.368 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.895 -176.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.1 t70 . . . . . 0 C--N 1.285 -2.238 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.661 179.128 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.464 0.236 0 CA-C-O 120.442 0.163 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -100.87 132.9 46.05 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.2 p-80 -103.96 158.53 16.35 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.015 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -72.49 132.13 43.45 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 173.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -91.59 -13.36 32.1 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.29 0.567 . . . . 0.0 111.516 -175.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -139.01 168.15 20.47 Favored 'General case' 0 C--O 1.25 1.115 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 176.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -110.05 166.37 11.0 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 120.839 0.352 . . . . 0.0 110.562 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 64.6 m -154.21 120.33 5.35 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.0 t -73.69 -33.53 64.45 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.518 177.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.79 -67.86 3.49 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.349 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.5 tp -85.05 67.25 10.13 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 122.374 1.083 . . . . 0.0 111.558 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.481 ' H ' ' HD2' ' A' ' 13' ' ' PRO . 94.8 t -117.35 -58.22 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.793 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 173.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.481 ' HD2' ' H ' ' A' ' 12' ' ' VAL . 72.5 Cg_endo -79.2 141.02 16.0 Favored 'Trans proline' 0 N--CA 1.434 -1.972 0 N-CA-C 109.86 -0.861 . . . . 0.0 109.86 169.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -94.46 -41.1 9.55 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 176.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.12 -105.02 0.33 Allowed Glycine 0 N--CA 1.417 -2.574 0 CA-C-N 113.711 -1.586 . . . . 0.0 109.605 175.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.8 m -93.67 46.85 1.2 Allowed 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.919 0.866 . . . . 0.0 110.9 -177.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.406 ' HB2' ' HA ' ' A' ' 13' ' ' PRO . 3.4 m-20 -79.02 28.56 0.22 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.12 1.368 . . . . 0.0 111.947 -178.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.6 p -93.47 19.67 8.14 Favored 'General case' 0 C--N 1.273 -2.756 0 CA-C-O 121.519 0.676 . . . . 0.0 110.314 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.428 ' HA ' ' NE1' ' A' ' 22' ' ' TRP . 18.4 m -73.01 -28.76 62.56 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.761 -177.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.421 ' HD3' ' H ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -71.28 -10.12 59.23 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.689 0.757 . . . . 0.0 110.769 177.184 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -76.92 -21.1 55.35 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.258 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.428 ' NE1' ' HA ' ' A' ' 19' ' ' SER . 47.0 p-90 -113.67 -31.46 6.47 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 177.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.476 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 42.1 t80 -86.26 116.85 24.7 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.001 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -125.81 84.85 60.14 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.416 ' HD3' ' CD2' ' A' ' 23' ' ' TYR . 9.3 Cg_endo -54.4 -46.59 32.31 Favored 'Trans proline' 0 C--N 1.333 -0.282 0 C-N-CA 122.786 2.324 . . . . 0.0 115.818 -171.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -97.84 13.86 29.09 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -173.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.561 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 15.2 tp -83.3 145.84 28.86 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.504 -178.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.2 t -96.89 169.65 9.7 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -58.81 -50.32 74.42 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 123.524 0.729 . . . . 0.0 111.736 -175.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -58.34 -40.29 81.78 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.122 0.487 . . . . 0.0 111.083 -177.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -74.98 -29.91 61.03 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.872 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.92 -43.48 83.22 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.966 -0.754 . . . . 0.0 108.966 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 77.3 mt -66.24 -39.12 83.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.248 177.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.52 -32.24 70.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.782 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.404 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 49.8 mt -73.15 -47.06 47.15 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.569 0.699 . . . . 0.0 110.61 173.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.557 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 67.8 mt -69.68 -18.36 63.55 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -177.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.447 ' HB3' HG21 ' A' ' 77' ' ' VAL . 21.0 ptmt -84.28 -0.67 53.29 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.346 0.593 . . . . 0.0 110.073 176.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -114.05 -43.12 3.27 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.111 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 35' ' ' LEU . 43.3 mtpt -74.77 162.99 28.17 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.421 -176.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -70.22 138.48 86.98 Favored Pre-proline 0 C--N 1.308 -1.204 0 C-N-CA 124.212 1.005 . . . . 0.0 111.827 -174.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -57.28 114.04 1.76 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.676 2.251 . . . . 0.0 111.413 175.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.27 -22.69 3.94 Favored Glycine 0 N--CA 1.425 -2.077 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 -174.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.42 158.55 28.67 Favored 'General case' 0 C--O 1.251 1.181 0 CA-C-N 115.029 -0.585 . . . . 0.0 109.908 177.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -152.47 176.23 11.89 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -175.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -156.38 154.83 31.14 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 170.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 23' ' ' TYR . 66.6 mt -125.02 130.54 73.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.561 ' HD2' ' O ' ' A' ' 27' ' ' LEU . 28.1 ptt85 -133.05 171.27 14.21 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -72.82 132.03 43.05 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 171.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.5 m -67.81 -32.77 73.56 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 -177.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 60.9 m80 71.91 -39.59 0.45 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.321 1.048 . . . . 0.0 113.167 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.2 m -58.59 -41.44 85.76 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 123.795 0.838 . . . . 0.0 111.18 178.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.49 150.7 45.49 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -84.56 135.02 34.38 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.65 38.45 50.84 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -177.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.55 133.16 39.96 Favored 'General case' 0 C--O 1.249 1.028 0 CA-C-O 120.891 0.377 . . . . 0.0 110.394 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.403 ' HB3' ' CG2' ' A' ' 46' ' ' ILE . 47.3 m-85 -116.73 126.83 53.71 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -91.39 114.15 4.45 Favored Glycine 0 C--N 1.288 -2.084 0 C-N-CA 120.148 -1.025 . . . . 0.0 111.324 -177.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.401 ' HB3' ' O ' ' A' ' 84' ' ' PHE . 2.2 tm? -92.08 117.77 30.16 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.65 115.73 30.43 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.4 tp -110.64 123.76 50.61 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.303 -177.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.557 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 22.3 tptm -91.23 114.35 26.85 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 176.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 80' ' ' LEU . 18.2 m -104.17 170.65 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.25 -58.28 5.13 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 p -161.85 124.15 1.73 Allowed Pre-proline 0 C--N 1.312 -1.06 0 C-N-CA 124.521 1.128 . . . . 0.0 108.713 176.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.627 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 35.6 Cg_exo -59.68 -47.1 17.22 Favored 'Trans proline' 0 CA--C 1.578 2.678 0 C-N-CA 121.688 1.592 . . . . 0.0 111.947 174.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.627 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 74.8 Cg_endo -73.46 153.29 49.87 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 123.19 2.593 . . . . 0.0 110.756 173.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -63.79 -46.92 7.81 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.402 2.068 . . . . 0.0 112.567 177.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.6 p -119.74 -8.28 9.92 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.401 ' HA ' ' CG ' ' A' ' 66' ' ' PRO . . . 66.8 36.57 4.49 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 124.414 1.086 . . . . 0.0 113.237 177.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.424 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 73.8 mt-30 -63.61 -48.85 79.77 Favored Pre-proline 0 CA--C 1.565 1.519 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.339 172.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 70' ' ' GLN . 18.3 Cg_endo -62.45 113.38 1.91 Allowed 'Trans proline' 0 C--N 1.389 2.709 0 C-N-CA 122.04 1.827 . . . . 0.0 111.919 173.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 57.0 t-105 -115.17 146.49 41.34 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.354 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -127.05 -28.82 2.84 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.834 0.35 . . . . 0.0 111.689 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 133.32 -41.71 1.45 Allowed Glycine 0 CA--C 1.489 -1.536 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.541 ' HB3' ' HB2' ' A' ' 78' ' ' GLU . 5.2 m-20 -68.11 118.56 59.97 Favored Pre-proline 0 C--N 1.299 -1.623 0 C-N-CA 123.862 0.865 . . . . 0.0 109.839 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 75' ' ' ASP . 5.7 Cg_exo -77.21 -79.64 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 121.902 1.735 . . . . 0.0 112.722 177.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 37' ' ' LYS . 3.2 p -73.74 -28.31 24.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 120.943 0.402 . . . . 0.0 111.624 -177.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.541 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 53.1 mp0 -68.28 -19.72 64.72 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.416 ' HG2' ' HB2' ' A' ' 75' ' ' ASP . 8.0 mm100 -78.62 -36.25 44.39 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 171.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.503 ' O ' HG22 ' A' ' 62' ' ' VAL . 49.5 mt -75.87 -25.71 56.41 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.838 -176.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 89.9 t -88.92 116.25 30.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -101.36 130.81 47.62 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -109.84 126.17 53.54 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.222 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.401 ' O ' ' HB3' ' A' ' 58' ' ' LEU . 98.0 m-85 -133.15 123.14 25.13 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 176.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.9 pp -96.84 131.95 43.08 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 118.709 -1.196 . . . . 0.0 111.113 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 79.7 mt -92.35 122.58 43.93 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 C-N-CA 124.568 1.147 . . . . 0.0 108.98 -178.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -99.84 146.82 26.18 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.482 ' HB ' HG12 ' A' ' 93' ' ' VAL . 9.7 t -127.88 142.27 51.32 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.41 -158.36 7.95 Favored Glycine 0 N--CA 1.433 -1.508 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -177.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.15 3.85 4.8 Favored 'Trans proline' 0 N--CA 1.482 0.847 0 C-N-CA 122.914 2.409 . . . . 0.0 113.566 -174.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -111.71 -42.1 3.9 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.89 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 158.9 -154.5 25.59 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.482 HG12 ' HB ' ' A' ' 88' ' ' THR . 10.7 m -104.02 147.66 9.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -178.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.9 pttp -146.07 141.98 28.12 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -176.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.2 mt -85.65 131.68 33.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -67.58 101.76 1.06 Allowed 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 102.37 45.56 1.68 Allowed Glycine 0 N--CA 1.429 -1.831 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.735 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.444 ' HB2' ' CD ' ' A' ' 101' ' ' GLU . 24.4 p -115.57 124.25 30.25 Favored Pre-proline 0 C--N 1.312 -1.049 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 177.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.93 -44.06 2.17 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.54 2.16 . . . . 0.0 115.316 -175.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.9 m -120.36 -16.37 8.43 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.833 -172.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.444 ' CD ' ' HB2' ' A' ' 98' ' ' CYS . 5.4 mp0 -60.34 125.21 81.26 Favored Pre-proline 0 C--N 1.3 -1.56 0 C-N-CA 123.276 0.631 . . . . 0.0 112.27 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -87.05 -167.67 0.37 Allowed 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 123.128 2.552 . . . . 0.0 110.967 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -81.65 109.74 16.35 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -81.48 147.26 29.8 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -78.88 -23.66 63.63 Favored Glycine 0 C--N 1.302 -1.317 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.06 -178.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.8 p -143.62 161.31 38.85 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.418 ' O ' HG23 ' A' ' 111' ' ' VAL . 94.6 mt -71.29 -31.69 67.75 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 173.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 m -56.85 -40.12 75.54 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.651 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.36 -50.81 71.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.995 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.2 pp -68.77 -29.02 67.32 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.648 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 107' ' ' LEU . 49.5 t -64.93 -50.28 75.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.145 0.498 . . . . 0.0 110.391 177.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.7 t -72.49 -38.52 68.14 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.508 -177.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -73.61 -36.46 65.48 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -174.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -76.52 -0.66 23.91 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.3 m -75.01 -40.69 60.48 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 170.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 63.8 mt -86.24 -44.34 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.128 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.3 m -136.16 94.85 13.79 Favored Pre-proline 0 C--N 1.303 -1.444 0 O-C-N 122.104 -0.373 . . . . 0.0 111.295 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -86.77 108.04 0.77 Allowed 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 123.008 2.472 . . . . 0.0 109.983 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.438 ' HB ' ' OE2' ' A' ' 101' ' ' GLU . 33.9 mt -89.63 -73.54 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.285 -177.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.9 t -66.72 -34.02 76.93 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.215 0.531 . . . . 0.0 110.222 176.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 81.5 mt -71.57 124.79 91.47 Favored Pre-proline 0 C--N 1.311 -1.071 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.701 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -65.04 -20.61 63.76 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.437 2.758 . . . . 0.0 113.354 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 78.0 m -136.99 169.18 18.2 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 80.6 m -73.59 136.51 43.95 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 123.261 0.351 . . . . 0.0 111.045 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 111' ' ' VAL . 22.7 tp -81.88 118.14 22.7 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -122.54 141.94 51.14 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.308 0.575 . . . . 0.0 111.273 -176.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.405 ' N ' HD12 ' A' ' 127' ' ' ILE . 2.8 mp -101.85 109.82 60.58 Favored Pre-proline 0 C--N 1.303 -1.422 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -74.44 -27.99 10.65 Favored 'Trans proline' 0 C--N 1.324 -0.745 0 C-N-CA 121.74 1.627 . . . . 0.0 112.275 -178.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.3 m -76.53 -16.36 59.64 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.679 -1.146 . . . . 0.0 113.109 -175.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.425 ' HD3' ' C ' ' A' ' 130' ' ' LYS . 12.2 tmtt? -149.74 128.19 12.24 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -177.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.406 ' N ' ' HD3' ' A' ' 130' ' ' LYS . 27.2 t70 . . . . . 0 C--N 1.288 -2.077 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 174.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 CA--C 1.507 -0.693 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 -97.93 115.75 28.76 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -131.19 160.79 33.79 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 39.2 m80 69.72 173.16 0.3 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.242 1.017 . . . . 0.0 111.907 176.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -141.56 100.99 3.89 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -126.99 -58.07 1.3 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.452 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 71.82 130.55 0.04 OUTLIER 'General case' 0 C--O 1.242 0.708 0 O-C-N 124.44 1.087 . . . . 0.0 112.31 -177.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.3 m -82.53 108.32 15.84 Favored 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 m -51.96 94.62 0.01 OUTLIER 'General case' 0 C--O 1.241 0.646 0 C-N-CA 125.002 1.321 . . . . 0.0 112.906 -176.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.1 90.51 0.47 Allowed Glycine 0 N--CA 1.436 -1.333 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.3 tp -178.98 -80.04 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.1 m -148.75 145.03 19.01 Favored Pre-proline 0 C--N 1.309 -1.179 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -47.5 -47.14 18.62 Favored 'Trans proline' 0 N--CA 1.476 0.481 0 C-N-CA 123.609 2.873 . . . . 0.0 113.935 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -98.44 19.36 14.59 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.326 0.584 . . . . 0.0 111.596 -176.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -130.88 39.36 1.8 Allowed Glycine 0 CA--C 1.496 -1.152 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.6 t -102.0 28.71 5.54 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -134.52 135.86 42.66 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.804 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.7 p -107.29 5.33 27.46 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -177.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.5 m -69.62 -24.13 63.6 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.972 -175.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.46 ' HD3' ' H ' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -81.13 -9.93 59.73 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 120.443 -0.503 . . . . 0.0 112.347 -177.658 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -76.6 -49.83 15.35 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.205 0.526 . . . . 0.0 111.588 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.454 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 29.6 p-90 -85.0 -12.95 52.09 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.768 -174.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -95.42 103.95 15.83 Favored 'General case' 0 N--CA 1.422 -1.831 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.683 -176.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.44 89.98 9.15 Favored Pre-proline 0 C--N 1.294 -1.844 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.099 174.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.73 18.79 0.81 Allowed 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 123.242 2.628 . . . . 0.0 112.411 -176.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -109.75 -3.73 16.55 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.79 -176.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.8 tp -101.19 130.61 47.31 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -172.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.0 m -79.45 170.68 16.23 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.593 0.757 . . . . 0.0 110.306 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -56.62 -53.71 54.51 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -69.85 -29.86 67.2 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.071 0.463 . . . . 0.0 110.654 -176.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -71.2 -33.42 69.92 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.686 176.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.4 -41.36 93.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.607 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 77.0 mt -67.3 -42.42 87.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.135 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.74 -28.78 67.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.857 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.71 -40.44 25.33 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.976 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.3 mp -86.73 -19.61 28.9 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -60.86 -36.56 79.48 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -92.92 3.01 56.49 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.307 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -99.4 169.58 9.23 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.708 0.766 . . . . 0.0 112.633 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -81.84 159.66 65.53 Favored Pre-proline 0 C--N 1.296 -1.722 0 C-N-CA 125.867 1.667 . . . . 0.0 111.368 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.02 111.88 2.79 Favored 'Trans proline' 0 C--N 1.36 1.172 0 C-N-CA 122.417 2.078 . . . . 0.0 110.32 176.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.88 -20.83 3.6 Favored Glycine 0 C--N 1.287 -2.159 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -176.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.01 136.49 48.4 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -151.75 173.04 15.21 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -177.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -155.91 158.05 37.32 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.454 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 65.8 mt -122.54 116.25 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.081 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 174.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.1 ptt-85 -108.23 -175.02 2.66 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -100.03 128.4 46.12 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.7 m -88.02 95.58 10.18 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.325 0.583 . . . . 0.0 110.162 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -73.86 11.98 0.77 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.775 0.797 . . . . 0.0 112.475 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.9 t -86.81 -15.81 38.13 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -146.28 -171.54 3.75 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -125.23 134.94 52.15 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 171.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.18 22.85 56.39 Favored Glycine 0 C--N 1.308 -1.006 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -128.52 127.63 42.77 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -101.37 162.1 13.15 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.29 118.54 3.43 Favored Glycine 0 C--N 1.286 -2.229 0 C-N-CA 119.875 -1.155 . . . . 0.0 111.474 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -98.8 127.48 44.74 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -178.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -122.6 117.35 25.63 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.6 tp -110.29 128.08 55.34 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 123.719 0.637 . . . . 0.0 110.287 -176.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -88.69 114.08 24.93 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 177.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 80' ' ' LEU . 25.5 m -103.58 171.49 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.84 -60.35 2.74 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.409 ' HB ' ' HG2' ' A' ' 66' ' ' PRO . 2.1 p -159.32 141.93 10.21 Favored Pre-proline 0 N--CA 1.433 -1.276 0 C-N-CA 124.923 1.289 . . . . 0.0 108.478 176.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.653 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 36.3 Cg_exo -59.62 -44.33 32.68 Favored 'Trans proline' 0 CA--C 1.574 2.508 0 C-N-CA 121.75 1.633 . . . . 0.0 111.645 171.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.653 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 59.1 Cg_endo -68.99 146.95 66.68 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 122.68 2.254 . . . . 0.0 110.038 170.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 66' ' ' PRO . 34.3 Cg_exo -62.13 -42.03 31.93 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.695 2.263 . . . . 0.0 113.103 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.4 m -118.56 -18.99 8.95 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.86 0.362 . . . . 0.0 110.235 -177.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.447 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 67.68 24.44 8.41 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.168 0.987 . . . . 0.0 112.564 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -67.92 -38.35 14.07 Favored Pre-proline 0 CA--C 1.558 1.262 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.968 172.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -68.05 108.91 1.82 Allowed 'Trans proline' 0 C--N 1.38 2.224 0 C-N-CA 121.208 1.272 . . . . 0.0 109.119 167.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -131.33 145.72 51.98 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -175.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -138.4 -37.59 0.55 Allowed 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.871 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.81 -57.41 0.03 OUTLIER Glycine 0 CA--C 1.48 -2.109 0 N-CA-C 107.27 -2.332 . . . . 0.0 107.27 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 54.84 93.83 0.05 OUTLIER Pre-proline 0 N--CA 1.468 0.433 0 C-N-CA 125.104 1.362 . . . . 0.0 113.975 169.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -83.37 165.53 14.4 Favored 'Trans proline' 0 C--O 1.243 0.743 0 C-N-CA 122.504 2.136 . . . . 0.0 112.347 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 p -68.99 -27.2 34.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.594 0.711 . . . . 0.0 110.592 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -66.51 -15.95 63.77 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.349 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -85.11 -19.47 31.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.567 0.699 . . . . 0.0 109.471 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.426 ' O ' HG22 ' A' ' 62' ' ' VAL . 72.2 mt -80.71 -11.27 59.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.005 -178.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.0 t -100.59 108.84 23.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -87.18 131.54 34.15 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -177.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -105.08 125.63 51.19 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.259 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -140.88 131.46 25.48 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 176.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.32 154.66 17.14 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 117.878 -1.529 . . . . 0.0 110.963 176.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.406 ' CG2' HG22 ' A' ' 93' ' ' VAL . 78.5 mt -115.37 125.97 72.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.408 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.973 -176.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.499 ' CD ' ' HE2' ' A' ' 96' ' ' LYS . 47.4 mt-10 -105.86 138.39 42.13 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.616 ' HB ' HG23 ' A' ' 93' ' ' VAL . 5.6 t -121.45 147.51 45.65 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.52 -167.05 29.52 Favored Glycine 0 N--CA 1.423 -2.217 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.91 -14.21 35.53 Favored 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 123.637 2.891 . . . . 0.0 114.636 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -89.0 -24.66 22.32 Favored 'General case' 0 CA--C 1.5 -0.966 0 O-C-N 121.752 -0.592 . . . . 0.0 111.401 176.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 132.53 -160.12 23.64 Favored Glycine 0 N--CA 1.423 -2.19 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -177.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.706 HG12 ' H ' ' A' ' 105' ' ' GLY . 7.7 p -118.38 136.85 54.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -177.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.19 169.13 25.48 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.424 ' HB ' ' HG3' ' A' ' 101' ' ' GLU . 59.7 mt -85.77 143.07 12.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-O 120.86 0.362 . . . . 0.0 110.929 -177.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.499 ' HE2' ' CD ' ' A' ' 87' ' ' GLU . 20.6 ttmm -99.17 140.57 33.14 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 172.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.08 43.06 4.19 Favored Glycine 0 CA--C 1.493 -1.303 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 24.5 p -129.73 157.61 76.11 Favored Pre-proline 0 N--CA 1.42 -1.968 0 CA-C-N 114.702 -0.749 . . . . 0.0 111.106 -171.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -65.56 -59.13 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 N-CA-C 107.72 -1.685 . . . . 0.0 107.72 167.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 67.0 m -164.32 125.57 2.2 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 124.522 1.129 . . . . 0.0 108.357 175.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.506 ' OE2' ' HB ' ' A' ' 119' ' ' ILE . 49.4 mm-40 -122.52 138.34 29.12 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.18 155.82 66.71 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.186 1.924 . . . . 0.0 110.688 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -91.59 99.48 12.39 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -64.62 -70.3 0.24 Allowed 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.353 0.597 . . . . 0.0 111.548 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.706 ' H ' HG12 ' A' ' 93' ' ' VAL . . . 145.17 -68.82 0.4 Allowed Glycine 0 C--N 1.3 -1.464 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 178.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.2 m -108.25 158.77 17.17 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.84 -36.53 82.54 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.4 t -64.81 -36.55 84.68 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.02 -47.36 83.39 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 175.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.3 tt -54.8 -50.79 67.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.113 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.518 ' HA ' HD23 ' A' ' 125' ' ' LEU . 69.1 t -61.55 -50.7 79.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.26 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.1 t -66.61 -31.68 72.53 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.171 0.51 . . . . 0.0 111.342 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -88.68 -18.97 26.79 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 121.711 -0.618 . . . . 0.0 112.657 -178.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -78.58 -9.36 59.33 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.137 0.494 . . . . 0.0 111.249 173.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.7 m -72.58 -27.62 62.3 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 170.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 35.2 mt -89.37 -60.14 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.575 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 27.0 m -120.57 99.17 47.86 Favored Pre-proline 0 N--CA 1.433 -1.324 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.968 -176.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -93.09 101.18 0.16 Allowed 'Trans proline' 0 N--CA 1.431 -2.169 0 C-N-CA 122.649 2.233 . . . . 0.0 109.482 172.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.506 ' HB ' ' OE2' ' A' ' 101' ' ' GLU . 63.8 mt -86.78 -62.36 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.12 -177.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.2 m -83.96 -16.88 42.49 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.273 0.559 . . . . 0.0 111.177 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.4 mt -90.12 123.7 65.19 Favored Pre-proline 0 C--N 1.305 -1.339 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -65.04 -30.19 56.52 Favored 'Trans proline' 0 N--CA 1.476 0.445 0 C-N-CA 122.808 2.339 . . . . 0.0 112.454 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 61.1 m -114.42 147.12 39.73 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.4 p -63.4 136.03 57.35 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 111' ' ' VAL . 18.8 tp -79.76 86.43 5.34 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -93.55 124.29 37.45 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.393 -175.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.461 ' H ' HD12 ' A' ' 127' ' ' ILE . 3.4 mp -70.78 112.04 11.82 Favored Pre-proline 0 C--N 1.315 -0.905 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -68.17 -31.89 28.47 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.366 2.044 . . . . 0.0 112.107 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 34.4 t 71.9 0.6 3.59 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.596 1.158 . . . . 0.0 111.057 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? -128.56 123.57 33.77 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.4 t70 . . . . . 0 C--O 1.258 1.507 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 177.26 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mmm . . . . . 0 N--CA 1.467 0.42 0 CA-C-O 120.403 0.144 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -72.11 117.36 13.64 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.382 -0.199 . . . . 0.0 111.474 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 39.9 m-70 70.89 18.4 6.08 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.326 1.05 . . . . 0.0 111.292 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -163.22 83.87 0.49 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.745 178.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -156.37 125.63 6.14 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.453 178.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -156.21 169.26 24.95 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -78.63 154.87 29.88 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.4 m -54.34 -37.14 64.55 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -175.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.1 m -87.19 -13.71 43.19 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.31 -72.72 1.4 Allowed Glycine 0 C--O 1.241 0.549 0 N-CA-C 111.613 -0.595 . . . . 0.0 111.613 -176.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.6 tp -171.96 -53.62 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 124.524 1.129 . . . . 0.0 108.829 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.2 t 61.03 81.23 0.24 Allowed Pre-proline 0 N--CA 1.473 0.688 0 C-N-CA 124.727 1.211 . . . . 0.0 109.895 -176.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -85.32 30.44 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.722 2.282 . . . . 0.0 113.529 -173.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -105.38 76.47 1.22 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.582 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -108.55 -3.24 32.77 Favored Glycine 0 CA--C 1.493 -1.308 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.276 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.5 p -101.41 13.84 33.81 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.78 0.8 . . . . 0.0 110.915 -176.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.515 ' O ' ' HE2' ' A' ' 20' ' ' LYS . 2.0 m-20 -95.35 118.92 32.95 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.926 -177.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.63 7.05 15.92 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -174.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.8 m -100.32 -19.66 16.22 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.439 177.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.515 ' HE2' ' O ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -66.31 3.52 0.9 Allowed 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 -176.469 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -85.42 -40.27 16.62 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 14.7 p-90 -120.74 -8.94 9.41 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -172.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -92.19 110.84 22.23 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.653 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.55 ' HB3' HD13 ' A' ' 27' ' ' LEU . 1.3 mptp? -128.52 89.03 50.7 Favored Pre-proline 0 C--N 1.313 -0.988 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.41 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.09 -1.64 8.27 Favored 'Trans proline' 0 CA--C 1.552 1.395 0 C-N-CA 122.722 2.282 . . . . 0.0 114.649 -177.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -90.84 -21.73 21.32 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.312 0.577 . . . . 0.0 109.87 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.55 HD13 ' HB3' ' A' ' 24' ' ' LYS . 9.8 mp -86.22 142.28 28.7 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -174.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.3 m -111.31 178.09 4.45 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 174.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -47.05 -52.28 15.41 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -58.45 -43.46 88.85 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.773 0.829 . . . . 0.0 110.73 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -70.79 -32.59 69.74 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.373 -177.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.2 -41.23 86.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.413 0.625 . . . . 0.0 109.803 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 72.0 mt -66.33 -40.41 86.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.828 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.83 -29.5 68.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.202 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.03 -47.45 11.68 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.444 HD12 HG13 ' A' ' 81' ' ' VAL . 72.6 mt -74.28 -19.44 60.49 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -176.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -72.01 -18.36 61.97 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.114 174.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -93.78 -35.54 12.71 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.386 178.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 36' ' ' LEU . 24.2 mmmt -77.38 171.11 15.38 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -71.59 164.28 59.25 Favored Pre-proline 0 C--N 1.314 -0.96 0 C-N-CA 126.753 2.021 . . . . 0.0 111.71 -176.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -75.91 126.5 9.42 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 121.815 1.677 . . . . 0.0 108.37 169.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.02 -9.62 43.38 Favored Glycine 0 C--N 1.292 -1.915 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -175.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.08 155.61 26.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.439 ' CG ' HD22 ' A' ' 125' ' ' LEU . 15.0 p90 -156.56 170.8 21.54 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.763 -173.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -156.43 149.99 24.66 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 172.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 68.7 mt -121.05 129.59 75.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -139.94 172.44 12.77 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.503 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -75.52 137.15 40.68 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 t -86.33 129.57 34.81 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -90.86 -14.84 31.0 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.5 t -70.5 -45.58 65.37 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.409 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -134.7 142.71 46.88 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -85.71 138.22 32.27 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.9 21.46 50.11 Favored Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.26 144.85 48.62 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 115.537 -0.332 . . . . 0.0 110.22 -178.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -116.28 132.82 56.56 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.3 120.25 5.69 Favored Glycine 0 C--N 1.287 -2.151 0 C-N-CA 119.932 -1.127 . . . . 0.0 111.46 -177.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -95.82 120.49 36.18 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.4 ' HB2' HH12 ' A' ' 47' ' ' ARG . . . -112.76 125.04 53.89 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.515 HD11 ' HB3' ' A' ' 123' ' ' CYS . 3.4 tm? -123.66 126.8 47.22 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -178.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -89.2 114.79 26.15 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 80' ' ' LEU . 32.8 m -99.67 171.64 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.26 -47.2 36.55 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.4 p -156.06 129.57 4.54 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 124.347 1.059 . . . . 0.0 108.988 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.651 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 28.0 Cg_exo -62.43 -45.08 15.73 Favored 'Trans proline' 0 CA--C 1.57 2.308 0 C-N-CA 121.884 1.723 . . . . 0.0 113.017 174.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.757 ' HG2' ' HB2' ' A' ' 69' ' ' ALA . 37.4 Cg_endo -63.94 142.66 82.74 Favored 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 122.273 1.982 . . . . 0.0 110.396 174.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -61.53 -34.48 85.31 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 123.349 2.7 . . . . 0.0 113.861 -174.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.1 p -119.07 -42.22 2.71 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.757 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 72.37 7.47 5.66 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 124.82 1.248 . . . . 0.0 113.106 174.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.443 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 64.8 tt0 -72.53 -55.75 4.35 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-O 119.121 -0.466 . . . . 0.0 112.028 -178.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 70' ' ' GLN . 6.9 Cg_endo -88.08 62.87 3.38 Favored 'Trans proline' 0 C--N 1.365 1.427 0 C-N-CA 121.461 1.44 . . . . 0.0 111.108 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.416 ' HE1' ' HB3' ' A' ' 75' ' ' ASP . 59.7 t-105 -160.66 141.27 11.59 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 113.353 -1.749 . . . . 0.0 110.441 -176.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.83 80.16 0.63 Allowed 'General case' 0 N--CA 1.413 -2.298 0 CA-C-O 122.635 1.207 . . . . 0.0 110.429 169.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.17 40.88 0.49 Allowed Glycine 0 C--N 1.301 -1.393 0 CA-C-N 114.213 -1.358 . . . . 0.0 112.165 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.416 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 6.9 p-10 -136.5 127.8 16.79 Favored Pre-proline 0 C--N 1.305 -1.337 0 CA-C-O 120.755 0.312 . . . . 0.0 111.054 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 79' ' ' GLN . 8.4 Cg_endo -91.55 177.37 1.89 Allowed 'Trans proline' 0 N--CA 1.436 -1.875 0 C-N-CA 121.829 1.686 . . . . 0.0 109.4 168.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.7 p -58.89 -24.99 27.99 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-O 121.603 0.716 . . . . 0.0 111.632 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.7 -26.77 64.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.006 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.461 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 8.5 tp-100 -80.95 -16.68 52.82 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 121.144 0.497 . . . . 0.0 109.711 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.453 ' O ' HG22 ' A' ' 62' ' ' VAL . 77.4 mt -74.53 -12.59 60.51 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-O 121.68 0.753 . . . . 0.0 109.991 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.444 HG13 HD12 ' A' ' 36' ' ' LEU . 74.7 t -88.3 125.9 41.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 176.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.404 ' NE ' ' HA ' ' A' ' 82' ' ' ARG . 3.9 mmp_? -105.23 143.84 32.84 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -118.75 133.87 55.54 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -139.15 167.33 22.3 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.05 138.11 41.83 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.94 177.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.522 HG12 HG12 ' A' ' 95' ' ' ILE . 80.1 mt -97.03 114.82 34.99 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-N 114.187 -1.369 . . . . 0.0 107.395 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -99.62 137.23 38.39 Favored 'General case' 0 C--N 1.273 -2.727 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.542 ' HB ' HG12 ' A' ' 93' ' ' VAL . 6.1 t -113.06 143.44 44.33 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -155.83 -157.97 8.56 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -73.18 -14.28 25.81 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.224 1.949 . . . . 0.0 112.823 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.467 ' HD2' ' N ' ' A' ' 91' ' ' LYS . 0.1 OUTLIER -84.88 -28.77 25.76 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 121.519 0.675 . . . . 0.0 110.331 177.739 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 139.19 -147.5 19.26 Favored Glycine 0 N--CA 1.433 -1.562 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.542 HG12 ' HB ' ' A' ' 88' ' ' THR . 15.0 m -113.52 141.5 29.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.67 150.31 26.17 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.674 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.522 HG12 HG12 ' A' ' 86' ' ' ILE . 83.3 mt -86.14 133.76 28.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.704 0.764 . . . . 0.0 111.309 -176.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -93.01 124.17 36.8 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 173.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 113.94 42.6 0.84 Allowed Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -174.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 120' ' ' SER . 13.5 p -129.34 144.9 54.6 Favored Pre-proline 0 N--CA 1.428 -1.529 0 CA-C-N 115.421 -0.39 . . . . 0.0 110.123 -175.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -67.33 -28.13 39.88 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.395 2.064 . . . . 0.0 111.928 176.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.5 t -153.86 -89.87 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.441 ' OE2' ' HB ' ' A' ' 95' ' ' ILE . 28.2 tt0 65.78 133.03 0.04 OUTLIER Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 125.377 1.471 . . . . 0.0 112.986 173.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -79.2 172.58 14.53 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.412 2.075 . . . . 0.0 112.557 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -92.39 131.89 37.2 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 175.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -102.42 170.7 7.89 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -177.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -99.55 -52.69 1.19 Allowed Glycine 0 C--N 1.3 -1.447 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.5 m -111.72 153.85 25.86 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.491 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 64.4 mt -63.24 -36.68 84.45 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.4 m -54.23 -30.19 49.24 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.486 1.114 . . . . 0.0 112.158 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.53 -41.95 92.53 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.112 -177.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 107' ' ' LEU . 4.2 pp -77.0 -31.33 56.38 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.969 0.414 . . . . 0.0 110.081 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.442 ' HA ' ' CD1' ' A' ' 125' ' ' LEU . 55.3 t -59.5 -54.73 30.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.455 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.4 m -72.48 -25.71 61.52 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.905 -177.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -84.13 -36.99 22.53 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.988 -176.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -72.13 -5.22 33.96 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -177.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.6 m -74.37 -31.9 62.56 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.6 mt -94.93 -50.16 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.972 -178.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 45.3 m -132.88 96.75 17.67 Favored Pre-proline 0 C--N 1.31 -1.142 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.979 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -81.86 114.23 2.58 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.702 2.268 . . . . 0.0 109.715 176.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 65.3 mt -91.49 -64.69 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 120.771 0.32 . . . . 0.0 110.512 -176.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.56 ' HB3' ' HB3' ' A' ' 98' ' ' CYS . 2.3 p -74.95 -49.66 19.35 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.467 0.651 . . . . 0.0 110.263 176.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.404 ' CD2' HD21 ' A' ' 125' ' ' LEU . 7.9 mp -65.87 137.69 96.15 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.877 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -80.53 -9.8 13.45 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.637 2.225 . . . . 0.0 112.92 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.515 ' HB3' HD11 ' A' ' 60' ' ' LEU . 44.8 t -136.35 150.69 48.96 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -178.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 24.8 p -71.82 146.11 48.21 Favored 'General case' 0 C--O 1.252 1.198 0 O-C-N 123.775 0.672 . . . . 0.0 110.555 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.442 ' CD1' ' HA ' ' A' ' 111' ' ' VAL . 91.6 mt -77.81 128.19 33.61 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.388 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -106.4 103.04 12.41 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 127' ' ' ILE . 3.4 mp -88.69 122.58 69.15 Favored Pre-proline 0 C--N 1.313 -1.002 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.865 -176.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.05 -35.37 90.16 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 123.162 2.574 . . . . 0.0 112.116 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.0 m 67.19 -25.63 0.12 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 126.008 1.723 . . . . 0.0 115.281 175.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -110.82 121.79 46.23 Favored 'General case' 0 N--CA 1.434 -1.253 0 O-C-N 121.789 -0.569 . . . . 0.0 111.559 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.9 t70 . . . . . 0 C--N 1.303 -1.44 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 173.206 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 ttm . . . . . 0 CA--C 1.516 -0.343 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -79.24 -90.22 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.404 ' CE1' ' HA ' ' A' ' 7' ' ' HIS . 34.6 t-80 -179.76 126.83 0.08 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -170.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -132.92 -83.35 0.47 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -111.9 -5.45 14.35 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -176.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -103.77 114.07 28.05 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.404 ' HA ' ' CE1' ' A' ' 3' ' ' HIS . 14.9 p-80 -73.86 116.6 14.66 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.785 0.802 . . . . 0.0 111.766 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.9 m -92.0 42.43 1.1 Allowed 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.674 0.75 . . . . 0.0 109.832 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.2 m -135.41 164.17 28.38 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.32 -92.27 1.34 Allowed Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -157.78 149.72 22.09 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.8 t -118.6 99.95 51.31 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 174.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.61 138.27 19.1 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.721 2.281 . . . . 0.0 112.892 -175.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -109.67 141.46 42.2 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.023 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.75 35.04 72.93 Favored Glycine 0 N--CA 1.44 -1.05 0 O-C-N 123.428 0.455 . . . . 0.0 112.328 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.3 m -79.0 -18.03 54.36 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 122.18 0.991 . . . . 0.0 110.206 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -122.57 129.65 52.16 Favored 'General case' 0 C--N 1.274 -2.697 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.418 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.5 p -118.55 12.23 13.12 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.4 m -56.8 -40.53 76.11 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.618 -177.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -60.0 -25.08 64.99 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -178.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -77.26 -27.82 53.31 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 120.876 0.369 . . . . 0.0 111.141 -177.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.0 p-90 -119.1 -17.97 8.83 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -176.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -94.42 110.22 22.02 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.657 -176.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.08 94.27 14.43 Favored Pre-proline 0 C--N 1.309 -1.188 0 C-N-CA 124.407 1.083 . . . . 0.0 108.644 174.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 47' ' ' ARG . 83.3 Cg_endo -75.0 -23.22 14.0 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.856 3.038 . . . . 0.0 117.463 -169.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -101.43 14.55 31.61 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 118.9 0.773 . . . . 0.0 111.167 -174.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.3 tp -88.66 135.3 33.57 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.6 m -82.87 163.54 21.08 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 122.341 -0.225 . . . . 0.0 110.971 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -52.88 -51.48 60.95 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -173.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -65.44 -37.35 86.63 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.414 0.626 . . . . 0.0 110.999 -176.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -72.08 -28.32 63.24 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.496 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.15 -45.18 74.25 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 175.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.458 HG23 HG21 ' A' ' 81' ' ' VAL . 77.1 mt -63.49 -35.1 71.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.52 177.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.99 -34.67 43.55 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.261 176.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.558 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 3.8 mm? -72.33 -50.41 27.05 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.502 0.667 . . . . 0.0 109.506 174.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.1 mp -70.64 -13.53 62.12 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -173.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -84.79 -1.25 56.12 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.543 0.687 . . . . 0.0 109.26 174.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -114.84 -30.44 6.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.876 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 35' ' ' LEU . 61.8 mmtt -80.28 -179.05 6.9 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -174.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -83.82 156.33 64.51 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.718 -177.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -66.16 115.08 3.28 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 121.922 1.748 . . . . 0.0 108.933 171.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 124.56 -17.56 7.34 Favored Glycine 0 C--N 1.297 -1.593 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -174.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.48 151.99 37.94 Favored 'General case' 0 C--O 1.249 1.06 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -154.44 174.87 14.3 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.333 -174.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -156.43 151.19 25.93 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 171.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.3 mt -120.22 129.66 75.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 19.9 ptt180 -119.51 172.74 7.43 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -100.56 127.28 46.99 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.1 m -107.53 119.43 39.41 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -173.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 -79.9 76.13 6.6 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.902 0.858 . . . . 0.0 108.971 174.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 t -136.2 -52.07 0.72 Allowed 'General case' 0 C--N 1.271 -2.805 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -128.86 168.97 15.16 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 176.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -88.58 121.74 31.28 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.361 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.81 50.97 7.41 Favored Glycine 0 N--CA 1.422 -2.263 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 86' ' ' ILE . . . -124.06 113.68 18.72 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.427 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 57.2 m-85 -98.78 125.14 44.05 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.296 -0.865 . . . . 0.0 108.707 -178.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.51 111.51 4.22 Favored Glycine 0 C--N 1.289 -2.033 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.318 -176.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 83' ' ' HIS . 38.9 tp -91.5 121.81 33.53 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -107.2 118.9 37.93 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 174.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.5 tp -114.73 130.88 56.9 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 123.496 0.497 . . . . 0.0 110.562 -177.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -90.66 113.71 25.83 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.516 ' HB ' ' SG ' ' A' ' 123' ' ' CYS . 17.7 m -98.25 162.13 2.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.6 -56.52 5.21 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 p -163.17 136.8 4.53 Favored Pre-proline 0 N--CA 1.425 -1.723 0 C-N-CA 126.883 2.073 . . . . 0.0 105.612 175.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.671 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 36.4 Cg_exo -59.81 -46.59 19.18 Favored 'Trans proline' 0 CA--C 1.572 2.419 0 C-N-CA 120.929 1.086 . . . . 0.0 111.339 172.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.671 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 67.3 Cg_endo -67.75 149.58 78.72 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 122.606 2.204 . . . . 0.0 110.13 172.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.01 -41.56 7.37 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.104 1.87 . . . . 0.0 112.435 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 33.1 t -110.78 -32.39 6.87 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.389 -177.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.586 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 64.82 38.16 6.86 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 123.86 0.864 . . . . 0.0 110.515 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -59.71 -44.54 97.54 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.018 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -70.25 95.56 0.6 Allowed 'Trans proline' 0 C--N 1.374 1.882 0 N-CA-C 108.746 -1.29 . . . . 0.0 108.746 167.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 56.4 t-105 -113.14 150.46 32.15 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.203 -173.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -137.61 -46.38 0.55 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 122.431 1.11 . . . . 0.0 108.032 176.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 146.57 -76.94 0.26 Allowed Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 107.323 -2.311 . . . . 0.0 107.323 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 72.95 135.35 0.05 OUTLIER Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 125.269 1.428 . . . . 0.0 111.265 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.56 156.02 59.38 Favored 'Trans proline' 0 C--O 1.239 0.533 0 C-N-CA 122.389 2.059 . . . . 0.0 110.947 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.8 p -62.01 -21.55 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.55 0.691 . . . . 0.0 110.281 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -66.05 -21.29 66.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.547 178.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -82.98 -28.18 29.91 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.252 0.549 . . . . 0.0 109.571 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.469 ' O ' HG22 ' A' ' 62' ' ' VAL . 2.8 mm? -84.92 -7.99 58.94 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.984 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.458 HG21 HG23 ' A' ' 33' ' ' ILE . 92.6 t -103.56 102.05 13.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 173.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -96.25 143.33 27.43 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.798 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.471 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 69.6 m80 -113.25 123.23 49.68 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.29 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -124.98 131.68 53.38 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 1.0 OUTLIER -102.98 132.19 49.41 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 118.756 -1.177 . . . . 0.0 112.666 179.737 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 55' ' ' ALA . 4.0 mp -87.64 125.24 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 175.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -99.39 125.83 45.16 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 92' ' ' GLY . 11.0 t -114.55 142.07 46.91 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 175.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.21 -138.3 4.4 Favored Glycine 0 N--CA 1.418 -2.516 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -67.84 -24.29 40.42 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.901 2.401 . . . . 0.0 113.971 -175.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -88.79 -17.85 28.94 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.583 0.706 . . . . 0.0 110.503 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.536 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 114.9 -152.51 18.09 Favored Glycine 0 N--CA 1.424 -2.166 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 -178.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.476 HG12 ' HB ' ' A' ' 88' ' ' THR . 6.3 m -104.79 125.99 59.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.82 150.87 26.52 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 121.804 -0.56 . . . . 0.0 109.966 177.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 75.8 mt -73.96 131.28 35.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 123.306 0.379 . . . . 0.0 110.961 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -72.89 119.59 17.34 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 123.976 0.91 . . . . 0.0 109.325 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.62 15.01 48.21 Favored Glycine 0 C--O 1.243 0.677 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.756 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.501 ' SG ' ' HB2' ' A' ' 120' ' ' SER . 19.4 t -85.05 125.36 70.65 Favored Pre-proline 0 N--CA 1.435 -1.187 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -53.02 -28.71 41.4 Favored 'Trans proline' 0 N--CA 1.487 1.098 0 C-N-CA 123.69 2.927 . . . . 0.0 113.652 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.2 m -142.33 119.11 11.14 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 178.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -90.95 116.63 66.83 Favored Pre-proline 0 C--N 1.283 -2.321 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -82.1 -19.32 6.95 Favored 'Trans proline' 0 C--N 1.328 -0.551 0 C-N-CA 122.204 1.936 . . . . 0.0 114.193 -176.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 50.83 98.87 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.215 0 C-N-CA 126.667 1.987 . . . . 0.0 113.234 -176.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.426 ' CD2' ' HB3' ' A' ' 110' ' ' LEU . 77.8 m-85 -111.67 178.84 4.19 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.67 -30.73 2.52 Favored Glycine 0 C--N 1.305 -1.183 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.729 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.0 m -115.36 143.83 44.69 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.426 ' O ' HG23 ' A' ' 111' ' ' VAL . 57.9 mt -62.51 -43.07 99.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.6 t -60.92 -29.46 69.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.926 0.393 . . . . 0.0 110.925 -177.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.46 -43.09 98.35 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.518 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.458 HD23 HG23 ' A' ' 93' ' ' VAL . 3.7 pp -76.3 -30.92 57.94 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.961 178.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.528 ' HA ' HD23 ' A' ' 125' ' ' LEU . 56.4 t -62.74 -51.65 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.69 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.6 t -65.31 -25.46 67.63 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.563 -176.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.482 ' HA ' ' OE1' ' A' ' 113' ' ' GLN . 9.3 mm-40 -85.27 -30.55 23.69 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.141 -0.623 . . . . 0.0 111.728 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 49.3 m80 -74.52 -6.66 49.68 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.062 0.458 . . . . 0.0 111.702 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.0 m -71.84 -29.99 64.98 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 173.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 60.3 mt -100.21 -53.01 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.664 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.7 m -120.8 96.29 48.76 Favored Pre-proline 0 N--CA 1.434 -1.256 0 CA-C-O 120.99 0.424 . . . . 0.0 111.727 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.451 ' HB2' ' O ' ' A' ' 121' ' ' LEU . 44.1 Cg_endo -75.1 101.64 1.5 Allowed 'Trans proline' 0 N--CA 1.43 -2.213 0 C-N-CA 121.324 1.349 . . . . 0.0 109.982 173.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 45.6 mt -76.6 -59.82 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.261 0.553 . . . . 0.0 109.925 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.501 ' HB2' ' SG ' ' A' ' 98' ' ' CYS . 21.5 t -84.51 -29.84 25.65 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.568 0.699 . . . . 0.0 109.482 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.451 ' O ' ' HB2' ' A' ' 118' ' ' PRO . 6.9 mp -80.69 142.8 53.49 Favored Pre-proline 0 C--N 1.299 -1.615 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.212 -175.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -82.89 -20.01 5.59 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.379 2.053 . . . . 0.0 112.02 176.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.516 ' SG ' ' HB ' ' A' ' 62' ' ' VAL . 83.8 m -126.72 160.52 30.58 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 60.3 m -72.6 140.79 48.24 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 123.545 0.528 . . . . 0.0 110.562 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.528 HD23 ' HA ' ' A' ' 111' ' ' VAL . 22.8 tp -85.74 102.38 13.59 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -110.07 119.65 39.95 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -173.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.4 mp -61.77 123.61 77.93 Favored Pre-proline 0 C--O 1.247 0.934 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.162 -176.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -54.87 -50.9 11.7 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 123.042 2.494 . . . . 0.0 112.477 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.9 m 59.27 18.22 6.44 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.5 1.12 . . . . 0.0 112.191 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.41 175.18 9.31 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 -177.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.261 1.667 0 O-C-N 124.499 1.124 . . . . 0.0 112.265 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.5 mmt . . . . . 0 CA--C 1.504 -0.825 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -71.01 -63.72 1.05 Allowed 'General case' 0 C--N 1.323 -0.547 0 O-C-N 123.552 0.533 . . . . 0.0 112.337 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -89.49 -55.31 3.71 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.032 0.444 . . . . 0.0 110.874 -175.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -166.02 -177.21 4.1 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 -176.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -64.26 116.88 6.44 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 172.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -75.03 17.78 0.21 Allowed 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -168.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 35.7 m170 -85.83 127.4 34.56 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 175.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 56.2 m 69.82 19.24 7.18 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 123.949 0.781 . . . . 0.0 110.761 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.6 t -71.39 -45.97 61.47 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.551 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.29 172.65 13.78 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 83.8 mt -100.27 104.25 15.72 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 177.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.4 t 63.63 77.32 0.32 Allowed Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -170.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.69 109.56 0.6 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.229 2.619 . . . . 0.0 112.602 -175.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -148.74 172.01 15.3 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -122.43 -110.36 2.05 Favored Glycine 0 N--CA 1.418 -2.55 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 175.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.2 p -100.08 7.11 44.88 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.816 0.817 . . . . 0.0 111.181 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -100.69 108.78 20.72 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.151 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.6 p -115.1 18.41 16.29 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 115.208 -0.905 . . . . 0.0 108.599 175.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.8 m -92.37 -43.45 9.23 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.771 -174.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.08 -5.13 8.81 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -176.027 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -78.26 -20.8 50.93 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.368 0.604 . . . . 0.0 109.553 175.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.484 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 37.9 p-90 -122.83 -30.66 3.79 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.239 176.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 38.4 t80 -95.22 122.06 37.51 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 120.981 0.42 . . . . 0.0 110.516 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.25 104.79 2.41 Favored Pre-proline 0 C--N 1.306 -1.307 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.946 174.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.36 22.96 0.55 Allowed 'Trans proline' 0 N--CA 1.486 1.031 0 C-N-CA 123.738 2.959 . . . . 0.0 114.116 -174.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -98.97 -12.28 20.78 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.461 0.648 . . . . 0.0 109.481 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.537 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 3.8 mm? -92.86 130.33 38.49 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.565 -178.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.1 m -90.66 175.85 6.88 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 172.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -57.54 -46.89 83.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 118.219 0.463 . . . . 0.0 112.143 -178.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -66.85 -38.59 86.66 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.561 0.696 . . . . 0.0 110.492 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -66.57 -37.65 85.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.096 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.6 -41.73 90.98 Favored 'General case' 0 CA--C 1.509 -0.635 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.265 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 72.5 mt -63.17 -48.01 89.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.68 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.412 ' HA ' ' CD ' ' A' ' 37' ' ' LYS . . . -63.34 -30.13 71.32 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.374 0.607 . . . . 0.0 111.775 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.08 -49.03 11.38 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.463 -178.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.528 ' HG ' ' HB2' ' A' ' 61' ' ' LYS . 16.1 tp -80.13 -16.93 53.87 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.538 -173.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.433 ' HB2' HG21 ' A' ' 77' ' ' VAL . 14.9 ptmm? -63.06 -31.26 72.35 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 122.061 -0.399 . . . . 0.0 110.796 178.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -82.02 -14.48 55.87 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.835 0.826 . . . . 0.0 110.283 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -85.93 162.84 18.37 Favored 'General case' 0 C--O 1.254 1.331 0 CA-C-O 121.665 0.745 . . . . 0.0 111.382 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.08 144.02 98.25 Favored Pre-proline 0 C--N 1.305 -1.345 0 CA-C-N 113.728 -1.578 . . . . 0.0 111.531 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.22 111.16 1.71 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.87 1.714 . . . . 0.0 109.029 171.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.87 -20.7 6.35 Favored Glycine 0 N--CA 1.427 -1.961 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -172.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.25 154.47 30.97 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-O 120.973 0.416 . . . . 0.0 110.07 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.402 ' CG ' HD22 ' A' ' 125' ' ' LEU . 26.1 p90 -149.0 163.79 36.47 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.191 -176.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -146.04 146.92 31.14 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 171.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 23' ' ' TYR . 60.1 mt -120.36 137.61 53.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.537 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -143.25 -175.75 4.66 Favored 'General case' 0 C--N 1.28 -2.446 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.543 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -78.74 128.11 32.98 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 175.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.408 ' HB2' ' N ' ' A' ' 57' ' ' GLY . 21.0 t -85.3 103.64 14.42 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -177.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -77.25 74.8 3.81 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-O 122.23 1.014 . . . . 0.0 109.861 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 72.3 m -157.1 -47.2 0.07 Allowed 'General case' 0 C--N 1.271 -2.836 0 CA-C-N 113.406 -1.724 . . . . 0.0 108.873 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -131.06 147.96 52.68 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -82.3 135.81 35.15 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.58 33.11 48.64 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -130.56 131.73 45.18 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.417 0.627 . . . . 0.0 109.706 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -111.48 123.69 50.75 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.408 ' N ' ' HB2' ' A' ' 49' ' ' SER . . . -85.1 124.84 6.93 Favored Glycine 0 C--N 1.295 -1.722 0 C-N-CA 119.971 -1.109 . . . . 0.0 111.801 -175.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -104.45 119.23 38.5 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.57 126.2 54.74 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -121.7 123.84 42.84 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.528 ' HB2' ' HG ' ' A' ' 36' ' ' LEU . 22.4 tptm -88.41 120.77 30.09 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.793 -178.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 80' ' ' LEU . 34.3 m -113.83 157.52 14.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 173.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.25 -38.06 71.95 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 p -158.37 132.22 4.97 Favored Pre-proline 0 N--CA 1.444 -0.729 0 C-N-CA 125.495 1.518 . . . . 0.0 107.737 176.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.631 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 23.4 Cg_exo -62.15 -44.02 21.43 Favored 'Trans proline' 0 CA--C 1.565 2.055 0 C-N-CA 122.068 1.845 . . . . 0.0 113.182 175.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.631 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 73.6 Cg_endo -70.91 160.7 48.53 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.722 2.282 . . . . 0.0 110.307 173.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -65.16 -54.17 0.7 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.074 1.85 . . . . 0.0 112.344 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.8 p -110.56 -27.59 8.89 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.087 -175.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.478 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 63.88 38.15 9.11 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 123.588 0.755 . . . . 0.0 109.501 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.459 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 34.5 tt0 -54.16 -51.56 76.38 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.959 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.459 ' HD3' ' HB3' ' A' ' 70' ' ' GLN . 2.4 Cg_endo -89.73 101.96 0.33 Allowed 'Trans proline' 0 N--CA 1.436 -1.903 0 C-N-CA 121.611 1.54 . . . . 0.0 111.158 175.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 47.4 t-105 -96.44 144.49 26.51 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -139.59 -41.44 0.45 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.147 0.499 . . . . 0.0 110.668 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.83 77.95 0.03 OUTLIER Glycine 0 CA--C 1.476 -2.379 0 N-CA-C 108.449 -1.861 . . . . 0.0 108.449 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -123.47 101.92 36.76 Favored Pre-proline 0 C--N 1.294 -1.824 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -173.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -88.78 -175.66 1.27 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.502 2.135 . . . . 0.0 114.245 -175.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.433 HG21 ' HB2' ' A' ' 37' ' ' LYS . 9.7 p -62.01 -23.85 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 115.077 -0.965 . . . . 0.0 113.306 -175.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.15 -23.92 67.66 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.681 0.277 . . . . 0.0 111.437 176.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.416 ' HG2' ' HG2' ' A' ' 65' ' ' PRO . 8.3 tt0 -92.04 -30.07 16.24 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 178.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.491 ' O ' HG22 ' A' ' 62' ' ' VAL . 64.4 mt -66.41 -33.91 76.78 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.574 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 95.6 t -85.51 109.98 19.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 172.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -84.16 133.98 34.59 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -176.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.431 ' CD2' HH22 ' A' ' 47' ' ' ARG . 5.6 m80 -113.45 122.76 48.29 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -132.53 154.96 49.46 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 176.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -125.5 137.02 53.94 Favored 'General case' 0 C--N 1.283 -2.299 0 C-N-CA 118.631 -1.227 . . . . 0.0 110.93 176.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 86.0 mt -92.57 117.08 35.16 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.81 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.135 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.422 ' OE1' ' HE3' ' A' ' 96' ' ' LYS . 50.8 mt-10 -109.43 144.69 37.31 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.41 ' HB ' HG23 ' A' ' 93' ' ' VAL . 3.4 t -118.62 131.96 56.18 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.33 -144.73 4.17 Favored Glycine 0 N--CA 1.429 -1.78 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.385 -178.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -61.87 -44.15 22.14 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.868 2.379 . . . . 0.0 113.864 -177.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.464 ' HD2' ' N ' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -75.91 -41.93 50.44 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.917 -176.428 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.6 -154.94 25.94 Favored Glycine 0 N--CA 1.425 -2.069 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.41 HG23 ' HB ' ' A' ' 88' ' ' THR . 8.8 p -111.94 126.09 69.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.41 ' HG2' ' OE1' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -162.56 178.12 8.84 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.755 -178.375 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 58.8 mt -88.12 143.92 10.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 C-N-CA 123.598 0.759 . . . . 0.0 112.693 -169.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.422 ' HE3' ' OE1' ' A' ' 87' ' ' GLU . 25.0 ttmt -95.46 136.89 35.27 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 170.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.83 55.0 1.69 Allowed Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -175.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.463 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 11.9 p -135.31 154.28 78.57 Favored Pre-proline 0 C--N 1.311 -1.103 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -167.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 98' ' ' CYS . 2.2 Cg_endo -84.9 -56.54 0.02 OUTLIER 'Trans proline' 0 CA--C 1.558 1.69 0 C-N-CA 122.995 2.463 . . . . 0.0 112.633 173.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.0 m -149.88 131.54 14.94 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -177.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.41 ' OE1' ' HG2' ' A' ' 94' ' ' LYS . 43.9 mt-10 -140.46 140.08 21.98 Favored Pre-proline 0 C--N 1.297 -1.68 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.94 153.65 29.2 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.024 1.816 . . . . 0.0 107.694 166.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -92.98 112.32 24.24 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.46 -0.775 . . . . 0.0 110.797 -178.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.424 ' HE1' ' OE1' ' A' ' 113' ' ' GLN . 29.4 m-85 -89.0 157.43 18.37 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.11 -173.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -97.04 -27.67 9.25 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.556 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 53.8 m -141.69 157.29 45.24 Favored 'General case' 0 C--O 1.244 0.766 0 O-C-N 122.233 -0.569 . . . . 0.0 110.838 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.9 -35.12 72.51 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.449 0.7 . . . . 0.0 111.771 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.1 t -51.95 -31.21 27.95 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.85 0.86 . . . . 0.0 111.76 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.409 ' O ' ' HG3' ' A' ' 113' ' ' GLN . . . -73.7 -48.58 31.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 122.229 -0.295 . . . . 0.0 111.246 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 pp -67.7 -29.46 68.73 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.204 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 78.6 t -67.86 -48.65 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.32 176.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.5 p -68.51 -44.85 73.76 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.424 ' OE1' ' HE1' ' A' ' 104' ' ' PHE . 66.4 mt-30 -66.22 -41.53 89.95 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.718 -178.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.532 ' HA ' ' O ' ' A' ' 117' ' ' SER . 58.1 m80 -77.79 -9.94 59.29 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.7 t -76.05 -23.51 55.1 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 174.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 72.2 mt -99.94 -66.87 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.806 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.532 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 20.2 m -102.62 117.72 60.2 Favored Pre-proline 0 N--CA 1.433 -1.276 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.814 -175.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -82.35 88.96 1.22 Allowed 'Trans proline' 0 N--CA 1.439 -1.697 0 C-N-CA 121.882 1.721 . . . . 0.0 110.267 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 52.2 mt -88.63 -69.98 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.467 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.6 m -88.73 -6.73 57.23 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.117 0.484 . . . . 0.0 111.319 -178.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.7 mt -118.61 145.12 36.8 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -176.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.26 -36.51 45.77 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.947 2.431 . . . . 0.0 113.613 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 60.8 m -123.65 159.88 28.37 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 85.1 m -73.34 139.63 46.16 Favored 'General case' 0 N--CA 1.434 -1.246 0 O-C-N 123.686 0.616 . . . . 0.0 109.722 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.402 HD22 ' CG ' ' A' ' 44' ' ' PHE . 84.8 mt -65.37 110.79 2.76 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.583 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -89.38 95.36 10.25 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 174.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 58.6 mt -65.52 126.28 91.24 Favored Pre-proline 0 C--N 1.302 -1.484 0 CA-C-N 113.966 -1.47 . . . . 0.0 108.997 -178.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.11 -63.31 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.861 1.707 . . . . 0.0 110.223 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 34.5 t 67.12 -44.74 0.46 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.056 1.342 . . . . 0.0 112.666 177.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -113.17 -166.21 1.06 Allowed 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 123.932 0.893 . . . . 0.0 109.988 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 C--N 1.295 -1.785 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.761 179.889 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ppp? . . . . . 0 CA--C 1.51 -0.581 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -149.3 -58.49 0.21 Allowed 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.7 m170 53.44 81.81 0.09 Allowed 'General case' 0 C--O 1.243 0.717 0 O-C-N 124.212 0.945 . . . . 0.0 112.205 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -66.1 -53.32 39.43 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.93 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -91.24 80.71 5.56 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.09 0.471 . . . . 0.0 111.234 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -97.49 71.01 2.29 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 174.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -176.24 173.24 2.19 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 113.162 -1.836 . . . . 0.0 106.156 -176.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.1 m -93.33 157.38 16.27 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.048 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.7 m -64.3 107.89 1.45 Allowed 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 121.31 0.576 . . . . 0.0 109.786 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.15 -25.06 1.26 Allowed Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -176.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 33.3 tp -89.66 27.16 1.57 Allowed 'General case' 0 CA--C 1.55 0.946 0 CA-C-O 122.289 1.042 . . . . 0.0 109.962 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.6 t -106.82 132.72 20.68 Favored Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -55.38 106.96 0.21 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 122.54 2.16 . . . . 0.0 110.489 175.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.581 ' HD2' ' O ' ' A' ' 17' ' ' ASP . 28.9 ttm180 -99.82 -23.85 14.85 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.287 -172.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.97 33.26 5.84 Favored Glycine 0 N--CA 1.434 -1.49 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.619 -176.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.6 m 52.94 43.62 31.43 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.115 0.966 . . . . 0.0 111.908 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.581 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 11.6 t70 -117.41 139.82 50.38 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.214 -176.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.1 p -133.84 18.23 3.85 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.868 0.842 . . . . 0.0 108.738 172.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.3 m -93.99 -33.31 13.49 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.627 -175.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -16.32 61.14 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.048 0.451 . . . . 0.0 111.672 -177.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -66.22 -40.06 90.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.506 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.416 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 11.8 p-90 -104.76 -5.67 21.04 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -94.11 113.16 25.06 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.961 -176.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.411 ' HB3' HD23 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -132.02 87.67 43.53 Favored Pre-proline 0 C--N 1.311 -1.109 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.5 178.622 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.14 -12.57 17.44 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.706 2.271 . . . . 0.0 115.254 -172.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -96.79 19.31 12.75 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.078 0.465 . . . . 0.0 111.27 -177.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.56 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 4.4 mm? -105.95 128.56 53.88 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.363 0.601 . . . . 0.0 112.25 -178.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.8 t -88.86 173.42 8.53 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 174.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.417 ' O ' HG13 ' A' ' 33' ' ' ILE . 11.0 ttm180 -48.96 -56.93 7.41 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.545 0.738 . . . . 0.0 112.36 -174.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -66.21 -37.3 85.23 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.999 -172.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -75.58 -32.08 60.22 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.269 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.57 89.96 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 175.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 29' ' ' ARG . 89.6 mt -59.99 -46.42 94.15 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.656 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.556 178.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' A' ' 37' ' ' LYS . . . -59.02 -44.97 91.78 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 41.2 mt -64.87 -47.34 78.21 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.706 0.765 . . . . 0.0 111.593 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.566 ' HG ' ' HB2' ' A' ' 61' ' ' LYS . 51.5 tp -70.52 -38.14 74.22 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.291 -1.322 . . . . 0.0 113.835 -173.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 14.3 ptmm? -56.75 -30.57 63.72 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -175.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -98.73 8.8 44.53 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.53 0.681 . . . . 0.0 111.077 -177.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . 0.261 45.3 mtmt -84.15 -85.64 0.13 Allowed 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 119.18 -1.008 . . . . 0.0 113.382 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -173.48 136.9 0.71 Allowed Pre-proline 0 C--N 1.289 -2.024 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -176.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -58.56 107.3 0.33 Allowed 'Trans proline' 0 C--O 1.246 0.906 0 C-N-CA 122.519 2.146 . . . . 0.0 110.704 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.45 -25.82 4.73 Favored Glycine 0 N--CA 1.426 -1.972 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -175.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.421 ' O ' HD11 ' A' ' 36' ' ' LEU . . . -76.06 155.19 35.05 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-O 121.093 0.473 . . . . 0.0 110.362 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -146.2 178.33 8.31 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.431 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -156.64 149.46 23.79 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 169.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.416 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 61.1 mt -113.69 124.07 69.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.56 ' HD2' ' O ' ' A' ' 27' ' ' LEU . 39.1 ptt85 -117.28 -177.25 3.18 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.398 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -98.92 136.66 38.6 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.9 t -109.81 152.98 25.03 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.376 0.608 . . . . 0.0 112.212 -172.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -117.62 92.52 3.86 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-O 121.964 0.888 . . . . 0.0 108.884 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.4 m -153.85 -50.92 0.1 Allowed 'General case' 0 C--N 1.258 -3.401 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 177.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -130.88 143.32 50.64 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 104.068 -2.567 . . . . 0.0 104.068 171.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -81.22 120.46 24.92 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.52 30.63 4.88 Favored Glycine 0 C--N 1.295 -1.708 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -171.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -119.29 145.4 46.15 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.491 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 85.1 m-85 -115.55 143.06 45.88 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.31 123.03 7.67 Favored Glycine 0 C--N 1.285 -2.281 0 C-N-CA 119.995 -1.098 . . . . 0.0 110.432 -178.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -99.61 119.87 38.77 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -114.41 121.93 45.08 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 176.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.8 tt -123.05 123.86 41.82 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -176.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.566 ' HB2' ' HG ' ' A' ' 36' ' ' LEU . 22.1 tptm -90.25 113.44 25.27 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 80' ' ' LEU . 17.9 m -99.02 171.26 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.02 -56.57 4.54 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 176.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.411 ' HA ' HD12 ' A' ' 80' ' ' LEU . 9.4 p -158.67 132.45 4.96 Favored Pre-proline 0 C--N 1.309 -1.189 0 C-N-CA 125.294 1.437 . . . . 0.0 108.287 177.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.61 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 35.7 Cg_exo -59.73 -42.14 48.99 Favored 'Trans proline' 0 CA--C 1.577 2.65 0 C-N-CA 121.376 1.384 . . . . 0.0 111.545 171.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.61 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 95.3 Cg_endo -76.89 172.25 16.53 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 122.991 2.46 . . . . 0.0 110.153 170.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.62 -44.91 43.57 Favored 'Trans proline' 0 C--N 1.362 1.241 0 C-N-CA 122.873 2.382 . . . . 0.0 112.633 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.5 m -143.49 -15.3 0.65 Allowed 'General case' 0 C--O 1.247 0.968 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.344 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.478 ' HB2' ' CG ' ' A' ' 66' ' ' PRO . . . 58.38 43.63 19.55 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 123.884 0.873 . . . . 0.0 108.688 -174.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -57.68 -48.23 97.57 Favored Pre-proline 0 N--CA 1.447 -0.606 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.819 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -76.41 87.6 1.43 Allowed 'Trans proline' 0 C--N 1.371 1.734 0 CA-C-N 120.495 1.212 . . . . 0.0 109.746 171.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 31.4 t-105 -81.78 141.52 33.43 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.674 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -122.9 -33.11 3.41 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.306 -0.958 . . . . 0.0 112.102 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.03 68.12 0.02 OUTLIER Glycine 0 CA--C 1.466 -2.976 0 N-CA-C 106.097 -2.801 . . . . 0.0 106.097 -176.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -104.4 110.9 64.94 Favored Pre-proline 0 C--N 1.284 -2.24 0 CA-C-N 113.381 -1.409 . . . . 0.0 111.215 -168.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -73.84 159.83 44.5 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.12 1.88 . . . . 0.0 111.437 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.456 ' HA ' HD23 ' A' ' 80' ' ' LEU . 8.6 p -62.99 -20.78 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.462 0.648 . . . . 0.0 110.676 -178.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -67.75 -13.32 62.02 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 124.065 0.946 . . . . 0.0 111.396 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -87.67 -38.36 15.93 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.47 ' O ' HG22 ' A' ' 62' ' ' VAL . 2.7 mm? -73.15 -27.57 61.74 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.866 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.501 HG13 HD23 ' A' ' 36' ' ' LEU . 69.2 t -86.18 110.08 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 171.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -91.78 134.27 34.89 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.408 -0.814 . . . . 0.0 108.853 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -114.26 122.5 46.93 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.298 0.57 . . . . 0.0 110.579 178.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -129.75 160.17 34.25 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -123.14 150.49 43.21 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.657 -1.217 . . . . 0.0 111.927 174.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.491 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 81.6 mt -108.81 131.1 60.41 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.792 0 CA-C-N 114.068 -1.424 . . . . 0.0 107.615 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -115.54 137.47 52.03 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 1.7 t -110.81 118.72 36.91 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 171.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -135.52 -148.09 5.57 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.85 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -71.25 -34.1 10.42 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 122.56 2.173 . . . . 0.0 113.875 -177.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -75.72 -26.49 57.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.129 0.49 . . . . 0.0 111.034 178.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 139.04 -153.52 22.82 Favored Glycine 0 N--CA 1.425 -2.087 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 88' ' ' THR . 13.9 p -112.04 130.87 64.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.23 170.01 23.22 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.425 ' HB ' ' SG ' ' A' ' 98' ' ' CYS . 64.1 mt -81.16 140.46 16.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -52.39 -53.05 49.95 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 123.601 0.761 . . . . 0.0 109.926 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.65 23.79 5.47 Favored Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 115.086 -0.961 . . . . 0.0 114.666 -176.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.425 ' SG ' ' HB ' ' A' ' 95' ' ' ILE . 31.1 p -116.02 103.09 53.71 Favored Pre-proline 0 N--CA 1.435 -1.2 0 CA-C-N 118.315 1.057 . . . . 0.0 110.551 174.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -100.6 28.47 0.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.124 2.549 . . . . 0.0 110.053 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.3 p -75.54 -78.71 0.11 Allowed 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.438 -176.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -166.68 -59.07 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -79.12 126.23 6.92 Favored 'Trans proline' 0 N--CA 1.44 -1.668 0 N-CA-C 115.813 1.428 . . . . 0.0 115.813 -165.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -97.72 121.03 39.15 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 168.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.556 ' CD2' ' HB3' ' A' ' 110' ' ' LEU . 60.0 m-85 -94.46 166.29 12.13 Favored 'General case' 0 C--N 1.289 -2.024 0 O-C-N 123.395 0.434 . . . . 0.0 111.177 -170.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.22 -36.78 6.93 Favored Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 121.108 -0.568 . . . . 0.0 111.991 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.9 m -140.98 169.41 17.68 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 122.497 -0.414 . . . . 0.0 109.943 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.471 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 94.8 mt -62.36 -40.05 95.17 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.107 0.563 . . . . 0.0 112.198 -176.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.0 t -52.53 -40.46 62.52 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.218 0.607 . . . . 0.0 112.037 -178.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.58 96.41 Favored 'General case' 0 C--O 1.247 0.954 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.556 ' HB3' ' CD2' ' A' ' 104' ' ' PHE . 4.4 pp -72.55 -28.73 63.01 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 120.912 0.387 . . . . 0.0 110.919 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 40.6 t -63.78 -54.59 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.132 177.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 45.9 m -65.28 -36.67 84.83 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.502 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -57.77 -48.18 80.39 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.434 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.474 ' HA ' ' O ' ' A' ' 117' ' ' SER . 71.6 m80 -87.53 -2.49 58.65 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.5 t -79.33 -31.15 43.03 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 67.4 mt -95.85 -58.96 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.424 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 21.6 m -111.57 105.3 56.71 Favored Pre-proline 0 N--CA 1.434 -1.247 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.835 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -75.29 85.35 1.57 Allowed 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 121.696 1.597 . . . . 0.0 110.076 175.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.0 mt -72.51 -73.85 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.908 -177.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.1 m -98.89 1.18 45.46 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.664 0.745 . . . . 0.0 111.318 -176.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.4 mt -105.29 137.6 19.3 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.78 -10.93 29.76 Favored 'Trans proline' 0 N--CA 1.485 1.023 0 C-N-CA 122.885 2.39 . . . . 0.0 113.701 -177.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 52.3 t -141.01 151.52 44.17 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 13.2 p -76.67 142.65 40.5 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 176.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 90.1 mt -73.02 120.17 18.27 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 123.741 0.651 . . . . 0.0 109.738 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -101.41 120.07 39.72 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mt -105.29 109.59 63.39 Favored Pre-proline 0 N--CA 1.429 -1.483 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -84.68 -5.11 9.95 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 C-N-CA 122.725 2.283 . . . . 0.0 113.08 -176.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.4 m 60.6 26.47 16.17 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 124.898 1.279 . . . . 0.0 110.117 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.4 149.43 26.13 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 114.211 -1.359 . . . . 0.0 107.804 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.3 t70 . . . . . 0 C--N 1.262 -3.21 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.263 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.6 ttm . . . . . 0 CA--C 1.52 -0.187 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -117.45 140.46 49.56 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -83.43 -21.39 32.96 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.272 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -77.19 130.15 36.9 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 174.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -82.05 -15.48 53.41 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.046 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.4 m80 62.47 77.44 0.33 Allowed 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.036 0.934 . . . . 0.0 109.415 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -84.72 170.25 13.45 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.141 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.5 m -76.11 15.98 0.49 Allowed 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 m -68.88 -34.21 75.05 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 173.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.34 42.58 2.12 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 49.2 tp -88.96 104.87 17.37 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.6 m -79.35 148.18 70.01 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -45.25 -59.53 1.13 Allowed 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 123.672 2.915 . . . . 0.0 112.338 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -134.43 -49.63 0.78 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.5 12.13 25.58 Favored Glycine 0 CA--C 1.494 -1.251 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.08 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.7 m -89.39 13.4 13.73 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.774 0.797 . . . . 0.0 110.762 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.481 ' O ' ' HD2' ' A' ' 20' ' ' LYS . 18.6 m-20 -112.48 139.76 47.79 Favored 'General case' 0 CA--C 1.478 -1.819 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.1 p -83.1 15.29 2.89 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 122.417 1.103 . . . . 0.0 111.827 -175.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 36.2 t -80.06 -21.56 43.26 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.27 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.481 ' HD2' ' O ' ' A' ' 17' ' ' ASP . 0.1 OUTLIER -68.95 -4.55 17.1 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -173.887 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -86.19 -12.09 50.72 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 122.114 -0.366 . . . . 0.0 110.78 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.444 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 53.3 p-90 -142.48 -28.95 0.58 Allowed 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -175.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.435 ' HB2' ' CE3' ' A' ' 22' ' ' TRP . 55.4 t80 -92.46 114.26 26.76 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.331 0.586 . . . . 0.0 112.535 -173.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.9 96.56 2.92 Favored Pre-proline 0 C--N 1.306 -1.314 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.816 172.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.95 3.78 6.7 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 123.26 2.64 . . . . 0.0 114.227 -173.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -85.11 -14.66 46.42 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.701 0.762 . . . . 0.0 109.504 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.3 tp -89.2 134.86 33.87 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.367 -169.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.8 t -92.27 177.5 6.13 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-O 120.875 0.369 . . . . 0.0 110.015 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.401 ' HA ' ' CZ ' ' A' ' 47' ' ' ARG . 17.1 ttm180 -54.48 -56.11 22.13 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 124.506 1.122 . . . . 0.0 113.4 -172.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -65.31 -40.59 93.97 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.386 0.612 . . . . 0.0 111.1 -174.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -65.45 -35.83 82.1 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.162 -177.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.33 -40.07 96.28 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.376 178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 73.4 mt -67.95 -41.23 84.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.197 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.11 -31.61 70.21 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.245 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.2 mt -79.81 -39.83 29.92 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.396 0.617 . . . . 0.0 111.707 175.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.9 tp -75.6 -28.74 59.0 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.065 -173.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.2 ptmm? -64.05 -15.07 58.69 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.31 0.576 . . . . 0.0 111.385 178.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -95.5 -13.63 24.36 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.316 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -99.27 174.32 6.36 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.919 0.39 . . . . 0.0 111.457 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -92.94 158.74 37.11 Favored Pre-proline 0 C--N 1.304 -1.376 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.061 -173.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -59.61 120.81 8.85 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 122.472 2.114 . . . . 0.0 110.873 175.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.81 -14.52 10.55 Favored Glycine 0 C--N 1.298 -1.543 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -176.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.75 151.67 27.36 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.462 ' CG ' HD22 ' A' ' 125' ' ' LEU . 22.5 p90 -152.16 162.03 41.74 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -175.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -150.48 147.32 27.36 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 174.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.444 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 64.6 mt -118.96 127.29 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 CA-C-O 121.692 0.758 . . . . 0.0 109.673 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.41 HH22 ' CD2' ' A' ' 83' ' ' HIS . 26.5 ptt-85 -125.3 -173.96 2.94 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -92.27 135.06 34.31 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 174.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 70.2 m -83.64 99.16 10.03 Favored 'General case' 0 N--CA 1.426 -1.631 0 C-N-CA 120.221 -0.591 . . . . 0.0 109.407 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -74.15 69.5 1.52 Allowed 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 121.98 0.895 . . . . 0.0 109.794 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.3 m -157.63 -36.46 0.07 Allowed 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 113.352 -1.749 . . . . 0.0 108.412 -177.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -133.4 166.98 21.27 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -110.89 130.12 55.68 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.78 24.5 38.26 Favored Glycine 0 C--N 1.304 -1.205 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.418 ' HB1' HD23 ' A' ' 85' ' ' LEU . . . -134.17 122.44 22.83 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-O 121.673 0.749 . . . . 0.0 110.146 -178.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -96.66 155.91 16.57 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -118.19 120.72 4.82 Favored Glycine 0 C--N 1.273 -2.952 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.45 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.2 tp -98.45 121.7 40.72 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 124.296 0.644 . . . . 0.0 109.275 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.15 112.93 25.37 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.7 tp -108.78 129.54 55.38 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 123.528 0.518 . . . . 0.0 109.7 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -88.83 119.3 29.21 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.7 m -108.38 165.71 4.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.32 -58.73 5.2 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.516 HG21 ' H ' ' A' ' 69' ' ' ALA . 0.6 OUTLIER -164.64 145.47 6.41 Favored Pre-proline 0 C--N 1.314 -0.97 0 C-N-CA 123.545 0.738 . . . . 0.0 110.663 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.569 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 16.3 Cg_exo -63.05 -49.82 4.5 Favored 'Trans proline' 0 CA--C 1.571 2.344 0 C-N-CA 121.933 1.756 . . . . 0.0 109.44 168.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.569 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 15.9 Cg_endo -57.55 179.81 0.13 Allowed 'Trans proline' 0 C--N 1.392 2.831 0 C-N-CA 122.825 2.35 . . . . 0.0 110.841 162.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -71.82 -47.46 0.46 Allowed 'Trans proline' 0 C--N 1.357 1.001 0 N-CA-C 108.072 -1.549 . . . . 0.0 108.072 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 71.5 m -160.79 111.68 1.81 Allowed 'General case' 0 N--CA 1.407 -2.608 0 N-CA-C 103.442 -2.799 . . . . 0.0 103.442 171.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.516 ' H ' HG21 ' A' ' 64' ' ' THR . . . -58.41 76.15 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 124.031 0.932 . . . . 0.0 113.085 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.467 ' H ' ' HD2' ' A' ' 71' ' ' PRO . 51.4 tt0 -87.82 -47.43 0.47 Allowed Pre-proline 0 C--N 1.286 -2.156 0 CA-C-N 114.578 -1.192 . . . . 0.0 107.892 172.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.467 ' HD2' ' H ' ' A' ' 70' ' ' GLN . 20.2 Cg_endo -65.51 109.19 1.35 Allowed 'Trans proline' 0 C--N 1.377 2.05 0 N-CA-C 108.654 -1.325 . . . . 0.0 108.654 165.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -81.83 137.32 35.29 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.981 -175.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -126.17 -36.75 2.3 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.763 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 167.73 -48.34 0.24 Allowed Glycine 0 CA--C 1.467 -2.93 0 N-CA-C 107.335 -2.306 . . . . 0.0 107.335 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 39.49 78.38 0.37 Allowed Pre-proline 0 C--N 1.316 -0.87 0 C-N-CA 126.817 2.047 . . . . 0.0 114.647 168.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -75.38 163.2 34.95 Favored 'Trans proline' 0 C--O 1.242 0.701 0 C-N-CA 122.251 1.967 . . . . 0.0 111.518 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -67.11 -30.29 48.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 120.985 0.421 . . . . 0.0 111.182 -178.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -70.71 -18.77 62.8 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.202 0.525 . . . . 0.0 110.473 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -79.09 -22.77 44.76 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.6 mt -89.35 5.69 43.92 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.962 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.8 t -117.85 141.47 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -109.45 137.39 47.37 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.41 ' CD2' HH22 ' A' ' 47' ' ' ARG . 26.8 m80 -117.7 122.77 44.4 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 121.439 0.638 . . . . 0.0 111.669 178.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -135.57 143.38 45.62 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 177.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.418 HD23 ' HB1' ' A' ' 55' ' ' ALA . 3.9 mp -96.42 162.61 13.41 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.263 -1.375 . . . . 0.0 108.726 174.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 80.2 mt -125.13 110.83 25.69 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.014 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 174.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.462 ' OE1' ' HD3' ' A' ' 96' ' ' LYS . 30.1 mt-10 -99.72 148.93 23.84 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -175.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.565 ' HB ' HG23 ' A' ' 93' ' ' VAL . 5.3 t -135.56 141.86 45.25 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -149.74 -155.45 6.8 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.35 -27.22 84.45 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.17 2.58 . . . . 0.0 113.876 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.72 -48.68 16.1 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 120.739 0.305 . . . . 0.0 111.689 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.63 -144.12 8.99 Favored Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.565 HG23 ' HB ' ' A' ' 88' ' ' THR . 12.2 p -123.78 142.49 40.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.64 157.48 31.96 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.155 0.182 . . . . 0.0 111.214 -171.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 58.0 mt -81.56 136.8 22.35 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 CA-C-O 121.207 0.527 . . . . 0.0 110.891 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.462 ' HD3' ' OE1' ' A' ' 87' ' ' GLU . 43.5 tptt -83.38 135.2 34.79 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 124.492 1.117 . . . . 0.0 111.172 -176.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.68 34.55 13.31 Favored Glycine 0 CA--C 1.499 -0.94 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.118 176.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.6 ' SG ' ' HB3' ' A' ' 100' ' ' SER . 47.0 t -142.26 143.15 26.26 Favored Pre-proline 0 N--CA 1.425 -1.68 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -87.36 10.34 3.57 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 123.318 2.678 . . . . 0.0 110.64 177.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.6 ' HB3' ' SG ' ' A' ' 98' ' ' CYS . 40.5 t -125.47 -164.63 1.32 Allowed 'General case' 0 N--CA 1.393 -3.306 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 -178.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 68.4 100.53 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.794 0 C-N-CA 125.674 1.59 . . . . 0.0 112.295 -179.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.94 -162.99 0.15 Allowed 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 122.968 2.445 . . . . 0.0 111.654 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -94.33 96.53 9.61 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -78.32 161.22 27.37 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -76.36 -51.57 6.62 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.524 178.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 39.0 m -137.68 166.7 23.31 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.6 mp -58.72 -36.28 74.04 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 123.166 0.587 . . . . 0.0 110.98 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.1 m -51.21 -37.74 48.45 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.232 1.013 . . . . 0.0 111.482 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.14 -50.08 65.21 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.196 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.457 HD12 ' N ' ' A' ' 111' ' ' VAL . 4.1 pp -68.21 -35.06 77.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.879 0.371 . . . . 0.0 110.592 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.457 ' N ' HD12 ' A' ' 110' ' ' LEU . 47.9 t -58.31 -50.79 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.683 176.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 45.7 p -69.42 -22.78 63.66 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.409 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -88.79 -39.55 13.82 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.928 0.394 . . . . 0.0 111.405 -174.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -75.47 -0.84 21.51 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.7 m -74.56 -28.49 60.96 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 170.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 68.8 mt -97.95 -49.03 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.217 -178.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.9 m -121.71 99.83 44.38 Favored Pre-proline 0 N--CA 1.44 -0.959 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.174 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -81.47 100.89 1.17 Allowed 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.144 1.896 . . . . 0.0 109.727 174.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 65.0 mt -90.29 -73.8 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.135 -174.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.549 ' HB3' ' SG ' ' A' ' 98' ' ' CYS . 2.7 p -77.74 -27.41 50.45 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 122.038 0.923 . . . . 0.0 110.094 177.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.5 mt -83.12 129.68 60.12 Favored Pre-proline 0 N--CA 1.427 -1.587 0 CA-C-N 114.144 -1.389 . . . . 0.0 109.237 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -75.78 -4.33 15.06 Favored 'Trans proline' 0 N--CA 1.485 1.021 0 C-N-CA 122.893 2.395 . . . . 0.0 112.702 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 82.9 m -143.61 152.59 41.57 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.449 ' SG ' ' HD3' ' A' ' 126' ' ' ARG . 21.5 p -82.07 148.63 28.48 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.952 0.406 . . . . 0.0 111.487 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.462 HD22 ' CG ' ' A' ' 44' ' ' PHE . 86.7 mt -74.19 117.42 15.98 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.449 ' HD3' ' SG ' ' A' ' 124' ' ' CYS . 24.2 mmm180 -104.41 109.73 21.71 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.241 0.543 . . . . 0.0 110.221 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.466 HG22 ' H ' ' A' ' 129' ' ' SER . 3.4 mp -96.03 126.66 43.69 Favored Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -64.09 -29.79 65.65 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.408 2.072 . . . . 0.0 111.485 177.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.466 ' H ' HG22 ' A' ' 127' ' ' ILE . 19.8 t 78.1 -36.29 0.21 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.678 1.591 . . . . 0.0 111.681 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -133.33 -171.43 2.69 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 120.947 0.404 . . . . 0.0 110.206 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 . . . . . 0 C--N 1.297 -1.683 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -179.827 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptm . . . . . 0 C--O 1.235 0.318 0 CA-C-O 120.507 0.194 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -118.88 0.97 11.48 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 174.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -139.53 -168.75 2.54 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.9 m80 64.36 35.71 9.56 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 122.068 0.937 . . . . 0.0 109.226 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -66.11 133.66 51.17 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.559 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.451 ' HA ' ' O ' ' A' ' 9' ' ' SER . 57.6 m-70 68.71 19.0 8.63 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.207 1.003 . . . . 0.0 112.148 178.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -59.14 -31.03 68.59 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.407 0.622 . . . . 0.0 111.635 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.5 t -169.15 -39.16 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 6' ' ' HIS . 5.3 m -77.36 93.04 3.99 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 170.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.5 -97.23 0.21 Allowed Glycine 0 N--CA 1.428 -1.857 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -89.05 113.54 24.67 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.842 0.353 . . . . 0.0 111.617 -176.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -103.96 127.4 29.4 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 175.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -86.78 21.18 1.1 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.112 2.542 . . . . 0.0 113.215 -177.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -79.75 127.25 31.97 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.0 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.73 34.46 6.57 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -177.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.57 ' HA ' ' OG ' ' A' ' 108' ' ' SER . 45.4 p -87.27 17.16 4.54 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 121.906 0.86 . . . . 0.0 110.895 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -84.44 -168.83 2.33 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.675 -176.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.335 80.5 p 76.54 -4.71 2.31 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 127.483 2.313 . . . . 0.0 114.967 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.491 ' O ' ' HB3' ' A' ' 23' ' ' TYR . 20.0 m -62.66 -31.84 72.79 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.671 0.748 . . . . 0.0 109.483 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -10.64 33.64 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 177.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -98.38 -62.26 1.27 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.804 0.335 . . . . 0.0 111.093 176.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 24.8 p-90 -94.05 -8.65 39.17 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -171.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.491 ' HB3' ' O ' ' A' ' 19' ' ' SER . 70.2 t80 -100.5 120.0 39.35 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.865 -175.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -131.23 88.94 43.07 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 175.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.83 -31.82 67.55 Favored 'Trans proline' 0 N--CA 1.482 0.834 0 C-N-CA 122.482 2.121 . . . . 0.0 113.347 -172.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 42.4 p-80 -84.74 -0.32 53.26 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 124.107 0.963 . . . . 0.0 112.776 -174.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.462 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 14.4 tp -85.76 152.37 23.1 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -176.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 t -110.28 174.86 5.66 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 120.628 0.251 . . . . 0.0 110.432 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 -56.91 -50.36 72.78 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -174.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -64.77 -32.01 73.5 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.126 0.488 . . . . 0.0 111.326 -175.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -74.83 -39.36 61.67 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.326 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.49 -43.44 93.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.395 0.617 . . . . 0.0 109.948 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 78.1 mt -65.62 -39.7 85.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.966 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.455 ' O ' ' HG2' ' A' ' 37' ' ' LYS . . . -57.71 -49.44 76.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.277 178.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.8 -36.29 82.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.075 0.464 . . . . 0.0 111.336 178.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.419 ' CD1' HD22 ' A' ' 45' ' ' LEU . 6.6 mp -81.2 -14.81 57.17 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -177.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.489 ' HB3' HG21 ' A' ' 77' ' ' VAL . 17.8 ptpt -80.28 -15.05 57.83 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.673 177.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -100.23 -3.72 30.92 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.187 176.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -101.38 174.63 5.89 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -176.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -91.53 144.65 29.91 Favored Pre-proline 0 C--N 1.305 -1.343 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.14 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.02 118.44 4.98 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.083 2.522 . . . . 0.0 112.094 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.37 -11.71 9.09 Favored Glycine 0 N--CA 1.435 -1.41 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -174.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.65 147.87 37.24 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.405 ' HB2' HD11 ' A' ' 58' ' ' LEU . 36.1 p90 -150.68 171.5 17.06 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -176.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.419 HD22 ' CD1' ' A' ' 36' ' ' LEU . 1.5 pt? -161.56 154.52 20.75 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 172.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.3 mt -121.48 134.92 63.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 121.061 0.457 . . . . 0.0 110.565 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.533 ' HG3' ' O ' ' A' ' 48' ' ' ASP . 23.8 ptt-85 -127.39 -173.69 2.97 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 177.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.533 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 13.1 t70 -82.4 150.75 26.94 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 174.033 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 70.8 m -66.25 -26.75 67.5 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 119.307 0.958 . . . . 0.0 112.12 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 35.4 t60 69.73 -46.75 0.59 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 124.909 1.284 . . . . 0.0 111.873 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.2 t -71.67 -33.5 68.91 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 123.775 0.83 . . . . 0.0 110.35 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -122.36 154.36 37.77 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -177.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -102.39 126.73 49.51 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 123.812 0.695 . . . . 0.0 110.41 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.13 22.67 34.57 Favored Glycine 0 C--N 1.308 -1.024 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -178.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.62 144.02 47.65 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 120.898 0.38 . . . . 0.0 110.162 -177.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -112.64 139.0 48.62 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -101.96 111.63 4.12 Favored Glycine 0 C--N 1.294 -1.797 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.378 -177.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.405 HD11 ' HB2' ' A' ' 44' ' ' PHE . 39.3 tp -91.31 130.49 37.17 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 123.88 0.872 . . . . 0.0 109.306 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -114.44 128.71 56.48 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 175.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.2 tp -122.27 129.54 52.3 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 123.553 0.533 . . . . 0.0 110.546 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -93.1 114.28 26.77 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 28.4 m -106.82 164.14 4.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 173.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.07 -59.24 3.02 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.9 p -149.22 141.73 15.36 Favored Pre-proline 0 N--CA 1.421 -1.877 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.629 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 39.1 Cg_exo -59.99 -44.71 28.1 Favored 'Trans proline' 0 CA--C 1.57 2.279 0 C-N-CA 121.675 1.583 . . . . 0.0 111.659 174.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.629 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 85.6 Cg_endo -75.78 149.72 33.98 Favored 'Trans proline' 0 C--N 1.381 2.272 0 C-N-CA 122.416 2.077 . . . . 0.0 109.559 171.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.18 -48.11 6.89 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.148 1.899 . . . . 0.0 112.629 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.9 p -116.71 -9.1 11.34 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.855 0.36 . . . . 0.0 111.363 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 59.4 44.05 15.64 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.562 -178.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -50.38 -52.33 55.8 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 113.902 -1.499 . . . . 0.0 110.787 175.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.45 93.43 0.98 Allowed 'Trans proline' 0 N--CA 1.441 -1.568 0 CA-C-N 120.308 1.146 . . . . 0.0 109.352 169.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 53.0 t-105 -86.55 137.16 32.73 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.562 -175.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -124.7 -42.12 2.09 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.206 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.24 56.39 1.0 Allowed Glycine 0 C--N 1.299 -1.524 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -89.94 139.93 27.57 Favored Pre-proline 0 C--N 1.306 -1.289 0 CA-C-N 115.091 -0.555 . . . . 0.0 109.855 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.19 167.93 26.06 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.893 2.395 . . . . 0.0 113.829 -175.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.489 HG21 ' HB3' ' A' ' 37' ' ' LYS . 2.3 p -59.53 -32.74 49.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.336 176.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 -65.1 -18.68 65.5 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.073 0.463 . . . . 0.0 110.881 177.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -92.4 -36.05 13.35 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.95 -35.8 82.33 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.156 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 89.6 t -70.71 113.04 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.516 ' NE ' ' HA ' ' A' ' 82' ' ' ARG . 1.7 mmp_? -87.25 144.6 26.74 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.795 -176.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -125.84 124.47 40.98 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 120.974 0.416 . . . . 0.0 110.352 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -132.13 132.86 43.63 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.482 ' HG ' ' HB2' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -97.06 140.59 31.35 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.972 -1.091 . . . . 0.0 112.229 177.029 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 77.4 mt -107.61 120.68 59.36 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.419 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -105.78 138.01 42.7 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -175.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.435 ' HB ' HG23 ' A' ' 93' ' ' VAL . 3.9 t -116.36 124.75 50.84 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.65 -162.66 9.52 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 -178.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.55 -31.82 49.9 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.205 2.603 . . . . 0.0 112.631 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -71.04 -21.88 62.21 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 175.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 132.63 -159.47 23.45 Favored Glycine 0 CA--C 1.488 -1.601 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.435 HG23 ' HB ' ' A' ' 88' ' ' THR . 14.6 p -104.01 127.18 58.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.711 ' HG2' ' CD2' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -149.73 167.03 27.63 Favored 'General case' 0 C--O 1.201 -1.493 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.24 -171.665 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 66.6 mt -93.2 143.88 10.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.405 -176.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.482 ' HB2' ' HG ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -44.69 -46.56 10.37 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.675 1.59 . . . . 0.0 112.124 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -127.01 63.89 0.59 Allowed Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.44 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 11.1 p -85.05 122.85 74.1 Favored Pre-proline 0 C--N 1.304 -1.391 0 CA-C-O 120.678 0.275 . . . . 0.0 110.391 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -80.29 10.42 3.24 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 122.752 2.301 . . . . 0.0 113.365 -176.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.8 m -154.82 -162.46 1.38 Allowed 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.436 ' HG3' ' CD1' ' A' ' 103' ' ' TYR . 37.2 tt0 -109.88 106.37 58.19 Favored Pre-proline 0 C--N 1.294 -1.816 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -175.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -89.42 -80.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.653 0 C-N-CA 122.066 1.844 . . . . 0.0 112.149 171.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.711 ' CD2' ' HG2' ' A' ' 94' ' ' LYS . 51.8 m-85 43.49 79.36 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 127.381 2.272 . . . . 0.0 112.805 178.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.411 ' O ' HG12 ' A' ' 93' ' ' VAL . 98.0 m-85 -107.08 -178.36 3.62 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.279 -177.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -86.35 -36.9 9.3 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.009 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.8 m -132.9 158.51 42.41 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 122.456 -0.438 . . . . 0.0 110.487 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 75.1 mt -55.21 -46.78 75.93 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 123.13 0.572 . . . . 0.0 111.463 178.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.57 ' OG ' ' HA ' ' A' ' 16' ' ' SER . 24.3 p -54.6 -31.21 56.6 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 123.242 0.617 . . . . 0.0 112.401 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.18 -39.14 82.58 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.113 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 111' ' ' VAL . 3.8 pp -80.31 -29.81 38.13 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.687 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.437 ' N ' HD12 ' A' ' 110' ' ' LEU . 40.6 t -63.41 -54.48 32.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.629 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.7 m -68.64 -20.61 64.47 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.303 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -78.26 -40.82 35.94 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.646 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.515 ' HA ' ' O ' ' A' ' 117' ' ' SER . 66.8 m80 -80.18 3.02 21.99 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -174.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 125' ' ' LEU . 10.7 p -86.15 -39.88 16.22 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 172.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.5 mt -84.01 -48.14 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.271 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 19.6 m -121.86 93.06 48.78 Favored Pre-proline 0 N--CA 1.425 -1.706 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.835 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.57 73.43 5.6 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.855 2.37 . . . . 0.0 110.873 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 67.5 mt -68.8 -60.8 2.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.13 -178.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.3 m -83.72 -49.96 8.62 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.551 -175.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -73.4 139.96 78.84 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.867 -177.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.88 -18.39 46.94 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 123.09 2.527 . . . . 0.0 111.994 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 43.6 t -127.94 154.75 45.21 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 4.0 p -71.61 145.01 49.26 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 177.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.401 ' O ' ' HB3' ' A' ' 115' ' ' SER . 74.2 mt -79.41 106.31 11.35 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -90.38 103.78 16.42 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.336 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.547 ' H ' HD12 ' A' ' 127' ' ' ILE . 1.8 mp -90.38 128.12 50.3 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -73.91 -29.59 10.08 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 121.435 1.423 . . . . 0.0 110.21 174.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.451 ' H ' HG22 ' A' ' 127' ' ' ILE . 4.4 m -80.96 -1.53 44.07 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 125.203 1.401 . . . . 0.0 113.243 -175.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.444 ' HB3' ' HB ' ' A' ' 127' ' ' ILE . 17.6 tppt? -140.19 145.86 37.99 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 . . . . . 0 C--N 1.29 -2.01 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.936 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.34 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -90.37 106.47 18.52 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.059 0.457 . . . . 0.0 111.776 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -96.32 -49.65 5.11 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -119.22 -50.24 2.36 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.069 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.484 ' CE1' ' HB2' ' A' ' 8' ' ' SER . 18.9 t60 69.05 88.97 0.11 Allowed 'General case' 0 C--O 1.242 0.686 0 O-C-N 124.486 1.116 . . . . 0.0 109.615 -175.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -110.6 114.4 27.76 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.917 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 48.83 72.76 0.26 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.259 1.423 . . . . 0.0 111.95 175.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.484 ' HB2' ' CE1' ' A' ' 5' ' ' HIS . 19.9 m -134.59 77.3 1.68 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.687 0.756 . . . . 0.0 110.03 178.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.6 t -166.4 156.3 11.85 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.61 104.46 3.15 Favored Glycine 0 N--CA 1.423 -2.173 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.94 114.85 18.22 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 176.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.2 t -115.69 100.22 53.32 Favored Pre-proline 0 C--N 1.294 -1.84 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -176.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.85 85.29 1.65 Allowed 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.194 1.93 . . . . 0.0 109.871 177.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 73.33 -52.39 0.7 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.508 1.523 . . . . 0.0 111.254 -176.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 177.03 -97.76 0.11 Allowed Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 107.907 -2.077 . . . . 0.0 107.907 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.1 t -135.46 24.67 3.46 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 173.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.93 24.0 0.79 Allowed 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 112.527 -2.124 . . . . 0.0 109.296 -177.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.553 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 2.0 p -76.07 -10.65 59.59 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -174.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.5 m -74.32 -36.17 63.68 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.313 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.77 -5.86 40.81 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.553 ' CD2' ' HA ' ' A' ' 18' ' ' THR . 25.6 m-85 -81.08 -24.12 38.0 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.079 175.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.476 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 54.0 p-90 -116.6 -32.28 5.24 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -93.16 114.54 27.07 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.217 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . 0.252 0.1 OUTLIER -155.24 98.28 2.37 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-O 121.711 0.767 . . . . 0.0 111.266 175.361 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -83.35 19.43 1.34 Allowed 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 124.047 3.165 . . . . 0.0 114.62 -173.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -99.43 -4.03 32.37 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.993 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.7 mp -92.99 140.96 28.92 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.817 0.818 . . . . 0.0 112.952 -177.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 m -90.05 177.26 6.5 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.043 -1.435 . . . . 0.0 107.707 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -50.49 -56.56 11.04 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.249 0.62 . . . . 0.0 110.635 177.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -65.86 -35.31 80.29 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.709 -175.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -66.94 -38.69 86.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.088 178.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.44 -42.07 99.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.577 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 82.9 mt -64.82 -45.83 93.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.107 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.421 ' HA ' ' CD ' ' A' ' 37' ' ' LYS . . . -59.83 -32.95 71.14 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.702 0.763 . . . . 0.0 111.83 178.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.14 -50.08 17.48 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 70.1 mt -71.09 -26.26 62.97 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -175.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.421 ' CD ' ' HA ' ' A' ' 34' ' ' ALA . 14.3 ptmm? -65.11 -24.49 67.44 Favored 'General case' 0 C--N 1.316 -0.883 0 O-C-N 121.908 -0.495 . . . . 0.0 110.567 178.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -84.37 -40.36 17.96 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.753 176.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.574 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -68.58 151.42 46.78 Favored 'General case' 0 C--O 1.248 1.015 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.222 -176.278 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -75.11 138.35 72.36 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.815 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -45.45 120.24 3.11 Favored 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 124.265 3.31 . . . . 0.0 114.121 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.87 -24.43 6.38 Favored Glycine 0 N--CA 1.434 -1.476 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -176.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.08 151.66 45.23 Favored 'General case' 0 C--O 1.249 1.031 0 CA-C-N 114.975 -0.613 . . . . 0.0 110.016 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.419 ' HZ ' HG13 ' A' ' 111' ' ' VAL . 23.6 p90 -153.6 170.93 19.63 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 -175.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -147.42 145.7 29.31 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 171.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.476 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 60.7 mt -111.56 123.33 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.067 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -124.1 179.91 4.68 Favored 'General case' 0 C--N 1.275 -2.66 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 177.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -84.98 154.02 22.4 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 175.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.6 t -81.82 133.87 35.37 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -90.95 -22.89 20.62 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 121.833 0.825 . . . . 0.0 108.98 177.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.7 m -72.53 -52.82 13.99 Favored 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 114.347 -1.297 . . . . 0.0 109.784 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -126.77 138.55 53.38 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.33 0.585 . . . . 0.0 111.348 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -88.77 138.03 31.78 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 176.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.22 11.67 58.29 Favored Glycine 0 C--N 1.305 -1.143 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -172.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -135.3 153.88 51.73 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-N 114.631 -0.784 . . . . 0.0 109.111 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.5 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 52.6 m-85 -115.83 171.58 7.68 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 176.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.18 133.13 8.87 Favored Glycine 0 C--N 1.282 -2.437 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -111.22 115.61 29.66 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.34 125.36 50.51 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.493 HD21 ' SG ' ' A' ' 123' ' ' CYS . 50.4 tp -124.08 129.83 51.53 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 123.395 0.435 . . . . 0.0 111.782 -173.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.562 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 22.3 tptm -91.77 114.24 26.72 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 174.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 80' ' ' LEU . 24.3 m -101.64 171.08 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 175.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.61 -55.6 6.62 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.44 ' HB ' ' HG2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -159.18 142.98 10.94 Favored Pre-proline 0 N--CA 1.421 -1.892 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.508 -178.277 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.595 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 16.8 Cg_exo -61.46 -50.27 5.97 Favored 'Trans proline' 0 CA--C 1.555 1.542 0 C-N-CA 122.208 1.939 . . . . 0.0 110.094 172.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.595 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 10.8 Cg_endo -54.76 136.03 69.88 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 122.105 1.87 . . . . 0.0 109.653 163.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.19 -11.55 21.14 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.64 2.227 . . . . 0.0 112.674 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.4 p -130.1 -37.28 1.48 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.912 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.437 ' HA ' ' HB2' ' A' ' 66' ' ' PRO . . . 72.9 23.04 2.9 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 125.096 1.358 . . . . 0.0 111.989 178.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -62.91 -49.05 83.73 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.598 173.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.14 105.87 1.27 Allowed 'Trans proline' 0 C--N 1.386 2.502 0 C-N-CA 121.047 1.165 . . . . 0.0 110.126 170.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 68.2 t-105 -96.1 149.06 22.03 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.78 -175.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -133.62 -36.71 0.95 Allowed 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.878 175.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.36 34.38 29.28 Favored Glycine 0 CA--C 1.503 -0.685 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.9 p30 -90.28 153.8 46.6 Favored Pre-proline 0 C--N 1.298 -1.642 0 CA-C-N 114.163 -1.019 . . . . 0.0 111.127 -177.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_exo -34.51 146.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.366 1.499 1 C-N-CA 125.99 4.46 . . . . 0.0 117.684 -175.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.1 p -70.24 -13.97 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.221 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -64.9 -16.05 62.77 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.809 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -92.02 -24.81 19.08 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 121.114 0.483 . . . . 0.0 109.781 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.483 HD23 ' HD3' ' A' ' 65' ' ' PRO . 79.1 mt -76.02 -26.06 56.3 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.013 0.911 . . . . 0.0 109.01 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.5 t -93.88 123.88 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 173.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.477 ' NE ' ' HA ' ' A' ' 82' ' ' ARG . 4.1 mmp_? -104.89 151.01 24.38 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -123.91 124.62 43.02 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.627 0.727 . . . . 0.0 111.772 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -128.13 170.38 13.02 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 pp -135.25 157.81 45.96 Favored 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.485 176.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.5 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 39.4 mt -111.34 123.68 67.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -173.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -102.77 129.55 49.46 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 123.733 0.813 . . . . 0.0 109.016 -176.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.512 ' HB ' HG23 ' A' ' 93' ' ' VAL . 2.6 t -116.77 132.76 56.61 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 120.928 0.394 . . . . 0.0 110.304 174.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.65 -159.82 8.34 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.56 -31.9 49.66 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.008 2.472 . . . . 0.0 113.713 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -80.57 -36.23 33.24 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.701 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 163.31 -163.15 35.38 Favored Glycine 0 N--CA 1.422 -2.238 0 C-N-CA 119.911 -1.138 . . . . 0.0 112.124 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.512 HG23 ' HB ' ' A' ' 88' ' ' THR . 14.0 p -116.11 126.75 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.283 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.561 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 0.0 OUTLIER -151.27 173.88 13.95 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 116.048 -0.523 . . . . 0.0 112.388 -177.249 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.45 ' HB ' ' OG ' ' A' ' 120' ' ' SER . 70.2 mt -97.61 141.81 15.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-O 121.74 0.781 . . . . 0.0 112.975 -171.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -65.74 132.58 49.1 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 125.122 1.369 . . . . 0.0 108.926 174.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.42 -9.59 38.6 Favored Glycine 0 C--N 1.312 -0.778 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.568 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 37.8 t -142.24 141.04 20.17 Favored Pre-proline 0 N--CA 1.422 -1.866 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.58 -40.38 47.47 Favored 'Trans proline' 0 C--O 1.244 0.805 0 C-N-CA 121.555 1.504 . . . . 0.0 109.385 176.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.561 ' OG ' ' HB2' ' A' ' 94' ' ' LYS 0.38 1.8 p 49.41 67.36 0.9 Allowed 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 123.443 1.592 . . . . 0.0 114.06 -177.17 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.505 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 41.8 mt-10 -49.63 -36.72 18.59 Favored Pre-proline 0 C--N 1.303 -1.446 0 CA-C-N 111.525 -2.579 . . . . 0.0 115.652 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 101' ' ' GLU . 7.3 Cg_endo -53.6 -33.11 67.4 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.134 1.889 . . . . 0.0 114.732 177.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 48.75 99.58 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 126.211 1.805 . . . . 0.0 111.982 -172.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -74.31 139.39 44.17 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.745 -176.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.03 -42.25 20.26 Favored Glycine 0 C--N 1.304 -1.223 0 C-N-CA 120.042 -1.075 . . . . 0.0 110.706 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.8 m -133.22 159.89 38.87 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.421 ' O ' ' HB3' ' A' ' 110' ' ' LEU . 96.1 mt -58.61 -31.67 68.29 Favored 'General case' 0 C--O 1.215 -0.711 0 C-N-CA 123.626 0.77 . . . . 0.0 112.045 -178.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.9 m -61.27 -32.12 71.94 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-O 120.846 0.355 . . . . 0.0 111.589 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.5 -31.82 62.32 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.562 0.696 . . . . 0.0 109.555 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.421 ' HB3' ' O ' ' A' ' 107' ' ' LEU . 3.7 tt -67.62 -45.37 75.62 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.537 -1.21 . . . . 0.0 109.354 176.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.446 HG21 ' CE2' ' A' ' 22' ' ' TRP . 73.2 t -71.13 -39.11 73.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.137 -0.938 . . . . 0.0 113.177 -177.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.7 t -68.97 -21.81 64.15 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.151 0.5 . . . . 0.0 110.997 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -107.11 177.96 4.7 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.398 -178.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.532 ' HA ' ' O ' ' A' ' 117' ' ' SER . 7.0 m-70 73.48 -10.43 1.05 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.969 0.908 . . . . 0.0 113.21 -177.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.0 m -73.26 -32.8 64.9 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 169.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 61.2 mt -88.24 -62.23 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.859 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.532 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 26.6 t -116.54 99.96 53.13 Favored Pre-proline 0 N--CA 1.434 -1.238 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.32 99.12 1.08 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.78 2.32 . . . . 0.0 110.812 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.434 ' HB ' ' CE1' ' A' ' 114' ' ' HIS . 67.6 mt -99.51 -51.32 10.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.225 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.45 ' OG ' ' HB ' ' A' ' 95' ' ' ILE . 34.7 t -80.89 -42.35 21.59 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.644 -177.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.425 HD12 HD22 ' A' ' 60' ' ' LEU . 1.8 mm? -89.83 144.11 31.14 Favored Pre-proline 0 N--CA 1.434 -1.25 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.294 -178.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -63.41 -32.21 71.79 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.987 2.458 . . . . 0.0 111.757 177.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.493 ' SG ' HD21 ' A' ' 60' ' ' LEU . 26.3 p -109.45 169.87 8.43 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 23.2 m -70.14 132.71 46.23 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 176.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 29.2 tp -82.37 131.98 35.22 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -136.39 128.14 29.07 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.455 ' H ' HD12 ' A' ' 127' ' ' ILE . 3.0 mp -66.24 125.14 89.73 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -61.29 -50.34 6.06 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.049 1.833 . . . . 0.0 111.299 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.495 ' HA ' ' CG ' ' A' ' 21' ' ' PHE . 65.6 p 56.18 13.21 1.14 Allowed 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.124 1.769 . . . . 0.0 114.403 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.493 ' HD3' ' C ' ' A' ' 130' ' ' LYS . 11.5 tmtt? -166.66 116.71 0.92 Allowed 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 . . . . . 0 C--N 1.301 -1.521 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 173.669 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.0 p . . . . . 0 N--CA 1.446 -0.666 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.1 p -58.2 -45.0 88.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -174.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -13.25 62.11 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -74.48 -35.74 63.28 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.154 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.491 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 41.3 p-90 -110.36 -26.7 9.42 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 114.058 1.132 . . . . 0.0 114.058 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -90.81 113.32 25.44 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.316 0.579 . . . . 0.0 111.656 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.66 93.89 4.21 Favored Pre-proline 0 C--N 1.299 -1.627 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.846 174.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 47' ' ' ARG . 97.0 Cg_endo -76.43 -0.09 10.04 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 123.58 2.853 . . . . 0.0 114.334 -172.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -94.93 -1.54 52.35 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.088 0.471 . . . . 0.0 111.752 -173.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.533 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 73.3 mt -94.86 145.88 24.6 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.309 0.576 . . . . 0.0 111.746 -178.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.455 ' HA ' ' NH1' ' A' ' 47' ' ' ARG . 23.1 t -100.74 177.23 5.05 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.1 ttt180 -52.99 -53.4 50.57 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.654 0.782 . . . . 0.0 112.585 -173.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -64.0 -32.47 74.02 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.981 0.419 . . . . 0.0 111.411 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.426 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 15.7 mm-40 -73.03 -34.57 66.42 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.822 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.05 -44.94 83.13 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.414 0.626 . . . . 0.0 109.619 178.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.8 mt -63.93 -36.39 76.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.425 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.19 -36.04 72.49 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.481 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 4.4 mm? -75.78 -47.84 24.19 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.278 174.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.3 mt -66.42 -21.54 66.22 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -174.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -74.25 -5.24 40.89 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.417 0.627 . . . . 0.0 111.47 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -112.57 5.46 17.89 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 35' ' ' LEU . 31.3 mmmt -110.98 145.17 38.88 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.385 0.612 . . . . 0.0 110.992 -177.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -76.74 141.57 68.82 Favored Pre-proline 0 C--N 1.301 -1.531 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.221 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -47.64 118.9 3.28 Favored 'Trans proline' 0 C--N 1.364 1.375 0 C-N-CA 123.938 3.092 . . . . 0.0 113.467 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.24 -30.51 3.47 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.39 151.89 39.62 Favored 'General case' 0 C--O 1.253 1.239 0 CA-C-O 120.717 0.294 . . . . 0.0 110.54 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -147.32 175.9 10.42 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.671 -176.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -149.59 147.37 28.06 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 170.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.491 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 62.4 mt -112.19 122.21 66.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.533 ' HD2' ' O ' ' A' ' 27' ' ' LEU . 28.5 ptt85 -121.09 -173.94 2.72 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -95.22 153.51 17.63 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.5 t -97.39 132.35 43.19 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.95 0.881 . . . . 0.0 111.131 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -85.3 -14.79 45.45 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.803 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.7 m -78.53 -51.74 9.51 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.195 -175.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -128.98 144.22 51.12 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -73.76 132.93 43.14 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.01 31.65 25.55 Favored Glycine 0 N--CA 1.436 -1.367 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.146 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.0 145.97 49.98 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.424 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 87.3 m-85 -113.72 134.47 54.73 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.83 118.02 5.15 Favored Glycine 0 N--CA 1.421 -2.356 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.042 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -96.69 118.29 32.84 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.98 119.75 40.3 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.0 tp -121.37 131.56 54.26 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.473 -176.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -88.81 113.99 24.96 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 175.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 80' ' ' LEU . 26.1 m -102.26 169.52 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.999 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.64 -57.6 4.0 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.87 118.81 2.15 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.134 0.974 . . . . 0.0 110.697 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.613 ' N ' ' HD3' ' A' ' 66' ' ' PRO . 21.5 Cg_endo -99.42 12.31 0.64 Allowed 'Trans proline' 0 CA--C 1.601 3.847 0 C-N-CA 122.84 2.36 . . . . 0.0 118.037 178.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.613 ' HD3' ' N ' ' A' ' 65' ' ' PRO . 2.0 Cg_endo -93.58 164.92 2.31 Favored 'Trans proline' 0 C--N 1.384 2.407 0 CA-C-N 123.051 2.125 . . . . 0.0 111.218 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -74.03 -22.16 17.43 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 121.861 1.707 . . . . 0.0 111.782 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.1 p -134.45 -43.2 0.77 Allowed 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.392 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.437 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 75.84 3.76 3.83 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.026 1.33 . . . . 0.0 112.982 177.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.461 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 34.9 tt0 -86.68 -52.44 0.43 Allowed Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 172.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.461 ' HD3' ' HB3' ' A' ' 70' ' ' GLN . 7.3 Cg_exo -76.02 107.09 2.39 Favored 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 121.317 1.344 . . . . 0.0 108.708 171.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 59.6 t-105 -117.56 135.42 53.97 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.934 -177.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -158.15 81.7 0.85 Allowed 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 114.616 -1.174 . . . . 0.0 108.609 174.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -169.94 -178.55 41.02 Favored Glycine 0 C--N 1.268 -3.208 0 CA-C-N 113.734 -1.575 . . . . 0.0 110.28 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -89.8 115.87 64.95 Favored Pre-proline 0 C--N 1.294 -1.829 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.55 ' O ' ' HG ' ' A' ' 80' ' ' LEU . 47.5 Cg_exo -32.47 -78.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 125.098 3.865 . . . . 0.0 117.048 -172.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -73.31 -30.08 29.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -174.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -71.23 -26.77 63.07 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.83 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.468 ' OE1' ' HA ' ' A' ' 79' ' ' GLN . 4.9 tp60 -88.01 -18.06 29.82 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 121.139 0.495 . . . . 0.0 110.225 177.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 76' ' ' PRO . 91.1 mt -80.99 -12.01 59.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.482 0.658 . . . . 0.0 109.26 174.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.8 t -96.13 118.99 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -103.17 142.32 34.36 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.768 -177.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -123.36 122.08 37.41 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.387 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -126.72 170.09 12.49 Favored 'General case' 0 C--N 1.273 -2.728 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -135.86 135.38 39.73 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 118.767 -1.173 . . . . 0.0 112.119 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.594 ' CG2' ' HB ' ' A' ' 93' ' ' VAL . 59.5 mt -94.24 110.78 24.14 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 CA-C-N 114.014 -1.448 . . . . 0.0 107.408 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -105.57 121.22 43.52 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.831 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.716 ' HB ' HG12 ' A' ' 93' ' ' VAL . 1.4 t -94.95 118.68 32.21 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.691 0.758 . . . . 0.0 110.36 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -106.43 -157.99 21.74 Favored Glycine 0 N--CA 1.427 -1.946 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -66.4 -26.7 47.78 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.964 1.776 . . . . 0.0 110.528 176.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -73.74 -73.34 0.22 Allowed 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.167 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 179.02 -151.22 10.07 Favored Glycine 0 N--CA 1.423 -2.191 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.716 HG12 ' HB ' ' A' ' 88' ' ' THR . 35.7 m -103.71 145.9 12.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 O-C-N 123.739 0.317 . . . . 0.0 110.865 -176.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.75 155.8 30.49 Favored 'General case' 0 C--O 1.259 1.565 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 176.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.58 HG12 HG12 ' A' ' 86' ' ' ILE . 59.4 mt -94.39 114.12 30.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.429 0.633 . . . . 0.0 111.765 -176.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -62.15 120.75 11.5 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.392 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.39 -28.61 2.44 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.61 ' SG ' HG22 ' A' ' 119' ' ' ILE . 49.6 t -112.98 132.1 22.5 Favored Pre-proline 0 N--CA 1.426 -1.656 0 CA-C-N 114.817 -0.691 . . . . 0.0 110.201 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 98' ' ' CYS . 95.4 Cg_endo -99.51 11.38 0.67 Allowed 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 122.628 2.219 . . . . 0.0 112.525 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.0 m -122.81 18.64 10.23 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.82 0.343 . . . . 0.0 111.087 -174.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -113.39 136.73 21.9 Favored Pre-proline 0 C--N 1.31 -1.111 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -174.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -82.33 -179.68 4.83 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.135 2.557 . . . . 0.0 113.292 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -98.93 108.55 21.26 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -76.44 -60.36 2.37 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.291 0.567 . . . . 0.0 110.21 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.609 ' H ' HG22 ' A' ' 93' ' ' VAL . . . 124.37 -66.53 0.52 Allowed Glycine 0 C--N 1.306 -1.131 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 177.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.7 m -93.61 150.62 20.28 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.13 -41.28 94.96 Favored 'General case' 0 C--O 1.216 -0.661 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.354 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 38.6 t -54.94 -31.37 60.39 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.229 0.612 . . . . 0.0 111.028 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.28 -49.28 74.67 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.378 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.452 HD12 ' N ' ' A' ' 111' ' ' VAL . 4.1 pp -75.01 -32.44 61.62 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 120.838 0.351 . . . . 0.0 110.936 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.452 ' N ' HD12 ' A' ' 110' ' ' LEU . 69.7 t -63.09 -44.66 99.63 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.821 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.569 178.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.3 t -73.28 -21.83 60.51 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.006 0.432 . . . . 0.0 111.819 177.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -83.42 -4.64 58.68 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 121.388 0.613 . . . . 0.0 110.085 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 125' ' ' LEU . 6.0 p80 -42.62 -50.4 5.42 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 126.694 1.997 . . . . 0.0 115.893 -173.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.4 t -103.7 4.78 35.74 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 121.438 0.637 . . . . 0.0 109.286 -172.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.5 mt -99.47 -48.54 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.8 m -141.27 86.21 11.38 Favored Pre-proline 0 N--CA 1.437 -1.103 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.459 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.88 89.49 1.13 Allowed 'Trans proline' 0 N--CA 1.44 -1.649 0 C-N-CA 121.681 1.587 . . . . 0.0 108.054 173.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.61 HG22 ' SG ' ' A' ' 98' ' ' CYS . 36.3 mt -90.28 -64.02 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.79 -174.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.4 ' HA ' ' HB2' ' A' ' 98' ' ' CYS . 7.8 t -73.4 -30.25 63.13 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 120.851 0.358 . . . . 0.0 111.073 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.66 127.21 73.65 Favored Pre-proline 0 N--CA 1.435 -1.203 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.417 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -69.23 -24.45 32.1 Favored 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 122.327 2.018 . . . . 0.0 111.457 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.415 ' SG ' ' HB ' ' A' ' 62' ' ' VAL . 83.4 m -114.74 145.73 41.76 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 53.4 m -64.16 111.88 2.77 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.124 0.488 . . . . 0.0 109.937 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 114' ' ' HIS . 27.9 tp -58.21 135.79 57.16 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 125.0 1.32 . . . . 0.0 110.041 -176.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -130.92 134.99 47.26 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.1 mp -80.96 136.15 50.93 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo . . . . . 0 CA--C 1.543 0.928 0 C-N-CA 122.131 1.887 . . . . 0.0 112.129 177.367 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.3 p . . . . . 0 N--CA 1.435 -1.18 0 CA-C-O 120.774 0.321 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.5 m -45.46 -60.86 1.93 Allowed 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 125.853 1.661 . . . . 0.0 112.805 -173.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.41 ' HE2' ' CE2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -67.48 -12.69 60.9 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -176.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.41 ' CE2' ' HE2' ' A' ' 20' ' ' LYS . 74.6 m-85 -76.99 -23.24 52.29 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.419 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.434 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 31.3 p-90 -121.0 -24.75 5.51 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.506 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 35.8 t80 -95.31 116.79 29.24 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.992 -0.442 . . . . 0.0 110.045 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.488 ' CB ' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -138.04 97.9 9.65 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.097 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.88 21.55 0.37 Allowed 'Trans proline' 0 CA--C 1.552 1.418 0 C-N-CA 123.326 2.684 . . . . 0.0 113.977 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -114.78 -20.44 10.62 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.241 0.543 . . . . 0.0 110.088 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.488 HD23 ' CB ' ' A' ' 24' ' ' LYS . 3.5 mm? -76.75 120.51 22.01 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.668 0.747 . . . . 0.0 111.355 -175.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.0 p -85.27 177.69 7.75 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.57 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -49.7 -55.85 12.34 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.079 0.952 . . . . 0.0 111.622 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -72.78 -32.45 65.6 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.98 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -70.77 -33.53 70.88 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.871 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.98 -42.51 99.86 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.576 0.703 . . . . 0.0 109.13 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 85.0 mt -65.27 -44.01 95.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.465 178.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.48 -28.64 68.5 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.375 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.03 -51.99 10.12 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 57.2 mt -72.84 -25.56 61.16 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -174.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -56.91 -33.8 67.31 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -89.51 -21.29 23.01 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.543 0.687 . . . . 0.0 110.77 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -78.62 164.77 24.36 Favored 'General case' 0 C--O 1.255 1.389 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -172.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.54 137.38 76.79 Favored Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 111.917 -2.401 . . . . 0.0 111.329 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -63.0 107.56 0.65 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.922 1.748 . . . . 0.0 109.342 170.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.46 -17.93 5.52 Favored Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 -175.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.37 154.96 27.4 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 120.644 0.259 . . . . 0.0 110.66 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.485 ' CG ' HD11 ' A' ' 125' ' ' LEU . 5.4 p90 -149.45 177.68 9.49 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.279 -174.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -155.31 147.09 23.26 Favored 'General case' 0 C--O 1.253 1.237 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 169.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 23' ' ' TYR . 63.2 mt -117.81 135.33 58.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.442 HH12 ' HB2' ' A' ' 59' ' ' ALA . 0.1 OUTLIER -144.73 162.45 36.7 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 174.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.07 131.88 48.69 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 173.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.433 ' HB3' ' O ' ' A' ' 52' ' ' PHE . 30.4 t -75.67 118.81 18.9 Favored 'General case' 0 N--CA 1.413 -2.312 0 C-N-CA 119.024 -1.071 . . . . 0.0 109.087 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 27.6 m-70 -77.24 -16.11 59.17 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.87 175.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.0 m -84.11 -46.79 11.58 Favored 'General case' 0 N--CA 1.408 -2.568 0 CA-C-N 114.229 -1.35 . . . . 0.0 109.535 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.433 ' O ' ' HB3' ' A' ' 49' ' ' SER . 89.9 m-85 -127.15 127.97 45.41 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-O 121.35 0.595 . . . . 0.0 111.095 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -83.61 128.03 34.2 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.658 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.22 15.75 52.63 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -177.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.74 160.81 36.99 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -122.4 129.88 52.53 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.95 115.58 4.14 Favored Glycine 0 C--N 1.293 -1.832 0 C-N-CA 119.968 -1.11 . . . . 0.0 111.302 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -93.29 119.56 32.58 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.442 ' HB2' HH12 ' A' ' 47' ' ' ARG . . . -114.53 129.76 56.69 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.42 HD21 ' SG ' ' A' ' 123' ' ' CYS . 58.9 tp -126.85 128.62 46.81 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 123.488 0.493 . . . . 0.0 110.801 -177.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 22.3 tptm -88.36 115.14 25.66 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 176.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.489 HG12 ' SG ' ' A' ' 123' ' ' CYS . 34.1 m -105.82 170.69 2.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.87 -48.48 12.33 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 p -167.29 120.97 0.79 Allowed Pre-proline 0 C--N 1.32 -0.681 0 C-N-CA 125.291 1.436 . . . . 0.0 109.025 178.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.63 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 28.2 Cg_exo -60.57 -46.84 15.65 Favored 'Trans proline' 0 CA--C 1.575 2.567 0 C-N-CA 121.149 1.232 . . . . 0.0 110.993 170.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.63 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 85.1 Cg_endo -77.73 158.66 31.72 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.86 2.374 . . . . 0.0 109.917 173.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -70.03 -54.16 0.22 Allowed 'Trans proline' 0 CA--C 1.551 1.357 0 C-N-CA 121.715 1.61 . . . . 0.0 112.189 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.1 m -104.86 -19.84 13.76 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.837 0.351 . . . . 0.0 110.906 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 66.98 34.7 5.07 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 124.169 0.987 . . . . 0.0 111.274 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -60.68 -44.29 94.78 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.857 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.62 82.39 0.73 Allowed 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 121.11 1.206 . . . . 0.0 111.285 173.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 36.4 t-105 -85.87 136.73 33.18 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.0 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.9 mtmm -127.06 6.66 6.53 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -173.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.03 24.58 44.11 Favored Glycine 0 CA--C 1.489 -1.543 0 N-CA-C 108.554 -1.819 . . . . 0.0 108.554 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -86.21 127.05 63.06 Favored Pre-proline 0 N--CA 1.423 -1.799 0 CA-C-N 113.744 -1.228 . . . . 0.0 111.308 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -96.26 -165.12 0.1 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.7 0 C-N-CA 122.938 2.425 . . . . 0.0 110.867 176.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.463 ' HA ' HD23 ' A' ' 80' ' ' LEU . 9.8 p -56.46 -21.3 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 123.633 0.773 . . . . 0.0 112.405 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -62.56 -33.63 75.33 Favored 'General case' 0 C--O 1.213 -0.819 0 C-N-CA 122.853 0.461 . . . . 0.0 110.909 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.62 -20.34 56.84 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 121.461 0.648 . . . . 0.0 109.819 -178.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 77' ' ' VAL . 3.5 mm? -81.03 -3.08 50.56 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.097 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.9 t -101.66 104.83 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.875 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 174.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -78.85 139.76 38.28 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -120.65 122.44 40.49 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-O 121.872 0.844 . . . . 0.0 111.688 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -131.41 170.74 14.25 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.48 136.82 41.58 Favored 'General case' 0 C--N 1.283 -2.325 0 C-N-CA 119.944 -0.703 . . . . 0.0 111.088 175.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.429 HG12 HG12 ' A' ' 95' ' ' ILE . 74.9 mt -91.43 114.72 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.632 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 178.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.548 ' CD ' ' HE2' ' A' ' 96' ' ' LYS . 30.7 mt-10 -99.75 140.08 34.47 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.737 ' HB ' HG12 ' A' ' 93' ' ' VAL . 1.3 t -116.17 127.46 54.81 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.439 0.638 . . . . 0.0 110.626 175.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.4 -169.97 14.01 Favored Glycine 0 N--CA 1.424 -2.163 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.2 -27.81 31.4 Favored 'Trans proline' 0 CA--C 1.553 1.43 0 C-N-CA 123.425 2.75 . . . . 0.0 114.858 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.48 ' HD2' ' N ' ' A' ' 91' ' ' LYS . 10.7 mptt -80.28 -21.32 42.8 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.073 0.463 . . . . 0.0 111.121 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.28 -149.07 16.88 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.737 HG12 ' HB ' ' A' ' 88' ' ' THR . 31.3 m -104.64 149.08 8.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.41 155.02 19.49 Favored 'General case' 0 C--O 1.251 1.147 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.429 HG12 HG12 ' A' ' 86' ' ' ILE . 71.6 mt -86.94 114.34 25.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.423 0.63 . . . . 0.0 111.311 -176.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.548 ' HE2' ' CD ' ' A' ' 87' ' ' GLU . 19.4 ttmm -64.83 126.93 29.52 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.438 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 110.13 40.05 1.45 Allowed Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 120' ' ' SER . 35.5 t -142.33 132.4 12.44 Favored Pre-proline 0 N--CA 1.432 -1.33 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -178.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -86.8 8.11 4.57 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.602 2.202 . . . . 0.0 112.648 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.6 m -148.4 -148.0 0.24 Allowed 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 80.75 123.93 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.135 0 C-N-CA 124.963 1.305 . . . . 0.0 113.161 174.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.16 171.28 18.6 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.681 2.254 . . . . 0.0 111.74 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -95.59 132.38 40.79 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -108.25 154.68 21.42 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -178.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -95.4 -25.27 14.21 Favored Glycine 0 C--N 1.3 -1.42 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.772 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 11.1 m -122.65 144.62 49.01 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 90.2 mt -62.56 -37.83 87.69 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.196 0.522 . . . . 0.0 109.661 175.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.3 m -54.17 -34.44 60.49 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.593 1.157 . . . . 0.0 111.163 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.9 -39.32 83.62 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.7 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.48 HD12 ' N ' ' A' ' 111' ' ' VAL . 4.0 pp -76.2 -36.98 58.36 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.144 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.48 ' N ' HD12 ' A' ' 110' ' ' LEU . 43.0 t -55.9 -51.79 56.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.727 177.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.4 m -71.94 -26.71 62.39 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.967 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -83.46 -37.85 22.62 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -176.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -72.3 -6.17 41.31 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -174.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.8 m -75.26 -24.35 57.59 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 171.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 65.5 mt -101.61 -50.02 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.426 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.8 m -120.4 97.84 48.75 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.241 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.78 92.11 1.1 Allowed 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.473 2.115 . . . . 0.0 109.565 174.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 23.6 mt -84.97 -67.62 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.28 -174.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.444 ' HB3' ' HB2' ' A' ' 98' ' ' CYS . 4.8 p -77.67 -33.54 53.33 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.88 0.848 . . . . 0.0 110.338 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.418 HD22 HD22 ' A' ' 60' ' ' LEU . 49.6 mt -84.73 140.83 38.06 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.137 -177.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.56 -11.3 15.69 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.863 2.375 . . . . 0.0 113.454 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.489 ' SG ' HG12 ' A' ' 62' ' ' VAL . 22.6 p -136.05 162.21 33.54 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 59.6 m -69.33 138.38 53.71 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 123.485 0.49 . . . . 0.0 110.021 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.485 HD11 ' CG ' ' A' ' 44' ' ' PHE . 19.6 tp -77.72 121.34 23.89 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.744 -175.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -95.76 114.47 26.21 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 123.51 0.724 . . . . 0.0 110.577 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 66.8 mt -81.15 121.97 81.05 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 175.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 CA--C 1.535 0.528 0 C-N-CA 122.646 2.231 . . . . 0.0 113.681 -176.319 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.0 p . . . . . 0 N--CA 1.425 -1.69 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.8 m -73.59 -33.06 64.44 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.609 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -61.46 -18.26 58.17 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -79.21 -26.91 42.53 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.539 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 21.9 p-90 -131.91 -9.49 3.48 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -175.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -98.92 113.38 25.5 Favored 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.655 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.07 91.1 9.03 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.983 175.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.94 -17.08 46.4 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.904 2.403 . . . . 0.0 113.891 -175.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -71.86 -18.89 62.03 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.037 0.446 . . . . 0.0 111.294 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.9 tp -80.54 139.17 36.47 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.116 0.484 . . . . 0.0 110.61 -176.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.575 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 15.5 m -91.95 168.2 11.58 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.046 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -57.12 -51.68 68.31 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.067 0.947 . . . . 0.0 113.39 -175.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.87 -39.8 95.56 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 121.561 0.696 . . . . 0.0 110.985 -176.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.575 ' OE1' ' HB2' ' A' ' 28' ' ' SER . 21.1 mp0 -67.03 -40.12 87.13 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.862 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.93 -41.77 75.1 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 123.197 0.599 . . . . 0.0 111.627 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 60.1 mt -65.2 -35.67 75.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.867 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.1 -33.04 72.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.778 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.91 -40.52 65.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.043 0.449 . . . . 0.0 110.647 177.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.465 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 75.6 mt -76.16 -27.1 56.85 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -175.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -77.22 -3.37 39.32 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.551 0.691 . . . . 0.0 109.934 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -106.19 -5.29 19.38 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.747 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.552 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -119.74 170.2 9.43 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.111 0.482 . . . . 0.0 112.177 -175.244 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -85.85 160.31 53.0 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.294 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 61' ' ' LYS . 10.8 Cg_endo -56.11 127.47 26.17 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.775 2.316 . . . . 0.0 111.265 173.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.41 -24.01 8.28 Favored Glycine 0 N--CA 1.434 -1.446 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.56 146.61 40.32 Favored 'General case' 0 C--O 1.253 1.239 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -151.87 177.52 10.34 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 121.019 0.438 . . . . 0.0 110.119 -176.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -162.05 150.04 14.68 Favored 'General case' 0 C--O 1.251 1.152 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 173.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.539 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 68.6 mt -123.93 134.16 67.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.458 HH22 ' CD2' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -133.59 173.62 11.31 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.241 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -80.06 146.5 31.9 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.1 t -99.56 139.94 34.47 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.528 0.68 . . . . 0.0 111.682 -176.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -99.59 -8.5 24.41 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.476 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.5 t -76.38 -40.87 49.86 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -129.9 140.92 50.88 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -83.57 124.63 30.97 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.989 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.42 31.66 18.56 Favored Glycine 0 N--CA 1.435 -1.385 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -177.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.75 157.98 45.31 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.971 -0.615 . . . . 0.0 109.602 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -124.65 161.06 27.1 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.34 123.56 5.55 Favored Glycine 0 C--N 1.288 -2.091 0 C-N-CA 119.908 -1.139 . . . . 0.0 111.036 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 84' ' ' PHE . 2.2 tm? -101.68 130.51 48.06 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 123.947 0.899 . . . . 0.0 108.74 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.41 ' HB2' HH12 ' A' ' 47' ' ' ARG . . . -119.28 125.34 48.87 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 175.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.5 tp -119.88 131.3 55.21 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 123.686 0.616 . . . . 0.0 110.535 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 41' ' ' PRO . 22.3 tptm -88.5 116.05 26.45 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 80' ' ' LEU . 18.7 m -109.94 171.77 2.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.79 -60.07 2.54 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.4 p -150.81 138.38 12.1 Favored Pre-proline 0 C--N 1.308 -1.207 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.247 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.678 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 24.4 Cg_exo -61.46 -43.55 27.15 Favored 'Trans proline' 0 CA--C 1.577 2.67 0 C-N-CA 121.969 1.779 . . . . 0.0 111.854 171.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.678 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 56.4 Cg_endo -68.25 143.16 57.71 Favored 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 122.547 2.164 . . . . 0.0 110.105 170.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.88 -32.81 35.26 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.547 2.165 . . . . 0.0 112.644 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.9 t -114.27 -42.74 3.29 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.079 0.466 . . . . 0.0 110.096 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.593 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 74.56 -3.04 2.66 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.972 1.309 . . . . 0.0 112.134 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.461 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 8.6 tt0 -59.72 -50.09 88.57 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 171.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.461 ' HD3' ' HB3' ' A' ' 70' ' ' GLN . 16.9 Cg_exo -70.56 101.23 1.0 Allowed 'Trans proline' 0 C--N 1.374 1.88 0 N-CA-C 106.615 -2.11 . . . . 0.0 106.615 164.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 46.3 t-105 -109.87 150.11 28.89 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.376 -172.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -114.29 -63.0 1.51 Allowed 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.98 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 158.3 67.0 0.01 OUTLIER Glycine 0 CA--C 1.471 -2.718 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -118.94 121.51 30.44 Favored Pre-proline 0 C--N 1.285 -2.238 0 CA-C-N 114.695 -0.753 . . . . 0.0 109.971 -169.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -85.16 178.56 4.59 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.304 2.003 . . . . 0.0 112.129 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.0 p -57.31 -30.12 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 123.353 0.661 . . . . 0.0 112.681 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.3 mp0 -68.84 -19.74 64.27 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.975 -0.453 . . . . 0.0 111.46 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.684 HE21 ' HA ' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -84.69 -19.74 32.31 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.487 ' O ' HG22 ' A' ' 62' ' ' VAL . 46.7 mt -74.26 -17.47 60.87 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.8 t -87.74 112.58 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 173.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -98.55 131.5 44.72 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -176.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.458 ' CD2' HH22 ' A' ' 47' ' ' ARG . 36.0 m80 -105.07 124.5 49.64 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 121.402 0.62 . . . . 0.0 112.02 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.417 ' O ' ' HB3' ' A' ' 58' ' ' LEU . 93.9 m-85 -131.3 126.73 36.11 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 177.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.9 pp -99.1 144.49 28.18 Favored 'General case' 0 C--N 1.285 -2.228 0 C-N-CA 118.443 -1.303 . . . . 0.0 111.132 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 62.5 mt -105.82 135.23 44.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.367 -174.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.452 ' OE1' ' HA ' ' A' ' 96' ' ' LYS . 30.6 mt-10 -116.55 142.75 46.47 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -176.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.428 ' HB ' HG23 ' A' ' 93' ' ' VAL . 4.7 t -131.39 139.51 49.47 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 175.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.22 -161.04 11.56 Favored Glycine 0 N--CA 1.433 -1.502 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.29 -17.66 61.14 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.038 2.492 . . . . 0.0 113.88 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.419 ' HD2' ' H ' ' A' ' 91' ' ' LYS . 9.7 mptt -79.72 -42.04 25.48 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 122.076 0.941 . . . . 0.0 109.217 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 146.71 -154.42 25.96 Favored Glycine 0 N--CA 1.422 -2.296 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.428 HG23 ' HB ' ' A' ' 88' ' ' THR . 12.4 p -114.02 137.82 45.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.98 171.93 19.13 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.503 ' HB ' ' HB3' ' A' ' 98' ' ' CYS . 58.7 mt -90.54 143.85 10.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 17.0 tppt? -48.02 -45.63 32.11 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.576 1.151 . . . . 0.0 112.482 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -120.44 62.15 0.5 Allowed Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.812 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.503 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 19.7 p -98.7 127.8 34.53 Favored Pre-proline 0 C--N 1.299 -1.588 0 CA-C-O 120.931 0.396 . . . . 0.0 111.429 178.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -90.04 32.93 0.34 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.242 2.628 . . . . 0.0 110.13 174.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.1 t -92.69 -147.65 0.23 Allowed 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.538 ' H ' ' HD2' ' A' ' 102' ' ' PRO . 17.9 tp10 -152.62 -55.52 0.02 OUTLIER Pre-proline 0 C--N 1.289 -2.05 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.733 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.538 ' HD2' ' H ' ' A' ' 101' ' ' GLU . 88.5 Cg_endo -77.81 158.72 31.41 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 121.384 1.39 . . . . 0.0 113.155 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -100.21 157.13 16.81 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -114.02 165.28 12.78 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.7 -47.04 3.54 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.304 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.7 m -121.87 159.25 27.19 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 111' ' ' VAL . 95.2 mt -57.22 -45.73 83.57 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 122.815 0.446 . . . . 0.0 111.757 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 72.4 m -54.26 -29.36 46.61 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.73 -48.83 67.93 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.494 0.187 . . . . 0.0 110.601 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.88 -26.15 63.11 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.158 0.504 . . . . 0.0 110.642 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 107' ' ' LEU . 73.5 t -67.5 -51.69 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.299 176.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 28.6 t -68.25 -27.84 66.69 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.221 0.534 . . . . 0.0 110.467 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.505 ' NE2' ' HB2' ' A' ' 117' ' ' SER . 0.6 OUTLIER -63.28 -50.48 69.96 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.427 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -77.19 -0.37 24.84 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -176.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 7.1 m -75.55 -37.22 60.15 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.486 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 73.3 mt -101.31 -53.94 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.083 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.505 ' HB2' ' NE2' ' A' ' 113' ' ' GLN . 19.9 m -107.94 97.6 21.84 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 116' ' ' ILE . 5.8 Cg_exo -78.64 84.53 2.01 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 122.412 2.075 . . . . 0.0 110.388 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 68.8 mt -80.96 -54.67 9.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.556 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.7 m -92.39 -15.6 27.03 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.453 0.644 . . . . 0.0 110.524 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 71.7 mt -112.6 136.88 21.53 Favored Pre-proline 0 N--CA 1.428 -1.541 0 CA-C-N 115.435 -0.802 . . . . 0.0 108.907 -175.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.476 ' HG2' HG11 ' A' ' 62' ' ' VAL . 71.7 Cg_endo -76.64 -5.84 16.41 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.537 2.158 . . . . 0.0 112.677 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 50.8 t -128.86 149.59 50.69 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 21.2 m -71.33 133.25 45.87 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 16.6 tp -77.77 138.02 38.77 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.247 -175.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 126' ' ' ARG . 23.3 mmt180 -122.41 118.2 27.82 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.533 0.683 . . . . 0.0 111.95 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.526 ' H ' HD12 ' A' ' 127' ' ' ILE . 2.7 mp -91.46 135.31 28.13 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -176.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo . . . . . 0 N--CA 1.48 0.731 0 C-N-CA 122.053 1.835 . . . . 0.0 110.926 175.719 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.9 p . . . . . 0 N--CA 1.428 -1.573 0 CA-C-O 121.881 0.848 . . . . 0.0 110.788 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.432 ' HA ' ' CE2' ' A' ' 22' ' ' TRP . 14.8 m -68.31 -30.15 69.07 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 114.22 -1.354 . . . . 0.0 111.785 -177.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -61.03 -22.29 64.41 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -176.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -76.71 -28.56 55.89 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.392 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.432 ' CE2' ' HA ' ' A' ' 19' ' ' SER . 26.0 p-90 -116.54 -18.07 10.46 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -93.55 119.76 33.0 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.909 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.57 100.14 3.14 Favored Pre-proline 0 C--N 1.308 -1.234 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.246 173.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.484 ' HA ' ' HB2' ' A' ' 47' ' ' ARG . 98.1 Cg_endo -79.72 -4.23 13.35 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.952 2.435 . . . . 0.0 113.471 -173.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -92.63 -12.11 32.47 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.014 -177.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.521 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 17.5 tp -86.47 124.02 32.33 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.0 m -75.9 173.24 11.44 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -173.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.4 tpp180 -57.84 -53.67 55.62 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.726 0.811 . . . . 0.0 110.935 -175.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -67.31 -30.55 70.43 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.278 -177.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -76.32 -35.9 58.55 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.276 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.93 97.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.595 0.712 . . . . 0.0 109.712 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 82.8 mt -66.71 -43.31 90.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.465 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.5 -30.9 70.0 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.501 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.33 -44.77 43.46 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.794 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.49 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 65.0 mt -74.3 -25.14 59.4 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -177.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -71.78 -19.02 62.07 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 121.665 -0.647 . . . . 0.0 110.285 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -89.21 -10.16 48.1 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.601 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.671 ' HE2' ' HA ' ' A' ' 39' ' ' LYS . 3.8 mmpt? -108.68 164.78 12.07 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -176.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.0 151.71 86.34 Favored Pre-proline 0 C--N 1.309 -1.171 0 CA-C-N 112.667 -2.06 . . . . 0.0 108.863 -175.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -61.04 131.37 36.58 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.636 1.557 . . . . 0.0 109.529 173.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.91 -13.2 31.98 Favored Glycine 0 C--N 1.302 -1.351 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.3 151.21 31.22 Favored 'General case' 0 C--O 1.246 0.898 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -154.73 164.72 38.37 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -175.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -152.31 157.12 40.9 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 172.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.402 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 57.6 mt -127.11 132.1 70.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.521 ' HD2' ' O ' ' A' ' 27' ' ' LEU . 7.2 ptm180 -127.87 153.77 46.25 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 175.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -60.07 127.41 31.74 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.3 t -77.51 119.18 20.74 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -86.87 -20.9 26.77 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 m -61.24 -49.93 75.13 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 112.883 -1.962 . . . . 0.0 110.237 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -125.55 133.27 52.37 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -82.73 121.93 27.52 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.785 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.86 23.67 14.89 Favored Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.23 152.1 51.64 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 121.147 0.499 . . . . 0.0 110.035 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -120.58 136.17 54.88 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.73 112.13 4.34 Favored Glycine 0 C--N 1.284 -2.309 0 C-N-CA 120.039 -1.077 . . . . 0.0 111.005 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 44.7 tp -87.05 130.42 34.49 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -113.31 119.49 37.86 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 176.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.4 tp -115.68 130.17 56.75 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 123.65 0.594 . . . . 0.0 110.603 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.49 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 22.6 tptm -88.71 115.07 25.98 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.6 m -105.4 171.33 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 175.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.86 -54.39 10.24 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.6 p -160.22 142.98 9.91 Favored Pre-proline 0 C--N 1.319 -0.722 0 C-N-CA 124.753 1.221 . . . . 0.0 108.112 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.67 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 24.1 Cg_exo -62.57 -49.48 5.63 Favored 'Trans proline' 0 CA--C 1.576 2.579 0 C-N-CA 121.613 1.542 . . . . 0.0 111.386 169.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.67 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 69.3 Cg_endo -68.2 151.67 76.68 Favored 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 122.813 2.342 . . . . 0.0 109.866 173.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -59.09 -48.75 13.01 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.396 2.064 . . . . 0.0 112.617 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.6 p -118.57 -22.34 7.56 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.663 -177.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.429 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 67.42 34.77 4.56 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 124.056 0.943 . . . . 0.0 109.813 -177.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.426 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 64.5 tt0 -59.67 -51.18 82.8 Favored Pre-proline 0 CA--C 1.553 1.084 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.496 177.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.426 ' HD3' ' HB3' ' A' ' 70' ' ' GLN . 4.4 Cg_endo -83.24 114.4 2.17 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 121.156 1.238 . . . . 0.0 110.025 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 38.7 t-105 -125.68 143.08 51.19 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 120.983 0.42 . . . . 0.0 110.215 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -127.54 -61.25 1.14 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 175.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -178.49 65.88 0.08 OUTLIER Glycine 0 CA--C 1.486 -1.758 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 177.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -82.32 130.36 59.78 Favored Pre-proline 0 C--N 1.297 -1.685 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -175.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.57 159.54 32.05 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.256 1.97 . . . . 0.0 113.096 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.6 p -66.22 -14.8 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 121.828 0.823 . . . . 0.0 110.392 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -68.73 -13.49 62.41 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.89 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.434 ' HB3' ' HG2' ' A' ' 65' ' ' PRO . 81.9 mm-40 -89.44 -25.27 21.58 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 121.04 0.447 . . . . 0.0 110.305 176.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.447 HD23 ' HD3' ' A' ' 65' ' ' PRO . 69.3 mt -74.92 -22.66 58.48 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.793 0.806 . . . . 0.0 109.156 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.434 HG13 HD12 ' A' ' 36' ' ' LEU . 98.1 t -100.4 127.36 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 174.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.499 ' NE ' ' HA ' ' A' ' 82' ' ' ARG . 3.5 mmp_? -107.32 139.88 41.11 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.941 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -116.1 122.71 45.94 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.248 0.547 . . . . 0.0 110.522 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -129.3 128.27 42.84 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.406 ' H ' HD23 ' A' ' 85' ' ' LEU . 0.9 OUTLIER -96.37 138.28 34.2 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 118.901 -1.12 . . . . 0.0 111.017 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.7 mt -102.56 119.12 50.47 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.079 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -101.64 143.88 31.05 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -176.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.475 ' HB ' HG23 ' A' ' 93' ' ' VAL . 4.2 t -127.69 120.28 27.67 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-O 121.569 0.7 . . . . 0.0 110.229 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -140.67 -154.84 6.33 Favored Glycine 0 N--CA 1.435 -1.433 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.25 -15.82 28.34 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.118 1.878 . . . . 0.0 111.029 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -72.71 -27.89 62.33 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.415 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 122.83 -153.89 16.99 Favored Glycine 0 N--CA 1.426 -2.025 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -175.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.475 HG23 ' HB ' ' A' ' 88' ' ' THR . 13.2 p -118.27 132.56 67.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.32 157.72 36.19 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.109 -178.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 98' ' ' CYS . 85.6 mt -72.42 140.55 17.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -78.85 128.72 33.72 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 108.69 -54.4 0.55 Allowed Glycine 0 N--CA 1.437 -1.237 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.471 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 49.7 t -139.88 121.92 9.89 Favored Pre-proline 0 N--CA 1.414 -2.273 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 176.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -73.09 -53.7 0.13 Allowed 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 121.741 1.628 . . . . 0.0 110.535 -177.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.2 t 156.21 -83.99 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 129.004 2.922 . . . . 0.0 103.263 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.652 ' HB2' ' HD3' ' A' ' 102' ' ' PRO . 45.7 mt-10 -144.5 -59.55 0.02 OUTLIER Pre-proline 0 N--CA 1.435 -1.202 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 173.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.652 ' HD3' ' HB2' ' A' ' 101' ' ' GLU . 16.6 Cg_endo -101.29 -172.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 121.345 1.363 . . . . 0.0 110.457 171.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -105.97 125.65 51.25 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 173.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.491 ' CD1' ' HB3' ' A' ' 110' ' ' LEU . 97.2 m-85 -84.59 172.64 11.43 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -172.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -101.4 -23.98 9.18 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.218 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.2 m -145.98 160.27 42.09 Favored 'General case' 0 C--O 1.247 0.954 0 O-C-N 122.289 -0.536 . . . . 0.0 110.658 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.92 -48.03 82.26 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 123.356 0.662 . . . . 0.0 112.589 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 m -54.61 -31.95 57.99 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.005 0.522 . . . . 0.0 112.02 -175.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.612 ' O ' ' HG2' ' A' ' 113' ' ' GLN . . . -63.8 -51.71 63.55 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.426 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.491 ' HB3' ' CD1' ' A' ' 104' ' ' PHE . 4.3 pp -70.2 -27.67 64.68 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.711 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.77 -53.22 44.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.742 178.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.1 t -64.35 -29.59 70.65 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.566 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.612 ' HG2' ' O ' ' A' ' 109' ' ' ALA . 81.3 mm-40 -68.01 -33.89 75.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.778 0.323 . . . . 0.0 110.905 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -82.1 -0.02 42.73 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 26.0 m -85.45 -21.73 28.6 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 172.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 67.6 mt -106.14 -49.1 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.653 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.2 m -120.43 102.12 45.73 Favored Pre-proline 0 C--N 1.302 -1.486 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.429 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.33 84.82 1.64 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.351 2.034 . . . . 0.0 109.942 175.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 72.5 mt -87.79 -67.53 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.935 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.2 m -85.03 -11.25 55.8 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.435 0.636 . . . . 0.0 110.936 -176.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 76.2 mt -120.16 137.89 26.48 Favored Pre-proline 0 N--CA 1.429 -1.479 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.493 -175.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -64.48 -34.03 54.98 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.621 2.214 . . . . 0.0 112.341 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 66.2 m -111.61 157.16 20.73 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 9.9 p -81.53 143.59 31.92 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 72.0 mt -78.01 119.12 21.0 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 123.109 0.256 . . . . 0.0 111.612 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -94.97 105.78 17.72 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 175.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.9 mt -78.0 121.87 84.65 Favored Pre-proline 0 C--N 1.301 -1.533 0 CA-C-N 115.305 -0.862 . . . . 0.0 112.063 -171.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 C--N 1.357 1.001 0 C-N-CA 123.471 2.781 . . . . 0.0 112.513 -179.195 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.417 ' HA ' ' CE1' ' A' ' 21' ' ' PHE . 26.8 p . . . . . 0 N--CA 1.451 -0.406 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.2 m -101.11 -37.81 8.42 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.279 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -13.09 58.05 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.417 ' CE1' ' HA ' ' A' ' 18' ' ' THR . 96.9 m-85 -64.0 -50.79 67.14 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.232 0.539 . . . . 0.0 110.18 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.408 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 46.5 p-90 -109.89 -19.03 13.26 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -175.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -95.94 113.79 25.45 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.436 0.636 . . . . 0.0 111.61 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.81 94.55 5.43 Favored Pre-proline 0 C--N 1.303 -1.427 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.437 173.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -78.16 2.95 7.5 Favored 'Trans proline' 0 C--O 1.223 -0.24 0 C-N-CA 123.447 2.765 . . . . 0.0 115.23 -171.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -97.21 -3.22 41.25 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.066 -0.653 . . . . 0.0 111.885 -177.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.413 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 76.2 mt -91.42 134.03 34.97 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 120.946 0.403 . . . . 0.0 110.168 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.0 t -90.66 177.83 6.24 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.272 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -48.31 -57.48 5.94 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.863 1.265 . . . . 0.0 111.162 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.63 -32.03 73.38 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.829 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -75.55 -37.3 60.09 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.085 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.13 -42.63 95.21 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.603 0.716 . . . . 0.0 109.751 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 78.7 mt -66.57 -40.85 87.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.365 177.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.76 -27.32 67.88 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.522 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.4 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 4.5 mm? -81.29 -53.1 6.63 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 172.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.489 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 52.7 mt -61.89 -24.5 66.98 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -174.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -57.23 -35.53 69.81 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -102.22 6.66 40.76 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.637 0.732 . . . . 0.0 110.546 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 35' ' ' LEU . 75.6 mmtt -94.4 156.63 16.4 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.988 177.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.72 149.16 56.41 Favored Pre-proline 0 C--N 1.296 -1.757 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.6 -176.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 61' ' ' LYS . 78.3 Cg_exo -53.34 118.94 5.39 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.634 2.223 . . . . 0.0 111.098 175.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.94 -22.18 6.85 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -176.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.51 147.05 36.01 Favored 'General case' 0 C--O 1.247 0.926 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.451 ' CD1' HD22 ' A' ' 125' ' ' LEU . 33.0 p90 -150.6 165.59 32.88 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -175.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -151.72 150.9 30.72 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.408 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 57.7 mt -116.26 127.14 73.95 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.413 ' HD2' ' O ' ' A' ' 27' ' ' LEU . 50.1 ptt85 -125.44 170.98 10.86 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.92 -176.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -88.63 136.78 32.82 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 176.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.3 m -116.8 123.52 47.32 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 121.411 0.624 . . . . 0.0 112.345 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -84.88 80.51 9.25 Favored 'General case' 0 CA--C 1.487 -1.454 0 CA-C-O 122.304 1.05 . . . . 0.0 108.316 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.3 t -142.28 -62.24 0.44 Allowed 'General case' 0 C--N 1.268 -2.966 0 CA-C-N 113.128 -1.851 . . . . 0.0 107.271 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -126.83 161.77 27.43 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -78.51 121.12 24.17 Favored 'General case' 0 C--O 1.254 1.339 0 CA-C-O 121.182 0.515 . . . . 0.0 110.827 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.7 46.59 9.53 Favored Glycine 0 N--CA 1.437 -1.297 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.68 116.31 22.17 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 121.222 0.534 . . . . 0.0 109.738 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -103.12 118.29 36.47 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.39 122.47 6.48 Favored Glycine 0 C--N 1.277 -2.733 0 C-N-CA 119.839 -1.172 . . . . 0.0 111.239 -177.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 31.7 tp -93.94 124.55 38.02 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.64 121.32 44.76 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 60.3 tp -116.88 126.46 53.04 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 123.039 0.536 . . . . 0.0 110.501 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 21.9 tptm -89.0 115.68 26.74 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.7 m -110.11 170.36 3.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.58 -59.56 3.26 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.6 p -157.66 140.36 10.66 Favored Pre-proline 0 C--N 1.311 -1.071 0 C-N-CA 124.396 1.078 . . . . 0.0 108.204 177.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.647 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 31.3 Cg_exo -59.75 -44.14 33.27 Favored 'Trans proline' 0 CA--C 1.573 2.448 0 C-N-CA 121.999 1.799 . . . . 0.0 111.937 173.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.647 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 78.3 Cg_endo -70.89 154.17 63.4 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.402 2.068 . . . . 0.0 109.02 169.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.42 -47.56 1.0 Allowed 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 121.98 1.787 . . . . 0.0 112.11 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.4 p -103.06 -43.92 5.36 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.004 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.546 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 67.89 23.12 8.46 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.524 1.13 . . . . 0.0 110.602 -177.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -65.25 -47.16 71.73 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.42 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -57.99 120.82 8.97 Favored 'Trans proline' 0 C--N 1.376 1.992 0 N-CA-C 106.436 -2.179 . . . . 0.0 106.436 165.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -34.71 127.74 0.48 Allowed 'General case' 0 C--O 1.243 0.742 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -166.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -139.31 73.49 1.43 Allowed 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 113.899 -1.5 . . . . 0.0 108.88 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.96 48.06 1.0 Allowed Glycine 0 C--N 1.289 -2.047 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 175.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -98.8 146.62 31.96 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -176.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -50.24 157.43 3.07 Favored 'Trans proline' 0 C--O 1.246 0.919 0 C-N-CA 123.527 2.818 . . . . 0.0 114.011 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.5 p -61.94 -11.65 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.851 -178.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -62.03 -27.64 69.02 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 122.833 0.453 . . . . 0.0 110.687 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.47 ' HG2' ' HG2' ' A' ' 65' ' ' PRO . 7.7 tt0 -79.1 -33.59 44.27 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.019 0.438 . . . . 0.0 109.904 177.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.8 mt -72.15 -20.11 61.66 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.468 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 81.7 t -94.12 118.96 41.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 173.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -99.3 129.06 45.49 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 -178.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -106.43 122.92 47.25 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-O 121.28 0.562 . . . . 0.0 111.089 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -130.08 131.11 45.63 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 176.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.2 pp -102.99 140.6 37.05 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 118.32 -1.352 . . . . 0.0 111.584 -175.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.545 HG12 HG12 ' A' ' 95' ' ' ILE . 63.8 mt -102.18 126.1 56.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.587 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.524 ' OE2' ' HE2' ' A' ' 96' ' ' LYS . 38.5 mt-10 -103.53 146.02 29.15 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 92' ' ' GLY . 4.6 t -130.27 128.73 42.17 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 170.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.77 -137.22 2.22 Favored Glycine 0 N--CA 1.427 -1.95 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.829 -177.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.44 1.93 7.4 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.302 2.668 . . . . 0.0 113.721 -175.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -112.34 -20.6 11.76 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.722 0.772 . . . . 0.0 111.714 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 121.98 -154.26 16.76 Favored Glycine 0 CA--C 1.485 -1.819 0 N-CA-C 108.021 -2.032 . . . . 0.0 108.021 -177.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.5 p -107.92 127.1 64.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.59 ' HG2' ' CD2' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -158.02 151.54 23.52 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -172.713 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.545 HG12 HG12 ' A' ' 86' ' ' ILE . 60.3 mt -83.35 133.39 29.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.85 -177.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.524 ' HE2' ' OE2' ' A' ' 87' ' ' GLU . 18.2 ttmm -90.38 140.79 29.37 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.039 176.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.99 3.29 24.83 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -177.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 52.7 t -143.04 140.93 18.5 Favored Pre-proline 0 N--CA 1.422 -1.836 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 98' ' ' CYS . 19.4 Cg_endo -99.5 -2.49 0.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.539 2.159 . . . . 0.0 111.526 174.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.2 m -100.37 -10.28 21.38 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.396 -174.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 8.1 tp10 -74.41 127.16 88.04 Favored Pre-proline 0 N--CA 1.426 -1.651 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -174.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 101' ' ' GLU . 6.1 Cg_exo -73.75 -177.4 3.11 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.376 2.051 . . . . 0.0 112.051 177.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.59 ' CD2' ' HG2' ' A' ' 94' ' ' LYS . 83.6 m-85 -110.88 119.1 37.96 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -106.14 174.49 5.86 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.645 -176.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -97.91 -39.87 3.71 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.913 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 51.1 m -128.45 162.17 27.8 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.73 -37.35 87.3 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 120.9 0.381 . . . . 0.0 110.271 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.0 m -51.59 -35.22 40.57 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.494 1.117 . . . . 0.0 112.04 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.67 -43.43 76.2 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.606 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 pp -74.55 -29.09 61.23 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.976 0.417 . . . . 0.0 111.175 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 75.6 t -64.77 -51.54 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.964 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.3 t -69.04 -31.97 71.14 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.427 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -63.98 -40.8 97.22 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.662 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.572 ' CD2' ' HA ' ' A' ' 118' ' ' PRO . 30.9 m80 -73.7 -3.88 30.96 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.9 m -82.8 -29.85 29.27 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 171.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.7 mt -90.83 -53.01 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.901 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.6 m -135.33 106.3 10.17 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.572 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 48.0 Cg_endo -78.73 100.9 1.4 Allowed 'Trans proline' 0 N--CA 1.437 -1.823 0 C-N-CA 121.413 1.409 . . . . 0.0 111.171 176.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 68.6 mt -84.07 -65.08 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.798 -176.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.7 m -85.98 -28.54 24.16 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.315 0.578 . . . . 0.0 111.415 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 63.6 mt -93.47 133.37 28.39 Favored Pre-proline 0 C--N 1.293 -1.868 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.146 -176.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.0 -13.47 31.57 Favored 'Trans proline' 0 N--CA 1.482 0.798 0 C-N-CA 123.092 2.528 . . . . 0.0 112.497 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 43.9 t -123.92 148.52 46.8 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.508 ' SG ' ' HG3' ' A' ' 118' ' ' PRO . 45.6 m -73.29 147.16 44.78 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.451 HD22 ' CD1' ' A' ' 44' ' ' PHE . 44.5 mt -78.5 114.14 17.15 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.294 0.569 . . . . 0.0 111.452 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -97.17 96.64 8.57 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.1 mp -62.64 129.86 93.15 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo . . . . . 0 C--N 1.36 1.172 0 C-N-CA 123.176 2.584 . . . . 0.0 112.67 179.68 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.3 p . . . . . 0 N--CA 1.429 -1.508 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.9 m -68.97 -35.49 76.81 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.587 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.04 -11.09 45.89 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -177.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -76.22 -25.65 55.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.961 0.41 . . . . 0.0 110.264 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.529 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 37.0 p-90 -125.83 -26.1 3.53 Favored 'General case' 0 C--O 1.208 -1.082 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -176.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -84.43 111.29 19.33 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.599 -0.688 . . . . 0.0 111.022 -176.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -134.71 85.09 37.16 Favored Pre-proline 0 C--N 1.313 -0.978 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.48 -8.14 17.09 Favored 'Trans proline' 0 C--N 1.333 -0.264 0 C-N-CA 122.327 2.018 . . . . 0.0 113.538 -173.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -93.69 -5.36 48.71 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.318 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.8 tp -94.51 126.96 40.13 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -173.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.5 m -83.85 173.9 10.86 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.068 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -52.21 -55.28 22.13 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.23 1.012 . . . . 0.0 112.506 -175.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -55.7 -44.73 77.68 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.835 0.826 . . . . 0.0 110.684 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -73.39 -31.49 63.93 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 113.828 -1.533 . . . . 0.0 111.17 -174.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.39 74.76 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.447 0.641 . . . . 0.0 110.083 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 76.7 mt -68.13 -37.64 78.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.824 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.61 -32.48 70.45 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.645 175.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.432 ' O ' ' HB3' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -76.47 -47.86 21.52 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.28 -178.112 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.44 HD13 HD22 ' A' ' 45' ' ' LEU . 5.7 mp -75.2 -16.54 60.48 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -177.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -80.17 -8.82 59.61 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.326 174.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 35' ' ' LEU . 5.1 t70 -91.14 -41.2 11.15 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.017 177.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -91.59 179.56 5.62 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -176.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -86.86 153.45 54.89 Favored Pre-proline 0 C--N 1.31 -1.118 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 -172.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.09 122.78 12.15 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 122.24 1.96 . . . . 0.0 109.946 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.93 -24.89 5.36 Favored Glycine 0 N--CA 1.42 -2.378 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -175.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.8 148.93 39.88 Favored 'General case' 0 C--O 1.248 0.991 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.408 ' CE1' ' HB3' ' A' ' 125' ' ' LEU . 34.1 p90 -149.12 167.05 26.96 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -178.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.44 HD22 HD13 ' A' ' 36' ' ' LEU . 1.8 pt? -152.58 151.98 31.29 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 174.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.529 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 55.4 mt -113.12 113.34 43.77 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.1 ptt-85 -109.3 -173.82 2.36 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -90.48 129.46 36.65 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 172.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.1 t -82.65 107.45 15.29 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -78.29 75.04 4.82 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 122.459 1.123 . . . . 0.0 110.77 -175.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.3 m -150.61 -45.71 0.12 Allowed 'General case' 0 C--N 1.267 -2.989 0 CA-C-N 113.613 -1.63 . . . . 0.0 108.901 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -131.01 154.38 48.25 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -84.3 121.63 27.78 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.91 37.46 7.28 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.08 119.89 21.61 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.415 ' HB3' ' CG2' ' A' ' 46' ' ' ILE . 63.6 m-85 -97.97 136.58 38.05 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -101.88 106.76 3.06 Favored Glycine 0 C--N 1.286 -2.218 0 C-N-CA 120.324 -0.941 . . . . 0.0 110.984 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -85.14 117.87 24.36 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 82' ' ' ARG . . . -115.03 125.67 53.84 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.9 tp -120.7 127.1 51.72 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 123.958 0.786 . . . . 0.0 109.446 -177.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -88.96 114.74 25.91 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.447 HG12 ' SG ' ' A' ' 123' ' ' CYS . 33.3 m -104.25 169.37 2.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.219 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.88 -43.38 25.1 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 p -160.89 123.01 1.74 Allowed Pre-proline 0 C--N 1.32 -0.707 0 C-N-CA 124.93 1.292 . . . . 0.0 109.534 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.653 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 23.9 Cg_exo -64.85 -47.49 5.0 Favored 'Trans proline' 0 CA--C 1.566 2.101 0 C-N-CA 121.916 1.744 . . . . 0.0 112.232 172.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.714 ' HG2' ' HB2' ' A' ' 69' ' ' ALA . 58.1 Cg_endo -71.79 134.17 23.32 Favored 'Trans proline' 0 C--N 1.384 2.425 0 C-N-CA 121.626 1.551 . . . . 0.0 109.959 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.88 -24.47 33.86 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.806 2.337 . . . . 0.0 113.01 -176.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.4 t -115.38 -37.8 3.95 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.714 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 64.34 32.06 12.41 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.957 0.903 . . . . 0.0 112.965 174.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -63.03 -46.17 86.79 Favored Pre-proline 0 CA--C 1.557 1.234 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -56.4 123.04 12.87 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 121.804 1.669 . . . . 0.0 112.089 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -108.88 132.43 54.05 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.051 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -147.26 7.87 0.91 Allowed 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 124.413 1.085 . . . . 0.0 109.536 177.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.54 117.63 0.76 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -172.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -108.74 107.23 59.91 Favored Pre-proline 0 C--N 1.296 -1.742 0 CA-C-O 121.333 0.587 . . . . 0.0 111.256 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -85.42 148.15 10.05 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.12 1.88 . . . . 0.0 109.972 174.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.2 p -53.37 -25.54 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 123.612 0.765 . . . . 0.0 112.722 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -70.71 -27.02 63.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.237 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.2 -31.55 62.69 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.35 -4.48 33.63 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.493 -177.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 73.6 t -91.89 119.13 38.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 6.2 mmp_? -93.26 149.57 21.13 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -129.06 122.91 30.97 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.896 0.379 . . . . 0.0 111.052 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -133.28 128.36 35.62 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.505 HD23 ' H ' ' A' ' 85' ' ' LEU . 1.6 pt? -99.04 140.38 33.27 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.582 -1.247 . . . . 0.0 112.711 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.422 HG12 HG12 ' A' ' 95' ' ' ILE . 86.0 mt -104.05 119.34 52.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 114.066 -1.425 . . . . 0.0 107.579 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -99.35 144.34 28.57 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.471 ' HB ' HG12 ' A' ' 93' ' ' VAL . 8.8 t -129.33 153.06 48.22 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.28 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.19 -142.77 4.41 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.38 -22.36 29.34 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.559 2.172 . . . . 0.0 112.742 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -73.51 -50.36 21.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.871 0.843 . . . . 0.0 109.793 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 150.89 -125.08 1.83 Allowed Glycine 0 N--CA 1.422 -2.288 0 N-CA-C 107.505 -2.238 . . . . 0.0 107.505 -177.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.471 HG12 ' HB ' ' A' ' 88' ' ' THR . 16.9 m -127.31 139.49 51.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 175.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.93 145.09 24.61 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.067 -0.396 . . . . 0.0 110.983 177.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.422 HG12 HG12 ' A' ' 86' ' ' ILE . 60.3 mt -75.79 140.58 17.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -57.47 -52.85 63.71 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -105.41 52.33 0.72 Allowed Glycine 0 CA--C 1.495 -1.189 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.821 -174.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.432 ' HA ' ' OG ' ' A' ' 120' ' ' SER . 6.7 p -86.52 123.06 71.64 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 123.764 0.332 . . . . 0.0 111.717 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -65.35 -32.12 51.14 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.644 2.229 . . . . 0.0 113.09 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.3 m -145.4 -19.14 0.48 Allowed 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.6 ' OE2' ' HB ' ' A' ' 119' ' ' ILE . 12.9 mp0 -54.5 128.66 61.04 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -176.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -85.33 -161.35 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.766 2.311 . . . . 0.0 110.572 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -87.19 129.42 34.96 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -103.74 161.49 13.88 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.64 -56.44 2.37 Favored Glycine 0 C--N 1.297 -1.584 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.295 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.9 m -116.05 151.46 35.49 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.07 -35.88 72.01 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.021 0.528 . . . . 0.0 110.671 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 m -51.86 -34.89 42.91 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.647 1.179 . . . . 0.0 112.119 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.84 -42.88 76.57 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.413 -176.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 111' ' ' VAL . 4.4 pp -73.49 -38.83 65.26 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.179 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.461 ' N ' HD12 ' A' ' 110' ' ' LEU . 75.2 t -59.81 -46.06 94.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.398 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.0 p -69.57 -37.97 77.22 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -79.85 -28.33 40.06 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.567 -176.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -77.28 -0.1 24.14 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.6 m -80.44 -18.47 48.7 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 170.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 64.7 mt -108.93 -59.53 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.795 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.9 m -113.97 99.43 50.39 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.539 -177.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -90.7 107.57 0.32 Allowed 'Trans proline' 0 N--CA 1.443 -1.486 0 C-N-CA 122.895 2.397 . . . . 0.0 110.919 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.6 ' HB ' ' OE2' ' A' ' 101' ' ' GLU . 25.9 mt -95.18 -64.33 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.432 ' OG ' ' HA ' ' A' ' 98' ' ' CYS . 52.2 m -66.43 -35.39 80.18 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.42 0.629 . . . . 0.0 111.068 174.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -82.65 136.18 45.43 Favored Pre-proline 0 N--CA 1.439 -1.013 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.663 -176.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.97 -19.15 30.72 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.574 2.183 . . . . 0.0 112.256 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.447 ' SG ' HG12 ' A' ' 62' ' ' VAL . 28.5 p -144.13 163.63 33.03 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 25.3 p -71.23 157.69 37.69 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.381 0.61 . . . . 0.0 112.479 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.408 ' HB3' ' CE1' ' A' ' 44' ' ' PHE . 64.8 mt -83.64 115.16 22.02 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.212 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -94.81 104.31 16.22 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.0 mp -69.18 120.98 80.26 Favored Pre-proline 0 C--N 1.317 -0.819 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo . . . . . 0 C--N 1.36 1.164 0 C-N-CA 123.436 2.758 . . . . 0.0 113.091 -177.42 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 N--CA 1.437 -1.103 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.9 t -64.66 -44.65 89.73 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.288 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -4.53 3.53 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -81.95 -35.77 28.69 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.318 0.58 . . . . 0.0 109.511 174.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.434 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 44.7 p-90 -109.46 -28.17 9.06 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -91.32 119.33 31.26 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.55 0.691 . . . . 0.0 110.734 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.42 99.15 5.87 Favored Pre-proline 0 C--N 1.297 -1.683 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.657 172.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.22 -25.11 26.82 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 123.006 2.471 . . . . 0.0 113.629 -171.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -93.96 13.32 23.16 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.433 -173.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.9 tp -92.02 145.52 24.46 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.7 t -99.47 172.31 7.4 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.215 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -55.89 -53.34 57.96 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.299 1.04 . . . . 0.0 112.005 -174.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -67.5 -33.96 76.17 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.1 0.476 . . . . 0.0 111.25 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -70.68 -33.11 70.57 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.221 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.6 -40.67 97.54 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.751 0.786 . . . . 0.0 109.506 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 70.0 mt -69.22 -37.56 76.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 114.755 -1.112 . . . . 0.0 109.582 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.51 -33.8 64.07 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.06 177.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.507 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 4.6 mm? -78.7 -55.73 4.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.105 0.479 . . . . 0.0 110.259 174.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 47.2 mt -59.75 -28.91 67.79 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -174.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -64.55 -28.07 69.39 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.924 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -95.9 -21.61 17.96 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.23 0.538 . . . . 0.0 110.475 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' A' ' 35' ' ' LEU . 26.2 mtpp -77.91 150.34 34.09 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-O 121.021 0.439 . . . . 0.0 110.818 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -75.05 151.36 86.14 Favored Pre-proline 0 C--N 1.309 -1.187 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.566 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -52.1 121.99 9.8 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 123.429 2.753 . . . . 0.0 112.839 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.81 -23.36 7.03 Favored Glycine 0 N--CA 1.432 -1.627 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.2 145.08 44.45 Favored 'General case' 0 C--O 1.246 0.913 0 O-C-N 124.057 0.504 . . . . 0.0 110.513 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.493 ' CG ' HD11 ' A' ' 125' ' ' LEU . 12.7 p90 -142.83 171.96 13.34 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.34 -176.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -158.49 152.8 24.17 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 172.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.434 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 55.8 mt -125.3 134.01 67.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.4 ptt-85 -133.38 -178.69 5.1 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -83.2 147.87 27.77 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.2 m -78.16 139.81 38.99 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.157 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -84.96 -36.07 21.62 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.9 m -69.2 -46.79 66.59 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.738 -176.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -131.1 146.41 52.35 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -87.11 148.97 25.0 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.67 23.05 70.96 Favored Glycine 0 CA--C 1.499 -0.962 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.59 137.1 43.45 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -110.52 121.85 46.32 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.68 114.56 3.95 Favored Glycine 0 N--CA 1.424 -2.112 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.276 -176.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 42.6 tp -94.0 123.62 37.48 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -112.91 122.15 46.78 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 176.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.4 tp -115.65 128.69 56.1 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.42 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 22.0 tptm -88.72 114.82 25.75 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 80' ' ' LEU . 29.3 m -108.61 171.73 2.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.76 -51.56 12.39 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.6 p -151.63 125.72 4.44 Favored Pre-proline 0 N--CA 1.431 -1.414 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.244 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.65 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 34.9 Cg_exo -60.1 -45.68 22.51 Favored 'Trans proline' 0 CA--C 1.577 2.652 0 C-N-CA 121.859 1.706 . . . . 0.0 111.506 169.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.65 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 46.5 Cg_endo -63.72 161.17 33.32 Favored 'Trans proline' 0 C--N 1.391 2.778 0 C-N-CA 122.934 2.423 . . . . 0.0 110.054 171.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.33 -40.89 45.64 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.42 2.08 . . . . 0.0 112.831 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.1 p -137.57 -17.97 1.27 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.435 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 65.33 33.47 9.02 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.059 0.944 . . . . 0.0 111.513 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -65.49 -45.7 68.84 Favored Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.452 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -74.29 103.72 1.73 Allowed 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 121.119 1.213 . . . . 0.0 109.148 169.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 56.0 t-105 -107.8 143.67 36.05 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.12 -175.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -134.93 8.72 3.52 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.77 51.23 4.11 Favored Glycine 0 CA--C 1.49 -1.48 0 C-N-CA 119.726 -1.226 . . . . 0.0 110.37 -175.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -91.32 119.09 68.77 Favored Pre-proline 0 N--CA 1.437 -1.107 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -49.66 146.66 14.86 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.818 3.012 . . . . 0.0 115.168 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.485 HG23 HD12 ' A' ' 80' ' ' LEU . 7.5 p -60.13 -21.03 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 CA-C-O 122.23 1.014 . . . . 0.0 109.794 174.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -69.65 -20.14 63.6 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.359 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -90.31 -7.86 52.31 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.651 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.485 HD12 HG23 ' A' ' 77' ' ' VAL . 80.2 mt -83.53 -6.23 59.39 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 122.091 0.948 . . . . 0.0 108.844 177.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.8 t -85.87 134.25 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.27 174.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -111.05 130.7 55.52 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -109.71 122.86 48.44 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.049 0.452 . . . . 0.0 111.522 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -133.27 147.75 51.93 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 177.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -119.05 131.06 55.93 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 118.709 -1.196 . . . . 0.0 112.314 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.55 HG12 HG12 ' A' ' 95' ' ' ILE . 78.8 mt -87.7 118.23 33.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 178.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.558 ' OE1' ' HE2' ' A' ' 96' ' ' LYS . 39.8 mt-10 -98.97 138.9 35.41 Favored 'General case' 0 C--N 1.27 -2.867 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.539 ' HB ' HG12 ' A' ' 93' ' ' VAL . 7.2 t -120.43 116.66 25.89 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-O 121.989 0.899 . . . . 0.0 109.929 178.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -125.84 -166.69 12.33 Favored Glycine 0 N--CA 1.416 -2.651 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.483 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -68.49 -11.47 32.03 Favored 'Trans proline' 0 C--N 1.331 -0.351 0 C-N-CA 122.949 2.433 . . . . 0.0 113.173 -176.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.529 ' HD3' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -97.06 -17.16 20.16 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.911 179.513 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 136.19 -164.07 25.07 Favored Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -177.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.539 HG12 ' HB ' ' A' ' 88' ' ' THR . 8.3 m -104.97 148.41 9.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.492 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -164.81 157.89 16.89 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.233 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.661 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 60.5 mt -92.27 131.95 37.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.627 0.727 . . . . 0.0 112.008 -174.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.558 ' HE2' ' OE1' ' A' ' 87' ' ' GLU . 22.3 ttmm -88.78 132.87 34.44 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 172.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.49 7.1 7.71 Favored Glycine 0 C--N 1.308 -1.027 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -172.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.415 ' SG ' HG22 ' A' ' 119' ' ' ILE . 42.3 t -142.42 142.36 23.39 Favored Pre-proline 0 N--CA 1.428 -1.567 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -87.73 -13.92 3.84 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.264 1.976 . . . . 0.0 113.244 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.0 m -85.79 -82.76 0.18 Allowed 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.661 ' HG3' ' O ' ' A' ' 95' ' ' ILE . 28.2 mm-40 46.95 97.26 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 117.603 2.445 . . . . 0.0 117.603 174.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -81.63 147.79 15.72 Favored 'Trans proline' 0 N--CA 1.437 -1.845 0 C-N-CA 122.015 1.81 . . . . 0.0 108.926 172.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -76.98 123.38 26.25 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.6 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.429 ' CE2' ' HB3' ' A' ' 110' ' ' LEU . 59.9 m-85 -103.54 164.38 11.7 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.18 -53.5 2.49 Favored Glycine 0 C--N 1.305 -1.156 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.625 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 61.9 m -116.04 160.73 19.89 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 122.918 -0.166 . . . . 0.0 110.977 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.33 -35.17 79.5 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.938 0.399 . . . . 0.0 110.985 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -55.26 -30.82 60.84 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 123.912 0.885 . . . . 0.0 111.479 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.33 -49.33 69.85 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.419 -178.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.589 ' H ' HD13 ' A' ' 110' ' ' LEU 0.293 0.0 OUTLIER -72.52 -28.58 62.95 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.972 -179.78 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 73.4 t -63.65 -49.42 82.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 123.656 0.598 . . . . 0.0 110.076 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.0 t -68.45 -37.88 80.62 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.044 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -75.22 -40.57 59.0 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.472 ' HA ' ' O ' ' A' ' 117' ' ' SER . 25.4 m80 -67.7 -10.96 57.03 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.8 t -72.96 -32.09 65.0 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 175.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 62.4 mt -96.44 -53.5 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 19.8 m -114.77 103.57 54.74 Favored Pre-proline 0 N--CA 1.436 -1.141 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.633 -177.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -78.45 89.35 1.36 Allowed 'Trans proline' 0 N--CA 1.44 -1.657 0 C-N-CA 122.527 2.151 . . . . 0.0 110.922 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.415 HG22 ' SG ' ' A' ' 98' ' ' CYS . 43.5 mt -74.58 -66.57 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.56 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.5 t -85.11 -31.22 23.44 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.645 0.736 . . . . 0.0 110.111 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 69.5 mt -83.92 139.56 40.09 Favored Pre-proline 0 C--N 1.303 -1.444 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.377 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -76.81 -10.58 18.34 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.664 2.243 . . . . 0.0 112.893 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 45.1 t -137.37 160.83 37.97 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 39.3 m -70.61 136.0 48.86 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.493 HD11 ' CG ' ' A' ' 44' ' ' PHE . 23.9 tp -75.07 132.7 41.46 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.52 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.543 ' O ' ' HD3' ' A' ' 128' ' ' PRO . 36.6 mmt180 -118.07 128.81 55.12 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mp -95.26 106.31 25.25 Favored Pre-proline 0 C--N 1.312 -1.023 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.543 ' HD3' ' O ' ' A' ' 126' ' ' ARG . 33.6 Cg_exo . . . . . 0 N--CA 1.457 -0.652 0 C-N-CA 122.266 1.977 . . . . 0.0 111.988 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.9 p . . . . . 0 N--CA 1.434 -1.273 0 CA-C-O 122.02 0.914 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.9 m -75.9 -7.71 55.19 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.847 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.89 -16.56 53.26 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 119.936 -0.706 . . . . 0.0 111.695 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -69.75 -25.55 63.88 Favored 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -175.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 19.6 p-90 -113.25 -4.21 13.75 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.191 0.52 . . . . 0.0 111.917 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -107.45 114.32 28.25 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.786 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.66 96.97 3.53 Favored Pre-proline 0 C--N 1.295 -1.78 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.574 174.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.517 ' HA ' ' HB2' ' A' ' 47' ' ' ARG . 66.3 Cg_endo -79.81 13.96 2.0 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.443 2.762 . . . . 0.0 114.038 -171.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -102.92 -6.58 22.3 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 120.859 0.361 . . . . 0.0 110.421 -176.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.477 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 75.9 mt -87.32 142.54 27.81 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.478 0.656 . . . . 0.0 111.762 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 87.3 p -89.17 177.81 6.53 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.983 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -63.05 -43.25 99.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -55.08 -48.2 73.86 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.316 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -70.31 -34.39 72.66 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.381 -178.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.451 ' HA ' HD11 ' A' ' 45' ' ' LEU . . . -65.2 -44.59 87.87 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.237 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 51.2 mt -66.64 -38.94 82.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.486 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.06 -40.37 89.21 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.377 0.608 . . . . 0.0 110.346 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -46.0 69.56 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.055 -179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 72.4 mt -74.86 -17.19 60.63 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -176.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.401 ' HB3' HG21 ' A' ' 77' ' ' VAL . 18.4 ptpt -83.06 -11.28 58.18 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.149 -1.021 . . . . 0.0 110.37 177.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -93.91 -24.3 17.75 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.606 0.717 . . . . 0.0 109.454 175.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -99.91 164.52 11.98 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -72.49 156.91 89.84 Favored Pre-proline 0 C--N 1.287 -2.127 0 CA-C-N 112.177 -2.283 . . . . 0.0 112.749 -176.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -60.46 126.31 19.64 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.892 2.395 . . . . 0.0 111.379 175.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 112.96 -7.74 25.47 Favored Glycine 0 C--N 1.303 -1.25 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -176.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.49 150.3 32.98 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-N 115.534 -0.333 . . . . 0.0 110.341 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.527 ' CD1' HD11 ' A' ' 125' ' ' LEU . 9.8 p90 -149.25 167.63 25.5 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.451 HD11 ' HA ' ' A' ' 32' ' ' ALA . 2.5 pt? -155.97 148.72 24.04 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 171.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.406 ' CG2' ' HB3' ' A' ' 56' ' ' TYR . 63.2 mt -120.79 130.27 74.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-O 121.124 0.488 . . . . 0.0 110.656 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.517 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -137.82 -176.96 4.6 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.044 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -62.66 134.39 56.25 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.8 t -74.57 136.38 42.09 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.371 0.605 . . . . 0.0 110.704 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -72.75 -27.06 61.8 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.325 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.2 m -81.13 -52.26 7.57 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.965 -175.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -137.73 145.26 42.28 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -175.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -82.98 151.92 25.66 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 173.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.03 9.96 81.52 Favored Glycine 0 C--N 1.305 -1.179 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.44 144.48 48.16 Favored 'General case' 0 N--CA 1.406 -2.648 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.406 ' HB3' ' CG2' ' A' ' 46' ' ' ILE . 76.6 m-85 -116.9 126.34 52.83 Favored 'General case' 0 C--N 1.273 -2.749 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.433 ' O ' ' HD3' ' A' ' 47' ' ' ARG . . . -83.76 115.15 4.0 Favored Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.031 -177.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.7 tp -95.59 121.63 37.5 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 123.728 0.811 . . . . 0.0 109.03 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.57 127.56 53.1 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -124.04 125.59 44.79 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -176.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.495 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 21.7 tptm -88.34 114.62 25.15 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.675 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 80' ' ' LEU . 20.0 m -96.85 167.61 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.07 -59.11 2.87 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 174.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.4 ' HB ' ' HG2' ' A' ' 66' ' ' PRO . 0.6 OUTLIER -155.73 141.72 12.91 Favored Pre-proline 0 N--CA 1.428 -1.529 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.84 177.349 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.65 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 32.0 Cg_exo -59.47 -42.79 45.04 Favored 'Trans proline' 0 CA--C 1.573 2.454 0 C-N-CA 122.283 1.989 . . . . 0.0 112.61 174.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.65 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 39.7 Cg_endo -65.13 148.12 88.91 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 122.832 2.354 . . . . 0.0 109.77 172.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.79 -37.14 88.67 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.749 2.299 . . . . 0.0 113.048 -177.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.7 t -132.37 -11.07 3.22 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.949 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.455 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 69.83 31.99 3.31 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 124.345 1.058 . . . . 0.0 112.923 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -64.14 -43.75 74.95 Favored Pre-proline 0 CA--C 1.556 1.199 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.631 173.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -84.69 101.3 0.79 Allowed 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 121.446 1.43 . . . . 0.0 109.893 167.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 34.6 t-105 -92.53 146.66 23.51 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.909 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -121.82 -36.52 3.01 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.966 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.44 14.12 12.09 Favored Glycine 0 C--N 1.3 -1.466 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.31 -176.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -64.53 134.09 95.89 Favored Pre-proline 0 C--N 1.316 -0.865 0 C-N-CA 122.63 0.372 . . . . 0.0 110.701 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.1 173.19 14.91 Favored 'Trans proline' 0 C--O 1.245 0.844 0 C-N-CA 123.042 2.495 . . . . 0.0 113.855 -175.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.401 HG21 ' HB3' ' A' ' 37' ' ' LYS . 2.1 p -56.42 -30.31 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.478 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -58.78 -25.11 62.78 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 122.955 0.502 . . . . 0.0 112.238 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -92.05 -14.23 29.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.059 0.457 . . . . 0.0 110.56 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.528 ' O ' HG22 ' A' ' 62' ' ' VAL . 72.9 mt -81.95 -13.07 58.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 122.006 0.908 . . . . 0.0 108.642 178.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.2 t -94.91 111.37 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 175.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.412 ' NH2' ' HB3' ' A' ' 65' ' ' PRO . 32.4 mmt180 -85.19 147.46 26.59 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.428 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.9 m80 -126.13 123.21 37.79 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.586 0.708 . . . . 0.0 111.723 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -132.49 163.52 28.63 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 106.282 -1.748 . . . . 0.0 106.282 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -130.02 132.65 46.31 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.047 176.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 94' ' ' LYS . 75.1 mt -90.84 110.65 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.332 0 CA-C-N 114.48 -1.236 . . . . 0.0 107.668 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -100.2 152.69 19.98 Favored 'General case' 0 C--N 1.268 -2.954 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.507 ' HB ' HG12 ' A' ' 93' ' ' VAL . 4.3 t -134.14 148.82 51.01 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-O 121.214 0.531 . . . . 0.0 110.675 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.45 -159.51 11.15 Favored Glycine 0 N--CA 1.42 -2.384 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.37 -21.44 72.68 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.929 2.419 . . . . 0.0 112.939 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -88.83 -5.79 57.79 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.733 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 110.36 -147.56 17.44 Favored Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.507 HG12 ' HB ' ' A' ' 88' ' ' THR . 12.1 m -108.11 151.95 10.08 Favored 'Isoleucine or valine' 0 C--O 1.252 1.23 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 13.8 pttp -151.38 147.95 27.53 Favored 'General case' 0 C--N 1.311 -1.078 0 O-C-N 123.777 0.673 . . . . 0.0 109.859 -175.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.517 ' HB ' ' OE2' ' A' ' 101' ' ' GLU . 76.5 mt -101.46 108.38 23.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -75.36 119.06 18.94 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 120.984 0.421 . . . . 0.0 110.071 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 121.22 -2.74 11.47 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.072 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 24.1 p -70.93 152.9 94.96 Favored Pre-proline 0 C--N 1.317 -0.809 0 C-N-CA 123.026 0.53 . . . . 0.0 110.006 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -72.41 -52.64 0.17 Allowed 'Trans proline' 0 C--O 1.24 0.616 0 C-N-CA 121.729 1.619 . . . . 0.0 110.16 173.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.2 m -144.99 139.86 27.79 Favored 'General case' 0 N--CA 1.41 -2.467 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.517 ' OE2' ' HB ' ' A' ' 95' ' ' ILE . 38.3 tt0 -166.56 142.67 3.88 Favored Pre-proline 0 C--N 1.297 -1.713 0 O-C-N 123.479 0.487 . . . . 0.0 112.165 -176.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -92.71 160.62 2.83 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 123.171 2.581 . . . . 0.0 110.3 168.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -74.07 127.02 31.84 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -79.14 -72.59 0.38 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.023 0.439 . . . . 0.0 111.248 -176.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.44 ' H ' HG22 ' A' ' 93' ' ' VAL . . . 148.91 -58.6 0.46 Allowed Glycine 0 C--N 1.309 -0.929 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.1 m -132.53 155.9 47.79 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.475 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 10.7 mp -53.11 -46.31 68.65 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.436 0.46 . . . . 0.0 111.164 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.4 m -53.83 -30.75 46.65 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.898 0.879 . . . . 0.0 112.458 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.58 -37.12 73.89 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 120.64 0.257 . . . . 0.0 111.288 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 107' ' ' LEU . 4.3 pp -80.35 -23.43 40.53 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.462 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 107' ' ' LEU . 70.8 t -71.44 -40.31 72.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.388 177.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.0 p -70.25 -22.86 62.84 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.029 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.625 ' HG2' ' H ' ' A' ' 114' ' ' HIS . 8.5 tt0 -95.2 -172.51 2.69 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 177.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.625 ' H ' ' HG2' ' A' ' 113' ' ' GLN . 57.2 m80 77.87 -26.07 0.19 Allowed 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.9 m -66.81 -41.9 86.79 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 173.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 65.8 mt -74.23 -66.25 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.404 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.7 m -125.75 118.79 24.26 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -78.75 101.09 1.42 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.238 1.959 . . . . 0.0 111.002 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 56.5 mt -95.02 -71.15 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.508 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.0 m -71.28 -30.2 65.99 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.343 0.592 . . . . 0.0 110.554 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 85.9 mt -101.49 148.81 35.74 Favored Pre-proline 0 C--N 1.304 -1.399 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.104 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 1.7 Cg_endo -77.43 -29.29 4.89 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.007 1.805 . . . . 0.0 113.109 -178.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 79.9 m -114.8 155.03 27.51 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.81 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 64.7 m -62.68 122.72 16.57 Favored 'General case' 0 C--O 1.241 0.606 0 O-C-N 123.982 0.802 . . . . 0.0 109.645 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.527 HD11 ' CD1' ' A' ' 44' ' ' PHE . 27.4 tp -74.11 134.56 42.89 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.724 -173.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -117.96 129.03 55.36 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 127' ' ' ILE . 3.4 mp -93.29 132.98 29.24 Favored Pre-proline 0 C--O 1.193 -1.884 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -174.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 N--CA 1.488 1.185 0 C-N-CA 122.842 2.362 . . . . 0.0 112.898 179.123 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 35.0 p . . . . . 0 N--CA 1.408 -2.549 0 CA-C-O 120.659 0.266 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.407 ' HA ' ' CE2' ' A' ' 22' ' ' TRP . 48.3 p -53.38 -49.55 66.98 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -173.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -10.19 57.8 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 119.86 -0.736 . . . . 0.0 112.614 -177.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -83.34 -25.19 31.67 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.528 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.407 ' CE2' ' HA ' ' A' ' 19' ' ' SER . 27.0 p-90 -119.39 -22.09 7.19 Favored 'General case' 0 C--O 1.214 -0.795 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 52.1 t80 -90.97 112.77 24.8 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.775 -177.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.78 92.07 41.27 Favored Pre-proline 0 C--N 1.315 -0.929 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 175.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -57.64 -44.41 41.74 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 123.341 2.694 . . . . 0.0 115.942 -169.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -104.96 16.91 25.08 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.368 0.604 . . . . 0.0 111.364 -170.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.5 tp -74.62 146.25 42.6 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 85.4 p -93.0 166.66 12.26 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.96 -0.462 . . . . 0.0 110.257 -175.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -57.02 -49.41 75.88 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.939 0.399 . . . . 0.0 110.934 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -60.89 -34.82 75.24 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.296 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -75.87 -30.83 59.01 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.928 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.42 -43.14 77.81 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 75.8 mt -66.58 -40.22 85.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.624 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.21 -34.55 70.52 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.373 0.669 . . . . 0.0 111.104 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.72 -49.63 15.56 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.526 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 67.2 mt -68.49 -32.61 72.72 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -175.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -63.51 -21.54 66.38 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.065 0.459 . . . . 0.0 111.43 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -90.32 -10.14 45.18 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.275 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.65 -178.34 3.63 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.758 -174.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -99.96 160.72 26.47 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.111 -177.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -59.04 125.99 19.75 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 122.491 2.127 . . . . 0.0 111.673 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.51 -22.57 9.38 Favored Glycine 0 N--CA 1.43 -1.729 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.3 148.76 46.8 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.992 -0.374 . . . . 0.0 109.992 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.402 ' HB2' HD11 ' A' ' 58' ' ' LEU . 43.2 p90 -153.56 168.53 25.88 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.043 -175.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -153.15 152.43 31.26 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 172.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 23' ' ' TYR . 55.8 mt -121.98 133.19 69.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -127.02 -173.9 3.01 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -84.69 127.72 34.24 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 171.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.4 t -79.21 108.07 12.45 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -66.1 -6.53 13.48 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.75 -1.114 . . . . 0.0 113.912 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.1 p -77.62 -18.34 56.88 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.507 0.67 . . . . 0.0 110.977 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -135.83 -174.55 3.69 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -124.14 121.29 34.73 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.12 0.486 . . . . 0.0 109.918 172.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.04 43.65 8.05 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.37 159.33 41.36 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.563 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 50.5 m-85 -112.31 150.11 31.47 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.328 -176.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 85' ' ' LEU . . . -126.76 116.45 2.5 Favored Glycine 0 C--N 1.282 -2.458 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.402 HD11 ' HB2' ' A' ' 44' ' ' PHE . 50.5 tp -94.77 123.24 38.11 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 123.144 0.578 . . . . 0.0 109.84 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -107.57 115.61 30.46 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 175.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.3 tp -110.79 127.52 55.41 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 123.491 0.494 . . . . 0.0 110.487 -177.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.526 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 26.7 tptp -88.64 115.49 26.2 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.426 HG11 ' HG2' ' A' ' 122' ' ' PRO . 31.4 m -106.96 164.91 4.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.66 -53.26 43.69 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.489 ' HB ' ' HG2' ' A' ' 66' ' ' PRO . 1.3 p -159.76 140.73 9.14 Favored Pre-proline 0 N--CA 1.423 -1.8 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 175.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.6 ' CD ' ' HD2' ' A' ' 66' ' ' PRO . 30.1 Cg_exo -56.7 -43.18 57.34 Favored 'Trans proline' 0 CA--C 1.571 2.327 0 C-N-CA 122.215 1.944 . . . . 0.0 112.704 175.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.6 ' HD2' ' CD ' ' A' ' 65' ' ' PRO . 43.5 Cg_endo -62.81 153.4 72.93 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.182 2.588 . . . . 0.0 110.426 171.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -57.31 -45.35 35.49 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.524 2.149 . . . . 0.0 112.632 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.9 m -133.44 1.32 3.42 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.511 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 60.16 38.22 20.36 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.828 0.851 . . . . 0.0 111.856 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -54.74 -49.74 89.77 Favored Pre-proline 0 CA--C 1.552 1.055 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.933 177.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -78.0 139.83 17.58 Favored 'Trans proline' 0 C--N 1.366 1.479 0 CA-C-N 120.253 1.126 . . . . 0.0 111.406 173.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -96.47 136.62 36.72 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -132.68 -12.22 3.02 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.038 0.447 . . . . 0.0 110.502 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.48 56.12 4.38 Favored Glycine 0 CA--C 1.493 -1.299 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -175.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -83.63 132.86 47.95 Favored Pre-proline 0 C--N 1.289 -2.024 0 C-N-CA 123.563 0.745 . . . . 0.0 111.395 -175.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -81.93 166.84 16.73 Favored 'Trans proline' 0 N--CA 1.445 -1.327 0 C-N-CA 122.122 1.881 . . . . 0.0 111.827 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.8 p -61.2 -24.47 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.486 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -65.26 -26.67 68.19 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.957 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.422 ' HG2' ' HG2' ' A' ' 65' ' ' PRO . 7.6 tt0 -82.35 -27.73 32.01 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.109 0.48 . . . . 0.0 109.957 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.0 mt -74.72 -11.7 60.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.553 0.692 . . . . 0.0 110.367 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.2 t -103.15 118.47 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -100.36 129.78 46.38 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 -178.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -107.24 121.76 45.18 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 121.038 0.447 . . . . 0.0 109.8 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -127.79 118.37 23.61 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.412 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 4.2 pp -96.24 139.34 32.53 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.111 -177.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.563 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 76.9 mt -99.97 129.24 50.94 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 CA-C-N 114.402 -1.272 . . . . 0.0 107.935 -177.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.598 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 35.3 mt-10 -99.11 157.38 16.4 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -177.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.703 ' HB ' HG12 ' A' ' 93' ' ' VAL . 4.4 t -147.54 128.89 14.84 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 175.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.39 -141.9 3.67 Favored Glycine 0 N--CA 1.426 -2.013 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.389 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.62 -47.63 25.72 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.723 2.949 . . . . 0.0 113.108 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -74.57 -60.73 2.15 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 167.46 -146.17 10.44 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 119.976 -1.107 . . . . 0.0 111.627 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.703 HG12 ' HB ' ' A' ' 88' ' ' THR . 22.0 m -104.9 149.36 8.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 O-C-N 124.007 0.475 . . . . 0.0 111.078 -175.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.89 157.64 3.04 Favored 'General case' 0 C--O 1.252 1.187 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 172.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.496 HG12 HG12 ' A' ' 86' ' ' ILE . 71.9 mt -76.17 129.15 37.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-O 121.959 0.885 . . . . 0.0 112.35 -178.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -69.77 121.17 16.72 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.55 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 109.72 -1.16 30.47 Favored Glycine 0 C--N 1.306 -1.118 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.627 ' SG ' ' HB2' ' A' ' 101' ' ' GLU . 37.9 t -108.81 110.26 61.12 Favored Pre-proline 0 N--CA 1.431 -1.396 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -96.45 21.24 0.43 Allowed 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.098 2.532 . . . . 0.0 112.671 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.5 m -138.13 31.91 2.4 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.852 0.834 . . . . 0.0 109.093 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.627 ' HB2' ' SG ' ' A' ' 98' ' ' CYS . 29.7 tt0 -134.46 123.5 16.49 Favored Pre-proline 0 N--CA 1.426 -1.675 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.588 -173.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.37 174.76 12.26 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.594 2.196 . . . . 0.0 112.076 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -86.25 129.03 34.98 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -106.93 172.78 6.63 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -98.41 -54.8 1.14 Allowed Glycine 0 C--N 1.304 -1.225 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.103 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.5 m -105.95 153.78 21.5 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 123.128 0.571 . . . . 0.0 110.028 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.429 HD21 ' CD2' ' A' ' 56' ' ' TYR . 92.6 mt -65.35 -36.19 83.25 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.049 0.452 . . . . 0.0 110.041 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.8 m -53.05 -29.25 28.84 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.001 0.92 . . . . 0.0 112.697 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.73 -41.83 74.75 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.552 ' H ' HD13 ' A' ' 110' ' ' LEU 0.306 0.0 OUTLIER -80.07 -32.36 39.31 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.215 177.285 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.455 ' HA ' HD23 ' A' ' 125' ' ' LEU . 67.6 t -57.08 -42.68 79.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.307 0.575 . . . . 0.0 110.91 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.8 p -72.15 -33.44 67.74 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.984 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -80.01 -36.35 36.02 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.509 ' HA ' ' O ' ' A' ' 117' ' ' SER . 27.9 m-70 -71.65 -5.47 33.89 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -174.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.8 m -73.33 -30.08 63.11 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 172.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.425 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 52.9 mt -101.03 -52.16 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.109 -177.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 38.8 t -111.72 95.87 30.11 Favored Pre-proline 0 N--CA 1.424 -1.773 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.036 -175.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 116' ' ' ILE . 5.8 Cg_endo -85.78 74.54 3.43 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 122.733 2.289 . . . . 0.0 109.942 178.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.1 mt -66.19 -56.24 15.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.861 -175.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.563 ' HB3' ' SG ' ' A' ' 98' ' ' CYS . 2.4 p -96.31 6.18 49.34 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.081 -177.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 69.2 mt -123.49 140.84 34.89 Favored Pre-proline 0 C--N 1.308 -1.199 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.755 -173.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.426 ' HG2' HG11 ' A' ' 62' ' ' VAL . 72.4 Cg_endo -79.03 -8.44 15.45 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.576 2.184 . . . . 0.0 112.033 177.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 77.1 m -140.29 168.81 18.93 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 59.3 m -79.21 145.76 33.45 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 120.733 0.301 . . . . 0.0 110.27 -178.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 111' ' ' VAL . 15.5 tp -85.6 108.73 18.12 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -106.65 107.47 18.5 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.54 0.686 . . . . 0.0 111.721 -174.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 58.2 mt -65.74 120.92 72.64 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.763 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 0 C--N 1.351 0.7 0 C-N-CA 122.246 1.964 . . . . 0.0 111.735 179.173 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.421 -1.915 0 CA-C-O 122.144 0.974 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.464 ' HA ' ' CE2' ' A' ' 22' ' ' TRP . 27.1 m -66.77 -22.25 66.04 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.501 177.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.72 0.46 5.54 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.882 -1.054 . . . . 0.0 113.076 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -94.52 -27.12 16.13 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 122.233 -0.292 . . . . 0.0 110.486 174.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.464 ' CE2' ' HA ' ' A' ' 19' ' ' SER . 31.0 p-90 -134.49 -8.24 2.52 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -170.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -96.75 114.39 26.03 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.029 -0.669 . . . . 0.0 111.327 -176.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -120.02 86.57 37.17 Favored Pre-proline 0 C--O 1.2 -1.528 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 176.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -54.11 -40.9 79.79 Favored 'Trans proline' 0 N--CA 1.479 0.628 0 C-N-CA 123.264 2.643 . . . . 0.0 115.936 -170.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -97.32 10.13 40.43 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -171.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.7 tp -75.61 136.81 40.47 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.454 0.645 . . . . 0.0 110.657 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.1 m -80.56 161.11 24.94 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.641 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.413 ' HA ' HH21 ' A' ' 47' ' ' ARG . 28.2 ttm180 -56.71 -51.42 68.87 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.275 0.63 . . . . 0.0 110.961 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -59.46 -44.66 92.93 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.583 0.706 . . . . 0.0 110.909 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -69.81 -30.53 68.07 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.863 -176.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.52 -36.97 82.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.667 0.746 . . . . 0.0 110.306 178.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 72.4 mt -69.73 -40.23 78.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.593 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.76 -33.31 73.86 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.789 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.87 -36.14 75.25 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.569 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.547 ' HB3' ' HG2' ' A' ' 61' ' ' LYS . 63.8 mt -87.85 -22.33 24.51 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -71.3 -9.42 58.09 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.571 0.7 . . . . 0.0 110.594 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -91.89 -25.18 19.06 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.43 174.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -106.71 155.58 19.52 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -169.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -66.07 156.5 84.16 Favored Pre-proline 0 C--N 1.32 -0.696 0 C-N-CA 125.334 1.454 . . . . 0.0 113.321 -172.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.24 111.96 1.26 Allowed 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 122.876 2.384 . . . . 0.0 111.045 175.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.05 -18.21 5.33 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -176.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.77 147.36 35.35 Favored 'General case' 0 C--O 1.251 1.146 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 177.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.401 ' HB2' HD11 ' A' ' 58' ' ' LEU . 25.0 p90 -153.17 169.48 22.9 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -175.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -160.35 154.33 22.98 Favored 'General case' 0 C--O 1.254 1.307 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 173.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 56.9 mt -126.8 137.61 57.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 123.354 0.409 . . . . 0.0 109.922 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.505 HH22 ' CD2' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -134.67 177.9 7.42 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 177.125 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -74.08 130.02 38.99 Favored 'General case' 0 C--O 1.249 1.034 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 175.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.0 t -82.56 92.76 7.17 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-O 121.526 0.679 . . . . 0.0 109.242 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -75.44 76.36 2.5 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-O 122.322 1.058 . . . . 0.0 108.782 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.5 t -161.87 -40.97 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 112.804 -1.998 . . . . 0.0 107.877 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -135.93 142.98 44.7 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -76.84 133.79 39.24 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.273 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.13 37.36 28.92 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.62 143.51 47.36 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -115.55 133.26 56.2 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.449 ' O ' ' HD3' ' A' ' 47' ' ' ARG . . . -97.83 119.14 6.32 Favored Glycine 0 C--N 1.283 -2.376 0 C-N-CA 119.836 -1.173 . . . . 0.0 112.018 -176.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.401 HD11 ' HB2' ' A' ' 44' ' ' PHE . 48.3 tp -97.4 136.08 38.36 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.422 ' HB2' HH12 ' A' ' 47' ' ' ARG . . . -122.04 129.97 52.88 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 173.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.4 tp -127.59 132.05 49.86 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 123.505 0.503 . . . . 0.0 110.957 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.547 ' HG2' ' HB3' ' A' ' 36' ' ' LEU . 0.7 OUTLIER -88.55 115.61 26.2 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 174.716 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.7 m -102.29 171.85 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.85 -56.09 6.36 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 p -152.57 137.6 11.03 Favored Pre-proline 0 N--CA 1.435 -1.204 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.477 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.501 ' HD2' ' CD ' ' A' ' 66' ' ' PRO . 16.6 Cg_exo -65.51 -44.7 8.14 Favored 'Trans proline' 0 CA--C 1.568 2.19 0 C-N-CA 121.625 1.55 . . . . 0.0 110.91 173.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.501 ' CD ' ' HD2' ' A' ' 65' ' ' PRO . 14.8 Cg_exo -71.14 165.6 31.9 Favored 'Trans proline' 0 C--N 1.397 3.098 0 C-N-CA 122.219 1.946 . . . . 0.0 109.87 168.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -50.58 -35.63 47.13 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.472 2.781 . . . . 0.0 112.953 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 65.2 m -151.7 -13.39 0.2 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 63.36 41.17 7.88 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.857 0.863 . . . . 0.0 111.835 175.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.403 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 22.0 mp0 -58.88 -51.8 79.27 Favored Pre-proline 0 CA--C 1.553 1.082 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.269 171.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 70' ' ' GLN . 30.2 Cg_endo -63.4 127.91 21.17 Favored 'Trans proline' 0 C--N 1.387 2.578 0 C-N-CA 122.072 1.848 . . . . 0.0 112.049 176.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -98.98 139.48 34.56 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.195 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -136.79 16.43 3.08 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.173 0.589 . . . . 0.0 110.067 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.34 64.53 1.76 Allowed Glycine 0 CA--C 1.486 -1.752 0 N-CA-C 107.024 -2.43 . . . . 0.0 107.024 -172.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -104.58 103.19 38.55 Favored Pre-proline 0 C--N 1.301 -1.524 0 CA-C-N 114.953 -0.623 . . . . 0.0 110.358 -172.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.516 ' HB2' ' OE1' ' A' ' 78' ' ' GLU . 71.7 Cg_endo -78.8 175.53 10.88 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.052 1.835 . . . . 0.0 111.236 177.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 p -68.96 -28.2 38.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.568 0.699 . . . . 0.0 110.589 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.516 ' OE1' ' HB2' ' A' ' 76' ' ' PRO . 11.7 mp0 -66.52 -22.09 66.17 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.172 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -78.03 -18.16 56.18 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.651 0.738 . . . . 0.0 109.607 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.0 mt -84.13 -4.16 58.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.427 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.0 t -92.72 118.73 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -90.85 145.78 24.48 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.505 ' CD2' HH22 ' A' ' 47' ' ' ARG . 29.7 m80 -120.52 125.56 48.16 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.195 0.521 . . . . 0.0 111.793 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -138.32 131.96 30.87 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.484 HD23 ' H ' ' A' ' 85' ' ' LEU . 1.6 pt? -104.83 142.36 34.86 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.893 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.442 ' CG2' HG22 ' A' ' 93' ' ' VAL . 4.6 mp -98.83 123.59 51.53 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.083 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.414 ' OE1' ' HD3' ' A' ' 96' ' ' LYS . 48.5 mt-10 -98.86 139.76 34.06 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.502 ' HB ' HG23 ' A' ' 93' ' ' VAL . 12.1 t -133.35 153.41 51.62 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.33 -152.21 11.33 Favored Glycine 0 N--CA 1.42 -2.415 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.73 -13.14 37.81 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.662 2.241 . . . . 0.0 112.669 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -86.62 -6.84 58.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.329 0.585 . . . . 0.0 110.6 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 109.42 -140.32 15.66 Favored Glycine 0 N--CA 1.427 -1.924 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.502 HG23 ' HB ' ' A' ' 88' ' ' THR . 12.5 p -132.28 126.3 55.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -146.77 140.99 26.25 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.391 -0.818 . . . . 0.0 112.969 -176.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.4 mt -72.04 126.75 33.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.562 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.414 ' HD3' ' OE1' ' A' ' 87' ' ' GLU . 25.7 tptp -76.01 97.91 4.15 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.511 ' O ' ' HD3' ' A' ' 99' ' ' PRO . . . 135.81 4.12 2.46 Favored Glycine 0 N--CA 1.425 -2.084 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.505 -176.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 46.0 t -93.23 104.79 13.09 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 97' ' ' GLY . 72.8 Cg_endo -89.64 -10.23 3.77 Favored 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 121.878 1.718 . . . . 0.0 112.419 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.4 t -71.16 -75.17 0.13 Allowed 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 176.32 103.9 0.1 Allowed Pre-proline 0 C--O 1.234 0.277 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.499 ' HB2' ' HB2' ' A' ' 94' ' ' LYS . 23.3 Cg_endo -96.25 -128.18 0.01 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.887 0 C-N-CA 122.841 2.361 . . . . 0.0 112.435 177.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.42 ' H ' ' HB2' ' A' ' 102' ' ' PRO . 89.2 m-85 62.43 86.87 0.11 Allowed 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 125.55 1.54 . . . . 0.0 111.231 -175.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -110.7 177.38 4.69 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 113.955 -1.475 . . . . 0.0 108.722 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -88.13 -48.01 4.22 Favored Glycine 0 C--N 1.314 -0.68 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.344 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.2 m -134.28 160.1 38.92 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 66.0 mt -56.84 -44.47 82.12 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.543 0.337 . . . . 0.0 111.389 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 32.3 t -54.91 -31.26 59.97 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.817 0.847 . . . . 0.0 111.102 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.33 -44.27 88.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.013 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.56 ' H ' HD13 ' A' ' 110' ' ' LEU 0.302 0.0 OUTLIER -80.26 -31.17 38.47 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 119.146 -1.021 . . . . 0.0 112.01 177.608 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.7 t -61.87 -54.2 37.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.169 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.1 t -70.5 -31.62 68.79 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -174.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -68.65 -25.91 65.06 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.726 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.465 ' CD2' ' H ' ' A' ' 119' ' ' ILE . 45.7 m80 -77.37 -0.98 27.76 Favored 'General case' 0 C--O 1.214 -0.814 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 35.1 m -78.42 -29.28 47.06 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 172.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 61.2 mt -96.66 -59.51 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.086 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.2 m -114.07 110.51 48.5 Favored Pre-proline 0 N--CA 1.428 -1.535 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.404 -175.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -75.13 98.37 1.16 Allowed 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 121.802 1.668 . . . . 0.0 109.603 174.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.465 ' H ' ' CD2' ' A' ' 114' ' ' HIS . 62.3 mt -91.67 -68.78 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.1 -176.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.0 t -90.37 -11.39 40.72 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.269 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 60.0 mt -117.69 144.44 34.35 Favored Pre-proline 0 C--N 1.295 -1.773 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -175.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -72.28 -24.01 20.23 Favored 'Trans proline' 0 N--CA 1.477 0.52 0 C-N-CA 122.767 2.311 . . . . 0.0 113.143 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 71.9 m -119.47 162.43 18.87 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 81.0 m -86.64 143.23 27.72 Favored 'General case' 0 N--CA 1.429 -1.522 0 O-C-N 123.467 0.479 . . . . 0.0 109.793 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 75.8 mt -76.44 118.82 19.52 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -95.08 98.83 10.94 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 13.8 mt -97.8 134.16 22.63 Favored Pre-proline 0 C--N 1.276 -2.616 0 CA-C-N 113.822 -1.536 . . . . 0.0 109.0 -172.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo . . . . . 0 N--CA 1.484 0.926 0 C-N-CA 123.265 2.643 . . . . 0.0 112.131 176.449 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.7 p . . . . . 0 N--CA 1.429 -1.493 0 CA-C-O 122.068 0.937 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.9 m -70.66 -33.97 71.53 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.819 -173.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -7.51 33.69 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.371 -178.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -74.74 -36.15 62.63 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.897 0.38 . . . . 0.0 110.711 177.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.44 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 36.6 p-90 -103.56 -14.17 16.28 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.165 0.507 . . . . 0.0 111.789 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -94.31 112.58 24.38 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.471 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -127.08 91.62 46.29 Favored Pre-proline 0 C--N 1.312 -1.062 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 175.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.12 -7.67 21.43 Favored 'Trans proline' 0 C--N 1.331 -0.353 0 C-N-CA 122.377 2.051 . . . . 0.0 112.835 -175.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -100.37 -15.3 18.02 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.18 -176.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.5 tp -81.67 120.9 25.68 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.308 -168.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 m -76.72 165.43 24.74 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.939 -177.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -54.63 -50.99 66.8 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -174.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -65.82 -29.68 70.19 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.338 0.59 . . . . 0.0 111.384 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -77.09 -35.96 56.09 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.616 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.36 -41.38 98.84 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.765 176.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.442 ' HA ' HG21 ' A' ' 81' ' ' VAL . 87.0 mt -66.31 -45.33 89.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.86 177.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.07 -27.95 69.26 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.184 0.516 . . . . 0.0 111.911 178.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.44 -49.31 12.51 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 6.7 mp -70.33 -26.56 63.82 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -177.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -70.25 -13.14 62.04 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.446 0.641 . . . . 0.0 109.869 176.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -97.34 -32.72 11.74 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.495 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -85.54 -10.49 55.89 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -172.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.5 t70 73.1 148.59 0.12 Allowed Pre-proline 0 N--CA 1.506 2.339 0 O-C-N 123.532 0.52 . . . . 0.0 111.905 175.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' A' ' 61' ' ' LYS . 88.1 Cg_exo -45.52 118.96 2.4 Favored 'Trans proline' 0 C--N 1.389 2.711 0 C-N-CA 123.726 2.95 . . . . 0.0 115.014 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.87 -35.25 2.22 Favored Glycine 0 N--CA 1.427 -1.959 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.039 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.98 144.1 50.62 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-O 121.153 0.501 . . . . 0.0 111.194 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -145.18 165.94 26.87 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -154.55 157.11 37.8 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 172.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.44 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 65.5 mt -122.75 128.71 75.36 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.1 ptt-85 -121.72 179.69 4.4 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -95.49 130.99 42.13 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.1 m -89.78 136.95 32.74 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 120.762 0.315 . . . . 0.0 110.287 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -91.58 -23.55 19.86 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.1 t -71.93 -35.59 69.67 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.728 -176.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -128.43 149.38 50.59 Favored 'General case' 0 C--O 1.242 0.7 0 O-C-N 121.985 -0.447 . . . . 0.0 110.187 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -82.81 120.78 26.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.595 -176.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.58 29.97 57.08 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.565 178.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -113.86 133.84 55.17 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.454 ' CD2' HD21 ' A' ' 107' ' ' LEU . 44.7 m-85 -107.87 124.66 50.43 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.74 114.63 4.48 Favored Glycine 0 C--N 1.286 -2.211 0 C-N-CA 120.075 -1.059 . . . . 0.0 111.226 -176.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.3 tp -92.35 128.97 38.39 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -118.86 127.73 53.79 Favored 'General case' 0 C--N 1.282 -2.37 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 175.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.4 tp -123.01 131.85 53.88 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 123.522 0.514 . . . . 0.0 109.946 -177.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 41' ' ' PRO . 27.2 tptp -87.89 114.51 24.57 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.411 HG21 ' HE ' ' A' ' 82' ' ' ARG . 23.6 m -108.08 172.33 2.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.386 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.59 -48.63 21.49 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -163.21 143.72 7.16 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 123.142 0.577 . . . . 0.0 111.859 -178.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.67 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 37.4 Cg_exo -63.71 -46.97 7.88 Favored 'Trans proline' 0 CA--C 1.578 2.709 0 C-N-CA 121.774 1.65 . . . . 0.0 111.316 164.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.67 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 81.3 Cg_endo -71.66 171.22 16.82 Favored 'Trans proline' 0 C--N 1.398 3.146 0 C-N-CA 123.057 2.505 . . . . 0.0 109.05 171.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -66.45 -60.43 0.11 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 121.532 1.488 . . . . 0.0 112.205 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.1 p -123.23 -7.1 8.25 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.677 -178.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 64.19 33.73 11.54 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.225 1.01 . . . . 0.0 111.117 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.422 ' HB2' ' HD3' ' A' ' 71' ' ' PRO . 28.1 mt-30 -60.66 -46.97 97.19 Favored Pre-proline 0 CA--C 1.553 1.072 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.25 175.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 70' ' ' GLN . 2.3 Cg_endo -84.99 108.01 1.13 Allowed 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 121.496 1.464 . . . . 0.0 109.539 172.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 49.0 t-105 -93.44 141.21 28.71 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.722 -176.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -119.26 -53.51 2.24 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.489 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 161.17 56.91 0.02 OUTLIER Glycine 0 CA--C 1.471 -2.7 0 N-CA-C 107.622 -2.191 . . . . 0.0 107.622 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -88.33 113.48 55.43 Favored Pre-proline 0 C--N 1.288 -2.098 0 CA-C-N 113.515 -1.342 . . . . 0.0 111.925 -171.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -85.66 164.42 10.64 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.195 1.93 . . . . 0.0 111.868 176.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.9 p -60.7 -19.73 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 121.597 0.713 . . . . 0.0 110.779 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -63.5 -21.72 66.48 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 123.951 0.9 . . . . 0.0 111.297 178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -92.82 -13.9 28.51 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 121.066 0.46 . . . . 0.0 110.902 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.9 mt -82.53 -8.54 59.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.968 0.89 . . . . 0.0 109.534 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.442 HG21 ' HA ' ' A' ' 33' ' ' ILE . 89.9 t -109.49 107.82 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.998 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 174.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.517 ' NH2' ' HA ' ' A' ' 65' ' ' PRO . 77.4 mtt180 -87.27 147.75 25.4 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.177 -177.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -123.73 122.61 38.52 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.14 -175.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -130.99 156.49 45.03 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.403 ' HG ' ' HB3' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -125.35 133.45 52.56 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.765 178.741 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.494 HG12 HG12 ' A' ' 95' ' ' ILE . 78.0 mt -94.31 113.98 30.0 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.432 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.203 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.83 128.22 46.96 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.599 ' HB ' HG12 ' A' ' 93' ' ' VAL . 9.3 t -99.62 115.82 30.3 Favored 'General case' 0 N--CA 1.413 -2.296 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 176.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -115.13 -170.08 16.18 Favored Glycine 0 N--CA 1.42 -2.414 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -177.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.65 -20.83 69.8 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.038 2.492 . . . . 0.0 112.92 -178.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -87.76 -39.74 14.66 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.923 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 158.97 -158.2 29.2 Favored Glycine 0 N--CA 1.431 -1.645 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 -177.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.599 HG12 ' HB ' ' A' ' 88' ' ' THR . 6.4 m -103.37 130.95 52.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -177.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.72 154.39 48.56 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.628 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.494 HG12 HG12 ' A' ' 86' ' ' ILE . 33.7 mt -94.06 130.42 43.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.439 0.638 . . . . 0.0 110.896 -174.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.403 ' HB3' ' HG ' ' A' ' 85' ' ' LEU . 33.1 ttmt -102.03 143.77 31.46 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.337 176.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 105.1 8.15 36.72 Favored Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 -172.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 59.4 m -121.23 153.06 58.11 Favored Pre-proline 0 N--CA 1.423 -1.818 0 CA-C-N 114.105 -1.048 . . . . 0.0 109.395 -176.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -57.52 -58.39 0.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.153 1.902 . . . . 0.0 110.424 176.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.8 m -162.55 108.86 1.23 Allowed 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 122.839 0.456 . . . . 0.0 110.371 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.461 ' HG2' ' HB ' ' A' ' 119' ' ' ILE . 51.4 mt-10 -128.89 133.49 25.27 Favored Pre-proline 0 C--N 1.299 -1.593 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.96 176.53 6.04 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.603 2.869 . . . . 0.0 115.775 -170.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -87.79 113.48 23.49 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.642 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -90.48 161.75 15.37 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.98 -58.21 9.39 Favored Glycine 0 CA--C 1.509 -0.309 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.486 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.5 m -136.78 171.85 13.88 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.454 HD21 ' CD2' ' A' ' 56' ' ' TYR . 95.1 mt -53.5 -47.2 70.07 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.643 0.589 . . . . 0.0 110.654 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.7 m -52.95 -29.65 30.05 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.592 1.157 . . . . 0.0 112.747 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.43 -36.93 71.46 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 120.889 0.376 . . . . 0.0 111.306 -177.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 107' ' ' LEU . 4.2 pp -80.1 -21.66 43.02 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.599 0.714 . . . . 0.0 110.06 178.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 107' ' ' LEU . 88.1 t -70.68 -42.9 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.416 176.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.6 p -72.96 -44.55 60.99 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 122.16 -0.338 . . . . 0.0 111.349 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -77.76 12.33 1.74 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.423 ' HB2' ' H ' ' A' ' 125' ' ' LEU . 35.0 p-80 -53.96 -35.1 61.42 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.182 1.393 . . . . 0.0 111.16 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 41.9 p -98.87 -4.06 33.89 Favored 'General case' 0 N--CA 1.401 -2.889 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.461 -172.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 52.2 mt -106.31 -42.79 6.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.25 -175.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.3 t -135.93 81.14 40.53 Favored Pre-proline 0 N--CA 1.435 -1.222 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.986 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -98.03 96.07 0.07 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.033 0 C-N-CA 122.425 2.083 . . . . 0.0 109.054 172.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.461 ' HB ' ' HG2' ' A' ' 101' ' ' GLU . 58.6 mt -90.89 -57.06 4.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.856 -175.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 27.6 t -91.76 -30.83 16.03 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.923 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.53 118.59 55.41 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.621 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.475 ' HG3' ' CZ ' ' A' ' 82' ' ' ARG . 89.4 Cg_endo -83.02 -3.89 11.14 Favored 'Trans proline' 0 C--O 1.243 0.735 0 C-N-CA 123.022 2.482 . . . . 0.0 112.265 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 84.8 m -145.32 149.26 34.5 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 79.0 m -88.93 148.4 23.83 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.423 ' H ' ' HB2' ' A' ' 114' ' ' HIS . 58.7 mt -70.3 107.27 3.68 Favored 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.513 -175.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -80.2 99.78 7.97 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.859 -0.526 . . . . 0.0 110.168 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.574 ' H ' HD12 ' A' ' 127' ' ' ILE . 3.9 mp -71.12 121.77 85.11 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.79 -177.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 N--CA 1.491 1.345 0 C-N-CA 123.087 2.525 . . . . 0.0 113.381 -177.868 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.6 p . . . . . 0 N--CA 1.413 -2.296 0 CA-C-O 121.519 0.676 . . . . 0.0 110.314 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.428 ' HA ' ' NE1' ' A' ' 22' ' ' TRP . 18.4 m -73.01 -28.76 62.56 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.761 -177.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.421 ' HD3' ' H ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -71.28 -10.12 59.23 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.689 0.757 . . . . 0.0 110.769 177.184 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -76.92 -21.1 55.35 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.258 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.428 ' NE1' ' HA ' ' A' ' 19' ' ' SER . 47.0 p-90 -113.67 -31.46 6.47 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 177.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.476 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 42.1 t80 -86.26 116.85 24.7 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.001 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -125.81 84.85 60.14 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.416 ' HD3' ' CD2' ' A' ' 23' ' ' TYR . 9.3 Cg_endo -54.4 -46.59 32.31 Favored 'Trans proline' 0 C--N 1.333 -0.282 0 C-N-CA 122.786 2.324 . . . . 0.0 115.818 -171.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -97.84 13.86 29.09 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -173.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.561 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 15.2 tp -83.3 145.84 28.86 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.504 -178.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.2 t -96.89 169.65 9.7 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -58.81 -50.32 74.42 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 123.524 0.729 . . . . 0.0 111.736 -175.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -58.34 -40.29 81.78 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.122 0.487 . . . . 0.0 111.083 -177.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -74.98 -29.91 61.03 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.872 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.92 -43.48 83.22 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.966 -0.754 . . . . 0.0 108.966 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 77.3 mt -66.24 -39.12 83.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.248 177.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.52 -32.24 70.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.782 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.404 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 49.8 mt -73.15 -47.06 47.15 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.569 0.699 . . . . 0.0 110.61 173.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.557 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 67.8 mt -69.68 -18.36 63.55 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -177.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.447 ' HB3' HG21 ' A' ' 77' ' ' VAL . 21.0 ptmt -84.28 -0.67 53.29 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.346 0.593 . . . . 0.0 110.073 176.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -114.05 -43.12 3.27 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.111 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 35' ' ' LEU . 43.3 mtpt -74.77 162.99 28.17 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.421 -176.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -70.22 138.48 86.98 Favored Pre-proline 0 C--N 1.308 -1.204 0 C-N-CA 124.212 1.005 . . . . 0.0 111.827 -174.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -57.28 114.04 1.76 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.676 2.251 . . . . 0.0 111.413 175.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.27 -22.69 3.94 Favored Glycine 0 N--CA 1.425 -2.077 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 -174.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.42 158.55 28.67 Favored 'General case' 0 C--O 1.251 1.181 0 CA-C-N 115.029 -0.585 . . . . 0.0 109.908 177.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -152.47 176.23 11.89 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -175.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -156.38 154.83 31.14 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 170.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 23' ' ' TYR . 66.6 mt -125.02 130.54 73.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.561 ' HD2' ' O ' ' A' ' 27' ' ' LEU . 28.1 ptt85 -133.05 171.27 14.21 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -72.82 132.03 43.05 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 171.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.5 m -67.81 -32.77 73.56 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 -177.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 39.9 m-70 71.91 -39.59 0.45 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.321 1.048 . . . . 0.0 113.167 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.2 m -58.59 -41.44 85.76 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 123.795 0.838 . . . . 0.0 111.18 178.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.49 150.7 45.49 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -84.56 135.02 34.38 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.65 38.45 50.84 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -177.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.55 133.16 39.96 Favored 'General case' 0 C--O 1.249 1.028 0 CA-C-O 120.891 0.377 . . . . 0.0 110.394 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.403 ' HB3' ' CG2' ' A' ' 46' ' ' ILE . 47.3 m-85 -116.73 126.83 53.71 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -91.39 114.15 4.45 Favored Glycine 0 C--N 1.288 -2.084 0 C-N-CA 120.148 -1.025 . . . . 0.0 111.324 -177.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.401 ' HB3' ' O ' ' A' ' 84' ' ' PHE . 2.2 tm? -92.08 117.77 30.16 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.65 115.73 30.43 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.4 tp -110.64 123.76 50.61 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.303 -177.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.557 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 22.3 tptm -91.23 114.35 26.85 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 176.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 80' ' ' LEU . 18.2 m -104.17 170.65 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.25 -58.28 5.13 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 p -161.85 124.15 1.73 Allowed Pre-proline 0 C--N 1.312 -1.06 0 C-N-CA 124.521 1.128 . . . . 0.0 108.713 176.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.627 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 35.6 Cg_exo -59.68 -47.1 17.22 Favored 'Trans proline' 0 CA--C 1.578 2.678 0 C-N-CA 121.688 1.592 . . . . 0.0 111.947 174.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.627 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 74.8 Cg_endo -73.46 153.29 49.87 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 123.19 2.593 . . . . 0.0 110.756 173.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -63.79 -46.92 7.81 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.402 2.068 . . . . 0.0 112.567 177.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.6 p -119.74 -8.28 9.92 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.401 ' HA ' ' CG ' ' A' ' 66' ' ' PRO . . . 66.8 36.57 4.49 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 124.414 1.086 . . . . 0.0 113.237 177.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.424 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 73.8 mt-30 -63.61 -48.85 79.77 Favored Pre-proline 0 CA--C 1.565 1.519 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.339 172.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 70' ' ' GLN . 18.3 Cg_endo -62.45 113.38 1.91 Allowed 'Trans proline' 0 C--N 1.389 2.709 0 C-N-CA 122.04 1.827 . . . . 0.0 111.919 173.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 57.0 t-105 -115.17 146.49 41.34 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.354 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -127.05 -28.82 2.84 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.834 0.35 . . . . 0.0 111.689 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 133.32 -41.71 1.45 Allowed Glycine 0 CA--C 1.489 -1.536 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.541 ' HB3' ' HB2' ' A' ' 78' ' ' GLU . 5.2 m-20 -68.11 118.56 59.97 Favored Pre-proline 0 C--N 1.299 -1.623 0 C-N-CA 123.862 0.865 . . . . 0.0 109.839 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 75' ' ' ASP . 5.7 Cg_exo -77.21 -79.64 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 121.902 1.735 . . . . 0.0 112.722 177.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 37' ' ' LYS . 3.2 p -73.74 -28.31 24.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 120.943 0.402 . . . . 0.0 111.624 -177.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.541 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 53.1 mp0 -68.28 -19.72 64.72 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.416 ' HG2' ' HB2' ' A' ' 75' ' ' ASP . 8.0 mm100 -78.62 -36.25 44.39 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 171.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.503 ' O ' HG22 ' A' ' 62' ' ' VAL . 49.5 mt -75.87 -25.71 56.41 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.838 -176.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 89.9 t -88.92 116.25 30.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -101.36 130.81 47.62 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -109.84 126.17 53.54 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.222 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.401 ' O ' ' HB3' ' A' ' 58' ' ' LEU . 98.0 m-85 -133.15 123.14 25.13 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 176.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.9 pp -96.84 131.95 43.08 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 118.709 -1.196 . . . . 0.0 111.113 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 79.7 mt -92.35 122.58 43.93 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 C-N-CA 124.568 1.147 . . . . 0.0 108.98 -178.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -99.84 146.82 26.18 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.482 ' HB ' HG12 ' A' ' 93' ' ' VAL . 9.7 t -127.88 142.27 51.32 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.41 -158.36 7.95 Favored Glycine 0 N--CA 1.433 -1.508 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -177.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.15 3.85 4.8 Favored 'Trans proline' 0 N--CA 1.482 0.847 0 C-N-CA 122.914 2.409 . . . . 0.0 113.566 -174.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -111.71 -42.1 3.9 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.89 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 158.9 -154.5 25.59 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.482 HG12 ' HB ' ' A' ' 88' ' ' THR . 10.7 m -104.02 147.66 9.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -178.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.9 pttp -146.07 141.98 28.12 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -176.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.2 mt -85.65 131.68 33.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -67.58 101.76 1.06 Allowed 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 102.37 45.56 1.68 Allowed Glycine 0 N--CA 1.429 -1.831 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.735 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.444 ' HB2' ' CD ' ' A' ' 101' ' ' GLU . 24.4 p -115.57 124.25 30.25 Favored Pre-proline 0 C--N 1.312 -1.049 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 177.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.93 -44.06 2.17 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.54 2.16 . . . . 0.0 115.316 -175.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.9 m -120.36 -16.37 8.43 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.833 -172.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.444 ' CD ' ' HB2' ' A' ' 98' ' ' CYS . 5.4 mp0 -60.34 125.21 81.26 Favored Pre-proline 0 C--N 1.3 -1.56 0 C-N-CA 123.276 0.631 . . . . 0.0 112.27 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -87.05 -167.67 0.37 Allowed 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 123.128 2.552 . . . . 0.0 110.967 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -81.65 109.74 16.35 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -81.48 147.26 29.8 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -78.88 -23.66 63.63 Favored Glycine 0 C--N 1.302 -1.317 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.06 -178.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.8 p -143.62 161.31 38.85 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.418 ' O ' HG23 ' A' ' 111' ' ' VAL . 94.6 mt -71.29 -31.69 67.75 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 173.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 m -56.85 -40.12 75.54 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.651 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.36 -50.81 71.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.995 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.2 pp -68.77 -29.02 67.32 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.648 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 107' ' ' LEU . 49.5 t -64.93 -50.28 75.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.145 0.498 . . . . 0.0 110.391 177.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.7 t -72.49 -38.52 68.14 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.508 -177.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -73.61 -36.46 65.48 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -174.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -76.52 -0.66 23.91 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.3 m -75.01 -40.69 60.48 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 170.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 63.8 mt -86.24 -44.34 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.128 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.3 m -136.16 94.85 13.79 Favored Pre-proline 0 C--N 1.303 -1.444 0 O-C-N 122.104 -0.373 . . . . 0.0 111.295 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -86.77 108.04 0.77 Allowed 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 123.008 2.472 . . . . 0.0 109.983 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.438 ' HB ' ' OE2' ' A' ' 101' ' ' GLU . 33.9 mt -89.63 -73.54 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.285 -177.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.9 t -66.72 -34.02 76.93 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.215 0.531 . . . . 0.0 110.222 176.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 81.5 mt -71.57 124.79 91.47 Favored Pre-proline 0 C--N 1.311 -1.071 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.701 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -65.04 -20.61 63.76 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.437 2.758 . . . . 0.0 113.354 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 78.0 m -136.99 169.18 18.2 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 80.6 m -73.59 136.51 43.95 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 123.261 0.351 . . . . 0.0 111.045 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 111' ' ' VAL . 22.7 tp -81.88 118.14 22.7 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -122.54 141.94 51.14 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.308 0.575 . . . . 0.0 111.273 -176.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.405 ' N ' HD12 ' A' ' 127' ' ' ILE . 2.8 mp -101.85 109.82 60.58 Favored Pre-proline 0 C--N 1.303 -1.422 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--N 1.324 -0.745 0 C-N-CA 121.74 1.627 . . . . 0.0 112.275 -178.882 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.7 p . . . . . 0 N--CA 1.435 -1.188 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.5 m -69.62 -24.13 63.6 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.972 -175.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.46 ' HD3' ' H ' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -81.13 -9.93 59.73 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 120.443 -0.503 . . . . 0.0 112.347 -177.658 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -76.6 -49.83 15.35 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.205 0.526 . . . . 0.0 111.588 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.454 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 29.6 p-90 -85.0 -12.95 52.09 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.768 -174.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -95.42 103.95 15.83 Favored 'General case' 0 N--CA 1.422 -1.831 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.683 -176.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.44 89.98 9.15 Favored Pre-proline 0 C--N 1.294 -1.844 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.099 174.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.73 18.79 0.81 Allowed 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 123.242 2.628 . . . . 0.0 112.411 -176.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -109.75 -3.73 16.55 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.79 -176.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.8 tp -101.19 130.61 47.31 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -172.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.0 m -79.45 170.68 16.23 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.593 0.757 . . . . 0.0 110.306 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -56.62 -53.71 54.51 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -69.85 -29.86 67.2 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.071 0.463 . . . . 0.0 110.654 -176.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -71.2 -33.42 69.92 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.686 176.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.4 -41.36 93.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.607 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 77.0 mt -67.3 -42.42 87.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.135 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.74 -28.78 67.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.857 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.71 -40.44 25.33 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.976 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.3 mp -86.73 -19.61 28.9 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -60.86 -36.56 79.48 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -92.92 3.01 56.49 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.307 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -99.4 169.58 9.23 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.708 0.766 . . . . 0.0 112.633 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -81.84 159.66 65.53 Favored Pre-proline 0 C--N 1.296 -1.722 0 C-N-CA 125.867 1.667 . . . . 0.0 111.368 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.02 111.88 2.79 Favored 'Trans proline' 0 C--N 1.36 1.172 0 C-N-CA 122.417 2.078 . . . . 0.0 110.32 176.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.88 -20.83 3.6 Favored Glycine 0 C--N 1.287 -2.159 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -176.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.01 136.49 48.4 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -151.75 173.04 15.21 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -177.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -155.91 158.05 37.32 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.454 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 65.8 mt -122.54 116.25 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.081 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 174.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.1 ptt-85 -108.23 -175.02 2.66 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -100.03 128.4 46.12 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.7 m -88.02 95.58 10.18 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.325 0.583 . . . . 0.0 110.162 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -73.86 11.98 0.77 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.775 0.797 . . . . 0.0 112.475 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.9 t -86.81 -15.81 38.13 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -146.28 -171.54 3.75 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -125.23 134.94 52.15 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 171.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.18 22.85 56.39 Favored Glycine 0 C--N 1.308 -1.006 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -128.52 127.63 42.77 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -101.37 162.1 13.15 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.29 118.54 3.43 Favored Glycine 0 C--N 1.286 -2.229 0 C-N-CA 119.875 -1.155 . . . . 0.0 111.474 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -98.8 127.48 44.74 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -178.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -122.6 117.35 25.63 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.6 tp -110.29 128.08 55.34 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 123.719 0.637 . . . . 0.0 110.287 -176.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -88.69 114.08 24.93 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 177.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 80' ' ' LEU . 25.5 m -103.58 171.49 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.84 -60.35 2.74 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.409 ' HB ' ' HG2' ' A' ' 66' ' ' PRO . 2.1 p -159.32 141.93 10.21 Favored Pre-proline 0 N--CA 1.433 -1.276 0 C-N-CA 124.923 1.289 . . . . 0.0 108.478 176.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.653 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 36.3 Cg_exo -59.62 -44.33 32.68 Favored 'Trans proline' 0 CA--C 1.574 2.508 0 C-N-CA 121.75 1.633 . . . . 0.0 111.645 171.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.653 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 59.1 Cg_endo -68.99 146.95 66.68 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 122.68 2.254 . . . . 0.0 110.038 170.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 66' ' ' PRO . 34.3 Cg_exo -62.13 -42.03 31.93 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.695 2.263 . . . . 0.0 113.103 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.4 m -118.56 -18.99 8.95 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.86 0.362 . . . . 0.0 110.235 -177.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.447 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 67.68 24.44 8.41 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.168 0.987 . . . . 0.0 112.564 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -67.92 -38.35 14.07 Favored Pre-proline 0 CA--C 1.558 1.262 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.968 172.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -68.05 108.91 1.82 Allowed 'Trans proline' 0 C--N 1.38 2.224 0 C-N-CA 121.208 1.272 . . . . 0.0 109.119 167.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -131.33 145.72 51.98 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -175.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -138.4 -37.59 0.55 Allowed 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.871 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.81 -57.41 0.03 OUTLIER Glycine 0 CA--C 1.48 -2.109 0 N-CA-C 107.27 -2.332 . . . . 0.0 107.27 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 54.84 93.83 0.05 OUTLIER Pre-proline 0 N--CA 1.468 0.433 0 C-N-CA 125.104 1.362 . . . . 0.0 113.975 169.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -83.37 165.53 14.4 Favored 'Trans proline' 0 C--O 1.243 0.743 0 C-N-CA 122.504 2.136 . . . . 0.0 112.347 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 p -68.99 -27.2 34.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.594 0.711 . . . . 0.0 110.592 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -66.51 -15.95 63.77 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.349 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -85.11 -19.47 31.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.567 0.699 . . . . 0.0 109.471 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.426 ' O ' HG22 ' A' ' 62' ' ' VAL . 72.2 mt -80.71 -11.27 59.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.005 -178.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.0 t -100.59 108.84 23.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -87.18 131.54 34.15 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -177.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -105.08 125.63 51.19 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.259 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -140.88 131.46 25.48 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 176.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.32 154.66 17.14 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 117.878 -1.529 . . . . 0.0 110.963 176.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.406 ' CG2' HG22 ' A' ' 93' ' ' VAL . 78.5 mt -115.37 125.97 72.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.408 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.973 -176.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.499 ' CD ' ' HE2' ' A' ' 96' ' ' LYS . 47.4 mt-10 -105.86 138.39 42.13 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.616 ' HB ' HG23 ' A' ' 93' ' ' VAL . 5.6 t -121.45 147.51 45.65 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.52 -167.05 29.52 Favored Glycine 0 N--CA 1.423 -2.217 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.91 -14.21 35.53 Favored 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 123.637 2.891 . . . . 0.0 114.636 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -89.0 -24.66 22.32 Favored 'General case' 0 CA--C 1.5 -0.966 0 O-C-N 121.752 -0.592 . . . . 0.0 111.401 176.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 132.53 -160.12 23.64 Favored Glycine 0 N--CA 1.423 -2.19 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -177.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.706 HG12 ' H ' ' A' ' 105' ' ' GLY . 7.7 p -118.38 136.85 54.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -177.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.19 169.13 25.48 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.424 ' HB ' ' HG3' ' A' ' 101' ' ' GLU . 59.7 mt -85.77 143.07 12.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-O 120.86 0.362 . . . . 0.0 110.929 -177.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.499 ' HE2' ' CD ' ' A' ' 87' ' ' GLU . 20.6 ttmm -99.17 140.57 33.14 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 172.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.08 43.06 4.19 Favored Glycine 0 CA--C 1.493 -1.303 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 24.5 p -129.73 157.61 76.11 Favored Pre-proline 0 N--CA 1.42 -1.968 0 CA-C-N 114.702 -0.749 . . . . 0.0 111.106 -171.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -65.56 -59.13 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 N-CA-C 107.72 -1.685 . . . . 0.0 107.72 167.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 67.0 m -164.32 125.57 2.2 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 124.522 1.129 . . . . 0.0 108.357 175.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.506 ' OE2' ' HB ' ' A' ' 119' ' ' ILE . 49.4 mm-40 -122.52 138.34 29.12 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.18 155.82 66.71 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.186 1.924 . . . . 0.0 110.688 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -91.59 99.48 12.39 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -64.62 -70.3 0.24 Allowed 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.353 0.597 . . . . 0.0 111.548 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.706 ' H ' HG12 ' A' ' 93' ' ' VAL . . . 145.17 -68.82 0.4 Allowed Glycine 0 C--N 1.3 -1.464 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 178.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.2 m -108.25 158.77 17.17 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.84 -36.53 82.54 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.4 t -64.81 -36.55 84.68 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.02 -47.36 83.39 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 175.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.3 tt -54.8 -50.79 67.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.113 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.518 ' HA ' HD23 ' A' ' 125' ' ' LEU . 69.1 t -61.55 -50.7 79.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.26 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.1 t -66.61 -31.68 72.53 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.171 0.51 . . . . 0.0 111.342 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -88.68 -18.97 26.79 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 121.711 -0.618 . . . . 0.0 112.657 -178.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -78.58 -9.36 59.33 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.137 0.494 . . . . 0.0 111.249 173.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.7 m -72.58 -27.62 62.3 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 170.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 35.2 mt -89.37 -60.14 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.575 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 27.0 m -120.57 99.17 47.86 Favored Pre-proline 0 N--CA 1.433 -1.324 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.968 -176.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -93.09 101.18 0.16 Allowed 'Trans proline' 0 N--CA 1.431 -2.169 0 C-N-CA 122.649 2.233 . . . . 0.0 109.482 172.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.506 ' HB ' ' OE2' ' A' ' 101' ' ' GLU . 63.8 mt -86.78 -62.36 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.12 -177.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.2 m -83.96 -16.88 42.49 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.273 0.559 . . . . 0.0 111.177 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.4 mt -90.12 123.7 65.19 Favored Pre-proline 0 C--N 1.305 -1.339 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -65.04 -30.19 56.52 Favored 'Trans proline' 0 N--CA 1.476 0.445 0 C-N-CA 122.808 2.339 . . . . 0.0 112.454 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 61.1 m -114.42 147.12 39.73 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.4 p -63.4 136.03 57.35 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 111' ' ' VAL . 18.8 tp -79.76 86.43 5.34 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -93.55 124.29 37.45 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.393 -175.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.461 ' H ' HD12 ' A' ' 127' ' ' ILE . 3.4 mp -70.78 112.04 11.82 Favored Pre-proline 0 C--N 1.315 -0.905 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo . . . . . 0 C--N 1.345 0.391 0 C-N-CA 122.366 2.044 . . . . 0.0 112.107 -178.685 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.434 -1.271 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.8 m -100.32 -19.66 16.22 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.439 177.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.31 3.52 0.9 Allowed 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 -176.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -85.42 -40.27 16.62 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 14.7 p-90 -120.74 -8.94 9.41 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -172.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -92.19 110.84 22.23 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.653 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.55 ' HB3' HD13 ' A' ' 27' ' ' LEU . 1.3 mptp? -128.52 89.03 50.7 Favored Pre-proline 0 C--N 1.313 -0.988 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.41 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.09 -1.64 8.27 Favored 'Trans proline' 0 CA--C 1.552 1.395 0 C-N-CA 122.722 2.282 . . . . 0.0 114.649 -177.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -90.84 -21.73 21.32 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.312 0.577 . . . . 0.0 109.87 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.55 HD13 ' HB3' ' A' ' 24' ' ' LYS . 9.8 mp -86.22 142.28 28.7 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -174.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.3 m -111.31 178.09 4.45 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 174.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -47.05 -52.28 15.41 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -58.45 -43.46 88.85 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.773 0.829 . . . . 0.0 110.73 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -70.79 -32.59 69.74 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.373 -177.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.2 -41.23 86.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.413 0.625 . . . . 0.0 109.803 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 72.0 mt -66.33 -40.41 86.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.828 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.83 -29.5 68.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.202 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.03 -47.45 11.68 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.444 HD12 HG13 ' A' ' 81' ' ' VAL . 72.6 mt -74.28 -19.44 60.49 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -176.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -72.01 -18.36 61.97 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.114 174.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -93.78 -35.54 12.71 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.386 178.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 36' ' ' LEU . 24.2 mmmt -77.38 171.11 15.38 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -71.59 164.28 59.25 Favored Pre-proline 0 C--N 1.314 -0.96 0 C-N-CA 126.753 2.021 . . . . 0.0 111.71 -176.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -75.91 126.5 9.42 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 121.815 1.677 . . . . 0.0 108.37 169.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.02 -9.62 43.38 Favored Glycine 0 C--N 1.292 -1.915 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -175.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.08 155.61 26.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.439 ' CG ' HD22 ' A' ' 125' ' ' LEU . 15.0 p90 -156.56 170.8 21.54 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.763 -173.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -156.43 149.99 24.66 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 172.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 68.7 mt -121.05 129.59 75.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -139.94 172.44 12.77 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.503 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -75.52 137.15 40.68 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 t -86.33 129.57 34.81 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -90.86 -14.84 31.0 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.5 t -70.5 -45.58 65.37 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.409 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -134.7 142.71 46.88 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -85.71 138.22 32.27 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.9 21.46 50.11 Favored Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.26 144.85 48.62 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 115.537 -0.332 . . . . 0.0 110.22 -178.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -116.28 132.82 56.56 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.3 120.25 5.69 Favored Glycine 0 C--N 1.287 -2.151 0 C-N-CA 119.932 -1.127 . . . . 0.0 111.46 -177.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -95.82 120.49 36.18 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.4 ' HB2' HH12 ' A' ' 47' ' ' ARG . . . -112.76 125.04 53.89 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.515 HD11 ' HB3' ' A' ' 123' ' ' CYS . 3.4 tm? -123.66 126.8 47.22 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -178.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -89.2 114.79 26.15 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 80' ' ' LEU . 32.8 m -99.67 171.64 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.26 -47.2 36.55 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.4 p -156.06 129.57 4.54 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 124.347 1.059 . . . . 0.0 108.988 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.651 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 28.0 Cg_exo -62.43 -45.08 15.73 Favored 'Trans proline' 0 CA--C 1.57 2.308 0 C-N-CA 121.884 1.723 . . . . 0.0 113.017 174.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.757 ' HG2' ' HB2' ' A' ' 69' ' ' ALA . 37.4 Cg_endo -63.94 142.66 82.74 Favored 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 122.273 1.982 . . . . 0.0 110.396 174.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -61.53 -34.48 85.31 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 123.349 2.7 . . . . 0.0 113.861 -174.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.1 p -119.07 -42.22 2.71 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.757 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 72.37 7.47 5.66 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 124.82 1.248 . . . . 0.0 113.106 174.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.443 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 64.8 tt0 -72.53 -55.75 4.35 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-O 119.121 -0.466 . . . . 0.0 112.028 -178.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 70' ' ' GLN . 6.9 Cg_endo -88.08 62.87 3.38 Favored 'Trans proline' 0 C--N 1.365 1.427 0 C-N-CA 121.461 1.44 . . . . 0.0 111.108 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.416 ' HE1' ' HB3' ' A' ' 75' ' ' ASP . 59.7 t-105 -160.66 141.27 11.59 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 113.353 -1.749 . . . . 0.0 110.441 -176.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.83 80.16 0.63 Allowed 'General case' 0 N--CA 1.413 -2.298 0 CA-C-O 122.635 1.207 . . . . 0.0 110.429 169.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.17 40.88 0.49 Allowed Glycine 0 C--N 1.301 -1.393 0 CA-C-N 114.213 -1.358 . . . . 0.0 112.165 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.416 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 6.9 p-10 -136.5 127.8 16.79 Favored Pre-proline 0 C--N 1.305 -1.337 0 CA-C-O 120.755 0.312 . . . . 0.0 111.054 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 79' ' ' GLN . 8.4 Cg_endo -91.55 177.37 1.89 Allowed 'Trans proline' 0 N--CA 1.436 -1.875 0 C-N-CA 121.829 1.686 . . . . 0.0 109.4 168.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.7 p -58.89 -24.99 27.99 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-O 121.603 0.716 . . . . 0.0 111.632 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.7 -26.77 64.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.006 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.461 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 8.5 tp-100 -80.95 -16.68 52.82 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 121.144 0.497 . . . . 0.0 109.711 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.453 ' O ' HG22 ' A' ' 62' ' ' VAL . 77.4 mt -74.53 -12.59 60.51 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-O 121.68 0.753 . . . . 0.0 109.991 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.444 HG13 HD12 ' A' ' 36' ' ' LEU . 74.7 t -88.3 125.9 41.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 176.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.404 ' NE ' ' HA ' ' A' ' 82' ' ' ARG . 3.9 mmp_? -105.23 143.84 32.84 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -118.75 133.87 55.54 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -139.15 167.33 22.3 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.05 138.11 41.83 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.94 177.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.522 HG12 HG12 ' A' ' 95' ' ' ILE . 80.1 mt -97.03 114.82 34.99 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-N 114.187 -1.369 . . . . 0.0 107.395 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -99.62 137.23 38.39 Favored 'General case' 0 C--N 1.273 -2.727 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.542 ' HB ' HG12 ' A' ' 93' ' ' VAL . 6.1 t -113.06 143.44 44.33 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -155.83 -157.97 8.56 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -73.18 -14.28 25.81 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.224 1.949 . . . . 0.0 112.823 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.467 ' HD2' ' N ' ' A' ' 91' ' ' LYS . 0.1 OUTLIER -84.88 -28.77 25.76 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 121.519 0.675 . . . . 0.0 110.331 177.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 139.19 -147.5 19.26 Favored Glycine 0 N--CA 1.433 -1.562 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.542 HG12 ' HB ' ' A' ' 88' ' ' THR . 15.0 m -113.52 141.5 29.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.67 150.31 26.17 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.674 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.522 HG12 HG12 ' A' ' 86' ' ' ILE . 83.3 mt -86.14 133.76 28.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.704 0.764 . . . . 0.0 111.309 -176.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -93.01 124.17 36.8 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 173.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 113.94 42.6 0.84 Allowed Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -174.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 120' ' ' SER . 13.5 p -129.34 144.9 54.6 Favored Pre-proline 0 N--CA 1.428 -1.529 0 CA-C-N 115.421 -0.39 . . . . 0.0 110.123 -175.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -67.33 -28.13 39.88 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.395 2.064 . . . . 0.0 111.928 176.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.5 t -153.86 -89.87 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.441 ' OE2' ' HB ' ' A' ' 95' ' ' ILE . 28.2 tt0 65.78 133.03 0.04 OUTLIER Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 125.377 1.471 . . . . 0.0 112.986 173.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -79.2 172.58 14.53 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.412 2.075 . . . . 0.0 112.557 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -92.39 131.89 37.2 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 175.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -102.42 170.7 7.89 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -177.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -99.55 -52.69 1.19 Allowed Glycine 0 C--N 1.3 -1.447 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.5 m -111.72 153.85 25.86 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.491 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 64.4 mt -63.24 -36.68 84.45 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.4 m -54.23 -30.19 49.24 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.486 1.114 . . . . 0.0 112.158 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.53 -41.95 92.53 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.112 -177.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 107' ' ' LEU . 4.2 pp -77.0 -31.33 56.38 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.969 0.414 . . . . 0.0 110.081 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.442 ' HA ' ' CD1' ' A' ' 125' ' ' LEU . 55.3 t -59.5 -54.73 30.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.455 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.4 m -72.48 -25.71 61.52 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.905 -177.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -84.13 -36.99 22.53 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.988 -176.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -72.13 -5.22 33.96 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -177.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.6 m -74.37 -31.9 62.56 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.6 mt -94.93 -50.16 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.972 -178.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 45.3 m -132.88 96.75 17.67 Favored Pre-proline 0 C--N 1.31 -1.142 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.979 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -81.86 114.23 2.58 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.702 2.268 . . . . 0.0 109.715 176.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 65.3 mt -91.49 -64.69 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 120.771 0.32 . . . . 0.0 110.512 -176.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.56 ' HB3' ' HB3' ' A' ' 98' ' ' CYS . 2.3 p -74.95 -49.66 19.35 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.467 0.651 . . . . 0.0 110.263 176.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.404 ' CD2' HD21 ' A' ' 125' ' ' LEU . 7.9 mp -65.87 137.69 96.15 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.877 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -80.53 -9.8 13.45 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.637 2.225 . . . . 0.0 112.92 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.515 ' HB3' HD11 ' A' ' 60' ' ' LEU . 44.8 t -136.35 150.69 48.96 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -178.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 24.8 p -71.82 146.11 48.21 Favored 'General case' 0 C--O 1.252 1.198 0 O-C-N 123.775 0.672 . . . . 0.0 110.555 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.442 ' CD1' ' HA ' ' A' ' 111' ' ' VAL . 91.6 mt -77.81 128.19 33.61 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.388 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -106.4 103.04 12.41 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 127' ' ' ILE . 3.4 mp -88.69 122.58 69.15 Favored Pre-proline 0 C--N 1.313 -1.002 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.865 -176.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo . . . . . 0 C--N 1.358 1.05 0 C-N-CA 123.162 2.574 . . . . 0.0 112.116 -179.704 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.5 p . . . . . 0 N--CA 1.425 -1.683 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.4 m -56.8 -40.53 76.11 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.618 -177.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -60.0 -25.08 64.99 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -178.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -77.26 -27.82 53.31 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 120.876 0.369 . . . . 0.0 111.141 -177.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.0 p-90 -119.1 -17.97 8.83 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -176.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -94.42 110.22 22.02 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.657 -176.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.08 94.27 14.43 Favored Pre-proline 0 C--N 1.309 -1.188 0 C-N-CA 124.407 1.083 . . . . 0.0 108.644 174.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 47' ' ' ARG . 83.3 Cg_endo -75.0 -23.22 14.0 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.856 3.038 . . . . 0.0 117.463 -169.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -101.43 14.55 31.61 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 118.9 0.773 . . . . 0.0 111.167 -174.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.3 tp -88.66 135.3 33.57 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.6 m -82.87 163.54 21.08 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 122.341 -0.225 . . . . 0.0 110.971 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -52.88 -51.48 60.95 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -173.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -65.44 -37.35 86.63 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.414 0.626 . . . . 0.0 110.999 -176.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -72.08 -28.32 63.24 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.496 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.15 -45.18 74.25 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 175.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.458 HG23 HG21 ' A' ' 81' ' ' VAL . 77.1 mt -63.49 -35.1 71.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.52 177.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.99 -34.67 43.55 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.261 176.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.558 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 3.8 mm? -72.33 -50.41 27.05 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.502 0.667 . . . . 0.0 109.506 174.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.1 mp -70.64 -13.53 62.12 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -173.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -84.79 -1.25 56.12 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.543 0.687 . . . . 0.0 109.26 174.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -114.84 -30.44 6.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.876 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 35' ' ' LEU . 61.8 mmtt -80.28 -179.05 6.9 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -174.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -83.82 156.33 64.51 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.718 -177.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -66.16 115.08 3.28 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 121.922 1.748 . . . . 0.0 108.933 171.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 124.56 -17.56 7.34 Favored Glycine 0 C--N 1.297 -1.593 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -174.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.48 151.99 37.94 Favored 'General case' 0 C--O 1.249 1.06 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -154.44 174.87 14.3 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.333 -174.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -156.43 151.19 25.93 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 171.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.3 mt -120.22 129.66 75.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 19.9 ptt180 -119.51 172.74 7.43 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -100.56 127.28 46.99 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.1 m -107.53 119.43 39.41 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -173.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 -79.9 76.13 6.6 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.902 0.858 . . . . 0.0 108.971 174.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 t -136.2 -52.07 0.72 Allowed 'General case' 0 C--N 1.271 -2.805 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -128.86 168.97 15.16 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 176.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -88.58 121.74 31.28 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.361 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.81 50.97 7.41 Favored Glycine 0 N--CA 1.422 -2.263 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 86' ' ' ILE . . . -124.06 113.68 18.72 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.427 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 57.2 m-85 -98.78 125.14 44.05 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.296 -0.865 . . . . 0.0 108.707 -178.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.51 111.51 4.22 Favored Glycine 0 C--N 1.289 -2.033 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.318 -176.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 83' ' ' HIS . 38.9 tp -91.5 121.81 33.53 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -107.2 118.9 37.93 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 174.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.5 tp -114.73 130.88 56.9 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 123.496 0.497 . . . . 0.0 110.562 -177.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -90.66 113.71 25.83 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.516 ' HB ' ' SG ' ' A' ' 123' ' ' CYS . 17.7 m -98.25 162.13 2.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.6 -56.52 5.21 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 p -163.17 136.8 4.53 Favored Pre-proline 0 N--CA 1.425 -1.723 0 C-N-CA 126.883 2.073 . . . . 0.0 105.612 175.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.671 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 36.4 Cg_exo -59.81 -46.59 19.18 Favored 'Trans proline' 0 CA--C 1.572 2.419 0 C-N-CA 120.929 1.086 . . . . 0.0 111.339 172.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.671 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 67.3 Cg_endo -67.75 149.58 78.72 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 122.606 2.204 . . . . 0.0 110.13 172.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.01 -41.56 7.37 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.104 1.87 . . . . 0.0 112.435 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 33.1 t -110.78 -32.39 6.87 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.389 -177.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.586 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 64.82 38.16 6.86 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 123.86 0.864 . . . . 0.0 110.515 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -59.71 -44.54 97.54 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.018 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -70.25 95.56 0.6 Allowed 'Trans proline' 0 C--N 1.374 1.882 0 N-CA-C 108.746 -1.29 . . . . 0.0 108.746 167.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 56.4 t-105 -113.14 150.46 32.15 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.203 -173.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -137.61 -46.38 0.55 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 122.431 1.11 . . . . 0.0 108.032 176.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 146.57 -76.94 0.26 Allowed Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 107.323 -2.311 . . . . 0.0 107.323 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 72.95 135.35 0.05 OUTLIER Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 125.269 1.428 . . . . 0.0 111.265 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.56 156.02 59.38 Favored 'Trans proline' 0 C--O 1.239 0.533 0 C-N-CA 122.389 2.059 . . . . 0.0 110.947 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.8 p -62.01 -21.55 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.55 0.691 . . . . 0.0 110.281 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -66.05 -21.29 66.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.547 178.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -82.98 -28.18 29.91 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.252 0.549 . . . . 0.0 109.571 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.469 ' O ' HG22 ' A' ' 62' ' ' VAL . 2.8 mm? -84.92 -7.99 58.94 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.984 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.458 HG21 HG23 ' A' ' 33' ' ' ILE . 92.6 t -103.56 102.05 13.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 173.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -96.25 143.33 27.43 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.798 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.471 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 69.6 m80 -113.25 123.23 49.68 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.29 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -124.98 131.68 53.38 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 1.0 OUTLIER -102.98 132.19 49.41 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 118.756 -1.177 . . . . 0.0 112.666 179.737 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 55' ' ' ALA . 4.0 mp -87.64 125.24 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 175.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -99.39 125.83 45.16 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 92' ' ' GLY . 11.0 t -114.55 142.07 46.91 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 175.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.21 -138.3 4.4 Favored Glycine 0 N--CA 1.418 -2.516 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -67.84 -24.29 40.42 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.901 2.401 . . . . 0.0 113.971 -175.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -88.79 -17.85 28.94 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.583 0.706 . . . . 0.0 110.503 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.536 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 114.9 -152.51 18.09 Favored Glycine 0 N--CA 1.424 -2.166 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 -178.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.476 HG12 ' HB ' ' A' ' 88' ' ' THR . 6.3 m -104.79 125.99 59.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.82 150.87 26.52 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 121.804 -0.56 . . . . 0.0 109.966 177.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 75.8 mt -73.96 131.28 35.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 123.306 0.379 . . . . 0.0 110.961 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -72.89 119.59 17.34 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 123.976 0.91 . . . . 0.0 109.325 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.62 15.01 48.21 Favored Glycine 0 C--O 1.243 0.677 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.756 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.501 ' SG ' ' HB2' ' A' ' 120' ' ' SER . 19.4 t -85.05 125.36 70.65 Favored Pre-proline 0 N--CA 1.435 -1.187 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -53.02 -28.71 41.4 Favored 'Trans proline' 0 N--CA 1.487 1.098 0 C-N-CA 123.69 2.927 . . . . 0.0 113.652 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.2 m -142.33 119.11 11.14 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 178.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -90.95 116.63 66.83 Favored Pre-proline 0 C--N 1.283 -2.321 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -82.1 -19.32 6.95 Favored 'Trans proline' 0 C--N 1.328 -0.551 0 C-N-CA 122.204 1.936 . . . . 0.0 114.193 -176.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 50.83 98.87 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.215 0 C-N-CA 126.667 1.987 . . . . 0.0 113.234 -176.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.426 ' CD2' ' HB3' ' A' ' 110' ' ' LEU . 77.8 m-85 -111.67 178.84 4.19 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.67 -30.73 2.52 Favored Glycine 0 C--N 1.305 -1.183 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.729 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.0 m -115.36 143.83 44.69 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.426 ' O ' HG23 ' A' ' 111' ' ' VAL . 57.9 mt -62.51 -43.07 99.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.6 t -60.92 -29.46 69.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.926 0.393 . . . . 0.0 110.925 -177.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.46 -43.09 98.35 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.518 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.458 HD23 HG23 ' A' ' 93' ' ' VAL . 3.7 pp -76.3 -30.92 57.94 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.961 178.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.528 ' HA ' HD23 ' A' ' 125' ' ' LEU . 56.4 t -62.74 -51.65 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.69 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.6 t -65.31 -25.46 67.63 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.563 -176.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.482 ' HA ' ' OE1' ' A' ' 113' ' ' GLN . 9.3 mm-40 -85.27 -30.55 23.69 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.141 -0.623 . . . . 0.0 111.728 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 49.3 m80 -74.52 -6.66 49.68 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.062 0.458 . . . . 0.0 111.702 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.0 m -71.84 -29.99 64.98 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 173.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 60.3 mt -100.21 -53.01 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.664 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.7 m -120.8 96.29 48.76 Favored Pre-proline 0 N--CA 1.434 -1.256 0 CA-C-O 120.99 0.424 . . . . 0.0 111.727 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.451 ' HB2' ' O ' ' A' ' 121' ' ' LEU . 44.1 Cg_endo -75.1 101.64 1.5 Allowed 'Trans proline' 0 N--CA 1.43 -2.213 0 C-N-CA 121.324 1.349 . . . . 0.0 109.982 173.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 45.6 mt -76.6 -59.82 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.261 0.553 . . . . 0.0 109.925 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.501 ' HB2' ' SG ' ' A' ' 98' ' ' CYS . 21.5 t -84.51 -29.84 25.65 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.568 0.699 . . . . 0.0 109.482 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.451 ' O ' ' HB2' ' A' ' 118' ' ' PRO . 6.9 mp -80.69 142.8 53.49 Favored Pre-proline 0 C--N 1.299 -1.615 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.212 -175.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -82.89 -20.01 5.59 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.379 2.053 . . . . 0.0 112.02 176.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.516 ' SG ' ' HB ' ' A' ' 62' ' ' VAL . 83.8 m -126.72 160.52 30.58 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 60.3 m -72.6 140.79 48.24 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 123.545 0.528 . . . . 0.0 110.562 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.528 HD23 ' HA ' ' A' ' 111' ' ' VAL . 22.8 tp -85.74 102.38 13.59 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -110.07 119.65 39.95 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -173.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.4 mp -61.77 123.61 77.93 Favored Pre-proline 0 C--O 1.247 0.934 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.162 -176.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo . . . . . 0 C--N 1.359 1.101 0 C-N-CA 123.042 2.494 . . . . 0.0 112.477 179.728 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.6 p . . . . . 0 N--CA 1.419 -1.976 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.8 m -92.37 -43.45 9.23 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.771 -174.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.08 -5.13 8.81 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -176.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -78.26 -20.8 50.93 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.368 0.604 . . . . 0.0 109.553 175.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.484 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 37.9 p-90 -122.83 -30.66 3.79 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.239 176.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 38.4 t80 -95.22 122.06 37.51 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 120.981 0.42 . . . . 0.0 110.516 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.25 104.79 2.41 Favored Pre-proline 0 C--N 1.306 -1.307 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.946 174.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.36 22.96 0.55 Allowed 'Trans proline' 0 N--CA 1.486 1.031 0 C-N-CA 123.738 2.959 . . . . 0.0 114.116 -174.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -98.97 -12.28 20.78 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.461 0.648 . . . . 0.0 109.481 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.537 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 3.8 mm? -92.86 130.33 38.49 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.565 -178.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.1 m -90.66 175.85 6.88 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 172.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -57.54 -46.89 83.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 118.219 0.463 . . . . 0.0 112.143 -178.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -66.85 -38.59 86.66 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.561 0.696 . . . . 0.0 110.492 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -66.57 -37.65 85.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.096 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.6 -41.73 90.98 Favored 'General case' 0 CA--C 1.509 -0.635 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.265 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 72.5 mt -63.17 -48.01 89.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.68 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.412 ' HA ' ' CD ' ' A' ' 37' ' ' LYS . . . -63.34 -30.13 71.32 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.374 0.607 . . . . 0.0 111.775 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.08 -49.03 11.38 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.463 -178.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.528 ' HG ' ' HB2' ' A' ' 61' ' ' LYS . 16.1 tp -80.13 -16.93 53.87 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.538 -173.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.433 ' HB2' HG21 ' A' ' 77' ' ' VAL . 14.9 ptmm? -63.06 -31.26 72.35 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 122.061 -0.399 . . . . 0.0 110.796 178.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -82.02 -14.48 55.87 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.835 0.826 . . . . 0.0 110.283 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -85.93 162.84 18.37 Favored 'General case' 0 C--O 1.254 1.331 0 CA-C-O 121.665 0.745 . . . . 0.0 111.382 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.08 144.02 98.25 Favored Pre-proline 0 C--N 1.305 -1.345 0 CA-C-N 113.728 -1.578 . . . . 0.0 111.531 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.22 111.16 1.71 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.87 1.714 . . . . 0.0 109.029 171.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.87 -20.7 6.35 Favored Glycine 0 N--CA 1.427 -1.961 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -172.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.25 154.47 30.97 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-O 120.973 0.416 . . . . 0.0 110.07 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.402 ' CG ' HD22 ' A' ' 125' ' ' LEU . 26.1 p90 -149.0 163.79 36.47 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.191 -176.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -146.04 146.92 31.14 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 171.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 23' ' ' TYR . 60.1 mt -120.36 137.61 53.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.537 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -143.25 -175.75 4.66 Favored 'General case' 0 C--N 1.28 -2.446 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.543 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -78.74 128.11 32.98 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 175.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.408 ' HB2' ' N ' ' A' ' 57' ' ' GLY . 21.0 t -85.3 103.64 14.42 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -177.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -77.25 74.8 3.81 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-O 122.23 1.014 . . . . 0.0 109.861 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 72.3 m -157.1 -47.2 0.07 Allowed 'General case' 0 C--N 1.271 -2.836 0 CA-C-N 113.406 -1.724 . . . . 0.0 108.873 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -131.06 147.96 52.68 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -82.3 135.81 35.15 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.58 33.11 48.64 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -130.56 131.73 45.18 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.417 0.627 . . . . 0.0 109.706 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -111.48 123.69 50.75 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.408 ' N ' ' HB2' ' A' ' 49' ' ' SER . . . -85.1 124.84 6.93 Favored Glycine 0 C--N 1.295 -1.722 0 C-N-CA 119.971 -1.109 . . . . 0.0 111.801 -175.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -104.45 119.23 38.5 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.57 126.2 54.74 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -121.7 123.84 42.84 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.528 ' HB2' ' HG ' ' A' ' 36' ' ' LEU . 22.4 tptm -88.41 120.77 30.09 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.793 -178.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 80' ' ' LEU . 34.3 m -113.83 157.52 14.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 173.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.25 -38.06 71.95 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 p -158.37 132.22 4.97 Favored Pre-proline 0 N--CA 1.444 -0.729 0 C-N-CA 125.495 1.518 . . . . 0.0 107.737 176.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.631 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 23.4 Cg_exo -62.15 -44.02 21.43 Favored 'Trans proline' 0 CA--C 1.565 2.055 0 C-N-CA 122.068 1.845 . . . . 0.0 113.182 175.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.631 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 73.6 Cg_endo -70.91 160.7 48.53 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.722 2.282 . . . . 0.0 110.307 173.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -65.16 -54.17 0.7 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.074 1.85 . . . . 0.0 112.344 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.8 p -110.56 -27.59 8.89 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.087 -175.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.478 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 63.88 38.15 9.11 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 123.588 0.755 . . . . 0.0 109.501 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.459 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 34.5 tt0 -54.16 -51.56 76.38 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.959 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.459 ' HD3' ' HB3' ' A' ' 70' ' ' GLN . 2.4 Cg_endo -89.73 101.96 0.33 Allowed 'Trans proline' 0 N--CA 1.436 -1.903 0 C-N-CA 121.611 1.54 . . . . 0.0 111.158 175.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 47.4 t-105 -96.44 144.49 26.51 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -139.59 -41.44 0.45 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.147 0.499 . . . . 0.0 110.668 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.83 77.95 0.03 OUTLIER Glycine 0 CA--C 1.476 -2.379 0 N-CA-C 108.449 -1.861 . . . . 0.0 108.449 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -123.47 101.92 36.76 Favored Pre-proline 0 C--N 1.294 -1.824 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -173.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -88.78 -175.66 1.27 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.502 2.135 . . . . 0.0 114.245 -175.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.433 HG21 ' HB2' ' A' ' 37' ' ' LYS . 9.7 p -62.01 -23.85 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 115.077 -0.965 . . . . 0.0 113.306 -175.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.15 -23.92 67.66 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.681 0.277 . . . . 0.0 111.437 176.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.416 ' HG2' ' HG2' ' A' ' 65' ' ' PRO . 8.3 tt0 -92.04 -30.07 16.24 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 178.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.491 ' O ' HG22 ' A' ' 62' ' ' VAL . 64.4 mt -66.41 -33.91 76.78 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.574 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 95.6 t -85.51 109.98 19.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 172.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -84.16 133.98 34.59 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -176.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.431 ' CD2' HH22 ' A' ' 47' ' ' ARG . 5.6 m80 -113.45 122.76 48.29 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -132.53 154.96 49.46 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 176.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -125.5 137.02 53.94 Favored 'General case' 0 C--N 1.283 -2.299 0 C-N-CA 118.631 -1.227 . . . . 0.0 110.93 176.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 86.0 mt -92.57 117.08 35.16 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.81 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.135 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.422 ' OE1' ' HE3' ' A' ' 96' ' ' LYS . 50.8 mt-10 -109.43 144.69 37.31 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.41 ' HB ' HG23 ' A' ' 93' ' ' VAL . 3.4 t -118.62 131.96 56.18 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.33 -144.73 4.17 Favored Glycine 0 N--CA 1.429 -1.78 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.385 -178.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -61.87 -44.15 22.14 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.868 2.379 . . . . 0.0 113.864 -177.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.464 ' HD2' ' N ' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -75.91 -41.93 50.44 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.917 -176.428 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.6 -154.94 25.94 Favored Glycine 0 N--CA 1.425 -2.069 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.41 HG23 ' HB ' ' A' ' 88' ' ' THR . 8.8 p -111.94 126.09 69.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.41 ' HG2' ' OE1' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -162.56 178.12 8.84 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.755 -178.375 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 58.8 mt -88.12 143.92 10.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 C-N-CA 123.598 0.759 . . . . 0.0 112.693 -169.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.422 ' HE3' ' OE1' ' A' ' 87' ' ' GLU . 25.0 ttmt -95.46 136.89 35.27 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 170.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.83 55.0 1.69 Allowed Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -175.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.463 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 11.9 p -135.31 154.28 78.57 Favored Pre-proline 0 C--N 1.311 -1.103 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -167.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 98' ' ' CYS . 2.2 Cg_endo -84.9 -56.54 0.02 OUTLIER 'Trans proline' 0 CA--C 1.558 1.69 0 C-N-CA 122.995 2.463 . . . . 0.0 112.633 173.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.0 m -149.88 131.54 14.94 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -177.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.41 ' OE1' ' HG2' ' A' ' 94' ' ' LYS . 43.9 mt-10 -140.46 140.08 21.98 Favored Pre-proline 0 C--N 1.297 -1.68 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.94 153.65 29.2 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.024 1.816 . . . . 0.0 107.694 166.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -92.98 112.32 24.24 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.46 -0.775 . . . . 0.0 110.797 -178.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.424 ' HE1' ' OE1' ' A' ' 113' ' ' GLN . 29.4 m-85 -89.0 157.43 18.37 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.11 -173.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -97.04 -27.67 9.25 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.556 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 53.8 m -141.69 157.29 45.24 Favored 'General case' 0 C--O 1.244 0.766 0 O-C-N 122.233 -0.569 . . . . 0.0 110.838 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.9 -35.12 72.51 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.449 0.7 . . . . 0.0 111.771 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.1 t -51.95 -31.21 27.95 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.85 0.86 . . . . 0.0 111.76 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.409 ' O ' ' HG3' ' A' ' 113' ' ' GLN . . . -73.7 -48.58 31.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 122.229 -0.295 . . . . 0.0 111.246 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 pp -67.7 -29.46 68.73 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.204 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 78.6 t -67.86 -48.65 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.32 176.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.5 p -68.51 -44.85 73.76 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.424 ' OE1' ' HE1' ' A' ' 104' ' ' PHE . 66.4 mt-30 -66.22 -41.53 89.95 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.718 -178.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.532 ' HA ' ' O ' ' A' ' 117' ' ' SER . 58.1 m80 -77.79 -9.94 59.29 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.7 t -76.05 -23.51 55.1 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 174.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 72.2 mt -99.94 -66.87 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.806 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.532 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 20.2 m -102.62 117.72 60.2 Favored Pre-proline 0 N--CA 1.433 -1.276 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.814 -175.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -82.35 88.96 1.22 Allowed 'Trans proline' 0 N--CA 1.439 -1.697 0 C-N-CA 121.882 1.721 . . . . 0.0 110.267 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 52.2 mt -88.63 -69.98 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.467 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.6 m -88.73 -6.73 57.23 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.117 0.484 . . . . 0.0 111.319 -178.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.7 mt -118.61 145.12 36.8 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -176.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.26 -36.51 45.77 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.947 2.431 . . . . 0.0 113.613 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 60.8 m -123.65 159.88 28.37 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 85.1 m -73.34 139.63 46.16 Favored 'General case' 0 N--CA 1.434 -1.246 0 O-C-N 123.686 0.616 . . . . 0.0 109.722 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.402 HD22 ' CG ' ' A' ' 44' ' ' PHE . 84.8 mt -65.37 110.79 2.76 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.583 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -89.38 95.36 10.25 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 174.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 58.6 mt -65.52 126.28 91.24 Favored Pre-proline 0 C--N 1.302 -1.484 0 CA-C-N 113.966 -1.47 . . . . 0.0 108.997 -178.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 N--CA 1.452 -0.915 0 C-N-CA 121.861 1.707 . . . . 0.0 110.223 176.698 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.1 p . . . . . 0 N--CA 1.435 -1.196 0 CA-C-O 121.868 0.842 . . . . 0.0 108.738 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.3 m -93.99 -33.31 13.49 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.627 -175.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -16.32 61.14 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.048 0.451 . . . . 0.0 111.672 -177.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -66.22 -40.06 90.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.506 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.416 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 11.8 p-90 -104.76 -5.67 21.04 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -94.11 113.16 25.06 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.961 -176.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.411 ' HB3' HD23 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -132.02 87.67 43.53 Favored Pre-proline 0 C--N 1.311 -1.109 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.5 178.622 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.14 -12.57 17.44 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.706 2.271 . . . . 0.0 115.254 -172.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -96.79 19.31 12.75 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.078 0.465 . . . . 0.0 111.27 -177.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.56 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 4.4 mm? -105.95 128.56 53.88 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.363 0.601 . . . . 0.0 112.25 -178.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.8 t -88.86 173.42 8.53 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 174.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.417 ' O ' HG13 ' A' ' 33' ' ' ILE . 11.0 ttm180 -48.96 -56.93 7.41 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.545 0.738 . . . . 0.0 112.36 -174.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -66.21 -37.3 85.23 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.999 -172.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -75.58 -32.08 60.22 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.269 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.57 89.96 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 175.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 29' ' ' ARG . 89.6 mt -59.99 -46.42 94.15 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.656 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.556 178.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' A' ' 37' ' ' LYS . . . -59.02 -44.97 91.78 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 41.2 mt -64.87 -47.34 78.21 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.706 0.765 . . . . 0.0 111.593 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.566 ' HG ' ' HB2' ' A' ' 61' ' ' LYS . 51.5 tp -70.52 -38.14 74.22 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.291 -1.322 . . . . 0.0 113.835 -173.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 14.3 ptmm? -56.75 -30.57 63.72 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -175.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -98.73 8.8 44.53 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.53 0.681 . . . . 0.0 111.077 -177.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . 0.261 45.3 mtmt -84.15 -85.64 0.13 Allowed 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 119.18 -1.008 . . . . 0.0 113.382 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -173.48 136.9 0.71 Allowed Pre-proline 0 C--N 1.289 -2.024 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -176.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -58.56 107.3 0.33 Allowed 'Trans proline' 0 C--O 1.246 0.906 0 C-N-CA 122.519 2.146 . . . . 0.0 110.704 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.45 -25.82 4.73 Favored Glycine 0 N--CA 1.426 -1.972 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -175.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.421 ' O ' HD11 ' A' ' 36' ' ' LEU . . . -76.06 155.19 35.05 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-O 121.093 0.473 . . . . 0.0 110.362 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -146.2 178.33 8.31 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.431 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -156.64 149.46 23.79 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 169.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.416 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 61.1 mt -113.69 124.07 69.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.56 ' HD2' ' O ' ' A' ' 27' ' ' LEU . 39.1 ptt85 -117.28 -177.25 3.18 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.398 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -98.92 136.66 38.6 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.9 t -109.81 152.98 25.03 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.376 0.608 . . . . 0.0 112.212 -172.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -117.62 92.52 3.86 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-O 121.964 0.888 . . . . 0.0 108.884 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.4 m -153.85 -50.92 0.1 Allowed 'General case' 0 C--N 1.258 -3.401 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 177.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -130.88 143.32 50.64 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 104.068 -2.567 . . . . 0.0 104.068 171.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -81.22 120.46 24.92 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.52 30.63 4.88 Favored Glycine 0 C--N 1.295 -1.708 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -171.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -119.29 145.4 46.15 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.491 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 85.1 m-85 -115.55 143.06 45.88 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.31 123.03 7.67 Favored Glycine 0 C--N 1.285 -2.281 0 C-N-CA 119.995 -1.098 . . . . 0.0 110.432 -178.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -99.61 119.87 38.77 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -114.41 121.93 45.08 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 176.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.8 tt -123.05 123.86 41.82 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -176.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.566 ' HB2' ' HG ' ' A' ' 36' ' ' LEU . 22.1 tptm -90.25 113.44 25.27 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 80' ' ' LEU . 17.9 m -99.02 171.26 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.02 -56.57 4.54 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 176.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.411 ' HA ' HD12 ' A' ' 80' ' ' LEU . 9.4 p -158.67 132.45 4.96 Favored Pre-proline 0 C--N 1.309 -1.189 0 C-N-CA 125.294 1.437 . . . . 0.0 108.287 177.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.61 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 35.7 Cg_exo -59.73 -42.14 48.99 Favored 'Trans proline' 0 CA--C 1.577 2.65 0 C-N-CA 121.376 1.384 . . . . 0.0 111.545 171.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.61 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 95.3 Cg_endo -76.89 172.25 16.53 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 122.991 2.46 . . . . 0.0 110.153 170.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.62 -44.91 43.57 Favored 'Trans proline' 0 C--N 1.362 1.241 0 C-N-CA 122.873 2.382 . . . . 0.0 112.633 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.5 m -143.49 -15.3 0.65 Allowed 'General case' 0 C--O 1.247 0.968 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.344 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.478 ' HB2' ' CG ' ' A' ' 66' ' ' PRO . . . 58.38 43.63 19.55 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 123.884 0.873 . . . . 0.0 108.688 -174.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -57.68 -48.23 97.57 Favored Pre-proline 0 N--CA 1.447 -0.606 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.819 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -76.41 87.6 1.43 Allowed 'Trans proline' 0 C--N 1.371 1.734 0 CA-C-N 120.495 1.212 . . . . 0.0 109.746 171.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 31.4 t-105 -81.78 141.52 33.43 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.674 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -122.9 -33.11 3.41 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.306 -0.958 . . . . 0.0 112.102 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.03 68.12 0.02 OUTLIER Glycine 0 CA--C 1.466 -2.976 0 N-CA-C 106.097 -2.801 . . . . 0.0 106.097 -176.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -104.4 110.9 64.94 Favored Pre-proline 0 C--N 1.284 -2.24 0 CA-C-N 113.381 -1.409 . . . . 0.0 111.215 -168.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -73.84 159.83 44.5 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.12 1.88 . . . . 0.0 111.437 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.456 ' HA ' HD23 ' A' ' 80' ' ' LEU . 8.6 p -62.99 -20.78 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.462 0.648 . . . . 0.0 110.676 -178.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -67.75 -13.32 62.02 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 124.065 0.946 . . . . 0.0 111.396 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -87.67 -38.36 15.93 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.47 ' O ' HG22 ' A' ' 62' ' ' VAL . 2.7 mm? -73.15 -27.57 61.74 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.866 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.501 HG13 HD23 ' A' ' 36' ' ' LEU . 69.2 t -86.18 110.08 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 171.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -91.78 134.27 34.89 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.408 -0.814 . . . . 0.0 108.853 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -114.26 122.5 46.93 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.298 0.57 . . . . 0.0 110.579 178.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -129.75 160.17 34.25 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -123.14 150.49 43.21 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.657 -1.217 . . . . 0.0 111.927 174.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.491 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 81.6 mt -108.81 131.1 60.41 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.792 0 CA-C-N 114.068 -1.424 . . . . 0.0 107.615 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -115.54 137.47 52.03 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 1.7 t -110.81 118.72 36.91 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 171.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -135.52 -148.09 5.57 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.85 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -71.25 -34.1 10.42 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 122.56 2.173 . . . . 0.0 113.875 -177.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -75.72 -26.49 57.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.129 0.49 . . . . 0.0 111.034 178.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 139.04 -153.52 22.82 Favored Glycine 0 N--CA 1.425 -2.087 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 88' ' ' THR . 13.9 p -112.04 130.87 64.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.23 170.01 23.22 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.425 ' HB ' ' SG ' ' A' ' 98' ' ' CYS . 64.1 mt -81.16 140.46 16.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -52.39 -53.05 49.95 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 123.601 0.761 . . . . 0.0 109.926 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.65 23.79 5.47 Favored Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 115.086 -0.961 . . . . 0.0 114.666 -176.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.425 ' SG ' ' HB ' ' A' ' 95' ' ' ILE . 31.1 p -116.02 103.09 53.71 Favored Pre-proline 0 N--CA 1.435 -1.2 0 CA-C-N 118.315 1.057 . . . . 0.0 110.551 174.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -100.6 28.47 0.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.124 2.549 . . . . 0.0 110.053 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.3 p -75.54 -78.71 0.11 Allowed 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.438 -176.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -166.68 -59.07 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -79.12 126.23 6.92 Favored 'Trans proline' 0 N--CA 1.44 -1.668 0 N-CA-C 115.813 1.428 . . . . 0.0 115.813 -165.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -97.72 121.03 39.15 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 168.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.556 ' CD2' ' HB3' ' A' ' 110' ' ' LEU . 60.0 m-85 -94.46 166.29 12.13 Favored 'General case' 0 C--N 1.289 -2.024 0 O-C-N 123.395 0.434 . . . . 0.0 111.177 -170.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.22 -36.78 6.93 Favored Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 121.108 -0.568 . . . . 0.0 111.991 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.9 m -140.98 169.41 17.68 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 122.497 -0.414 . . . . 0.0 109.943 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.471 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 94.8 mt -62.36 -40.05 95.17 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.107 0.563 . . . . 0.0 112.198 -176.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.0 t -52.53 -40.46 62.52 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.218 0.607 . . . . 0.0 112.037 -178.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.58 96.41 Favored 'General case' 0 C--O 1.247 0.954 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.556 ' HB3' ' CD2' ' A' ' 104' ' ' PHE . 4.4 pp -72.55 -28.73 63.01 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 120.912 0.387 . . . . 0.0 110.919 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 40.6 t -63.78 -54.59 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.132 177.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 45.9 m -65.28 -36.67 84.83 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.502 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -57.77 -48.18 80.39 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.434 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.474 ' HA ' ' O ' ' A' ' 117' ' ' SER . 71.6 m80 -87.53 -2.49 58.65 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.5 t -79.33 -31.15 43.03 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 67.4 mt -95.85 -58.96 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.424 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 21.6 m -111.57 105.3 56.71 Favored Pre-proline 0 N--CA 1.434 -1.247 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.835 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -75.29 85.35 1.57 Allowed 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 121.696 1.597 . . . . 0.0 110.076 175.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.0 mt -72.51 -73.85 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.908 -177.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.1 m -98.89 1.18 45.46 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.664 0.745 . . . . 0.0 111.318 -176.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.4 mt -105.29 137.6 19.3 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.78 -10.93 29.76 Favored 'Trans proline' 0 N--CA 1.485 1.023 0 C-N-CA 122.885 2.39 . . . . 0.0 113.701 -177.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 52.3 t -141.01 151.52 44.17 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 13.2 p -76.67 142.65 40.5 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 176.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 90.1 mt -73.02 120.17 18.27 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 123.741 0.651 . . . . 0.0 109.738 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -101.41 120.07 39.72 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mt -105.29 109.59 63.39 Favored Pre-proline 0 N--CA 1.429 -1.483 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 C--N 1.32 -0.949 0 C-N-CA 122.725 2.283 . . . . 0.0 113.08 -176.606 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.1 p . . . . . 0 CA--C 1.54 0.566 0 CA-C-O 122.417 1.103 . . . . 0.0 111.827 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 36.2 t -80.06 -21.56 43.26 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.27 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.95 -4.55 17.1 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -173.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -86.19 -12.09 50.72 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 122.114 -0.366 . . . . 0.0 110.78 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.444 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 53.3 p-90 -142.48 -28.95 0.58 Allowed 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -175.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.435 ' HB2' ' CE3' ' A' ' 22' ' ' TRP . 55.4 t80 -92.46 114.26 26.76 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.331 0.586 . . . . 0.0 112.535 -173.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.9 96.56 2.92 Favored Pre-proline 0 C--N 1.306 -1.314 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.816 172.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.95 3.78 6.7 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 123.26 2.64 . . . . 0.0 114.227 -173.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -85.11 -14.66 46.42 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.701 0.762 . . . . 0.0 109.504 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.3 tp -89.2 134.86 33.87 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.367 -169.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.8 t -92.27 177.5 6.13 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-O 120.875 0.369 . . . . 0.0 110.015 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.401 ' HA ' ' CZ ' ' A' ' 47' ' ' ARG . 17.1 ttm180 -54.48 -56.11 22.13 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 124.506 1.122 . . . . 0.0 113.4 -172.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -65.31 -40.59 93.97 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.386 0.612 . . . . 0.0 111.1 -174.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -65.45 -35.83 82.1 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.162 -177.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.33 -40.07 96.28 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.376 178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 73.4 mt -67.95 -41.23 84.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.197 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.11 -31.61 70.21 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.245 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.2 mt -79.81 -39.83 29.92 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.396 0.617 . . . . 0.0 111.707 175.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.9 tp -75.6 -28.74 59.0 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.065 -173.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.2 ptmm? -64.05 -15.07 58.69 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.31 0.576 . . . . 0.0 111.385 178.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -95.5 -13.63 24.36 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.316 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -99.27 174.32 6.36 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.919 0.39 . . . . 0.0 111.457 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -92.94 158.74 37.11 Favored Pre-proline 0 C--N 1.304 -1.376 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.061 -173.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -59.61 120.81 8.85 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 122.472 2.114 . . . . 0.0 110.873 175.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.81 -14.52 10.55 Favored Glycine 0 C--N 1.298 -1.543 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -176.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.75 151.67 27.36 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.462 ' CG ' HD22 ' A' ' 125' ' ' LEU . 22.5 p90 -152.16 162.03 41.74 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -175.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -150.48 147.32 27.36 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 174.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.444 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 64.6 mt -118.96 127.29 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 CA-C-O 121.692 0.758 . . . . 0.0 109.673 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.41 HH22 ' CD2' ' A' ' 83' ' ' HIS . 26.5 ptt-85 -125.3 -173.96 2.94 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -92.27 135.06 34.31 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 174.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 70.2 m -83.64 99.16 10.03 Favored 'General case' 0 N--CA 1.426 -1.631 0 C-N-CA 120.221 -0.591 . . . . 0.0 109.407 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -74.15 69.5 1.52 Allowed 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 121.98 0.895 . . . . 0.0 109.794 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.3 m -157.63 -36.46 0.07 Allowed 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 113.352 -1.749 . . . . 0.0 108.412 -177.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -133.4 166.98 21.27 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -110.89 130.12 55.68 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.78 24.5 38.26 Favored Glycine 0 C--N 1.304 -1.205 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.418 ' HB1' HD23 ' A' ' 85' ' ' LEU . . . -134.17 122.44 22.83 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-O 121.673 0.749 . . . . 0.0 110.146 -178.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -96.66 155.91 16.57 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -118.19 120.72 4.82 Favored Glycine 0 C--N 1.273 -2.952 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.45 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.2 tp -98.45 121.7 40.72 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 124.296 0.644 . . . . 0.0 109.275 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.15 112.93 25.37 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.7 tp -108.78 129.54 55.38 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 123.528 0.518 . . . . 0.0 109.7 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -88.83 119.3 29.21 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.7 m -108.38 165.71 4.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.32 -58.73 5.2 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.516 HG21 ' H ' ' A' ' 69' ' ' ALA . 0.6 OUTLIER -164.64 145.47 6.41 Favored Pre-proline 0 C--N 1.314 -0.97 0 C-N-CA 123.545 0.738 . . . . 0.0 110.663 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.569 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 16.3 Cg_exo -63.05 -49.82 4.5 Favored 'Trans proline' 0 CA--C 1.571 2.344 0 C-N-CA 121.933 1.756 . . . . 0.0 109.44 168.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.569 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 15.9 Cg_endo -57.55 179.81 0.13 Allowed 'Trans proline' 0 C--N 1.392 2.831 0 C-N-CA 122.825 2.35 . . . . 0.0 110.841 162.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -71.82 -47.46 0.46 Allowed 'Trans proline' 0 C--N 1.357 1.001 0 N-CA-C 108.072 -1.549 . . . . 0.0 108.072 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 71.5 m -160.79 111.68 1.81 Allowed 'General case' 0 N--CA 1.407 -2.608 0 N-CA-C 103.442 -2.799 . . . . 0.0 103.442 171.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.516 ' H ' HG21 ' A' ' 64' ' ' THR . . . -58.41 76.15 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 124.031 0.932 . . . . 0.0 113.085 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.467 ' H ' ' HD2' ' A' ' 71' ' ' PRO . 8.1 tt0 -87.82 -47.43 0.47 Allowed Pre-proline 0 C--N 1.286 -2.156 0 CA-C-N 114.578 -1.192 . . . . 0.0 107.892 172.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.467 ' HD2' ' H ' ' A' ' 70' ' ' GLN . 20.2 Cg_endo -65.51 109.19 1.35 Allowed 'Trans proline' 0 C--N 1.377 2.05 0 N-CA-C 108.654 -1.325 . . . . 0.0 108.654 165.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -81.83 137.32 35.29 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.981 -175.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -126.17 -36.75 2.3 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.763 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 167.73 -48.34 0.24 Allowed Glycine 0 CA--C 1.467 -2.93 0 N-CA-C 107.335 -2.306 . . . . 0.0 107.335 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 39.49 78.38 0.37 Allowed Pre-proline 0 C--N 1.316 -0.87 0 C-N-CA 126.817 2.047 . . . . 0.0 114.647 168.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -75.38 163.2 34.95 Favored 'Trans proline' 0 C--O 1.242 0.701 0 C-N-CA 122.251 1.967 . . . . 0.0 111.518 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -67.11 -30.29 48.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 120.985 0.421 . . . . 0.0 111.182 -178.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -70.71 -18.77 62.8 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.202 0.525 . . . . 0.0 110.473 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -79.09 -22.77 44.76 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.6 mt -89.35 5.69 43.92 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.962 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.8 t -117.85 141.47 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -109.45 137.39 47.37 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.41 ' CD2' HH22 ' A' ' 47' ' ' ARG . 26.8 m80 -117.7 122.77 44.4 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 121.439 0.638 . . . . 0.0 111.669 178.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -135.57 143.38 45.62 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 177.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.418 HD23 ' HB1' ' A' ' 55' ' ' ALA . 3.9 mp -96.42 162.61 13.41 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.263 -1.375 . . . . 0.0 108.726 174.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 80.2 mt -125.13 110.83 25.69 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.014 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 174.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.462 ' OE1' ' HD3' ' A' ' 96' ' ' LYS . 30.1 mt-10 -99.72 148.93 23.84 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -175.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.565 ' HB ' HG23 ' A' ' 93' ' ' VAL . 5.3 t -135.56 141.86 45.25 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -149.74 -155.45 6.8 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.35 -27.22 84.45 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.17 2.58 . . . . 0.0 113.876 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.72 -48.68 16.1 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 120.739 0.305 . . . . 0.0 111.689 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.63 -144.12 8.99 Favored Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.565 HG23 ' HB ' ' A' ' 88' ' ' THR . 12.2 p -123.78 142.49 40.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.64 157.48 31.96 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.155 0.182 . . . . 0.0 111.214 -171.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 58.0 mt -81.56 136.8 22.35 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 CA-C-O 121.207 0.527 . . . . 0.0 110.891 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.462 ' HD3' ' OE1' ' A' ' 87' ' ' GLU . 43.5 tptt -83.38 135.2 34.79 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 124.492 1.117 . . . . 0.0 111.172 -176.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.68 34.55 13.31 Favored Glycine 0 CA--C 1.499 -0.94 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.118 176.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.6 ' SG ' ' HB3' ' A' ' 100' ' ' SER . 47.0 t -142.26 143.15 26.26 Favored Pre-proline 0 N--CA 1.425 -1.68 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -87.36 10.34 3.57 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 123.318 2.678 . . . . 0.0 110.64 177.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.6 ' HB3' ' SG ' ' A' ' 98' ' ' CYS . 40.5 t -125.47 -164.63 1.32 Allowed 'General case' 0 N--CA 1.393 -3.306 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 -178.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 68.4 100.53 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.794 0 C-N-CA 125.674 1.59 . . . . 0.0 112.295 -179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.94 -162.99 0.15 Allowed 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 122.968 2.445 . . . . 0.0 111.654 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -94.33 96.53 9.61 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -78.32 161.22 27.37 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -76.36 -51.57 6.62 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.524 178.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 39.0 m -137.68 166.7 23.31 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.6 mp -58.72 -36.28 74.04 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 123.166 0.587 . . . . 0.0 110.98 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.1 m -51.21 -37.74 48.45 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.232 1.013 . . . . 0.0 111.482 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.14 -50.08 65.21 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.196 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.457 HD12 ' N ' ' A' ' 111' ' ' VAL . 4.1 pp -68.21 -35.06 77.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.879 0.371 . . . . 0.0 110.592 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.457 ' N ' HD12 ' A' ' 110' ' ' LEU . 47.9 t -58.31 -50.79 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.683 176.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 45.7 p -69.42 -22.78 63.66 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.409 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -88.79 -39.55 13.82 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.928 0.394 . . . . 0.0 111.405 -174.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -75.47 -0.84 21.51 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.7 m -74.56 -28.49 60.96 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 170.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 68.8 mt -97.95 -49.03 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.217 -178.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.9 m -121.71 99.83 44.38 Favored Pre-proline 0 N--CA 1.44 -0.959 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.174 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -81.47 100.89 1.17 Allowed 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.144 1.896 . . . . 0.0 109.727 174.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 65.0 mt -90.29 -73.8 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.135 -174.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.549 ' HB3' ' SG ' ' A' ' 98' ' ' CYS . 2.7 p -77.74 -27.41 50.45 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 122.038 0.923 . . . . 0.0 110.094 177.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.5 mt -83.12 129.68 60.12 Favored Pre-proline 0 N--CA 1.427 -1.587 0 CA-C-N 114.144 -1.389 . . . . 0.0 109.237 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -75.78 -4.33 15.06 Favored 'Trans proline' 0 N--CA 1.485 1.021 0 C-N-CA 122.893 2.395 . . . . 0.0 112.702 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 82.9 m -143.61 152.59 41.57 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.449 ' SG ' ' HD3' ' A' ' 126' ' ' ARG . 21.5 p -82.07 148.63 28.48 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.952 0.406 . . . . 0.0 111.487 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.462 HD22 ' CG ' ' A' ' 44' ' ' PHE . 86.7 mt -74.19 117.42 15.98 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.449 ' HD3' ' SG ' ' A' ' 124' ' ' CYS . 24.2 mmm180 -104.41 109.73 21.71 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.241 0.543 . . . . 0.0 110.221 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mp -96.03 126.66 43.69 Favored Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo . . . . . 0 C--N 1.352 0.762 0 C-N-CA 122.408 2.072 . . . . 0.0 111.485 177.772 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.335 80.5 p . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.491 ' O ' ' HB3' ' A' ' 23' ' ' TYR . 20.0 m -62.66 -31.84 72.79 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.671 0.748 . . . . 0.0 109.483 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -10.64 33.64 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 177.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -98.38 -62.26 1.27 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.804 0.335 . . . . 0.0 111.093 176.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 24.8 p-90 -94.05 -8.65 39.17 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -171.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.491 ' HB3' ' O ' ' A' ' 19' ' ' SER . 70.2 t80 -100.5 120.0 39.35 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.865 -175.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -131.23 88.94 43.07 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 175.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.83 -31.82 67.55 Favored 'Trans proline' 0 N--CA 1.482 0.834 0 C-N-CA 122.482 2.121 . . . . 0.0 113.347 -172.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -84.74 -0.32 53.26 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 124.107 0.963 . . . . 0.0 112.776 -174.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.462 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 14.4 tp -85.76 152.37 23.1 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -176.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 t -110.28 174.86 5.66 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 120.628 0.251 . . . . 0.0 110.432 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 -56.91 -50.36 72.78 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -174.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -64.77 -32.01 73.5 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.126 0.488 . . . . 0.0 111.326 -175.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -74.83 -39.36 61.67 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.326 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.49 -43.44 93.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.395 0.617 . . . . 0.0 109.948 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 78.1 mt -65.62 -39.7 85.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.966 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.455 ' O ' ' HG2' ' A' ' 37' ' ' LYS . . . -57.71 -49.44 76.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.277 178.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.8 -36.29 82.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.075 0.464 . . . . 0.0 111.336 178.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.419 ' CD1' HD22 ' A' ' 45' ' ' LEU . 6.6 mp -81.2 -14.81 57.17 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -177.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.489 ' HB3' HG21 ' A' ' 77' ' ' VAL . 17.8 ptpt -80.28 -15.05 57.83 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.673 177.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -100.23 -3.72 30.92 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.187 176.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -101.38 174.63 5.89 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -176.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -91.53 144.65 29.91 Favored Pre-proline 0 C--N 1.305 -1.343 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.14 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.02 118.44 4.98 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.083 2.522 . . . . 0.0 112.094 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.37 -11.71 9.09 Favored Glycine 0 N--CA 1.435 -1.41 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -174.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.65 147.87 37.24 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.405 ' HB2' HD11 ' A' ' 58' ' ' LEU . 36.1 p90 -150.68 171.5 17.06 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -176.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.419 HD22 ' CD1' ' A' ' 36' ' ' LEU . 1.5 pt? -161.56 154.52 20.75 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 172.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.3 mt -121.48 134.92 63.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 121.061 0.457 . . . . 0.0 110.565 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.533 ' HG3' ' O ' ' A' ' 48' ' ' ASP . 23.8 ptt-85 -127.39 -173.69 2.97 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 177.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.533 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 13.1 t70 -82.4 150.75 26.94 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 174.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 70.8 m -66.25 -26.75 67.5 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 119.307 0.958 . . . . 0.0 112.12 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 35.4 t60 69.73 -46.75 0.59 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 124.909 1.284 . . . . 0.0 111.873 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.2 t -71.67 -33.5 68.91 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 123.775 0.83 . . . . 0.0 110.35 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -122.36 154.36 37.77 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -177.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -102.39 126.73 49.51 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 123.812 0.695 . . . . 0.0 110.41 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.13 22.67 34.57 Favored Glycine 0 C--N 1.308 -1.024 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -178.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.62 144.02 47.65 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 120.898 0.38 . . . . 0.0 110.162 -177.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -112.64 139.0 48.62 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -101.96 111.63 4.12 Favored Glycine 0 C--N 1.294 -1.797 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.378 -177.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.405 HD11 ' HB2' ' A' ' 44' ' ' PHE . 39.3 tp -91.31 130.49 37.17 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 123.88 0.872 . . . . 0.0 109.306 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -114.44 128.71 56.48 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 175.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.2 tp -122.27 129.54 52.3 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 123.553 0.533 . . . . 0.0 110.546 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -93.1 114.28 26.77 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 28.4 m -106.82 164.14 4.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 173.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.07 -59.24 3.02 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.9 p -149.22 141.73 15.36 Favored Pre-proline 0 N--CA 1.421 -1.877 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.629 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 39.1 Cg_exo -59.99 -44.71 28.1 Favored 'Trans proline' 0 CA--C 1.57 2.279 0 C-N-CA 121.675 1.583 . . . . 0.0 111.659 174.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.629 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 85.6 Cg_endo -75.78 149.72 33.98 Favored 'Trans proline' 0 C--N 1.381 2.272 0 C-N-CA 122.416 2.077 . . . . 0.0 109.559 171.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.18 -48.11 6.89 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.148 1.899 . . . . 0.0 112.629 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.9 p -116.71 -9.1 11.34 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.855 0.36 . . . . 0.0 111.363 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 59.4 44.05 15.64 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.562 -178.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -50.38 -52.33 55.8 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 113.902 -1.499 . . . . 0.0 110.787 175.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.45 93.43 0.98 Allowed 'Trans proline' 0 N--CA 1.441 -1.568 0 CA-C-N 120.308 1.146 . . . . 0.0 109.352 169.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 53.0 t-105 -86.55 137.16 32.73 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.562 -175.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -124.7 -42.12 2.09 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.206 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.24 56.39 1.0 Allowed Glycine 0 C--N 1.299 -1.524 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -89.94 139.93 27.57 Favored Pre-proline 0 C--N 1.306 -1.289 0 CA-C-N 115.091 -0.555 . . . . 0.0 109.855 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.19 167.93 26.06 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.893 2.395 . . . . 0.0 113.829 -175.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.489 HG21 ' HB3' ' A' ' 37' ' ' LYS . 2.3 p -59.53 -32.74 49.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.336 176.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 -65.1 -18.68 65.5 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.073 0.463 . . . . 0.0 110.881 177.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -92.4 -36.05 13.35 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.95 -35.8 82.33 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.156 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 89.6 t -70.71 113.04 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.516 ' NE ' ' HA ' ' A' ' 82' ' ' ARG . 1.7 mmp_? -87.25 144.6 26.74 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.795 -176.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -125.84 124.47 40.98 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 120.974 0.416 . . . . 0.0 110.352 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -132.13 132.86 43.63 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.482 ' HG ' ' HB2' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -97.06 140.59 31.35 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.972 -1.091 . . . . 0.0 112.229 177.029 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 77.4 mt -107.61 120.68 59.36 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.419 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -105.78 138.01 42.7 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -175.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.435 ' HB ' HG23 ' A' ' 93' ' ' VAL . 3.9 t -116.36 124.75 50.84 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.65 -162.66 9.52 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 -178.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.55 -31.82 49.9 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.205 2.603 . . . . 0.0 112.631 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -71.04 -21.88 62.21 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 175.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 132.63 -159.47 23.45 Favored Glycine 0 CA--C 1.488 -1.601 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.435 HG23 ' HB ' ' A' ' 88' ' ' THR . 14.6 p -104.01 127.18 58.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.711 ' HG2' ' CD2' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -149.73 167.03 27.63 Favored 'General case' 0 C--O 1.201 -1.493 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.24 -171.665 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 66.6 mt -93.2 143.88 10.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.405 -176.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.482 ' HB2' ' HG ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -44.69 -46.56 10.37 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.675 1.59 . . . . 0.0 112.124 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -127.01 63.89 0.59 Allowed Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.44 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 11.1 p -85.05 122.85 74.1 Favored Pre-proline 0 C--N 1.304 -1.391 0 CA-C-O 120.678 0.275 . . . . 0.0 110.391 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -80.29 10.42 3.24 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 122.752 2.301 . . . . 0.0 113.365 -176.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.8 m -154.82 -162.46 1.38 Allowed 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.436 ' HG3' ' CD1' ' A' ' 103' ' ' TYR . 37.2 tt0 -109.88 106.37 58.19 Favored Pre-proline 0 C--N 1.294 -1.816 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -175.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -89.42 -80.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.653 0 C-N-CA 122.066 1.844 . . . . 0.0 112.149 171.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.711 ' CD2' ' HG2' ' A' ' 94' ' ' LYS . 51.8 m-85 43.49 79.36 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 127.381 2.272 . . . . 0.0 112.805 178.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.411 ' O ' HG12 ' A' ' 93' ' ' VAL . 98.0 m-85 -107.08 -178.36 3.62 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.279 -177.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -86.35 -36.9 9.3 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.009 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.8 m -132.9 158.51 42.41 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 122.456 -0.438 . . . . 0.0 110.487 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 75.1 mt -55.21 -46.78 75.93 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 123.13 0.572 . . . . 0.0 111.463 178.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 24.3 p -54.6 -31.21 56.6 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 123.242 0.617 . . . . 0.0 112.401 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.18 -39.14 82.58 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.113 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 111' ' ' VAL . 3.8 pp -80.31 -29.81 38.13 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.687 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.437 ' N ' HD12 ' A' ' 110' ' ' LEU . 40.6 t -63.41 -54.48 32.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.629 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.7 m -68.64 -20.61 64.47 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.303 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -78.26 -40.82 35.94 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.646 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.515 ' HA ' ' O ' ' A' ' 117' ' ' SER . 66.8 m80 -80.18 3.02 21.99 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -174.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 125' ' ' LEU . 10.7 p -86.15 -39.88 16.22 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 172.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.5 mt -84.01 -48.14 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.271 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 19.6 m -121.86 93.06 48.78 Favored Pre-proline 0 N--CA 1.425 -1.706 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.835 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.57 73.43 5.6 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.855 2.37 . . . . 0.0 110.873 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 67.5 mt -68.8 -60.8 2.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.13 -178.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.3 m -83.72 -49.96 8.62 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.551 -175.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -73.4 139.96 78.84 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.867 -177.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.88 -18.39 46.94 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 123.09 2.527 . . . . 0.0 111.994 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 43.6 t -127.94 154.75 45.21 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 4.0 p -71.61 145.01 49.26 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 177.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.401 ' O ' ' HB3' ' A' ' 115' ' ' SER . 74.2 mt -79.41 106.31 11.35 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -90.38 103.78 16.42 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.336 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.547 ' H ' HD12 ' A' ' 127' ' ' ILE . 1.8 mp -90.38 128.12 50.3 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo . . . . . 0 CA--C 1.531 0.373 0 C-N-CA 121.435 1.423 . . . . 0.0 110.21 174.507 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.553 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 2.0 p . . . . . 0 N--CA 1.425 -1.725 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.5 m -74.32 -36.17 63.68 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.313 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.77 -5.86 40.81 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.553 ' CD2' ' HA ' ' A' ' 18' ' ' THR . 25.6 m-85 -81.08 -24.12 38.0 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.079 175.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.476 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 54.0 p-90 -116.6 -32.28 5.24 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -93.16 114.54 27.07 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.217 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . 0.252 0.1 OUTLIER -155.24 98.28 2.37 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-O 121.711 0.767 . . . . 0.0 111.266 175.361 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -83.35 19.43 1.34 Allowed 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 124.047 3.165 . . . . 0.0 114.62 -173.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -99.43 -4.03 32.37 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.993 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.7 mp -92.99 140.96 28.92 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.817 0.818 . . . . 0.0 112.952 -177.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 m -90.05 177.26 6.5 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.043 -1.435 . . . . 0.0 107.707 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -50.49 -56.56 11.04 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.249 0.62 . . . . 0.0 110.635 177.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -65.86 -35.31 80.29 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.709 -175.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -66.94 -38.69 86.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.088 178.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.44 -42.07 99.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.577 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 82.9 mt -64.82 -45.83 93.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.107 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.421 ' HA ' ' CD ' ' A' ' 37' ' ' LYS . . . -59.83 -32.95 71.14 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.702 0.763 . . . . 0.0 111.83 178.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.14 -50.08 17.48 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 70.1 mt -71.09 -26.26 62.97 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -175.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.421 ' CD ' ' HA ' ' A' ' 34' ' ' ALA . 14.3 ptmm? -65.11 -24.49 67.44 Favored 'General case' 0 C--N 1.316 -0.883 0 O-C-N 121.908 -0.495 . . . . 0.0 110.567 178.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -84.37 -40.36 17.96 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.753 176.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.574 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -68.58 151.42 46.78 Favored 'General case' 0 C--O 1.248 1.015 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.222 -176.278 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -75.11 138.35 72.36 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.815 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -45.45 120.24 3.11 Favored 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 124.265 3.31 . . . . 0.0 114.121 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.87 -24.43 6.38 Favored Glycine 0 N--CA 1.434 -1.476 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -176.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.08 151.66 45.23 Favored 'General case' 0 C--O 1.249 1.031 0 CA-C-N 114.975 -0.613 . . . . 0.0 110.016 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.419 ' HZ ' HG13 ' A' ' 111' ' ' VAL . 23.6 p90 -153.6 170.93 19.63 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 -175.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -147.42 145.7 29.31 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 171.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.476 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 60.7 mt -111.56 123.33 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.067 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -124.1 179.91 4.68 Favored 'General case' 0 C--N 1.275 -2.66 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 177.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -84.98 154.02 22.4 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 175.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.6 t -81.82 133.87 35.37 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -90.95 -22.89 20.62 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 121.833 0.825 . . . . 0.0 108.98 177.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.7 m -72.53 -52.82 13.99 Favored 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 114.347 -1.297 . . . . 0.0 109.784 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -126.77 138.55 53.38 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.33 0.585 . . . . 0.0 111.348 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -88.77 138.03 31.78 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 176.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.22 11.67 58.29 Favored Glycine 0 C--N 1.305 -1.143 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -172.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -135.3 153.88 51.73 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-N 114.631 -0.784 . . . . 0.0 109.111 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.5 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 52.6 m-85 -115.83 171.58 7.68 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 176.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.18 133.13 8.87 Favored Glycine 0 C--N 1.282 -2.437 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -111.22 115.61 29.66 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.34 125.36 50.51 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.493 HD21 ' SG ' ' A' ' 123' ' ' CYS . 50.4 tp -124.08 129.83 51.53 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 123.395 0.435 . . . . 0.0 111.782 -173.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.562 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 22.3 tptm -91.77 114.24 26.72 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 174.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 80' ' ' LEU . 24.3 m -101.64 171.08 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 175.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.61 -55.6 6.62 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.44 ' HB ' ' HG2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -159.18 142.98 10.94 Favored Pre-proline 0 N--CA 1.421 -1.892 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.508 -178.277 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.595 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 16.8 Cg_exo -61.46 -50.27 5.97 Favored 'Trans proline' 0 CA--C 1.555 1.542 0 C-N-CA 122.208 1.939 . . . . 0.0 110.094 172.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.595 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 10.8 Cg_endo -54.76 136.03 69.88 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 122.105 1.87 . . . . 0.0 109.653 163.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.19 -11.55 21.14 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.64 2.227 . . . . 0.0 112.674 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.4 p -130.1 -37.28 1.48 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.912 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.437 ' HA ' ' HB2' ' A' ' 66' ' ' PRO . . . 72.9 23.04 2.9 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 125.096 1.358 . . . . 0.0 111.989 178.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -62.91 -49.05 83.73 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.598 173.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.14 105.87 1.27 Allowed 'Trans proline' 0 C--N 1.386 2.502 0 C-N-CA 121.047 1.165 . . . . 0.0 110.126 170.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 68.2 t-105 -96.1 149.06 22.03 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.78 -175.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -133.62 -36.71 0.95 Allowed 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.878 175.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.36 34.38 29.28 Favored Glycine 0 CA--C 1.503 -0.685 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.9 p30 -90.28 153.8 46.6 Favored Pre-proline 0 C--N 1.298 -1.642 0 CA-C-N 114.163 -1.019 . . . . 0.0 111.127 -177.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_exo -34.51 146.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.366 1.499 1 C-N-CA 125.99 4.46 . . . . 0.0 117.684 -175.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.1 p -70.24 -13.97 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.221 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -64.9 -16.05 62.77 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.809 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -92.02 -24.81 19.08 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 121.114 0.483 . . . . 0.0 109.781 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.483 HD23 ' HD3' ' A' ' 65' ' ' PRO . 79.1 mt -76.02 -26.06 56.3 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.013 0.911 . . . . 0.0 109.01 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.5 t -93.88 123.88 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 173.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.477 ' NE ' ' HA ' ' A' ' 82' ' ' ARG . 4.1 mmp_? -104.89 151.01 24.38 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -123.91 124.62 43.02 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.627 0.727 . . . . 0.0 111.772 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -128.13 170.38 13.02 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 pp -135.25 157.81 45.96 Favored 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.485 176.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.5 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 39.4 mt -111.34 123.68 67.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -173.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -102.77 129.55 49.46 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 123.733 0.813 . . . . 0.0 109.016 -176.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.512 ' HB ' HG23 ' A' ' 93' ' ' VAL . 2.6 t -116.77 132.76 56.61 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 120.928 0.394 . . . . 0.0 110.304 174.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.65 -159.82 8.34 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.56 -31.9 49.66 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.008 2.472 . . . . 0.0 113.713 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -80.57 -36.23 33.24 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.701 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 163.31 -163.15 35.38 Favored Glycine 0 N--CA 1.422 -2.238 0 C-N-CA 119.911 -1.138 . . . . 0.0 112.124 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.512 HG23 ' HB ' ' A' ' 88' ' ' THR . 14.0 p -116.11 126.75 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.283 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.561 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 0.0 OUTLIER -151.27 173.88 13.95 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 116.048 -0.523 . . . . 0.0 112.388 -177.249 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.45 ' HB ' ' OG ' ' A' ' 120' ' ' SER . 70.2 mt -97.61 141.81 15.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-O 121.74 0.781 . . . . 0.0 112.975 -171.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -65.74 132.58 49.1 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 125.122 1.369 . . . . 0.0 108.926 174.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.42 -9.59 38.6 Favored Glycine 0 C--N 1.312 -0.778 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.568 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 37.8 t -142.24 141.04 20.17 Favored Pre-proline 0 N--CA 1.422 -1.866 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.58 -40.38 47.47 Favored 'Trans proline' 0 C--O 1.244 0.805 0 C-N-CA 121.555 1.504 . . . . 0.0 109.385 176.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.561 ' OG ' ' HB2' ' A' ' 94' ' ' LYS 0.38 1.8 p 49.41 67.36 0.9 Allowed 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 123.443 1.592 . . . . 0.0 114.06 -177.17 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.505 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 41.8 mt-10 -49.63 -36.72 18.59 Favored Pre-proline 0 C--N 1.303 -1.446 0 CA-C-N 111.525 -2.579 . . . . 0.0 115.652 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 101' ' ' GLU . 7.3 Cg_endo -53.6 -33.11 67.4 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.134 1.889 . . . . 0.0 114.732 177.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 48.75 99.58 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 126.211 1.805 . . . . 0.0 111.982 -172.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -74.31 139.39 44.17 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.745 -176.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.03 -42.25 20.26 Favored Glycine 0 C--N 1.304 -1.223 0 C-N-CA 120.042 -1.075 . . . . 0.0 110.706 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.8 m -133.22 159.89 38.87 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.421 ' O ' ' HB3' ' A' ' 110' ' ' LEU . 96.1 mt -58.61 -31.67 68.29 Favored 'General case' 0 C--O 1.215 -0.711 0 C-N-CA 123.626 0.77 . . . . 0.0 112.045 -178.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.9 m -61.27 -32.12 71.94 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-O 120.846 0.355 . . . . 0.0 111.589 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.5 -31.82 62.32 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.562 0.696 . . . . 0.0 109.555 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.421 ' HB3' ' O ' ' A' ' 107' ' ' LEU . 3.7 tt -67.62 -45.37 75.62 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.537 -1.21 . . . . 0.0 109.354 176.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.446 HG21 ' CE2' ' A' ' 22' ' ' TRP . 73.2 t -71.13 -39.11 73.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.137 -0.938 . . . . 0.0 113.177 -177.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.7 t -68.97 -21.81 64.15 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.151 0.5 . . . . 0.0 110.997 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -107.11 177.96 4.7 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.398 -178.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.532 ' HA ' ' O ' ' A' ' 117' ' ' SER . 7.0 m-70 73.48 -10.43 1.05 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.969 0.908 . . . . 0.0 113.21 -177.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.0 m -73.26 -32.8 64.9 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 169.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 61.2 mt -88.24 -62.23 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.859 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.532 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 26.6 t -116.54 99.96 53.13 Favored Pre-proline 0 N--CA 1.434 -1.238 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.32 99.12 1.08 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.78 2.32 . . . . 0.0 110.812 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.434 ' HB ' ' CE1' ' A' ' 114' ' ' HIS . 67.6 mt -99.51 -51.32 10.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.225 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.45 ' OG ' ' HB ' ' A' ' 95' ' ' ILE . 34.7 t -80.89 -42.35 21.59 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.644 -177.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.425 HD12 HD22 ' A' ' 60' ' ' LEU . 1.8 mm? -89.83 144.11 31.14 Favored Pre-proline 0 N--CA 1.434 -1.25 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.294 -178.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -63.41 -32.21 71.79 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.987 2.458 . . . . 0.0 111.757 177.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.493 ' SG ' HD21 ' A' ' 60' ' ' LEU . 26.3 p -109.45 169.87 8.43 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 23.2 m -70.14 132.71 46.23 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 176.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 29.2 tp -82.37 131.98 35.22 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -136.39 128.14 29.07 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.455 ' H ' HD12 ' A' ' 127' ' ' ILE . 3.0 mp -66.24 125.14 89.73 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo . . . . . 0 C--N 1.35 0.651 0 C-N-CA 122.049 1.833 . . . . 0.0 111.299 -179.253 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.496 -1.11 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.458 ' HD2' ' CD2' ' A' ' 3' ' ' HIS . 9.9 t60 -79.17 -42.4 26.2 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -176.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.458 ' CD2' ' HD2' ' A' ' 2' ' ' HIS . 94.5 m-70 -135.22 160.96 36.75 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -128.11 101.68 6.38 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -86.39 151.75 23.29 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -72.95 142.1 47.8 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 119.404 -0.919 . . . . 0.0 108.523 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 29.8 t60 -72.88 87.88 1.32 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.574 0.702 . . . . 0.0 111.48 -175.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.8 t -134.14 -2.2 2.87 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.3 m -105.22 6.51 33.02 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-O 121.819 0.819 . . . . 0.0 110.467 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.04 139.28 14.48 Favored Glycine 0 N--CA 1.423 -2.176 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.519 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 85.5 mt -106.7 159.33 16.3 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.7 t -104.48 96.49 10.25 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.519 ' HD3' ' O ' ' A' ' 11' ' ' LEU . 43.3 Cg_endo -95.19 145.13 1.42 Allowed 'Trans proline' 0 N--CA 1.438 -1.754 0 C-N-CA 122.389 2.059 . . . . 0.0 111.903 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -122.69 -50.72 1.95 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.58 61.95 4.14 Favored Glycine 0 CA--C 1.518 0.268 0 N-CA-C 115.098 0.799 . . . . 0.0 115.098 172.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.3 t -99.73 -1.6 37.38 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 122.088 0.947 . . . . 0.0 109.419 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -84.84 100.41 11.54 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 114.705 -1.134 . . . . 0.0 107.986 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.0 p -112.9 3.49 16.34 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.703 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.1 p -58.2 -45.0 88.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -174.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -13.25 62.11 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -74.48 -35.74 63.28 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.154 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.491 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 41.3 p-90 -110.36 -26.7 9.42 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 114.058 1.132 . . . . 0.0 114.058 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -90.81 113.32 25.44 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.316 0.579 . . . . 0.0 111.656 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.66 93.89 4.21 Favored Pre-proline 0 C--N 1.299 -1.627 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.846 174.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 47' ' ' ARG . 97.0 Cg_endo -76.43 -0.09 10.04 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 123.58 2.853 . . . . 0.0 114.334 -172.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -94.93 -1.54 52.35 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.088 0.471 . . . . 0.0 111.752 -173.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.533 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 73.3 mt -94.86 145.88 24.6 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.309 0.576 . . . . 0.0 111.746 -178.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.455 ' HA ' ' NH1' ' A' ' 47' ' ' ARG . 23.1 t -100.74 177.23 5.05 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.1 ttt180 -52.99 -53.4 50.57 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.654 0.782 . . . . 0.0 112.585 -173.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -64.0 -32.47 74.02 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.981 0.419 . . . . 0.0 111.411 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.426 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 15.7 mm-40 -73.03 -34.57 66.42 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.822 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.05 -44.94 83.13 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.414 0.626 . . . . 0.0 109.619 178.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.8 mt -63.93 -36.39 76.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.425 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.19 -36.04 72.49 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.481 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 4.4 mm? -75.78 -47.84 24.19 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.278 174.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.3 mt -66.42 -21.54 66.22 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -174.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -74.25 -5.24 40.89 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.417 0.627 . . . . 0.0 111.47 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -112.57 5.46 17.89 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 35' ' ' LEU . 31.3 mmmt -110.98 145.17 38.88 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.385 0.612 . . . . 0.0 110.992 -177.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -76.74 141.57 68.82 Favored Pre-proline 0 C--N 1.301 -1.531 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.221 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -47.64 118.9 3.28 Favored 'Trans proline' 0 C--N 1.364 1.375 0 C-N-CA 123.938 3.092 . . . . 0.0 113.467 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.24 -30.51 3.47 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.39 151.89 39.62 Favored 'General case' 0 C--O 1.253 1.239 0 CA-C-O 120.717 0.294 . . . . 0.0 110.54 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -147.32 175.9 10.42 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.671 -176.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -149.59 147.37 28.06 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 170.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.491 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 62.4 mt -112.19 122.21 66.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.533 ' HD2' ' O ' ' A' ' 27' ' ' LEU . 28.5 ptt85 -121.09 -173.94 2.72 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -95.22 153.51 17.63 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.5 t -97.39 132.35 43.19 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.95 0.881 . . . . 0.0 111.131 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -85.3 -14.79 45.45 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.803 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.7 m -78.53 -51.74 9.51 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.195 -175.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -128.98 144.22 51.12 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -73.76 132.93 43.14 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.01 31.65 25.55 Favored Glycine 0 N--CA 1.436 -1.367 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.146 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.0 145.97 49.98 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.424 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 87.3 m-85 -113.72 134.47 54.73 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.83 118.02 5.15 Favored Glycine 0 N--CA 1.421 -2.356 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.042 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -96.69 118.29 32.84 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.98 119.75 40.3 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.0 tp -121.37 131.56 54.26 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.473 -176.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -88.81 113.99 24.96 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 175.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 80' ' ' LEU . 26.1 m -102.26 169.52 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.999 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.64 -57.6 4.0 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.87 118.81 2.15 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.134 0.974 . . . . 0.0 110.697 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.613 ' N ' ' HD3' ' A' ' 66' ' ' PRO . 21.5 Cg_endo -99.42 12.31 0.64 Allowed 'Trans proline' 0 CA--C 1.601 3.847 0 C-N-CA 122.84 2.36 . . . . 0.0 118.037 178.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.613 ' HD3' ' N ' ' A' ' 65' ' ' PRO . 2.0 Cg_endo -93.58 164.92 2.31 Favored 'Trans proline' 0 C--N 1.384 2.407 0 CA-C-N 123.051 2.125 . . . . 0.0 111.218 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -74.03 -22.16 17.43 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 121.861 1.707 . . . . 0.0 111.782 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.1 p -134.45 -43.2 0.77 Allowed 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.392 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.437 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 75.84 3.76 3.83 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.026 1.33 . . . . 0.0 112.982 177.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.461 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 34.9 tt0 -86.68 -52.44 0.43 Allowed Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 172.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.461 ' HD3' ' HB3' ' A' ' 70' ' ' GLN . 7.3 Cg_exo -76.02 107.09 2.39 Favored 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 121.317 1.344 . . . . 0.0 108.708 171.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 59.6 t-105 -117.56 135.42 53.97 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.934 -177.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -158.15 81.7 0.85 Allowed 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 114.616 -1.174 . . . . 0.0 108.609 174.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -169.94 -178.55 41.02 Favored Glycine 0 C--N 1.268 -3.208 0 CA-C-N 113.734 -1.575 . . . . 0.0 110.28 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -89.8 115.87 64.95 Favored Pre-proline 0 C--N 1.294 -1.829 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.55 ' O ' ' HG ' ' A' ' 80' ' ' LEU . 47.5 Cg_exo -32.47 -78.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 125.098 3.865 . . . . 0.0 117.048 -172.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -73.31 -30.08 29.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -174.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -71.23 -26.77 63.07 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.83 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.468 ' OE1' ' HA ' ' A' ' 79' ' ' GLN . 4.9 tp60 -88.01 -18.06 29.82 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 121.139 0.495 . . . . 0.0 110.225 177.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 76' ' ' PRO . 91.1 mt -80.99 -12.01 59.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.482 0.658 . . . . 0.0 109.26 174.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.8 t -96.13 118.99 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -103.17 142.32 34.36 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.768 -177.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -123.36 122.08 37.41 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.387 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -126.72 170.09 12.49 Favored 'General case' 0 C--N 1.273 -2.728 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -135.86 135.38 39.73 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 118.767 -1.173 . . . . 0.0 112.119 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.594 ' CG2' ' HB ' ' A' ' 93' ' ' VAL . 59.5 mt -94.24 110.78 24.14 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 CA-C-N 114.014 -1.448 . . . . 0.0 107.408 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -105.57 121.22 43.52 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.831 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.716 ' HB ' HG12 ' A' ' 93' ' ' VAL . 1.4 t -94.95 118.68 32.21 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.691 0.758 . . . . 0.0 110.36 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -106.43 -157.99 21.74 Favored Glycine 0 N--CA 1.427 -1.946 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -66.4 -26.7 47.78 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.964 1.776 . . . . 0.0 110.528 176.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -73.74 -73.34 0.22 Allowed 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.167 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 179.02 -151.22 10.07 Favored Glycine 0 N--CA 1.423 -2.191 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.716 HG12 ' HB ' ' A' ' 88' ' ' THR . 35.7 m -103.71 145.9 12.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 O-C-N 123.739 0.317 . . . . 0.0 110.865 -176.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.75 155.8 30.49 Favored 'General case' 0 C--O 1.259 1.565 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 176.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.58 HG12 HG12 ' A' ' 86' ' ' ILE . 59.4 mt -94.39 114.12 30.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.429 0.633 . . . . 0.0 111.765 -176.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -62.15 120.75 11.5 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.392 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.39 -28.61 2.44 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.61 ' SG ' HG22 ' A' ' 119' ' ' ILE . 49.6 t -112.98 132.1 22.5 Favored Pre-proline 0 N--CA 1.426 -1.656 0 CA-C-N 114.817 -0.691 . . . . 0.0 110.201 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 98' ' ' CYS . 95.4 Cg_endo -99.51 11.38 0.67 Allowed 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 122.628 2.219 . . . . 0.0 112.525 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.0 m -122.81 18.64 10.23 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.82 0.343 . . . . 0.0 111.087 -174.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -113.39 136.73 21.9 Favored Pre-proline 0 C--N 1.31 -1.111 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -174.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -82.33 -179.68 4.83 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.135 2.557 . . . . 0.0 113.292 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -98.93 108.55 21.26 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -76.44 -60.36 2.37 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.291 0.567 . . . . 0.0 110.21 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.609 ' H ' HG22 ' A' ' 93' ' ' VAL . . . 124.37 -66.53 0.52 Allowed Glycine 0 C--N 1.306 -1.131 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 177.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.7 m -93.61 150.62 20.28 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.13 -41.28 94.96 Favored 'General case' 0 C--O 1.216 -0.661 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.354 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 38.6 t -54.94 -31.37 60.39 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.229 0.612 . . . . 0.0 111.028 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.28 -49.28 74.67 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.378 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.452 HD12 ' N ' ' A' ' 111' ' ' VAL . 4.1 pp -75.01 -32.44 61.62 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 120.838 0.351 . . . . 0.0 110.936 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.452 ' N ' HD12 ' A' ' 110' ' ' LEU . 69.7 t -63.09 -44.66 99.63 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.821 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.569 178.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.3 t -73.28 -21.83 60.51 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.006 0.432 . . . . 0.0 111.819 177.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -83.42 -4.64 58.68 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 121.388 0.613 . . . . 0.0 110.085 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 125' ' ' LEU . 6.0 p80 -42.62 -50.4 5.42 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 126.694 1.997 . . . . 0.0 115.893 -173.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.4 t -103.7 4.78 35.74 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 121.438 0.637 . . . . 0.0 109.286 -172.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.5 mt -99.47 -48.54 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.8 m -141.27 86.21 11.38 Favored Pre-proline 0 N--CA 1.437 -1.103 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.459 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.88 89.49 1.13 Allowed 'Trans proline' 0 N--CA 1.44 -1.649 0 C-N-CA 121.681 1.587 . . . . 0.0 108.054 173.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.61 HG22 ' SG ' ' A' ' 98' ' ' CYS . 36.3 mt -90.28 -64.02 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.79 -174.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.4 ' HA ' ' HB2' ' A' ' 98' ' ' CYS . 7.8 t -73.4 -30.25 63.13 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 120.851 0.358 . . . . 0.0 111.073 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.66 127.21 73.65 Favored Pre-proline 0 N--CA 1.435 -1.203 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.417 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -69.23 -24.45 32.1 Favored 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 122.327 2.018 . . . . 0.0 111.457 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.415 ' SG ' ' HB ' ' A' ' 62' ' ' VAL . 83.4 m -114.74 145.73 41.76 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 53.4 m -64.16 111.88 2.77 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.124 0.488 . . . . 0.0 109.937 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 114' ' ' HIS . 27.9 tp -58.21 135.79 57.16 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 125.0 1.32 . . . . 0.0 110.041 -176.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.513 ' HD2' ' OD1' ' A' ' 131' ' ' ASP . 20.3 mmt180 -130.92 134.99 47.26 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.576 HG22 ' H ' ' A' ' 129' ' ' SER . 4.1 mp -80.96 136.15 50.93 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -53.58 -36.84 82.1 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.131 1.887 . . . . 0.0 112.129 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.576 ' H ' HG22 ' A' ' 127' ' ' ILE . 3.9 m -84.08 -33.43 24.39 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.025 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -133.38 124.9 28.0 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -173.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.513 ' OD1' ' HD2' ' A' ' 126' ' ' ARG . 13.8 t70 . . . . . 0 C--N 1.288 -2.075 0 CA-C-N 113.851 -1.522 . . . . 0.0 107.959 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 CA--C 1.504 -0.812 0 CA-C-O 120.895 0.378 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -117.82 117.11 28.41 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -88.91 113.06 24.04 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -66.62 148.55 51.75 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -173.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -79.54 117.24 20.3 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 174.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -61.92 -65.68 0.65 Allowed 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -129.4 -50.47 1.18 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.2 m 55.38 73.64 0.41 Allowed 'General case' 0 C--O 1.245 0.852 0 CA-C-O 122.19 0.995 . . . . 0.0 110.207 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.3 m -77.3 45.57 0.47 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.33 -1.305 . . . . 0.0 112.317 -175.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.49 47.62 3.66 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.0 mt -117.57 127.56 54.09 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.5 t -101.37 126.95 32.85 Favored Pre-proline 0 C--N 1.289 -2.038 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.02 107.25 2.06 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 122.422 2.081 . . . . 0.0 110.835 175.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -88.79 80.41 7.2 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 122.042 0.925 . . . . 0.0 109.653 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.3 52.64 0.53 Allowed Glycine 0 N--CA 1.427 -1.91 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 m -112.62 15.82 19.91 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.181 0.991 . . . . 0.0 108.907 -177.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -97.67 85.63 3.62 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.756 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.3 p -98.7 -0.06 43.61 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.317 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.5 m -45.46 -60.86 1.93 Allowed 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 125.853 1.661 . . . . 0.0 112.805 -173.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.41 ' HE2' ' CE2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -67.48 -12.69 60.9 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -176.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.41 ' CE2' ' HE2' ' A' ' 20' ' ' LYS . 74.6 m-85 -76.99 -23.24 52.29 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.419 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.434 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 31.3 p-90 -121.0 -24.75 5.51 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.506 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 35.8 t80 -95.31 116.79 29.24 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.992 -0.442 . . . . 0.0 110.045 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.488 ' CB ' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -138.04 97.9 9.65 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.097 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.88 21.55 0.37 Allowed 'Trans proline' 0 CA--C 1.552 1.418 0 C-N-CA 123.326 2.684 . . . . 0.0 113.977 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -114.78 -20.44 10.62 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.241 0.543 . . . . 0.0 110.088 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.488 HD23 ' CB ' ' A' ' 24' ' ' LYS . 3.5 mm? -76.75 120.51 22.01 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.668 0.747 . . . . 0.0 111.355 -175.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.0 p -85.27 177.69 7.75 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.57 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -49.7 -55.85 12.34 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.079 0.952 . . . . 0.0 111.622 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -72.78 -32.45 65.6 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.98 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -70.77 -33.53 70.88 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.871 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.98 -42.51 99.86 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.576 0.703 . . . . 0.0 109.13 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 85.0 mt -65.27 -44.01 95.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.465 178.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.48 -28.64 68.5 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.375 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.03 -51.99 10.12 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 57.2 mt -72.84 -25.56 61.16 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -174.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -56.91 -33.8 67.31 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -89.51 -21.29 23.01 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.543 0.687 . . . . 0.0 110.77 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -78.62 164.77 24.36 Favored 'General case' 0 C--O 1.255 1.389 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -172.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.54 137.38 76.79 Favored Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 111.917 -2.401 . . . . 0.0 111.329 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -63.0 107.56 0.65 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.922 1.748 . . . . 0.0 109.342 170.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.46 -17.93 5.52 Favored Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 -175.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.37 154.96 27.4 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 120.644 0.259 . . . . 0.0 110.66 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.485 ' CG ' HD11 ' A' ' 125' ' ' LEU . 5.4 p90 -149.45 177.68 9.49 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.279 -174.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -155.31 147.09 23.26 Favored 'General case' 0 C--O 1.253 1.237 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 169.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 23' ' ' TYR . 63.2 mt -117.81 135.33 58.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.442 HH12 ' HB2' ' A' ' 59' ' ' ALA . 0.1 OUTLIER -144.73 162.45 36.7 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 174.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.07 131.88 48.69 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 173.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.433 ' HB3' ' O ' ' A' ' 52' ' ' PHE . 30.4 t -75.67 118.81 18.9 Favored 'General case' 0 N--CA 1.413 -2.312 0 C-N-CA 119.024 -1.071 . . . . 0.0 109.087 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 27.6 m-70 -77.24 -16.11 59.17 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.87 175.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.0 m -84.11 -46.79 11.58 Favored 'General case' 0 N--CA 1.408 -2.568 0 CA-C-N 114.229 -1.35 . . . . 0.0 109.535 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.433 ' O ' ' HB3' ' A' ' 49' ' ' SER . 89.9 m-85 -127.15 127.97 45.41 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-O 121.35 0.595 . . . . 0.0 111.095 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -83.61 128.03 34.2 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.658 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.22 15.75 52.63 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -177.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.74 160.81 36.99 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -122.4 129.88 52.53 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.95 115.58 4.14 Favored Glycine 0 C--N 1.293 -1.832 0 C-N-CA 119.968 -1.11 . . . . 0.0 111.302 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -93.29 119.56 32.58 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.442 ' HB2' HH12 ' A' ' 47' ' ' ARG . . . -114.53 129.76 56.69 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.42 HD21 ' SG ' ' A' ' 123' ' ' CYS . 58.9 tp -126.85 128.62 46.81 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 123.488 0.493 . . . . 0.0 110.801 -177.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 22.3 tptm -88.36 115.14 25.66 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 176.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.489 HG12 ' SG ' ' A' ' 123' ' ' CYS . 34.1 m -105.82 170.69 2.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.87 -48.48 12.33 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 p -167.29 120.97 0.79 Allowed Pre-proline 0 C--N 1.32 -0.681 0 C-N-CA 125.291 1.436 . . . . 0.0 109.025 178.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.63 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 28.2 Cg_exo -60.57 -46.84 15.65 Favored 'Trans proline' 0 CA--C 1.575 2.567 0 C-N-CA 121.149 1.232 . . . . 0.0 110.993 170.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.63 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 85.1 Cg_endo -77.73 158.66 31.72 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.86 2.374 . . . . 0.0 109.917 173.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -70.03 -54.16 0.22 Allowed 'Trans proline' 0 CA--C 1.551 1.357 0 C-N-CA 121.715 1.61 . . . . 0.0 112.189 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.1 m -104.86 -19.84 13.76 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.837 0.351 . . . . 0.0 110.906 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 66.98 34.7 5.07 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 124.169 0.987 . . . . 0.0 111.274 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -60.68 -44.29 94.78 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.857 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.62 82.39 0.73 Allowed 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 121.11 1.206 . . . . 0.0 111.285 173.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 36.4 t-105 -85.87 136.73 33.18 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.0 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.9 mtmm -127.06 6.66 6.53 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -173.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.03 24.58 44.11 Favored Glycine 0 CA--C 1.489 -1.543 0 N-CA-C 108.554 -1.819 . . . . 0.0 108.554 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -86.21 127.05 63.06 Favored Pre-proline 0 N--CA 1.423 -1.799 0 CA-C-N 113.744 -1.228 . . . . 0.0 111.308 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -96.26 -165.12 0.1 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.7 0 C-N-CA 122.938 2.425 . . . . 0.0 110.867 176.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.463 ' HA ' HD23 ' A' ' 80' ' ' LEU . 9.8 p -56.46 -21.3 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 123.633 0.773 . . . . 0.0 112.405 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -62.56 -33.63 75.33 Favored 'General case' 0 C--O 1.213 -0.819 0 C-N-CA 122.853 0.461 . . . . 0.0 110.909 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.62 -20.34 56.84 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 121.461 0.648 . . . . 0.0 109.819 -178.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 77' ' ' VAL . 3.5 mm? -81.03 -3.08 50.56 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.097 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.9 t -101.66 104.83 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.875 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 174.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -78.85 139.76 38.28 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -120.65 122.44 40.49 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-O 121.872 0.844 . . . . 0.0 111.688 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -131.41 170.74 14.25 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.48 136.82 41.58 Favored 'General case' 0 C--N 1.283 -2.325 0 C-N-CA 119.944 -0.703 . . . . 0.0 111.088 175.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.429 HG12 HG12 ' A' ' 95' ' ' ILE . 74.9 mt -91.43 114.72 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.632 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 178.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.548 ' CD ' ' HE2' ' A' ' 96' ' ' LYS . 30.7 mt-10 -99.75 140.08 34.47 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.737 ' HB ' HG12 ' A' ' 93' ' ' VAL . 1.3 t -116.17 127.46 54.81 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.439 0.638 . . . . 0.0 110.626 175.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.4 -169.97 14.01 Favored Glycine 0 N--CA 1.424 -2.163 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.2 -27.81 31.4 Favored 'Trans proline' 0 CA--C 1.553 1.43 0 C-N-CA 123.425 2.75 . . . . 0.0 114.858 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.48 ' HD2' ' N ' ' A' ' 91' ' ' LYS . 10.7 mptt -80.28 -21.32 42.8 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.073 0.463 . . . . 0.0 111.121 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.28 -149.07 16.88 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.737 HG12 ' HB ' ' A' ' 88' ' ' THR . 31.3 m -104.64 149.08 8.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.41 155.02 19.49 Favored 'General case' 0 C--O 1.251 1.147 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.429 HG12 HG12 ' A' ' 86' ' ' ILE . 71.6 mt -86.94 114.34 25.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.423 0.63 . . . . 0.0 111.311 -176.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.548 ' HE2' ' CD ' ' A' ' 87' ' ' GLU . 19.4 ttmm -64.83 126.93 29.52 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.438 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 110.13 40.05 1.45 Allowed Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 120' ' ' SER . 35.5 t -142.33 132.4 12.44 Favored Pre-proline 0 N--CA 1.432 -1.33 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -178.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -86.8 8.11 4.57 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.602 2.202 . . . . 0.0 112.648 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.6 m -148.4 -148.0 0.24 Allowed 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 80.75 123.93 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.135 0 C-N-CA 124.963 1.305 . . . . 0.0 113.161 174.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.16 171.28 18.6 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.681 2.254 . . . . 0.0 111.74 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -95.59 132.38 40.79 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -108.25 154.68 21.42 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -178.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -95.4 -25.27 14.21 Favored Glycine 0 C--N 1.3 -1.42 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.772 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 11.1 m -122.65 144.62 49.01 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 90.2 mt -62.56 -37.83 87.69 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.196 0.522 . . . . 0.0 109.661 175.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.3 m -54.17 -34.44 60.49 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.593 1.157 . . . . 0.0 111.163 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.9 -39.32 83.62 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.7 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.48 HD12 ' N ' ' A' ' 111' ' ' VAL . 4.0 pp -76.2 -36.98 58.36 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.144 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.48 ' N ' HD12 ' A' ' 110' ' ' LEU . 43.0 t -55.9 -51.79 56.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.727 177.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.4 m -71.94 -26.71 62.39 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.967 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -83.46 -37.85 22.62 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -176.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -72.3 -6.17 41.31 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -174.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.8 m -75.26 -24.35 57.59 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 171.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 65.5 mt -101.61 -50.02 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.426 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.8 m -120.4 97.84 48.75 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.241 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.78 92.11 1.1 Allowed 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.473 2.115 . . . . 0.0 109.565 174.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 23.6 mt -84.97 -67.62 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.28 -174.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.444 ' HB3' ' HB2' ' A' ' 98' ' ' CYS . 4.8 p -77.67 -33.54 53.33 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.88 0.848 . . . . 0.0 110.338 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.418 HD22 HD22 ' A' ' 60' ' ' LEU . 49.6 mt -84.73 140.83 38.06 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.137 -177.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.56 -11.3 15.69 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.863 2.375 . . . . 0.0 113.454 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.489 ' SG ' HG12 ' A' ' 62' ' ' VAL . 22.6 p -136.05 162.21 33.54 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 59.6 m -69.33 138.38 53.71 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 123.485 0.49 . . . . 0.0 110.021 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.485 HD11 ' CG ' ' A' ' 44' ' ' PHE . 19.6 tp -77.72 121.34 23.89 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.744 -175.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 131' ' ' ASP . 7.7 tpt180 -95.76 114.47 26.21 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 123.51 0.724 . . . . 0.0 110.577 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 66.8 mt -81.15 121.97 81.05 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 175.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.07 -41.28 65.46 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 122.646 2.231 . . . . 0.0 113.681 -176.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.7 t -86.42 -5.62 59.12 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -175.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -112.31 80.02 1.29 Allowed 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 118.903 -1.119 . . . . 0.0 111.632 -175.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.488 ' HB3' ' CZ ' ' A' ' 126' ' ' ARG . 32.0 t70 . . . . . 0 C--O 1.249 1.052 0 C-N-CA 127.063 2.145 . . . . 0.0 108.021 174.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.465 0.299 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -138.99 101.56 4.32 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.712 0.768 . . . . 0.0 111.067 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -105.88 -66.12 1.02 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -159.86 133.2 6.96 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -157.54 98.57 1.68 Allowed 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.423 0.63 . . . . 0.0 109.326 175.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -81.84 105.37 12.91 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.491 0.662 . . . . 0.0 109.614 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -146.61 92.5 2.16 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -177.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.7 m -66.16 153.84 41.32 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.127 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.1 m 70.78 -62.27 0.45 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.87 1.268 . . . . 0.0 111.805 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.8 83.84 1.51 Allowed Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 68.4 tp -73.99 -36.09 64.5 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.9 m -89.29 126.63 57.99 Favored Pre-proline 0 N--CA 1.429 -1.49 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.536 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -75.75 79.14 2.91 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.016 1.81 . . . . 0.0 109.701 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -80.3 91.87 5.69 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.548 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -134.93 23.51 3.52 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.5 m 56.42 58.05 4.49 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 123.896 0.878 . . . . 0.0 111.305 -176.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -74.2 116.28 14.67 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 177.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.0 p -92.78 -15.64 26.34 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -173.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.8 m -73.59 -33.06 64.44 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.609 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -61.46 -18.26 58.17 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -79.21 -26.91 42.53 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.539 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 21.9 p-90 -131.91 -9.49 3.48 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -175.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -98.92 113.38 25.5 Favored 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.655 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.07 91.1 9.03 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.983 175.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.94 -17.08 46.4 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.904 2.403 . . . . 0.0 113.891 -175.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -71.86 -18.89 62.03 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.037 0.446 . . . . 0.0 111.294 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.9 tp -80.54 139.17 36.47 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.116 0.484 . . . . 0.0 110.61 -176.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.575 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 15.5 m -91.95 168.2 11.58 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.046 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -57.12 -51.68 68.31 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.067 0.947 . . . . 0.0 113.39 -175.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.87 -39.8 95.56 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 121.561 0.696 . . . . 0.0 110.985 -176.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.575 ' OE1' ' HB2' ' A' ' 28' ' ' SER . 21.1 mp0 -67.03 -40.12 87.13 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.862 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.93 -41.77 75.1 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 123.197 0.599 . . . . 0.0 111.627 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 60.1 mt -65.2 -35.67 75.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.867 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.1 -33.04 72.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.778 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.91 -40.52 65.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.043 0.449 . . . . 0.0 110.647 177.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.465 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 75.6 mt -76.16 -27.1 56.85 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -175.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -77.22 -3.37 39.32 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.551 0.691 . . . . 0.0 109.934 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -106.19 -5.29 19.38 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.747 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.552 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -119.74 170.2 9.43 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.111 0.482 . . . . 0.0 112.177 -175.244 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -85.85 160.31 53.0 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.294 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 61' ' ' LYS . 10.8 Cg_endo -56.11 127.47 26.17 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.775 2.316 . . . . 0.0 111.265 173.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.41 -24.01 8.28 Favored Glycine 0 N--CA 1.434 -1.446 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.56 146.61 40.32 Favored 'General case' 0 C--O 1.253 1.239 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -151.87 177.52 10.34 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 121.019 0.438 . . . . 0.0 110.119 -176.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -162.05 150.04 14.68 Favored 'General case' 0 C--O 1.251 1.152 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 173.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.539 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 68.6 mt -123.93 134.16 67.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.458 HH22 ' CD2' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -133.59 173.62 11.31 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.241 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -80.06 146.5 31.9 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.1 t -99.56 139.94 34.47 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.528 0.68 . . . . 0.0 111.682 -176.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -99.59 -8.5 24.41 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.476 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.5 t -76.38 -40.87 49.86 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -129.9 140.92 50.88 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -83.57 124.63 30.97 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.989 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.42 31.66 18.56 Favored Glycine 0 N--CA 1.435 -1.385 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -177.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.75 157.98 45.31 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.971 -0.615 . . . . 0.0 109.602 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -124.65 161.06 27.1 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.34 123.56 5.55 Favored Glycine 0 C--N 1.288 -2.091 0 C-N-CA 119.908 -1.139 . . . . 0.0 111.036 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 84' ' ' PHE . 2.2 tm? -101.68 130.51 48.06 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 123.947 0.899 . . . . 0.0 108.74 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.41 ' HB2' HH12 ' A' ' 47' ' ' ARG . . . -119.28 125.34 48.87 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 175.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.5 tp -119.88 131.3 55.21 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 123.686 0.616 . . . . 0.0 110.535 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 41' ' ' PRO . 22.3 tptm -88.5 116.05 26.45 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 80' ' ' LEU . 18.7 m -109.94 171.77 2.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.79 -60.07 2.54 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.4 p -150.81 138.38 12.1 Favored Pre-proline 0 C--N 1.308 -1.207 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.247 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.678 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 24.4 Cg_exo -61.46 -43.55 27.15 Favored 'Trans proline' 0 CA--C 1.577 2.67 0 C-N-CA 121.969 1.779 . . . . 0.0 111.854 171.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.678 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 56.4 Cg_endo -68.25 143.16 57.71 Favored 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 122.547 2.164 . . . . 0.0 110.105 170.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.88 -32.81 35.26 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.547 2.165 . . . . 0.0 112.644 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.9 t -114.27 -42.74 3.29 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.079 0.466 . . . . 0.0 110.096 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.593 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 74.56 -3.04 2.66 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.972 1.309 . . . . 0.0 112.134 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.461 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 8.6 tt0 -59.72 -50.09 88.57 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 171.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.461 ' HD3' ' HB3' ' A' ' 70' ' ' GLN . 16.9 Cg_exo -70.56 101.23 1.0 Allowed 'Trans proline' 0 C--N 1.374 1.88 0 N-CA-C 106.615 -2.11 . . . . 0.0 106.615 164.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 46.3 t-105 -109.87 150.11 28.89 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.376 -172.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -114.29 -63.0 1.51 Allowed 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.98 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 158.3 67.0 0.01 OUTLIER Glycine 0 CA--C 1.471 -2.718 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -118.94 121.51 30.44 Favored Pre-proline 0 C--N 1.285 -2.238 0 CA-C-N 114.695 -0.753 . . . . 0.0 109.971 -169.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -85.16 178.56 4.59 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.304 2.003 . . . . 0.0 112.129 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.0 p -57.31 -30.12 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 123.353 0.661 . . . . 0.0 112.681 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.3 mp0 -68.84 -19.74 64.27 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.975 -0.453 . . . . 0.0 111.46 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.684 HE21 ' HA ' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -84.69 -19.74 32.31 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.487 ' O ' HG22 ' A' ' 62' ' ' VAL . 46.7 mt -74.26 -17.47 60.87 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.8 t -87.74 112.58 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 173.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -98.55 131.5 44.72 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -176.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.458 ' CD2' HH22 ' A' ' 47' ' ' ARG . 36.0 m80 -105.07 124.5 49.64 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 121.402 0.62 . . . . 0.0 112.02 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.417 ' O ' ' HB3' ' A' ' 58' ' ' LEU . 93.9 m-85 -131.3 126.73 36.11 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 177.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.9 pp -99.1 144.49 28.18 Favored 'General case' 0 C--N 1.285 -2.228 0 C-N-CA 118.443 -1.303 . . . . 0.0 111.132 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 62.5 mt -105.82 135.23 44.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.367 -174.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.452 ' OE1' ' HA ' ' A' ' 96' ' ' LYS . 30.6 mt-10 -116.55 142.75 46.47 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -176.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.428 ' HB ' HG23 ' A' ' 93' ' ' VAL . 4.7 t -131.39 139.51 49.47 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 175.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.22 -161.04 11.56 Favored Glycine 0 N--CA 1.433 -1.502 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.29 -17.66 61.14 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.038 2.492 . . . . 0.0 113.88 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.419 ' HD2' ' H ' ' A' ' 91' ' ' LYS . 9.7 mptt -79.72 -42.04 25.48 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 122.076 0.941 . . . . 0.0 109.217 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 146.71 -154.42 25.96 Favored Glycine 0 N--CA 1.422 -2.296 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.428 HG23 ' HB ' ' A' ' 88' ' ' THR . 12.4 p -114.02 137.82 45.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.98 171.93 19.13 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.503 ' HB ' ' HB3' ' A' ' 98' ' ' CYS . 58.7 mt -90.54 143.85 10.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 17.0 tppt? -48.02 -45.63 32.11 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.576 1.151 . . . . 0.0 112.482 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -120.44 62.15 0.5 Allowed Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.812 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.503 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 19.7 p -98.7 127.8 34.53 Favored Pre-proline 0 C--N 1.299 -1.588 0 CA-C-O 120.931 0.396 . . . . 0.0 111.429 178.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -90.04 32.93 0.34 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.242 2.628 . . . . 0.0 110.13 174.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.1 t -92.69 -147.65 0.23 Allowed 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.538 ' H ' ' HD2' ' A' ' 102' ' ' PRO . 17.9 tp10 -152.62 -55.52 0.02 OUTLIER Pre-proline 0 C--N 1.289 -2.05 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.733 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.538 ' HD2' ' H ' ' A' ' 101' ' ' GLU . 88.5 Cg_endo -77.81 158.72 31.41 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 121.384 1.39 . . . . 0.0 113.155 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -100.21 157.13 16.81 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -114.02 165.28 12.78 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.7 -47.04 3.54 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.304 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.7 m -121.87 159.25 27.19 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 111' ' ' VAL . 95.2 mt -57.22 -45.73 83.57 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 122.815 0.446 . . . . 0.0 111.757 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 72.4 m -54.26 -29.36 46.61 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.73 -48.83 67.93 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.494 0.187 . . . . 0.0 110.601 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.88 -26.15 63.11 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.158 0.504 . . . . 0.0 110.642 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 107' ' ' LEU . 73.5 t -67.5 -51.69 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.299 176.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 28.6 t -68.25 -27.84 66.69 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.221 0.534 . . . . 0.0 110.467 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.505 ' NE2' ' HB2' ' A' ' 117' ' ' SER . 0.6 OUTLIER -63.28 -50.48 69.96 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.427 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -77.19 -0.37 24.84 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -176.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 7.1 m -75.55 -37.22 60.15 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.486 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 73.3 mt -101.31 -53.94 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.083 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.505 ' HB2' ' NE2' ' A' ' 113' ' ' GLN . 19.9 m -107.94 97.6 21.84 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 116' ' ' ILE . 5.8 Cg_exo -78.64 84.53 2.01 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 122.412 2.075 . . . . 0.0 110.388 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 68.8 mt -80.96 -54.67 9.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.556 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.7 m -92.39 -15.6 27.03 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.453 0.644 . . . . 0.0 110.524 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 71.7 mt -112.6 136.88 21.53 Favored Pre-proline 0 N--CA 1.428 -1.541 0 CA-C-N 115.435 -0.802 . . . . 0.0 108.907 -175.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.476 ' HG2' HG11 ' A' ' 62' ' ' VAL . 71.7 Cg_endo -76.64 -5.84 16.41 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.537 2.158 . . . . 0.0 112.677 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 50.8 t -128.86 149.59 50.69 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 21.2 m -71.33 133.25 45.87 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 16.6 tp -77.77 138.02 38.77 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.247 -175.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 126' ' ' ARG . 23.3 mmt180 -122.41 118.2 27.82 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.533 0.683 . . . . 0.0 111.95 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.612 HG22 ' H ' ' A' ' 129' ' ' SER . 2.7 mp -91.46 135.31 28.13 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -176.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.01 -27.47 79.48 Favored 'Trans proline' 0 N--CA 1.48 0.731 0 C-N-CA 122.053 1.835 . . . . 0.0 110.926 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.612 ' H ' HG22 ' A' ' 127' ' ' ILE . 15.7 t -81.03 -4.92 56.8 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.839 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.447 ' HD3' ' C ' ' A' ' 130' ' ' LYS . 11.4 tmtt? -106.15 119.62 39.69 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 . . . . . 0 C--N 1.296 -1.755 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 176.683 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.499 -1.012 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -125.75 122.58 36.66 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 176.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 72.82 149.35 0.1 Allowed 'General case' 0 C--O 1.249 1.064 0 C-N-CA 124.957 1.303 . . . . 0.0 110.547 -176.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -75.32 148.7 39.09 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 174.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.3 p80 -68.79 120.03 14.09 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 119.522 -0.871 . . . . 0.0 108.992 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -81.29 -20.02 41.72 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 31.1 t60 70.9 113.69 0.05 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.066 1.746 . . . . 0.0 110.713 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.3 m 71.51 103.16 0.07 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.756 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.2 m -65.16 -48.84 72.09 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.413 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.0 61.91 0.65 Allowed Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 178.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.4 mt 73.8 -14.83 0.62 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 125.272 1.429 . . . . 0.0 112.294 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.9 m -132.13 147.52 66.13 Favored Pre-proline 0 C--N 1.305 -1.353 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 173.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -52.01 -62.92 0.3 Allowed 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.79 2.327 . . . . 0.0 110.959 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 45.1 mtm180 -127.09 -74.52 0.59 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 170.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -146.2 -18.63 0.14 Allowed Glycine 0 N--CA 1.436 -1.342 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.288 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . 0.287 10.3 p 56.78 69.02 0.78 Allowed 'General case' 0 C--O 1.245 0.852 0 C-N-CA 124.375 1.07 . . . . 0.0 111.085 -175.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 11.5 m-20 -73.37 105.23 4.66 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-N 113.459 -1.701 . . . . 0.0 110.043 -178.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.9 p -86.38 -20.93 27.52 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-O 121.881 0.848 . . . . 0.0 110.788 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.432 ' HA ' ' CE2' ' A' ' 22' ' ' TRP . 14.8 m -68.31 -30.15 69.07 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 114.22 -1.354 . . . . 0.0 111.785 -177.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 17' ' ' ASP . 65.9 pttt -61.03 -22.29 64.41 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.545 ' CG ' ' HA ' ' A' ' 129' ' ' SER . 97.7 m-85 -76.71 -28.56 55.89 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.392 -177.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.432 ' CE2' ' HA ' ' A' ' 19' ' ' SER . 26.0 p-90 -116.54 -18.07 10.46 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -93.55 119.76 33.0 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.909 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.57 100.14 3.14 Favored Pre-proline 0 C--N 1.308 -1.234 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.246 173.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.484 ' HA ' ' HB2' ' A' ' 47' ' ' ARG . 98.1 Cg_endo -79.72 -4.23 13.35 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.952 2.435 . . . . 0.0 113.471 -173.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -92.63 -12.11 32.47 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.014 -177.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.521 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 17.5 tp -86.47 124.02 32.33 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.0 m -75.9 173.24 11.44 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -173.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.4 tpp180 -57.84 -53.67 55.62 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.726 0.811 . . . . 0.0 110.935 -175.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -67.31 -30.55 70.43 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.278 -177.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -76.32 -35.9 58.55 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.276 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.93 97.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.595 0.712 . . . . 0.0 109.712 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 82.8 mt -66.71 -43.31 90.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.465 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.5 -30.9 70.0 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.501 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.33 -44.77 43.46 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.794 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.49 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 65.0 mt -74.3 -25.14 59.4 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -177.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -71.78 -19.02 62.07 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 121.665 -0.647 . . . . 0.0 110.285 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -89.21 -10.16 48.1 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.601 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.671 ' HE2' ' HA ' ' A' ' 39' ' ' LYS . 3.8 mmpt? -108.68 164.78 12.07 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -176.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.0 151.71 86.34 Favored Pre-proline 0 C--N 1.309 -1.171 0 CA-C-N 112.667 -2.06 . . . . 0.0 108.863 -175.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -61.04 131.37 36.58 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.636 1.557 . . . . 0.0 109.529 173.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.91 -13.2 31.98 Favored Glycine 0 C--N 1.302 -1.351 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.3 151.21 31.22 Favored 'General case' 0 C--O 1.246 0.898 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -154.73 164.72 38.37 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -175.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -152.31 157.12 40.9 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 172.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.402 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 57.6 mt -127.11 132.1 70.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.521 ' HD2' ' O ' ' A' ' 27' ' ' LEU . 7.2 ptm180 -127.87 153.77 46.25 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 175.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -60.07 127.41 31.74 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.3 t -77.51 119.18 20.74 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -86.87 -20.9 26.77 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 m -61.24 -49.93 75.13 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 112.883 -1.962 . . . . 0.0 110.237 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -125.55 133.27 52.37 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -82.73 121.93 27.52 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.785 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.86 23.67 14.89 Favored Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.23 152.1 51.64 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 121.147 0.499 . . . . 0.0 110.035 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -120.58 136.17 54.88 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.73 112.13 4.34 Favored Glycine 0 C--N 1.284 -2.309 0 C-N-CA 120.039 -1.077 . . . . 0.0 111.005 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 44.7 tp -87.05 130.42 34.49 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -113.31 119.49 37.86 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 176.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.4 tp -115.68 130.17 56.75 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 123.65 0.594 . . . . 0.0 110.603 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.49 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 22.6 tptm -88.71 115.07 25.98 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.6 m -105.4 171.33 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 175.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.86 -54.39 10.24 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.6 p -160.22 142.98 9.91 Favored Pre-proline 0 C--N 1.319 -0.722 0 C-N-CA 124.753 1.221 . . . . 0.0 108.112 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.67 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 24.1 Cg_exo -62.57 -49.48 5.63 Favored 'Trans proline' 0 CA--C 1.576 2.579 0 C-N-CA 121.613 1.542 . . . . 0.0 111.386 169.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.67 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 69.3 Cg_endo -68.2 151.67 76.68 Favored 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 122.813 2.342 . . . . 0.0 109.866 173.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -59.09 -48.75 13.01 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.396 2.064 . . . . 0.0 112.617 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.6 p -118.57 -22.34 7.56 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.663 -177.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.429 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 67.42 34.77 4.56 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 124.056 0.943 . . . . 0.0 109.813 -177.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.426 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 64.5 tt0 -59.67 -51.18 82.8 Favored Pre-proline 0 CA--C 1.553 1.084 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.496 177.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.426 ' HD3' ' HB3' ' A' ' 70' ' ' GLN . 4.4 Cg_endo -83.24 114.4 2.17 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 121.156 1.238 . . . . 0.0 110.025 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 38.7 t-105 -125.68 143.08 51.19 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 120.983 0.42 . . . . 0.0 110.215 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -127.54 -61.25 1.14 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 175.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -178.49 65.88 0.08 OUTLIER Glycine 0 CA--C 1.486 -1.758 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 177.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -82.32 130.36 59.78 Favored Pre-proline 0 C--N 1.297 -1.685 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -175.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.57 159.54 32.05 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.256 1.97 . . . . 0.0 113.096 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.6 p -66.22 -14.8 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 121.828 0.823 . . . . 0.0 110.392 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -68.73 -13.49 62.41 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.89 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.434 ' HB3' ' HG2' ' A' ' 65' ' ' PRO . 81.9 mm-40 -89.44 -25.27 21.58 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 121.04 0.447 . . . . 0.0 110.305 176.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.447 HD23 ' HD3' ' A' ' 65' ' ' PRO . 69.3 mt -74.92 -22.66 58.48 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.793 0.806 . . . . 0.0 109.156 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.434 HG13 HD12 ' A' ' 36' ' ' LEU . 98.1 t -100.4 127.36 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 174.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.499 ' NE ' ' HA ' ' A' ' 82' ' ' ARG . 3.5 mmp_? -107.32 139.88 41.11 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.941 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -116.1 122.71 45.94 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.248 0.547 . . . . 0.0 110.522 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -129.3 128.27 42.84 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.406 ' H ' HD23 ' A' ' 85' ' ' LEU . 0.9 OUTLIER -96.37 138.28 34.2 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 118.901 -1.12 . . . . 0.0 111.017 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.7 mt -102.56 119.12 50.47 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.079 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -101.64 143.88 31.05 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -176.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.475 ' HB ' HG23 ' A' ' 93' ' ' VAL . 4.2 t -127.69 120.28 27.67 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-O 121.569 0.7 . . . . 0.0 110.229 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -140.67 -154.84 6.33 Favored Glycine 0 N--CA 1.435 -1.433 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.25 -15.82 28.34 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.118 1.878 . . . . 0.0 111.029 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -72.71 -27.89 62.33 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.415 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 122.83 -153.89 16.99 Favored Glycine 0 N--CA 1.426 -2.025 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -175.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.475 HG23 ' HB ' ' A' ' 88' ' ' THR . 13.2 p -118.27 132.56 67.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.32 157.72 36.19 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.109 -178.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 98' ' ' CYS . 85.6 mt -72.42 140.55 17.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -78.85 128.72 33.72 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 108.69 -54.4 0.55 Allowed Glycine 0 N--CA 1.437 -1.237 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.471 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 49.7 t -139.88 121.92 9.89 Favored Pre-proline 0 N--CA 1.414 -2.273 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 176.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -73.09 -53.7 0.13 Allowed 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 121.741 1.628 . . . . 0.0 110.535 -177.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.2 t 156.21 -83.99 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 129.004 2.922 . . . . 0.0 103.263 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.652 ' HB2' ' HD3' ' A' ' 102' ' ' PRO . 45.7 mt-10 -144.5 -59.55 0.02 OUTLIER Pre-proline 0 N--CA 1.435 -1.202 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 173.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.652 ' HD3' ' HB2' ' A' ' 101' ' ' GLU . 16.6 Cg_endo -101.29 -172.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 121.345 1.363 . . . . 0.0 110.457 171.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -105.97 125.65 51.25 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 173.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.491 ' CD1' ' HB3' ' A' ' 110' ' ' LEU . 97.2 m-85 -84.59 172.64 11.43 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -172.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -101.4 -23.98 9.18 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.218 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.2 m -145.98 160.27 42.09 Favored 'General case' 0 C--O 1.247 0.954 0 O-C-N 122.289 -0.536 . . . . 0.0 110.658 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.92 -48.03 82.26 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 123.356 0.662 . . . . 0.0 112.589 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 m -54.61 -31.95 57.99 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.005 0.522 . . . . 0.0 112.02 -175.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.612 ' O ' ' HG2' ' A' ' 113' ' ' GLN . . . -63.8 -51.71 63.55 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.426 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.491 ' HB3' ' CD1' ' A' ' 104' ' ' PHE . 4.3 pp -70.2 -27.67 64.68 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.711 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.77 -53.22 44.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.742 178.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.1 t -64.35 -29.59 70.65 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.566 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.612 ' HG2' ' O ' ' A' ' 109' ' ' ALA . 81.3 mm-40 -68.01 -33.89 75.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.778 0.323 . . . . 0.0 110.905 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -82.1 -0.02 42.73 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 26.0 m -85.45 -21.73 28.6 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 172.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 67.6 mt -106.14 -49.1 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.653 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.2 m -120.43 102.12 45.73 Favored Pre-proline 0 C--N 1.302 -1.486 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.429 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.33 84.82 1.64 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.351 2.034 . . . . 0.0 109.942 175.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 72.5 mt -87.79 -67.53 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.935 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.2 m -85.03 -11.25 55.8 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.435 0.636 . . . . 0.0 110.936 -176.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 76.2 mt -120.16 137.89 26.48 Favored Pre-proline 0 N--CA 1.429 -1.479 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.493 -175.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -64.48 -34.03 54.98 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.621 2.214 . . . . 0.0 112.341 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 66.2 m -111.61 157.16 20.73 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 9.9 p -81.53 143.59 31.92 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 72.0 mt -78.01 119.12 21.0 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 123.109 0.256 . . . . 0.0 111.612 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -94.97 105.78 17.72 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 175.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.509 HG22 ' H ' ' A' ' 129' ' ' SER . 50.9 mt -78.0 121.87 84.65 Favored Pre-proline 0 C--N 1.301 -1.533 0 CA-C-N 115.305 -0.862 . . . . 0.0 112.063 -171.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -84.81 4.94 6.54 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 123.471 2.781 . . . . 0.0 112.513 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.545 ' HA ' ' CG ' ' A' ' 21' ' ' PHE . 13.9 m -72.69 85.65 1.2 Allowed 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.172 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -77.22 -166.53 0.74 Allowed 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 112.071 -2.331 . . . . 0.0 111.365 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.7 t70 . . . . . 0 C--N 1.289 -2.022 0 CA-C-N 114.172 -1.377 . . . . 0.0 107.657 179.866 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 ttm . . . . . 0 C--O 1.244 0.791 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.409 ' HD2' ' H ' ' A' ' 4' ' ' HIS . 9.5 t60 -96.48 131.18 43.34 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 104.443 -2.428 . . . . 0.0 104.443 174.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 0.262 39.4 m-70 -72.31 -21.19 61.37 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -173.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.409 ' H ' ' HD2' ' A' ' 2' ' ' HIS . 56.0 m80 -84.99 89.92 7.71 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 103.83 -2.656 . . . . 0.0 103.83 164.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.432 ' HD1' ' CD2' ' A' ' 7' ' ' HIS . 9.7 t-80 -68.49 121.43 16.34 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.88 0.848 . . . . 0.0 112.738 -166.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -78.31 91.99 4.48 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.734 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.432 ' CD2' ' HD1' ' A' ' 5' ' ' HIS . 58.8 m80 -79.53 -83.56 0.09 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.681 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t 51.86 -102.98 0.14 Allowed 'General case' 0 C--O 1.253 1.284 0 O-C-N 124.303 1.002 . . . . 0.0 109.721 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.9 m 42.88 -148.62 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.466 1.107 . . . . 0.0 112.208 174.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.01 40.83 2.45 Favored Glycine 0 N--CA 1.427 -1.938 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 174.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.1 tt -95.91 -50.08 5.03 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.589 ' HB ' ' HD3' ' A' ' 13' ' ' PRO . 93.4 t -68.02 -58.89 7.12 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.47 176.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.589 ' HD3' ' HB ' ' A' ' 12' ' ' VAL . 23.9 Cg_endo -86.08 105.47 0.78 Allowed 'Trans proline' 0 C--N 1.371 1.715 0 N-CA-C 106.756 -2.055 . . . . 0.0 106.756 167.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -60.79 100.14 0.1 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -168.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -123.18 10.84 8.71 Favored Glycine 0 C--N 1.315 -0.627 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.8 p -106.15 22.92 14.9 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.517 -0.842 . . . . 0.0 110.79 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -55.71 106.85 0.28 Allowed 'General case' 0 N--CA 1.426 -1.673 0 C-N-CA 125.568 1.547 . . . . 0.0 110.982 -175.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.417 ' HA ' ' CE1' ' A' ' 21' ' ' PHE . 26.8 p 63.73 11.99 6.28 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 126.038 1.735 . . . . 0.0 112.977 175.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.2 m -101.11 -37.81 8.42 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.279 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -13.09 58.05 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.417 ' CE1' ' HA ' ' A' ' 18' ' ' THR . 96.9 m-85 -64.0 -50.79 67.14 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.232 0.539 . . . . 0.0 110.18 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.408 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 46.5 p-90 -109.89 -19.03 13.26 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -175.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -95.94 113.79 25.45 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.436 0.636 . . . . 0.0 111.61 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.81 94.55 5.43 Favored Pre-proline 0 C--N 1.303 -1.427 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.437 173.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -78.16 2.95 7.5 Favored 'Trans proline' 0 C--O 1.223 -0.24 0 C-N-CA 123.447 2.765 . . . . 0.0 115.23 -171.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -97.21 -3.22 41.25 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.066 -0.653 . . . . 0.0 111.885 -177.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.413 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 76.2 mt -91.42 134.03 34.97 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 120.946 0.403 . . . . 0.0 110.168 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.0 t -90.66 177.83 6.24 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.272 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -48.31 -57.48 5.94 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.863 1.265 . . . . 0.0 111.162 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.63 -32.03 73.38 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.829 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -75.55 -37.3 60.09 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.085 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.13 -42.63 95.21 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.603 0.716 . . . . 0.0 109.751 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 78.7 mt -66.57 -40.85 87.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.365 177.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.76 -27.32 67.88 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.522 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.4 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 4.5 mm? -81.29 -53.1 6.63 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 172.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.489 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 52.7 mt -61.89 -24.5 66.98 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -174.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -57.23 -35.53 69.81 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -102.22 6.66 40.76 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.637 0.732 . . . . 0.0 110.546 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 35' ' ' LEU . 75.6 mmtt -94.4 156.63 16.4 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.988 177.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.72 149.16 56.41 Favored Pre-proline 0 C--N 1.296 -1.757 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.6 -176.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 61' ' ' LYS . 78.3 Cg_exo -53.34 118.94 5.39 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.634 2.223 . . . . 0.0 111.098 175.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.94 -22.18 6.85 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -176.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.51 147.05 36.01 Favored 'General case' 0 C--O 1.247 0.926 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.451 ' CD1' HD22 ' A' ' 125' ' ' LEU . 33.0 p90 -150.6 165.59 32.88 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -175.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -151.72 150.9 30.72 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.408 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 57.7 mt -116.26 127.14 73.95 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.413 ' HD2' ' O ' ' A' ' 27' ' ' LEU . 50.1 ptt85 -125.44 170.98 10.86 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.92 -176.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -88.63 136.78 32.82 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 176.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.3 m -116.8 123.52 47.32 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 121.411 0.624 . . . . 0.0 112.345 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -84.88 80.51 9.25 Favored 'General case' 0 CA--C 1.487 -1.454 0 CA-C-O 122.304 1.05 . . . . 0.0 108.316 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.3 t -142.28 -62.24 0.44 Allowed 'General case' 0 C--N 1.268 -2.966 0 CA-C-N 113.128 -1.851 . . . . 0.0 107.271 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -126.83 161.77 27.43 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -78.51 121.12 24.17 Favored 'General case' 0 C--O 1.254 1.339 0 CA-C-O 121.182 0.515 . . . . 0.0 110.827 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.7 46.59 9.53 Favored Glycine 0 N--CA 1.437 -1.297 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.68 116.31 22.17 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 121.222 0.534 . . . . 0.0 109.738 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -103.12 118.29 36.47 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.39 122.47 6.48 Favored Glycine 0 C--N 1.277 -2.733 0 C-N-CA 119.839 -1.172 . . . . 0.0 111.239 -177.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 31.7 tp -93.94 124.55 38.02 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.64 121.32 44.76 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 60.3 tp -116.88 126.46 53.04 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 123.039 0.536 . . . . 0.0 110.501 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 21.9 tptm -89.0 115.68 26.74 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.7 m -110.11 170.36 3.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.58 -59.56 3.26 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.6 p -157.66 140.36 10.66 Favored Pre-proline 0 C--N 1.311 -1.071 0 C-N-CA 124.396 1.078 . . . . 0.0 108.204 177.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.647 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 31.3 Cg_exo -59.75 -44.14 33.27 Favored 'Trans proline' 0 CA--C 1.573 2.448 0 C-N-CA 121.999 1.799 . . . . 0.0 111.937 173.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.647 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 78.3 Cg_endo -70.89 154.17 63.4 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.402 2.068 . . . . 0.0 109.02 169.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.42 -47.56 1.0 Allowed 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 121.98 1.787 . . . . 0.0 112.11 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.4 p -103.06 -43.92 5.36 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.004 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.546 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 67.89 23.12 8.46 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.524 1.13 . . . . 0.0 110.602 -177.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -65.25 -47.16 71.73 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.42 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -57.99 120.82 8.97 Favored 'Trans proline' 0 C--N 1.376 1.992 0 N-CA-C 106.436 -2.179 . . . . 0.0 106.436 165.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -34.71 127.74 0.48 Allowed 'General case' 0 C--O 1.243 0.742 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -166.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -139.31 73.49 1.43 Allowed 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 113.899 -1.5 . . . . 0.0 108.88 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.96 48.06 1.0 Allowed Glycine 0 C--N 1.289 -2.047 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 175.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -98.8 146.62 31.96 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -176.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -50.24 157.43 3.07 Favored 'Trans proline' 0 C--O 1.246 0.919 0 C-N-CA 123.527 2.818 . . . . 0.0 114.011 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.5 p -61.94 -11.65 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.851 -178.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -62.03 -27.64 69.02 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 122.833 0.453 . . . . 0.0 110.687 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.47 ' HG2' ' HG2' ' A' ' 65' ' ' PRO . 7.7 tt0 -79.1 -33.59 44.27 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.019 0.438 . . . . 0.0 109.904 177.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.8 mt -72.15 -20.11 61.66 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.468 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 81.7 t -94.12 118.96 41.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 173.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -99.3 129.06 45.49 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 -178.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -106.43 122.92 47.25 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-O 121.28 0.562 . . . . 0.0 111.089 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -130.08 131.11 45.63 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 176.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.2 pp -102.99 140.6 37.05 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 118.32 -1.352 . . . . 0.0 111.584 -175.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.545 HG12 HG12 ' A' ' 95' ' ' ILE . 63.8 mt -102.18 126.1 56.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.587 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.524 ' OE2' ' HE2' ' A' ' 96' ' ' LYS . 38.5 mt-10 -103.53 146.02 29.15 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 92' ' ' GLY . 4.6 t -130.27 128.73 42.17 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 170.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.77 -137.22 2.22 Favored Glycine 0 N--CA 1.427 -1.95 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.829 -177.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.44 1.93 7.4 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.302 2.668 . . . . 0.0 113.721 -175.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -112.34 -20.6 11.76 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.722 0.772 . . . . 0.0 111.714 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 121.98 -154.26 16.76 Favored Glycine 0 CA--C 1.485 -1.819 0 N-CA-C 108.021 -2.032 . . . . 0.0 108.021 -177.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.5 p -107.92 127.1 64.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.59 ' HG2' ' CD2' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -158.02 151.54 23.52 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -172.713 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.545 HG12 HG12 ' A' ' 86' ' ' ILE . 60.3 mt -83.35 133.39 29.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.85 -177.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.524 ' HE2' ' OE2' ' A' ' 87' ' ' GLU . 18.2 ttmm -90.38 140.79 29.37 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.039 176.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.99 3.29 24.83 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -177.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 52.7 t -143.04 140.93 18.5 Favored Pre-proline 0 N--CA 1.422 -1.836 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 98' ' ' CYS . 19.4 Cg_endo -99.5 -2.49 0.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.539 2.159 . . . . 0.0 111.526 174.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.2 m -100.37 -10.28 21.38 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.396 -174.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 8.1 tp10 -74.41 127.16 88.04 Favored Pre-proline 0 N--CA 1.426 -1.651 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -174.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 101' ' ' GLU . 6.1 Cg_exo -73.75 -177.4 3.11 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.376 2.051 . . . . 0.0 112.051 177.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.59 ' CD2' ' HG2' ' A' ' 94' ' ' LYS . 83.6 m-85 -110.88 119.1 37.96 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -106.14 174.49 5.86 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.645 -176.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -97.91 -39.87 3.71 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.913 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 51.1 m -128.45 162.17 27.8 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.73 -37.35 87.3 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 120.9 0.381 . . . . 0.0 110.271 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.0 m -51.59 -35.22 40.57 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.494 1.117 . . . . 0.0 112.04 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.67 -43.43 76.2 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.606 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 pp -74.55 -29.09 61.23 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.976 0.417 . . . . 0.0 111.175 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 75.6 t -64.77 -51.54 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.964 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.3 t -69.04 -31.97 71.14 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.427 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -63.98 -40.8 97.22 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.662 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.572 ' CD2' ' HA ' ' A' ' 118' ' ' PRO . 30.9 m80 -73.7 -3.88 30.96 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.9 m -82.8 -29.85 29.27 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 171.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.7 mt -90.83 -53.01 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.901 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.6 m -135.33 106.3 10.17 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.572 ' HA ' ' CD2' ' A' ' 114' ' ' HIS . 48.0 Cg_endo -78.73 100.9 1.4 Allowed 'Trans proline' 0 N--CA 1.437 -1.823 0 C-N-CA 121.413 1.409 . . . . 0.0 111.171 176.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 68.6 mt -84.07 -65.08 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.798 -176.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.7 m -85.98 -28.54 24.16 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.315 0.578 . . . . 0.0 111.415 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 63.6 mt -93.47 133.37 28.39 Favored Pre-proline 0 C--N 1.293 -1.868 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.146 -176.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.0 -13.47 31.57 Favored 'Trans proline' 0 N--CA 1.482 0.798 0 C-N-CA 123.092 2.528 . . . . 0.0 112.497 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 43.9 t -123.92 148.52 46.8 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.508 ' SG ' ' HG3' ' A' ' 118' ' ' PRO . 45.6 m -73.29 147.16 44.78 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.451 HD22 ' CD1' ' A' ' 44' ' ' PHE . 44.5 mt -78.5 114.14 17.15 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.294 0.569 . . . . 0.0 111.452 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -97.17 96.64 8.57 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.1 mp -62.64 129.86 93.15 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -52.63 -42.97 58.85 Favored 'Trans proline' 0 C--N 1.36 1.172 0 C-N-CA 123.176 2.584 . . . . 0.0 112.67 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 20.4 m 59.05 11.79 2.13 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.039 1.336 . . . . 0.0 113.69 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -160.45 128.02 4.47 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 . . . . . 0 C--N 1.305 -1.366 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.406 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.3 mmm . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -121.26 139.76 52.97 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -116.76 171.34 7.95 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.623 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -84.14 110.01 18.17 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.492 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -80.67 -52.2 7.83 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 176.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -137.34 27.79 2.81 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 69.7 m80 68.13 -66.5 0.22 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.805 1.242 . . . . 0.0 110.227 -171.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.7 m -83.93 85.97 7.24 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 172.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.0 m -93.93 95.35 9.01 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.163 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.96 97.78 2.51 Favored Glycine 0 N--CA 1.427 -1.904 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -173.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.6 mt -75.82 105.79 7.04 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.33 0.586 . . . . 0.0 110.583 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.9 m -92.07 117.57 67.76 Favored Pre-proline 0 C--N 1.294 -1.818 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.167 175.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.31 -9.78 20.47 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 123.306 2.671 . . . . 0.0 113.83 -174.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.2 ptt180 -134.37 143.06 47.42 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 121.186 0.517 . . . . 0.0 111.896 -177.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -129.79 19.59 5.24 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.9 m -83.73 -15.19 49.55 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 122.087 0.946 . . . . 0.0 110.798 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -108.75 96.53 6.4 Favored 'General case' 0 C--N 1.268 -2.977 0 CA-C-N 113.727 -1.579 . . . . 0.0 109.029 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.3 p -95.53 -14.81 23.32 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.603 -171.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.9 m -68.97 -35.49 76.81 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.587 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.04 -11.09 45.89 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -177.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -76.22 -25.65 55.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.961 0.41 . . . . 0.0 110.264 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.529 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 37.0 p-90 -125.83 -26.1 3.53 Favored 'General case' 0 C--O 1.208 -1.082 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -176.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -84.43 111.29 19.33 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.599 -0.688 . . . . 0.0 111.022 -176.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -134.71 85.09 37.16 Favored Pre-proline 0 C--N 1.313 -0.978 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.48 -8.14 17.09 Favored 'Trans proline' 0 C--N 1.333 -0.264 0 C-N-CA 122.327 2.018 . . . . 0.0 113.538 -173.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -93.69 -5.36 48.71 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.318 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.8 tp -94.51 126.96 40.13 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -173.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.5 m -83.85 173.9 10.86 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.068 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -52.21 -55.28 22.13 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.23 1.012 . . . . 0.0 112.506 -175.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -55.7 -44.73 77.68 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.835 0.826 . . . . 0.0 110.684 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -73.39 -31.49 63.93 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 113.828 -1.533 . . . . 0.0 111.17 -174.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.39 74.76 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.447 0.641 . . . . 0.0 110.083 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 76.7 mt -68.13 -37.64 78.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.824 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.61 -32.48 70.45 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.645 175.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.432 ' O ' ' HB3' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -76.47 -47.86 21.52 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.28 -178.112 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.44 HD13 HD22 ' A' ' 45' ' ' LEU . 5.7 mp -75.2 -16.54 60.48 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -177.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -80.17 -8.82 59.61 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.326 174.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 35' ' ' LEU . 5.1 t70 -91.14 -41.2 11.15 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.017 177.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -91.59 179.56 5.62 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -176.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -86.86 153.45 54.89 Favored Pre-proline 0 C--N 1.31 -1.118 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 -172.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.09 122.78 12.15 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 122.24 1.96 . . . . 0.0 109.946 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.93 -24.89 5.36 Favored Glycine 0 N--CA 1.42 -2.378 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -175.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.8 148.93 39.88 Favored 'General case' 0 C--O 1.248 0.991 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.408 ' CE1' ' HB3' ' A' ' 125' ' ' LEU . 34.1 p90 -149.12 167.05 26.96 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -178.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.44 HD22 HD13 ' A' ' 36' ' ' LEU . 1.8 pt? -152.58 151.98 31.29 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 174.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.529 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 55.4 mt -113.12 113.34 43.77 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.1 ptt-85 -109.3 -173.82 2.36 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -90.48 129.46 36.65 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 172.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.1 t -82.65 107.45 15.29 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -78.29 75.04 4.82 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 122.459 1.123 . . . . 0.0 110.77 -175.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.3 m -150.61 -45.71 0.12 Allowed 'General case' 0 C--N 1.267 -2.989 0 CA-C-N 113.613 -1.63 . . . . 0.0 108.901 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -131.01 154.38 48.25 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -84.3 121.63 27.78 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.91 37.46 7.28 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.08 119.89 21.61 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.415 ' HB3' ' CG2' ' A' ' 46' ' ' ILE . 63.6 m-85 -97.97 136.58 38.05 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -101.88 106.76 3.06 Favored Glycine 0 C--N 1.286 -2.218 0 C-N-CA 120.324 -0.941 . . . . 0.0 110.984 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -85.14 117.87 24.36 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 82' ' ' ARG . . . -115.03 125.67 53.84 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.9 tp -120.7 127.1 51.72 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 123.958 0.786 . . . . 0.0 109.446 -177.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -88.96 114.74 25.91 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.447 HG12 ' SG ' ' A' ' 123' ' ' CYS . 33.3 m -104.25 169.37 2.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.219 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.88 -43.38 25.1 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 p -160.89 123.01 1.74 Allowed Pre-proline 0 C--N 1.32 -0.707 0 C-N-CA 124.93 1.292 . . . . 0.0 109.534 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.653 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 23.9 Cg_exo -64.85 -47.49 5.0 Favored 'Trans proline' 0 CA--C 1.566 2.101 0 C-N-CA 121.916 1.744 . . . . 0.0 112.232 172.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.714 ' HG2' ' HB2' ' A' ' 69' ' ' ALA . 58.1 Cg_endo -71.79 134.17 23.32 Favored 'Trans proline' 0 C--N 1.384 2.425 0 C-N-CA 121.626 1.551 . . . . 0.0 109.959 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.88 -24.47 33.86 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.806 2.337 . . . . 0.0 113.01 -176.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.4 t -115.38 -37.8 3.95 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.714 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 64.34 32.06 12.41 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.957 0.903 . . . . 0.0 112.965 174.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -63.03 -46.17 86.79 Favored Pre-proline 0 CA--C 1.557 1.234 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -56.4 123.04 12.87 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 121.804 1.669 . . . . 0.0 112.089 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -108.88 132.43 54.05 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.051 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -147.26 7.87 0.91 Allowed 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 124.413 1.085 . . . . 0.0 109.536 177.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.54 117.63 0.76 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -172.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -108.74 107.23 59.91 Favored Pre-proline 0 C--N 1.296 -1.742 0 CA-C-O 121.333 0.587 . . . . 0.0 111.256 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -85.42 148.15 10.05 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.12 1.88 . . . . 0.0 109.972 174.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.2 p -53.37 -25.54 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 123.612 0.765 . . . . 0.0 112.722 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -70.71 -27.02 63.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.237 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.2 -31.55 62.69 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.35 -4.48 33.63 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.493 -177.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 73.6 t -91.89 119.13 38.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 6.2 mmp_? -93.26 149.57 21.13 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -129.06 122.91 30.97 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.896 0.379 . . . . 0.0 111.052 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -133.28 128.36 35.62 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.505 HD23 ' H ' ' A' ' 85' ' ' LEU . 1.6 pt? -99.04 140.38 33.27 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.582 -1.247 . . . . 0.0 112.711 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.422 HG12 HG12 ' A' ' 95' ' ' ILE . 86.0 mt -104.05 119.34 52.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 114.066 -1.425 . . . . 0.0 107.579 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -99.35 144.34 28.57 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.471 ' HB ' HG12 ' A' ' 93' ' ' VAL . 8.8 t -129.33 153.06 48.22 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.28 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.19 -142.77 4.41 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.38 -22.36 29.34 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.559 2.172 . . . . 0.0 112.742 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -73.51 -50.36 21.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.871 0.843 . . . . 0.0 109.793 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 150.89 -125.08 1.83 Allowed Glycine 0 N--CA 1.422 -2.288 0 N-CA-C 107.505 -2.238 . . . . 0.0 107.505 -177.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.471 HG12 ' HB ' ' A' ' 88' ' ' THR . 16.9 m -127.31 139.49 51.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 175.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.93 145.09 24.61 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.067 -0.396 . . . . 0.0 110.983 177.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.422 HG12 HG12 ' A' ' 86' ' ' ILE . 60.3 mt -75.79 140.58 17.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -57.47 -52.85 63.71 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -105.41 52.33 0.72 Allowed Glycine 0 CA--C 1.495 -1.189 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.821 -174.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.432 ' HA ' ' OG ' ' A' ' 120' ' ' SER . 6.7 p -86.52 123.06 71.64 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 123.764 0.332 . . . . 0.0 111.717 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -65.35 -32.12 51.14 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.644 2.229 . . . . 0.0 113.09 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.3 m -145.4 -19.14 0.48 Allowed 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.6 ' OE2' ' HB ' ' A' ' 119' ' ' ILE . 12.9 mp0 -54.5 128.66 61.04 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -176.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -85.33 -161.35 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.766 2.311 . . . . 0.0 110.572 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -87.19 129.42 34.96 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -103.74 161.49 13.88 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.64 -56.44 2.37 Favored Glycine 0 C--N 1.297 -1.584 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.295 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.9 m -116.05 151.46 35.49 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.07 -35.88 72.01 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.021 0.528 . . . . 0.0 110.671 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 m -51.86 -34.89 42.91 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.647 1.179 . . . . 0.0 112.119 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.84 -42.88 76.57 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.413 -176.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 111' ' ' VAL . 4.4 pp -73.49 -38.83 65.26 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.179 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.461 ' N ' HD12 ' A' ' 110' ' ' LEU . 75.2 t -59.81 -46.06 94.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.398 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.0 p -69.57 -37.97 77.22 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -79.85 -28.33 40.06 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.567 -176.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -77.28 -0.1 24.14 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.6 m -80.44 -18.47 48.7 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 170.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 64.7 mt -108.93 -59.53 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.795 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.9 m -113.97 99.43 50.39 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.539 -177.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -90.7 107.57 0.32 Allowed 'Trans proline' 0 N--CA 1.443 -1.486 0 C-N-CA 122.895 2.397 . . . . 0.0 110.919 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.6 ' HB ' ' OE2' ' A' ' 101' ' ' GLU . 25.9 mt -95.18 -64.33 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.432 ' OG ' ' HA ' ' A' ' 98' ' ' CYS . 52.2 m -66.43 -35.39 80.18 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.42 0.629 . . . . 0.0 111.068 174.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -82.65 136.18 45.43 Favored Pre-proline 0 N--CA 1.439 -1.013 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.663 -176.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.97 -19.15 30.72 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.574 2.183 . . . . 0.0 112.256 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.447 ' SG ' HG12 ' A' ' 62' ' ' VAL . 28.5 p -144.13 163.63 33.03 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 25.3 p -71.23 157.69 37.69 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.381 0.61 . . . . 0.0 112.479 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.408 ' HB3' ' CE1' ' A' ' 44' ' ' PHE . 64.8 mt -83.64 115.16 22.02 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.212 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -94.81 104.31 16.22 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.0 mp -69.18 120.98 80.26 Favored Pre-proline 0 C--N 1.317 -0.819 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -45.26 -50.43 9.01 Favored 'Trans proline' 0 C--N 1.36 1.164 0 C-N-CA 123.436 2.758 . . . . 0.0 113.091 -177.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.9 m 58.95 18.26 6.07 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.206 1.002 . . . . 0.0 111.443 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.439 ' HD3' ' C ' ' A' ' 130' ' ' LYS . 12.1 tmtt? -144.69 132.49 21.23 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 33.9 t70 . . . . . 0 C--N 1.294 -1.804 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.262 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.9 mmm . . . . . 0 CA--C 1.502 -0.87 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -131.64 170.32 14.93 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 123.637 0.775 . . . . 0.0 109.213 177.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.4 p80 -96.67 -21.09 17.82 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.137 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -136.26 143.21 44.13 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 177.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -124.68 167.63 14.28 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.752 -176.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -96.45 108.7 21.29 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 176.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -82.09 125.84 31.32 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.345 -175.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.9 m -126.27 155.3 42.14 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.356 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.6 m -94.77 98.28 10.65 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.17 80.08 0.68 Allowed Glycine 0 N--CA 1.429 -1.83 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.512 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -157.46 167.43 30.23 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 p -115.58 105.95 51.16 Favored Pre-proline 0 C--N 1.295 -1.787 0 CA-C-O 121.14 0.495 . . . . 0.0 110.889 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.61 114.46 3.31 Favored 'Trans proline' 0 C--O 1.247 0.961 0 C-N-CA 122.44 2.094 . . . . 0.0 110.266 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 63.9 mtt85 -92.18 173.2 7.95 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.504 -176.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.22 53.35 4.76 Favored Glycine 0 CA--C 1.487 -1.699 0 N-CA-C 114.384 0.514 . . . . 0.0 114.384 -171.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.2 m 50.89 53.32 13.23 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 124.413 1.085 . . . . 0.0 111.529 176.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -74.32 90.68 2.14 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.535 0.683 . . . . 0.0 110.325 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.8 p -109.92 -10.74 14.72 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -174.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.9 t -64.66 -44.65 89.73 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.288 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -4.53 3.53 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -81.95 -35.77 28.69 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.318 0.58 . . . . 0.0 109.511 174.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.434 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 44.7 p-90 -109.46 -28.17 9.06 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -91.32 119.33 31.26 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.55 0.691 . . . . 0.0 110.734 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.42 99.15 5.87 Favored Pre-proline 0 C--N 1.297 -1.683 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.657 172.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.22 -25.11 26.82 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 123.006 2.471 . . . . 0.0 113.629 -171.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -93.96 13.32 23.16 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.433 -173.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.9 tp -92.02 145.52 24.46 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.7 t -99.47 172.31 7.4 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.215 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -55.89 -53.34 57.96 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.299 1.04 . . . . 0.0 112.005 -174.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -67.5 -33.96 76.17 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.1 0.476 . . . . 0.0 111.25 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -70.68 -33.11 70.57 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.221 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.6 -40.67 97.54 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.751 0.786 . . . . 0.0 109.506 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 70.0 mt -69.22 -37.56 76.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 114.755 -1.112 . . . . 0.0 109.582 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.51 -33.8 64.07 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.06 177.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.507 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 4.6 mm? -78.7 -55.73 4.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.105 0.479 . . . . 0.0 110.259 174.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 47.2 mt -59.75 -28.91 67.79 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -174.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -64.55 -28.07 69.39 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.924 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -95.9 -21.61 17.96 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.23 0.538 . . . . 0.0 110.475 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' A' ' 35' ' ' LEU . 26.2 mtpp -77.91 150.34 34.09 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-O 121.021 0.439 . . . . 0.0 110.818 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -75.05 151.36 86.14 Favored Pre-proline 0 C--N 1.309 -1.187 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.566 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -52.1 121.99 9.8 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 123.429 2.753 . . . . 0.0 112.839 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.81 -23.36 7.03 Favored Glycine 0 N--CA 1.432 -1.627 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.2 145.08 44.45 Favored 'General case' 0 C--O 1.246 0.913 0 O-C-N 124.057 0.504 . . . . 0.0 110.513 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.493 ' CG ' HD11 ' A' ' 125' ' ' LEU . 12.7 p90 -142.83 171.96 13.34 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.34 -176.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -158.49 152.8 24.17 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 172.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.434 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 55.8 mt -125.3 134.01 67.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.4 ptt-85 -133.38 -178.69 5.1 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -83.2 147.87 27.77 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.2 m -78.16 139.81 38.99 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.157 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -84.96 -36.07 21.62 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.9 m -69.2 -46.79 66.59 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.738 -176.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -131.1 146.41 52.35 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -87.11 148.97 25.0 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.67 23.05 70.96 Favored Glycine 0 CA--C 1.499 -0.962 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.59 137.1 43.45 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -110.52 121.85 46.32 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.68 114.56 3.95 Favored Glycine 0 N--CA 1.424 -2.112 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.276 -176.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 42.6 tp -94.0 123.62 37.48 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -112.91 122.15 46.78 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 176.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.4 tp -115.65 128.69 56.1 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.42 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 22.0 tptm -88.72 114.82 25.75 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 80' ' ' LEU . 29.3 m -108.61 171.73 2.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.76 -51.56 12.39 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.6 p -151.63 125.72 4.44 Favored Pre-proline 0 N--CA 1.431 -1.414 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.244 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.65 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 34.9 Cg_exo -60.1 -45.68 22.51 Favored 'Trans proline' 0 CA--C 1.577 2.652 0 C-N-CA 121.859 1.706 . . . . 0.0 111.506 169.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.65 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 46.5 Cg_endo -63.72 161.17 33.32 Favored 'Trans proline' 0 C--N 1.391 2.778 0 C-N-CA 122.934 2.423 . . . . 0.0 110.054 171.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.33 -40.89 45.64 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.42 2.08 . . . . 0.0 112.831 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.1 p -137.57 -17.97 1.27 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.435 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 65.33 33.47 9.02 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.059 0.944 . . . . 0.0 111.513 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -65.49 -45.7 68.84 Favored Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.452 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -74.29 103.72 1.73 Allowed 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 121.119 1.213 . . . . 0.0 109.148 169.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 56.0 t-105 -107.8 143.67 36.05 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.12 -175.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -134.93 8.72 3.52 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.77 51.23 4.11 Favored Glycine 0 CA--C 1.49 -1.48 0 C-N-CA 119.726 -1.226 . . . . 0.0 110.37 -175.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -91.32 119.09 68.77 Favored Pre-proline 0 N--CA 1.437 -1.107 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -49.66 146.66 14.86 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.818 3.012 . . . . 0.0 115.168 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.485 HG23 HD12 ' A' ' 80' ' ' LEU . 7.5 p -60.13 -21.03 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 CA-C-O 122.23 1.014 . . . . 0.0 109.794 174.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -69.65 -20.14 63.6 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.359 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -90.31 -7.86 52.31 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.651 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.485 HD12 HG23 ' A' ' 77' ' ' VAL . 80.2 mt -83.53 -6.23 59.39 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 122.091 0.948 . . . . 0.0 108.844 177.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.8 t -85.87 134.25 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.27 174.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -111.05 130.7 55.52 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -109.71 122.86 48.44 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.049 0.452 . . . . 0.0 111.522 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -133.27 147.75 51.93 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 177.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -119.05 131.06 55.93 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 118.709 -1.196 . . . . 0.0 112.314 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.55 HG12 HG12 ' A' ' 95' ' ' ILE . 78.8 mt -87.7 118.23 33.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 178.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.558 ' OE1' ' HE2' ' A' ' 96' ' ' LYS . 39.8 mt-10 -98.97 138.9 35.41 Favored 'General case' 0 C--N 1.27 -2.867 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.539 ' HB ' HG12 ' A' ' 93' ' ' VAL . 7.2 t -120.43 116.66 25.89 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-O 121.989 0.899 . . . . 0.0 109.929 178.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -125.84 -166.69 12.33 Favored Glycine 0 N--CA 1.416 -2.651 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.483 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -68.49 -11.47 32.03 Favored 'Trans proline' 0 C--N 1.331 -0.351 0 C-N-CA 122.949 2.433 . . . . 0.0 113.173 -176.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.529 ' HD3' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -97.06 -17.16 20.16 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.911 179.513 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 136.19 -164.07 25.07 Favored Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -177.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.539 HG12 ' HB ' ' A' ' 88' ' ' THR . 8.3 m -104.97 148.41 9.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.492 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -164.81 157.89 16.89 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.233 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.661 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 60.5 mt -92.27 131.95 37.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.627 0.727 . . . . 0.0 112.008 -174.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.558 ' HE2' ' OE1' ' A' ' 87' ' ' GLU . 22.3 ttmm -88.78 132.87 34.44 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 172.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.49 7.1 7.71 Favored Glycine 0 C--N 1.308 -1.027 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -172.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.415 ' SG ' HG22 ' A' ' 119' ' ' ILE . 42.3 t -142.42 142.36 23.39 Favored Pre-proline 0 N--CA 1.428 -1.567 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -87.73 -13.92 3.84 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.264 1.976 . . . . 0.0 113.244 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.0 m -85.79 -82.76 0.18 Allowed 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.661 ' HG3' ' O ' ' A' ' 95' ' ' ILE . 28.2 mm-40 46.95 97.26 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 117.603 2.445 . . . . 0.0 117.603 174.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -81.63 147.79 15.72 Favored 'Trans proline' 0 N--CA 1.437 -1.845 0 C-N-CA 122.015 1.81 . . . . 0.0 108.926 172.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -76.98 123.38 26.25 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.6 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.429 ' CE2' ' HB3' ' A' ' 110' ' ' LEU . 59.9 m-85 -103.54 164.38 11.7 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.18 -53.5 2.49 Favored Glycine 0 C--N 1.305 -1.156 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.625 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 61.9 m -116.04 160.73 19.89 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 122.918 -0.166 . . . . 0.0 110.977 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.33 -35.17 79.5 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.938 0.399 . . . . 0.0 110.985 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -55.26 -30.82 60.84 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 123.912 0.885 . . . . 0.0 111.479 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.33 -49.33 69.85 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.419 -178.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.589 ' H ' HD13 ' A' ' 110' ' ' LEU 0.293 0.0 OUTLIER -72.52 -28.58 62.95 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.972 -179.78 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 73.4 t -63.65 -49.42 82.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 123.656 0.598 . . . . 0.0 110.076 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.0 t -68.45 -37.88 80.62 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.044 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -75.22 -40.57 59.0 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.472 ' HA ' ' O ' ' A' ' 117' ' ' SER . 25.4 m80 -67.7 -10.96 57.03 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.8 t -72.96 -32.09 65.0 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 175.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 62.4 mt -96.44 -53.5 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 19.8 m -114.77 103.57 54.74 Favored Pre-proline 0 N--CA 1.436 -1.141 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.633 -177.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -78.45 89.35 1.36 Allowed 'Trans proline' 0 N--CA 1.44 -1.657 0 C-N-CA 122.527 2.151 . . . . 0.0 110.922 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.415 HG22 ' SG ' ' A' ' 98' ' ' CYS . 43.5 mt -74.58 -66.57 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.56 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.5 t -85.11 -31.22 23.44 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.645 0.736 . . . . 0.0 110.111 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 69.5 mt -83.92 139.56 40.09 Favored Pre-proline 0 C--N 1.303 -1.444 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.377 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -76.81 -10.58 18.34 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.664 2.243 . . . . 0.0 112.893 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 45.1 t -137.37 160.83 37.97 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 39.3 m -70.61 136.0 48.86 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.493 HD11 ' CG ' ' A' ' 44' ' ' PHE . 23.9 tp -75.07 132.7 41.46 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.52 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.543 ' O ' ' HD3' ' A' ' 128' ' ' PRO . 36.6 mmt180 -118.07 128.81 55.12 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mp -95.26 106.31 25.25 Favored Pre-proline 0 C--N 1.312 -1.023 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.543 ' HD3' ' O ' ' A' ' 126' ' ' ARG . 33.6 Cg_exo -62.75 -34.06 74.43 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.266 1.977 . . . . 0.0 111.988 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 34.1 t 70.93 17.05 6.4 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.554 1.141 . . . . 0.0 108.899 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -140.73 163.66 32.31 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 30.0 t70 . . . . . 0 C--N 1.292 -1.933 0 O-C-N 123.825 0.703 . . . . 0.0 110.207 -178.65 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.507 -0.685 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -121.99 -176.61 3.38 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -90.43 -14.11 33.53 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.925 0.869 . . . . 0.0 108.694 175.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -100.55 145.51 28.24 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 175.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -93.64 157.03 16.38 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -175.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -85.55 122.78 30.16 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -114.0 91.87 3.78 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.778 -178.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.8 m 65.12 -53.77 0.33 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 175.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.7 m -120.97 144.52 48.45 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -175.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.31 -175.94 39.54 Favored Glycine 0 N--CA 1.438 -1.186 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.72 120.39 14.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.032 0.444 . . . . 0.0 110.444 178.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.7 m -114.92 149.38 42.36 Favored Pre-proline 0 C--N 1.292 -1.907 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.319 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.03 19.41 1.03 Allowed 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.829 2.352 . . . . 0.0 112.187 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -115.19 121.81 44.11 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 160.26 30.08 0.02 OUTLIER Glycine 0 C--N 1.294 -1.786 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.233 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.8 t -103.69 40.46 1.42 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 177.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -113.6 137.48 51.52 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.19 -1.368 . . . . 0.0 107.318 -176.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.9 p -84.68 -1.07 55.63 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-O 122.02 0.914 . . . . 0.0 111.195 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.9 m -75.9 -7.71 55.19 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.847 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.89 -16.56 53.26 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 119.936 -0.706 . . . . 0.0 111.695 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -69.75 -25.55 63.88 Favored 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -175.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 19.6 p-90 -113.25 -4.21 13.75 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.191 0.52 . . . . 0.0 111.917 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -107.45 114.32 28.25 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.786 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.66 96.97 3.53 Favored Pre-proline 0 C--N 1.295 -1.78 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.574 174.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.517 ' HA ' ' HB2' ' A' ' 47' ' ' ARG . 66.3 Cg_endo -79.81 13.96 2.0 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.443 2.762 . . . . 0.0 114.038 -171.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -102.92 -6.58 22.3 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 120.859 0.361 . . . . 0.0 110.421 -176.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.477 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 75.9 mt -87.32 142.54 27.81 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.478 0.656 . . . . 0.0 111.762 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 87.3 p -89.17 177.81 6.53 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.983 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -63.05 -43.25 99.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -55.08 -48.2 73.86 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.316 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -70.31 -34.39 72.66 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.381 -178.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.451 ' HA ' HD11 ' A' ' 45' ' ' LEU . . . -65.2 -44.59 87.87 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.237 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 51.2 mt -66.64 -38.94 82.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.486 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.06 -40.37 89.21 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.377 0.608 . . . . 0.0 110.346 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -46.0 69.56 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.055 -179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 72.4 mt -74.86 -17.19 60.63 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -176.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.401 ' HB3' HG21 ' A' ' 77' ' ' VAL . 18.4 ptpt -83.06 -11.28 58.18 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.149 -1.021 . . . . 0.0 110.37 177.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -93.91 -24.3 17.75 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.606 0.717 . . . . 0.0 109.454 175.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -99.91 164.52 11.98 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -72.49 156.91 89.84 Favored Pre-proline 0 C--N 1.287 -2.127 0 CA-C-N 112.177 -2.283 . . . . 0.0 112.749 -176.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -60.46 126.31 19.64 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.892 2.395 . . . . 0.0 111.379 175.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 112.96 -7.74 25.47 Favored Glycine 0 C--N 1.303 -1.25 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -176.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.49 150.3 32.98 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-N 115.534 -0.333 . . . . 0.0 110.341 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.527 ' CD1' HD11 ' A' ' 125' ' ' LEU . 9.8 p90 -149.25 167.63 25.5 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.451 HD11 ' HA ' ' A' ' 32' ' ' ALA . 2.5 pt? -155.97 148.72 24.04 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 171.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.406 ' CG2' ' HB3' ' A' ' 56' ' ' TYR . 63.2 mt -120.79 130.27 74.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-O 121.124 0.488 . . . . 0.0 110.656 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.517 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -137.82 -176.96 4.6 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.044 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -62.66 134.39 56.25 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.8 t -74.57 136.38 42.09 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.371 0.605 . . . . 0.0 110.704 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -72.75 -27.06 61.8 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.325 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.2 m -81.13 -52.26 7.57 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.965 -175.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -137.73 145.26 42.28 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -175.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -82.98 151.92 25.66 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 173.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.03 9.96 81.52 Favored Glycine 0 C--N 1.305 -1.179 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.44 144.48 48.16 Favored 'General case' 0 N--CA 1.406 -2.648 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.406 ' HB3' ' CG2' ' A' ' 46' ' ' ILE . 76.6 m-85 -116.9 126.34 52.83 Favored 'General case' 0 C--N 1.273 -2.749 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.433 ' O ' ' HD3' ' A' ' 47' ' ' ARG . . . -83.76 115.15 4.0 Favored Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.031 -177.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.7 tp -95.59 121.63 37.5 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 123.728 0.811 . . . . 0.0 109.03 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.57 127.56 53.1 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -124.04 125.59 44.79 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -176.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.495 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 21.7 tptm -88.34 114.62 25.15 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.675 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 80' ' ' LEU . 20.0 m -96.85 167.61 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.07 -59.11 2.87 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 174.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.4 ' HB ' ' HG2' ' A' ' 66' ' ' PRO . 0.6 OUTLIER -155.73 141.72 12.91 Favored Pre-proline 0 N--CA 1.428 -1.529 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.84 177.349 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.65 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 32.0 Cg_exo -59.47 -42.79 45.04 Favored 'Trans proline' 0 CA--C 1.573 2.454 0 C-N-CA 122.283 1.989 . . . . 0.0 112.61 174.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.65 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 39.7 Cg_endo -65.13 148.12 88.91 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 122.832 2.354 . . . . 0.0 109.77 172.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.79 -37.14 88.67 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.749 2.299 . . . . 0.0 113.048 -177.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.7 t -132.37 -11.07 3.22 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.949 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.455 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 69.83 31.99 3.31 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 124.345 1.058 . . . . 0.0 112.923 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -64.14 -43.75 74.95 Favored Pre-proline 0 CA--C 1.556 1.199 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.631 173.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -84.69 101.3 0.79 Allowed 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 121.446 1.43 . . . . 0.0 109.893 167.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 34.6 t-105 -92.53 146.66 23.51 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.909 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -121.82 -36.52 3.01 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.966 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.44 14.12 12.09 Favored Glycine 0 C--N 1.3 -1.466 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.31 -176.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -64.53 134.09 95.89 Favored Pre-proline 0 C--N 1.316 -0.865 0 C-N-CA 122.63 0.372 . . . . 0.0 110.701 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.1 173.19 14.91 Favored 'Trans proline' 0 C--O 1.245 0.844 0 C-N-CA 123.042 2.495 . . . . 0.0 113.855 -175.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.401 HG21 ' HB3' ' A' ' 37' ' ' LYS . 2.1 p -56.42 -30.31 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.478 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -58.78 -25.11 62.78 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 122.955 0.502 . . . . 0.0 112.238 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -92.05 -14.23 29.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.059 0.457 . . . . 0.0 110.56 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.528 ' O ' HG22 ' A' ' 62' ' ' VAL . 72.9 mt -81.95 -13.07 58.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 122.006 0.908 . . . . 0.0 108.642 178.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.2 t -94.91 111.37 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 175.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.412 ' NH2' ' HB3' ' A' ' 65' ' ' PRO . 32.4 mmt180 -85.19 147.46 26.59 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.428 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.9 m80 -126.13 123.21 37.79 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.586 0.708 . . . . 0.0 111.723 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -132.49 163.52 28.63 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 106.282 -1.748 . . . . 0.0 106.282 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -130.02 132.65 46.31 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.047 176.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 94' ' ' LYS . 75.1 mt -90.84 110.65 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.332 0 CA-C-N 114.48 -1.236 . . . . 0.0 107.668 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -100.2 152.69 19.98 Favored 'General case' 0 C--N 1.268 -2.954 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.507 ' HB ' HG12 ' A' ' 93' ' ' VAL . 4.3 t -134.14 148.82 51.01 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-O 121.214 0.531 . . . . 0.0 110.675 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.45 -159.51 11.15 Favored Glycine 0 N--CA 1.42 -2.384 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.37 -21.44 72.68 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.929 2.419 . . . . 0.0 112.939 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -88.83 -5.79 57.79 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.733 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 110.36 -147.56 17.44 Favored Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.507 HG12 ' HB ' ' A' ' 88' ' ' THR . 12.1 m -108.11 151.95 10.08 Favored 'Isoleucine or valine' 0 C--O 1.252 1.23 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 13.8 pttp -151.38 147.95 27.53 Favored 'General case' 0 C--N 1.311 -1.078 0 O-C-N 123.777 0.673 . . . . 0.0 109.859 -175.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.517 ' HB ' ' OE2' ' A' ' 101' ' ' GLU . 76.5 mt -101.46 108.38 23.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -75.36 119.06 18.94 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 120.984 0.421 . . . . 0.0 110.071 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 121.22 -2.74 11.47 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.072 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 24.1 p -70.93 152.9 94.96 Favored Pre-proline 0 C--N 1.317 -0.809 0 C-N-CA 123.026 0.53 . . . . 0.0 110.006 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -72.41 -52.64 0.17 Allowed 'Trans proline' 0 C--O 1.24 0.616 0 C-N-CA 121.729 1.619 . . . . 0.0 110.16 173.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.2 m -144.99 139.86 27.79 Favored 'General case' 0 N--CA 1.41 -2.467 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.517 ' OE2' ' HB ' ' A' ' 95' ' ' ILE . 38.3 tt0 -166.56 142.67 3.88 Favored Pre-proline 0 C--N 1.297 -1.713 0 O-C-N 123.479 0.487 . . . . 0.0 112.165 -176.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -92.71 160.62 2.83 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 123.171 2.581 . . . . 0.0 110.3 168.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -74.07 127.02 31.84 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -79.14 -72.59 0.38 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.023 0.439 . . . . 0.0 111.248 -176.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.44 ' H ' HG22 ' A' ' 93' ' ' VAL . . . 148.91 -58.6 0.46 Allowed Glycine 0 C--N 1.309 -0.929 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.1 m -132.53 155.9 47.79 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.475 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 10.7 mp -53.11 -46.31 68.65 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.436 0.46 . . . . 0.0 111.164 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.4 m -53.83 -30.75 46.65 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.898 0.879 . . . . 0.0 112.458 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.58 -37.12 73.89 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 120.64 0.257 . . . . 0.0 111.288 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 107' ' ' LEU . 4.3 pp -80.35 -23.43 40.53 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.462 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 107' ' ' LEU . 70.8 t -71.44 -40.31 72.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.388 177.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.0 p -70.25 -22.86 62.84 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.029 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.625 ' HG2' ' H ' ' A' ' 114' ' ' HIS . 8.5 tt0 -95.2 -172.51 2.69 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 177.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.625 ' H ' ' HG2' ' A' ' 113' ' ' GLN . 57.2 m80 77.87 -26.07 0.19 Allowed 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.9 m -66.81 -41.9 86.79 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 173.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 65.8 mt -74.23 -66.25 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.404 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.7 m -125.75 118.79 24.26 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -78.75 101.09 1.42 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.238 1.959 . . . . 0.0 111.002 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 56.5 mt -95.02 -71.15 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.508 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.0 m -71.28 -30.2 65.99 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.343 0.592 . . . . 0.0 110.554 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 85.9 mt -101.49 148.81 35.74 Favored Pre-proline 0 C--N 1.304 -1.399 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.104 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 1.7 Cg_endo -77.43 -29.29 4.89 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.007 1.805 . . . . 0.0 113.109 -178.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 79.9 m -114.8 155.03 27.51 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.81 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 64.7 m -62.68 122.72 16.57 Favored 'General case' 0 C--O 1.241 0.606 0 O-C-N 123.982 0.802 . . . . 0.0 109.645 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.527 HD11 ' CD1' ' A' ' 44' ' ' PHE . 27.4 tp -74.11 134.56 42.89 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.724 -173.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -117.96 129.03 55.36 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.493 HG22 ' H ' ' A' ' 129' ' ' SER . 3.4 mp -93.29 132.98 29.24 Favored Pre-proline 0 C--O 1.193 -1.884 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -174.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.32 -32.51 81.56 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 C-N-CA 122.842 2.362 . . . . 0.0 112.898 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.493 ' H ' HG22 ' A' ' 127' ' ' ILE . 6.8 m -61.49 -29.82 70.22 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.847 0.859 . . . . 0.0 111.188 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.486 ' HD3' ' O ' ' A' ' 130' ' ' LYS . 6.9 tmtm? -151.32 92.2 1.76 Allowed 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.4 t70 . . . . . 0 C--N 1.284 -2.258 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 179.359 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.9 mtm . . . . . 0 N--CA 1.468 0.464 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -86.54 147.72 25.83 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 174.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -97.36 116.84 30.32 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.2 t60 73.22 142.41 0.06 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.214 1.006 . . . . 0.0 113.533 178.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 67.0 t60 -171.21 86.15 0.09 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.083 -1.417 . . . . 0.0 107.981 170.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.423 ' CE1' ' HB2' ' A' ' 8' ' ' SER . 13.6 t-80 -112.79 126.35 55.33 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -47.19 -54.14 11.43 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.081 0.952 . . . . 0.0 111.312 -177.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.423 ' HB2' ' CE1' ' A' ' 6' ' ' HIS . 4.5 m -68.64 -17.95 64.2 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -175.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.7 m -106.04 7.83 32.05 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.823 0.344 . . . . 0.0 110.813 -177.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.08 -31.49 0.33 Allowed Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.224 -0.989 . . . . 0.0 112.672 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 36.0 tp 60.07 45.11 12.3 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 122.59 1.186 . . . . 0.0 108.569 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.6 t -118.87 94.02 47.36 Favored Pre-proline 0 N--CA 1.437 -1.119 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.038 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -94.5 91.6 0.12 Allowed 'Trans proline' 0 N--CA 1.428 -2.351 0 C-N-CA 122.433 2.089 . . . . 0.0 110.587 175.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -87.9 -57.53 2.9 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 177.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -94.22 -90.26 1.65 Allowed Glycine 0 N--CA 1.407 -3.267 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 175.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.4 m 56.55 23.87 8.09 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 122.118 0.961 . . . . 0.0 110.498 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -119.85 155.66 32.2 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.457 -175.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 35.0 p -109.11 -7.2 15.36 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.739 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.407 ' HA ' ' CE2' ' A' ' 22' ' ' TRP . 48.3 p -53.38 -49.55 66.98 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -173.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -10.19 57.8 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 119.86 -0.736 . . . . 0.0 112.614 -177.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -83.34 -25.19 31.67 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.528 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.407 ' CE2' ' HA ' ' A' ' 19' ' ' SER . 27.0 p-90 -119.39 -22.09 7.19 Favored 'General case' 0 C--O 1.214 -0.795 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 52.1 t80 -90.97 112.77 24.8 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.775 -177.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.78 92.07 41.27 Favored Pre-proline 0 C--N 1.315 -0.929 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 175.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -57.64 -44.41 41.74 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 123.341 2.694 . . . . 0.0 115.942 -169.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -104.96 16.91 25.08 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.368 0.604 . . . . 0.0 111.364 -170.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.5 tp -74.62 146.25 42.6 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 85.4 p -93.0 166.66 12.26 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.96 -0.462 . . . . 0.0 110.257 -175.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -57.02 -49.41 75.88 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.939 0.399 . . . . 0.0 110.934 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -60.89 -34.82 75.24 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.296 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -75.87 -30.83 59.01 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.928 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.42 -43.14 77.81 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 75.8 mt -66.58 -40.22 85.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.624 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.21 -34.55 70.52 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.373 0.669 . . . . 0.0 111.104 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.72 -49.63 15.56 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.526 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 67.2 mt -68.49 -32.61 72.72 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -175.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -63.51 -21.54 66.38 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.065 0.459 . . . . 0.0 111.43 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -90.32 -10.14 45.18 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.275 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.65 -178.34 3.63 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.758 -174.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -99.96 160.72 26.47 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.111 -177.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -59.04 125.99 19.75 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 122.491 2.127 . . . . 0.0 111.673 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.51 -22.57 9.38 Favored Glycine 0 N--CA 1.43 -1.729 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.3 148.76 46.8 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.992 -0.374 . . . . 0.0 109.992 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.402 ' HB2' HD11 ' A' ' 58' ' ' LEU . 43.2 p90 -153.56 168.53 25.88 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.043 -175.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -153.15 152.43 31.26 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 172.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 23' ' ' TYR . 55.8 mt -121.98 133.19 69.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -127.02 -173.9 3.01 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -84.69 127.72 34.24 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 171.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.4 t -79.21 108.07 12.45 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -66.1 -6.53 13.48 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.75 -1.114 . . . . 0.0 113.912 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.1 p -77.62 -18.34 56.88 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.507 0.67 . . . . 0.0 110.977 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -135.83 -174.55 3.69 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -124.14 121.29 34.73 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.12 0.486 . . . . 0.0 109.918 172.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.04 43.65 8.05 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.37 159.33 41.36 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.563 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 50.5 m-85 -112.31 150.11 31.47 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.328 -176.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 85' ' ' LEU . . . -126.76 116.45 2.5 Favored Glycine 0 C--N 1.282 -2.458 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.402 HD11 ' HB2' ' A' ' 44' ' ' PHE . 50.5 tp -94.77 123.24 38.11 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 123.144 0.578 . . . . 0.0 109.84 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -107.57 115.61 30.46 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 175.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.3 tp -110.79 127.52 55.41 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 123.491 0.494 . . . . 0.0 110.487 -177.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.526 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 26.7 tptp -88.64 115.49 26.2 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.426 HG11 ' HG2' ' A' ' 122' ' ' PRO . 31.4 m -106.96 164.91 4.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.66 -53.26 43.69 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.489 ' HB ' ' HG2' ' A' ' 66' ' ' PRO . 1.3 p -159.76 140.73 9.14 Favored Pre-proline 0 N--CA 1.423 -1.8 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 175.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.6 ' CD ' ' HD2' ' A' ' 66' ' ' PRO . 30.1 Cg_exo -56.7 -43.18 57.34 Favored 'Trans proline' 0 CA--C 1.571 2.327 0 C-N-CA 122.215 1.944 . . . . 0.0 112.704 175.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.6 ' HD2' ' CD ' ' A' ' 65' ' ' PRO . 43.5 Cg_endo -62.81 153.4 72.93 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.182 2.588 . . . . 0.0 110.426 171.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -57.31 -45.35 35.49 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.524 2.149 . . . . 0.0 112.632 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.9 m -133.44 1.32 3.42 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.511 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 60.16 38.22 20.36 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.828 0.851 . . . . 0.0 111.856 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -54.74 -49.74 89.77 Favored Pre-proline 0 CA--C 1.552 1.055 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.933 177.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -78.0 139.83 17.58 Favored 'Trans proline' 0 C--N 1.366 1.479 0 CA-C-N 120.253 1.126 . . . . 0.0 111.406 173.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -96.47 136.62 36.72 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -132.68 -12.22 3.02 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.038 0.447 . . . . 0.0 110.502 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.48 56.12 4.38 Favored Glycine 0 CA--C 1.493 -1.299 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -175.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -83.63 132.86 47.95 Favored Pre-proline 0 C--N 1.289 -2.024 0 C-N-CA 123.563 0.745 . . . . 0.0 111.395 -175.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -81.93 166.84 16.73 Favored 'Trans proline' 0 N--CA 1.445 -1.327 0 C-N-CA 122.122 1.881 . . . . 0.0 111.827 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.8 p -61.2 -24.47 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.486 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -65.26 -26.67 68.19 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.957 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.422 ' HG2' ' HG2' ' A' ' 65' ' ' PRO . 7.6 tt0 -82.35 -27.73 32.01 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.109 0.48 . . . . 0.0 109.957 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.0 mt -74.72 -11.7 60.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.553 0.692 . . . . 0.0 110.367 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.2 t -103.15 118.47 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -100.36 129.78 46.38 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 -178.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -107.24 121.76 45.18 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 121.038 0.447 . . . . 0.0 109.8 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -127.79 118.37 23.61 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.412 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 4.2 pp -96.24 139.34 32.53 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.111 -177.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.563 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 76.9 mt -99.97 129.24 50.94 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 CA-C-N 114.402 -1.272 . . . . 0.0 107.935 -177.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.598 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 35.3 mt-10 -99.11 157.38 16.4 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -177.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.703 ' HB ' HG12 ' A' ' 93' ' ' VAL . 4.4 t -147.54 128.89 14.84 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 175.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.39 -141.9 3.67 Favored Glycine 0 N--CA 1.426 -2.013 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.389 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.62 -47.63 25.72 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.723 2.949 . . . . 0.0 113.108 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -74.57 -60.73 2.15 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 167.46 -146.17 10.44 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 119.976 -1.107 . . . . 0.0 111.627 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.703 HG12 ' HB ' ' A' ' 88' ' ' THR . 22.0 m -104.9 149.36 8.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 O-C-N 124.007 0.475 . . . . 0.0 111.078 -175.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.89 157.64 3.04 Favored 'General case' 0 C--O 1.252 1.187 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 172.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.496 HG12 HG12 ' A' ' 86' ' ' ILE . 71.9 mt -76.17 129.15 37.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-O 121.959 0.885 . . . . 0.0 112.35 -178.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -69.77 121.17 16.72 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.55 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 109.72 -1.16 30.47 Favored Glycine 0 C--N 1.306 -1.118 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.627 ' SG ' ' HB2' ' A' ' 101' ' ' GLU . 37.9 t -108.81 110.26 61.12 Favored Pre-proline 0 N--CA 1.431 -1.396 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -96.45 21.24 0.43 Allowed 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.098 2.532 . . . . 0.0 112.671 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.5 m -138.13 31.91 2.4 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.852 0.834 . . . . 0.0 109.093 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.627 ' HB2' ' SG ' ' A' ' 98' ' ' CYS . 29.7 tt0 -134.46 123.5 16.49 Favored Pre-proline 0 N--CA 1.426 -1.675 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.588 -173.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.37 174.76 12.26 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.594 2.196 . . . . 0.0 112.076 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -86.25 129.03 34.98 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -106.93 172.78 6.63 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -98.41 -54.8 1.14 Allowed Glycine 0 C--N 1.304 -1.225 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.103 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.5 m -105.95 153.78 21.5 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 123.128 0.571 . . . . 0.0 110.028 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.429 HD21 ' CD2' ' A' ' 56' ' ' TYR . 92.6 mt -65.35 -36.19 83.25 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.049 0.452 . . . . 0.0 110.041 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.8 m -53.05 -29.25 28.84 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.001 0.92 . . . . 0.0 112.697 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.73 -41.83 74.75 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.552 ' H ' HD13 ' A' ' 110' ' ' LEU 0.306 0.0 OUTLIER -80.07 -32.36 39.31 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.215 177.285 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.455 ' HA ' HD23 ' A' ' 125' ' ' LEU . 67.6 t -57.08 -42.68 79.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.307 0.575 . . . . 0.0 110.91 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.8 p -72.15 -33.44 67.74 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.984 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -80.01 -36.35 36.02 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.509 ' HA ' ' O ' ' A' ' 117' ' ' SER . 27.9 m-70 -71.65 -5.47 33.89 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -174.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.8 m -73.33 -30.08 63.11 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 172.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.425 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 52.9 mt -101.03 -52.16 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.109 -177.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 38.8 t -111.72 95.87 30.11 Favored Pre-proline 0 N--CA 1.424 -1.773 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.036 -175.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 116' ' ' ILE . 5.8 Cg_endo -85.78 74.54 3.43 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 122.733 2.289 . . . . 0.0 109.942 178.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.1 mt -66.19 -56.24 15.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.861 -175.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.563 ' HB3' ' SG ' ' A' ' 98' ' ' CYS . 2.4 p -96.31 6.18 49.34 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.081 -177.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 69.2 mt -123.49 140.84 34.89 Favored Pre-proline 0 C--N 1.308 -1.199 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.755 -173.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.426 ' HG2' HG11 ' A' ' 62' ' ' VAL . 72.4 Cg_endo -79.03 -8.44 15.45 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.576 2.184 . . . . 0.0 112.033 177.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 77.1 m -140.29 168.81 18.93 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 59.3 m -79.21 145.76 33.45 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 120.733 0.301 . . . . 0.0 110.27 -178.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 111' ' ' VAL . 15.5 tp -85.6 108.73 18.12 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -106.65 107.47 18.5 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.54 0.686 . . . . 0.0 111.721 -174.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 58.2 mt -65.74 120.92 72.64 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.763 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.7 -60.95 0.21 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.246 1.964 . . . . 0.0 111.735 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.4 t 60.31 18.37 7.94 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.193 0.997 . . . . 0.0 110.631 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -148.66 143.38 26.46 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.651 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 . . . . . 0 C--N 1.298 -1.655 0 C-N-CA 124.223 1.009 . . . . 0.0 109.234 175.615 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 ttm . . . . . 0 C--O 1.233 0.233 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -95.54 -11.69 26.98 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -175.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -83.99 112.93 20.63 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 173.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 82.1 t60 66.56 104.77 0.04 OUTLIER 'General case' 0 C--O 1.238 0.461 0 O-C-N 124.309 1.005 . . . . 0.0 111.183 -176.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -125.61 88.77 2.92 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.904 0.859 . . . . 0.0 110.684 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -78.75 -69.71 0.55 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.994 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -121.5 35.12 4.97 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 122.673 1.225 . . . . 0.0 108.178 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.8 t -88.69 84.59 6.71 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 174.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.6 p -109.56 104.76 13.85 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.976 -174.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.83 -35.93 43.76 Favored Glycine 0 CA--C 1.496 -1.118 0 N-CA-C 108.195 -1.962 . . . . 0.0 108.195 174.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.09 98.15 7.9 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 174.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.1 m -77.44 154.93 81.77 Favored Pre-proline 0 C--N 1.308 -1.23 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.466 -176.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.71 154.26 74.6 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 122.513 2.142 . . . . 0.0 110.915 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -64.79 118.17 8.59 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.366 -176.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.4 -33.48 5.52 Favored Glycine 0 N--CA 1.429 -1.801 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.988 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.7 m 57.7 33.66 23.51 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.902 0.881 . . . . 0.0 110.902 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -72.2 100.39 2.57 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 122.594 1.188 . . . . 0.0 112.297 -175.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.2 t -125.93 -4.83 6.9 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.512 177.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.464 ' HA ' ' CE2' ' A' ' 22' ' ' TRP . 27.1 m -66.77 -22.25 66.04 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.501 177.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.72 0.46 5.54 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.882 -1.054 . . . . 0.0 113.076 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -94.52 -27.12 16.13 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 122.233 -0.292 . . . . 0.0 110.486 174.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.464 ' CE2' ' HA ' ' A' ' 19' ' ' SER . 31.0 p-90 -134.49 -8.24 2.52 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -170.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -96.75 114.39 26.03 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.029 -0.669 . . . . 0.0 111.327 -176.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -120.02 86.57 37.17 Favored Pre-proline 0 C--O 1.2 -1.528 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 176.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -54.11 -40.9 79.79 Favored 'Trans proline' 0 N--CA 1.479 0.628 0 C-N-CA 123.264 2.643 . . . . 0.0 115.936 -170.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -97.32 10.13 40.43 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -171.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.7 tp -75.61 136.81 40.47 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.454 0.645 . . . . 0.0 110.657 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.1 m -80.56 161.11 24.94 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.641 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.413 ' HA ' HH21 ' A' ' 47' ' ' ARG . 28.2 ttm180 -56.71 -51.42 68.87 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.275 0.63 . . . . 0.0 110.961 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -59.46 -44.66 92.93 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.583 0.706 . . . . 0.0 110.909 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -69.81 -30.53 68.07 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.863 -176.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.52 -36.97 82.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.667 0.746 . . . . 0.0 110.306 178.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 72.4 mt -69.73 -40.23 78.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.593 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.76 -33.31 73.86 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.789 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.87 -36.14 75.25 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.569 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.547 ' HB3' ' HG2' ' A' ' 61' ' ' LYS . 63.8 mt -87.85 -22.33 24.51 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -71.3 -9.42 58.09 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.571 0.7 . . . . 0.0 110.594 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -91.89 -25.18 19.06 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.43 174.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -106.71 155.58 19.52 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -169.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -66.07 156.5 84.16 Favored Pre-proline 0 C--N 1.32 -0.696 0 C-N-CA 125.334 1.454 . . . . 0.0 113.321 -172.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.24 111.96 1.26 Allowed 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 122.876 2.384 . . . . 0.0 111.045 175.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.05 -18.21 5.33 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -176.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.77 147.36 35.35 Favored 'General case' 0 C--O 1.251 1.146 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 177.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.401 ' HB2' HD11 ' A' ' 58' ' ' LEU . 25.0 p90 -153.17 169.48 22.9 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -175.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -160.35 154.33 22.98 Favored 'General case' 0 C--O 1.254 1.307 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 173.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 56.9 mt -126.8 137.61 57.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 123.354 0.409 . . . . 0.0 109.922 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.505 HH22 ' CD2' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -134.67 177.9 7.42 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 177.125 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -74.08 130.02 38.99 Favored 'General case' 0 C--O 1.249 1.034 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 175.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.0 t -82.56 92.76 7.17 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-O 121.526 0.679 . . . . 0.0 109.242 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -75.44 76.36 2.5 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-O 122.322 1.058 . . . . 0.0 108.782 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.5 t -161.87 -40.97 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 112.804 -1.998 . . . . 0.0 107.877 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -135.93 142.98 44.7 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -76.84 133.79 39.24 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.273 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.13 37.36 28.92 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.62 143.51 47.36 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -115.55 133.26 56.2 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.449 ' O ' ' HD3' ' A' ' 47' ' ' ARG . . . -97.83 119.14 6.32 Favored Glycine 0 C--N 1.283 -2.376 0 C-N-CA 119.836 -1.173 . . . . 0.0 112.018 -176.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.401 HD11 ' HB2' ' A' ' 44' ' ' PHE . 48.3 tp -97.4 136.08 38.36 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.422 ' HB2' HH12 ' A' ' 47' ' ' ARG . . . -122.04 129.97 52.88 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 173.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.4 tp -127.59 132.05 49.86 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 123.505 0.503 . . . . 0.0 110.957 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.547 ' HG2' ' HB3' ' A' ' 36' ' ' LEU . 0.7 OUTLIER -88.55 115.61 26.2 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 174.716 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.7 m -102.29 171.85 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.85 -56.09 6.36 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 p -152.57 137.6 11.03 Favored Pre-proline 0 N--CA 1.435 -1.204 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.477 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.501 ' HD2' ' CD ' ' A' ' 66' ' ' PRO . 16.6 Cg_exo -65.51 -44.7 8.14 Favored 'Trans proline' 0 CA--C 1.568 2.19 0 C-N-CA 121.625 1.55 . . . . 0.0 110.91 173.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.501 ' CD ' ' HD2' ' A' ' 65' ' ' PRO . 14.8 Cg_exo -71.14 165.6 31.9 Favored 'Trans proline' 0 C--N 1.397 3.098 0 C-N-CA 122.219 1.946 . . . . 0.0 109.87 168.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -50.58 -35.63 47.13 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.472 2.781 . . . . 0.0 112.953 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 65.2 m -151.7 -13.39 0.2 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 63.36 41.17 7.88 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.857 0.863 . . . . 0.0 111.835 175.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.403 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 22.0 mp0 -58.88 -51.8 79.27 Favored Pre-proline 0 CA--C 1.553 1.082 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.269 171.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 70' ' ' GLN . 30.2 Cg_endo -63.4 127.91 21.17 Favored 'Trans proline' 0 C--N 1.387 2.578 0 C-N-CA 122.072 1.848 . . . . 0.0 112.049 176.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -98.98 139.48 34.56 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.195 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -136.79 16.43 3.08 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.173 0.589 . . . . 0.0 110.067 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.34 64.53 1.76 Allowed Glycine 0 CA--C 1.486 -1.752 0 N-CA-C 107.024 -2.43 . . . . 0.0 107.024 -172.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -104.58 103.19 38.55 Favored Pre-proline 0 C--N 1.301 -1.524 0 CA-C-N 114.953 -0.623 . . . . 0.0 110.358 -172.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.516 ' HB2' ' OE1' ' A' ' 78' ' ' GLU . 71.7 Cg_endo -78.8 175.53 10.88 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.052 1.835 . . . . 0.0 111.236 177.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 p -68.96 -28.2 38.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.568 0.699 . . . . 0.0 110.589 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.516 ' OE1' ' HB2' ' A' ' 76' ' ' PRO . 11.7 mp0 -66.52 -22.09 66.17 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.172 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -78.03 -18.16 56.18 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.651 0.738 . . . . 0.0 109.607 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.0 mt -84.13 -4.16 58.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.427 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.0 t -92.72 118.73 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -90.85 145.78 24.48 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.505 ' CD2' HH22 ' A' ' 47' ' ' ARG . 29.7 m80 -120.52 125.56 48.16 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.195 0.521 . . . . 0.0 111.793 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -138.32 131.96 30.87 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.484 HD23 ' H ' ' A' ' 85' ' ' LEU . 1.6 pt? -104.83 142.36 34.86 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.893 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.442 ' CG2' HG22 ' A' ' 93' ' ' VAL . 4.6 mp -98.83 123.59 51.53 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.083 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.414 ' OE1' ' HD3' ' A' ' 96' ' ' LYS . 48.5 mt-10 -98.86 139.76 34.06 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.502 ' HB ' HG23 ' A' ' 93' ' ' VAL . 12.1 t -133.35 153.41 51.62 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.33 -152.21 11.33 Favored Glycine 0 N--CA 1.42 -2.415 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.73 -13.14 37.81 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.662 2.241 . . . . 0.0 112.669 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -86.62 -6.84 58.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.329 0.585 . . . . 0.0 110.6 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 109.42 -140.32 15.66 Favored Glycine 0 N--CA 1.427 -1.924 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.502 HG23 ' HB ' ' A' ' 88' ' ' THR . 12.5 p -132.28 126.3 55.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -146.77 140.99 26.25 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.391 -0.818 . . . . 0.0 112.969 -176.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.4 mt -72.04 126.75 33.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.562 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.414 ' HD3' ' OE1' ' A' ' 87' ' ' GLU . 25.7 tptp -76.01 97.91 4.15 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.511 ' O ' ' HD3' ' A' ' 99' ' ' PRO . . . 135.81 4.12 2.46 Favored Glycine 0 N--CA 1.425 -2.084 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.505 -176.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 46.0 t -93.23 104.79 13.09 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 97' ' ' GLY . 72.8 Cg_endo -89.64 -10.23 3.77 Favored 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 121.878 1.718 . . . . 0.0 112.419 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.4 t -71.16 -75.17 0.13 Allowed 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 176.32 103.9 0.1 Allowed Pre-proline 0 C--O 1.234 0.277 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.499 ' HB2' ' HB2' ' A' ' 94' ' ' LYS . 23.3 Cg_endo -96.25 -128.18 0.01 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.887 0 C-N-CA 122.841 2.361 . . . . 0.0 112.435 177.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.42 ' H ' ' HB2' ' A' ' 102' ' ' PRO . 89.2 m-85 62.43 86.87 0.11 Allowed 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 125.55 1.54 . . . . 0.0 111.231 -175.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -110.7 177.38 4.69 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 113.955 -1.475 . . . . 0.0 108.722 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -88.13 -48.01 4.22 Favored Glycine 0 C--N 1.314 -0.68 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.344 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.2 m -134.28 160.1 38.92 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 66.0 mt -56.84 -44.47 82.12 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.543 0.337 . . . . 0.0 111.389 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 32.3 t -54.91 -31.26 59.97 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.817 0.847 . . . . 0.0 111.102 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.33 -44.27 88.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.013 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.56 ' H ' HD13 ' A' ' 110' ' ' LEU 0.302 0.0 OUTLIER -80.26 -31.17 38.47 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 119.146 -1.021 . . . . 0.0 112.01 177.608 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.7 t -61.87 -54.2 37.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.169 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.1 t -70.5 -31.62 68.79 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -174.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -68.65 -25.91 65.06 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.726 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.465 ' CD2' ' H ' ' A' ' 119' ' ' ILE . 45.7 m80 -77.37 -0.98 27.76 Favored 'General case' 0 C--O 1.214 -0.814 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 35.1 m -78.42 -29.28 47.06 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 172.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 61.2 mt -96.66 -59.51 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.086 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.2 m -114.07 110.51 48.5 Favored Pre-proline 0 N--CA 1.428 -1.535 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.404 -175.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -75.13 98.37 1.16 Allowed 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 121.802 1.668 . . . . 0.0 109.603 174.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.465 ' H ' ' CD2' ' A' ' 114' ' ' HIS . 62.3 mt -91.67 -68.78 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.1 -176.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.0 t -90.37 -11.39 40.72 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.269 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 60.0 mt -117.69 144.44 34.35 Favored Pre-proline 0 C--N 1.295 -1.773 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -175.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -72.28 -24.01 20.23 Favored 'Trans proline' 0 N--CA 1.477 0.52 0 C-N-CA 122.767 2.311 . . . . 0.0 113.143 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 71.9 m -119.47 162.43 18.87 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 81.0 m -86.64 143.23 27.72 Favored 'General case' 0 N--CA 1.429 -1.522 0 O-C-N 123.467 0.479 . . . . 0.0 109.793 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 75.8 mt -76.44 118.82 19.52 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -95.08 98.83 10.94 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.543 HG22 ' H ' ' A' ' 129' ' ' SER . 13.8 mt -97.8 134.16 22.63 Favored Pre-proline 0 C--N 1.276 -2.616 0 CA-C-N 113.822 -1.536 . . . . 0.0 109.0 -172.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -57.57 -20.75 43.06 Favored 'Trans proline' 0 N--CA 1.484 0.926 0 C-N-CA 123.265 2.643 . . . . 0.0 112.131 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.543 ' H ' HG22 ' A' ' 127' ' ' ILE . 22.5 t -64.17 -33.72 76.44 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.267 176.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -108.24 119.57 39.88 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -176.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.6 t70 . . . . . 0 C--N 1.294 -1.821 0 CA-C-O 118.493 -0.765 . . . . 0.0 109.645 -179.941 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 CA--C 1.509 -0.634 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -90.21 129.63 36.44 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 173.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 -91.09 -22.3 20.78 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-O 121.159 0.504 . . . . 0.0 110.274 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -114.51 131.57 56.6 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.176 -176.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -92.64 101.31 13.72 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -106.97 -51.72 2.88 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.963 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -106.68 -15.98 14.62 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.974 0.416 . . . . 0.0 111.4 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.9 t -88.64 103.39 15.88 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 175.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.0 m -89.55 -28.79 19.36 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.555 -177.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.06 -126.77 10.53 Favored Glycine 0 N--CA 1.438 -1.188 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -175.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -121.72 86.58 2.6 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 120.941 0.4 . . . . 0.0 109.971 176.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.438 ' HB ' ' HD3' ' A' ' 13' ' ' PRO . 61.9 t -80.15 -66.67 0.25 Allowed Pre-proline 0 CA--C 1.546 0.814 0 CA-C-O 119.104 -0.474 . . . . 0.0 111.53 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.438 ' HD3' ' HB ' ' A' ' 12' ' ' VAL . 51.9 Cg_endo -70.03 -37.1 8.96 Favored 'Trans proline' 0 C--N 1.376 2.005 0 CA-C-N 120.412 1.183 . . . . 0.0 112.002 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 53.39 175.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 126.446 1.899 . . . . 0.0 111.998 -176.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -135.83 -119.43 1.89 Allowed Glycine 0 N--CA 1.408 -3.197 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 176.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.0 m -136.06 19.04 3.21 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -85.97 81.74 8.39 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.566 -179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.7 p -113.01 2.35 15.71 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 122.068 0.937 . . . . 0.0 109.989 -177.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.9 m -70.66 -33.97 71.53 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.819 -173.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -7.51 33.69 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.371 -178.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -74.74 -36.15 62.63 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.897 0.38 . . . . 0.0 110.711 177.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.44 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 36.6 p-90 -103.56 -14.17 16.28 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.165 0.507 . . . . 0.0 111.789 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -94.31 112.58 24.38 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.471 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -127.08 91.62 46.29 Favored Pre-proline 0 C--N 1.312 -1.062 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 175.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.12 -7.67 21.43 Favored 'Trans proline' 0 C--N 1.331 -0.353 0 C-N-CA 122.377 2.051 . . . . 0.0 112.835 -175.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -100.37 -15.3 18.02 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.18 -176.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.5 tp -81.67 120.9 25.68 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.308 -168.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 m -76.72 165.43 24.74 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.939 -177.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -54.63 -50.99 66.8 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -174.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -65.82 -29.68 70.19 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.338 0.59 . . . . 0.0 111.384 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -77.09 -35.96 56.09 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.616 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.36 -41.38 98.84 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.765 176.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.442 ' HA ' HG21 ' A' ' 81' ' ' VAL . 87.0 mt -66.31 -45.33 89.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.86 177.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.07 -27.95 69.26 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.184 0.516 . . . . 0.0 111.911 178.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.44 -49.31 12.51 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 6.7 mp -70.33 -26.56 63.82 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -177.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -70.25 -13.14 62.04 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.446 0.641 . . . . 0.0 109.869 176.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -97.34 -32.72 11.74 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.495 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -85.54 -10.49 55.89 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -172.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.5 t70 73.1 148.59 0.12 Allowed Pre-proline 0 N--CA 1.506 2.339 0 O-C-N 123.532 0.52 . . . . 0.0 111.905 175.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' A' ' 61' ' ' LYS . 88.1 Cg_exo -45.52 118.96 2.4 Favored 'Trans proline' 0 C--N 1.389 2.711 0 C-N-CA 123.726 2.95 . . . . 0.0 115.014 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.87 -35.25 2.22 Favored Glycine 0 N--CA 1.427 -1.959 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.039 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.98 144.1 50.62 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-O 121.153 0.501 . . . . 0.0 111.194 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -145.18 165.94 26.87 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -154.55 157.11 37.8 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 172.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.44 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 65.5 mt -122.75 128.71 75.36 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.1 ptt-85 -121.72 179.69 4.4 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -95.49 130.99 42.13 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.1 m -89.78 136.95 32.74 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 120.762 0.315 . . . . 0.0 110.287 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -91.58 -23.55 19.86 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.1 t -71.93 -35.59 69.67 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.728 -176.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -128.43 149.38 50.59 Favored 'General case' 0 C--O 1.242 0.7 0 O-C-N 121.985 -0.447 . . . . 0.0 110.187 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -82.81 120.78 26.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.595 -176.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.58 29.97 57.08 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.565 178.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -113.86 133.84 55.17 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.454 ' CD2' HD21 ' A' ' 107' ' ' LEU . 44.7 m-85 -107.87 124.66 50.43 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.74 114.63 4.48 Favored Glycine 0 C--N 1.286 -2.211 0 C-N-CA 120.075 -1.059 . . . . 0.0 111.226 -176.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.3 tp -92.35 128.97 38.39 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -118.86 127.73 53.79 Favored 'General case' 0 C--N 1.282 -2.37 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 175.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.4 tp -123.01 131.85 53.88 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 123.522 0.514 . . . . 0.0 109.946 -177.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 41' ' ' PRO . 27.2 tptp -87.89 114.51 24.57 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.411 HG21 ' HE ' ' A' ' 82' ' ' ARG . 23.6 m -108.08 172.33 2.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.386 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.59 -48.63 21.49 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -163.21 143.72 7.16 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 123.142 0.577 . . . . 0.0 111.859 -178.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.67 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 37.4 Cg_exo -63.71 -46.97 7.88 Favored 'Trans proline' 0 CA--C 1.578 2.709 0 C-N-CA 121.774 1.65 . . . . 0.0 111.316 164.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.67 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 81.3 Cg_endo -71.66 171.22 16.82 Favored 'Trans proline' 0 C--N 1.398 3.146 0 C-N-CA 123.057 2.505 . . . . 0.0 109.05 171.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -66.45 -60.43 0.11 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 121.532 1.488 . . . . 0.0 112.205 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.1 p -123.23 -7.1 8.25 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.677 -178.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 64.19 33.73 11.54 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.225 1.01 . . . . 0.0 111.117 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.422 ' HB2' ' HD3' ' A' ' 71' ' ' PRO . 28.1 mt-30 -60.66 -46.97 97.19 Favored Pre-proline 0 CA--C 1.553 1.072 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.25 175.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 70' ' ' GLN . 2.3 Cg_endo -84.99 108.01 1.13 Allowed 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 121.496 1.464 . . . . 0.0 109.539 172.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 49.0 t-105 -93.44 141.21 28.71 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.722 -176.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -119.26 -53.51 2.24 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.489 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 161.17 56.91 0.02 OUTLIER Glycine 0 CA--C 1.471 -2.7 0 N-CA-C 107.622 -2.191 . . . . 0.0 107.622 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -88.33 113.48 55.43 Favored Pre-proline 0 C--N 1.288 -2.098 0 CA-C-N 113.515 -1.342 . . . . 0.0 111.925 -171.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -85.66 164.42 10.64 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.195 1.93 . . . . 0.0 111.868 176.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.9 p -60.7 -19.73 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 121.597 0.713 . . . . 0.0 110.779 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -63.5 -21.72 66.48 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 123.951 0.9 . . . . 0.0 111.297 178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -92.82 -13.9 28.51 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 121.066 0.46 . . . . 0.0 110.902 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.9 mt -82.53 -8.54 59.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.968 0.89 . . . . 0.0 109.534 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.442 HG21 ' HA ' ' A' ' 33' ' ' ILE . 89.9 t -109.49 107.82 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.998 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 174.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.517 ' NH2' ' HA ' ' A' ' 65' ' ' PRO . 77.4 mtt180 -87.27 147.75 25.4 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.177 -177.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -123.73 122.61 38.52 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.14 -175.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -130.99 156.49 45.03 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.403 ' HG ' ' HB3' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -125.35 133.45 52.56 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.765 178.741 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.494 HG12 HG12 ' A' ' 95' ' ' ILE . 78.0 mt -94.31 113.98 30.0 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.432 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.203 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.83 128.22 46.96 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.599 ' HB ' HG12 ' A' ' 93' ' ' VAL . 9.3 t -99.62 115.82 30.3 Favored 'General case' 0 N--CA 1.413 -2.296 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 176.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -115.13 -170.08 16.18 Favored Glycine 0 N--CA 1.42 -2.414 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -177.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.65 -20.83 69.8 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.038 2.492 . . . . 0.0 112.92 -178.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -87.76 -39.74 14.66 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.923 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 158.97 -158.2 29.2 Favored Glycine 0 N--CA 1.431 -1.645 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 -177.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.599 HG12 ' HB ' ' A' ' 88' ' ' THR . 6.4 m -103.37 130.95 52.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -177.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.72 154.39 48.56 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.628 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.494 HG12 HG12 ' A' ' 86' ' ' ILE . 33.7 mt -94.06 130.42 43.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.439 0.638 . . . . 0.0 110.896 -174.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.403 ' HB3' ' HG ' ' A' ' 85' ' ' LEU . 33.1 ttmt -102.03 143.77 31.46 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.337 176.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 105.1 8.15 36.72 Favored Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 -172.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 59.4 m -121.23 153.06 58.11 Favored Pre-proline 0 N--CA 1.423 -1.818 0 CA-C-N 114.105 -1.048 . . . . 0.0 109.395 -176.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -57.52 -58.39 0.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.153 1.902 . . . . 0.0 110.424 176.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.8 m -162.55 108.86 1.23 Allowed 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 122.839 0.456 . . . . 0.0 110.371 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.461 ' HG2' ' HB ' ' A' ' 119' ' ' ILE . 51.4 mt-10 -128.89 133.49 25.27 Favored Pre-proline 0 C--N 1.299 -1.593 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.96 176.53 6.04 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.603 2.869 . . . . 0.0 115.775 -170.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -87.79 113.48 23.49 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.642 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -90.48 161.75 15.37 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.98 -58.21 9.39 Favored Glycine 0 CA--C 1.509 -0.309 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.486 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.5 m -136.78 171.85 13.88 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.454 HD21 ' CD2' ' A' ' 56' ' ' TYR . 95.1 mt -53.5 -47.2 70.07 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.643 0.589 . . . . 0.0 110.654 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.7 m -52.95 -29.65 30.05 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.592 1.157 . . . . 0.0 112.747 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.43 -36.93 71.46 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 120.889 0.376 . . . . 0.0 111.306 -177.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 107' ' ' LEU . 4.2 pp -80.1 -21.66 43.02 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.599 0.714 . . . . 0.0 110.06 178.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 107' ' ' LEU . 88.1 t -70.68 -42.9 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.416 176.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.6 p -72.96 -44.55 60.99 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 122.16 -0.338 . . . . 0.0 111.349 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -77.76 12.33 1.74 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.423 ' HB2' ' H ' ' A' ' 125' ' ' LEU . 35.0 p-80 -53.96 -35.1 61.42 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.182 1.393 . . . . 0.0 111.16 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 41.9 p -98.87 -4.06 33.89 Favored 'General case' 0 N--CA 1.401 -2.889 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.461 -172.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 52.2 mt -106.31 -42.79 6.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.25 -175.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.3 t -135.93 81.14 40.53 Favored Pre-proline 0 N--CA 1.435 -1.222 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.986 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -98.03 96.07 0.07 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.033 0 C-N-CA 122.425 2.083 . . . . 0.0 109.054 172.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.461 ' HB ' ' HG2' ' A' ' 101' ' ' GLU . 58.6 mt -90.89 -57.06 4.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.856 -175.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 27.6 t -91.76 -30.83 16.03 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.923 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.53 118.59 55.41 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.621 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.475 ' HG3' ' CZ ' ' A' ' 82' ' ' ARG . 89.4 Cg_endo -83.02 -3.89 11.14 Favored 'Trans proline' 0 C--O 1.243 0.735 0 C-N-CA 123.022 2.482 . . . . 0.0 112.265 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 84.8 m -145.32 149.26 34.5 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 79.0 m -88.93 148.4 23.83 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.423 ' H ' ' HB2' ' A' ' 114' ' ' HIS . 58.7 mt -70.3 107.27 3.68 Favored 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.513 -175.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -80.2 99.78 7.97 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.859 -0.526 . . . . 0.0 110.168 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.574 ' H ' HD12 ' A' ' 127' ' ' ILE . 3.9 mp -71.12 121.77 85.11 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.79 -177.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.47 -15.17 41.44 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 123.087 2.525 . . . . 0.0 113.381 -177.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.537 ' H ' HG22 ' A' ' 127' ' ' ILE . 23.2 t -103.73 -6.45 21.5 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.59 -1.187 . . . . 0.0 111.859 -178.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.44 ' HB2' ' HB ' ' A' ' 127' ' ' ILE . 74.8 mmtt -124.7 139.4 53.89 Favored 'General case' 0 CA--C 1.489 -1.368 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.895 -176.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.1 t70 . . . . . 0 C--N 1.285 -2.238 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.661 179.128 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.464 0.236 0 CA-C-O 120.442 0.163 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -100.87 132.9 46.05 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.2 p-80 -103.96 158.53 16.35 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.015 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -72.49 132.13 43.45 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 173.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -91.59 -13.36 32.1 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.29 0.567 . . . . 0.0 111.516 -175.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -139.01 168.15 20.47 Favored 'General case' 0 C--O 1.25 1.115 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 176.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -110.05 166.37 11.0 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 120.839 0.352 . . . . 0.0 110.562 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 64.6 m -154.21 120.33 5.35 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.0 t -73.69 -33.53 64.45 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.518 177.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.79 -67.86 3.49 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.349 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.5 tp -85.05 67.25 10.13 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 122.374 1.083 . . . . 0.0 111.558 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.481 ' H ' ' HD2' ' A' ' 13' ' ' PRO . 94.8 t -117.35 -58.22 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.793 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 173.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.481 ' HD2' ' H ' ' A' ' 12' ' ' VAL . 72.5 Cg_endo -79.2 141.02 16.0 Favored 'Trans proline' 0 N--CA 1.434 -1.972 0 N-CA-C 109.86 -0.861 . . . . 0.0 109.86 169.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -94.46 -41.1 9.55 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 176.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.12 -105.02 0.33 Allowed Glycine 0 N--CA 1.417 -2.574 0 CA-C-N 113.711 -1.586 . . . . 0.0 109.605 175.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.8 m -93.67 46.85 1.2 Allowed 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.919 0.866 . . . . 0.0 110.9 -177.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.406 ' HB2' ' HA ' ' A' ' 13' ' ' PRO . 3.4 m-20 -79.02 28.56 0.22 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.12 1.368 . . . . 0.0 111.947 -178.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.6 p -93.47 19.67 8.14 Favored 'General case' 0 C--N 1.273 -2.756 0 CA-C-O 121.519 0.676 . . . . 0.0 110.314 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.428 ' HA ' ' NE1' ' A' ' 22' ' ' TRP . 18.4 m -73.01 -28.76 62.56 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.761 -177.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.421 ' HD3' ' H ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -71.28 -10.12 59.23 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.689 0.757 . . . . 0.0 110.769 177.184 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -76.92 -21.1 55.35 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.258 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.428 ' NE1' ' HA ' ' A' ' 19' ' ' SER . 47.0 p-90 -113.67 -31.46 6.47 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 177.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.476 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 42.1 t80 -86.26 116.85 24.7 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.001 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -125.81 84.85 60.14 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.416 ' HD3' ' CD2' ' A' ' 23' ' ' TYR . 9.3 Cg_endo -54.4 -46.59 32.31 Favored 'Trans proline' 0 C--N 1.333 -0.282 0 C-N-CA 122.786 2.324 . . . . 0.0 115.818 -171.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -97.84 13.86 29.09 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -173.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.561 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 15.2 tp -83.3 145.84 28.86 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.504 -178.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.2 t -96.89 169.65 9.7 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -58.81 -50.32 74.42 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 123.524 0.729 . . . . 0.0 111.736 -175.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -58.34 -40.29 81.78 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.122 0.487 . . . . 0.0 111.083 -177.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -74.98 -29.91 61.03 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.872 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.92 -43.48 83.22 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.966 -0.754 . . . . 0.0 108.966 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 77.3 mt -66.24 -39.12 83.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.248 177.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.52 -32.24 70.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.782 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.404 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 49.8 mt -73.15 -47.06 47.15 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.569 0.699 . . . . 0.0 110.61 173.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.557 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 67.8 mt -69.68 -18.36 63.55 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -177.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.447 ' HB3' HG21 ' A' ' 77' ' ' VAL . 21.0 ptmt -84.28 -0.67 53.29 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.346 0.593 . . . . 0.0 110.073 176.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -114.05 -43.12 3.27 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.111 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 35' ' ' LEU . 43.3 mtpt -74.77 162.99 28.17 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.421 -176.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -70.22 138.48 86.98 Favored Pre-proline 0 C--N 1.308 -1.204 0 C-N-CA 124.212 1.005 . . . . 0.0 111.827 -174.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -57.28 114.04 1.76 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.676 2.251 . . . . 0.0 111.413 175.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.27 -22.69 3.94 Favored Glycine 0 N--CA 1.425 -2.077 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 -174.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.42 158.55 28.67 Favored 'General case' 0 C--O 1.251 1.181 0 CA-C-N 115.029 -0.585 . . . . 0.0 109.908 177.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -152.47 176.23 11.89 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -175.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -156.38 154.83 31.14 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 170.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 23' ' ' TYR . 66.6 mt -125.02 130.54 73.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.561 ' HD2' ' O ' ' A' ' 27' ' ' LEU . 28.1 ptt85 -133.05 171.27 14.21 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -72.82 132.03 43.05 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 171.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.5 m -67.81 -32.77 73.56 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 -177.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 39.9 m-70 71.91 -39.59 0.45 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.321 1.048 . . . . 0.0 113.167 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.2 m -58.59 -41.44 85.76 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 123.795 0.838 . . . . 0.0 111.18 178.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.49 150.7 45.49 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -84.56 135.02 34.38 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.65 38.45 50.84 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -177.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.55 133.16 39.96 Favored 'General case' 0 C--O 1.249 1.028 0 CA-C-O 120.891 0.377 . . . . 0.0 110.394 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.403 ' HB3' ' CG2' ' A' ' 46' ' ' ILE . 47.3 m-85 -116.73 126.83 53.71 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -91.39 114.15 4.45 Favored Glycine 0 C--N 1.288 -2.084 0 C-N-CA 120.148 -1.025 . . . . 0.0 111.324 -177.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.401 ' HB3' ' O ' ' A' ' 84' ' ' PHE . 2.2 tm? -92.08 117.77 30.16 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.65 115.73 30.43 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.4 tp -110.64 123.76 50.61 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.303 -177.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.557 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 22.3 tptm -91.23 114.35 26.85 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 176.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 80' ' ' LEU . 18.2 m -104.17 170.65 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.25 -58.28 5.13 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 p -161.85 124.15 1.73 Allowed Pre-proline 0 C--N 1.312 -1.06 0 C-N-CA 124.521 1.128 . . . . 0.0 108.713 176.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.627 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 35.6 Cg_exo -59.68 -47.1 17.22 Favored 'Trans proline' 0 CA--C 1.578 2.678 0 C-N-CA 121.688 1.592 . . . . 0.0 111.947 174.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.627 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 74.8 Cg_endo -73.46 153.29 49.87 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 123.19 2.593 . . . . 0.0 110.756 173.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -63.79 -46.92 7.81 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.402 2.068 . . . . 0.0 112.567 177.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.6 p -119.74 -8.28 9.92 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.401 ' HA ' ' CG ' ' A' ' 66' ' ' PRO . . . 66.8 36.57 4.49 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 124.414 1.086 . . . . 0.0 113.237 177.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.424 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 73.8 mt-30 -63.61 -48.85 79.77 Favored Pre-proline 0 CA--C 1.565 1.519 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.339 172.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 70' ' ' GLN . 18.3 Cg_endo -62.45 113.38 1.91 Allowed 'Trans proline' 0 C--N 1.389 2.709 0 C-N-CA 122.04 1.827 . . . . 0.0 111.919 173.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 57.0 t-105 -115.17 146.49 41.34 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.354 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -127.05 -28.82 2.84 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.834 0.35 . . . . 0.0 111.689 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 133.32 -41.71 1.45 Allowed Glycine 0 CA--C 1.489 -1.536 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.541 ' HB3' ' HB2' ' A' ' 78' ' ' GLU . 5.2 m-20 -68.11 118.56 59.97 Favored Pre-proline 0 C--N 1.299 -1.623 0 C-N-CA 123.862 0.865 . . . . 0.0 109.839 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 75' ' ' ASP . 5.7 Cg_exo -77.21 -79.64 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 121.902 1.735 . . . . 0.0 112.722 177.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 37' ' ' LYS . 3.2 p -73.74 -28.31 24.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 120.943 0.402 . . . . 0.0 111.624 -177.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.541 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 53.1 mp0 -68.28 -19.72 64.72 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.416 ' HG2' ' HB2' ' A' ' 75' ' ' ASP . 8.0 mm100 -78.62 -36.25 44.39 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 171.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.503 ' O ' HG22 ' A' ' 62' ' ' VAL . 49.5 mt -75.87 -25.71 56.41 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.838 -176.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 89.9 t -88.92 116.25 30.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -101.36 130.81 47.62 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -109.84 126.17 53.54 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.222 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.401 ' O ' ' HB3' ' A' ' 58' ' ' LEU . 98.0 m-85 -133.15 123.14 25.13 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 176.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.9 pp -96.84 131.95 43.08 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 118.709 -1.196 . . . . 0.0 111.113 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 79.7 mt -92.35 122.58 43.93 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 C-N-CA 124.568 1.147 . . . . 0.0 108.98 -178.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -99.84 146.82 26.18 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.482 ' HB ' HG12 ' A' ' 93' ' ' VAL . 9.7 t -127.88 142.27 51.32 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.41 -158.36 7.95 Favored Glycine 0 N--CA 1.433 -1.508 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -177.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.15 3.85 4.8 Favored 'Trans proline' 0 N--CA 1.482 0.847 0 C-N-CA 122.914 2.409 . . . . 0.0 113.566 -174.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -111.71 -42.1 3.9 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.89 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 158.9 -154.5 25.59 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.482 HG12 ' HB ' ' A' ' 88' ' ' THR . 10.7 m -104.02 147.66 9.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -178.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.9 pttp -146.07 141.98 28.12 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -176.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.2 mt -85.65 131.68 33.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -67.58 101.76 1.06 Allowed 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 102.37 45.56 1.68 Allowed Glycine 0 N--CA 1.429 -1.831 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.735 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.444 ' HB2' ' CD ' ' A' ' 101' ' ' GLU . 24.4 p -115.57 124.25 30.25 Favored Pre-proline 0 C--N 1.312 -1.049 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 177.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.93 -44.06 2.17 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.54 2.16 . . . . 0.0 115.316 -175.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.9 m -120.36 -16.37 8.43 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.833 -172.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.444 ' CD ' ' HB2' ' A' ' 98' ' ' CYS . 5.4 mp0 -60.34 125.21 81.26 Favored Pre-proline 0 C--N 1.3 -1.56 0 C-N-CA 123.276 0.631 . . . . 0.0 112.27 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -87.05 -167.67 0.37 Allowed 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 123.128 2.552 . . . . 0.0 110.967 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -81.65 109.74 16.35 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -81.48 147.26 29.8 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -78.88 -23.66 63.63 Favored Glycine 0 C--N 1.302 -1.317 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.06 -178.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.8 p -143.62 161.31 38.85 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.418 ' O ' HG23 ' A' ' 111' ' ' VAL . 94.6 mt -71.29 -31.69 67.75 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 173.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 m -56.85 -40.12 75.54 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.651 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.36 -50.81 71.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.995 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.2 pp -68.77 -29.02 67.32 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.648 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 107' ' ' LEU . 49.5 t -64.93 -50.28 75.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.145 0.498 . . . . 0.0 110.391 177.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.7 t -72.49 -38.52 68.14 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.508 -177.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -73.61 -36.46 65.48 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -174.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -76.52 -0.66 23.91 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.3 m -75.01 -40.69 60.48 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 170.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 63.8 mt -86.24 -44.34 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.128 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.3 m -136.16 94.85 13.79 Favored Pre-proline 0 C--N 1.303 -1.444 0 O-C-N 122.104 -0.373 . . . . 0.0 111.295 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -86.77 108.04 0.77 Allowed 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 123.008 2.472 . . . . 0.0 109.983 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.438 ' HB ' ' OE2' ' A' ' 101' ' ' GLU . 33.9 mt -89.63 -73.54 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.285 -177.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.9 t -66.72 -34.02 76.93 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.215 0.531 . . . . 0.0 110.222 176.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 81.5 mt -71.57 124.79 91.47 Favored Pre-proline 0 C--N 1.311 -1.071 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.701 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -65.04 -20.61 63.76 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.437 2.758 . . . . 0.0 113.354 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 78.0 m -136.99 169.18 18.2 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 80.6 m -73.59 136.51 43.95 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 123.261 0.351 . . . . 0.0 111.045 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 111' ' ' VAL . 22.7 tp -81.88 118.14 22.7 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -122.54 141.94 51.14 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.308 0.575 . . . . 0.0 111.273 -176.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.405 ' N ' HD12 ' A' ' 127' ' ' ILE . 2.8 mp -101.85 109.82 60.58 Favored Pre-proline 0 C--N 1.303 -1.422 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -74.44 -27.99 10.65 Favored 'Trans proline' 0 C--N 1.324 -0.745 0 C-N-CA 121.74 1.627 . . . . 0.0 112.275 -178.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.3 m -76.53 -16.36 59.64 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.679 -1.146 . . . . 0.0 113.109 -175.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.425 ' HD3' ' C ' ' A' ' 130' ' ' LYS . 12.2 tmtt? -149.74 128.19 12.24 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -177.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.406 ' N ' ' HD3' ' A' ' 130' ' ' LYS . 27.2 t70 . . . . . 0 C--N 1.288 -2.077 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 174.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 CA--C 1.507 -0.693 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 -97.93 115.75 28.76 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -131.19 160.79 33.79 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 39.2 m80 69.72 173.16 0.3 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.242 1.017 . . . . 0.0 111.907 176.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -141.56 100.99 3.89 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -126.99 -58.07 1.3 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.452 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 71.82 130.55 0.04 OUTLIER 'General case' 0 C--O 1.242 0.708 0 O-C-N 124.44 1.087 . . . . 0.0 112.31 -177.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.3 m -82.53 108.32 15.84 Favored 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 m -51.96 94.62 0.01 OUTLIER 'General case' 0 C--O 1.241 0.646 0 C-N-CA 125.002 1.321 . . . . 0.0 112.906 -176.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.1 90.51 0.47 Allowed Glycine 0 N--CA 1.436 -1.333 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.3 tp -178.98 -80.04 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.1 m -148.75 145.03 19.01 Favored Pre-proline 0 C--N 1.309 -1.179 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -47.5 -47.14 18.62 Favored 'Trans proline' 0 N--CA 1.476 0.481 0 C-N-CA 123.609 2.873 . . . . 0.0 113.935 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -98.44 19.36 14.59 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.326 0.584 . . . . 0.0 111.596 -176.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -130.88 39.36 1.8 Allowed Glycine 0 CA--C 1.496 -1.152 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.6 t -102.0 28.71 5.54 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -134.52 135.86 42.66 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.804 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.7 p -107.29 5.33 27.46 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -177.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.5 m -69.62 -24.13 63.6 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.972 -175.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.46 ' HD3' ' H ' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -81.13 -9.93 59.73 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 120.443 -0.503 . . . . 0.0 112.347 -177.658 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -76.6 -49.83 15.35 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.205 0.526 . . . . 0.0 111.588 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.454 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 29.6 p-90 -85.0 -12.95 52.09 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.768 -174.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -95.42 103.95 15.83 Favored 'General case' 0 N--CA 1.422 -1.831 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.683 -176.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.44 89.98 9.15 Favored Pre-proline 0 C--N 1.294 -1.844 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.099 174.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.73 18.79 0.81 Allowed 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 123.242 2.628 . . . . 0.0 112.411 -176.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -109.75 -3.73 16.55 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.79 -176.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.8 tp -101.19 130.61 47.31 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -172.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.0 m -79.45 170.68 16.23 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.593 0.757 . . . . 0.0 110.306 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -56.62 -53.71 54.51 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -69.85 -29.86 67.2 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.071 0.463 . . . . 0.0 110.654 -176.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -71.2 -33.42 69.92 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.686 176.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.4 -41.36 93.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.607 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 77.0 mt -67.3 -42.42 87.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.135 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.74 -28.78 67.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.857 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.71 -40.44 25.33 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.976 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.3 mp -86.73 -19.61 28.9 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -60.86 -36.56 79.48 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -92.92 3.01 56.49 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.307 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -99.4 169.58 9.23 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.708 0.766 . . . . 0.0 112.633 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -81.84 159.66 65.53 Favored Pre-proline 0 C--N 1.296 -1.722 0 C-N-CA 125.867 1.667 . . . . 0.0 111.368 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.02 111.88 2.79 Favored 'Trans proline' 0 C--N 1.36 1.172 0 C-N-CA 122.417 2.078 . . . . 0.0 110.32 176.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.88 -20.83 3.6 Favored Glycine 0 C--N 1.287 -2.159 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -176.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.01 136.49 48.4 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -151.75 173.04 15.21 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -177.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -155.91 158.05 37.32 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.454 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 65.8 mt -122.54 116.25 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.081 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 174.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.1 ptt-85 -108.23 -175.02 2.66 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -100.03 128.4 46.12 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.7 m -88.02 95.58 10.18 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.325 0.583 . . . . 0.0 110.162 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -73.86 11.98 0.77 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.775 0.797 . . . . 0.0 112.475 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.9 t -86.81 -15.81 38.13 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -146.28 -171.54 3.75 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -125.23 134.94 52.15 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 171.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.18 22.85 56.39 Favored Glycine 0 C--N 1.308 -1.006 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -128.52 127.63 42.77 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -101.37 162.1 13.15 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.29 118.54 3.43 Favored Glycine 0 C--N 1.286 -2.229 0 C-N-CA 119.875 -1.155 . . . . 0.0 111.474 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -98.8 127.48 44.74 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -178.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -122.6 117.35 25.63 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.6 tp -110.29 128.08 55.34 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 123.719 0.637 . . . . 0.0 110.287 -176.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -88.69 114.08 24.93 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 177.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 80' ' ' LEU . 25.5 m -103.58 171.49 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.84 -60.35 2.74 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.409 ' HB ' ' HG2' ' A' ' 66' ' ' PRO . 2.1 p -159.32 141.93 10.21 Favored Pre-proline 0 N--CA 1.433 -1.276 0 C-N-CA 124.923 1.289 . . . . 0.0 108.478 176.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.653 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 36.3 Cg_exo -59.62 -44.33 32.68 Favored 'Trans proline' 0 CA--C 1.574 2.508 0 C-N-CA 121.75 1.633 . . . . 0.0 111.645 171.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.653 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 59.1 Cg_endo -68.99 146.95 66.68 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 122.68 2.254 . . . . 0.0 110.038 170.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 66' ' ' PRO . 34.3 Cg_exo -62.13 -42.03 31.93 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.695 2.263 . . . . 0.0 113.103 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.4 m -118.56 -18.99 8.95 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.86 0.362 . . . . 0.0 110.235 -177.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.447 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 67.68 24.44 8.41 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.168 0.987 . . . . 0.0 112.564 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -67.92 -38.35 14.07 Favored Pre-proline 0 CA--C 1.558 1.262 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.968 172.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -68.05 108.91 1.82 Allowed 'Trans proline' 0 C--N 1.38 2.224 0 C-N-CA 121.208 1.272 . . . . 0.0 109.119 167.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -131.33 145.72 51.98 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -175.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -138.4 -37.59 0.55 Allowed 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.871 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.81 -57.41 0.03 OUTLIER Glycine 0 CA--C 1.48 -2.109 0 N-CA-C 107.27 -2.332 . . . . 0.0 107.27 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 54.84 93.83 0.05 OUTLIER Pre-proline 0 N--CA 1.468 0.433 0 C-N-CA 125.104 1.362 . . . . 0.0 113.975 169.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -83.37 165.53 14.4 Favored 'Trans proline' 0 C--O 1.243 0.743 0 C-N-CA 122.504 2.136 . . . . 0.0 112.347 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 p -68.99 -27.2 34.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.594 0.711 . . . . 0.0 110.592 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -66.51 -15.95 63.77 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.349 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -85.11 -19.47 31.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.567 0.699 . . . . 0.0 109.471 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.426 ' O ' HG22 ' A' ' 62' ' ' VAL . 72.2 mt -80.71 -11.27 59.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.005 -178.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.0 t -100.59 108.84 23.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -87.18 131.54 34.15 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -177.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -105.08 125.63 51.19 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.259 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -140.88 131.46 25.48 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 176.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.32 154.66 17.14 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 117.878 -1.529 . . . . 0.0 110.963 176.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.406 ' CG2' HG22 ' A' ' 93' ' ' VAL . 78.5 mt -115.37 125.97 72.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.408 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.973 -176.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.499 ' CD ' ' HE2' ' A' ' 96' ' ' LYS . 47.4 mt-10 -105.86 138.39 42.13 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.616 ' HB ' HG23 ' A' ' 93' ' ' VAL . 5.6 t -121.45 147.51 45.65 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.52 -167.05 29.52 Favored Glycine 0 N--CA 1.423 -2.217 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.91 -14.21 35.53 Favored 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 123.637 2.891 . . . . 0.0 114.636 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -89.0 -24.66 22.32 Favored 'General case' 0 CA--C 1.5 -0.966 0 O-C-N 121.752 -0.592 . . . . 0.0 111.401 176.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 132.53 -160.12 23.64 Favored Glycine 0 N--CA 1.423 -2.19 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -177.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.706 HG12 ' H ' ' A' ' 105' ' ' GLY . 7.7 p -118.38 136.85 54.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -177.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.19 169.13 25.48 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.424 ' HB ' ' HG3' ' A' ' 101' ' ' GLU . 59.7 mt -85.77 143.07 12.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-O 120.86 0.362 . . . . 0.0 110.929 -177.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.499 ' HE2' ' CD ' ' A' ' 87' ' ' GLU . 20.6 ttmm -99.17 140.57 33.14 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 172.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.08 43.06 4.19 Favored Glycine 0 CA--C 1.493 -1.303 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 24.5 p -129.73 157.61 76.11 Favored Pre-proline 0 N--CA 1.42 -1.968 0 CA-C-N 114.702 -0.749 . . . . 0.0 111.106 -171.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -65.56 -59.13 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 N-CA-C 107.72 -1.685 . . . . 0.0 107.72 167.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 67.0 m -164.32 125.57 2.2 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 124.522 1.129 . . . . 0.0 108.357 175.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.506 ' OE2' ' HB ' ' A' ' 119' ' ' ILE . 49.4 mm-40 -122.52 138.34 29.12 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.18 155.82 66.71 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.186 1.924 . . . . 0.0 110.688 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -91.59 99.48 12.39 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -64.62 -70.3 0.24 Allowed 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.353 0.597 . . . . 0.0 111.548 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.706 ' H ' HG12 ' A' ' 93' ' ' VAL . . . 145.17 -68.82 0.4 Allowed Glycine 0 C--N 1.3 -1.464 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 178.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.2 m -108.25 158.77 17.17 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.84 -36.53 82.54 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.4 t -64.81 -36.55 84.68 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.02 -47.36 83.39 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 175.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.3 tt -54.8 -50.79 67.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.113 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.518 ' HA ' HD23 ' A' ' 125' ' ' LEU . 69.1 t -61.55 -50.7 79.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.26 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.1 t -66.61 -31.68 72.53 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.171 0.51 . . . . 0.0 111.342 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -88.68 -18.97 26.79 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 121.711 -0.618 . . . . 0.0 112.657 -178.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -78.58 -9.36 59.33 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.137 0.494 . . . . 0.0 111.249 173.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.7 m -72.58 -27.62 62.3 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 170.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 35.2 mt -89.37 -60.14 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.575 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 27.0 m -120.57 99.17 47.86 Favored Pre-proline 0 N--CA 1.433 -1.324 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.968 -176.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -93.09 101.18 0.16 Allowed 'Trans proline' 0 N--CA 1.431 -2.169 0 C-N-CA 122.649 2.233 . . . . 0.0 109.482 172.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.506 ' HB ' ' OE2' ' A' ' 101' ' ' GLU . 63.8 mt -86.78 -62.36 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.12 -177.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.2 m -83.96 -16.88 42.49 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.273 0.559 . . . . 0.0 111.177 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.4 mt -90.12 123.7 65.19 Favored Pre-proline 0 C--N 1.305 -1.339 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -65.04 -30.19 56.52 Favored 'Trans proline' 0 N--CA 1.476 0.445 0 C-N-CA 122.808 2.339 . . . . 0.0 112.454 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 61.1 m -114.42 147.12 39.73 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.4 p -63.4 136.03 57.35 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 111' ' ' VAL . 18.8 tp -79.76 86.43 5.34 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -93.55 124.29 37.45 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.393 -175.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.461 ' H ' HD12 ' A' ' 127' ' ' ILE . 3.4 mp -70.78 112.04 11.82 Favored Pre-proline 0 C--N 1.315 -0.905 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -68.17 -31.89 28.47 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.366 2.044 . . . . 0.0 112.107 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 34.4 t 71.9 0.6 3.59 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.596 1.158 . . . . 0.0 111.057 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? -128.56 123.57 33.77 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.4 t70 . . . . . 0 C--O 1.258 1.507 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 177.26 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mmm . . . . . 0 N--CA 1.467 0.42 0 CA-C-O 120.403 0.144 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -72.11 117.36 13.64 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.382 -0.199 . . . . 0.0 111.474 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 39.9 m-70 70.89 18.4 6.08 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.326 1.05 . . . . 0.0 111.292 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -163.22 83.87 0.49 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.745 178.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -156.37 125.63 6.14 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.453 178.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -156.21 169.26 24.95 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -78.63 154.87 29.88 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.4 m -54.34 -37.14 64.55 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -175.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.1 m -87.19 -13.71 43.19 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.31 -72.72 1.4 Allowed Glycine 0 C--O 1.241 0.549 0 N-CA-C 111.613 -0.595 . . . . 0.0 111.613 -176.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.6 tp -171.96 -53.62 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 124.524 1.129 . . . . 0.0 108.829 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.2 t 61.03 81.23 0.24 Allowed Pre-proline 0 N--CA 1.473 0.688 0 C-N-CA 124.727 1.211 . . . . 0.0 109.895 -176.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -85.32 30.44 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.722 2.282 . . . . 0.0 113.529 -173.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -105.38 76.47 1.22 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.582 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -108.55 -3.24 32.77 Favored Glycine 0 CA--C 1.493 -1.308 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.276 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.5 p -101.41 13.84 33.81 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.78 0.8 . . . . 0.0 110.915 -176.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.515 ' O ' ' HE2' ' A' ' 20' ' ' LYS . 2.0 m-20 -95.35 118.92 32.95 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.926 -177.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.63 7.05 15.92 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -174.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.8 m -100.32 -19.66 16.22 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.439 177.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.515 ' HE2' ' O ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -66.31 3.52 0.9 Allowed 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 -176.469 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -85.42 -40.27 16.62 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 14.7 p-90 -120.74 -8.94 9.41 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -172.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -92.19 110.84 22.23 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.653 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.55 ' HB3' HD13 ' A' ' 27' ' ' LEU . 1.3 mptp? -128.52 89.03 50.7 Favored Pre-proline 0 C--N 1.313 -0.988 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.41 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.09 -1.64 8.27 Favored 'Trans proline' 0 CA--C 1.552 1.395 0 C-N-CA 122.722 2.282 . . . . 0.0 114.649 -177.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -90.84 -21.73 21.32 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.312 0.577 . . . . 0.0 109.87 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.55 HD13 ' HB3' ' A' ' 24' ' ' LYS . 9.8 mp -86.22 142.28 28.7 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -174.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.3 m -111.31 178.09 4.45 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 174.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -47.05 -52.28 15.41 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -58.45 -43.46 88.85 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.773 0.829 . . . . 0.0 110.73 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -70.79 -32.59 69.74 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.373 -177.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.2 -41.23 86.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.413 0.625 . . . . 0.0 109.803 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 72.0 mt -66.33 -40.41 86.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.828 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.83 -29.5 68.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.202 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.03 -47.45 11.68 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.444 HD12 HG13 ' A' ' 81' ' ' VAL . 72.6 mt -74.28 -19.44 60.49 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -176.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -72.01 -18.36 61.97 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.114 174.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -93.78 -35.54 12.71 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.386 178.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 36' ' ' LEU . 24.2 mmmt -77.38 171.11 15.38 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -71.59 164.28 59.25 Favored Pre-proline 0 C--N 1.314 -0.96 0 C-N-CA 126.753 2.021 . . . . 0.0 111.71 -176.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -75.91 126.5 9.42 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 121.815 1.677 . . . . 0.0 108.37 169.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.02 -9.62 43.38 Favored Glycine 0 C--N 1.292 -1.915 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -175.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.08 155.61 26.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.439 ' CG ' HD22 ' A' ' 125' ' ' LEU . 15.0 p90 -156.56 170.8 21.54 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.763 -173.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -156.43 149.99 24.66 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 172.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 68.7 mt -121.05 129.59 75.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -139.94 172.44 12.77 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.503 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -75.52 137.15 40.68 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 t -86.33 129.57 34.81 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -90.86 -14.84 31.0 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.5 t -70.5 -45.58 65.37 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.409 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -134.7 142.71 46.88 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -85.71 138.22 32.27 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.9 21.46 50.11 Favored Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.26 144.85 48.62 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 115.537 -0.332 . . . . 0.0 110.22 -178.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -116.28 132.82 56.56 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.3 120.25 5.69 Favored Glycine 0 C--N 1.287 -2.151 0 C-N-CA 119.932 -1.127 . . . . 0.0 111.46 -177.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -95.82 120.49 36.18 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.4 ' HB2' HH12 ' A' ' 47' ' ' ARG . . . -112.76 125.04 53.89 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.515 HD11 ' HB3' ' A' ' 123' ' ' CYS . 3.4 tm? -123.66 126.8 47.22 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -178.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -89.2 114.79 26.15 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 80' ' ' LEU . 32.8 m -99.67 171.64 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.26 -47.2 36.55 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.4 p -156.06 129.57 4.54 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 124.347 1.059 . . . . 0.0 108.988 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.651 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 28.0 Cg_exo -62.43 -45.08 15.73 Favored 'Trans proline' 0 CA--C 1.57 2.308 0 C-N-CA 121.884 1.723 . . . . 0.0 113.017 174.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.757 ' HG2' ' HB2' ' A' ' 69' ' ' ALA . 37.4 Cg_endo -63.94 142.66 82.74 Favored 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 122.273 1.982 . . . . 0.0 110.396 174.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -61.53 -34.48 85.31 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 123.349 2.7 . . . . 0.0 113.861 -174.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.1 p -119.07 -42.22 2.71 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.757 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 72.37 7.47 5.66 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 124.82 1.248 . . . . 0.0 113.106 174.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.443 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 64.8 tt0 -72.53 -55.75 4.35 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-O 119.121 -0.466 . . . . 0.0 112.028 -178.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 70' ' ' GLN . 6.9 Cg_endo -88.08 62.87 3.38 Favored 'Trans proline' 0 C--N 1.365 1.427 0 C-N-CA 121.461 1.44 . . . . 0.0 111.108 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.416 ' HE1' ' HB3' ' A' ' 75' ' ' ASP . 59.7 t-105 -160.66 141.27 11.59 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 113.353 -1.749 . . . . 0.0 110.441 -176.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.83 80.16 0.63 Allowed 'General case' 0 N--CA 1.413 -2.298 0 CA-C-O 122.635 1.207 . . . . 0.0 110.429 169.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.17 40.88 0.49 Allowed Glycine 0 C--N 1.301 -1.393 0 CA-C-N 114.213 -1.358 . . . . 0.0 112.165 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.416 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 6.9 p-10 -136.5 127.8 16.79 Favored Pre-proline 0 C--N 1.305 -1.337 0 CA-C-O 120.755 0.312 . . . . 0.0 111.054 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 79' ' ' GLN . 8.4 Cg_endo -91.55 177.37 1.89 Allowed 'Trans proline' 0 N--CA 1.436 -1.875 0 C-N-CA 121.829 1.686 . . . . 0.0 109.4 168.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.7 p -58.89 -24.99 27.99 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-O 121.603 0.716 . . . . 0.0 111.632 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.7 -26.77 64.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.006 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.461 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 8.5 tp-100 -80.95 -16.68 52.82 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 121.144 0.497 . . . . 0.0 109.711 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.453 ' O ' HG22 ' A' ' 62' ' ' VAL . 77.4 mt -74.53 -12.59 60.51 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-O 121.68 0.753 . . . . 0.0 109.991 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.444 HG13 HD12 ' A' ' 36' ' ' LEU . 74.7 t -88.3 125.9 41.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 176.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.404 ' NE ' ' HA ' ' A' ' 82' ' ' ARG . 3.9 mmp_? -105.23 143.84 32.84 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -118.75 133.87 55.54 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -139.15 167.33 22.3 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.05 138.11 41.83 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.94 177.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.522 HG12 HG12 ' A' ' 95' ' ' ILE . 80.1 mt -97.03 114.82 34.99 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-N 114.187 -1.369 . . . . 0.0 107.395 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -99.62 137.23 38.39 Favored 'General case' 0 C--N 1.273 -2.727 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.542 ' HB ' HG12 ' A' ' 93' ' ' VAL . 6.1 t -113.06 143.44 44.33 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -155.83 -157.97 8.56 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -73.18 -14.28 25.81 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.224 1.949 . . . . 0.0 112.823 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.467 ' HD2' ' N ' ' A' ' 91' ' ' LYS . 0.1 OUTLIER -84.88 -28.77 25.76 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 121.519 0.675 . . . . 0.0 110.331 177.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 139.19 -147.5 19.26 Favored Glycine 0 N--CA 1.433 -1.562 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.542 HG12 ' HB ' ' A' ' 88' ' ' THR . 15.0 m -113.52 141.5 29.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.67 150.31 26.17 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.674 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.522 HG12 HG12 ' A' ' 86' ' ' ILE . 83.3 mt -86.14 133.76 28.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.704 0.764 . . . . 0.0 111.309 -176.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -93.01 124.17 36.8 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 173.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 113.94 42.6 0.84 Allowed Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -174.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 120' ' ' SER . 13.5 p -129.34 144.9 54.6 Favored Pre-proline 0 N--CA 1.428 -1.529 0 CA-C-N 115.421 -0.39 . . . . 0.0 110.123 -175.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -67.33 -28.13 39.88 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.395 2.064 . . . . 0.0 111.928 176.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.5 t -153.86 -89.87 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.441 ' OE2' ' HB ' ' A' ' 95' ' ' ILE . 28.2 tt0 65.78 133.03 0.04 OUTLIER Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 125.377 1.471 . . . . 0.0 112.986 173.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -79.2 172.58 14.53 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.412 2.075 . . . . 0.0 112.557 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -92.39 131.89 37.2 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 175.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -102.42 170.7 7.89 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -177.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -99.55 -52.69 1.19 Allowed Glycine 0 C--N 1.3 -1.447 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.5 m -111.72 153.85 25.86 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.491 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 64.4 mt -63.24 -36.68 84.45 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.4 m -54.23 -30.19 49.24 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.486 1.114 . . . . 0.0 112.158 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.53 -41.95 92.53 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.112 -177.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 107' ' ' LEU . 4.2 pp -77.0 -31.33 56.38 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.969 0.414 . . . . 0.0 110.081 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.442 ' HA ' ' CD1' ' A' ' 125' ' ' LEU . 55.3 t -59.5 -54.73 30.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.455 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.4 m -72.48 -25.71 61.52 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.905 -177.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -84.13 -36.99 22.53 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.988 -176.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -72.13 -5.22 33.96 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -177.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.6 m -74.37 -31.9 62.56 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.6 mt -94.93 -50.16 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.972 -178.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 45.3 m -132.88 96.75 17.67 Favored Pre-proline 0 C--N 1.31 -1.142 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.979 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -81.86 114.23 2.58 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.702 2.268 . . . . 0.0 109.715 176.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 65.3 mt -91.49 -64.69 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 120.771 0.32 . . . . 0.0 110.512 -176.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.56 ' HB3' ' HB3' ' A' ' 98' ' ' CYS . 2.3 p -74.95 -49.66 19.35 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.467 0.651 . . . . 0.0 110.263 176.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.404 ' CD2' HD21 ' A' ' 125' ' ' LEU . 7.9 mp -65.87 137.69 96.15 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.877 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -80.53 -9.8 13.45 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.637 2.225 . . . . 0.0 112.92 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.515 ' HB3' HD11 ' A' ' 60' ' ' LEU . 44.8 t -136.35 150.69 48.96 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -178.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 24.8 p -71.82 146.11 48.21 Favored 'General case' 0 C--O 1.252 1.198 0 O-C-N 123.775 0.672 . . . . 0.0 110.555 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.442 ' CD1' ' HA ' ' A' ' 111' ' ' VAL . 91.6 mt -77.81 128.19 33.61 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.388 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -106.4 103.04 12.41 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 127' ' ' ILE . 3.4 mp -88.69 122.58 69.15 Favored Pre-proline 0 C--N 1.313 -1.002 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.865 -176.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.05 -35.37 90.16 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 123.162 2.574 . . . . 0.0 112.116 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.0 m 67.19 -25.63 0.12 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 126.008 1.723 . . . . 0.0 115.281 175.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -110.82 121.79 46.23 Favored 'General case' 0 N--CA 1.434 -1.253 0 O-C-N 121.789 -0.569 . . . . 0.0 111.559 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.9 t70 . . . . . 0 C--N 1.303 -1.44 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 173.206 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 ttm . . . . . 0 CA--C 1.516 -0.343 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -79.24 -90.22 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -179.76 126.83 0.08 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -170.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -132.92 -83.35 0.47 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -111.9 -5.45 14.35 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -176.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -103.77 114.07 28.05 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -73.86 116.6 14.66 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.785 0.802 . . . . 0.0 111.766 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.9 m -92.0 42.43 1.1 Allowed 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.674 0.75 . . . . 0.0 109.832 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.2 m -135.41 164.17 28.38 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.32 -92.27 1.34 Allowed Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -157.78 149.72 22.09 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.8 t -118.6 99.95 51.31 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 174.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.61 138.27 19.1 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.721 2.281 . . . . 0.0 112.892 -175.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -109.67 141.46 42.2 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.023 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.75 35.04 72.93 Favored Glycine 0 N--CA 1.44 -1.05 0 O-C-N 123.428 0.455 . . . . 0.0 112.328 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.3 m -79.0 -18.03 54.36 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 122.18 0.991 . . . . 0.0 110.206 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -122.57 129.65 52.16 Favored 'General case' 0 C--N 1.274 -2.697 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.418 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.5 p -118.55 12.23 13.12 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.4 m -56.8 -40.53 76.11 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.618 -177.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -60.0 -25.08 64.99 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -178.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -77.26 -27.82 53.31 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 120.876 0.369 . . . . 0.0 111.141 -177.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.0 p-90 -119.1 -17.97 8.83 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -176.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -94.42 110.22 22.02 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.657 -176.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.08 94.27 14.43 Favored Pre-proline 0 C--N 1.309 -1.188 0 C-N-CA 124.407 1.083 . . . . 0.0 108.644 174.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 47' ' ' ARG . 83.3 Cg_endo -75.0 -23.22 14.0 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.856 3.038 . . . . 0.0 117.463 -169.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -101.43 14.55 31.61 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 118.9 0.773 . . . . 0.0 111.167 -174.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.3 tp -88.66 135.3 33.57 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.6 m -82.87 163.54 21.08 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 122.341 -0.225 . . . . 0.0 110.971 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -52.88 -51.48 60.95 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -173.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -65.44 -37.35 86.63 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.414 0.626 . . . . 0.0 110.999 -176.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -72.08 -28.32 63.24 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.496 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.15 -45.18 74.25 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 175.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.458 HG23 HG21 ' A' ' 81' ' ' VAL . 77.1 mt -63.49 -35.1 71.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.52 177.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.99 -34.67 43.55 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.261 176.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.558 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 3.8 mm? -72.33 -50.41 27.05 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.502 0.667 . . . . 0.0 109.506 174.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.1 mp -70.64 -13.53 62.12 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -173.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -84.79 -1.25 56.12 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.543 0.687 . . . . 0.0 109.26 174.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -114.84 -30.44 6.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.876 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 35' ' ' LEU . 61.8 mmtt -80.28 -179.05 6.9 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -174.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -83.82 156.33 64.51 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.718 -177.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -66.16 115.08 3.28 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 121.922 1.748 . . . . 0.0 108.933 171.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 124.56 -17.56 7.34 Favored Glycine 0 C--N 1.297 -1.593 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -174.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.48 151.99 37.94 Favored 'General case' 0 C--O 1.249 1.06 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -154.44 174.87 14.3 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.333 -174.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -156.43 151.19 25.93 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 171.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.3 mt -120.22 129.66 75.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 19.9 ptt180 -119.51 172.74 7.43 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -100.56 127.28 46.99 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.1 m -107.53 119.43 39.41 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -173.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 -79.9 76.13 6.6 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.902 0.858 . . . . 0.0 108.971 174.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 t -136.2 -52.07 0.72 Allowed 'General case' 0 C--N 1.271 -2.805 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -128.86 168.97 15.16 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 176.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -88.58 121.74 31.28 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.361 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.81 50.97 7.41 Favored Glycine 0 N--CA 1.422 -2.263 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 86' ' ' ILE . . . -124.06 113.68 18.72 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.427 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 57.2 m-85 -98.78 125.14 44.05 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.296 -0.865 . . . . 0.0 108.707 -178.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.51 111.51 4.22 Favored Glycine 0 C--N 1.289 -2.033 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.318 -176.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 83' ' ' HIS . 38.9 tp -91.5 121.81 33.53 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -107.2 118.9 37.93 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 174.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.5 tp -114.73 130.88 56.9 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 123.496 0.497 . . . . 0.0 110.562 -177.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -90.66 113.71 25.83 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.516 ' HB ' ' SG ' ' A' ' 123' ' ' CYS . 17.7 m -98.25 162.13 2.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.6 -56.52 5.21 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 p -163.17 136.8 4.53 Favored Pre-proline 0 N--CA 1.425 -1.723 0 C-N-CA 126.883 2.073 . . . . 0.0 105.612 175.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.671 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 36.4 Cg_exo -59.81 -46.59 19.18 Favored 'Trans proline' 0 CA--C 1.572 2.419 0 C-N-CA 120.929 1.086 . . . . 0.0 111.339 172.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.671 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 67.3 Cg_endo -67.75 149.58 78.72 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 122.606 2.204 . . . . 0.0 110.13 172.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.01 -41.56 7.37 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.104 1.87 . . . . 0.0 112.435 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 33.1 t -110.78 -32.39 6.87 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.389 -177.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.586 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 64.82 38.16 6.86 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 123.86 0.864 . . . . 0.0 110.515 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -59.71 -44.54 97.54 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.018 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -70.25 95.56 0.6 Allowed 'Trans proline' 0 C--N 1.374 1.882 0 N-CA-C 108.746 -1.29 . . . . 0.0 108.746 167.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 56.4 t-105 -113.14 150.46 32.15 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.203 -173.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -137.61 -46.38 0.55 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 122.431 1.11 . . . . 0.0 108.032 176.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 146.57 -76.94 0.26 Allowed Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 107.323 -2.311 . . . . 0.0 107.323 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 72.95 135.35 0.05 OUTLIER Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 125.269 1.428 . . . . 0.0 111.265 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.56 156.02 59.38 Favored 'Trans proline' 0 C--O 1.239 0.533 0 C-N-CA 122.389 2.059 . . . . 0.0 110.947 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.8 p -62.01 -21.55 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.55 0.691 . . . . 0.0 110.281 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -66.05 -21.29 66.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.547 178.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -82.98 -28.18 29.91 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.252 0.549 . . . . 0.0 109.571 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.469 ' O ' HG22 ' A' ' 62' ' ' VAL . 2.8 mm? -84.92 -7.99 58.94 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.984 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.458 HG21 HG23 ' A' ' 33' ' ' ILE . 92.6 t -103.56 102.05 13.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 173.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -96.25 143.33 27.43 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.798 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.471 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 69.6 m80 -113.25 123.23 49.68 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.29 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -124.98 131.68 53.38 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 1.0 OUTLIER -102.98 132.19 49.41 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 118.756 -1.177 . . . . 0.0 112.666 179.737 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 55' ' ' ALA . 4.0 mp -87.64 125.24 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 175.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -99.39 125.83 45.16 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 92' ' ' GLY . 11.0 t -114.55 142.07 46.91 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 175.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.21 -138.3 4.4 Favored Glycine 0 N--CA 1.418 -2.516 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -67.84 -24.29 40.42 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.901 2.401 . . . . 0.0 113.971 -175.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -88.79 -17.85 28.94 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.583 0.706 . . . . 0.0 110.503 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.536 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . 114.9 -152.51 18.09 Favored Glycine 0 N--CA 1.424 -2.166 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 -178.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.476 HG12 ' HB ' ' A' ' 88' ' ' THR . 6.3 m -104.79 125.99 59.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.82 150.87 26.52 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 121.804 -0.56 . . . . 0.0 109.966 177.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 75.8 mt -73.96 131.28 35.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 123.306 0.379 . . . . 0.0 110.961 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -72.89 119.59 17.34 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 123.976 0.91 . . . . 0.0 109.325 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.62 15.01 48.21 Favored Glycine 0 C--O 1.243 0.677 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.756 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.501 ' SG ' ' HB2' ' A' ' 120' ' ' SER . 19.4 t -85.05 125.36 70.65 Favored Pre-proline 0 N--CA 1.435 -1.187 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -53.02 -28.71 41.4 Favored 'Trans proline' 0 N--CA 1.487 1.098 0 C-N-CA 123.69 2.927 . . . . 0.0 113.652 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.2 m -142.33 119.11 11.14 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 178.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -90.95 116.63 66.83 Favored Pre-proline 0 C--N 1.283 -2.321 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -82.1 -19.32 6.95 Favored 'Trans proline' 0 C--N 1.328 -0.551 0 C-N-CA 122.204 1.936 . . . . 0.0 114.193 -176.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 50.83 98.87 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.215 0 C-N-CA 126.667 1.987 . . . . 0.0 113.234 -176.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.426 ' CD2' ' HB3' ' A' ' 110' ' ' LEU . 77.8 m-85 -111.67 178.84 4.19 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.67 -30.73 2.52 Favored Glycine 0 C--N 1.305 -1.183 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.729 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.0 m -115.36 143.83 44.69 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.426 ' O ' HG23 ' A' ' 111' ' ' VAL . 57.9 mt -62.51 -43.07 99.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.6 t -60.92 -29.46 69.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.926 0.393 . . . . 0.0 110.925 -177.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.46 -43.09 98.35 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.518 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.458 HD23 HG23 ' A' ' 93' ' ' VAL . 3.7 pp -76.3 -30.92 57.94 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.961 178.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.528 ' HA ' HD23 ' A' ' 125' ' ' LEU . 56.4 t -62.74 -51.65 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.69 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.6 t -65.31 -25.46 67.63 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.563 -176.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.482 ' HA ' ' OE1' ' A' ' 113' ' ' GLN . 9.3 mm-40 -85.27 -30.55 23.69 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.141 -0.623 . . . . 0.0 111.728 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 49.3 m80 -74.52 -6.66 49.68 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.062 0.458 . . . . 0.0 111.702 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.0 m -71.84 -29.99 64.98 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 173.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 60.3 mt -100.21 -53.01 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.664 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.7 m -120.8 96.29 48.76 Favored Pre-proline 0 N--CA 1.434 -1.256 0 CA-C-O 120.99 0.424 . . . . 0.0 111.727 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.451 ' HB2' ' O ' ' A' ' 121' ' ' LEU . 44.1 Cg_endo -75.1 101.64 1.5 Allowed 'Trans proline' 0 N--CA 1.43 -2.213 0 C-N-CA 121.324 1.349 . . . . 0.0 109.982 173.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 45.6 mt -76.6 -59.82 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.261 0.553 . . . . 0.0 109.925 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.501 ' HB2' ' SG ' ' A' ' 98' ' ' CYS . 21.5 t -84.51 -29.84 25.65 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.568 0.699 . . . . 0.0 109.482 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.451 ' O ' ' HB2' ' A' ' 118' ' ' PRO . 6.9 mp -80.69 142.8 53.49 Favored Pre-proline 0 C--N 1.299 -1.615 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.212 -175.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -82.89 -20.01 5.59 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.379 2.053 . . . . 0.0 112.02 176.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.516 ' SG ' ' HB ' ' A' ' 62' ' ' VAL . 83.8 m -126.72 160.52 30.58 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 60.3 m -72.6 140.79 48.24 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 123.545 0.528 . . . . 0.0 110.562 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.528 HD23 ' HA ' ' A' ' 111' ' ' VAL . 22.8 tp -85.74 102.38 13.59 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -110.07 119.65 39.95 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -173.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.4 mp -61.77 123.61 77.93 Favored Pre-proline 0 C--O 1.247 0.934 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.162 -176.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -54.87 -50.9 11.7 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 123.042 2.494 . . . . 0.0 112.477 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.9 m 59.27 18.22 6.44 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.5 1.12 . . . . 0.0 112.191 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.41 175.18 9.31 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 -177.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.261 1.667 0 O-C-N 124.499 1.124 . . . . 0.0 112.265 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.5 mmt . . . . . 0 CA--C 1.504 -0.825 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -71.01 -63.72 1.05 Allowed 'General case' 0 C--N 1.323 -0.547 0 O-C-N 123.552 0.533 . . . . 0.0 112.337 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -89.49 -55.31 3.71 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.032 0.444 . . . . 0.0 110.874 -175.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -166.02 -177.21 4.1 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 -176.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -64.26 116.88 6.44 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 172.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -75.03 17.78 0.21 Allowed 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -168.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 35.7 m170 -85.83 127.4 34.56 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 175.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 56.2 m 69.82 19.24 7.18 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 123.949 0.781 . . . . 0.0 110.761 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.6 t -71.39 -45.97 61.47 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.551 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.29 172.65 13.78 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 83.8 mt -100.27 104.25 15.72 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 177.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.4 t 63.63 77.32 0.32 Allowed Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -170.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.69 109.56 0.6 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.229 2.619 . . . . 0.0 112.602 -175.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -148.74 172.01 15.3 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -122.43 -110.36 2.05 Favored Glycine 0 N--CA 1.418 -2.55 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 175.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.2 p -100.08 7.11 44.88 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.816 0.817 . . . . 0.0 111.181 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -100.69 108.78 20.72 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.151 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.6 p -115.1 18.41 16.29 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 115.208 -0.905 . . . . 0.0 108.599 175.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.8 m -92.37 -43.45 9.23 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.771 -174.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.08 -5.13 8.81 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -176.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -78.26 -20.8 50.93 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.368 0.604 . . . . 0.0 109.553 175.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.484 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 37.9 p-90 -122.83 -30.66 3.79 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.239 176.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 38.4 t80 -95.22 122.06 37.51 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 120.981 0.42 . . . . 0.0 110.516 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.25 104.79 2.41 Favored Pre-proline 0 C--N 1.306 -1.307 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.946 174.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.36 22.96 0.55 Allowed 'Trans proline' 0 N--CA 1.486 1.031 0 C-N-CA 123.738 2.959 . . . . 0.0 114.116 -174.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -98.97 -12.28 20.78 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.461 0.648 . . . . 0.0 109.481 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.537 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 3.8 mm? -92.86 130.33 38.49 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.565 -178.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.1 m -90.66 175.85 6.88 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 172.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -57.54 -46.89 83.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 118.219 0.463 . . . . 0.0 112.143 -178.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -66.85 -38.59 86.66 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.561 0.696 . . . . 0.0 110.492 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -66.57 -37.65 85.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.096 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.6 -41.73 90.98 Favored 'General case' 0 CA--C 1.509 -0.635 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.265 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 72.5 mt -63.17 -48.01 89.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.68 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.412 ' HA ' ' CD ' ' A' ' 37' ' ' LYS . . . -63.34 -30.13 71.32 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.374 0.607 . . . . 0.0 111.775 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.08 -49.03 11.38 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.463 -178.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.528 ' HG ' ' HB2' ' A' ' 61' ' ' LYS . 16.1 tp -80.13 -16.93 53.87 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.538 -173.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.433 ' HB2' HG21 ' A' ' 77' ' ' VAL . 14.9 ptmm? -63.06 -31.26 72.35 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 122.061 -0.399 . . . . 0.0 110.796 178.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -82.02 -14.48 55.87 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.835 0.826 . . . . 0.0 110.283 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -85.93 162.84 18.37 Favored 'General case' 0 C--O 1.254 1.331 0 CA-C-O 121.665 0.745 . . . . 0.0 111.382 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.08 144.02 98.25 Favored Pre-proline 0 C--N 1.305 -1.345 0 CA-C-N 113.728 -1.578 . . . . 0.0 111.531 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.22 111.16 1.71 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.87 1.714 . . . . 0.0 109.029 171.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.87 -20.7 6.35 Favored Glycine 0 N--CA 1.427 -1.961 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -172.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.25 154.47 30.97 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-O 120.973 0.416 . . . . 0.0 110.07 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.402 ' CG ' HD22 ' A' ' 125' ' ' LEU . 26.1 p90 -149.0 163.79 36.47 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.191 -176.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -146.04 146.92 31.14 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 171.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 23' ' ' TYR . 60.1 mt -120.36 137.61 53.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.537 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -143.25 -175.75 4.66 Favored 'General case' 0 C--N 1.28 -2.446 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.543 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -78.74 128.11 32.98 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 175.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.408 ' HB2' ' N ' ' A' ' 57' ' ' GLY . 21.0 t -85.3 103.64 14.42 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -177.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -77.25 74.8 3.81 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-O 122.23 1.014 . . . . 0.0 109.861 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 72.3 m -157.1 -47.2 0.07 Allowed 'General case' 0 C--N 1.271 -2.836 0 CA-C-N 113.406 -1.724 . . . . 0.0 108.873 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -131.06 147.96 52.68 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -82.3 135.81 35.15 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.58 33.11 48.64 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -130.56 131.73 45.18 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.417 0.627 . . . . 0.0 109.706 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -111.48 123.69 50.75 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.408 ' N ' ' HB2' ' A' ' 49' ' ' SER . . . -85.1 124.84 6.93 Favored Glycine 0 C--N 1.295 -1.722 0 C-N-CA 119.971 -1.109 . . . . 0.0 111.801 -175.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -104.45 119.23 38.5 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.57 126.2 54.74 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -121.7 123.84 42.84 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.528 ' HB2' ' HG ' ' A' ' 36' ' ' LEU . 22.4 tptm -88.41 120.77 30.09 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.793 -178.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 80' ' ' LEU . 34.3 m -113.83 157.52 14.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 173.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.25 -38.06 71.95 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 p -158.37 132.22 4.97 Favored Pre-proline 0 N--CA 1.444 -0.729 0 C-N-CA 125.495 1.518 . . . . 0.0 107.737 176.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.631 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 23.4 Cg_exo -62.15 -44.02 21.43 Favored 'Trans proline' 0 CA--C 1.565 2.055 0 C-N-CA 122.068 1.845 . . . . 0.0 113.182 175.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.631 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 73.6 Cg_endo -70.91 160.7 48.53 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.722 2.282 . . . . 0.0 110.307 173.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -65.16 -54.17 0.7 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.074 1.85 . . . . 0.0 112.344 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.8 p -110.56 -27.59 8.89 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.087 -175.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.478 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . 63.88 38.15 9.11 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 123.588 0.755 . . . . 0.0 109.501 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.459 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 34.5 tt0 -54.16 -51.56 76.38 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.959 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.459 ' HD3' ' HB3' ' A' ' 70' ' ' GLN . 2.4 Cg_endo -89.73 101.96 0.33 Allowed 'Trans proline' 0 N--CA 1.436 -1.903 0 C-N-CA 121.611 1.54 . . . . 0.0 111.158 175.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 47.4 t-105 -96.44 144.49 26.51 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -139.59 -41.44 0.45 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.147 0.499 . . . . 0.0 110.668 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.83 77.95 0.03 OUTLIER Glycine 0 CA--C 1.476 -2.379 0 N-CA-C 108.449 -1.861 . . . . 0.0 108.449 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -123.47 101.92 36.76 Favored Pre-proline 0 C--N 1.294 -1.824 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -173.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -88.78 -175.66 1.27 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.502 2.135 . . . . 0.0 114.245 -175.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.433 HG21 ' HB2' ' A' ' 37' ' ' LYS . 9.7 p -62.01 -23.85 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 115.077 -0.965 . . . . 0.0 113.306 -175.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.15 -23.92 67.66 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.681 0.277 . . . . 0.0 111.437 176.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.416 ' HG2' ' HG2' ' A' ' 65' ' ' PRO . 8.3 tt0 -92.04 -30.07 16.24 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 178.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.491 ' O ' HG22 ' A' ' 62' ' ' VAL . 64.4 mt -66.41 -33.91 76.78 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.574 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 95.6 t -85.51 109.98 19.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 172.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -84.16 133.98 34.59 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -176.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.431 ' CD2' HH22 ' A' ' 47' ' ' ARG . 5.6 m80 -113.45 122.76 48.29 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -132.53 154.96 49.46 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 176.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -125.5 137.02 53.94 Favored 'General case' 0 C--N 1.283 -2.299 0 C-N-CA 118.631 -1.227 . . . . 0.0 110.93 176.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 86.0 mt -92.57 117.08 35.16 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.81 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.135 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.422 ' OE1' ' HE3' ' A' ' 96' ' ' LYS . 50.8 mt-10 -109.43 144.69 37.31 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.41 ' HB ' HG23 ' A' ' 93' ' ' VAL . 3.4 t -118.62 131.96 56.18 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.33 -144.73 4.17 Favored Glycine 0 N--CA 1.429 -1.78 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.385 -178.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -61.87 -44.15 22.14 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.868 2.379 . . . . 0.0 113.864 -177.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.464 ' HD2' ' N ' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -75.91 -41.93 50.44 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.917 -176.428 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.6 -154.94 25.94 Favored Glycine 0 N--CA 1.425 -2.069 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.41 HG23 ' HB ' ' A' ' 88' ' ' THR . 8.8 p -111.94 126.09 69.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.41 ' HG2' ' OE1' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -162.56 178.12 8.84 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.755 -178.375 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 58.8 mt -88.12 143.92 10.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 C-N-CA 123.598 0.759 . . . . 0.0 112.693 -169.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.422 ' HE3' ' OE1' ' A' ' 87' ' ' GLU . 25.0 ttmt -95.46 136.89 35.27 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 170.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.83 55.0 1.69 Allowed Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -175.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.463 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 11.9 p -135.31 154.28 78.57 Favored Pre-proline 0 C--N 1.311 -1.103 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -167.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 98' ' ' CYS . 2.2 Cg_endo -84.9 -56.54 0.02 OUTLIER 'Trans proline' 0 CA--C 1.558 1.69 0 C-N-CA 122.995 2.463 . . . . 0.0 112.633 173.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.0 m -149.88 131.54 14.94 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -177.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.41 ' OE1' ' HG2' ' A' ' 94' ' ' LYS . 43.9 mt-10 -140.46 140.08 21.98 Favored Pre-proline 0 C--N 1.297 -1.68 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.94 153.65 29.2 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.024 1.816 . . . . 0.0 107.694 166.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -92.98 112.32 24.24 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.46 -0.775 . . . . 0.0 110.797 -178.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.424 ' HE1' ' OE1' ' A' ' 113' ' ' GLN . 29.4 m-85 -89.0 157.43 18.37 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.11 -173.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -97.04 -27.67 9.25 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.556 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 53.8 m -141.69 157.29 45.24 Favored 'General case' 0 C--O 1.244 0.766 0 O-C-N 122.233 -0.569 . . . . 0.0 110.838 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.9 -35.12 72.51 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.449 0.7 . . . . 0.0 111.771 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.1 t -51.95 -31.21 27.95 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.85 0.86 . . . . 0.0 111.76 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.409 ' O ' ' HG3' ' A' ' 113' ' ' GLN . . . -73.7 -48.58 31.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 122.229 -0.295 . . . . 0.0 111.246 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 pp -67.7 -29.46 68.73 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.204 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 78.6 t -67.86 -48.65 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.32 176.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.5 p -68.51 -44.85 73.76 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.424 ' OE1' ' HE1' ' A' ' 104' ' ' PHE . 66.4 mt-30 -66.22 -41.53 89.95 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.718 -178.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.532 ' HA ' ' O ' ' A' ' 117' ' ' SER . 58.1 m80 -77.79 -9.94 59.29 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.7 t -76.05 -23.51 55.1 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 174.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 72.2 mt -99.94 -66.87 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.806 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.532 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 20.2 m -102.62 117.72 60.2 Favored Pre-proline 0 N--CA 1.433 -1.276 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.814 -175.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -82.35 88.96 1.22 Allowed 'Trans proline' 0 N--CA 1.439 -1.697 0 C-N-CA 121.882 1.721 . . . . 0.0 110.267 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 52.2 mt -88.63 -69.98 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.467 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.6 m -88.73 -6.73 57.23 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.117 0.484 . . . . 0.0 111.319 -178.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.7 mt -118.61 145.12 36.8 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -176.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.26 -36.51 45.77 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.947 2.431 . . . . 0.0 113.613 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 60.8 m -123.65 159.88 28.37 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 85.1 m -73.34 139.63 46.16 Favored 'General case' 0 N--CA 1.434 -1.246 0 O-C-N 123.686 0.616 . . . . 0.0 109.722 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.402 HD22 ' CG ' ' A' ' 44' ' ' PHE . 84.8 mt -65.37 110.79 2.76 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.583 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -89.38 95.36 10.25 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 174.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 58.6 mt -65.52 126.28 91.24 Favored Pre-proline 0 C--N 1.302 -1.484 0 CA-C-N 113.966 -1.47 . . . . 0.0 108.997 -178.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.11 -63.31 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.861 1.707 . . . . 0.0 110.223 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 34.5 t 67.12 -44.74 0.46 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.056 1.342 . . . . 0.0 112.666 177.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -113.17 -166.21 1.06 Allowed 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 123.932 0.893 . . . . 0.0 109.988 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 C--N 1.295 -1.785 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.761 179.889 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ppp? . . . . . 0 CA--C 1.51 -0.581 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -149.3 -58.49 0.21 Allowed 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.7 m170 53.44 81.81 0.09 Allowed 'General case' 0 C--O 1.243 0.717 0 O-C-N 124.212 0.945 . . . . 0.0 112.205 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -66.1 -53.32 39.43 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.93 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -91.24 80.71 5.56 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.09 0.471 . . . . 0.0 111.234 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -97.49 71.01 2.29 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 174.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -176.24 173.24 2.19 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 113.162 -1.836 . . . . 0.0 106.156 -176.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.1 m -93.33 157.38 16.27 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.048 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.7 m -64.3 107.89 1.45 Allowed 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 121.31 0.576 . . . . 0.0 109.786 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.15 -25.06 1.26 Allowed Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -176.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 33.3 tp -89.66 27.16 1.57 Allowed 'General case' 0 CA--C 1.55 0.946 0 CA-C-O 122.289 1.042 . . . . 0.0 109.962 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.6 t -106.82 132.72 20.68 Favored Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -55.38 106.96 0.21 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 122.54 2.16 . . . . 0.0 110.489 175.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.581 ' HD2' ' O ' ' A' ' 17' ' ' ASP . 28.9 ttm180 -99.82 -23.85 14.85 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.287 -172.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.97 33.26 5.84 Favored Glycine 0 N--CA 1.434 -1.49 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.619 -176.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.6 m 52.94 43.62 31.43 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.115 0.966 . . . . 0.0 111.908 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.581 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 11.6 t70 -117.41 139.82 50.38 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.214 -176.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.1 p -133.84 18.23 3.85 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.868 0.842 . . . . 0.0 108.738 172.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.3 m -93.99 -33.31 13.49 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.627 -175.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -16.32 61.14 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.048 0.451 . . . . 0.0 111.672 -177.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -66.22 -40.06 90.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.506 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.416 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 11.8 p-90 -104.76 -5.67 21.04 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -94.11 113.16 25.06 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.961 -176.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.411 ' HB3' HD23 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -132.02 87.67 43.53 Favored Pre-proline 0 C--N 1.311 -1.109 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.5 178.622 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.14 -12.57 17.44 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.706 2.271 . . . . 0.0 115.254 -172.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -96.79 19.31 12.75 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.078 0.465 . . . . 0.0 111.27 -177.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.56 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 4.4 mm? -105.95 128.56 53.88 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.363 0.601 . . . . 0.0 112.25 -178.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.8 t -88.86 173.42 8.53 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 174.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.417 ' O ' HG13 ' A' ' 33' ' ' ILE . 11.0 ttm180 -48.96 -56.93 7.41 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.545 0.738 . . . . 0.0 112.36 -174.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -66.21 -37.3 85.23 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.999 -172.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -75.58 -32.08 60.22 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.269 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.57 89.96 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 175.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 29' ' ' ARG . 89.6 mt -59.99 -46.42 94.15 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.656 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.556 178.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' A' ' 37' ' ' LYS . . . -59.02 -44.97 91.78 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 41.2 mt -64.87 -47.34 78.21 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.706 0.765 . . . . 0.0 111.593 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.566 ' HG ' ' HB2' ' A' ' 61' ' ' LYS . 51.5 tp -70.52 -38.14 74.22 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.291 -1.322 . . . . 0.0 113.835 -173.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 14.3 ptmm? -56.75 -30.57 63.72 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -175.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -98.73 8.8 44.53 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.53 0.681 . . . . 0.0 111.077 -177.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . 0.261 45.3 mtmt -84.15 -85.64 0.13 Allowed 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 119.18 -1.008 . . . . 0.0 113.382 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -173.48 136.9 0.71 Allowed Pre-proline 0 C--N 1.289 -2.024 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -176.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -58.56 107.3 0.33 Allowed 'Trans proline' 0 C--O 1.246 0.906 0 C-N-CA 122.519 2.146 . . . . 0.0 110.704 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.45 -25.82 4.73 Favored Glycine 0 N--CA 1.426 -1.972 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -175.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.421 ' O ' HD11 ' A' ' 36' ' ' LEU . . . -76.06 155.19 35.05 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-O 121.093 0.473 . . . . 0.0 110.362 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -146.2 178.33 8.31 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.431 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -156.64 149.46 23.79 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 169.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.416 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 61.1 mt -113.69 124.07 69.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.56 ' HD2' ' O ' ' A' ' 27' ' ' LEU . 39.1 ptt85 -117.28 -177.25 3.18 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.398 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -98.92 136.66 38.6 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.9 t -109.81 152.98 25.03 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.376 0.608 . . . . 0.0 112.212 -172.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -117.62 92.52 3.86 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-O 121.964 0.888 . . . . 0.0 108.884 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.4 m -153.85 -50.92 0.1 Allowed 'General case' 0 C--N 1.258 -3.401 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 177.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -130.88 143.32 50.64 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 104.068 -2.567 . . . . 0.0 104.068 171.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -81.22 120.46 24.92 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.52 30.63 4.88 Favored Glycine 0 C--N 1.295 -1.708 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -171.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -119.29 145.4 46.15 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.491 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 85.1 m-85 -115.55 143.06 45.88 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.31 123.03 7.67 Favored Glycine 0 C--N 1.285 -2.281 0 C-N-CA 119.995 -1.098 . . . . 0.0 110.432 -178.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -99.61 119.87 38.77 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -114.41 121.93 45.08 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 176.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.8 tt -123.05 123.86 41.82 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -176.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.566 ' HB2' ' HG ' ' A' ' 36' ' ' LEU . 22.1 tptm -90.25 113.44 25.27 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 80' ' ' LEU . 17.9 m -99.02 171.26 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.02 -56.57 4.54 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 176.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.411 ' HA ' HD12 ' A' ' 80' ' ' LEU . 9.4 p -158.67 132.45 4.96 Favored Pre-proline 0 C--N 1.309 -1.189 0 C-N-CA 125.294 1.437 . . . . 0.0 108.287 177.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.61 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 35.7 Cg_exo -59.73 -42.14 48.99 Favored 'Trans proline' 0 CA--C 1.577 2.65 0 C-N-CA 121.376 1.384 . . . . 0.0 111.545 171.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.61 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 95.3 Cg_endo -76.89 172.25 16.53 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 122.991 2.46 . . . . 0.0 110.153 170.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.62 -44.91 43.57 Favored 'Trans proline' 0 C--N 1.362 1.241 0 C-N-CA 122.873 2.382 . . . . 0.0 112.633 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.5 m -143.49 -15.3 0.65 Allowed 'General case' 0 C--O 1.247 0.968 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.344 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.478 ' HB2' ' CG ' ' A' ' 66' ' ' PRO . . . 58.38 43.63 19.55 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 123.884 0.873 . . . . 0.0 108.688 -174.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -57.68 -48.23 97.57 Favored Pre-proline 0 N--CA 1.447 -0.606 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.819 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -76.41 87.6 1.43 Allowed 'Trans proline' 0 C--N 1.371 1.734 0 CA-C-N 120.495 1.212 . . . . 0.0 109.746 171.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 31.4 t-105 -81.78 141.52 33.43 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.674 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -122.9 -33.11 3.41 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.306 -0.958 . . . . 0.0 112.102 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.03 68.12 0.02 OUTLIER Glycine 0 CA--C 1.466 -2.976 0 N-CA-C 106.097 -2.801 . . . . 0.0 106.097 -176.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -104.4 110.9 64.94 Favored Pre-proline 0 C--N 1.284 -2.24 0 CA-C-N 113.381 -1.409 . . . . 0.0 111.215 -168.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -73.84 159.83 44.5 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.12 1.88 . . . . 0.0 111.437 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.456 ' HA ' HD23 ' A' ' 80' ' ' LEU . 8.6 p -62.99 -20.78 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.462 0.648 . . . . 0.0 110.676 -178.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -67.75 -13.32 62.02 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 124.065 0.946 . . . . 0.0 111.396 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -87.67 -38.36 15.93 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.47 ' O ' HG22 ' A' ' 62' ' ' VAL . 2.7 mm? -73.15 -27.57 61.74 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.866 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.501 HG13 HD23 ' A' ' 36' ' ' LEU . 69.2 t -86.18 110.08 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 171.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -91.78 134.27 34.89 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.408 -0.814 . . . . 0.0 108.853 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -114.26 122.5 46.93 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.298 0.57 . . . . 0.0 110.579 178.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -129.75 160.17 34.25 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -123.14 150.49 43.21 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.657 -1.217 . . . . 0.0 111.927 174.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.491 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 81.6 mt -108.81 131.1 60.41 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.792 0 CA-C-N 114.068 -1.424 . . . . 0.0 107.615 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -115.54 137.47 52.03 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 1.7 t -110.81 118.72 36.91 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 171.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -135.52 -148.09 5.57 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.85 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -71.25 -34.1 10.42 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 122.56 2.173 . . . . 0.0 113.875 -177.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -75.72 -26.49 57.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.129 0.49 . . . . 0.0 111.034 178.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 139.04 -153.52 22.82 Favored Glycine 0 N--CA 1.425 -2.087 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 88' ' ' THR . 13.9 p -112.04 130.87 64.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.23 170.01 23.22 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.425 ' HB ' ' SG ' ' A' ' 98' ' ' CYS . 64.1 mt -81.16 140.46 16.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -52.39 -53.05 49.95 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 123.601 0.761 . . . . 0.0 109.926 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.65 23.79 5.47 Favored Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 115.086 -0.961 . . . . 0.0 114.666 -176.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.425 ' SG ' ' HB ' ' A' ' 95' ' ' ILE . 31.1 p -116.02 103.09 53.71 Favored Pre-proline 0 N--CA 1.435 -1.2 0 CA-C-N 118.315 1.057 . . . . 0.0 110.551 174.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -100.6 28.47 0.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.124 2.549 . . . . 0.0 110.053 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.3 p -75.54 -78.71 0.11 Allowed 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.438 -176.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -166.68 -59.07 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -79.12 126.23 6.92 Favored 'Trans proline' 0 N--CA 1.44 -1.668 0 N-CA-C 115.813 1.428 . . . . 0.0 115.813 -165.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -97.72 121.03 39.15 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 168.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.556 ' CD2' ' HB3' ' A' ' 110' ' ' LEU . 60.0 m-85 -94.46 166.29 12.13 Favored 'General case' 0 C--N 1.289 -2.024 0 O-C-N 123.395 0.434 . . . . 0.0 111.177 -170.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.22 -36.78 6.93 Favored Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 121.108 -0.568 . . . . 0.0 111.991 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.9 m -140.98 169.41 17.68 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 122.497 -0.414 . . . . 0.0 109.943 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.471 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 94.8 mt -62.36 -40.05 95.17 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.107 0.563 . . . . 0.0 112.198 -176.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.0 t -52.53 -40.46 62.52 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.218 0.607 . . . . 0.0 112.037 -178.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.58 96.41 Favored 'General case' 0 C--O 1.247 0.954 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.556 ' HB3' ' CD2' ' A' ' 104' ' ' PHE . 4.4 pp -72.55 -28.73 63.01 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 120.912 0.387 . . . . 0.0 110.919 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 40.6 t -63.78 -54.59 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.132 177.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 45.9 m -65.28 -36.67 84.83 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.502 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -57.77 -48.18 80.39 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.434 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.474 ' HA ' ' O ' ' A' ' 117' ' ' SER . 71.6 m80 -87.53 -2.49 58.65 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.5 t -79.33 -31.15 43.03 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 67.4 mt -95.85 -58.96 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.424 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 21.6 m -111.57 105.3 56.71 Favored Pre-proline 0 N--CA 1.434 -1.247 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.835 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -75.29 85.35 1.57 Allowed 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 121.696 1.597 . . . . 0.0 110.076 175.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.0 mt -72.51 -73.85 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.908 -177.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.1 m -98.89 1.18 45.46 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.664 0.745 . . . . 0.0 111.318 -176.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.4 mt -105.29 137.6 19.3 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.78 -10.93 29.76 Favored 'Trans proline' 0 N--CA 1.485 1.023 0 C-N-CA 122.885 2.39 . . . . 0.0 113.701 -177.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 52.3 t -141.01 151.52 44.17 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 13.2 p -76.67 142.65 40.5 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 176.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 90.1 mt -73.02 120.17 18.27 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 123.741 0.651 . . . . 0.0 109.738 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -101.41 120.07 39.72 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mt -105.29 109.59 63.39 Favored Pre-proline 0 N--CA 1.429 -1.483 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -84.68 -5.11 9.95 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 C-N-CA 122.725 2.283 . . . . 0.0 113.08 -176.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.4 m 60.6 26.47 16.17 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 124.898 1.279 . . . . 0.0 110.117 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.4 149.43 26.13 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 114.211 -1.359 . . . . 0.0 107.804 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.3 t70 . . . . . 0 C--N 1.262 -3.21 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.263 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.6 ttm . . . . . 0 CA--C 1.52 -0.187 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -117.45 140.46 49.56 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -83.43 -21.39 32.96 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.272 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -77.19 130.15 36.9 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 174.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -82.05 -15.48 53.41 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.046 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.4 m80 62.47 77.44 0.33 Allowed 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.036 0.934 . . . . 0.0 109.415 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -84.72 170.25 13.45 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.141 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.5 m -76.11 15.98 0.49 Allowed 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 m -68.88 -34.21 75.05 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 173.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.34 42.58 2.12 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 49.2 tp -88.96 104.87 17.37 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.6 m -79.35 148.18 70.01 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -45.25 -59.53 1.13 Allowed 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 123.672 2.915 . . . . 0.0 112.338 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -134.43 -49.63 0.78 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.5 12.13 25.58 Favored Glycine 0 CA--C 1.494 -1.251 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.08 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.7 m -89.39 13.4 13.73 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.774 0.797 . . . . 0.0 110.762 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.481 ' O ' ' HD2' ' A' ' 20' ' ' LYS . 18.6 m-20 -112.48 139.76 47.79 Favored 'General case' 0 CA--C 1.478 -1.819 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.1 p -83.1 15.29 2.89 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 122.417 1.103 . . . . 0.0 111.827 -175.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 36.2 t -80.06 -21.56 43.26 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.27 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.481 ' HD2' ' O ' ' A' ' 17' ' ' ASP . 0.1 OUTLIER -68.95 -4.55 17.1 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -173.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -86.19 -12.09 50.72 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 122.114 -0.366 . . . . 0.0 110.78 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.444 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 53.3 p-90 -142.48 -28.95 0.58 Allowed 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -175.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.435 ' HB2' ' CE3' ' A' ' 22' ' ' TRP . 55.4 t80 -92.46 114.26 26.76 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.331 0.586 . . . . 0.0 112.535 -173.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.9 96.56 2.92 Favored Pre-proline 0 C--N 1.306 -1.314 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.816 172.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.95 3.78 6.7 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 123.26 2.64 . . . . 0.0 114.227 -173.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -85.11 -14.66 46.42 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.701 0.762 . . . . 0.0 109.504 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.3 tp -89.2 134.86 33.87 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.367 -169.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.8 t -92.27 177.5 6.13 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-O 120.875 0.369 . . . . 0.0 110.015 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.401 ' HA ' ' CZ ' ' A' ' 47' ' ' ARG . 17.1 ttm180 -54.48 -56.11 22.13 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 124.506 1.122 . . . . 0.0 113.4 -172.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -65.31 -40.59 93.97 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.386 0.612 . . . . 0.0 111.1 -174.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -65.45 -35.83 82.1 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.162 -177.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.33 -40.07 96.28 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.376 178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 73.4 mt -67.95 -41.23 84.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.197 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.11 -31.61 70.21 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.245 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.2 mt -79.81 -39.83 29.92 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.396 0.617 . . . . 0.0 111.707 175.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.9 tp -75.6 -28.74 59.0 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.065 -173.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.2 ptmm? -64.05 -15.07 58.69 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.31 0.576 . . . . 0.0 111.385 178.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -95.5 -13.63 24.36 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.316 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -99.27 174.32 6.36 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.919 0.39 . . . . 0.0 111.457 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -92.94 158.74 37.11 Favored Pre-proline 0 C--N 1.304 -1.376 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.061 -173.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -59.61 120.81 8.85 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 122.472 2.114 . . . . 0.0 110.873 175.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.81 -14.52 10.55 Favored Glycine 0 C--N 1.298 -1.543 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -176.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.75 151.67 27.36 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.462 ' CG ' HD22 ' A' ' 125' ' ' LEU . 22.5 p90 -152.16 162.03 41.74 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -175.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -150.48 147.32 27.36 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 174.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.444 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 64.6 mt -118.96 127.29 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 CA-C-O 121.692 0.758 . . . . 0.0 109.673 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.41 HH22 ' CD2' ' A' ' 83' ' ' HIS . 26.5 ptt-85 -125.3 -173.96 2.94 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -92.27 135.06 34.31 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 174.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 70.2 m -83.64 99.16 10.03 Favored 'General case' 0 N--CA 1.426 -1.631 0 C-N-CA 120.221 -0.591 . . . . 0.0 109.407 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -74.15 69.5 1.52 Allowed 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 121.98 0.895 . . . . 0.0 109.794 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.3 m -157.63 -36.46 0.07 Allowed 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 113.352 -1.749 . . . . 0.0 108.412 -177.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -133.4 166.98 21.27 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -110.89 130.12 55.68 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.78 24.5 38.26 Favored Glycine 0 C--N 1.304 -1.205 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.418 ' HB1' HD23 ' A' ' 85' ' ' LEU . . . -134.17 122.44 22.83 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-O 121.673 0.749 . . . . 0.0 110.146 -178.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -96.66 155.91 16.57 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -118.19 120.72 4.82 Favored Glycine 0 C--N 1.273 -2.952 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.45 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.2 tp -98.45 121.7 40.72 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 124.296 0.644 . . . . 0.0 109.275 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.15 112.93 25.37 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.7 tp -108.78 129.54 55.38 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 123.528 0.518 . . . . 0.0 109.7 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -88.83 119.3 29.21 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.7 m -108.38 165.71 4.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.32 -58.73 5.2 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.516 HG21 ' H ' ' A' ' 69' ' ' ALA . 0.6 OUTLIER -164.64 145.47 6.41 Favored Pre-proline 0 C--N 1.314 -0.97 0 C-N-CA 123.545 0.738 . . . . 0.0 110.663 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.569 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 16.3 Cg_exo -63.05 -49.82 4.5 Favored 'Trans proline' 0 CA--C 1.571 2.344 0 C-N-CA 121.933 1.756 . . . . 0.0 109.44 168.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.569 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 15.9 Cg_endo -57.55 179.81 0.13 Allowed 'Trans proline' 0 C--N 1.392 2.831 0 C-N-CA 122.825 2.35 . . . . 0.0 110.841 162.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -71.82 -47.46 0.46 Allowed 'Trans proline' 0 C--N 1.357 1.001 0 N-CA-C 108.072 -1.549 . . . . 0.0 108.072 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 71.5 m -160.79 111.68 1.81 Allowed 'General case' 0 N--CA 1.407 -2.608 0 N-CA-C 103.442 -2.799 . . . . 0.0 103.442 171.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.516 ' H ' HG21 ' A' ' 64' ' ' THR . . . -58.41 76.15 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 124.031 0.932 . . . . 0.0 113.085 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.467 ' H ' ' HD2' ' A' ' 71' ' ' PRO . 8.1 tt0 -87.82 -47.43 0.47 Allowed Pre-proline 0 C--N 1.286 -2.156 0 CA-C-N 114.578 -1.192 . . . . 0.0 107.892 172.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.467 ' HD2' ' H ' ' A' ' 70' ' ' GLN . 20.2 Cg_endo -65.51 109.19 1.35 Allowed 'Trans proline' 0 C--N 1.377 2.05 0 N-CA-C 108.654 -1.325 . . . . 0.0 108.654 165.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -81.83 137.32 35.29 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.981 -175.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -126.17 -36.75 2.3 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.763 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 167.73 -48.34 0.24 Allowed Glycine 0 CA--C 1.467 -2.93 0 N-CA-C 107.335 -2.306 . . . . 0.0 107.335 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 39.49 78.38 0.37 Allowed Pre-proline 0 C--N 1.316 -0.87 0 C-N-CA 126.817 2.047 . . . . 0.0 114.647 168.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -75.38 163.2 34.95 Favored 'Trans proline' 0 C--O 1.242 0.701 0 C-N-CA 122.251 1.967 . . . . 0.0 111.518 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -67.11 -30.29 48.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 120.985 0.421 . . . . 0.0 111.182 -178.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -70.71 -18.77 62.8 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.202 0.525 . . . . 0.0 110.473 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -79.09 -22.77 44.76 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.6 mt -89.35 5.69 43.92 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.962 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.8 t -117.85 141.47 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -109.45 137.39 47.37 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.41 ' CD2' HH22 ' A' ' 47' ' ' ARG . 26.8 m80 -117.7 122.77 44.4 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 121.439 0.638 . . . . 0.0 111.669 178.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -135.57 143.38 45.62 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 177.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.418 HD23 ' HB1' ' A' ' 55' ' ' ALA . 3.9 mp -96.42 162.61 13.41 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.263 -1.375 . . . . 0.0 108.726 174.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 80.2 mt -125.13 110.83 25.69 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.014 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 174.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.462 ' OE1' ' HD3' ' A' ' 96' ' ' LYS . 30.1 mt-10 -99.72 148.93 23.84 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -175.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.565 ' HB ' HG23 ' A' ' 93' ' ' VAL . 5.3 t -135.56 141.86 45.25 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -149.74 -155.45 6.8 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.35 -27.22 84.45 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.17 2.58 . . . . 0.0 113.876 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.72 -48.68 16.1 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 120.739 0.305 . . . . 0.0 111.689 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.63 -144.12 8.99 Favored Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.565 HG23 ' HB ' ' A' ' 88' ' ' THR . 12.2 p -123.78 142.49 40.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.64 157.48 31.96 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.155 0.182 . . . . 0.0 111.214 -171.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 58.0 mt -81.56 136.8 22.35 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 CA-C-O 121.207 0.527 . . . . 0.0 110.891 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.462 ' HD3' ' OE1' ' A' ' 87' ' ' GLU . 43.5 tptt -83.38 135.2 34.79 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 124.492 1.117 . . . . 0.0 111.172 -176.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.68 34.55 13.31 Favored Glycine 0 CA--C 1.499 -0.94 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.118 176.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.6 ' SG ' ' HB3' ' A' ' 100' ' ' SER . 47.0 t -142.26 143.15 26.26 Favored Pre-proline 0 N--CA 1.425 -1.68 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -87.36 10.34 3.57 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 123.318 2.678 . . . . 0.0 110.64 177.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.6 ' HB3' ' SG ' ' A' ' 98' ' ' CYS . 40.5 t -125.47 -164.63 1.32 Allowed 'General case' 0 N--CA 1.393 -3.306 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 -178.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 68.4 100.53 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.794 0 C-N-CA 125.674 1.59 . . . . 0.0 112.295 -179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.94 -162.99 0.15 Allowed 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 122.968 2.445 . . . . 0.0 111.654 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -94.33 96.53 9.61 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -78.32 161.22 27.37 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -76.36 -51.57 6.62 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.524 178.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 39.0 m -137.68 166.7 23.31 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.6 mp -58.72 -36.28 74.04 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 123.166 0.587 . . . . 0.0 110.98 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.1 m -51.21 -37.74 48.45 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.232 1.013 . . . . 0.0 111.482 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.14 -50.08 65.21 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.196 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.457 HD12 ' N ' ' A' ' 111' ' ' VAL . 4.1 pp -68.21 -35.06 77.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.879 0.371 . . . . 0.0 110.592 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.457 ' N ' HD12 ' A' ' 110' ' ' LEU . 47.9 t -58.31 -50.79 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.683 176.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 45.7 p -69.42 -22.78 63.66 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.409 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -88.79 -39.55 13.82 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.928 0.394 . . . . 0.0 111.405 -174.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -75.47 -0.84 21.51 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.7 m -74.56 -28.49 60.96 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 170.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 68.8 mt -97.95 -49.03 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.217 -178.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.9 m -121.71 99.83 44.38 Favored Pre-proline 0 N--CA 1.44 -0.959 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.174 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -81.47 100.89 1.17 Allowed 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.144 1.896 . . . . 0.0 109.727 174.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 65.0 mt -90.29 -73.8 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.135 -174.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.549 ' HB3' ' SG ' ' A' ' 98' ' ' CYS . 2.7 p -77.74 -27.41 50.45 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 122.038 0.923 . . . . 0.0 110.094 177.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.5 mt -83.12 129.68 60.12 Favored Pre-proline 0 N--CA 1.427 -1.587 0 CA-C-N 114.144 -1.389 . . . . 0.0 109.237 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -75.78 -4.33 15.06 Favored 'Trans proline' 0 N--CA 1.485 1.021 0 C-N-CA 122.893 2.395 . . . . 0.0 112.702 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 82.9 m -143.61 152.59 41.57 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.449 ' SG ' ' HD3' ' A' ' 126' ' ' ARG . 21.5 p -82.07 148.63 28.48 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.952 0.406 . . . . 0.0 111.487 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.462 HD22 ' CG ' ' A' ' 44' ' ' PHE . 86.7 mt -74.19 117.42 15.98 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.449 ' HD3' ' SG ' ' A' ' 124' ' ' CYS . 24.2 mmm180 -104.41 109.73 21.71 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.241 0.543 . . . . 0.0 110.221 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.466 HG22 ' H ' ' A' ' 129' ' ' SER . 3.4 mp -96.03 126.66 43.69 Favored Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -64.09 -29.79 65.65 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.408 2.072 . . . . 0.0 111.485 177.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.466 ' H ' HG22 ' A' ' 127' ' ' ILE . 19.8 t 78.1 -36.29 0.21 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.678 1.591 . . . . 0.0 111.681 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -133.33 -171.43 2.69 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 120.947 0.404 . . . . 0.0 110.206 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 . . . . . 0 C--N 1.297 -1.683 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -179.827 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptm . . . . . 0 C--O 1.235 0.318 0 CA-C-O 120.507 0.194 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -118.88 0.97 11.48 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 174.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -139.53 -168.75 2.54 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.9 m80 64.36 35.71 9.56 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 122.068 0.937 . . . . 0.0 109.226 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -66.11 133.66 51.17 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.559 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.451 ' HA ' ' O ' ' A' ' 9' ' ' SER . 57.6 m-70 68.71 19.0 8.63 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.207 1.003 . . . . 0.0 112.148 178.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -59.14 -31.03 68.59 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.407 0.622 . . . . 0.0 111.635 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.5 t -169.15 -39.16 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 6' ' ' HIS . 5.3 m -77.36 93.04 3.99 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 170.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.5 -97.23 0.21 Allowed Glycine 0 N--CA 1.428 -1.857 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -89.05 113.54 24.67 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.842 0.353 . . . . 0.0 111.617 -176.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -103.96 127.4 29.4 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 175.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -86.78 21.18 1.1 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.112 2.542 . . . . 0.0 113.215 -177.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -79.75 127.25 31.97 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.0 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.73 34.46 6.57 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -177.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.57 ' HA ' ' OG ' ' A' ' 108' ' ' SER . 45.4 p -87.27 17.16 4.54 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 121.906 0.86 . . . . 0.0 110.895 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -84.44 -168.83 2.33 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.675 -176.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.335 80.5 p 76.54 -4.71 2.31 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 127.483 2.313 . . . . 0.0 114.967 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.491 ' O ' ' HB3' ' A' ' 23' ' ' TYR . 20.0 m -62.66 -31.84 72.79 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.671 0.748 . . . . 0.0 109.483 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -10.64 33.64 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 177.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -98.38 -62.26 1.27 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.804 0.335 . . . . 0.0 111.093 176.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 24.8 p-90 -94.05 -8.65 39.17 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -171.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.491 ' HB3' ' O ' ' A' ' 19' ' ' SER . 70.2 t80 -100.5 120.0 39.35 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.865 -175.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -131.23 88.94 43.07 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 175.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.83 -31.82 67.55 Favored 'Trans proline' 0 N--CA 1.482 0.834 0 C-N-CA 122.482 2.121 . . . . 0.0 113.347 -172.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -84.74 -0.32 53.26 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 124.107 0.963 . . . . 0.0 112.776 -174.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.462 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 14.4 tp -85.76 152.37 23.1 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -176.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 t -110.28 174.86 5.66 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 120.628 0.251 . . . . 0.0 110.432 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 -56.91 -50.36 72.78 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -174.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -64.77 -32.01 73.5 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.126 0.488 . . . . 0.0 111.326 -175.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -74.83 -39.36 61.67 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.326 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.49 -43.44 93.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.395 0.617 . . . . 0.0 109.948 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 78.1 mt -65.62 -39.7 85.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.966 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.455 ' O ' ' HG2' ' A' ' 37' ' ' LYS . . . -57.71 -49.44 76.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.277 178.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.8 -36.29 82.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.075 0.464 . . . . 0.0 111.336 178.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.419 ' CD1' HD22 ' A' ' 45' ' ' LEU . 6.6 mp -81.2 -14.81 57.17 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -177.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.489 ' HB3' HG21 ' A' ' 77' ' ' VAL . 17.8 ptpt -80.28 -15.05 57.83 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.673 177.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -100.23 -3.72 30.92 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.187 176.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -101.38 174.63 5.89 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -176.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -91.53 144.65 29.91 Favored Pre-proline 0 C--N 1.305 -1.343 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.14 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.02 118.44 4.98 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.083 2.522 . . . . 0.0 112.094 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.37 -11.71 9.09 Favored Glycine 0 N--CA 1.435 -1.41 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -174.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.65 147.87 37.24 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.405 ' HB2' HD11 ' A' ' 58' ' ' LEU . 36.1 p90 -150.68 171.5 17.06 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -176.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.419 HD22 ' CD1' ' A' ' 36' ' ' LEU . 1.5 pt? -161.56 154.52 20.75 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 172.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.3 mt -121.48 134.92 63.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 121.061 0.457 . . . . 0.0 110.565 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.533 ' HG3' ' O ' ' A' ' 48' ' ' ASP . 23.8 ptt-85 -127.39 -173.69 2.97 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 177.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.533 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 13.1 t70 -82.4 150.75 26.94 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 174.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 70.8 m -66.25 -26.75 67.5 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 119.307 0.958 . . . . 0.0 112.12 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 35.4 t60 69.73 -46.75 0.59 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 124.909 1.284 . . . . 0.0 111.873 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.2 t -71.67 -33.5 68.91 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 123.775 0.83 . . . . 0.0 110.35 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -122.36 154.36 37.77 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -177.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -102.39 126.73 49.51 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 123.812 0.695 . . . . 0.0 110.41 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.13 22.67 34.57 Favored Glycine 0 C--N 1.308 -1.024 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -178.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.62 144.02 47.65 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 120.898 0.38 . . . . 0.0 110.162 -177.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -112.64 139.0 48.62 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -101.96 111.63 4.12 Favored Glycine 0 C--N 1.294 -1.797 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.378 -177.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.405 HD11 ' HB2' ' A' ' 44' ' ' PHE . 39.3 tp -91.31 130.49 37.17 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 123.88 0.872 . . . . 0.0 109.306 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -114.44 128.71 56.48 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 175.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.2 tp -122.27 129.54 52.3 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 123.553 0.533 . . . . 0.0 110.546 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -93.1 114.28 26.77 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 28.4 m -106.82 164.14 4.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 173.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.07 -59.24 3.02 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.9 p -149.22 141.73 15.36 Favored Pre-proline 0 N--CA 1.421 -1.877 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.629 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 39.1 Cg_exo -59.99 -44.71 28.1 Favored 'Trans proline' 0 CA--C 1.57 2.279 0 C-N-CA 121.675 1.583 . . . . 0.0 111.659 174.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.629 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 85.6 Cg_endo -75.78 149.72 33.98 Favored 'Trans proline' 0 C--N 1.381 2.272 0 C-N-CA 122.416 2.077 . . . . 0.0 109.559 171.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.18 -48.11 6.89 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.148 1.899 . . . . 0.0 112.629 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.9 p -116.71 -9.1 11.34 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.855 0.36 . . . . 0.0 111.363 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 59.4 44.05 15.64 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.562 -178.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -50.38 -52.33 55.8 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 113.902 -1.499 . . . . 0.0 110.787 175.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.45 93.43 0.98 Allowed 'Trans proline' 0 N--CA 1.441 -1.568 0 CA-C-N 120.308 1.146 . . . . 0.0 109.352 169.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 53.0 t-105 -86.55 137.16 32.73 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.562 -175.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -124.7 -42.12 2.09 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.206 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.24 56.39 1.0 Allowed Glycine 0 C--N 1.299 -1.524 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -89.94 139.93 27.57 Favored Pre-proline 0 C--N 1.306 -1.289 0 CA-C-N 115.091 -0.555 . . . . 0.0 109.855 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.19 167.93 26.06 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.893 2.395 . . . . 0.0 113.829 -175.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.489 HG21 ' HB3' ' A' ' 37' ' ' LYS . 2.3 p -59.53 -32.74 49.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.336 176.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 -65.1 -18.68 65.5 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.073 0.463 . . . . 0.0 110.881 177.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -92.4 -36.05 13.35 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.95 -35.8 82.33 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.156 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 89.6 t -70.71 113.04 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.516 ' NE ' ' HA ' ' A' ' 82' ' ' ARG . 1.7 mmp_? -87.25 144.6 26.74 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.795 -176.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -125.84 124.47 40.98 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 120.974 0.416 . . . . 0.0 110.352 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -132.13 132.86 43.63 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.482 ' HG ' ' HB2' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -97.06 140.59 31.35 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.972 -1.091 . . . . 0.0 112.229 177.029 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 77.4 mt -107.61 120.68 59.36 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.419 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -105.78 138.01 42.7 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -175.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.435 ' HB ' HG23 ' A' ' 93' ' ' VAL . 3.9 t -116.36 124.75 50.84 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.65 -162.66 9.52 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 -178.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.55 -31.82 49.9 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.205 2.603 . . . . 0.0 112.631 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -71.04 -21.88 62.21 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 175.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 132.63 -159.47 23.45 Favored Glycine 0 CA--C 1.488 -1.601 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.435 HG23 ' HB ' ' A' ' 88' ' ' THR . 14.6 p -104.01 127.18 58.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.711 ' HG2' ' CD2' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -149.73 167.03 27.63 Favored 'General case' 0 C--O 1.201 -1.493 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.24 -171.665 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 66.6 mt -93.2 143.88 10.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.405 -176.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.482 ' HB2' ' HG ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -44.69 -46.56 10.37 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.675 1.59 . . . . 0.0 112.124 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -127.01 63.89 0.59 Allowed Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.44 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 11.1 p -85.05 122.85 74.1 Favored Pre-proline 0 C--N 1.304 -1.391 0 CA-C-O 120.678 0.275 . . . . 0.0 110.391 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -80.29 10.42 3.24 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 122.752 2.301 . . . . 0.0 113.365 -176.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.8 m -154.82 -162.46 1.38 Allowed 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.436 ' HG3' ' CD1' ' A' ' 103' ' ' TYR . 37.2 tt0 -109.88 106.37 58.19 Favored Pre-proline 0 C--N 1.294 -1.816 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -175.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -89.42 -80.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.653 0 C-N-CA 122.066 1.844 . . . . 0.0 112.149 171.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.711 ' CD2' ' HG2' ' A' ' 94' ' ' LYS . 51.8 m-85 43.49 79.36 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 127.381 2.272 . . . . 0.0 112.805 178.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.411 ' O ' HG12 ' A' ' 93' ' ' VAL . 98.0 m-85 -107.08 -178.36 3.62 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.279 -177.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -86.35 -36.9 9.3 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.009 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.8 m -132.9 158.51 42.41 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 122.456 -0.438 . . . . 0.0 110.487 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 75.1 mt -55.21 -46.78 75.93 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 123.13 0.572 . . . . 0.0 111.463 178.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.57 ' OG ' ' HA ' ' A' ' 16' ' ' SER . 24.3 p -54.6 -31.21 56.6 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 123.242 0.617 . . . . 0.0 112.401 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.18 -39.14 82.58 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.113 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 111' ' ' VAL . 3.8 pp -80.31 -29.81 38.13 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.687 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.437 ' N ' HD12 ' A' ' 110' ' ' LEU . 40.6 t -63.41 -54.48 32.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.629 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.7 m -68.64 -20.61 64.47 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.303 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -78.26 -40.82 35.94 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.646 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.515 ' HA ' ' O ' ' A' ' 117' ' ' SER . 66.8 m80 -80.18 3.02 21.99 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -174.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 125' ' ' LEU . 10.7 p -86.15 -39.88 16.22 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 172.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.5 mt -84.01 -48.14 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.271 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 19.6 m -121.86 93.06 48.78 Favored Pre-proline 0 N--CA 1.425 -1.706 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.835 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.57 73.43 5.6 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.855 2.37 . . . . 0.0 110.873 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 67.5 mt -68.8 -60.8 2.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.13 -178.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.3 m -83.72 -49.96 8.62 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.551 -175.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -73.4 139.96 78.84 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.867 -177.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.88 -18.39 46.94 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 123.09 2.527 . . . . 0.0 111.994 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 43.6 t -127.94 154.75 45.21 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 4.0 p -71.61 145.01 49.26 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 177.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.401 ' O ' ' HB3' ' A' ' 115' ' ' SER . 74.2 mt -79.41 106.31 11.35 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -90.38 103.78 16.42 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.336 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.547 ' H ' HD12 ' A' ' 127' ' ' ILE . 1.8 mp -90.38 128.12 50.3 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -73.91 -29.59 10.08 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 121.435 1.423 . . . . 0.0 110.21 174.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.451 ' H ' HG22 ' A' ' 127' ' ' ILE . 4.4 m -80.96 -1.53 44.07 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 125.203 1.401 . . . . 0.0 113.243 -175.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.444 ' HB3' ' HB ' ' A' ' 127' ' ' ILE . 17.6 tppt? -140.19 145.86 37.99 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 . . . . . 0 C--N 1.29 -2.01 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.936 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.34 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -90.37 106.47 18.52 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.059 0.457 . . . . 0.0 111.776 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -96.32 -49.65 5.11 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -119.22 -50.24 2.36 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.069 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.484 ' CE1' ' HB2' ' A' ' 8' ' ' SER . 18.9 t60 69.05 88.97 0.11 Allowed 'General case' 0 C--O 1.242 0.686 0 O-C-N 124.486 1.116 . . . . 0.0 109.615 -175.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -110.6 114.4 27.76 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.917 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 48.83 72.76 0.26 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.259 1.423 . . . . 0.0 111.95 175.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.484 ' HB2' ' CE1' ' A' ' 5' ' ' HIS . 19.9 m -134.59 77.3 1.68 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.687 0.756 . . . . 0.0 110.03 178.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.6 t -166.4 156.3 11.85 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.61 104.46 3.15 Favored Glycine 0 N--CA 1.423 -2.173 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.94 114.85 18.22 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 176.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.2 t -115.69 100.22 53.32 Favored Pre-proline 0 C--N 1.294 -1.84 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -176.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.85 85.29 1.65 Allowed 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.194 1.93 . . . . 0.0 109.871 177.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 73.33 -52.39 0.7 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.508 1.523 . . . . 0.0 111.254 -176.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 177.03 -97.76 0.11 Allowed Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 107.907 -2.077 . . . . 0.0 107.907 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.1 t -135.46 24.67 3.46 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 173.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.93 24.0 0.79 Allowed 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 112.527 -2.124 . . . . 0.0 109.296 -177.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.553 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 2.0 p -76.07 -10.65 59.59 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -174.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.5 m -74.32 -36.17 63.68 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.313 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.77 -5.86 40.81 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.553 ' CD2' ' HA ' ' A' ' 18' ' ' THR . 25.6 m-85 -81.08 -24.12 38.0 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.079 175.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.476 ' CZ3' HD12 ' A' ' 46' ' ' ILE . 54.0 p-90 -116.6 -32.28 5.24 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -93.16 114.54 27.07 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.217 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . 0.252 0.1 OUTLIER -155.24 98.28 2.37 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-O 121.711 0.767 . . . . 0.0 111.266 175.361 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -83.35 19.43 1.34 Allowed 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 124.047 3.165 . . . . 0.0 114.62 -173.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -99.43 -4.03 32.37 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.993 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.7 mp -92.99 140.96 28.92 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.817 0.818 . . . . 0.0 112.952 -177.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 m -90.05 177.26 6.5 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.043 -1.435 . . . . 0.0 107.707 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -50.49 -56.56 11.04 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.249 0.62 . . . . 0.0 110.635 177.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -65.86 -35.31 80.29 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.709 -175.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -66.94 -38.69 86.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.088 178.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.44 -42.07 99.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.577 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 82.9 mt -64.82 -45.83 93.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.107 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.421 ' HA ' ' CD ' ' A' ' 37' ' ' LYS . . . -59.83 -32.95 71.14 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.702 0.763 . . . . 0.0 111.83 178.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.14 -50.08 17.48 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 70.1 mt -71.09 -26.26 62.97 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -175.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.421 ' CD ' ' HA ' ' A' ' 34' ' ' ALA . 14.3 ptmm? -65.11 -24.49 67.44 Favored 'General case' 0 C--N 1.316 -0.883 0 O-C-N 121.908 -0.495 . . . . 0.0 110.567 178.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -84.37 -40.36 17.96 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.753 176.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.574 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -68.58 151.42 46.78 Favored 'General case' 0 C--O 1.248 1.015 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.222 -176.278 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -75.11 138.35 72.36 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.815 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -45.45 120.24 3.11 Favored 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 124.265 3.31 . . . . 0.0 114.121 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.87 -24.43 6.38 Favored Glycine 0 N--CA 1.434 -1.476 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -176.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.08 151.66 45.23 Favored 'General case' 0 C--O 1.249 1.031 0 CA-C-N 114.975 -0.613 . . . . 0.0 110.016 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.419 ' HZ ' HG13 ' A' ' 111' ' ' VAL . 23.6 p90 -153.6 170.93 19.63 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 -175.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -147.42 145.7 29.31 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 171.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.476 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 60.7 mt -111.56 123.33 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.067 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -124.1 179.91 4.68 Favored 'General case' 0 C--N 1.275 -2.66 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 177.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -84.98 154.02 22.4 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 175.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.6 t -81.82 133.87 35.37 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -90.95 -22.89 20.62 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 121.833 0.825 . . . . 0.0 108.98 177.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.7 m -72.53 -52.82 13.99 Favored 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 114.347 -1.297 . . . . 0.0 109.784 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -126.77 138.55 53.38 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.33 0.585 . . . . 0.0 111.348 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -88.77 138.03 31.78 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 176.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.22 11.67 58.29 Favored Glycine 0 C--N 1.305 -1.143 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -172.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -135.3 153.88 51.73 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-N 114.631 -0.784 . . . . 0.0 109.111 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.5 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 52.6 m-85 -115.83 171.58 7.68 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 176.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.18 133.13 8.87 Favored Glycine 0 C--N 1.282 -2.437 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -111.22 115.61 29.66 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.34 125.36 50.51 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.493 HD21 ' SG ' ' A' ' 123' ' ' CYS . 50.4 tp -124.08 129.83 51.53 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 123.395 0.435 . . . . 0.0 111.782 -173.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.562 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 22.3 tptm -91.77 114.24 26.72 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 174.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 80' ' ' LEU . 24.3 m -101.64 171.08 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 175.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.61 -55.6 6.62 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.44 ' HB ' ' HG2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -159.18 142.98 10.94 Favored Pre-proline 0 N--CA 1.421 -1.892 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.508 -178.277 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.595 ' HD2' ' HD2' ' A' ' 66' ' ' PRO . 16.8 Cg_exo -61.46 -50.27 5.97 Favored 'Trans proline' 0 CA--C 1.555 1.542 0 C-N-CA 122.208 1.939 . . . . 0.0 110.094 172.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.595 ' HD2' ' HD2' ' A' ' 65' ' ' PRO . 10.8 Cg_endo -54.76 136.03 69.88 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 122.105 1.87 . . . . 0.0 109.653 163.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.19 -11.55 21.14 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.64 2.227 . . . . 0.0 112.674 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.4 p -130.1 -37.28 1.48 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.912 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.437 ' HA ' ' HB2' ' A' ' 66' ' ' PRO . . . 72.9 23.04 2.9 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 125.096 1.358 . . . . 0.0 111.989 178.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -62.91 -49.05 83.73 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.598 173.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.14 105.87 1.27 Allowed 'Trans proline' 0 C--N 1.386 2.502 0 C-N-CA 121.047 1.165 . . . . 0.0 110.126 170.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 68.2 t-105 -96.1 149.06 22.03 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.78 -175.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -133.62 -36.71 0.95 Allowed 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.878 175.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.36 34.38 29.28 Favored Glycine 0 CA--C 1.503 -0.685 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.9 p30 -90.28 153.8 46.6 Favored Pre-proline 0 C--N 1.298 -1.642 0 CA-C-N 114.163 -1.019 . . . . 0.0 111.127 -177.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_exo -34.51 146.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.366 1.499 1 C-N-CA 125.99 4.46 . . . . 0.0 117.684 -175.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.1 p -70.24 -13.97 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.221 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -64.9 -16.05 62.77 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.809 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -92.02 -24.81 19.08 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 121.114 0.483 . . . . 0.0 109.781 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.483 HD23 ' HD3' ' A' ' 65' ' ' PRO . 79.1 mt -76.02 -26.06 56.3 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.013 0.911 . . . . 0.0 109.01 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.5 t -93.88 123.88 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 173.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.477 ' NE ' ' HA ' ' A' ' 82' ' ' ARG . 4.1 mmp_? -104.89 151.01 24.38 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -123.91 124.62 43.02 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.627 0.727 . . . . 0.0 111.772 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -128.13 170.38 13.02 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 pp -135.25 157.81 45.96 Favored 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.485 176.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.5 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 39.4 mt -111.34 123.68 67.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -173.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -102.77 129.55 49.46 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 123.733 0.813 . . . . 0.0 109.016 -176.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.512 ' HB ' HG23 ' A' ' 93' ' ' VAL . 2.6 t -116.77 132.76 56.61 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 120.928 0.394 . . . . 0.0 110.304 174.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.65 -159.82 8.34 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.56 -31.9 49.66 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.008 2.472 . . . . 0.0 113.713 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -80.57 -36.23 33.24 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.701 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 163.31 -163.15 35.38 Favored Glycine 0 N--CA 1.422 -2.238 0 C-N-CA 119.911 -1.138 . . . . 0.0 112.124 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.512 HG23 ' HB ' ' A' ' 88' ' ' THR . 14.0 p -116.11 126.75 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.283 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.561 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 0.0 OUTLIER -151.27 173.88 13.95 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 116.048 -0.523 . . . . 0.0 112.388 -177.249 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.45 ' HB ' ' OG ' ' A' ' 120' ' ' SER . 70.2 mt -97.61 141.81 15.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-O 121.74 0.781 . . . . 0.0 112.975 -171.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -65.74 132.58 49.1 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 125.122 1.369 . . . . 0.0 108.926 174.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.42 -9.59 38.6 Favored Glycine 0 C--N 1.312 -0.778 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.568 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 37.8 t -142.24 141.04 20.17 Favored Pre-proline 0 N--CA 1.422 -1.866 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.58 -40.38 47.47 Favored 'Trans proline' 0 C--O 1.244 0.805 0 C-N-CA 121.555 1.504 . . . . 0.0 109.385 176.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.561 ' OG ' ' HB2' ' A' ' 94' ' ' LYS 0.38 1.8 p 49.41 67.36 0.9 Allowed 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 123.443 1.592 . . . . 0.0 114.06 -177.17 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.505 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 41.8 mt-10 -49.63 -36.72 18.59 Favored Pre-proline 0 C--N 1.303 -1.446 0 CA-C-N 111.525 -2.579 . . . . 0.0 115.652 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 101' ' ' GLU . 7.3 Cg_endo -53.6 -33.11 67.4 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.134 1.889 . . . . 0.0 114.732 177.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 48.75 99.58 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 126.211 1.805 . . . . 0.0 111.982 -172.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -74.31 139.39 44.17 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.745 -176.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.03 -42.25 20.26 Favored Glycine 0 C--N 1.304 -1.223 0 C-N-CA 120.042 -1.075 . . . . 0.0 110.706 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.8 m -133.22 159.89 38.87 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.421 ' O ' ' HB3' ' A' ' 110' ' ' LEU . 96.1 mt -58.61 -31.67 68.29 Favored 'General case' 0 C--O 1.215 -0.711 0 C-N-CA 123.626 0.77 . . . . 0.0 112.045 -178.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.9 m -61.27 -32.12 71.94 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-O 120.846 0.355 . . . . 0.0 111.589 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.5 -31.82 62.32 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.562 0.696 . . . . 0.0 109.555 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.421 ' HB3' ' O ' ' A' ' 107' ' ' LEU . 3.7 tt -67.62 -45.37 75.62 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.537 -1.21 . . . . 0.0 109.354 176.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.446 HG21 ' CE2' ' A' ' 22' ' ' TRP . 73.2 t -71.13 -39.11 73.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.137 -0.938 . . . . 0.0 113.177 -177.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.7 t -68.97 -21.81 64.15 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.151 0.5 . . . . 0.0 110.997 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -107.11 177.96 4.7 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.398 -178.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.532 ' HA ' ' O ' ' A' ' 117' ' ' SER . 7.0 m-70 73.48 -10.43 1.05 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.969 0.908 . . . . 0.0 113.21 -177.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.0 m -73.26 -32.8 64.9 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 169.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 61.2 mt -88.24 -62.23 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.859 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.532 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 26.6 t -116.54 99.96 53.13 Favored Pre-proline 0 N--CA 1.434 -1.238 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.32 99.12 1.08 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.78 2.32 . . . . 0.0 110.812 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.434 ' HB ' ' CE1' ' A' ' 114' ' ' HIS . 67.6 mt -99.51 -51.32 10.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.225 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.45 ' OG ' ' HB ' ' A' ' 95' ' ' ILE . 34.7 t -80.89 -42.35 21.59 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.644 -177.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.425 HD12 HD22 ' A' ' 60' ' ' LEU . 1.8 mm? -89.83 144.11 31.14 Favored Pre-proline 0 N--CA 1.434 -1.25 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.294 -178.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -63.41 -32.21 71.79 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.987 2.458 . . . . 0.0 111.757 177.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.493 ' SG ' HD21 ' A' ' 60' ' ' LEU . 26.3 p -109.45 169.87 8.43 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 23.2 m -70.14 132.71 46.23 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 176.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 29.2 tp -82.37 131.98 35.22 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -136.39 128.14 29.07 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.455 ' H ' HD12 ' A' ' 127' ' ' ILE . 3.0 mp -66.24 125.14 89.73 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -61.29 -50.34 6.06 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.049 1.833 . . . . 0.0 111.299 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.495 ' HA ' ' CG ' ' A' ' 21' ' ' PHE . 65.6 p 56.18 13.21 1.14 Allowed 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.124 1.769 . . . . 0.0 114.403 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.493 ' HD3' ' C ' ' A' ' 130' ' ' LYS . 11.5 tmtt? -166.66 116.71 0.92 Allowed 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 . . . . . 0 C--N 1.301 -1.521 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 173.669 . . . . . . . . 0 0 . 1 stop_ save_